KR100581163B1 - A hybrid Bacillus thuringiensis toxin, a nucleic acid encoding the same and a method for controlling an insect with the same - Google Patents

A hybrid Bacillus thuringiensis toxin, a nucleic acid encoding the same and a method for controlling an insect with the same Download PDF

Info

Publication number
KR100581163B1
KR100581163B1 KR1020037002755A KR20037002755A KR100581163B1 KR 100581163 B1 KR100581163 B1 KR 100581163B1 KR 1020037002755 A KR1020037002755 A KR 1020037002755A KR 20037002755 A KR20037002755 A KR 20037002755A KR 100581163 B1 KR100581163 B1 KR 100581163B1
Authority
KR
South Korea
Prior art keywords
leu
ser
gly
glu
ile
Prior art date
Application number
KR1020037002755A
Other languages
Korean (ko)
Other versions
KR20030029858A (en
Inventor
나딘 바바라 카로찌
스콧 엠 라베
폴 제이 마일즈
그레고리 웨인 워렌
한 페트루스 테오도루스 데
Original Assignee
신젠타 파티서페이션즈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 신젠타 파티서페이션즈 아게 filed Critical 신젠타 파티서페이션즈 아게
Publication of KR20030029858A publication Critical patent/KR20030029858A/en
Application granted granted Critical
Publication of KR100581163B1 publication Critical patent/KR100581163B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20Bacteria; Substances produced thereby or obtained therefrom
    • A01N63/22Bacillus
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/44Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a nitrogen atom attached to the same carbon skeleton by a single or double bond, this nitrogen atom not being a member of a derivative or of a thio analogue of a carboxylic group, e.g. amino-carboxylic acids
    • A01N37/46N-acyl derivatives
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50Isolated enzymes; Isolated proteins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)
    • C07K14/325Bacillus thuringiensis crystal peptides, i.e. delta-endotoxins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8286Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146Genetically Modified [GMO] plants, e.g. transgenic plants

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

식물에서의 발현을 위해 최적화된 합성 뉴클레오타이드 서열은 독소 부분이 Cry1Ab의 도메인 I 및 II과 Cry1C의 도메인 III을 함유하는 다양한 형태의 하이브리드 바실러스 튜린지엔시스 델타-내독소 H04를 암호화한다. 당해 살충성 독소를 함유하는 조성물 및 제형은 곤충 해충을 방제할 수 있다. 추가로, 본 발명은 하이브리드 독소의 제조방법 및 당해 뉴클레오타이드 서열을 예를 들어 미생물에서 사용하여 해충을 방제하고 형질전환 식물에서 사용하여 곤충 내성을 부여하는 방법에 관한 것이다.Synthetic nucleotide sequences optimized for expression in plants encode various forms of hybrid Bacillus thuringiensis delta-endotoxin H04 in which the toxin moiety contains domains I and II of Cry1Ab and domain III of Cry1C. Compositions and formulations containing such pesticidal toxins can control insect pests. Further, the present invention relates to a method for producing a hybrid toxin and a method for controlling insect pests by using the nucleotide sequence in, for example, microorganisms and endowing insect resistance with transgenic plants.

하이브리드 바실러스 튜린지엔시스 독소, 형질전환, 키메라 유전자, 살충성 독소Hybrid Bacillus thuringiensis toxin, transformation, chimeric gene, insecticidal toxin

Description

하이브리드 바실러스 튜린지엔시스 독소, 이를 암호화하는 핵산 및 이를 사용한 해충의 방제방법{A hybrid Bacillus thuringiensis toxin, a nucleic acid encoding the same and a method for controlling an insect with the same}Hybrid Bacillus thuringiensis toxin, a nucleic acid encoding the same and a method for controlling an insect with the same}

본 발명은, 바실러스 튜린지엔시스(Bacillus thuringiensis) 살충성 결정 단백질로부터 유래된 살충성 독소, 발현하여 당해 독소를 생성하는 핵산 서열 및 당해 독소 및 상응하는 핵산 서열을 제조 및 사용하여 해충을 방제하는 방법에 관한 것이다.The present invention provides insecticidal toxins derived from Bacillus thuringiensis insecticidal determinant proteins, nucleic acid sequences that express and produce the toxins, and methods for preparing and using the toxins and corresponding nucleic acid sequences to control pests. It is about.

해충은 작물 손실의 주된 원인이다. 미국에서만, 다양한 곤충 속에 의한 감염으로 인해 매년 수조 달러가 손실되고 있다. 밭작물의 손실 이외에도, 해충은 야채 및 과일 재배자, 관상용 꽃 생산자에게 부담을 가하여 원예사 및 자택소유자에게도 손해를 입힌다. Pests are a major source of crop loss. In the United States alone, trillions of dollars are lost every year due to infections with various insects. In addition to the loss of field crops, pests also burden gardeners and homeowners by burdening vegetable and fruit growers and ornamental flower producers.

해충은 주로 곤충 성장의 억제, 곤충 영양공급이나 번식의 예방 또는 곤충의 사멸을 통해 활성인 화학 살충제를 집중 적용함으로써 방제된다. 따라서, 우수한 곤충 방제가 달성될 수 있으나, 상기 화학물질은 때때로 다른 익충에게도 영향을 미칠 수 있다. 화학 살충제의 광범위한 사용으로 초래되는 또 다른 문제는 내성 곤충 변종의 출현이다. 이는 다양한 내성 조정 전략으로 부분적으로 완화되었으나, 대안적 해충 방제제에 대한 요구가 증가하고 있다.Pests are controlled primarily by the intensive application of active chemical insecticides through inhibition of insect growth, prevention of insect nutrition or reproduction, or death of insects. Thus, good insect control can be achieved, but the chemical can sometimes affect other worms. Another problem resulting from the widespread use of chemical pesticides is the emergence of resistant insect strains. This has been partially alleviated by various resistance control strategies, but there is an increasing demand for alternative pest control agents.

살충성 독소를 발현하는 바실러스 튜린지엔스 균주와 같은 생물학적 곤충 방제제가 적용되어 만족스러운 결과와 함께 화학 살충제에 대한 대안 또는 보완물을 제공한 바 있다. 바실러스 튜린지엔시스는 그람 양성 호기성 내포자 형성 세균의 대규모 그룹에 속한다. 비. 세레우스(B. cereus) 또는 비. 안트라시스(B. anthracis)와 같은 매우 밀접하게 관련된 다른 바실러스 종과 달리, 이제까지 공지된 바실러스 튜린지엔스 종의 대부분은 포자형성 과정중에 이의 결정 구조에 기인하며 일반적으로 결정체로서도 지칭되는 부포자 봉입체를 생산한다. 상기 결정체는 소위 δ-내독소인, 살충적으로 활성인 결정 전독소 단백질로 이루어진다. 이들 단백질 결정은 바실러스 튜린지엔시스의 곤충에 대한 독성을 야기한다. δ-내독소는 결정체를 경구 섭취한 후 결정체가 표적 곤충의 위액에 용해될 때까지 살충 활성을 나타내지 않는다. 대부분의 경우에, 실제 독성 성분은 곤충의 소화관으로부터의 프로테아제 작용에 의해 유발되는 단백질분해 절단의 결과로서 전독소로부터 방출된다. 다양한 바실러스 튜린지엔스 균주의 δ-내독소는 특정 표적 곤충, 특히 다양한 인시류, 초시류 및 파리류 유충에 관한 높은 특이성 및 이들 유충에 대한 고도의 활성을 특징으로 한다. 바실러스 튜린지엔스의 δ-내독소를 사용할 경우의 추가의 잇점은 당해 독소가 사람, 기타 포유동물, 조류 및 어류에는 무해하다는 사실에 있다.Biological insect control agents such as Bacillus thuringiens strains expressing insecticidal toxins have been applied to provide alternatives or supplements to chemical insecticides with satisfactory results. Bacillus thuringiensis belongs to a large group of Gram-positive aerobic spore-forming bacteria. ratio. B. cereus or b. Unlike other closely related Bacillus species, such as B. anthracis, most of the Bacillus thuringiens species known so far are due to their crystal structure during the sporulation process and are generally referred to as crystals. To produce. The crystal consists of a pesticidally active crystalline protoxin protein, the so-called δ-endotoxin. These protein crystals cause toxicity to insects of Bacillus thuringiensis. δ-endotoxins do not exhibit pesticidal activity until after crystals have been orally ingested until the crystals dissolve in the gastric juice of the target insect. In most cases, the actual toxic components are released from the pretoxins as a result of proteolytic cleavage caused by the protease action from the insect's digestive tract. The δ-endotoxins of the various Bacillus thuringiens strains are characterized by high specificity with respect to certain target insects, in particular various poultry, superpod and fly larvae and high activity against these larvae. A further advantage when using the δ-endotoxin of Bacillus thuringiens is that the toxin is harmless to humans, other mammals, birds and fish.

서열 상동성 및 살충 특이성에 기초하여, 바실러스 튜린지엔스 결정 단백질은 상이한 부류로 분류되었다. 140kDa 전독소로서 생산되며 인시목에 대해 활성인 Cry1 부류의 단백질이 가장 잘 연구되어 있다. 결정 단백질의 작용 방식은 어느 정도까지는 설명되어 있다. 경구 섭취 후 결정은 유충의 중간창자의 알칼리성 환경에서 용해된다. 이어서, 가용화된 단백질은 중간창자 프로테이나제(예: 트립신)에 의해, 곤충 중간창자의 상피 세포 상의 수용체에 결합하여 세포막으로 침투하는 약 65kDa의 프로테이나제-내성 독성 단편으로 처리된다. 이는 결국에 세포의 파열 및 유충의 사멸을 초래한다.Based on sequence homology and pesticidal specificity, Bacillus thuringiensis crystalline proteins have been classified into different classes. The Cry1 family of proteins, produced as 140kDa protoxins and active against the eyes, are best studied. The mode of action of crystalline proteins has been described to some extent. After oral ingestion, the crystals dissolve in the alkaline environment of the larva's mesenteric. The solubilized protein is then treated with a mesenchymal proteinase (such as trypsin) to about 65 kDa proteinase-resistant toxic fragment that binds to receptors on epithelial cells of the insect mesent and penetrates the cell membrane. This eventually leads to cell rupture and death of the larvae.

특정 결정 단백질의 활성 스펙트럼은 민감성 곤충의 중간창자 상피 세포 상의 수용체 발생에 의해 상당한 범위까지 측정된다. 스펙트럼은 결정 단백질의 가용화의 효율성 및 이의 생체내 단백질분해 활성화에 의해 동시-측정된다. 결정 단백질의 중간창자 상피 수용체에의 결합의 중요성은 결정 단백질 중 하나에 대한 발전된 내성을 지니는 곤충에 있어 내성 곤충의 중간창자 상피 세포에 대한 결정 단백질의 결합이 현저하게 감소된다는 것으로 추가로 입증된다.The activity spectrum of certain crystalline proteins is measured to a significant extent by receptor development on mesenteric epithelial cells of sensitive insects. Spectra are co-measured by the efficiency of solubilization of the crystalline protein and its proteolytic activation in vivo. The importance of the binding of the crystalline protein to the mesenteric epithelial receptor is further evidenced that in insects with advanced resistance to one of the crystalline proteins, the binding of the crystalline protein to the mesenteric epithelial cells of the resistant insect is significantly reduced.

과거 수년간, 이들 결정 단백질의 일부를 암호화하는 유전자가 분리되었으며 이종 숙주에서 이들의 발현은 경제적으로 중요한 해충의 방제를 위한 또 다른 도구를 제공하는 것으로 나타났다. 특히, 바실러스 튜린지엔스 결정 단백질과 같은 형질전환 식물내의 살충성 독소의 발현은 선택된 해충에 대한 효과적 보호를 제공하였으며 이러한 독소를 발현하는 형질전환 식물이 상품화되어 농부들은 화학적 곤충 방제제의 적용을 감소시킬 수 있었다. 또한, 특정 곤충 또는 곤충류에 대한 살충 활성의 정도를 증가시키거나 독소 단백질이 활성을 나타내는 곤충의 스펙트럼을 확장시키도록 디자인된 선택된 조합의 기능을 갖는 재조합 독소를 발현시킬 수도 있다. 예를 들어, 천연에서 발견되지 않는 신규 서열을 갖는 키메라 살충성 단백질은 하나의 δ-내독소로부터의 독소 부분과 상이한 δ-내독소의 전독소 (테일) 부분을 조합하여 작제할 수 있다[참조문헌: WO 98/15170, 이는 본원에서 참조로 인용된다].Over the past years, genes encoding some of these deterministic proteins have been isolated and their expression in heterologous hosts has been shown to provide another tool for the control of economically important pests. In particular, the expression of pesticidal toxins in transgenic plants, such as Bacillus thuringiensis crystalline protein, provided effective protection against selected pests and commercialized transgenic plants expressing these toxins reduced farmers' application of chemical insect control agents. I could make it. It is also possible to express recombinant toxins with the selected combination of functions designed to increase the degree of pesticidal activity against a particular insect or insect species or to broaden the spectrum of insects in which the toxin protein is active. For example, a chimeric insecticidal protein having a novel sequence not found in nature can be constructed by combining a toxin portion from one δ-endotoxin and a different pretoxin (tail) portion of a different δ-endotoxin. Document: WO 98/15170, which is incorporated herein by reference.

결정 단백질의 독성 단편은 3개의 개별적 구조 도메인으로 이루어진 것으로 사료된다. 가장 N-말단에 위치한 도메인인 도메인 I은 7개의 α-헬릭스로 이루어지며, 부분적으로 또는 전체적으로 표적 세포 막내에 삽입되어 있을 수 있다. 도메인 II는 소위 격자-입체형태의 3 β-시트를 포함한다. 대부분의 조사자들은 도메인 II가 수용체와 상호작용하여 이로써 독소 특이성을 결정하는 것으로 사료하고 있다. 또한, 특이적 독성 및 높은 친화성 결합에 있어 도메인 II 잔기와 관련되는 다수의 증거가 있다. 가장 C-말단에 위치한 도메인인 도메인 III은 소위 젤리롤 입체형태의 2개의 β-시트로 이루어지며, 또한 특이성을 결정한다. 예를 들어, 암호화 영역 간의 생체내 재조합에 의해 독소들 간에 도메인 III을 교환하여 특이적 활성을 변화시킬 수 있다. 이러한 하이브리드를 사용한 결합 실험은 도메인 III이 표적 곤충의 추정된 수용체에 결합하는 것과 관련된다는 것을 제시하며, 이는 도메인 III이 수용체 인식에서의 역활을 통해 특이성에서 그 역활을 발휘할 수 있다는 것을 시사한다. Cry1 서열에 비추어 볼때, 도메인 I은 아미노산 잔기 28번부터 260번까지, 도메인 II은 약 260번부터 460번까지, 도메인 III은 약 460번부터 600번까지에 해당된다[참조문헌: Nakamura et al., Agric. Biol. Chem. 54(3): 715-724 (1990); Li et al., Nature 353: 815-821 (1991); Ge et al., J. Biol. Chem. 266(27): 17954-17958 (1991); and Honee et al., Mol. Microbiol. 5(11): 2799-2806 (1991); 각각은 본원에서 참조로 인용된다]. 본원에서 참조로 인용되는 미국 특허 제5,736,131호에는, C-말단에 제1 Cry 단백질의 도메인 III을 포함하며 N-말단에 제2 Cry 단백질의 도메인 I과 II를 포함하는 바실러스 튜린지엔스 하이브리드 독소 단편이 기재되어 있다. 이러한 하이브리드 결정 단백질은 변경된 살충 특이성을 갖는다. 예를 들어, 문헌[참조문헌: De Maagd et al., Appl. Environ Microbiol. 62(5): 1537-1543 (1996)]에 또한 기재되어 있는 H04 하이브리드 독소는 N-말단에 Cry1Ab의 도메인 I과 II를 포함하며 C-말단에 Cry1C의 도메인 III을 포함한다. 보고에 의하면 H04는 모체 Cry1Ab 독소에 비해 스포돕테라 엑시구아(Spodoptera exigua; 파밤나방)에 대해 고도로 독성이며 Cry1C 모체 독소에 비해 보다 독성이다[참조문헌: Bosch et al., FEMS Microbiology Letters 118: 129-134 (1994); Bosch et al., Bio/Technology 12: 915-918 (1994); De Maagd et al., Appl. Environ. Microbiol. 62(8): 2753-2757 (1996); 및 De Maagd et al., Mol. Microbiol. 31(2): 463-471 (1999); 각각은 본원에서 참조로 인용된다]. Toxic fragments of crystalline proteins are believed to consist of three separate structural domains. Domain I, the most N-terminal domain, consists of seven α-helices and may be partially or wholly inserted into the target cell membrane. Domain II comprises 3 β-sheets in the so-called lattice-stereoform. Most investigators believe that domain II interacts with the receptor, thereby determining toxin specificity. In addition, there is a great deal of evidence associated with domain II residues in specific toxicity and high affinity binding. Domain III, the most C-terminal domain, consists of two β-sheets in the so-called jellyroll conformation and also determines specificity. For example, specific activity can be changed by exchanging domain III between toxins by in vivo recombination between coding regions. Binding experiments using these hybrids suggest that Domain III is involved in binding to putative receptors of target insects, suggesting that Domain III may play a role in specificity through its role in receptor recognition. In light of the Cry1 sequence, domain I corresponds to amino acid residues 28 to 260, domain II to about 260 to 460, and domain III to about 460 to 600 (see Nakamura et al. , Agric. Biol. Chem. 54 (3): 715-724 (1990); Li et al., Nature 353: 815-821 (1991); Ge et al., J. Biol. Chem. 266 (27): 17954-17958 (1991); and Honee et al., Mol. Microbiol. 5 (11): 2799-2806 (1991); Each is incorporated herein by reference]. US Pat. No. 5,736,131, which is incorporated herein by reference, contains a Bacillus thuringiens hybrid toxin fragment comprising domain III of the first Cry protein at the C-terminus and domains I and II of the second Cry protein at the N-terminus. This is described. Such hybrid crystal proteins have altered pesticidal specificity. See, eg, De Maagd et al., Appl. Environ Microbiol. 62 (5): 1537-1543 (1996) also includes domains I and II of Cry1Ab at the N-terminus and domain III of Cry1C at the C-terminus. Reportedly, H04 is highly toxic to Spodoptera exigua compared to the parent Cry1Ab toxin and more toxic to the Cry1C parent toxin [Bosch et al., FEMS Microbiology Letters 118: 129]. -134 (1994); Bosch et al., Bio / Technology 12: 915-918 (1994); De Maagd et al., Appl. Environ. Microbiol. 62 (8): 2753-2757 (1996); And De Maagd et al., Mol. Microbiol. 31 (2): 463-471 (1999); Each is incorporated herein by reference].

육종 프로그램 및 유전공학을 통해 곤충 내성 유전자의 혼입으로 달성된 이전의 성공에도 불구하고, 신규하고 효과적인 곤충 방제제를 발견에 대한 요구가 절실하지만 실현되지 않고 있다. 특히, 유럽조명나방(European Corn Borer) 및 밤나방(Fall Army Worm)과 같이 경제적으로 중요한 해충을 표적으로 하며 현재의 곤충 방제제에 내성인 곤충 종을 효과적으로 방제하는 방제제가 필요하다. 또한, 적용되어 환경에 대한 부담을 최소화시키는 제제가 바람직하다.Despite the previous success achieved with the incorporation of insect resistance genes through breeding programs and genetic engineering, the need for finding new and effective insect control agents is urgent but not realized. In particular, there is a need for control agents that target economically important pests such as European Corn Borer and Fall Army Worm and effectively control insect species that are resistant to current insect control agents. Also preferred are formulations that are applied to minimize the burden on the environment.

본 발명은, 식물에서의 발현을 위해 최적화된 합성 뉴클레오타이드 서열을 포함하여, 하이브리드 바실러스 튜린지엔스 독소를 암호화하는 신규 유전자를 제공 함으로써 상기한 요구를 충족시킨다. 바람직한 양태에서, 신규 유전자 서열은 독소 부분이 Cry1Ab의 도메인 I과 II 및 Cry1C의 도메인 III를 함유하는 하이브리드 바실러스 튜린지엔시스 델타-내독소 H04의 다양한 형태를 암호화한다. 당해 신규 유전자에 의해 암호화되는 하이브리드 바실러스 튜린지엔시스 독소는 밤나방, 분홍면화씨벌레(pink bollworm), 담배나방(tobacco budworm), 유럽조명나방 및 배추좀나방(diamondback moth)과 같이 경제적으로 중요한 해충에 대해 고도로 활성이다. 하이브리드 바실러스 튜린지엔시스 독소를 다수의 곤충 방제 전략에서 사용하여 환경에 대한 영향력을 최소로 하면서 최대의 효율성을 수득할 수 있다.The present invention fulfills these needs by providing novel genes encoding hybrid Bacillus thuringiensis toxins, including synthetic nucleotide sequences optimized for expression in plants. In a preferred embodiment, the new gene sequence encodes various forms of the hybrid Bacillus thuringiensis delta-endotoxin H04 wherein the toxin moiety contains domains I and II of Cry1Ab and domain III of Cry1C. The hybrid Bacillus thuringiensis toxin encoded by this new gene is responsible for economically important pests such as chestnut moth, pink bollworm, tobacco budworm, European moth and diamondback moth. Highly active. Hybrid Bacillus thuringiensis toxins can be used in many insect control strategies to achieve maximum efficiency with minimal impact on the environment.

본 발명은 추가로 본 발명의 뉴클레오타이드 서열의 발현으로 생성되는 하이브리드 살충성 독소, 및 생존, 성장 또는 번식하는 해충의 능력을 억제하거나 농작물에서 곤충과 관련된 손상 또는 손실을 제한할 수 있는 당해 하이브리드 살충성 독소를 함유하는 조성물 및 제형에 관한 것이다. 또한, 본 발명은 하이브리드 독소의 제조방법 및 예를 들어, 형질전환 식물에서 당해 뉴클레오타이드 서열을 사용하여 살충 내성을 부여하는 방법, 및 독소 및 당해 독소를 포함하는 조성물 및 제형을 사용하는 방법, 예를 들어, 당해 독소, 조성물 또는 제형을 곤충 감염된 지역, 예방적으로 처리될 곤충 민감성 지역 또는 식물에 적용하여 해로운 곤충에 대한 보호 또는 내성을 부여하는 방법에 관한 것이다. 하이브리드 독소를 다수의 곤충 방제 전략에서 사용하여 환경에 대한 영향력을 최소로 하면서 최대의 효율성을 수득할 수 있다.The present invention further provides hybrid insecticidal toxins produced by the expression of the nucleotide sequences of the present invention, and those hybrid insecticidals that can inhibit the ability of pests to survive, grow or reproduce or limit damage or loss associated with insects in crops. It relates to compositions and formulations containing toxins. In addition, the present invention provides a method for preparing a hybrid toxin and a method for conferring insecticidal resistance using the nucleotide sequence in a transformed plant, for example, and a method for using the toxin and a composition and formulation containing the toxin, for example. For example, the present invention relates to methods of applying such toxins, compositions or formulations to insect infected areas, insect sensitive areas or plants to be treated prophylactically to confer protection or resistance to harmful insects. Hybrid toxins can be used in many insect control strategies to achieve maximum efficiency with minimal impact on the environment.

하나의 양상에 따라서, 본 발명은 Cry1C 독소로부터의 도메인 III에 아미노 에서 카복시 방향으로 결합된 Cry1Ab 독소로부터의 도메인 I과 II을 포함하는 하이브리드 바실러스 튜린지엔시스 독소의 유효량을 곤충에게 전달함을 포함하여, 밤나방, 분홍면화씨벌레, 담배나방, 유럽조명나방 및 배추좀나방으로 이루어진 그룹으로부터 선택되는 곤충을 방제하는 방법을 제공한다. 바람직한 양태에서, 하이브리드 바실러스 튜린지엔시스 독소는 서열 2, 4, 6, 8 또는 10과 90% 이상 동일한 아미노산 서열을 포함한다. 보다 바람직한 양태에서, 하이브리드 바실러스 튜린지엔시스 독소는 서열 2, 4, 6, 8 또는 10을 포함한다.According to one aspect, the present invention comprises delivering to an insect an effective amount of a hybrid Bacillus thuringiensis toxin comprising domains I and II from the Cry1Ab toxin bound in the amino to carboxy direction to domain III from the Cry1C toxin And insects selected from the group consisting of chestnut moth, pink cotton worm, tobacco moth, European light moth and Chinese cabbage moth. In a preferred embodiment, the hybrid Bacillus thuringiensis toxin comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 2, 4, 6, 8 or 10. In a more preferred embodiment, the hybrid Bacillus thuringiensis toxin comprises SEQ ID NO: 2, 4, 6, 8 or 10.

본 발명의 상기 기술한 방법의 다른 양태에서, 하이브리드 바실러스 튜린지엔시스 독소는 Cry1C 테일 영역 또는 Cry1Ab 테일 영역과 같은 C-말단 테일 영역을 포함한다. C-말단 테일 영역은 전장일 수 있거나, 예를 들어, 약 40개의 아미노산 길이로 절단될 수 있다.In another embodiment of the above described method of the invention, the hybrid Bacillus thuringiensis toxin comprises a C-terminal tail region, such as a Cry1C tail region or a Cry1Ab tail region. The C-terminal tail region can be full length or can be cleaved, for example, to about 40 amino acids in length.

본 발명의 상기 기술한 방법의 바람직한 양태에서, 유효량의 하이브리드 바실러스 튜린지엔시스 독소를 곤충에게 전달하는 것은, 곤충에게 하이브리드 바실러스 튜린지엔시스 독소를 암호화하는 뉴클레오타이드 서열을 포함하는 재조합 DNA 서열로 형질전환된 형질전환 식물 조직을 공급하거나 곤충을 이와 접촉시키는 것을 포함하며, 여기서 상기 형질전환 식물 조직에서 하이브리드 바실러스 튜린지엔시스 독소의 발현은 곤충에 대한 내성을 부여한다. 바람직하게는, 상기 뉴클레오타이드 서열은 서열 1, 3, 5, 7 또는 9와 실질적으로 동일하다.In a preferred embodiment of the above-described method of the invention, delivering an effective amount of a hybrid Bacillus thuringiensis toxin to an insect is transformed into a recombinant DNA sequence comprising a nucleotide sequence encoding the hybrid Bacillus thuringiensis toxin to the insect. Feeding transgenic plant tissues or contacting insects thereto, wherein expression of the hybrid Bacillus thuringiensis toxin in the transgenic plant tissue confers resistance to insects. Preferably, the nucleotide sequence is substantially identical to SEQ ID NO: 1, 3, 5, 7 or 9.

다른 양상에 따라서, 본 발명은, (a) Cry1C 독소로부터의 도메인 III에 아미노에서 카복시 방향으로 결합된 Cry1Ab 독소로부터의 도메인 I 및 II을 포함하는 N-말단 독소 부분 및 (b) Cry1Ab 독소로부터의 C-말단 테일 영역을 포함하는 하이브리드 바실러스 튜린지엔시스 독소를 암호화하는 뉴클레오타이드 서열을 포함하는 분리된 핵산 분자를 제공한다. 바람직하게는, 하이브리드 바실러스 튜린지엔시스 독소는 서열 6, 8 또는 10과 90% 이상 동일한 아미노산 서열을 포함한다. 보다 바람직하게는, 하이브리드 바실러스 튜린지엔시스 독소는 서열 6, 8 또는 10을 포함한다. 보다 더욱 바람직하게는, 상기 뉴클레오타이드 서열은 서열 5, 7 또는 9와 90% 이상 동일하다. 가장 바람직하게는, 상기 뉴클레오타이드 서열은 서열 5, 7 또는 9를 포함한다.According to another aspect, the invention provides an N-terminal toxin moiety comprising (a) domains I and II from Cry1Ab toxin bound in amino to carboxy direction to domain III from Cry1C toxin and (b) from Cry1Ab toxin An isolated nucleic acid molecule is provided comprising a nucleotide sequence encoding a hybrid Bacillus thuringiensis toxin comprising a C-terminal tail region. Preferably, the hybrid Bacillus thuringiensis toxin comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 6, 8, or 10. More preferably, the hybrid Bacillus thuringiensis toxin comprises SEQ ID NO: 6, 8 or 10. Even more preferably, the nucleotide sequence is at least 90% identical to SEQ ID NO: 5, 7 or 9. Most preferably, the nucleotide sequence comprises SEQ ID NO: 5, 7 or 9.

본 발명은 상기 기술한 바와 같은 본 발명의 핵산 분자에 작동적으로 연결된 이종 프로모터 서열을 포함하는 키메라 유전자; 상기 키메라 유전자를 포함하는 재조합 벡터; 상기 키메라 유전자를 포함하는 형질전환 숙주 세포(예: 식물 세포); 상기 형질전환 식물 세포를 포함하는 형질전환 식물(예: 옥수수, 면화, 벼 또는 양배추 식물); 및 상기 형질전환 식물 유래의 종자를 추가로 제공한다.The present invention provides a chimeric gene comprising a heterologous promoter sequence operably linked to a nucleic acid molecule of the invention as described above; A recombinant vector comprising the chimeric gene; Transgenic host cells (eg, plant cells) comprising said chimeric genes; Transgenic plants (eg, corn, cotton, rice or cabbage plants) comprising said transgenic plant cells; And seed from the transgenic plant.

또 다른 양상에 따라서, 본 발명은, (a) 식물내에서 연관된 암호화 서열의 전사를 상승된 수준으로 촉진시키는 핵산 프로모터 서열 및 (b) 상기 프로모터 서열에 작동적으로 연결된 본 발명에 따르는 핵산 분자를 포함하는 키메라 유전자로 형질전환된 식물에서 하이브리드 바실러스 튜린지엔시스 독소를 발현시킴을 포함하여, 식물을 곤충으로부터 보호하는 방법으로서, 상기 식물에서 하이브리드 바실러스 튜린지엔시스 독소의 발현이 상기 식물을 곤충으로부터 보호하는 방법을 제공한다. According to another aspect, the present invention provides a nucleic acid promoter sequence that promotes (a) elevated levels of transcription of an associated coding sequence in a plant, and (b) a nucleic acid molecule according to the invention that is operably linked to said promoter sequence. A method of protecting a plant from insects, including the expression of a hybrid Bacillus thuringiensis toxin in a plant transformed with a chimeric gene comprising, wherein the expression of the hybrid Bacillus thuringiensis toxin in the plant protects the plant from insects. Provide a way to.             

또 다른 양상에 따라서, 본 발명은 (a) 본 발명에 따르는 형질전환 숙주 세포를 수득하는 단계 및 (b) 본 발명의 핵산 분자를 상기 형질전환 숙주 세포에서 발현시켜 곤충에 대해 활성인 하이브리드 바실러스 독소를 수득하는 단계를 포함하여, 곤충에 대해 활성인 하이브리드 바실러스 튜린지엔시스 독소를 제조하는 방법을 제공한다.According to another aspect, the present invention provides a hybrid Bacillus toxin that is active against an insect by (a) obtaining a transformed host cell according to the present invention and (b) expressing the nucleic acid molecule of the present invention in said transformed host cell. It provides a method for producing a hybrid Bacillus thuringiensis toxin active against insects, including the step of obtaining the same.

또 다른 양상에 따라서, 본 발명은, 본 발명에 따르는 핵산 분자를 식물내로 도입함을 포함하여, 곤충에 대해 내성인 식물을 제조하는 방법으로서, 상기 핵산 분자가 상기 식물내에서 곤충을 방제하기에 유효한 양으로 발현될 수 있는 방법을 제공한다.According to another aspect, the present invention provides a method for producing a plant resistant to insects, comprising introducing a nucleic acid molecule according to the present invention into a plant, wherein the nucleic acid molecule controls insects in the plant. Provided are methods that can be expressed in an effective amount.

또 다른 양상에 따라서, 본 발명은, 서열 3, 5, 7, 9, 11, 12, 13, 14, 15, 16 또는 17을 포함하는 분리된 핵산 분자; 이러한 핵산 분자에 작동적으로 연결된 이종 프로모터 서열을 포함하는 키메라 유전자; 이러한 키메라 유전자를 포함하는 재조합 벡터; 이러한 키메라 유전자를 포함하는 형질전환 숙주 세포(예: 식물 세포); 이러한 형질전환 식물 세포를 포함하는 형질전환 식물(예: 옥수수, 면화, 벼 또는 양배추 식물); 및 이러한 형질전환 식물 유래의 종자를 제공한다.According to another aspect, the invention provides an isolated nucleic acid molecule comprising SEQ ID NO: 3, 5, 7, 9, 11, 12, 13, 14, 15, 16 or 17; Chimeric genes comprising heterologous promoter sequences operably linked to such nucleic acid molecules; Recombinant vectors comprising such chimeric genes; Transgenic host cells (eg, plant cells) comprising such chimeric genes; Transgenic plants (eg, corn, cotton, rice or cabbage plants) comprising such transgenic plant cells; And seeds derived from such transgenic plants.

추가의 양상에 따라서, 본 발명은 (a) Cry1C 독소로부터의 도메인 III에 아미노에서 카복시 방향으로 결합된 Cry1Ab 독소로부터의 도메인 I 및 II을 포함하는 N-말단 독소 부분 및 (b) Cry1Ab 독소로부터의 C-말단 테일 영역을 포함하는 하이브리드 바실러스 튜린지엔시스 독소를 제공한다. 바람직하게는, 본 발명의 하이브리드 바실러스 튜린지엔시스 독소는 서열 6, 8 또는 10과 90% 이상 동일한 아미노산 서열을 포함한다. 보다 바람직하게는, 본 발명의 하이브리드 바실러스 튜린지엔시스 독소는 서열 6, 8 또는 10을 포함한다.According to a further aspect, the present invention relates to an N-terminal toxin moiety comprising (a) domains I and II from Cry1Ab toxin bound amino to carboxy to domain III from Cry1C toxin and (b) from Cry1Ab toxin A hybrid Bacillus thuringiensis toxin comprising a C-terminal tail region is provided. Preferably, the hybrid Bacillus thuringiensis toxin of the present invention comprises an amino acid sequence that is at least 90% identical to SEQ ID NO: 6, 8 or 10. More preferably, the hybrid Bacillus thuringiensis toxin of the present invention comprises SEQ ID NO: 6, 8 or 10.

추가의 양상에 따라서, 본 발명은 본 발명의 하이브리드 바실러스 튜린지엔시스 독소를 곤충을 방제하는데 유효한 양으로 포함하는 조성물을 제공한다.According to a further aspect, the present invention provides a composition comprising the hybrid Bacillus thuringiensis toxin of the present invention in an amount effective to control insects.

본 발명의 다른 양상 및 잇점은 하기의 본 발명의 설명 및 비제한적 실시예의 연구로부터 당해 분야의 숙련가에 명백할 것이다.
Other aspects and advantages of the invention will be apparent to those skilled in the art from the following description of the invention and the study of non-limiting examples.

서열 목록의 서열에 대한 간단한 설명Brief description of the sequences in the sequence listing

서열 1은 독소 부분이 N-말단에 Cry1Ab의 도메인 I과 II를 포함하며 C-말단에 Cry1C의 도메인 III을 포함하는, 문헌[참조문헌: De Maagd et al., Appl. Environ. Microbiol. 62(5): 1537-1543 (1996)]에 기술된 H04 하이브리드 독소와 전장 Cry1C 테일 부분을 암호화하는 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 1 has a toxin moiety comprising domains I and II of Cry1Ab at the N-terminus and domain III of Cry1C at the C-terminus. De Maagd et al., Appl. Environ. Microbiol. 62 (5): 1537-1543 (1996), presents a nucleotide sequence encoding the H04 hybrid toxin and full-length Cry1C tail portion.

서열 2는 Cry1Ab의 독소 도메인 I과 II 및 Cry1C의 독소 도메인 III과 함께 전장 Cry1C 테일 부분을 포함하는, 서열 1에 설명된 뉴클레오타이드 서열에 의해 암호화되는 H04 하이브리드 독소의 아미노산 서열을 제시한다.SEQ ID NO: 2 shows the amino acid sequence of the H04 hybrid toxin encoded by the nucleotide sequence described in SEQ ID NO: 1, comprising the full length Cry1C tail portion together with toxin domains I and II of Cry1Ab and toxin domain III of Cry1C.

서열 3은 트립신 부위가 절단된 것처럼 테일을 포함하지 않는 H04의 독소 부분을 암호화하는 합성 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 3 presents a synthetic nucleotide sequence that encodes a toxin portion of H04 that does not contain a tail as the trypsin site is cleaved.

서열 4는 서열 3에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04 독소 부분의 아미노산 서열을 제시한다.SEQ ID NO: 4 sets forth the amino acid sequence of the H04 toxin moiety encoded by the synthetic nucleotide sequence set forth in SEQ ID NO: 3.

서열 5는 H04의 독소 부분과 전장 Cry1Ab 테일 부분을 암호화하는 합성 뉴클 레오타이드 서열을 제시한다.SEQ ID NO: 5 shows a synthetic nucleotide sequence encoding the toxin portion of H04 and the full length Cry1Ab tail portion.

서열 6은 서열 5에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04+Cry1Ab 테일의 아미노산 서열을 제시한다.SEQ ID NO: 6 shows the amino acid sequence of the H04 + Cry1Ab tail encoded by the synthetic nucleotide sequence set forth in SEQ ID NO: 5.

서열 7은 H04의 독소 부분과 전장 Cry1Ab 테일 부분을 암호화하는 또 다른 합성 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 7 shows another synthetic nucleotide sequence that encodes a toxin portion of H04 and a full length Cry1Ab tail portion.

서열 8은 서열 7에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04+Cry1Ab 테일의 아미노산 서열을 제시한다.SEQ ID NO: 8 shows the amino acid sequence of the H04 + Cry1Ab tail encoded by the synthetic nucleotide sequence set forth in SEQ ID NO: 7.

서열 9는 H04의 독소 부분과 Cry1Ab 테일 부분의 처음 40개의 아미노산을 암호화하는 합성 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 9 shows a synthetic nucleotide sequence that encodes the first 40 amino acids of the toxin portion and Cry1Ab tail portion of H04.

서열 10은 서열 9에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04+ 40개 아미노산으로 절단된 Cry1Ab 테일의 아미노산 서열을 제시한다.SEQ ID NO: 10 shows the amino acid sequence of a Cry1Ab tail truncated to H04 + 40 amino acids encoded by the synthetic nucleotide sequence set forth in SEQ ID NO: 9.

서열 11은 서열 3에 제시된 바와 같은 테일을 포함하지 않는 H04의 독소 부분을 암호화하는 합성 뉴클레오타이드 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는 작제물 pNOV1308의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 11 shows the nucleotide sequence of construct pNOV1308 containing a constitutive corn ubiquitin promoter operably linked to a synthetic nucleotide sequence that encodes a toxin portion of H04 that does not include a tail as set forth in SEQ ID NO: 3.

서열 12는 서열 5에 제시된 바와 같은 H04의 독소 부분과 전장 Cry1Ab 테일 부분을 암호화하는 합성 뉴클레오타이드 서열에 작동적으로 연결된, 뿌리에 바람직한 옥수수 MTL 프로모터를 함유하는 작제물 pNOV1436의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 12 shows the nucleotide sequence of construct pNOV1436, which contains a preferred corn MTL promoter in the roots, operably linked to a synthetic nucleotide sequence encoding the toxin portion of H04 and the full length Cry1Ab tail portion as set forth in SEQ ID NO: 5.

서열 13은 서열 5에 제시된 바와 같은 H04의 독소 부분과 전장 Cry1Ab 테일 부분을 암호화하는 합성 뉴클레오타이드 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는 작제물 pNOV1441의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 13 shows the nucleotide sequence of construct pNOV1441 containing a constitutive corn ubiquitin promoter operably linked to a synthetic nucleotide sequence encoding the toxin portion of H04 and the full length Cry1Ab tail portion as set forth in SEQ ID NO: 5.

서열 14는 서열 7에 제시된 바와 같은 H04의 독소 부분과 전장 Cry1Ab 테일 부분을 암호화하는 합성 뉴클레오타이드 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는 작제물 pNOV1305의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 14 shows the nucleotide sequence of construct pNOV1305, which contains a constitutive corn ubiquitin promoter operably linked to a synthetic nucleotide sequence encoding a toxin portion of H04 and a full length Cry1Ab tail portion as set forth in SEQ ID NO: 7.

서열 15는 서열 7에 제시된 바와 같은 H04의 독소 부분과 전장 Cry1Ab 테일 부분을 암호화하는 합성 뉴클레오타이드 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는 작제물 pNOV1313의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 15 shows the nucleotide sequence of construct pNOV1313, which contains a constitutive corn ubiquitin promoter operably linked to a synthetic nucleotide sequence encoding a toxin portion of H04 and a full length Cry1Ab tail portion as set forth in SEQ ID NO: 7.

서열 16은 서열 9에 제시된 바와 같은 H04의 독소 부분과 Cry1Ab 테일의 처음 40개의 아미노산을 암호화하는 합성 뉴클레오타이드 서열에 작동적으로 연결된, 뿌리에 바람직한 옥수수 MTL 프로모터를 함유하는 작제물 pNOV1435의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 16 shows the nucleotide sequence of construct pNOV1435, which contains a desired maize MTL promoter for roots, operably linked to the toxin portion of H04 as shown in SEQ ID NO: 9 and the synthetic nucleotide sequence encoding the first 40 amino acids of the Cry1Ab tail do.

서열 17은 서열 9에 제시된 바와 같은 H04의 독소 부분과 Cry1Ab 테일의 처음 40개의 아미노산을 암호화하는 합성 뉴클레오타이드 서열에 작동적으로 연결된 아라비돕시스 액틴-2(Arabidopsis actin-2) 프로모터를 함유하는 작제물 pZU578의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 17 shows a fragment of construct pZU578 containing an arabidopsis actin-2 promoter operably linked to the toxin portion of H04 as shown in SEQ ID NO: 9 and a synthetic nucleotide sequence encoding the first 40 amino acids of the Cry1Ab tail. The nucleotide sequence is shown.

정의Justice

본 발명의 독소의 "활성"은 경구적 활성인 곤충 방제제로서의 독소 기능이 독성 효과를 나타내거나 곤충 영양공급을 중단 또는 방해할 수 있는 것을 의미한다. 본 발명의 독소가 곤충에게 전달되는 경우, 그 결과는 통상적으로 곤충의 사멸이거나 곤충은 당해 독소를 곤충이 이용할 수 있도록 하는 공급원을 섭취하지 않는다."Activity" of the toxin of the present invention means that the toxin function as an orally active insect control agent may have a toxic effect or interrupt or interrupt insect nutrition. When the toxin of the present invention is delivered to an insect, the result is usually the killing of the insect or the insect does not consume a source that makes the toxin available to the insect.

"연관된/작동적으로 연결된"은 물리적으로 또는 기능적으로 관련된 두 핵산 서열을 의미한다. 예를 들어, 프로모터 또는 조절 DNA 서열은, 두 서열이 작동적으로 연결되거나 조절 DNA 서열이 암호화 또는 구조 DNA 서열의 발현 수준에 영향을 미칠 수 있는 상황에 놓이는 경우에 RNA 또는 단백질을 암호화하는 DNA 서열과 "연관된"다고 언급된다. "Associated / operably linked" means two nucleic acid sequences that are physically or functionally related. For example, a promoter or regulatory DNA sequence is a DNA sequence that encodes an RNA or protein when the two sequences are operatively linked or when the regulatory DNA sequence is placed in a situation that can affect the expression level of the coding or structural DNA sequence. Is referred to as "associated".

"결합 부위"는 부위와 독성 사이의 결합이 부위와 독성 사이의 Ka가 약 104dm3mole-1 이상인 정도로 가역적인 분자 상의 부위를 의미한다."Binding site" means a site on a molecule that is reversible such that the binding between site and toxicity is at least about 10 4 dm 3 mole -1 .

"키메라 유전자"는, 프로모터 또는 조절 핵산 서열이 mRNA를 암호화하거나 단백질로서 발현되는 핵산 서열에 작동적으로 연결 또는 연관되어 있어, 조절 핵산 서열이 연관된 핵산 서열의 전사 또는 발현을 조절할 수 있는 재조합 핵산 서열이다. 키메라 유전자의 조절 핵산 서열은 천연에서 발견되는 바와 같이, 정상적으로는 연관된 핵산 서열에 작동적으로 연결되어 있지 않다.A “chimeric gene” is a recombinant nucleic acid sequence in which a promoter or regulatory nucleic acid sequence encodes or associates with a nucleic acid sequence that encodes an mRNA or is expressed as a protein, such that the regulatory nucleic acid sequence may regulate transcription or expression of the associated nucleic acid sequence. to be. The regulatory nucleic acid sequences of the chimeric genes are not operably linked to normally associated nucleic acid sequences, as found in nature.

"암호화 서열"은 mRNA, rRNA, tRNA, snRNA, 센스 RNA 또는 안티센스 RNA와 같은 RNA로 전사되는 핵산 서열이다. 바람직하게는, RNA는 유기체내에서 후속적으로 해독되어 단백질을 생산한다. A "coding sequence" is a nucleic acid sequence that is transcribed into RNA such as mRNA, rRNA, tRNA, snRNA, sense RNA, or antisense RNA. Preferably, RNA is subsequently translated into an organism to produce a protein.             

상보적: "상보적"은 역평행 뉴클레오타이드 서열내의 상보적 염기 잔기 사이에 수소 결합이 형성된 후 서로 쌍을 이룰 수 있는 역평행 뉴클레오타이드 서열을 포함하는 두 뉴클레오타이드 서열을 의미한다.Complementary: "Complementary" means two nucleotide sequences that include antiparallel nucleotide sequences that can pair with each other after hydrogen bonds are formed between complementary base residues in the antiparallel nucleotide sequence.

특정 핵산 서열의 "보존적으로 변형된 변이"는 동일하거나 본질적으로 동일한 아미노산 서열을 암호화하는 핵산 서열을 의미하거나, 핵산 서열이 아미노산 서열을 암호화하지 않을 경우에는 본질적으로 동일한 서열을 의미한다. 유전암호의 축퇴로 인해, 다수의 기능적으로 동일한 핵산은 임의 기정의 폴리펩타이드를 암호화한다. 예를 들어, 코돈 CGT, CGC, CGA, CGG, AGA 및 AGG는 모두 아미노산 아르기닌을 암호화한다. 따라서, 아르기닌이 코돈에 의해 정의되는 모든 위치에서, 코돈은 암호화된 단백질을 변경하지 않으면서 기술한 상응하는 코돈 중 어느 하나로 변경될 수 있다. 이러한 핵산 변이는 "보존적으로 변형된 변이"의 한 종류인 "침묵 변이(silent variation)"이다. 단백질을 암호화하는, 본원에서 기술하는 모든 핵산 서열은 달리 언급하지 않는 한 모든 가능한 잠재성 변이를 또한 가리킨다. 당해 숙련가는 표준 기술을 사용하여 핵산내의 각 코돈(통상적으로 메티오닌에 대한 유일한 코돈인 ATG 제외)을 변형시켜 기능적으로 동일한 분자를 수득할 수 있음을 인지할 수 있다. 따라서, 단백질을 암호화하는 핵산의 각 "잠재성 변이"는 각 기술된 서열에 내재되어 있다.A "conservatively modified variant" of a particular nucleic acid sequence means a nucleic acid sequence that encodes the same or essentially the same amino acid sequence, or if the nucleic acid sequence does not encode an amino acid sequence, it means essentially the same sequence. Due to the degeneracy of the genetic code, many functionally identical nucleic acids encode any given polypeptide. For example, codons CGT, CGC, CGA, CGG, AGA and AGG all encode the amino acid arginine. Thus, at all positions where arginine is defined by a codon, the codon can be altered to any of the corresponding codons described without altering the encoded protein. Such nucleic acid variations are "silent variations" which are a type of "conservatively modified variation". All nucleic acid sequences described herein that encode a protein also refer to all possible latent variations, unless stated otherwise. Those skilled in the art can appreciate that standard techniques can be used to modify each codon (except ATG, which is typically the only codon for methionine) to yield functionally identical molecules. Thus, each "potential variation" of a nucleic acid encoding a protein is inherent in each described sequence.

또한, 당해 숙련가는 아미노산 서열내의 적은 비율(통상적으로 5% 미만, 보다 통상적으로 1% 미만)의 아미노산을 변경, 첨가 또는 결실시키는 개개의 치환, 결실 또는 첨가가 변경으로 인해 아미노산이 화학적으로 유사한 아미노산으로 치환 된 "보존적으로 변형된 변이"라는 것을 인지할 것이다. 기능적으로 유사한 아미노산을 제공하는 보존적 치환 표는 당해 분야에 익히 공지되어 있다. 다음의 5개 그룹은 각각 서로에 대한 보존적 치환인 아미노산을 함유한다: 지방족: 글리신(G), 알라닌(A), 발린(V), 류신(L), 이소류신(I); 방향족: 페닐알라닌(F), 티로신(Y), 트립토판(W); 황-함유: 메티온닌(M), 시스테인(C); 염기성: 아르기닌(R), 라이신(K), 히스티딘(H); 산성: 아스파르트산(D), 글루탐산(E), 아스파라긴(N), 글루타민(Q)[참조문헌: Creighton (1984) Proteins, W.H. Freeman and Company]. 또한, 암호화된 서열내의 단일 아미노산 또는 적은 비율의 아미노산을 변경, 첨가 또는 결실시키는 개개의 치환, 결실 또는 첨가도 "보존적으로 변형된 변이"이다.In addition, those skilled in the art will recognize that amino acids are chemically similar amino acids due to alterations in individual substitutions, deletions or additions that alter, add, or delete a small proportion (typically less than 5%, more typically less than 1%) of amino acids in the amino acid sequence It will be recognized that it is a "conservatively modified variant" substituted with. Conservative substitution tables that provide functionally similar amino acids are well known in the art. The following five groups each contain amino acids that are conservative substitutions for one another: aliphatic: glycine (G), alanine (A), valine (V), leucine (L), isoleucine (I); Aromatic: phenylalanine (F), tyrosine (Y), tryptophan (W); Sulfur-containing: methionine (M), cysteine (C); Basic: arginine (R), lysine (K), histidine (H); Acidic: Aspartic Acid (D), Glutamic Acid (E), Asparagine (N), Glutamine (Q) [Creighton (1984) Proteins, W.H. Freeman and Company]. In addition, individual substitutions, deletions or additions that alter, add or delete a single amino acid or a small proportion of amino acids in an encoded sequence are also "conservatively modified variations".

곤충을 "방제"한다는 것은 생존, 성장, 영양공급 및/또는 번식하는 해충의 능력을 억제하거나 농작물에서 곤충과 관련된 손상이나 손실을 독성 효과를 통해 제한하는 것을 의미한다. 비록 곤충을 "방제"한다는 것이 바람직하게는 곤충을 치사시키는 것을 의미한다 해도, 곤충을 치사시키는 것을 의미할 수 있거나 의미할 수 없다."Controlling" an insect means inhibiting the insect's ability to survive, grow, nourish and / or propagate or limit the damage or loss associated with the insect in the crop through a toxic effect. Although "controlling" an insect preferably means killing the insect, it may or may not mean killing the insect.

상응하는: 본 발명의 범주에서, "에 상응하는" 또는 "에 상응하다"는 바실러스 튜린지엔시스의 상이한 δ-내독소의 핵산 암호화 서열 또는 아미노산 서열들이 서로 정렬될 경우에 특정 계산된 위치에 "상응하는" 핵산 또는 아미노산이 상기 위치와는 정렬되지만 특정 δ-내독소의 각각의 핵산 암호화 서열 또는 아미노산 서열에 대한 이러한 정확한 숫자상 위치에 반드시 존재하지 않는 핵산 또는 아미노산인 것을 의미한다. 마찬가지로, 특정 δ-내독소(예를 들어, Cry1B)의 암호화 또는 아 미노산 서열이 참조 δ-내독소(예를 들어, Cry1Ab)의 암호화 또는 아미노산 서열과 정렬되는 경우 Cry1Ab 서열의 임의 계산된 위치와 "상응하는" Cry1B 서열내의 핵산 또는 아미노산은, Cry1Ab의 상기 위치와는 정렬되나 Cry1B 독소의 각각의 핵산 암호화 서열 또는 아미노산 서열의 이러한 정확한 숫자상 위치에 반드시 존재하지 않는 핵산 또는 아미노산이다.Corresponding: Within the scope of the present invention, "corresponds to" or "corresponds to" means that the nucleic acid coding sequences or amino acid sequences of the different δ-endotoxins of Bacillus thuringiensis are aligned at certain calculated positions when aligned with each other. Corresponding "nucleic acid or amino acid is a nucleic acid or amino acid that is aligned with said position but is not necessarily present at this exact numerical position relative to each nucleic acid coding sequence or amino acid sequence of a particular δ-endotoxin. Likewise, if the coding or amino acid sequence of a particular δ-endotoxin (eg Cry1B) is aligned with the coding or amino acid sequence of a reference δ-endotoxin (eg Cry1Ab), and with any calculated position of the Cry1Ab sequence, A nucleic acid or amino acid within a “corresponding” Cry1B sequence is a nucleic acid or amino acid that is aligned with the position of Cry1Ab but is not necessarily present at this exact numerical position of each nucleic acid coding sequence or amino acid sequence of the Cry1B toxin.

독소를 "전달"한다는 것은 독소를 곤충과 접촉시켜 독성 효과 및 곤충의 방제를 초래하는 것을 의미한다. 독소는 다수의 인정된 방식, 예를 들어, 곤충에 의한 섭취에 의해 경구적으로 또는 곤충과의 접촉에 의해 형질전환 식물 발현, 제형화된 단백질 조성물(들), 분무가능한 단백질 조성물(들), 베이트 매트릭스(bait matrix) 또는 분야에 인정된 임의 기타 독소 전달 시스템을 통해 전달될 수 있다."Delivering" a toxin means contacting the toxin with an insect, resulting in toxic effects and control of the insect. Toxins can be expressed in a number of recognized ways, for example, by transgenic plant expression, formulated protein composition (s), sprayable protein composition (s), orally or by contact with insects, It may be delivered via a bait matrix or any other toxin delivery system known in the art.

본원에서 사용되는 "발현 카세트"는 종결 시그널에 작동가능하게 연결되어 있는 관심있는 뉴클레오타이드 서열에 작동가능하게 연결되어 있는 프로모터를 포함하여, 적절한 숙주 세포에서 상기 뉴클레오타이드 서열의 발현을 유도할 수 있는 핵산 서열을 의미한다. 발현 카세트는 또한 통상적으로 뉴클레오타이드 서열의 적절한 해독에 필요한 서열을 포함한다. 관심있는 뉴클레오타이드 서열을 포함하는 발현 카세트는 키메라일 수 있으며, 이는 발현 카세트의 성분 중 하나 이상이 발현 카세트의 다른 성분 중 하나 이상에 대해 이종임을 의미한다. 또한, 발현 카세트는 천연적으로 발생하는 것이지만 이종 발현에 유용한 재조합 형태로 수득된 것일 수 있다. 그러나 통상적으로, 발현 카세트는 숙주에 대해 이종이다. 즉, 발현 카세트의 특정 DNA 서열은 숙주 세포내에 천연적으로 존재하지 않으며 형질전환 과정에 의해 숙주 세포 또는 숙주 세포의 선조내로 도입되어야 한다. 발현 카세트내의 뉴클레오타이드 서열의 발현은 숙주 세포가 일부 특정 외부 자극원에 노출될 경우에만 전사를 개시하는 구성적 프로모터 또는 유도성 프로모터의 조절하에 있을 수 있다. 식물과 같은 다세포 유기체의 경우에서, 프로모터는 또한 특정 조직 또는 기관이나 발육 단계에 대해 특이적일 수 있다. As used herein, an "expression cassette" includes a nucleic acid sequence capable of inducing expression of said nucleotide sequence in a suitable host cell, including a promoter operably linked to a nucleotide sequence of interest operably linked to a termination signal. Means. Expression cassettes also typically include sequences required for proper translation of nucleotide sequences. An expression cassette comprising a nucleotide sequence of interest may be chimeric, meaning that one or more of the components of the expression cassette are heterologous to one or more of the other components of the expression cassette. In addition, expression cassettes may be naturally occurring but obtained in recombinant form useful for heterologous expression. Typically, however, expression cassettes are heterologous to the host. That is, the specific DNA sequence of the expression cassette is not naturally present in the host cell and must be introduced into the host cell or the progenitor of the host cell by the transformation process. Expression of the nucleotide sequence in the expression cassette may be under the control of a constitutive or inducible promoter that initiates transcription only when the host cell is exposed to some specific external stimulus. In the case of multicellular organisms such as plants, the promoter may also be specific for a particular tissue or organ or stage of development.

유전자: 용어 "유전자"는 생물학적 기능과 연관된 DNA의 임의 분절을 의미하며 광범위하게 사용된다. 따라서, 유전자는 발현에 필요한 암호화 서열 및/또는 조절 서열을 포함한다. 또한, 유전자는 예를 들어, 기타 단백질에 대한 인식 서열을 형성하는 비발현된 DNA 분절을 포함한다. 유전자는 관심있는 공급원으로부터의 클로닝 또는 공지되거나 추정된 서열 정보로부터의 합성을 포함하여 다양한 공급원으로부터 수득할 수 있으며 바람직한 파라미터를 지니도록 디자인된 서열을 포함할 수 있다.Gene: The term "gene" refers to any segment of DNA associated with a biological function and is used broadly. Thus, genes include coding sequences and / or regulatory sequences necessary for expression. In addition, genes include, for example, non-expressed DNA segments that form recognition sequences for other proteins. Genes can be obtained from a variety of sources, including cloning from a source of interest or synthesis from known or estimated sequence information, and can include sequences designed to have desirable parameters.

"관심있는 유전자"는 식물에게 전달될 경우 식물에게 항생제 내성, 바이러스 내성, 곤충 내성, 질병 내성 또는 다른 해충에 대한 내성, 제초제 내용성, 개선된 영양가, 공업 공정에서 개선된 효율 또는 변경된 생식 능력과 같은 바람직한 특성을 부여하는 임의 유전자를 의미한다. 또한, "관심있는 유전자"는 식물에서 상업적으로 가치있는 효소 또는 대사체의 생산을 위해 식물에게 전달되는 유전자일 수 있다."Genetic genes of interest", when delivered to plants, are characterized by antibiotic resistance, viral resistance, insect resistance, disease resistance or resistance to other pests, herbicide content, improved nutritional value, improved efficiency or altered fertility in industrial processes. Any gene that imparts the same desirable properties. In addition, a "gene of interest" may be a gene that is delivered to a plant for production of commercially valuable enzymes or metabolites in the plant.

본원에서 사용되는 바와 같이, "H04"는 독소 부분이 N-말단에 Cry1Ab의 도메인 I과 II를 포함하며 C-말단에 Cry1C의 도메인 III을 포함하는, 문헌[참조문헌: De Maagd et al., Appl. Environ. Microbiol. 62(5): 1537-1543 (1996)]에 기술된 하이브리드 Bt 독소를 의미한다.As used herein, "H04" refers to De Maagd et al., Wherein the toxin moiety comprises domains I and II of Cry1Ab at the N-terminus and domain III of Cry1C at the C-terminus. Appl. Environ. Microbiol. 62 (5): 1537-1543 (1996).

이종 핵산 서열: 본원에서 사용되는 용어 "이종 핵산[또는 DNA] 서열", "외인성 핵산[또는 DNA] 분절" 또는 "이종 유전자"는 각각 특정 숙주 세포에 대해 외래적인 공급원으로부터 기원하거나, 동일한 공급원으로부터 유래될 경우에는 이의 본래 형태로부터 변형된 서열을 의미한다. 따라서, 숙주 세포내의 이종 유전자는, 특정 숙주 세포에 대해 내인성이지만 예를 들어, 코돈 최적화의 사용을 통해 변형된 유전자를 포함한다. 본 용어는 또한 천연적으로 발생하는 서열의 비천연적으로 발생하는 다수의 복사체를 포함한다. 따라서, 본 용어는 세포에 대해 외래적 또는 이종성이거나, 세포에는 상동성이지만 그 요소가 전형적으로 발견되지 않는 숙주 세포 핵산 내의 위치에 존재하는 핵산 분절을 의미한다. 외인성 핵산 분절은 발현되어 외인성 펩타이드를 산출한다.Heterologous Nucleic Acid Sequence: As used herein, the terms “heterologous nucleic acid [or DNA] sequence”, “exogenous nucleic acid [or DNA] segment” or “heterologous gene” each originate from a source that is foreign to a particular host cell or from the same source). When derived, it means a sequence modified from its original form. Thus, heterologous genes in host cells include genes that are endogenous to a particular host cell but that have been modified, for example, through the use of codon optimization. The term also encompasses a number of non-naturally occurring copies of naturally occurring sequences. Thus, the term refers to a nucleic acid segment that is exotic or heterologous to a cell, or is located at a location within a host cell nucleic acid that is homologous to the cell but whose elements are typically not found. Exogenous nucleic acid segments are expressed to yield exogenous peptides.

"상동" 핵산[또는 DNA] 서열은 도입된 숙주 세포와 천연적으로 연관된 핵산[또는 DNA] 서열이다.A “homologous” nucleic acid [or DNA] sequence is a nucleic acid [or DNA] sequence naturally associated with the host cell into which it is introduced.

"상동 재조합"은 상동 핵산 분자 사이의 핵산 단편의 상호 교환이다."Homologous recombination" is the interchange of nucleic acid fragments between homologous nucleic acid molecules.

"일원형체성(homoplastidic)"은 모든 색소체가 유전적으로 동일한 식물, 식물 조직 또는 식물 세포를 의미한다. 이는 색소체가 형질전환되거나 돌연변이되거나 유전학적으로 변형되지 않았을 경우의 식물의 정상적인 상태이다 상이한 조직 또는 발달 단계에서, 색소체는 예를 들어, 엽록체, 전색소체, 에티오플라스트(etioplast), 녹말체 및 유색체 등과 같은 다른 형태를 취할 수 있 다."Homoplastidic" means a plant, plant tissue or plant cell in which all of the pigment bodies are genetically identical; This is the normal state of the plant when the pigment is not transformed, mutated or genetically modified. In different tissues or developmental stages, the pigment is for example chloroplasts, chromosomes, etioplasts, amyloids and It may take other forms, such as colored bodies.

2개 이상의 핵산 또는 단백질 서열의 범주에서 용어 "동일한" 또는 % "동일성"은 하기에서 기술하는 서열 비교 알고리듬을 사용하거나 시각적 검사에 의해 측정된 바와 같이, 비교하고 최대 상응성을 위해 정렬할 경우에, 동일하거나 동일한 아미노산 잔기 또는 뉴클레오타이드의 명시된 비율을 지니는 2개 이상의 서열 또는 부서열을 의미한다. The term “identical” or% “identity” in the category of two or more nucleic acid or protein sequences, when compared and aligned for maximum correspondence, as determined by visual inspection or using a sequence comparison algorithm described below. , Or two or more sequences or substrings having the specified proportion of identical or identical amino acid residues or nucleotides.

"살충성"은 곤충을 방제할 수 있는, 바람직하게는 곤충을 사멸시킬 수 있는 독성의 생물학적 활성도로서 정의된다."Pesticide" is defined as the toxic biological activity that can control insects, preferably kill them.

핵산 서열은 당해 핵산 서열이 참조 핵산 서열에 의해 암호화되는 폴리펩타이드와 동일한 아미노산 서열을 지니는 폴리펩타이드를 암호화할 경우 상기 핵산 서열과 "동일코딩(isocoding)"이다.A nucleic acid sequence is "isocoding" with the nucleic acid sequence when the nucleic acid sequence encodes a polypeptide having the same amino acid sequence as the polypeptide encoded by the reference nucleic acid sequence.

"분리된" 핵산 분자 또는 분리된 효소는 사람의 손에 의해 이의 천연 환경으로부터 떨어져 존재함으로써 천연의 생성물이 아닌 핵산 분자 또는 효소이다. 분리된 핵산 분자 또는 효소는 정제된 형태로 존재하거나, 예를 들어 재조합 숙주 세포와 같은 비천연 환경에 존재할 수 있다.A "isolated" nucleic acid molecule or an isolated enzyme is a nucleic acid molecule or enzyme that is not a natural product by being present away from its natural environment by a human hand. Isolated nucleic acid molecules or enzymes may be present in purified form or may be present in non-natural environments, such as, for example, recombinant host cells.

하이브리드 독소내의 독소 도메인 사이, 즉 본 발명에 따르는 하이브리드 살충성 독소의 도메인 II과 III 사이의 "연접부"는 하이브리드내의 상동 교차 영역 또는 부위이다. 교차 부위 좌측의 아미노산은 하나의 모체 독소로부터 유래되며, 교차 부위 좌측의 아미노산은 다른 모체 독소로부터 유래된다.The "junction" between the toxin domains in the hybrid toxin, ie between the domains II and III of the hybrid pesticidal toxin according to the invention, is a homologous cross-region or site in the hybrid. The amino acid to the left of the crossover site is derived from one parent toxin, and the amino acid to the left of the crossover site is derived from the other parent toxin.

성숙 단백질: 정상적으로 세포내 소기관을 표적으로 하며 전이 펩타이드가 제거된 단백질.Mature protein: A protein that normally targets intracellular organelles and has had its transfer peptides removed.

최소 프로모터: 불활성이거나 상부 활성화의 부재하에서 프로모터 활성이 크게 감소된 프로모터 요소, 특히 TATA 요소. 적합한 전사 인자의 존재하에서 최소 프로모터는 전사가 일어나도록 작용한다.Minimal promoter: promoter elements, particularly TATA elements, which are inactive or have greatly reduced promoter activity in the absence of upper activation. In the presence of suitable transcription factors, minimal promoters act to cause transcription.

천연의: 본 용어는 비형질전환된 세포의 게놈내에 존재하는 유전자를 의미한다.Natural: The term refers to a gene present in the genome of an untransformed cell.

천연적으로 발생하는: 용어 "천연적으로 발생하는"은 사람에 의해 인공적으로 생산된 것과 구별되는, 천연에서 발견될 수 있는 대상을 기술하는데 사용된다. 예를 들어, 천연의 공급원으로부터 분리될 수 있으며 실험실에서 사람에 의해 의도적으로 변형되지 않은, 유기체(바이러스를 포함)내에 존재하는 단백질 또는 뉴클레오타이드 서열이 천연적으로 발생하는 것이다.Naturally occurring: The term "naturally occurring" is used to describe a subject that can be found in nature, as distinct from that produced by man artificially. For example, naturally occurring proteins or nucleotide sequences present in organisms (including viruses) that can be isolated from natural sources and not intentionally modified by humans in the laboratory.

핵산: 용어 "핵산"은 일본쇄 또는 이본쇄 형태인 데옥시리보뉴클레오타이드 또는 리보뉴클레오타이드 또는 이들의 중합체를 의미한다. 달리 한정하지 않는 한, 본 용어는 참조 핵산과 유사한 결합 특성을 지니며 천연적으로 발생하는 뉴클레오타이드와 유사한 방식으로 대사되는, 천연 뉴클레오타이드의 공지된 유사체를 함유하는 핵산을 포함한다. 달리 명시하지 않는 한, 특정 핵산 서열은 이의 보존적으로 변형된 변이(예: 축퇴 코돈 치환) 및 상보적 서열과 명백하게 명시된 서열도 잠재적으로 포함한다. 구체적으로, 축퇴 코돈 치환은 하나 이상의 선택된(또는 모든) 코돈 중 제3 위치가 혼합된-염기 및/또는 데옥시이노신 잔기로 치환된 서열을 생성시킴으로써 달성될 수 있다[참조문헌: Batzer et al., Nucleic Acid Res. 19: 5081 (1991); Ohtsuka et al., J. Biol. Chem. 260:2605-2608(1985); Rossolini et al., Mol. Cell. Probes 8: 91-98 (1994)]. 용어 "핵산" 또는 "핵산 서열"은 유전자, cDNA 및 유전자에 의해 암호화되는 mRNA와 교환해서 사용할 수도 있다.Nucleic acid: The term “nucleic acid” means deoxyribonucleotides or ribonucleotides or polymers thereof in single- or double-stranded form. Unless defined otherwise, the term includes nucleic acids containing known analogues of natural nucleotides that have similar binding properties as the reference nucleic acid and are metabolized in a manner similar to naturally occurring nucleotides. Unless otherwise specified, a particular nucleic acid sequence potentially includes its conservatively modified variations (eg, degenerate codon substitutions) and complementary sequences and sequences explicitly specified. Specifically, degenerate codon substitutions can be achieved by generating sequences in which the third position of one or more selected (or all) codons is substituted with mixed-base and / or deoxyinosine residues. See Batzer et al. , Nucleic Acid Res. 19: 5081 (1991); Ohtsuka et al., J. Biol. Chem. 260: 2605-2608 (1985); Rossolini et al., Mol. Cell. Probes 8: 91-98 (1994). The term “nucleic acid” or “nucleic acid sequence” may be used interchangeably with genes, cDNAs, and mRNAs encoded by genes.

"ORF"는 개방 판독 프레임(Open Reading Frame)을 의미한다."ORF" means Open Reading Frame.

단백질의 "부분"이란, 상기 단백질에 포함되며 이의 연속적 서열의 80% 이상을 지니는 펩타이드를 의미한다.By “part” of a protein is meant a peptide contained in the protein and having at least 80% of its contiguous sequence.

"식물"은 임의 발단 단계상의 임의 식물, 특히 종자 식물이다."Plant" is any plant, especially seed plant, at any stage of development.

"식물 세포"는 원형질체 및 세포 벽을 포함하는 식물의 구조적 및 생리학적 단위이다. 식물 세포는 분리된 단일 세포 또는 배양된 세포의 형태일 수 있거나 예를 들어, 식물 조직, 식물 기관 또는 완전한 식물과 같은 고등하게 조직화된 단위의 일부일 수 있다."Plant cells" are structural and physiological units of plants, including protoplasts and cell walls. Plant cells may be in the form of isolated single cells or cultured cells or may be part of higher organized units such as, for example, plant tissues, plant organs or complete plants.

"식물 세포 배양물"은 예를 들어, 다양한 발달 단계상의 원형질체, 세포 배양 세포, 식물 조직내 세포, 화분, 화분관, 배주, 배낭, 접합체 및 배아와 같은 식물 단위의 배양물을 의미한다."Plant cell culture" means a culture of plant units such as, for example, protoplasts at various stages of development, cell culture cells, cells in plant tissues, pollen, pollen tubes, embryos, knapsacks, conjugates and embryos.

"식물질"은 잎, 줄기, 뿌리, 꽃 또는 꽃 부분, 과실, 화분, 난세포, 접합체, 종자, 삽목, 세포 또는 조직 배양물 또는 식물의 기타 다른 일부분 또는 생성물을 의미한다. "Plant" means a leaf, stem, root, flower or flower part, fruit, pollen, egg cell, conjugate, seed, cutting, cell or tissue culture or other part or product of a plant.

"식물 기관"은 뿌리, 줄기, 잎, 꽃눈 또는 배아와 같은 식물의 가시적으로 구조화되고 분화된 별개의 부분이다. A "plant organ" is a visually structured and differentiated discrete part of a plant such as roots, stems, leaves, flower buds or embryos.             

본원에서 사용되는 "식물 조직"은 구조적 및 기능적 단위로 조직화된 식물 세포의 그룹을 의미한다. 식물내 또는 배양물중의 식물의 임의 조직이 포함된다. 상기 용어는 완전한 식물, 식물 기관, 식물 종자, 조직 배양물 및 구조적 및/또는 기능적 단위로 조직화된 식물 세포의 임의 그룹을 포함하나 이에 제한되지 않는다. 상기 기재한 바와 같거나 본 정의에 포함되는 식물 조직의 임의 특정 유형과 관련하여 또는 이의 부재하에 상기 용어의 사용은 임의 기타 유형의 식물 조직을 배제하지 않는다.As used herein, "plant tissue" refers to a group of plant cells organized into structural and functional units. Any tissue of a plant in a plant or in culture is included. The term includes, but is not limited to, any group of complete plants, plant organs, plant seeds, tissue cultures, and plant cells organized into structural and / or functional units. The use of the term in connection with or without any particular type of plant tissue as described above or included in this definition does not exclude any other type of plant tissue.

"프로모터"는 RNA 폴리머라제 II에 대한 결합 부위를 함유하며 DNA의 전사를 개시하는 암호화 영역의 상부에 위치하는 해독되지 않는 DNA 서열이다. 프로모터 영역은 또한 유전자 발현의 조절자로서 작용하는 기타 요소를 포함할 수 있다.A "promoter" is an untranslated DNA sequence that contains a binding site for RNA polymerase II and is located on top of a coding region that initiates transcription of DNA. Promoter regions may also include other elements that act as regulators of gene expression.

"원형질체"는 세포 벽을 함유하지 않거나 세포 벽의 일부만을 함유하는 분리된 식물 세포이다.A "protoplasm" is an isolated plant cell that contains no cell wall or contains only a portion of the cell wall.

정제: 용어 "정제된"은 핵산 또는 단백질에 적용할 경우 핵산 또는 단백질이 천연 상태에서 관련된 다른 세포내 성분을 본질적으로 함유하지 않은 것을 가리킨다. 무수 또는 수용액중일 수 있으나 바람직하게는 균질 상태이다. 순도 및 균질성은 통상적으로 폴리아크릴아미드 겔 전기영동 또는 고성능 액체 크로마토그래피와 같은 분석적 화학 기술을 사용하여 측정한다. 제제중에 존재하는 주된 화학종인 단백질이 실질적으로 정제된다. 용어 "정제된"은 핵산 또는 단백질이 전기영동 겔에 필수적으로 하나의 밴드를 생성시키는 것을 가리킨다. 특히, 본 용어는 핵산 또는 단백질이 50% 이상 순수한, 보다 바람직하게는 85% 이상, 가장 바람직하게는 약 99% 이상 순수한 것을 의미한다.Purification: The term "purified", when applied to a nucleic acid or protein, indicates that the nucleic acid or protein is essentially free of other cellular components involved in its natural state. It may be anhydrous or in aqueous solution but is preferably homogeneous. Purity and homogeneity are typically measured using analytical chemistry techniques such as polyacrylamide gel electrophoresis or high performance liquid chromatography. Proteins, the major species present in the formulation, are substantially purified. The term "purified" refers to the nucleic acid or protein producing essentially one band in an electrophoretic gel. In particular, the term means that the nucleic acid or protein is at least 50% pure, more preferably at least 85%, most preferably at least about 99% pure.

두 핵산은, 이 두 핵산 각각으로부터의 서열이 자손 핵산으로서 배합된 경우 "재조합"된 것이다. 두 서열은 핵산 둘다가 재조합에 대한 기질이 될 경우 "직접적으로" 재조합된다. 두 서열은 이 서열들이 교차 올리고뉴클레오타이드와 같은 중간체를 사용하여 재조합될 경우 "간접적으로" 재조합된다. 간접적 재조합에 있어, 단지 하나의 서열만이 재조합에 대한 실제 기질이며, 일부 경우에서는 어떠한 서열도 재조합에 대한 기질이 아니다.Two nucleic acids are “recombined” when sequences from each of these two nucleic acids are combined as progeny nucleic acids. Both sequences are recombined "directly" if both nucleic acids are substrates for recombination. Both sequences are “indirectly” recombined when these sequences are recombined using an intermediate such as a cross oligonucleotide. In indirect recombination, only one sequence is the actual substrate for recombination, and in some cases no sequence is the substrate for recombination.

"조절 요소"는 뉴클레오타이드 서열의 발현을 조절하는데 관련된 서열을 의미한다. 조절 요소는 관심있는 뉴클레오타이드 서열에 작동가능하게 연결된 프로모터 및 종결 시그날을 포함한다. 이들은 또한 통상적으로 뉴클레오타이드 서열의 적절한 전사에 필요한 서열을 포함한다."Regulatory element" means a sequence that is involved in regulating the expression of a nucleotide sequence. Regulatory elements include promoters and termination signals operably linked to the nucleotide sequence of interest. They also typically include sequences required for proper transcription of the nucleotide sequence.

실질적으로 동일한: 2개의 핵산 또는 단백질 서열의 범주에서, 구 "실질적으로 동일한"은 하기의 서열 비교 알고리듬 중 하나를 사용하거나 시각적 검사에 의해 측정된 바와 같이, 비교하고 최대 상응성을 위해 정렬할 경우 60% 이상, 바람직하게는 80%, 보다 바람직하게는 90%, 보다 더욱 바람직하게는 95% 및 가장 바람직하게는 99% 이상의 뉴클레오타이드 또는 아미노산 잔기 동일성을 나타내는 2개 이상의 서열 또는 부서열을 의미한다. 바람직하게는 실질적 동일성은 길이가 약 50개 이상의 잔기인 서열의 영역, 보다 바람직하게는 약 100개 이상의 잔기의 영역에 걸쳐서 나타나며, 가장 바람직하게는 서열은 약 150개 이상의 잔기가 실질적으로 동일하다. 가장 바람직한 양태에서, 서열은 암호화 영역의 전체 길이에 걸쳐서 실 질적으로 동일하다. 또한, 실질적으로 동일한 핵산 또는 단백질 서열은 실질적으로 동일한 기능을 수행한다.Substantially identical: In the category of two nucleic acid or protein sequences, the phrase “substantially identical” when compared and aligned for maximum correspondence, as determined by visual inspection or using one of the following sequence comparison algorithms By at least 60%, preferably at least 80%, more preferably at least 90%, even more preferably at least 95% and most preferably at least 99% nucleotide or amino acid residue identity. Preferably substantially identity is shown over a region of a sequence that is at least about 50 residues in length, more preferably a region of at least about 100 residues, and most preferably the sequence is substantially identical at least about 150 residues. In the most preferred embodiment, the sequences are substantially identical over the entire length of the coding region. In addition, substantially identical nucleic acid or protein sequences perform substantially the same function.

서열 비교에 있어, 통상적으로 하나의 서열이 시험 서열과 비교되는 참조 서열로서 작용한다. 서열 비교 알고리듬을 사용할 경우, 시험 및 참조 서열을 컴퓨터에 입력하고, 필요에 따라 부서열 좌표를 디자인하고 서열 알고리듬 프로그램 매개변수를 디자인한다. 이어서, 서열 비교 알고리듬은 디자인된 프로그램 매개변수에 기초하여 참조 서열에 대한 시험 서열(들)의 % 서열 동일성을 계산한다.In sequence comparison, typically one sequence acts as a reference sequence to which the test sequence is compared. When using a sequence comparison algorithm, test and reference sequences are entered into a computer, designing subsequence coordinates and designing sequence algorithm program parameters as needed. The sequence comparison algorithm then calculates the% sequence identity of the test sequence (s) relative to the reference sequence based on the designed program parameters.

비교를 위한 최적의 서열 정렬은 문헌[참조문헌: Smith & Waterman, Adv. Appl. Math. 2:482 (1981)]의 국부적 상동성 알고리듬, 문헌[참조문헌: Needleman & Wunsch, J. Mol. Biol. 48:443 (1970)]의 상동성 알고리듬, 문헌[참조문헌: Pearson & Lipman, Proc. Natl'l. Acad. Sci. USA 85:2444 (1989)]의 유사성 방법용 탐색, 상기 알고리듬들의 컴퓨터화된 실행(GAP, BESTFIT, FASTA 및 TFASTA, 제조원: Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, WI) 또는 시각적 검사[참조문헌: Ausubel et al.)에 의해 수행할 수 있다.Optimal sequence alignments for comparison are described in Smith & Waterman, Adv. Appl. Math. 2: 482 (1981), the local homology algorithm, Needleman & Wunsch, J. Mol. Biol. 48: 443 (1970), the homology algorithm of Pearson & Lipman, Proc. Natl'l. Acad. Sci. USA 85: 2444 (1989), a search for similarity methods, computerized implementation of the algorithms (GAP, BESTFIT, FASTA and TFASTA, manufactured by Wisconsin Genetics Software Package, Genetics Computer Group, 575 Science Dr., Madison, WI). Or by visual inspection (Ausubel et al.).

% 서열 동일성 및 서열 유사성을 측정하는데 적합한 알고리듬의 한 예는, 문헌[참조문헌: Altschul et al., J. Mol. Biol. 215:403-410 (1990)]에 기술되어 있는 BLAST 알고리듬이다. BLAST 분석 수행용 소프트웨어는 기관[National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/)]을 통해 공개적으로 이용가능하다. 상기 알고리듬은 데이터베이스 서열내의 동일한 길이의 워드와 정렬되는 경우에 일부 양성-평가된 역치 스코어 T와 매치되거나 이를 만족시키는, 조회 서열내의 짧은 길이의 워드 W를 동정함으로써 높은 스코어의 서열 쌍(HSP)을 먼저 동정하는 것과 관련된다[참조문헌: Altschul et al., 1990]. 이러한 초기의 근접한 워드의 적중은 이들을 함유하는 보다 긴 HSP를 찾기 위해 탐색을 개시하는데 있어 기초로서 작용한다. 이어서 워드 명중은 누적 정렬 스코어가 보다 증가할 수 있는 한은 각 서열을 따라서 두 방향으로 확장된다. 누적 스코어는, 뉴클레오타이드 서열의 경우에는 매개변수 M(매치되는 잔기의 쌍에 대한 보상 스코어; 항상 >0) 및 N(미스매치되는 잔기에 대한 페널티 스코어; 항상 <0)을 사용하여 계산한다. 아미노산 서열의 경우에는, 득점 매트릭스를 사용하여 누적 스코어를 계산한다. 각 방향으로의 워드 적중의 확장은, 누적 정렬 스코어가 이의 최대로 성취된 값으로부터 X량 만큼 감소되고 누적 스코어가 하나 이상의 음성-득점 잔기 정렬의 축적으로 인해 0 또는 그 이하로 가까워지거나 서열의 말단에 도달할 경우에 중지된다. BLASTN 알고리듬 매개변수 W, T 및 X는 정렬의 민감성 및 속도를 결정한다. BLAST 프로그램(뉴클레오타이드 서열용)은 데폴트로서 워드길이 11, 기대값(E) 10, 컷오프 100, M=5, N=-4 및 두 서열의 비교를 사용한다. 아미노산 서열의 경우, BLASTP 프로그램은 데폴트로서 워드길이(W) 3, 기대값(E) 10 및 BLOSUM62 득점 매트릭스[참조문헌: Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89:10915 (1989)]를 사용한다.One example of a suitable algorithm for determining% sequence identity and sequence similarity is Altschul et al., J. Mol. Biol. 215: 403-410 (1990). Software for performing BLAST analyzes is publicly available through the National Center for Biotechnology Information (http://www.ncbi.nlm.nih.gov/). The algorithm generates a high score sequence pair (HSP) by identifying a short length word W in the query sequence that matches or satisfies some positive-evaluated threshold score T when aligned with words of equal length in the database sequence. First associated with identification (Altschul et al., 1990). This early close hit of words serves as the basis for initiating the search to find longer HSPs containing them. The word hit then expands in two directions along each sequence as long as the cumulative alignment score can be increased further. Cumulative scores are calculated using the parameters M (reward score for pairs of matched residues; always> 0) and N (penalty score for mismatched residues; always <0) for nucleotide sequences. For amino acid sequences, the scoring matrix is used to calculate the cumulative score. Expansion of the word hit in each direction results in a cumulative alignment score reduced by an amount of X from its maximum achieved value and the cumulative score approaching zero or less due to the accumulation of one or more negative-scoring residue alignments or the end of the sequence. It stops when it reaches. The BLASTN algorithm parameters W, T, and X determine the sensitivity and speed of the alignment. The BLAST program (for nucleotide sequences) uses a comparison of the two sequences as word length 11, expected value E 10, cutoff 100, M = 5, N = -4 as default. For amino acid sequences, the BLASTP program uses word length (W) 3, expected value (E) 10 and BLOSUM62 scoring matrices as defaults [Henikoff & Henikoff, Proc. Natl. Acad. Sci. USA 89: 10915 (1989).

% 서열 동일성을 계산하는 것 이외에, BLAST 알고리듬은 두 서열 간의 유사성에 대한 통계학적 분석을 또한 수행한다[참조문헌: Karlin & Altschun, Proc. Nat'l. Acad. Sci. USA 90: 5873-5787 (1993)]. BLAST 알고리듬에 의해 제공된 유사성의 한가지 척도는 2개의 뉴클레오타이드나 아미노산 서열 간의 매치가 우연히 발생할 확률의 지표를 제공하는 최소 총 확률(P(N))이다. 예를 들어, 시험 핵산 서열은 시험 핵산 서열과 참조 핵산 서열을 비교하여 최소 총 확률이 약 0.1 미만, 보다 바람직하게는 약 0.01 미만 및 가장 바람직하게는 약 0.001 미만인 경우에 참조 서열과 유사한 것으로 고려된다.In addition to calculating% sequence identity, the BLAST algorithm also performs a statistical analysis of the similarity between the two sequences. See Karlin & Altschun, Proc. Nat'l. Acad. Sci. USA 90: 5873-5787 (1993). One measure of similarity provided by the BLAST algorithm is the minimum total probability (P (N)), which provides an indication of the probability by which a match between two nucleotide or amino acid sequences will occur by chance. For example, a test nucleic acid sequence is considered similar to a reference sequence when the test nucleic acid sequence is compared to the reference nucleic acid sequence when the minimum total probability is less than about 0.1, more preferably less than about 0.01 and most preferably less than about 0.001. .

두 핵산 서열이 실질적으로 동일하다는 또 다른 지표는 상기 두 분자가 엄격한 조건(stringent condition)하에 서로 하이브리드화되는 가이다. 구 "에 특이적으로 하이브리드화하는"은 특정 뉴클레오타이드 서열이 복합 혼합물(예를 들어, 전체 세포의) DNA 또는 RNA 중에 존재하는 경우에 분자가 엄격한 조건하에 이 특정 뉴클레오타이드 서열에만 결합, 이중화 또는 하이브리드화하는 것을 의미한다. "실질적으로 결합하는"은 프로브 핵산과 표적 핵산 간의 상보적 하이브리드화를 의미하며, 표적 핵산 서열의 목적하는 검출을 수행하기 위해 하이브리드화 매질의 엄격도를 감소시켜 수용할 수 있는 소수의 미스매치를 포함한다.Another indication that two nucleic acid sequences are substantially identical is whether the two molecules hybridize to each other under stringent conditions. The phrase “hybridizing specifically” refers to binding, duplication or hybridization to only this particular nucleotide sequence under stringent conditions when the particular nucleotide sequence is present in a complex mixture (eg, of whole cells) DNA or RNA. I mean. "Substantially binding" means complementary hybridization between a probe nucleic acid and a target nucleic acid, with a small number of mismatches that can be accommodated by reducing the stringency of the hybridization medium to effect the desired detection of the target nucleic acid sequence. Include.

서던(Southern) 및 노던(Northern) 하이브리드화와 같은 핵산 하이브리드화 실험의 범주에서 "엄격한 하이브리드화 조건" 및 "엄격한 하이브리드화 세척 조건"은 서열 의존적이며 상이한 환경 매개변수하에 상이하다. 보다 긴 서열은 보다 고온에서 특이적으로 하이브리드화한다. 핵산의 하이브리드화에 관한 폭넓은 지침은 문헌[참조문헌: Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology-hybridization with Nucleic Acid Probes part I chapter 2 "Overview of principles of hybridization and the strategy of nucleic acid probe assays" Elsevier, New York]에서 찾아볼 수 있다. 일반적으로, 고도로 엄격한 하이브리드화 및 세척 조건은 소정의 이온 강도 및 pH에서 특정 서열에 대한 열 용융점(Tm)보다 약 5℃가 낮도록 선택한다. 통상적으로, "엄격한 조건"하에 프로브는 이의 표적 부서열과 하이브리드화할 수 있으나 다른 서열과는 하이브리드화하지 않는다.In the scope of nucleic acid hybridization experiments such as Southern and Northern hybridizations, "strict hybridization conditions" and "strict hybridization wash conditions" are sequence dependent and different under different environmental parameters. Longer sequences hybridize specifically at higher temperatures. For extensive guidance on hybridization of nucleic acids, see Tijssen (1993) Laboratory Techniques in Biochemistry and Molecular Biology-hybridization with Nucleic Acid Probes part I chapter 2 "Overview of principles of hybridization and the strategy of nucleic acid probe assays. "Elsevier, New York." In general, highly stringent hybridization and wash conditions are selected such that about 5 ° C. below the thermal melting point (T m ) for a particular sequence at a given ionic strength and pH. Typically, a probe can hybridize with its target substring under “strict conditions” but not with other sequences.

Tm은 (소정의 이온 강도 및 pH하에) 표적 서열의 50%가 완벽하게 매치된 프로브에 하이브리드화하는 온도이다. 매우 엄격한 조건은 특정 프로브에 대한 Tm과 동일하도록 선택한다. 서던 또는 노던 블롯에서 필터 상에 100개 이상의 상보적 잔기를 지니는 상보적 핵산의 하이브리드화에 대한 엄격한 하이브리드화 조건은 42℃에서 50% 포름아미드와 헤파린 1mg에서 밤새 하이브리드화를 수행하는 것이다. 고도로 엄격한 세척 조건의 예는 72℃에서 15분 동안 0.15M NaCl이다. 엄격한 세척 조건의 예는 65℃에서 15분 동안의 0.2×SSC 세척이다[참조문헌: SSC 완충액의 기술에 관한 Sambrook, infra,]. 흔히, 고도의 엄격도 세척은 배경 프로브 시그날을 제거하기 위해 낮은 엄격도 세척으로 진행한다. 예를 들어, 100개 이상의 뉴클레오타이드의 이중체에 대한 매질 엄격도 세척의 예는 45℃에서 15분 동안의 1×SSC이다. 예를 들어, 100개 이상의 뉴클레오타이드의 이중체에 대한 낮은 엄격도 세척의 예는 40℃에서 15분 동안의 4 내지 6×SSC이다. 짧은 프로브(예를 들어, 약 10개 내지 50개의 뉴클레오타이드)의 경우, 엄격한 조건은 통상적으로 pH 7.0 내지 8.3에서 약 1.0M 미만의 Na 이온의 염 농도, 통상적으로 약 0.01 내지 1.0M Na 이온 농도(또는 기타 염)이며 온도는 통상적으로 약 30℃ 이상이다. 엄격한 조건은 포름아미드와 같은 불안정화제를 첨가하여 달성할 수도 있다. 일반적으로, 특정 하이브리드화 검정시에 비관련된 프로브에서 관찰되는 것의 2배(또는 그 이상)인 시그날 대 노이즈 비는 특이적 하이브리드화의 검출을 나타낸다. 엄격한 조건하에 서로 하이브리드화하지 않는 핵산이라도 이들이 암호화하는 단백질이 실질적으로 동일한 경우에는 여전히 실질적으로 동일하다. 이는 예를 들어, 핵산의 복사체가 유전암호에 의해 허용된 최대 코돈 축퇴성을 사용하여 생성될 경우에 발생한다.T m is the temperature at which 50% of the target sequence hybridizes to a perfectly matched probe (under some ionic strength and pH). Very stringent conditions are chosen to be equal to the T m for a particular probe. Stringent hybridization conditions for hybridization of complementary nucleic acids with more than 100 complementary residues on a filter in Southern or Northern blots are to perform hybridization overnight at 42 ° C. with 50% formamide and 1 mg of heparin. An example of highly stringent washing conditions is 0.15 M NaCl for 15 minutes at 72 ° C. An example of stringent washing conditions is a 0.2 × SSC wash for 15 minutes at 65 ° C. (Sambrook, Infra, on the description of SSC buffer). Often, high stringency washes proceed with low stringency washes to remove background probe signals. For example, an example of medium stringency washing for duplexes of 100 or more nucleotides is 1 × SSC for 15 minutes at 45 ° C. For example, an example of a low stringency wash for duplexes of 100 or more nucleotides is 4-6 × SSC for 15 minutes at 40 ° C. For short probes (e.g., about 10 to 50 nucleotides) stringent conditions are typically at salt concentrations of Na ions of less than about 1.0 M, typically from about 0.01 to 1.0 M Na ion concentration, at pH 7.0 to 8.3 Or other salts) and the temperature is typically at least about 30 ° C. Stringent conditions may also be achieved by the addition of destabilizing agents such as formamide. In general, a signal to noise ratio that is twice (or more) than that observed in unrelated probes in a particular hybridization assay indicates detection of specific hybridization. Even nucleic acids that do not hybridize to each other under stringent conditions are still substantially identical if the proteins they encode are substantially identical. This occurs, for example, when a copy of a nucleic acid is produced using the maximum codon degeneracy allowed by the genetic code.

다음은 본 발명의 참조 서열과 실질적으로 동일한 상동성 뉴클레오타이드 서열을 클로닝하는데 사용할 수 있는 하이브리드화/세척 조건 세트의 예이다: 참조 뉴클레오타이드 서열은 바람직하게는 50℃에서 7% 나트륨 도데실 설페이트(SDS), 0.5M NaPO4, 1mM EDTA에서와 50℃에서 2×SSC, 0.1% SDS에서의 세척, 보다 바람직하게는 50℃에서 7% 나트륨 도데실 설페이트(SDS), 0.5M NaPO4, 1mM EDTA에서와 50℃에서 1×SSC, 0.1% SDS에서의 세척, 보다 바람직하게는 50℃에서 7% 나트륨 도데실 설페이트(SDS), 0.5M NaPO4, 1mM EDTA에서와 50℃에서 0.5×SSC, 0.1% SDS에서의 세척, 바람직하게는 50℃에서 7% 나트륨 도데실 설페이트(SDS), 0.5M NaPO4, 1mM EDTA에서와 50℃에서 0.1×SSC, 0.1% SDS에서의 세척, 보다 바람직하게는 50℃에서 7% 나트륨 도데실 설페이트(SDS), 0.5M NaPO4, 1mM EDTA에서와 50℃에서 0.1×SSC, 0.1% SDS에서의 세척 조건하에 하이브리드화한다.The following is an example of a set of hybridization / wash conditions that can be used to clone homologous nucleotide sequences that are substantially identical to the reference sequences of the present invention: The reference nucleotide sequence is preferably 7% sodium dodecyl sulfate (SDS) at 50 ° C. In 0.5 M NaPO 4 , 1 mM EDTA and at 50 ° C., 2 × SSC, 0.1% SDS, more preferably at 50 ° C., 7% sodium dodecyl sulfate (SDS), 0.5 M NaPO 4 , 1 mM EDTA 1 × SSC at 50 ° C., wash in 0.1% SDS, more preferably 7% sodium dodecyl sulfate (SDS) at 50 ° C., 0.5M NaPO 4 , 0.5 × SSC, 0.1% SDS at 50 ° C. Wash at, preferably at 7% sodium dodecyl sulfate (SDS) at 50 ° C., 0.5 M NaPO 4 , 1 mM EDTA and at 50 ° C. at 0.1 × SSC, at 0.1% SDS, more preferably at 50 ° C. 7% Sodium Dodecyl Sulfate (SDS), 0.5 M NaPO 4 , 0.1 × SSC, 0. at 1 mM EDTA and at 50 ° C. Hybridize under wash conditions in 1% SDS.

2개의 핵산 서열 또는 단백질이 실질적으로 동일하다는 추가의 지표는 제1 핵산에 의해 암호화되는 단백질이 제2 핵산에 의해 암호화되는 단백질과 면역학적으로 교차 반응성이거나 이와 특이적으로 결합하는 것이다. 따라서, 단백질이 통상적으로 제2 단백질과 실질적으로 동일하다면, 이때는 예를 들어, 두 단백질이 보존적 치환만이 상이한 경우이다.A further indicator that two nucleic acid sequences or proteins are substantially identical is that the protein encoded by the first nucleic acid is immunologically cross-reactive or specifically binds to the protein encoded by the second nucleic acid. Thus, if a protein is typically substantially identical to a second protein, then this is the case, for example, when the two proteins differ only in conservative substitutions.

구 "항체에 특이적으로(또는 선택적으로) 결합하는" 또는 "와 특이적으로(또는 선택적으로) 면역반응성인"은 단백질 또는 펩타이드를 가리킬 경우 단백질의 이종 집단 및 기타 생물제제(biologics)의 존재하에 단백질의 존재의 결정요인인 결합 반응을 의미한다. 따라서, 디자인된 면역검정 조건하에, 명시된 항체는 특정 단백질에 결합하며 샘플 중에 존재하는 다른 단백질에는 상당량으로 결합하지 않는다. 이러한 조건하에 항체에의 특이적 결합은 특정 단백질에 대한 특이성을 위해 선택된 항체를 요한다. 예를 들어, 본 발명의 핵산 서열 중 어느 하나에 의해 암호화되는 아미노산 서열을 함유하는 단백질에 대해 발생한 항체를 선택하여 상기 단백질과는 특이적으로 면역반응성이나 다형 변이체를 제외한 다른 단백질과는 면역반응성이 아닌 항체를 수득할 수 있다. 다양한 면역검정 형식을 특정 단백질과 특이적으로 면역반응성인 항체를 선택하는데 사용할 수 있다. 예를 들어, 고체상 ELISA 면역검정, 웨스턴 블롯 또는 면역조직화학을 단백질과 특이적으로 면역반응 성인 모노클로날 항체를 선택하는데 통상적으로 사용한다[참조문헌: 특이적 면역반응성을 측정하는데 사용할 수 있는 면역검정 형식 및 조건에 관해, Harlow and Lane (1988) Antibodies, A Laboratory Manual, Cold Spring Harbor Publications, New York "Harlow and Lane")]. 통상적으로, 특이적 또는 선택적 반응은 2배 이상의 배경 시그날 또는 노이즈일 수 있으며, 보다 통상적으로는 10배 내지 100배 이상의 배경 시그날 또는 노이즈일 수 있다.The phrase “specifically (or selectively) binds to an antibody” or “specifically (or selectively) immunoreactive with” refers to a protein or peptide and the presence of a heterogeneous population of proteins and other biologics Under a binding reaction that is a determinant of the presence of a protein. Thus, under the designed immunoassay conditions, the specified antibody binds to a particular protein and does not bind to other proteins present in the sample in significant amounts. Specific binding to antibodies under these conditions requires an antibody selected for specificity for the particular protein. For example, an antibody generated against a protein containing an amino acid sequence encoded by any of the nucleic acid sequences of the present invention may be selected so that the immunoreactivity with other proteins except for the immunoreactivity or polymorphic variants is specific. Non-antibodies can be obtained. Various immunoassay formats can be used to select antibodies that are specifically immunoreactive with specific proteins. For example, solid phase ELISA immunoassays, Western blots or immunohistochemistry are commonly used to select immunoreactive adult monoclonal antibodies specifically for proteins. [Immune can be used to measure specific immunoreactivity. For assay format and conditions, Harlow and Lane (1988) Antibodies, A Laboratory Manual, Cold Spring Harbor Publications, New York "Harlow and Lane"). Typically, the specific or selective response may be two or more times background signal or noise, more typically 10 to 100 times or more background signal or noise.

"부서열"은 보다 긴 각각의 핵산 또는 아미노산(예: 단백질) 서열의 일부를 포함하는 핵산 또는 아미노산의 서열을 의미한다."Subsequence" means a sequence of nucleic acids or amino acids comprising a portion of each longer nucleic acid or amino acid (eg protein) sequence.

"합성 "은 천연 서열에 존재하지 않는 구조적 특징을 포함하는 뉴클레오타이드 서열을 의미한다. 예를 들어, 단자엽식물 및/또는 쌍자엽식물 유전자의 G+C 함량 및 정상 코돈 분포와 보다 밀접하게 유사한 인공 서열이 합성이라고 언급된다."Synthetic" means a nucleotide sequence that includes structural features not present in the native sequence. For example, artificial sequences that are more closely similar to the G + C content and normal codon distribution of monocotyledonous and / or dicotyledonous genes are referred to as synthetic.

"형질전환"은 이종 핵산을 숙주 세포 또는 유기체내로 도입하는 과정이다. 특히, "형질전환"은 DNA 분자를 관심있는 유기체의 게놈내로 안정하게 삽입하는 것을 의미한다. 형질전환된 세포, 조직 또는 곤충은 형질전환 과정의 최종 생성물 뿐만 아니라 이의 형질전환 자손도 포함하는 것으로 이해된다."Transformation" is the process of introducing a heterologous nucleic acid into a host cell or organism. In particular, “transformation” means the stable insertion of a DNA molecule into the genome of an organism of interest. Transformed cells, tissues or insects are understood to include not only the end product of the transformation process but also the transgenic offspring thereof.

"형질전환된/형질전환/재조합"은 이종 핵산 분자가 도입된 세균 또는 식물과 같은 숙주 유기체를 의미한다. 핵산 분자는 숙주의 게놈내로 안정하게 삽입될 수 있거나, 염색체외 분자로서 존재할 수도 있다. 이러한 염색체외 분자는 자가 복제할 수 있다. 형질전환된 세포, 조직 또는 식물은 형질전환 과정의 최종 생성물 뿐만 아니라, 이의 형질전환 자손도 포함하는 것으로 이해된다. "비형질전환된", " 비형질전환" 또는 "비재조합" 숙주는 야생형 유기체, 예를 들어, 이종 핵산 분자를 함유하지 않는 세균 또는 식물을 의미한다."Transformed / transformed / recombinant" means a host organism, such as a bacterium or plant, into which a heterologous nucleic acid molecule has been introduced. Nucleic acid molecules can be stably inserted into the genome of a host or can exist as extrachromosomal molecules. Such extrachromosomal molecules can autonomously replicate. Transformed cells, tissues or plants are understood to include not only the end product of the transformation process, but also their transformed progeny. By "untransformed", "untransformed" or "unrecombinant" host is meant a bacterium or plant that does not contain a wild type organism, eg, a heterologous nucleic acid molecule.

뉴클레오타이드는 다음의 표준 약어에 의한 염기로 명시한다: 아데닌(A), 사이토신(C), 티민(T) 및 구아닌(G). 마찬가지로 아미노산을 다음 표준 약어로 명시한다: 알라닌(Ala; A), 아르기닌(Arg; R), 아스파라긴(Asn; N), 아스파르트산(Asp; D), 시스테인(Cys; C), 글루타민(Gln; Q), 글루탐산(Glu; E), 글리신(Gly; G), 히스티딘(His: H), 이소류신(Ile; I), 류신(Leu; L), 라이신(Lys; K), 메티오닌(Met; M), 페닐알라닌(Phe; F), 프롤린(Pro; P), 세린(Ser; S), 트레오닌(Thr; T), 트립토판(Trp; W), 티로신(Tyr; Y) 및 발린(Val; V). 또한, (Xaa; X)는 임의 아미노산을 나타낸다.Nucleotides are specified as bases by the following standard abbreviations: adenine (A), cytosine (C), thymine (T) and guanine (G). Likewise amino acids are designated by the following standard abbreviations: alanine (Ala; A), arginine (Arg; R), asparagine (Asn; N), aspartic acid (Asp; D), cysteine (Cys; C), glutamine (Gln; Q), glutamic acid (Glu; E), glycine (Gly; G), histidine (His: H), isoleucine (Ile; I), leucine (Leu; L), lysine (Lys; K), methionine (Met; M ), Phenylalanine (Phe; F), proline (Pro; P), serine (Ser; S), threonine (Thr; T), tryptophan (Trp; W), tyrosine (Tyr; Y) and valine (Val; V) . In addition, (Xaa; X) represents an arbitrary amino acid.

본 발명은 발현하여 신규한 독소를 생성하는 신규한 핵산 서열 및 당해 독소를 제조 및 사용하여 해충을 방제하는 방법에 관한 것이다. 특히, 본 발명은 독소 부분이 Cry1Ab의 도메인 I과 II 및 Cry1C의 도메인 III를 함유하는 다양한 형태의 하이브리드 바실러스 튜린지엔시스 델타-내독소 H04를 암호화하는, 식물에서의 발현을 위해 최적화된 합성 유전자 서열에 관한 것이다. 천연 Cry1Ab 및 Cry1C 유전자로부터 작제된, H04 하이브리드 독소를 암호화하는 하이브리드 유전자는 미국 특허 제5,736,131호 및 문헌[참조문헌: De Maagd et al., Appl. Environ. Microbiol. 62(5): 1537-1543 (1996)]에 기재되어 있다. 본 발명의 합성 H04 유전자를 작제하기에 바람직한 방법은 WO 93/07278에 기재되어 있다. 당해 신규한 유전자 서열에 의해 암호화되는 하이브리드 바실러스 튜린지엔시스 독소는 밤나방, 분홍면화씨벌 레, 담배나방, 유럽조명나방 및 배추좀나방과 같은 경제적으로 중요한 해충에 대해 고도로 활성적이다. 하이브리드 바실러스 튜린지엔시스 독소를 다수의 곤충 방제 전략에서 사용하여 환경에 대한 영향력을 최소로 하면서 최대의 효율성을 수득할 수 있다.The present invention relates to novel nucleic acid sequences that express and produce new toxins and methods of preparing and using the toxins to control pests. In particular, the present invention provides synthetic gene sequences optimized for expression in plants wherein the toxin moiety encodes various forms of hybrid Bacillus thuringiensis delta-endotoxin H04 containing domains I and II of Cry1Ab and domain III of Cry1C. It is about. Hybrid genes encoding the H04 hybrid toxin, constructed from native Cry1Ab and Cry1C genes, are described in US Pat. No. 5,736,131 and in De Maagd et al., Appl. Environ. Microbiol. 62 (5): 1537-1543 (1996). Preferred methods for constructing the synthetic H04 gene of the present invention are described in WO 93/07278. Hybrid Bacillus thuringiensis toxins encoded by this novel gene sequence are highly active against economically important pests such as chestnut moth, pink cotton seedling, tobacco moth, European light moth and cabbage moth. Hybrid Bacillus thuringiensis toxins can be used in many insect control strategies to achieve maximum efficiency with minimal impact on the environment.

본 발명은 본 발명의 살충성 독소를 암호화하는 뉴클레오타이드 서열을 포함하는 DNA 분자를 포함한다. 본 발명은 본 발명의 핵산 서열을 포함하는 재조합 벡터를 추가로 포함한다. 상기 벡터에서, 핵산 서열은 바람직하게는 뉴클레오타이드 서열을 발현할 수 있는 숙주 세포내에서 뉴클레오이드 서열을 발현하기 위한 조절 요소를 포함하는 발현 카세트내에 포함된다. 이러한 조절 요소는 통상적으로 프로모터 및 종결 시그널을 포함하며, 바람직하게는 본 발명의 핵산 서열에 의해 암호화되는 단백질이 효율적으로 전사되도록 하는 요소를 또한 포함한다. 당해 핵산 서열을 포함하는 벡터는 통상적으로 특히 숙주 세포내에서 바람직하게는 염색체외 분자로서 복제할 수 있으므로 본 발명의 핵산 서열을 숙주 세포내에서 증폭시키는데 사용된다. 하나의 양태에서, 이러한 벡터용 숙주 세포로는 세균, 특히 바실러스 튜린지엔시스 또는 이. 콜라이와 같은 미생물이 있다. 다른 양태에서, 이러한 재조합 벡터용 숙주 세포로는 내생식물 또는 착생식물이 있다. 이러한 벡터용으로 바람직한 숙주 세포로는 식물 세포와 같은 진핵 세포가 있다. 옥수수 세포와 같은 식물 세포가 가장 바람직한 숙주 세포이다.The present invention includes a DNA molecule comprising a nucleotide sequence encoding a pesticidal toxin of the present invention. The present invention further includes a recombinant vector comprising the nucleic acid sequence of the present invention. In such vectors, the nucleic acid sequence is preferably contained in an expression cassette comprising regulatory elements for expressing the nucleotide sequence in a host cell capable of expressing the nucleotide sequence. Such regulatory elements typically include a promoter and a termination signal, and preferably also include elements that allow the protein encoded by the nucleic acid sequences of the invention to be efficiently transcribed. The vector comprising the nucleic acid sequence is usually used for amplifying the nucleic acid sequence of the present invention in the host cell since it can replicate particularly preferably as an extrachromosomal molecule in the host cell. In one embodiment, host cells for such vectors include bacteria, in particular Bacillus thuringiensis or E. coli. There are microorganisms such as E. coli. In other embodiments, such host cells for recombinant vectors include endogenous or complex plants. Preferred host cells for such vectors include eukaryotic cells such as plant cells. Plant cells such as corn cells are the most preferred host cells.

특히 바람직한 양태에서, 본 발명의 살충성 독소는 식물에서 발현된다. 상기 경우에, 유효량의 독소를 발현하는 형질전환 식물은 식물 자신을 해충으로부터 보호한다. 곤충이 이러한 형질전환 식물을 먹이로 할 경우, 발현된 독소도 섭취하게 된다. 이는 곤충이 식물 조직을 먹어들어가는 것을 방해하거나 심지어 곤충을 손상시키거나 치사시킬 수 있다.In a particularly preferred embodiment, the pesticidal toxins of the invention are expressed in plants. In this case, the transgenic plant expressing an effective amount of toxins protects the plant itself from pests. When insects feed on these transgenic plants, they also consume the expressed toxins. This can interfere with insects eating into plant tissue or even damage or even kill insects.

본원에서 기술하는 핵산 서열은 종래의 재조합 DNA 기술을 사용하여 식물 세포내로 혼입할 수 있다. 일반적으로, 이는 본 발명의 암호화 서열을 당해 분야에 공지된 표준 클로닝 과정을 사용하여 당해 암호화 서열에 대해 이종인(즉, 당해 암호화 서열이 존재하지 않는) 발현 시스템내로 삽입시키는 것과 관련된다. 벡터는 삽입된 단백질-암호화 서열의 전사 및 해독에 필수적인 요소를 함유한다. 플라스미드, 박테리오파지 바이러스 및 기타 변형된 바이러스와 같은 당해 분야에 공지된 다수의 벡터 시스템을 사용할 수 있다. 적합 벡터는, 바이러스 벡터(예: 람다 벡터 시스템 λgtl1, λgtl0 및 Charon 4), 플라스미드 벡터(예: pBI121, pBR322, pACYC177, pACYC184, pAR 시리즈, pKK223-3, pUC8, pUC9, pUC18, pUC19, pLG339, pRK290, pKC37, pKC101, pCDNAII) 및 기타 유사한 시스템을 포함하나 이에 제한되지 않는다. 형질전환된 세포를 완전한 식물로 재생시켜 본 발명의 뉴클레오타이드 서열이 형질전환 식물에게 곤충 내성을 부여하게 할 수 있다.The nucleic acid sequences described herein can be incorporated into plant cells using conventional recombinant DNA techniques. In general, this involves inserting a coding sequence of the invention into an expression system that is heterologous to the coding sequence (ie, no such coding sequence exists) using standard cloning procedures known in the art. The vector contains elements essential for the transcription and translation of the inserted protein-coding sequence. Many vector systems known in the art can be used, such as plasmids, bacteriophage viruses and other modified viruses. Suitable vectors include viral vectors (e.g. lambda vector systems λgtl1, λgtl0 and Charon 4), plasmid vectors (e.g. pBI121, pBR322, pACYC177, pACYC184, pAR series, pKK223-3, pUC8, pUC9, pUC18, pUC19, pLG339, pRK290, pKC37, pKC101, pCDNAII) and other similar systems. The transformed cells can be regenerated into complete plants so that the nucleotide sequences of the invention confer insect resistance to the transgenic plants.

본 발명에 따라서 형질전환된 식물은 단자엽식물 또는 쌍자엽식물일 수 있으며, 옥수수, 밀, 보리, 호밀, 고구마, 잠두, 완두, 치커리, 상추, 양배추, 꽃양배추, 브로콜리, 순무, 무, 시금치, 아스파라거스, 양파, 마늘, 후추, 셀러리, 호박(squash), 펌프킨 호박(pumpkin), 삼, 주키니 호박(zucchini), 사과, 배, 모과, 멜론(예: 수박), 서양자두, 체리, 복숭아, 승도복숭아, 살구, 딸기, 포도, 나무딸기, 검은딸기, 파인애플, 아보카도, 파파야, 망고, 바나나, 대두, 토마토, 수수, 사탕수수, 사탕무, 해바라기, 평지, 클로버, 담배, 당근, 면화, 알팔파, 감자, 가지, 오이, 아라비돕시스(Arabidopsis), 및 침엽수와 낙엽수와 같은 목본 식물을 포함하나 이에 제한되지 않는다. 일단 목적하는 뉴클레오타이드 서열이 특정한 식물 종으로 형질전환되면, 그 종내에서 전파시킬 수 있거나, 종래의 육종 기술을 사용하여 특히, 시판용 변종을 포함하는 동일한 종의 다른 변종으로 이동시킬 수 있다.Plants transformed according to the present invention may be monocots or dicotyledons, corn, wheat, barley, rye, sweet potatoes, green beans, peas, chicory, lettuce, cabbage, cauliflower, broccoli, turnips, radishes, spinach, asparagus , Onion, garlic, pepper, celery, squash, pumpkin, hemp, zucchini, apple, pear, quince, melon (e.g. watermelon), plum, cherry, peach, nectarine Peach, Apricot, Strawberry, Grape, Raspberry, Blackberry, Pineapple, Avocado, Papaya, Mango, Banana, Soybean, Tomato, Sorghum, Sugarcane, Beets, Sunflowers, Rape, Clover, Tobacco, Carrots, Cotton, Alfalfa, Potatoes , Branches, cucumbers, Arabidopsis, and woody plants such as conifers and deciduous trees. Once the desired nucleotide sequence is transformed into a particular plant species, it can be propagated within that species or can be transferred to other variants of the same species, including commercially available varieties, using conventional breeding techniques.

형질전환 식물에서의 발현을 위해 본 발명의 뉴클레오타이드 서열은 변형 및 최적화를 필요로 할 수 있다. 다수의 경우에서 미생물로부터의 유전자를 변형시키기 않고 식물내에서 고수준으로 발현시킬 수 있으나, 형질전환 식물에서의 낮은 발현은 식물에서 바람직하지 않은 코돈을 가진 이종 뉴클레오타이드 서열로부터 기인할 수 있다. 당해 분야에는 모든 유기체가 코돈 용법에 대해 특정한 선호도를 나타내며 본 발명에서 기술하는 뉴클레오타이드 서열의 코돈은 이에 의해 암호화된 아미노산을 유지하면서 식물의 선호도에 맞게 변형될 수 있는 것으로 공지되어 있다. 게다가, 식물내에서의 높은 발현은 약 35% 이상, 바람직하게는 약 45% 이상, 보다 바람직하게는 약 50% 이상 및 가장 바람직하게는 약 60% 이상의 GC 함량을 갖는 암호 서열로부터 최적으로 달성된다. 낮은 GC 함량을 갖는 미생물의 뉴클레오타이드 서열은 메시지를 불안정하게 할 수 있는 ATTTA 모티프 및 부적절한 폴리아데닐화를 유발할 수 있는 AATAAA 모티프의 존재로 인해 식물내에서 불량하게 발현할 수 있다. 비록 바람직한 유전자 서열이 적절하게 단자엽식물 및 쌍자엽식물 종 모두에서 발현될 수 있다 해도, 서열은 선호도가 상이하게 나타남에 따라[참조문헌: Murray et al., Nucl. Acids Res. 17: 477-498 (1989))] 단자엽식물 또는 쌍자엽식물의 특정한 코돈 선호도 및 GC 함량 선호도를 책임지도록 변형시킬 수 있다. 또한, 뉴클레오타이드는 메시지 절단을 유발할 수 있는 변칙적인 스플라이싱(splicing) 부위의 존재를 선별한다. 상기 기술한 바와 같은 뉴클레오타이드 서열내에서 이루어질 필요가 있는 모든 변형은 부위 지정 돌연변이유발, PCR 등, 및 공개 특허원 EP 0 385 962, EP 0 359 472 및 WO 93/07278에 기술된 방법을 사용한 유전자 합성법과 같은 익히 공지된 기술을 사용하여 이루어진다. Nucleotide sequences of the invention may require modification and optimization for expression in transgenic plants. In many cases, genes from microorganisms can be expressed at high levels in plants without modification, but low expression in transgenic plants can result from heterologous nucleotide sequences with undesirable codons in the plant. It is known in the art that all organisms exhibit particular preferences for codon usage and that the codons of the nucleotide sequences described herein can be modified to suit plant preferences while maintaining the encoded amino acids. Moreover, high expression in plants is optimally achieved from coding sequences having a GC content of at least about 35%, preferably at least about 45%, more preferably at least about 50% and most preferably at least about 60%. . Nucleotide sequences of microorganisms with low GC content may be poorly expressed in plants due to the presence of ATTTA motifs that may destabilize the message and AATAAA motifs that may cause inappropriate polyadenylation. Although preferred gene sequences may be appropriately expressed in both monocotyledonous and dicotyledonous species, as sequences appear to differ in preference (Murray et al., Nucl. Acids Res. 17: 477-498 (1989))] can be modified to be responsible for particular codon preferences and GC content preferences of monocots or dicots. Nucleotides also screen for the presence of anomalous splicing sites that can cause message cleavage. All modifications that need to be made in the nucleotide sequence as described above are gene synthesis using site directed mutagenesis, PCR, etc., and the methods described in published patent applications EP 0 385 962, EP 0 359 472 and WO 93/07278. It is accomplished using well known techniques such as.

해독의 효율적인 개시를 위해 개시 메티오닌에 인접한 서열은 변형을 요할 수 있다. 예를 들어, 식물에서 효과적인 것으로 공지된 서열을 삽입하여 변형시킬 수 있다. 조시(Joshi)는 식물에 적절한 컨센서스(consensus)를 보고한 바 있으며[참조문헌: NAR 15: 6643-6653 (1987)] 클론테크(Clontech)는 추가의 컨센서스 해독 개시인자를 제시하고 있다[참조문헌: 1993/1994 catalog, page 210]. 이들 컨센서스는 본 발명의 뉴클레오타이드 서열과 함께 사용하기에 적합하다. 상기 서열들은 ATG를 포함하여 여기까지(제2 아미노산은 변형되지 않은 상태로 남아 있음) 또는 ATG 다음의 GTC를 포함하여 여기까지(형질전환유전자의 제2 아미노산이 변형될 가능성이 있음)의 뉴클레오타이드 서열을 포함한 작제물내로 삽입된다. Sequences adjacent to the starting methionine may require modification for efficient initiation of translation. For example, a sequence known to be effective in a plant can be inserted and modified. Josi has reported consensus appropriate for plants (NAR 15: 6643-6653 (1987)) and Clontech has suggested additional consensus detoxification initiators [Ref. : 1993/1994 catalog, page 210]. These consensus are suitable for use with the nucleotide sequences of the invention. The sequences are nucleotide sequences up to and including ATG (second amino acid remains unmodified) or up to and including GTC following ATG (possibly the second amino acid of the transgene is likely to be modified). It is inserted into the construct, including.

형질전환 식물내에서 뉴클레오타이드 서열의 발현은 식물에서 기능적인 것으로 나타난 프로모터에 의해 추진된다. 프로모터의 선택은 발현을 위한 시공간적인 요건 및 표적 종에 따라 다양할 수 있다. 따라서, 잎, 열매, 화서(예: 수상화서, 원추화서, 속대(cob) 등), 뿌리 및/또는 종자에서의 본 발명의 뉴클레오타이드 서열의 발현이 바람직하다. 그러나, 다수의 경우에 한 종류 이상의 해충에 대한 보호가 요구되므로 다수의 조직에서의 발현이 바람직하다. 쌍자엽식물의 많은 프로모터가 단자엽식물에서 작동되고 반대로 단자엽 식물의 많은 프로모터가 쌍자엽식물에서 작동되는 것으로 제시되어 왔으나, 쌍자엽식물에서의 발현에는 쌍자엽 프로모터가 선택되고 단자엽식물에서의 발현에는 단자엽식물 프로모터가 선택되는 것이 이상적이다. 그러나, 선택된 프로모터의 유래에 대한 제한은 없으며, 즉, 이들 프로모터가 목적하는 세포에서 뉴클레오타이드 서열의 발현을 추진하는데 작용하는 것이면 충분하다. Expression of nucleotide sequences in transgenic plants is driven by promoters that have been shown to be functional in the plant. The choice of promoter can vary depending on the spatiotemporal requirements for expression and the target species. Thus, the expression of the nucleotide sequences of the invention in leaves, fruits, inflorescences (eg, inflorescences, cones, cobs, etc.), roots and / or seeds is preferred. However, in many cases, protection against more than one kind of pest is required, so expression in multiple tissues is preferred. Many promoters of dicotyledons have been shown to operate on monocots and conversely, many promoters of monocotyledonous plants have been shown to operate on dicotyledonous plants. It is ideal to be. However, there are no restrictions on the origin of the selected promoter, i.e., it is sufficient that these promoters act to drive the expression of nucleotide sequences in the cells of interest.

구조적으로 발현되는 바람직한 프로모터로는 액틴 또는 유비퀴틴을 암호화하는 유전자로부터의 프로모터, 및 CaMV 35S 및 19S 프로모터가 포함된다. 본 발명의 뉴클레오타이드 서열은 또한 화학적으로 조절되는 프로모터의 조절하에서 발현될 수 있다. 이는 작물이 유도 화학물질로 처리된 경우에만 살충성 독소가 합성되게 할 수 있다. 유전자 발현의 화학적 유도에 바람직한 기술은 공개 출원 제EP 0 332 104호 및 미국 특허 제5,614,395호에 상세히 기술되어 있다. 화학적 유도에 바람직한 프로모터는 담배 PR-1a 프로모터이다. Preferred promoters that are structurally expressed include promoters from genes encoding actin or ubiquitin, and CaMV 35S and 19S promoters. Nucleotide sequences of the invention can also be expressed under the control of chemically regulated promoters. This can cause the insecticidal toxin to be synthesized only if the crop is treated with derived chemicals. Preferred techniques for chemical induction of gene expression are described in detail in published application EP 0 332 104 and US Pat. No. 5,614,395. A preferred promoter for chemical induction is the tobacco PR-1a promoter.

프로모터의 바람직한 카테고리는 상처 유도성인 것이다. 상처 부위 및 식물병원체의 감염 부위에서 발현하는 많은 프로모터들이 기술되어 있다. 이상적으로, 이러한 프로모터는 감염 부위에서만 국소적으로 활성을 나타내며, 이러한 방식으로 침입 해충을 치사시키는 살충성 독소를 합성하는데 필요한 살충성 독소만이 세포내 에 축척된다. 이러한 종류의 바람직한 프로모터로는 문헌[참조문헌: Stanford et al., Mol. Gen. Genet. 215: 200-208 (1989), Xu et al., Plant Molec. Biol. 22: 573-588 (1993), Logemann et al., Plant Cell 1: 151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22: 783-792 (1993), Firek et al. Plant Molec. Biol. 22: 129-142 (1993) and Warner et al., Plant J. 3: 191-201 (1993)]에 기술된 프로모터가 포함된다.A preferred category of promoter is one that is wound inducible. Many promoters are described that express at the wound site and at the site of infection of phytopathogens. Ideally, such promoters are only active locally at the site of infection, and in this way only the pesticidal toxins needed to synthesize pesticidal toxins that kill invading pests are accumulated in the cell. Preferred promoters of this kind are described in Stanford et al., Mol. Gen. Genet. 215: 200-208 (1989), Xu et al., Plant Molec. Biol. 22: 573-588 (1993), Logemann et al., Plant Cell 1: 151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22: 783-792 (1993), Firek et al. Plant Molec. Biol. 22: 129-142 (1993) and Warner et al., Plant J. 3: 191-201 (1993).

바람직한 조직 특이적 발현 패턴은 녹색 조직 특이적, 뿌리 특이적, 줄기 특이적, 과실 특이적 및 꽃 특이적인 것을 포함한다. 녹색 조직에서의 발현에 적합한 프로모터로는 광합성에 관련된 유전자를 조절하는 많은 것들이 포함되며 이들 중에서 다수가 단자엽식물 및 쌍자엽식물로부터 클로닝되어 왔다. 바람직한 프로모터는 포스포에놀 카르복실라제 유전자로부터의 옥수수 PEPC 프로모터이다[참조문헌: Hudspeth & Grula, Plant Molec. Biol. 12: 579-589 (1989)]. 뿌리 특이적 발현에 바람직한 프로모터는 문헌[참조: de Framond, FEBS 290: 103-106 (1991); EP 0 452 269]에 기술된 옥수수 메탈로티오네인(metallothinein)형 프로모터이다. 바람직한 줄기 특이적 프로모터는 미국 특허 제5,625,136호에 기술되어 있는 것으로 옥수수 trpA 유전자의 발현을 추진하는 프로모터이다. Preferred tissue specific expression patterns include green tissue specific, root specific, stem specific, fruit specific and flower specific. Suitable promoters for expression in green tissues include many that regulate genes involved in photosynthesis, many of which have been cloned from monocotyledonous and dicotyledonous plants. Preferred promoters are corn PEPC promoters from the phosphoenol carboxylase gene. See Hudspeth & Grula, Plant Molec. Biol. 12: 579-589 (1989). Preferred promoters for root specific expression are described in de Framond, FEBS 290: 103-106 (1991); EP 0 452 269, a corn metallothinein type promoter. Preferred stem specific promoters are those promoters that drive the expression of the maize trpA gene as described in US Pat. No. 5,625,136.

본 발명의 특히 바람직한 양태는 뿌리에 바람직한 또는 뿌리-특이적 방식으로 본 발명의 뉴클레오타이드 서열 중 하나 이상을 발현하는 형질전환 식물이다. 추가의 바람직한 양태는 상처-유도성 또는 병원체 감염-유도성 방식으로 뉴클레오타이드 서열을 발현하는 형질전환 식물이다. Particularly preferred embodiments of the invention are transgenic plants which express one or more of the nucleotide sequences of the invention in a preferred or root-specific manner in the roots. A further preferred embodiment is a transgenic plant that expresses the nucleotide sequence in a wound-induced or pathogen infection-induced manner.             

적합한 프로모터의 선택 이외에, 살충성 독소를 식물내에서 발현하기 위한 작제는 이종 뉴클레오타이드 서열의 하부에 연결되는 적절한 전사 터미네이터를 요한다. 이러한 터미네이터의 몇 가지는 입수가능하며 당해 분야에 공지되어 있다(예: CaMV로부터 tm1, rbcS로부터의 E9). 식물에서 작용하는 것으로 공지된 모든 입수가능한 터미네이터를 본 발명에서 사용할 수 있다. In addition to the selection of suitable promoters, constructs for expressing pesticidal toxins in plants require an appropriate transcription terminator that is linked to the bottom of the heterologous nucleotide sequence. Some of these terminators are available and are known in the art (eg tm1 from CaMV, E9 from rbcS). All available terminators known to function in plants can be used in the present invention.

다수의 다른 서열을 본 발명에 기술된 DNA 분자용 발현 카세트내로 혼입할 수 있다. 이들 서열로는 인트론 서열(예: Adh1 및 bronze1로부터의 인트론 서열) 및 바이러스 리더 서열(예: TMV, MCMV 및 AMV로부터의 리더 서열)과 같이 발현을 증강시키는 것으로 나타난 서열이 포함된다. Many other sequences can be incorporated into the expression cassettes for the DNA molecules described herein. These sequences include sequences that have been shown to enhance expression, such as intron sequences (eg, intron sequences from Adh1 and bronze1) and viral leader sequences (eg, leader sequences from TMV, MCMV, and AMV).

본 발명의 뉴클레오타이드 서열의 발현이 식물내의 상이한 세포내 국재화를 표적으로 하는 것이 바람직할 수 있다. 일부 경우에서, 세포질내의 국재화가 바람직할 수 있으며, 다른 경우에서는 일부 아세포 소기관내의 국재화가 바람직할 수 있다. 효소를 암호화하는 형질전환유전자의 아세포 국재화는 당해 분야에 익히 공지된 기술을 사용하여 이루어진다. 통상적으로, 공지된 소기관을 표적으로 하는 유전자 생성물로부터의 표적 펩타이드를 암호화하는 DNA를 조작하고 뉴클레오타이드 서열의 상부에 융합시킨다. 이러한 다수의 표적 세열은 엽록체용으로 공지되어 있으며, 이종 작제물에서의 이의 작용이 제시되어 있다. 본 발명의 뉴클레오타이드의 발현은 또한 숙주 세포의 소포체 또는 액포를 표적으로 한다. 이를 달성하기 위한 기술은 당해 분야에 익히 공지되어 있다.It may be desirable for the expression of the nucleotide sequences of the present invention to target different intracellular localization in plants. In some cases, localization in the cytoplasm may be desirable, while in other cases localization in some blast organelles may be desirable. Subcellular localization of the transgene encoding the enzyme is accomplished using techniques well known in the art. Typically, DNA encoding a target peptide from a gene product targeting a known organelle is engineered and fused to the top of the nucleotide sequence. Many of these target fragments are known for chloroplasts and their action in heterologous constructs is shown. Expression of the nucleotides of the invention also targets vesicles or vacuoles of the host cell. Techniques for achieving this are well known in the art.

식물의 형질전환에 적합한 벡터는 본 명세서의 다른 곳에도 기술되어 있다. 아그로박테리움(Agrobacterium)-매개된 형질전환을 위해 하나 이상의 T-DNA 경계 서열을 지니는 이원 벡터 또는 하나 이상의 T-DNA 경계 서열을 지닌 벡터가 적합한 반면, 직접적인 유전자 전달을 위해서는 어떠한 백터도 적합하며 관심있는 작제물만을 함유한 선형 DNA가 바람직할 수 있다. 직접적인 유전자 전달의 경우에, 단일 DNA 종으로의 형질전환 또는 동시형질전환이 사용될 수 있다[참조문헌: Schocher et al. Biotechnology 4: 1093-1096 (1986)]. 직접적인 유전자 전달 및 아그로박테리움-매개된 전달 둘다의 경우, 형질전환은 통상적으로(반드시 필수적인 것은 아니지만) 항생제(예: 가나마이신, 하이그로마이신 또는 메토트렉세이트) 또는 제초제(바스타)에 대한 내성을 제공할 수 있는 선택성 마커를 사용하여 수행한다. 그러나, 이러한 마커의 예로는, 네오마이신 포스포트랜스퍼라제, 하이그로마이신 포스포트랜스퍼라제, 디하이드로폴레이트 리덕타제, 포스피노트리신 아세틸트랜스퍼사제, 2, 2-디클로로프로피온산 데할로게나제, 아세토하이드록시산 신타제, 5-에놀피루빌-시키메이트-포스페이트 신타제, 할로아릴니트릴라제, 프로토포르히리노겐 옥시다제, 아세틸-코엔자임 A 카복실라제, 디하이드로프테로에이트 신타제, 클로람페니콜 아세틸 트랜스퍼라제 및 β-글루쿠로니다제가 있다. 명확한 선택을 제공하는 또 다른 종류의 마커로는 만노스 만노스-6-포스페이트 이소머라제를 대사시키는 능력을 제공하는 만노스-6-포스페이트 이소머라제(MPI/PMI) 유전자가 있다. 그러나, 식물 형질전환을 위한 선택가능한 또는 선별가능한 마커의 선택은 본 발명에서 중요하지 않다. Suitable vectors for plant transformation are also described elsewhere herein. While binary vectors with one or more T-DNA border sequences or vectors with one or more T-DNA border sequences are suitable for Agrobacterium-mediated transformation, any vector is suitable for direct gene transfer and is of interest. Linear DNA containing only existing constructs may be desirable. In the case of direct gene transfer, transformation or cotransformation into a single DNA species can be used. Schocher et al. Biotechnology 4: 1093-1096 (1986)]. For both direct gene transfer and Agrobacterium-mediated delivery, transformation is usually (but not necessarily necessary) to provide resistance to antibiotics (eg kanamycin, hygromycin or methotrexate) or herbicides (vasta). This is done using selectable markers. However, examples of such markers include neomycin phosphotransferase, hygromycin phosphotransferase, dihydrofolate reductase, phosphinothricin acetyltransferase, 2, 2-dichloropropionic acid dehalogenase, aceto Hydroxy acid synthase, 5-enolpyrubil-succimate-phosphate synthase, haloarylnitrilease, protophorhirinogen oxidase, acetyl-coenzyme A carboxylase, dihydrophteroate synthase, chloramphenicol acetyl Transferases and β-glucuronidase. Another class of markers that provides a clear choice is the mannose-6-phosphate isomerase (MPI / PMI) gene, which provides the ability to metabolize mannose mannose-6-phosphate isomerase. However, the selection of selectable or selectable markers for plant transformation is not critical to the present invention.

상기 기술한 재조합 DNA는 당해에 인정된 다수의 방식으로 식물 세포내로 도입할 수 있다. 당해 분야의 숙련가는 방법의 선택이 형질전환의 대상이 되는 식물의 종류에 따라 결정된다는 것을 이해할 것이다. 식물 세포를 형질전환시키기에 적합한 방법으로는 미세주입[참조문헌: Crossway et al., BioTechniques 4:320-334 (1986)], 전기천공[참조문헌: Riggs at al, Proc. Natl. Acad. Sci. USA 83:5602-5606 (1986)], 아그로박테리움-매개된 형질전환[참조문헌: Hinchee et al., Biotechnology 6:915-921 (1988); Ishida et al., Nature Biotechnology 14:745-750 (June 1996)(옥수수 형질전환에 관해)], 직접적인 유전자 전달[참조문헌: Paszkowski et al., EMBO J. 3:2717-2722 (1984); Hayashimoto et al., Plant Physiol. 93:857-863 (1990)](벼), 및 아그라세투스 인코포레이티드(Agracetus, Inc., Madison, Wisconsin) 및 듀퐁 인코포레이티드(Dupont, Inc., Wilmington, Dalaware)에서 입수한 장비를 사용한 탄도 입자 가속이 포함된다[참조문헌: Sanford et al., 미국 특허 제4,945,050호; 및 McCabe et al., Biotechnology 6:923-926(1988); Weissinger et al., Annual Rev. Genet. 22:421-477(1988); Sanford et al., Particulate Science and Technology 5:27-3791987)(양파); Svab et al., Proc. Natl. Acad. Sci. USA 87: 8526-8530(1990)(담배 엽록체); Christou et al., Plant Physiol. 87:671-674(1998)(대두); McCabe et al., Bio/Technology 6:923-926(1998)(대두); Klein et al., Proc. Natl. Acad. Sci. USA, 85:4305-4309(1998)(옥수수); Klein et al., Bio/Technology 6:559-563(1988)(옥수수); Klein et al., Plant Physiol. 91:440-444(1998)(옥수수); Fromm et al., Bio/Technology 8:833-839(1990); and Gordon-Kamm et al., Plant Cell 2:603-618(1990)(옥수수); Koziel et al., Biotechnology 11:194-200(1993)(옥수수); Shimamoto et al., Nature 338:274-277(1998)(벼); Christou et al., Biotechnology 9:957-962(1991)(벼); Datta et al., Bio/Technology 8:736-740(1990)(벼); 유럽 특허원 제EP 0 332 581호(오리새 및 기타 벼과); Vasil et al., Biotechnology 11:1153-1558(1993)(밀); Weeks et al., Plant Physiol. 102:1077-1084(1993)(밀); Wan et al., Plant physiol. 104:37-48(1994)(보리); Jahne et al., Theor. Appl. Genet. 89:525-533(1994)(보리); Umbeck et al., Bio/Techonology 5:263-266(1987)(면화); Casas et al., Proc. Natl. Acad. Sci. USA 90:11212-11216(Dec. 1993)(수수); Somer et al., Bio/Technology 10:1589-1594(Dec. 1992)(귀리), Torbert et al., Plant Cell Reports 14:635-640(1995)(귀리); Weeks et al., Plant Physiol. 102:1077-1084(1993)(밀); Chang et al., WO 94/13822(밀) and Nehra et al., The Plant Journal 5:285-297(1994)(밀)]. 재조합 DNA 분자를 미세사출성 충격(microprojectile bombardment)에 의해 옥수수내로 도입하기에 특히 바람직한 양태는 문헌[참조문헌: Koziel et al., Biotechnology 11: 194-200 (1993), Hill et al., Euphytica 85:119-123 (1995) 및 Koziel et al., Annals of the New York Academy of Sciences 792:164-171 (1996)]에서 찾아볼 수 있다. 추가의 바람직한 양태는 EP 0 292 435에 기술된 옥수수용 원형질체 형질전환 방법이다. 식물의 형질전환은 단일 DNA 종 또는 다수의 DNA 종(즉, 동시형질전환)으로 이루어질 수 있으며 이들 두 기술은 본 발명의 암호화 서열과 함께 사용하기에 적합하다.The recombinant DNA described above can be introduced into plant cells in a number of ways that are recognized in the art. Those skilled in the art will understand that the choice of method depends on the type of plant to be transformed. Suitable methods for transforming plant cells include microinjection (Crossway et al., BioTechniques 4: 320-334 (1986)), electroporation [Riggs at al, Proc. Natl. Acad. Sci. USA 83: 5602-5606 (1986)], Agrobacterium-mediated transformation (Hinchee et al., Biotechnology 6: 915-921 (1988); Ishida et al., Nature Biotechnology 14: 745-750 (June 1996) (relative to corn transformation), direct gene transfer [Paszkowski et al., EMBO J. 3: 2717-2722 (1984); Hayashimoto et al., Plant Physiol. 93: 857-863 (1990)] (rice), and Agratus, Inc. (Madison, Wisconsin) and Dupont Inc. (Dupont, Inc., Wilmington, Dalaware). Ballistic particle acceleration using equipment is included [Sanford et al., US Pat. No. 4,945,050; And McCabe et al., Biotechnology 6: 923-926 (1988); Weissinger et al., Annual Rev. Genet. 22: 421-477 (1988); Sanford et al., Particulate Science and Technology 5: 27-3791987) (onions); Svab et al., Proc. Natl. Acad. Sci. USA 87: 8526-8530 (1990) (tobacco chloroplasts); Christou et al., Plant Physiol. 87: 671-674 (1998) (soybeans); McCabe et al., Bio / Technology 6: 923-926 (1998) (soy); Klein et al., Proc. Natl. Acad. Sci. USA, 85: 4305-4309 (1998) (corn); Klein et al., Bio / Technology 6: 559-563 (1988) (corn); Klein et al., Plant Physiol. 91: 440-444 (1998) (corn); Fromm et al., Bio / Technology 8: 833-839 (1990); and Gordon-Kamm et al., Plant Cell 2: 603-618 (1990) (corn); Koziel et al., Biotechnology 11: 194-200 (1993) (corn); Shimamoto et al., Nature 338: 274-277 (1998) (rice); Christou et al., Biotechnology 9: 957-962 (1991) (rice); Datta et al., Bio / Technology 8: 736-740 (1990) (rice); European Patent Application EP 0 332 581 (duck and other rice family); Vasil et al., Biotechnology 11: 1153-1558 (1993) (wheat); Weeks et al., Plant Physiol. 102: 1077-1084 (1993) (wheat); Wan et al., Plant physiol. 104: 37-48 (1994) (barley); Jahne et al., Theor. Appl. Genet. 89: 525-533 (1994) (barley); Umbeck et al., Bio / Techonology 5: 263-266 (1987) (cotton); Casas et al., Proc. Natl. Acad. Sci. USA 90: 11212-11216 (Dec. 1993) (sorghum); Somer et al., Bio / Technology 10: 1589-1594 (Dec. 1992) (oats), Torbert et al., Plant Cell Reports 14: 635-640 (1995) (oats); Weeks et al., Plant Physiol. 102: 1077-1084 (1993) (wheat); Chang et al., WO 94/13822 (wheat) and Nehra et al., The Plant Journal 5: 285-297 (1994) (wheat)]. Particularly preferred embodiments for introducing recombinant DNA molecules into maize by microprojectile bombardment are described in Koziel et al., Biotechnology 11: 194-200 (1993), Hill et al., Euphytica 85 : 119-123 (1995) and Koziel et al., Annals of the New York Academy of Sciences 792: 164-171 (1996). A further preferred embodiment is the protoplast transformation method for corn, described in EP 0 292 435. Plant transformation may consist of a single DNA species or multiple DNA species (ie, cotransformation) and these two techniques are suitable for use with the coding sequences of the present invention.

또 다른 바람직한 양태에서, 본 발명의 뉴클레오타이드 서열은 플라스미드 게놈내로 직접적으로 형질전환된다. 색소체 형질전환의 주된 잇점은 색소체가 일반적으로 충분한 변형없이도 세균 유전자를 발현할 수 있으며 단일 프로모터의 조절하에 다수의 개방 판독 프레임을 발현할 수 있다는 점이다. 색소체 형질전환 기술은 미국 특허 제5,451,513호, 제5,545,817호 및 제5,545,818호, PCT 출원 제WO 95/16783호 및 문헌[참조문헌: McBride et al. (1994) Proc. Natl. Acad. Sci. USA 91, 7301-7305]에 광범위하게 기술되어 있다. 엽록체 형질전환용 기본 기술은, 예를 들어, 생물제제 또는 원형질체 형질전환(예: 염화칼슘 또는 PEG 매개된 형질전환)을 사용하여 선택가능한 마커에 플랭킹된 클로닝된 색소체 DNA의 영역과 함께 관심있는 유전자를 적합한 표적 조직내로 도입하는 것과 관련된다. 표적 서열로 지정한 1 내지 1.5kb 플랭킹 영역은 색소체 게놈과의 상동 재조합을 용이하게 하며 이로써 플라스톰(plastome)의 특정 영역의 치환 또는 변형을 가능케 한다. 처음에는, 엽록체 16S rRNA에서의 점 돌연변이 및 스펙티노마이신 및/또는 스트렙토마이신에 대한 내성을 제공하는 rps12 유전자를 형질전환에 대한 선택가능한 마커로서 사용한다[참조문헌: Svab, Z., Hajdukiewicz, P., and Maliga, P. (1990) Proc. Natl. Acad. Sci. USA 87, 8526-8530; Staub, J. M., and Maliga, P. (1992) Plant Cell 4, 39-45]. 이로 인해 표적 잎의 100회 충돌당 약 1회의 빈도로 안정한 일원형체성 형질전환체가 생성된다. 이들 마커 간의 클로닝 부위의 존재는 외래 유전자의 도입을 위한 색소체 표적 벡터의 형성을 가능케 했다[참조문헌: Staub, J. M., and Maliga, P.(1993) EMBO J. 12: 601-606]. 형질전환 빈도의 실질적인 증가는 열성 rRNA 또는 r-단백질 항생제 내성 유전자를 우성 선택가능한 마커(스펙티노마이신-해독 효소 아미노글리코시드-3'-아데닐트랜스퍼라제를 암호화하는 세균 aadA 유전자)로 대체함으로써 수득한다[참조문헌: Svab, Z., and Maliga, P. (1993) Proc. Natl. Acad. Sci. USA 90, 913-917]. 이전에, 상기 마커는 녹조류 클라미도모나스 레인하드티의 색소체 게놈의 고-빈도 형질전환에 성공적으로 사용되었다[참조문헌: Goldschmidt-Clermont, M. (1991) Nucl. Acids Res. 19, 4083-4089]. 색소체 형질전환에 유용한 기타 선택가능한 마커는 당해 분야에 공지되어 있으며 본 발명의 범주에 포함된다. 통상적으로 형질전환 후에 약 15회 내지 20회의 세포분열 주기가 일원형체성 상태에 도달하는데 요구된다. 유전자가 상동 재조합에 의해 각각의 식물 세포내에 존재하는 환상 색소체 게놈의 모든 수천개의 복사체에 삽입되는 색소체 발현은 전체 가용성 식물 단백질의 10%를 쉽게 초과할 수 있는 발현 수준을 허용하는 핵-발현된 유전자에 비해 보다 유리한 막대한 복제수를 사용한다. 바람직한 양태에서, 본 발명의 뉴클레오타이드 서열은 색소체 표적 벡터내로 삽입되어 목적하는 식물 숙주의 색소체 게놈내로 형질전환된다. 본 발명의 뉴클레오타이드 서열을 함유하는 색소체 게놈에 대해 일원형체성이며, 바람직하게는 당해 뉴클레오타이드 서열을 고도로 발현할 수 있는 식물이 수득된다.In another preferred embodiment, the nucleotide sequences of the invention are transformed directly into the plasmid genome. The main advantage of chromatin transformation is that the pigment can generally express bacterial genes without sufficient modification and can express multiple open reading frames under the control of a single promoter. Chromosome transformation techniques are described in US Pat. Nos. 5,451,513, 5,545,817 and 5,545,818, PCT Application WO 95/16783, and McBride et al. (1994) Proc. Natl. Acad. Sci. USA 91, 7301-7305. Basic techniques for chloroplast transformation include genes of interest with regions of cloned chromatin DNA flanked in selectable markers, for example using biologic or protoplast transformation (eg calcium chloride or PEG mediated transformation). Is introduced into a suitable target tissue. The 1-1.5 kb flanking region designated as the target sequence facilitates homologous recombination with the chromosomal genome, thereby allowing replacement or modification of specific regions of the plasma. Initially, the point mutation in chloroplast 16S rRNA and the rps12 gene, which provides resistance to spectinomycin and / or streptomycin, are used as selectable markers for transformation. Svab, Z., Hajdukiewicz, P ., and Maliga, P. (1990) Proc. Natl. Acad. Sci. USA 87, 8526-8530; Staub, J. M., and Maliga, P. (1992) Plant Cell 4, 39-45]. This results in a stable monocyclic transformant at about 1 frequency per 100 collisions of the target leaf. The presence of a cloning site between these markers allowed the formation of a chromatin target vector for introduction of foreign genes (Staub, J. M., and Maliga, P. (1993) EMBO J. 12: 601-606). Substantial increase in the frequency of transformation is obtained by replacing the recessive rRNA or r-protein antibiotic resistance gene with a dominant selectable marker (the bacterial aadA gene encoding spectinomycin-detoxifying enzyme aminoglycoside-3'-adenyltransferase) [Svab, Z., and Maliga, P. (1993) Proc. Natl. Acad. Sci. USA 90, 913-917. Previously, this marker has been used successfully for high-frequency transformation of the chromatin genome of the green alga Chlamydomonas Reinhardty (Goldschmidt-Clermont, M. (1991) Nucl. Acids Res. 19, 4083-4089. Other selectable markers useful for chromatin transformation are known in the art and are included within the scope of the present invention. Typically, about 15 to 20 cell division cycles after transformation are required to reach a monomorphic state. Chromosome expression, in which genes are inserted into all thousands of copies of the cyclic chromatin genome present in each plant cell by homologous recombination, is a nuclear-expressed gene that allows expression levels that can easily exceed 10% of the total soluble plant protein It uses a huge number of copies more advantageous than. In a preferred embodiment, the nucleotide sequence of the present invention is inserted into a pigment target vector and transformed into the pigment genome of the desired plant host. A plant is obtained that is monomorphic with respect to the chromatin genome containing the nucleotide sequence of the present invention, and is preferably capable of highly expressing the nucleotide sequence.

본 발명은 다음의 상세한 실시예를 참조로 하여 추가로 설명될 것이다. 이 들 실시예는 단지 설명을 위해 제공되며 달리 명시하지 않는 한 제한되지 않는다. 본원에서 사용되는 표준 재조합 DNA 및 분자 클로닝 기술은 당해 분야에 익히 공지되어 있으며 문헌[참조문헌: Ausubel (ed.), Current Protocols in Molecular Biology, John Wiley and Sons, Inc. (1994); T. Maniatis, E. F. Fritsch and J. Sambrook, Molecular Cloning: A Laboratory manual, Cold Spring Harbor laboratory, Cold Spring Harbor, NY(1989); 및 T.J. Silhavy, M.L.Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY(1984)]에 기술되어 있다.
The invention will be further explained with reference to the following detailed examples. These embodiments are provided for illustration only and are not limited unless specified otherwise. Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and described in Ausubel (ed.), Current Protocols in Molecular Biology, John Wiley and Sons, Inc. (1994); T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory manual, Cold Spring Harbor laboratory, Cold Spring Harbor, NY (1989); And TJ Silhavy, MLBerman and LW Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984).

실시예 1: H04 독소 단편의 발현 및 정제Example 1: Expression and Purification of H04 Toxin Fragment

필수적으로 Cry1Ab의 도메인 I과 II 및 Cry1C의 도메인 III으로 이루어진 Bt 독소를 암호화하는 H04 하이브리드 독소 유전자로부터 절단된 형태(문헌[참조문헌: De Maagd et al., Appl. Environ. Microbiol. 62(5): 1537-1543 (1996)]에 기술되어 있음)를 이. 콜라이에서 과발현시키기 위해 pBluescript SK-, 바실러스 셔틀 벡터 또는 pET 21b(+)와 같은 발현 벡터내로 클로닝시킨다. 세포를 50㎍/㎖ 암피실린을 함유하는 LB 배지에서 24시간 내지 48시간 동안 37℃ 진탕기(250rpm)로 증식시킨다. 세포를 10분 동안 7,000rpm에서 원심분리하여 수거한다. 펠렛을 브론슨(Bronson) 초음파기를 사용하여 10분 동안 2초 펄스로 초음파처리한다. 완전한 초음파처리를 현미경으로 점검한다. 가용성 분획을 10,000rpm에서 10분 동안 원심분리하여 제거한다. 결정 단백질을 함유하는 생성된 펠렛을 0.5M NaCl을 함유 하는 2% 트리톤 X-100로 4회 내지 5회 세척한다. 0.5M NaCl(4 내지 5배)로 연속적으로 세척하고 최종 펠렛을 증류수(2배)로 세척한다. 수득되는 펠렛은 37℃에서 2시간 동안 10mM 디티오트레이톨을 함유하는 50mM Na2CO3 완충액속에 가용성이다. 가용화된 단백질을 12,000rpm에서 10분 동안 원심분리하여 불용성 물질로부터 분리한다. 단백질 샘플을 생물검정을 위해 50mM Na2CO3 완충액(pH 9.0)으로 투석한다.
A form cleaved from the H04 hybrid toxin gene encoding essentially the Bt toxin consisting of domains I and II of Cry1Ab and domain III of Cry1C (De Maagd et al., Appl. Environ. Microbiol. 62 (5) : 1537-1543 (1996). Cloned into expression vectors such as pBluescript SK-, Bacillus shuttle vector or pET 21b (+) for overexpression in E. coli. Cells are grown on a 37 ° C. shaker (250 rpm) for 24 to 48 hours in LB medium containing 50 μg / ml ampicillin. Cells are harvested by centrifugation at 7,000 rpm for 10 minutes. The pellet is sonicated with a 2 second pulse for 10 minutes using a Bronson sonicator. Complete sonication is checked under a microscope. Soluble fractions are removed by centrifugation at 10,000 rpm for 10 minutes. The resulting pellet containing crystalline protein is washed 4-5 times with 2% Triton X-100 containing 0.5M NaCl. Wash sequentially with 0.5 M NaCl (4-5 times) and wash the final pellet with distilled water (2 times). The resulting pellets are soluble in 50 mM Na 2 CO 3 buffer containing 10 mM dithiothreitol at 37 ° C. for 2 hours. Solubilized protein is separated from insoluble material by centrifugation at 12,000 rpm for 10 minutes. Protein samples are dialyzed with 50 mM Na 2 CO 3 buffer (pH 9.0) for bioassay.

실시예 2: 생물검정Example 2: Bioassay

LC50를, 예를 들어, 실시예 1에서 상기 기술한 바와 같이 생성된 정제된 절단된 H04 단백질을 사용하여 밤나방, 분홍면화씨벌레, 담배나방 및 유럽조명나방에서 수행한다. 결과는 다음과 같다:LC50 is performed in chestnut moth, pink cotton worm, tobacco moth and European light moth using, for example, purified truncated H04 protein produced as described above in Example 1. The result is:

LC50 밤나방 133ng/cm2 LC50 Night Moth 133ng / cm 2

LC50 분홍면화씨벌레 691ng/cm2 LC50 Pink Cotton Seed Bug 691 ng / cm 2

LC50 담배나방 299ng/cm2 LC50 Tobacco Moth 299ng / cm 2

LC50 유럽조명나방 31ng/cm2
LC50 European Lighting Moth 31 ng / cm 2

실시예 3: 합성 H04 유전자 작제Example 3: Synthetic H04 Gene Construction

H04의 독성 부분을 암호화하는 합성 뉴클레오타이드 서열은, 옥수수 선호도 코돈 표[참조문헌: Murray et al., Nucl Acids Res. 17:477-498, 1989; 이는 본원 에 참조로 인용된다]를 사용한 프로그램의 위스콘신 대학 GCG 프로그램 그룹에서 개발된 "Backtranslation" 프로그램을 사용하여, 문헌[참조문헌: De Maagd et al., Appl. Environ. Microbiol. 62(5): 1537-1543 (1996)]에 기술된 H04 하이브리드 독소 단편(Cry1Ab의 도메인 I과 II 및 Cry1C의 도메인 III)의 아미노산 서열을 역방향전사(backtrnaslating)시켜 디자인한다. 바람직하게는, 가장 빈번하게 사용된 옥수수 코돈을 WO 93/07278에 기술된 바와 같이 각각의 아미노산에 대해 사용한다.Synthetic nucleotide sequences encoding the toxic moiety of H04 can be found in the corn preference codon table [Murray et al., Nucl Acids Res. 17: 477-498, 1989; It is incorporated herein by reference, using the "Backtranslation" program developed by the University of Wisconsin GCG Program Group, which is described in De Maagd et al., Appl. Environ. Microbiol. 62 (5): 1537-1543 (1996)] is designed by backtrnaslating the amino acid sequence of the H04 hybrid toxin fragment (domains I and II of Cry1Ab and domain III of Cry1C). Preferably, the most frequently used corn codon is used for each amino acid as described in WO 93/07278.

H04의 독소 부분을 암호화하는 합성 뉴클레오타이드 서열은 수개의 단편으로서 작제할 수 있다. 각 단편은 유전자의 쇄 둘다를 나타내는 60 내지 75개 뉴클레오타이드 길이의 올리고머 10쌍을 하이브리드화하여 작제한다. 정확한 배향 및 집합을 위해 약 15개 뉴클레오타이드 중복부를 순차적 올리고뉴클레오타이드 쌍 사이에 디자인한다. 올리고뉴클레오타이드는 예를 들어, 제노시스 바이오테크놀로지(Genosys Biotechnologies Inc., TX)에 의해 작제될 수 있다. 올리고머의 각 쌍을 하이브리드화하고, 예를 들어, 판매원이 명시한 조건으로 효소 폴리뉴클레오타이드 키나제(제조원: New England Biolabs, Inc., MA)를 사용하여 인산화시킨다. 이어서 인산화된 단편 쌍을 예를 들어, 암피실린 내성 유전자를 함유하는 고복제 플라스미드 벡터내로 하이브리드 및 연결시키고, 예를 들어, 수용능이 있는 DH5α세포내로 형질전환시킨다. 상기 세포를 암피실린 함유 배지에 도말하고 37℃에서 밤새 배양한다. 콜로니를 삽입된 DNA에 대해 선별한다. DNA를 서열화하고 정확한 서열을 함유하는 클론을 선택한다. 이어서 단편을 단편들 사이의 고유한 제한 부위를 사용한 제한 분해, 연결 및 형질전환에 의해 연결시킨다. Synthetic nucleotide sequences encoding the toxin portion of H04 can be constructed as several fragments. Each fragment is constructed by hybridizing 10 pairs of oligomers of 60 to 75 nucleotides in length that represent both chains of the gene. About 15 nucleotide overlaps are designed between sequential oligonucleotide pairs for accurate orientation and aggregation. Oligonucleotides can be constructed, for example, by Genosys Biotechnologies Inc., TX. Each pair of oligomers is hybridized and phosphorylated using, for example, enzyme polynucleotide kinase (New England Biolabs, Inc., MA) under conditions specified by the salesman. Phosphorylated fragment pairs are then hybridized and linked into a high replicate plasmid vector containing, for example, an ampicillin resistance gene, and transformed, eg, into soluble DH5α cells. The cells are plated in ampicillin containing medium and incubated overnight at 37 ° C. Colonies are selected for inserted DNA. Sequencing the DNA and selecting clones containing the correct sequence. The fragments are then linked by restriction digestion, ligation and transformation using unique restriction sites between the fragments.                 

서열 3은 H04의 631개 아미노산 독소 부위(전독소 테일 영역을 함유하지 않음)를 암호화하는 합성 뉴클레오타이드 서열을 나타내며, 서열 4는 서열 3에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04 독소의 아미노산 서열을 나타낸다. 서열 11은 서열 3에 제시된 합성 H04 유전자 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는 작제물 pNOV1308의 아미노산 서열을 나타낸다.SEQ ID NO: 3 shows a synthetic nucleotide sequence that encodes the 631 amino acid toxin site of H04 (contains no pretoxin tail region), and SEQ ID NO: 4 shows the amino acid sequence of H04 toxin encoded by the synthetic nucleotide sequence described in SEQ ID NO: 3 Indicates. SEQ ID NO: 11 shows the amino acid sequence of construct pNOV1308 containing a constitutive corn ubiquitin promoter operably linked to the synthetic H04 gene sequence set forth in SEQ ID NO: 3.

H04 하이브리드의 독소 부분(Cry1Ab의 도메인 I과 II 및 Cry1C의 도메인 III)만을 암호화하는 상기 기술한 합성 유전자(서열 3) 이외에, 추가의 합성 H04 유전자를, 미국 특허 제5,625,136호(본원에서 참조로 인용된다)에 기술된 합성 cry1Ab 테일 영역 모두 또는 일부를 H04 독소 부분의 3' 말단에 융합시켜 작제한다.In addition to the synthetic genes described above that encode only the toxin portions of the H04 hybrid (domains I and II of Cry1Ab and domain III of Cry1C) (SEQ ID NO: 3), additional synthetic H04 genes are described in US Pat. No. 5,625,136, which is incorporated herein by reference. All or a portion of the synthetic cry1Ab tail region described in VII) is fused to the 3 'end of the H04 toxin portion.

서열 5는 H04의 독소 부분을 암호화하는 합성 뉴클레오타이드 서열과 전장 Cry1Ab 테일 부분을 암호화하는 합성 뉴클레오타이드 서열을 제시하며, 서열 6은 서열 5에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04+Cry1Ab 테일의 아미노산 서열을 제시한다. 서열 12는 서열 5에 제시된 합성 H04 유전자 서열에 작동적으로 연결된, 뿌리에 바람직한 옥수수 MTL 프로모터를 함유하는 작제물 pNOV1436의 뉴클레오타이드 서열을 제시한다. 서열 13은 서열 5에 제시된 합성 H04 유전자 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는, 작제물 pNOV1441의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 5 shows a synthetic nucleotide sequence encoding a toxin portion of H04 and a synthetic nucleotide sequence encoding a full length Cry1Ab tail portion, and SEQ ID NO: 6 is the amino acid sequence of the H04 + Cry1Ab tail encoded by the synthetic nucleotide sequence described in SEQ ID NO: 5 To present. SEQ ID NO: 12 shows the nucleotide sequence of construct pNOV1436, which contains a preferred corn MTL promoter for roots, operably linked to the synthetic H04 gene sequence set forth in SEQ ID NO: 5. SEQ ID NO: 13 shows the nucleotide sequence of construct pNOV1441, containing a constitutive corn ubiquitin promoter operably linked to the synthetic H04 gene sequence set forth in SEQ ID NO: 5.

서열 7은 H04의 독소 부분과 전장 Cry1Ab 테일 부분을 암호화하는 또 다른 합성 뉴클레오타이드 서열을 제시하며, 서열 8은 서열 7에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04+Cry1Ab 테일의 아미노산 서열을 제시한다. 서열 14는 서열 7에 제시된 합성 H04 유전자 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는 작제물 pNOV1305의 뉴클레오타이드 서열을 제시한다. 서열 15는 서열 7에 제시된 합성 H04 유전자 서열에 작동적으로 연결된 구성적 옥수수 유비퀴틴 프로모터를 함유하는 작제물 pNOV1313의 뉴클레오타이드 서열을 제시한다.SEQ ID NO: 7 shows another synthetic nucleotide sequence encoding the toxin portion of the H04 and full length Cry1Ab tail portion, and SEQ ID NO: 8 shows the amino acid sequence of the H04 + Cry1Ab tail encoded by the synthetic nucleotide sequence described in SEQ ID NO: 7. SEQ ID NO: 14 sets forth the nucleotide sequence of construct pNOV1305 containing a constitutive corn ubiquitin promoter operably linked to a synthetic H04 gene sequence set forth in SEQ ID NO: 7. SEQ ID NO: 15 shows the nucleotide sequence of construct pNOV1313 containing a constitutive corn ubiquitin promoter operably linked to a synthetic H04 gene sequence set forth in SEQ ID NO: 7.

서열 9는 H04의 독소 부분과 Cry1Ab 테일의 단지 처음 40개의 아미노산을 암호화하는 합성 뉴클레오타이드 서열을 제시하며, 서열 10은 서열 9에 설명된 합성 뉴클레오타이드 서열에 의해 암호화되는 H04+40개 아미노산으로 절단된 Cry1Ab 테일의 아미노산 서열을 제시한다. 서열 16은 서열 9에 제시된 합성 H04 유전자 서열에 작동적으로 연결된 뿌리에 바람직한 옥수수 MTL 프로모터를 함유하는 작제물 pNOV1435의 뉴클레오타이드 서열을 제시한다. 서열 17은 서열 9에 제시된 합성 H04 유전자 서열외에 작동적으로 연결된 아라비돕시스 액틴-2 프로모터를 함유하는 작제물 pZU578의 뉴클레오타이드 서열을 제시한다.
SEQ ID NO: 9 shows a synthetic nucleotide sequence that encodes the toxin portion of H04 and only the first 40 amino acids of the Cry1Ab tail, and SEQ ID NO: 10 is a Cry1Ab truncated to H04 + 40 amino acids encoded by the synthetic nucleotide sequence described in SEQ ID NO: 9 The amino acid sequence of the tail is shown. SEQ ID NO: 16 shows the nucleotide sequence of construct pNOV1435 containing a maize MTL promoter preferred for roots operably linked to the synthetic H04 gene sequence set forth in SEQ ID NO: 9. SEQ ID NO: 17 shows the nucleotide sequence of construct pZU578, containing an arabidopsis actin-2 promoter operably linked in addition to the synthetic H04 gene sequence set forth in SEQ ID NO: 9.

실시예 4: 암호화 서열 및 인접 서열의 변형Example 4: Modification of Coding Sequence and Contiguous Sequence

본원에서 기술하는 뉴클레오타이드 서열은 형질전환 숙주 세포에서 발현시키기 위해 변형시킬 수 있다. 당해 뉴클레오타이드 서열을 발현하며 세포내에서 살충성 독소를 생산하는 숙주 식물는 곤충 공격에 대한 증강된 내성을 나타내며, 이 로써 이러한 공격과 관련된 작물 손실을 방지하는데 필요한 것을 보다 잘 갖추고 있다.The nucleotide sequences described herein can be modified for expression in transgenic host cells. Host plants that express the nucleotide sequence and produce insecticidal toxins in the cell exhibit enhanced resistance to insect attacks, thereby better equipping them for preventing crop losses associated with such attacks.

미생물원으로부터 유래된 유전자의 식물내 형질전환 발현은 식물에서 당해 유전자 발현을 달성하고 최적화하기 위해 당해 유전자의 변형을 요할 수 있다. 특히, 개별적인 효소를 암호화하나 천연 미생물내에서 동일한 전사체에 의해 암호화되는 세균 ORF는 식물에서 개별적 전사체로서 유수하게 발현된다. 이를 달성하기 위해, 각각의 미생물 ORF를 개별적으로 분리하고, 당해 ORF의 5' 말단에 식물 프로모터 서열을, ORF의 3' 말단에 식물 전사 터미네이터를 제공하는 카세트내에서 클로닝시킨다. 분리된 ORF 서열은 바람직하게는 개시 ATG 코돈 및 종결 STOP 코돈을 포함하나, 개시 ATG 및 STOP 코돈 이외의 추가 서열을 포함할 수 있다. 또한, ORF는 절단뒬 수 있으나 필요한 활성은 여전히 유지할 수 있으며, 활성을 유지하는 절단된 형태인, 특히 긴 ORF가 형질전환 유기체내의 발현에서 바람직할 수 있다. "식물 프로모터" 및 "식물 전사 터미네이터"란, 식물 세포내에서 작동하는 프로모터 및 전사 터미네이터를 의미한다. 이는 바이러스(예: 컬리플라워 모자이크 바이러스)와 같은 비-식물 공급원으로부터 유래될 수 있는 프로모터 및 전사 터미네이터를 포함한다.In plant transgenic expression of genes derived from microbial sources may require modification of the genes to achieve and optimize the gene expression in the plant. In particular, bacterial ORFs encoding individual enzymes but encoded by the same transcript in natural microorganisms are prominently expressed as individual transcripts in plants. To accomplish this, each microbial ORF is isolated separately and cloned in a cassette providing a plant promoter sequence at the 5 'end of the ORF and a plant transcription terminator at the 3' end of the ORF. An isolated ORF sequence preferably comprises an initiating ATG codon and a terminating STOP codon, but may comprise additional sequences other than the initiating ATG and STOP codons. In addition, ORFs may be cleaved but still retain the required activity, and particularly long ORFs, which are truncated forms that retain activity, may be desirable for expression in the transgenic organism. "Plant promoter" and "plant transcription terminator" refer to promoters and transcription terminators that operate in plant cells. This includes promoters and transcription terminators that can be derived from non-plant sources such as viruses (eg, cauliflower mosaic virus).

일부 경우에서, ORF 암호화 서열 및 인접 서열의 변형이 요구된다. 변형은 관심있는 ORF를 함유하는 단편을 분리하고 이를 식물 프로모터의 하부에 삽입하는는 것만으로 충분하다. 예를 들어, 가프니(Gaffney) 등[참조문헌: Science 261: 754-756 (1993)]은 슈도모나스 nahG 유전자를, 암호화 서열을 변형시키지 않고 ATG 의 상부에 위치하는 슈도모나스 유전자 x bp와 STOP 코돈의 하부에 위치하는 y bp를 nahG ORF에 연결시킨채 CaMV 35S 프로모터 및 CaMV tml 터미네이터의 조절하에 형질전환 식물내에서 성공적으로 발현시킨 바 있다. 바람직하게는, 가능한 한 소량의 인접 미생물 서열이 ATG의 상부 및 STOP 코돈의 하부에 연결되어야 한다. 사실상, 이러한 작제는 제한 부위의 유용성에 따라 좌우될 수 있다.In some cases, modifications of ORF coding sequences and contiguous sequences are required. The modification is sufficient only to isolate the fragment containing the ORF of interest and insert it into the bottom of the plant promoter. For example, Gaffney et al. (Science 261: 754-756 (1993)) described the Pseudomonas nahG gene as the Pseudomonas gene x bp and STOP codon, which is located on top of ATG without altering the coding sequence. The underlying y bp has been successfully expressed in transgenic plants under the control of the CaMV 35S promoter and CaMV tml terminator while linked to nahG ORF. Preferably, as little contiguous microbial sequence as possible should be linked to the top of the ATG and the bottom of the STOP codon. In fact, such construction may depend on the availability of the restriction site.

다른 경우에서, 미생물원으로부터 유래된 유전자의 발현은 발현에 있어 문제를 제공할 수 있다. 이들 문제는 당해 분야에 잘 설명되어 있으며, 특히 바실러스와 같은 특정 공급원으로부터 유래된 유전자에서는 통상적인 것이다. 이들 문제는 본 발명의 뉴클레오타이드 서열에 적용될 수 있으며 이들 유전자의 변형을 당해 분야에 익히 공지된 기술을 사용하여 이룰 수 있다. 직면할 수 있는 문제는 다음과 같다:In other cases, expression of genes derived from microbial sources can provide a problem with expression. These problems are well described in the art, and are common in genes derived from certain sources, particularly Bacillus. These problems can be applied to the nucleotide sequences of the present invention and modifications of these genes can be accomplished using techniques well known in the art. The problems you may face include:

1. 코돈 용법1. Codon Usage

식물에서 바람직한 코돈 용법은 특정 미생물에서 바람직한 코돈 용법과 다르다. 클로닝된 미생물 ORF내의 코돈 용법과 식물 유전자(및 특히 표적 식물로부터의 유전자)에서의 용법을 비교하여, 바람직하게는 변형되어야 하는 ORF내에서 코돈을 동정할 수 있다. 통상적으로, 식물 진화는 단자엽식물의 제3 염기 위치에서 뉴클레오타이드 C 및 G를 강하게 선호하는 경향이 있는 반면에, 쌍자엽식물은 흔히 상기 위치에 뉴클레오타이드 A 또는 T를 사용한다. 유전자를 변형시켜 특정 표적 형질전환 식물에 바람직한 코돈 용법을 포함하도록 함으로써, 하기에서 기술하는 GC/AT 함량 및 변칙적 스플라이싱에 관한 다수의 문제를 해결할 수 있다. Preferred codon usage in plants differs from the preferred codon usage in certain microorganisms. By comparing codon usage in cloned microbial ORFs and usage in plant genes (and in particular genes from target plants), codons can preferably be identified in the ORF that should be modified. Typically, plant evolution tends to strongly favor nucleotides C and G at the third base position of the monocotyledonous plant, while dicotyledons often use nucleotides A or T at these positions. By modifying the gene to include the desired codon usage for specific target transgenic plants, many problems with GC / AT content and anomalous splicing described below can be addressed.                 

2. GC/AT 함량2. GC / AT content

식물 유전자는 통상적으로 35% 이상의 GC 함량을 지닌다. A 및 T 뉴클레오타이드가 풍부한 ORF 서열은 식물에서 몇 가지 문제를 일으킬 수 있다. 먼저, ATTTA 모티프는 메세지의 불안정화를 유발하는 것으로 사료되며 반감기가 짧은 많은 mRNA의 3' 말단에서 발견된다. 둘째로, 메세지내의 부적절한 위치에서 AATAAA와 같은 폴리아데닐화 시그날의 발생은 전사의 조기 중단을 유발하는 것으로 사료된다. 또한, 단자엽식물은 AT가 풍부한 서열을 스플라이싱 부위로서 인식할 수 있다(하기 참조).Plant genes typically have a GC content of at least 35%. ORF sequences rich in A and T nucleotides can cause some problems in plants. First, the ATTTA motif is thought to cause message destabilization and is found at the 3 'end of many mRNAs with short half-lives. Second, the generation of polyadenylation signals such as AATAAA at inappropriate locations in the message is thought to cause premature interruption of transcription. Monocots can also recognize AT-rich sequences as splicing sites (see below).

3. 개시 메티오닌에 인접한 서열3. Sequences Adjacent to Initiating Methionine

식물은 이의 메세지가 한정된 리보좀 결합 부위를 지니지 않는다는 점에서 미생물과 구별된다. 오히려, 리보좀이 메세지의 5' 말단에 결합하여 전사가 개시되는 첫번째 유효한 ATG를 탐색하는 것으로 사료된다. 그럼에도 불구하고, ATG에 인접한 특정 뉴클레오타이드에 대한 선호도가 있으며 미생물 유전자의 발현은 ATG에 진핵 컨센서스 전사 개시인자를 포함시킴으로써 증강시킬 수 있다. 클론텍[참조문헌: 1993/1994 catalog, page 210; 이는 본원에서 참조로 인용된다]은 한 서열을 식물에서 이. 콜라이 uidA 유전자를 발현시키기 위한 컨센서스 전사 개시인자로서 제시한 바 있다. 또한, 조시[참조문헌: NAR 15:6643-6653 (1987), 이는 본원에 참조로 인용된다]는 ATG에 인접한 다수의 식물 서열을 비교하였고 다른 컨센서스 서열을 제시한 바 있다. 식물에서 미생물 ORF의 발현시키는데 어려움에 직면한 상황하에서는 이들 서열 중 하나를 개시 ATG에 포함시켜 전사를 개선시킬 수 있다. 이러한 경우에, 컨센서스의 마지막 3개의 뉴클레오타이드는 이의 두번째 AA 잔기의 변형으로 인해, 변형된 서열내에 포함시키기에 적절하지 않을 수 있다. 개시 메티오닌에 인접한 바람직한 서열은 상이한 식물 종 간에 상이할 수 있다. 진뱅크(GenBank) 데이터베이스에 위치한 14개의 옥수수 유전자의 조사는 다음 결과를 제공한다:Plants are distinguished from microorganisms in that their messages do not have defined ribosomal binding sites. Rather, it is believed that ribosomes bind to the 5 'end of the message to search for the first valid ATG to initiate transcription. Nevertheless, there is a preference for certain nucleotides adjacent to ATG and the expression of microbial genes can be enhanced by including eukaryotic consensus transcription initiators in ATG. Clontech [Ref. 1993/1994 catalog, page 210; Which is incorporated herein by reference. It has been suggested as a consensus transcription initiator for expressing the E. coli uidA gene. In addition, Josh (NAR 15: 6643-6653 (1987), which is incorporated herein by reference), compared a number of plant sequences adjacent to ATG and presented different consensus sequences. In situations facing difficulties in expressing the microbial ORF in plants, one of these sequences may be included in the starting ATG to improve transcription. In such cases, the last three nucleotides of the consensus may not be suitable for inclusion in the modified sequence due to the modification of its second AA residue. Preferred sequences adjacent to the starting methionine may differ between different plant species. A survey of 14 corn genes in the GenBank database gives the following results:

14개 옥수수 유전자에서 개시 ATG 앞의 위치Position Before Initiation ATG in 14 Corn Genes

Figure 112003006523766-pct00001

Figure 112003006523766-pct00001

상기 분석은 뉴클레오타이드 서열이 혼입된 목적하는 식물 종, 및 바람직한 뉴클레오타이드를 포함하도록 변형된 ATG에 인접한 서열에 대해 수행할 수 있다.
The analysis can be performed on the desired plant species into which the nucleotide sequence is incorporated, and the sequence adjacent to the ATG modified to include the desired nucleotide.

4. 변칙적 스플라이싱 부위의 제거4. Removal of anomalous splicing sites

비-식물 공급원으로부터 클로닝되었으며 식물에서의 발현에 최적화되지 않은 유전자는 식물에서 5' 또는 3' 스플라이싱 위치로서 인식되고 절단될 수 있기 때문에 절단되거나 결실된 메세지를 생성할 수 있는 모티프를 함유할 수도 있다. 이들 부위는 당해 분야에 익히 공지된 기술을 사용하여 제거할 수 있다.Genes cloned from non-plant sources and not optimized for expression in plants may contain motifs that can produce truncated or deleted messages because they can be recognized and cleaved as 5 'or 3' splicing sites in plants. It may be. These sites can be removed using techniques well known in the art.

암호화 서열 및 인접 서열을 변형시키기 위한 기술은 당해 분야에 익히 공지 되어 있다. 미생물 ORF의 초기 발현이 저조하고 상기 기술한 서열에 대한 변경이 이루어지는 것이 바람직하다고 간주되는 경우에, 합성 유전자의 작제를 당해 분야에 익히 공지된 방법에 따라서 달성할 수 있다. 이들 방법은 예를 들어, 모두 본원에서 참조로 인용되는 공개특허공보 제EP 0 385 962호, 제EP 0 359 472호 및 제WO 93/07278호에 기재되어 있다. 대부분의 경우에 유전자 작제물의 발현은 유전자를 형질전환 식물로 전달시키기 전에 일시적 검정 프로토콜(이는 당해 분야에 익히 공지되어 있다)을 사용하여 검정하는 것이 바람직하다.
Techniques for modifying coding sequences and contiguous sequences are well known in the art. If it is deemed that initial expression of the microbial ORF is poor and alterations to the sequences described above are desired, the construction of synthetic genes can be accomplished according to methods well known in the art. These methods are described, for example, in Publications EP 0 385 962, EP 0 359 472 and WO 93/07278, all of which are incorporated herein by reference. In most cases, expression of the gene construct is preferably assayed using a transient assay protocol (which is well known in the art) prior to delivering the gene to the transgenic plant.

실시예 5: 식물 발현 카세트의 작제Example 5: Construction of Plant Expression Cassettes

먼저, 형질전환 식물에서 발현시키고자 하는 암호화 서열을 식물에서 발현가능한 적합한 프로모터 뒤에서 발현 카세트로서 집합시킨다. 발현 카세트는 형질전환유전자의 발현을 위해 필요하거나 선택된 임의 추가의 유전자를 포함할 수도 있다. 이러한 서열은 전사 터미네이터, 발현을 증강시키는 외인성 서열(예: 인트론), 중추적 서열, 및 유전자 생성물을 특정 기관 및 세포 격실로 표적화시키기 위한 서열을 포함하나 이에 제한되지 않는다. 이로써 이러한 발현 카세트는 하기에서 기술하는 형질전환 벡터로 쉽게 전달시킬 수 있다. 다음은 통상의 발현 카세트의 다양한 성분에 관한 설명이다.First, the coding sequence to be expressed in the transgenic plant is collected as an expression cassette behind a suitable promoter expressible in the plant. The expression cassette may comprise any additional genes required or selected for expression of the transgene. Such sequences include, but are not limited to, transcriptional terminators, exogenous sequences that enhance expression (eg, introns), pivotal sequences, and sequences for targeting gene products to specific organ and cell compartments. This expression cassette can thus be readily delivered to the transformation vectors described below. The following is a description of the various components of a conventional expression cassette.

1. 프로모터1. Promoter

발현 카세트에서 사용되는 프로모터의 선택은 형질전환 식물내의 형질전환유전자의 시공간적 발현 패턴을 결정할 수 있다. 선택된 프로모터는 특정 세포 유형(예: 잎 상피세포, 잎살 세포, 뿌리 피질 세포) 또는 특정 조직이나 기관(예: 뿌리, 잎 또는 꽃)에서 특정 형질전환유전자를 발현할 수 있으며, 선택은 유전자 생성물의 목적하는 축적 위치를 반영할 수 있다. 또는, 선택된 프로모터는 유도성 조건하에 유전자의 발현을 유도할 수 있다. 프로모터는 이의 강도, 즉 전사를 촉진하는 능력이 다양하다. 사용되는 숙주 세포 시스템에 따라서, 유전자의 천연 프로모터를 포함하여, 다수의 적합한 프로모터의 어느 하나를 사용할 수 있다. 다음은 발현 카세트에서 사용될 수 있는 프로모터의 비제한적 예이다.The choice of promoter used in the expression cassette can determine the spatiotemporal expression pattern of the transgene in the transgenic plant. Selected promoters can express specific transgenes in specific cell types (e.g. leaf epithelial cells, foliar cells, root cortical cells) or in specific tissues or organs (e.g. roots, leaves or flowers) and selection of gene products The desired accumulation position can be reflected. Alternatively, the selected promoter can induce the expression of a gene under inducible conditions. Promoters vary in their strength, the ability to promote transcription. Depending on the host cell system used, any of a number of suitable promoters can be used, including the natural promoter of the gene. The following are non-limiting examples of promoters that can be used in expression cassettes.

a. 구성적 발현, 유비퀴틴 프로모터:a. Constitutive expression, ubiquitin promoters:

유비퀴틴은 많은 세포 유형에서 축적되어 있는 것으로 공지된 유전자 생성물로서, 형질전환 식물에 사용하기 위해 수가지 종으로부터 이의 프로모터가 클로닝되었다(예: 해바라기[참조문헌: Binet et al. Plant Science 79:87-94(1991)], 옥수수[참조문헌: Christensen et al. Plant Molec.Biol. 12:619-632(1989)]). 옥수수 유비퀴틴 프로모터는 형질전환 단자엽식물에서 개발되었으며, 이의 서열과 단자엽식물 형질전환을 위해 작제한 벡터가 본원에서 참조로 인용되는 특허 공보 제EP 0 342 926호에 기재되어 있다. 또한, 문헌[참조문헌: Taylor et al., Plant Cell Rep. 12: 491-495 (1993)]에는 옥수수 유비퀴틴 프로모터와 제1의 인트론을 포함하며 벡터 및 미세사출성 충격을 통해 도입시킨 경우 다수의 단자엽식물의 세포 현탁액중에서 활성이 높은 벡터가 기재되어 있다. 본 발명의 뉴클레오타이드 서열과 함께 사용하기에는 아라비돕시스 유비퀴틴 프로모터가 이상적이다. 당해 유비퀴틴 프로모터는 형질전환 식물, 단자엽식물 및 쌍자엽식물 둘다에서의 유전자 발현에 적합하다. 적합합 벡터는 pAHC25의 유도체 또는 적절한 유비퀴틴 프로모터 및/또는 인트론 서열을 도입시켜 변형시킨 것으로서, 본원에서 기술하는 임의 형질전환 벡터이다.Ubiquitin is a gene product known to accumulate in many cell types, and its promoters have been cloned from several species for use in transgenic plants (e.g. sunflowers: Binet et al. Plant Science 79: 87- 94 (1991)], corn (Christensen et al. Plant Molec. Biol. 12: 619-632 (1989)). Corn ubiquitin promoters were developed in transgenic monocots and their sequences and vectors constructed for monocot plant transformation are described in patent publication EP 0 342 926, which is incorporated herein by reference. See also Taylor et al., Plant Cell Rep. 12: 491-495 (1993) describe a vector that contains a corn ubiquitin promoter and a first intron and is highly active in cell suspensions of a number of monocotyledonous plants when introduced via vectors and microinjection bombardment. The Arabidopsis ubiquitin promoter is ideal for use with the nucleotide sequences of the present invention. The ubiquitin promoter is suitable for gene expression in both transgenic plants, monocotyledonous and dicotyledonous plants. Suitable conformation vectors are any transformation vectors described herein, as modified by introducing a derivative of pAHC25 or an appropriate ubiquitin promoter and / or intron sequence.

b. 구성적 발현, CaMV 35S 프로모터:b. Constitutive expression, CaMV 35S promoter:

플라스미드 pCGN1761의 작제는 본원에서 참조로 인용되는 공개 특허원 제EP 0 392 225호(실시예 23)에 기재되어 있다. pCGN1761은 "이중" CaMV 35S 프로모터, tml 전사 터미네이터 및 상기 프로모터와 터미네이터 사이의 고유한 EcoRI 부위를 포함하고 pUC형의 골격을 갖는다. pCGN1761의 유도체는 기존의 EcoRI 부위 이외에 NotI 및 XhoI 부위를 포함하는 변형된 폴리링커를 갖도록 작제한다. 상기 유도체를 pCGN1761ENX라 지정한다. pCGN1761ENX는 형질전환 식물에서 35S 프로모터의 조절하에 발현시키기 위해 이의 폴리링커내의 cDNA 서열 또는 암호화 서열(미생물 ORF 서열을 포함)을 클로닝하는데 유용하다. 이러한 작제물의 전체 35S 프로모터-암호화 서열-tml 터미네이터 카세트는, 하기 기술하는 바와 같은 형질전환 벡터로 전달시키기 위해 상기 프로모터의 5'에 위치하는 HindIII, SphI, SalI 및 XbaI 부위에서 절단될 수 있고, 터미네이터의 3'에 위치하는 XbaI, BamHI 및 BglI 부위에서 절단할 수 있다. 또한, 다른 프로모터로 대체하기 위해, 이중 35S 프로모터 단편을 HindIII, SphI, SalI, XbaI 또는 PstI로 5' 절단하고 폴리링커 제한 부위(EcoRI, NotI 또는 XhoI) 중 임의 부위 3' 절단하여 제거할 수 있다. 경우에 따라, 클로닝 부위 주변의 변형을 전사를 증강시킬 수 있는 서열을 도입하여 이룰 수 있다. 이는 특히 과발현이 바람직한 경우 유용하다. 예를 들어, pCGN1761ENX 는 본원에서 참조로 인용되는 미국 특허 제5,639,949호의 실시예 37에 기술된 전사 개시 부위를 최적화시켜 변형시킬 수 있다.The construction of plasmid pCGN1761 is described in published patent application EP 0 392 225 (Example 23), which is incorporated herein by reference. pCGN1761 contains a "double" CaMV 35S promoter, a tml transcription terminator and a unique EcoRI site between the promoter and terminator and has a pUC backbone. Derivatives of pCGN1761 are constructed to have modified polylinkers comprising NotI and XhoI sites in addition to existing EcoRI sites. The derivative is designated pCGN1761ENX. pCGN1761ENX is useful for cloning cDNA sequences or coding sequences (including microbial ORF sequences) in its polylinkers for expression under the control of a 35S promoter in transgenic plants. The entire 35S promoter-coding sequence-tml terminator cassette of this construct can be cleaved at the HindIII, SphI, SalI and XbaI sites located at 5 'of the promoter for delivery to a transformation vector as described below, Cleavage can be made at the XbaI, BamHI and BglI sites located 3 'of the terminator. In addition, to replace with other promoters, the double 35S promoter fragment can be removed by 5 ′ cleavage with HindIII, SphI, SalI, XbaI or PstI and 3 ′ cleavage of any site of polylinker restriction sites (EcoRI, NotI or XhoI). . If desired, modifications around the cloning site can be achieved by introducing sequences that can enhance transcription. This is particularly useful when overexpression is desired. For example, pCGN1761ENX can be modified by optimizing the transcription initiation site described in Example 37 of US Pat. No. 5,639,949, which is incorporated herein by reference.

c. 구성적 발현, 액틴 프로모터c. Constitutive expression, actin promoter

액틴의 여러 이소형은 대부분의 세포 형태에서 발현되는 것으로 알려져 있으며, 따라서 액틴 프로모터는 구조적 프로모터로서 많이 사용된다. 특히, 벼의 Act1 유전자 유래의 프로모터가 클로닝되었고 특성화되었다[참조: McElroy et al. Plant Cell 2:163-171(1990)]. 상기 프로모터의 1.3kb 단편은 벼의 원형질체내에서 발현되는데 필요한 모든 조절 인자를 함유하는 것으로 밝혀졌다. 또한, 특히 단자엽식물에서 사용하기 위해 Act1 프로모터를 기초로 한 다양한 발현 벡터가 작제되었다[참조: McElroy et al., Mol.Gen.Genet. 231:150-160(1991)]. 이들 벡터는 Act1-인트론 1, Adh1 5' 플랭킹 서열 및 Adh1-인트론 1(옥수수 알콜 데하이드로게나제 유전자 유래) 및 CaMV 35S 프로모터로부터의 서열을 포함한다. 최고의 발현율을 나타내는 벡터는 35S와 Act1 인트론의 융합체 또는 Act1 5' 플랭킹 서열과 Act1 인트론의 융합체이다. 개시 ATG(GUS 리포터 유전자의 ATG) 주위에 있는 서열의 최적화 또한 발현을 향상시킨다. 맥엘로이 등[참조문헌: Mol.Gen.Genet.231:150-160(1991)]에 의해 기재된 프로모터 발현 카세트는 유전자의 발현을 위해 용이하게 변형시킬 수 있고, 특히 단자엽 숙주에서 사용하기에 매우 적합하다. 예를 들어, 맥엘로이 작제물로부터 프로모터 함유 단편을 제거하고 pCGN1761ENX 내의 이중 35S 프로모터를 대체시키면 특정 유전자 서열 또는 삽입용으로 사용할 수 있다. 이와 같이 작제된 융합 유전자는 적당한 형질전환 벡터로 전달시킬 수 있다. 별도의 보고서에서 제1 인트론을 지닌 벼의 Act1 프로모터가 배양된 보리 세포에서 높은 발현을 유도하는 것으로 밝혀져 있다[참조: Chibbar et al., Plant Cell Rep. 12: 506-509 (1993)].Several isoforms of actin are known to be expressed in most cell types, so actin promoters are frequently used as structural promoters. In particular, promoters from the Act1 gene of rice have been cloned and characterized. McElroy et al. Plant Cell 2: 163-171 (1990). The 1.3 kb fragment of this promoter was found to contain all the regulatory factors necessary for expression in the protoplasts of rice. In addition, various expression vectors based on the Act1 promoter have been constructed, particularly for use in monocots. McElroy et al., Mol. Gen. Genet. 231: 150-160 (1991). These vectors include Actl-intron 1, Adh1 5 'flanking sequences and sequences from Adh1-intron 1 (from corn alcohol dehydrogenase gene) and CaMV 35S promoters. The vector with the highest expression rate is either a fusion of 35S with Act1 intron or a fusion of Act1 5 'flanking sequence with Act1 intron. Optimization of the sequence around the starting ATG (ATG of the GUS reporter gene) also enhances expression. Promoter expression cassettes described by McElroy et al. (Mol. Gen. Genet. 231: 150-160 (1991)) can be readily modified for expression of genes and are particularly well suited for use in monocotyledonous hosts. Do. For example, removing promoter-containing fragments from the McElroy construct and replacing the double 35S promoter in pCGN1761ENX can be used for specific gene sequences or insertions. The fusion gene thus constructed can be delivered to a suitable transformation vector. In a separate report, the Act1 promoter of rice with a first intron was found to induce high expression in cultured barley cells. See Chibbar et al., Plant Cell Rep. 12: 506-509 (1993).

d. 유도성 발현, PR-1 프로모터: d. Inducible Expression, PR-1 Promoter:

pCGN1761ENX 내의 이중 35S 프로모터는 적합하게 높은 발현 수준을 야기할 수 있는 선택된 어떠한 다른 프로모터로도 대체시킬 수 있다. 예를 들어, 담배 PR-1a 프로모터와 같이 미국 특허 제5,614,395호에 기재된 화학적으로 조절가능한 프로모터 중 하나가 이중 35S 프로모터를 대체할 수 있다. 또는, 문헌[참조문헌: Lebel et al., Plant J. 16:223-233 (1998)]에 기재된 아라비돕시스 PR-1 프로모터를 사용할 수 있다. 선택된 프로모터는 바람직하게는 제한 효소를 사용하여 이의공급원으로부터 절단하지만, 적절한 말단 제한 부위를 지니는 프라이머를 사용하여 PCR-증폭시킬 수 있다. PCR 증폭을 수행해야할 경우, 증폭 에러를 점검하기 위해 표적 벡터내의 증폭된 프로모터를 클로닝한 후에 프로모터를 재서열화해야 한다. 화학적으로/병원체 조절가능한 담배 PR-1a 프로모터를 플라스미드 pCIB1004로부터 절단하고(작제를 위해, 본원에서 참조로 인용되는 EP 0 332 104의 실시예 21 참조) 플라스미드 pCGN1716ENX로 전달시킨다[참조문헌: Uknes et al., Plant Cell 4: 645-656 (1992)]. pCIB1004는 NcoI로 절단하고 수득되는 선형화된 단편의 3' 돌출부를 T4 DNA 폴리머라제로 처리하여 평활 말단화시킨다. 이어서 단편을 HindIII로 절단하고 수득되는 PR-1a 프로모터 함유 단편을 겔 정제하고, 이중 35S 프로모터가 제거된 pCGN1761ENX로 클로닝한다. 이는 XhoI로 절단하고 T4 폴리머라제로 평활 말단화시킨 다음, HindIII로 절단하고 pCIB1004 프로모터 단편이 클로닝된 보다 큰 벡터-터미네이터 함유 단편을 분리함으로써 수행한다. 이로써 PR-1a 프로모터와 tml 터미네이터를 함유하는 PRpCGN1761ENX 및 EcoRI과 NotI 부위를 함유하는 개재 폴리링커가 수득된다. 선택된 암호화 서열을 상기 벡터내로 삽입시킬 수 있으며, 이어서 융합 생성물(즉, 프로모터-유전자-터미네이터)을 상기 기술한 벡터를 포함하는 임의 선택된 형질전환 벡터로 전달시킬 수 있다. 미국 특허 제5,523,311호 및 제5,614,395호에 기술된 벤조티아디아졸, 이소니코틴산 및 살리실산 화합물을 포함하는 다양한 화학적 조절제를 사용하여, 본 발명에 따라서 형질전환된 식물에서 선택된 암호화 서열의 발현을 유도할 수 있다. The dual 35S promoter in pCGN1761ENX can be replaced with any other promoter selected that can result in a suitably high expression level. For example, one of the chemically controllable promoters described in US Pat. No. 5,614,395, such as the tobacco PR-1a promoter, may replace the dual 35S promoter. Alternatively, the Arabidopsis PR-1 promoter described in Lebel et al., Plant J. 16: 223-233 (1998) can be used. The selected promoter is preferably cleaved from its source using restriction enzymes, but can be PCR-amplified using primers with appropriate terminal restriction sites. If PCR amplification is to be performed, the promoter should be resequenced after cloning the amplified promoter in the target vector to check for amplification errors. The chemically / pathogen control tobacco PR-1a promoter is cleaved from plasmid pCIB1004 (for construction, see Example 21 of EP 0 332 104, incorporated herein by reference) and transferred to plasmid pCGN1716ENX (Uknes et al. , Plant Cell 4: 645-656 (1992). pCIB1004 is cleaved with NcoI and blunt ended by treatment of the 3 ′ overhang of the linearized fragments obtained with T4 DNA polymerase. The fragment is then cleaved with HindIII and the resulting PR-1a promoter containing fragment is gel purified and cloned into pCGN1761ENX, of which 35S promoter has been removed. This is done by cleaving with XhoI, blunt ended with T4 polymerase, then cleaving with HindIII and separating the larger vector-terminator containing fragments from which the pCIB1004 promoter fragment was cloned. This gives PRpCGN1761ENX containing the PR-1a promoter and tml terminator, and an intervening polylinker containing EcoRI and NotI sites. The selected coding sequence can be inserted into the vector and then the fusion product (ie, promoter-gene-terminator) can be delivered to any selected transformation vector comprising the vector described above. Various chemical modulators, including the benzothiadiazole, isnicotinic acid and salicylic acid compounds described in US Pat. Nos. 5,523,311 and 5,614,395, can be used to induce the expression of coding sequences selected in plants transformed according to the present invention. have.

e. 유도성 발현, 에탄올-유도성 프로모터:e. Inducible Expression, Ethanol-Induced Promoters:

에탄올과 같은 특정 알콜이나 케톤에 의해 유도될 수 있는 프로모터도 본 발명의 암호화 서열의 발현을 유도하는데 사용할 수 있다. 이러한 프로모터로는 아스퍼질러스 니듈란스(Aspergillus nidulans)로부터의 alcA 유전자 프로모터[참조문헌: Caddick et al.(1998) Nat Biotechnol 16:177-180]가 있다. 에이.니듈란스에서, alcA 유전자는 화학적 유도인자의 존재하에 AlcR 전사 인자에 의해 발현이 조절되는 알콜 데하이드로게나제 I을 암호화한다. 본 발명의 목적을 위해, 최소 35S 프로모터에 융합되어 있는 alcA 유전자 프로모터 서열을 포함하는 플라스미드 palcA:CAT 내의 CAT 암호화 서열[참조문헌: Caddick et al. (1988) Nat Biotechnol 16:177-180]을 본 발명의 암호화 서열로 대체시켜, alcA 유전자 프로모터의 조절하에 암호화 서열을 지니는 발현 카세트를 형성시킨다. 이는 당해 분야에 공지된 방 법을 사용하여 수행한다. Promoters that can be induced by certain alcohols or ketones, such as ethanol, can also be used to drive expression of the coding sequences of the invention. Such promoters include the alcA gene promoter from Aspergillus nidulans (Caddick et al. (1998) Nat Biotechnol 16: 177-180). In A. nidulans, the alcA gene encodes alcohol dehydrogenase I, whose expression is regulated by AlcR transcription factors in the presence of chemical inducers. For the purposes of the present invention, a CAT coding sequence in plasmid palcA: CAT comprising alcA gene promoter sequence fused to at least 35S promoter [Caddick et al. (1988) Nat Biotechnol 16: 177-180] is replaced with the coding sequence of the present invention to form an expression cassette with the coding sequence under the control of the alcA gene promoter. This is done using methods known in the art.

f. 유도성 발현, 글루코코르티코이드-유도성 프로모터f. Inducible expression, glucocorticoid-inducible promoter

스테로이드 호르몬에 기초한 시스템을 사용하는 본 발명의 핵산 서열의 발현 유도 또한 본 발명에 포함된다. 예를 들어, 글루코코르티코이드-매개된 유도 시스템을 사용하고[참조문헌: Aoyama and Chua(1997) The Plant Journal 11:605-612]. 글루코코르티코이드, 예를 들어, 합성 글루코코르티코이드, 바람직하게는 덱사메타손을 바람직하게는 0.1 내지 1mM의 농도, 보다 바람직하게는 10mM 내지 100mM 범위의 농도로 적용하여 유전자 발현을 유도한다. 본 발명의 목적을 위해, 루시퍼라제 유전자 서열을 본 발명의 핵산 서열로 대체시켜, GAL4 상부스트림 활성화 서열의 6개 복사체의 조절하에 본 발명의 핵산 서열이 35S 최소 프로모터에 융합되어 있는 발현 카세트를 제조한다. 이는 당해 분야에 익히 공지된 방법을 사용하여 수행한다. 트랜스-작용 인자는 랫트 글루코코르티코이드 수용체의 호르몬-결합 도메인[참조문헌: Picard et al.(1988) Cell 54: 1073-1080]에 융합된 헤르페스 바이러스 단백질 VP16의 트랜스활성화 도메인[참조문헌: Triezenberg et al. (1988) Genes Devel. 2:718-729]과 융합된 GAL4 DNA-결합 도메인[참조문헌: Keegan et al. (1986) Science 231:699-704]을 포함한다. 상기 융합 단백질의 발현은 당해 분야에 공지되어 있거나 본원에서 기술하는 식물에서 발현시키기에 적합한 임의 프로모터에 의해 조절된다. 또한, 상기 발현 카세트는 6xGAL4/최소 프로모터에 융합되어 있는 본 발명의 핵산 서열을 포함하는 식물에 포함되어 있다. 따라서, 융합 단백질의 조직-특이성 또는 기관-특이성은 당해 살충성 독소의 유도적 조직-특이성 또 는 기관-특이성을 유도하여 달성된다.Induction of expression of nucleic acid sequences of the present invention using systems based on steroid hormones is also included in the present invention. For example, using a glucocorticoid-mediated induction system (Aoyama and Chua (1997) The Plant Journal 11: 605-612). Glucocorticoids, such as synthetic glucocorticoids, preferably dexamethasone, are preferably applied at concentrations ranging from 0.1 to 1 mM, more preferably at concentrations ranging from 10 mM to 100 mM. For the purposes of the present invention, the luciferase gene sequence is replaced with the nucleic acid sequence of the present invention to produce an expression cassette in which the nucleic acid sequence of the present invention is fused to a 35S minimal promoter under the control of six copies of the GAL4 upstream activating sequence. do. This is done using methods well known in the art. The trans-acting factor is the transactivation domain of the herpes virus protein VP16 fused to the hormone-binding domain of the rat glucocorticoid receptor (Picard et al. (1988) Cell 54: 1073-1080) [TriZenberg et al. . (1988) Genes Devel. 2: 718-729] and GAL4 DNA-binding domains [Keegan et al. (1986) Science 231: 699-704. Expression of the fusion protein is controlled by any promoter suitable for expression in plants known in the art or described herein. The expression cassette is also included in a plant comprising the nucleic acid sequence of the invention fused to a 6xGAL4 / minimal promoter. Thus, tissue-specific or organ-specificity of the fusion protein is achieved by inducing inducible tissue-specific or organ-specificity of the pesticidal toxin.

g. 뿌리 특이적 발현:g. Root Specific Expression:

유전자 발현의 다른 패턴은 뿌리 발현이다. 적합한 뿌리 프로모터는 본원에서 참조로 인용되는 문헌[참조: de Framond, FEBS 290:103-106(1991)] 및 미국 특허 제 5,466,785호에 기술된 옥수수 메탈로티오네인형(MTL) 유전자의 프로모터이다. 상기 "MTL" 프로모터를 선택된 유전자의 삽입을 위해 pCGN1761ENX와 같은 적당한 벡터에 전달시키고 이어서 전체 프로모터-유전자-터미네이터 카세트를 관심있는 형질전환 벡터에 전달시킨다.Another pattern of gene expression is root expression. Suitable root promoters are promoters of the maize metallothionein (MTL) gene described in de Framond, FEBS 290: 103-106 (1991), and US Pat. No. 5,466,785, which is incorporated herein by reference. The "MTL" promoter is transferred to a suitable vector, such as pCGN1761ENX for insertion of the selected gene, followed by transfer of the entire promoter-gene-terminator cassette to the transformation vector of interest.

h. 상처-유도성 프로모터:h. Wound-induced promoters:

상처-유도성 프로모터 또한 유전자 발현에 적합할 수 있다. 다수의 이러한 프로모터는 문헌[참조문헌: Xu et al. Plant Molec. Biol. 22:573-588 (1993), Logemann et al. Plant Cell 1:151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22:783-792 (1993), Firek et al. Plant Molec. Biol. 22:129-142(1993), Warner et al. Plant J. 3:191-201(1993)]에 기재되어 있고, 모두 본 발명에서 사용하기에 적합하다. 로지맨(Logemann) 등은 쌍자엽 감자 wunI 유전자의 5' 상부 서열을 기술하고 있다. 수(Xu) 등은 쌍자엽 감자로부터의 상처 유도성 프로모터(pin2)가 단자엽 벼에서 활성적임을 제시하고 있다. 또한, 로마이어(Rohrmeier) 및 렐레(Lehle)는 상처 유도성이고 표준 기술에 의해 동족 프로모터를 분리하는데 사용할 수 있는 옥수수 Wip1 cDNA의 클로닝에 대해서 기술하고 있다. 유사하게, 피렉(Firek) 등과 워너(Warner) 등은 국소적 상처 및 병원균 침입 부위에서 발현되는 단자엽 아스파라거스 오피시날리스(Asparagus officinalis)로부터의 상처 유도성 유전자를 기술하였다. 이들 프로모터는 당해 분야에 공지된 클로닝 기술을 사용하여 적합한 벡터로 전달시키고 본 발명에 따르는 유전자에 융합시켜, 상기 유전잘를 식물 상처 부위에서 발현시키는데 사용할 수 있다.Wound-induced promoters may also be suitable for gene expression. Many such promoters are described in Xu et al. Plant Molec. Biol. 22: 573-588 (1993), Logemann et al. Plant Cell 1: 151-158 (1989), Rohrmeier & Lehle, Plant Molec. Biol. 22: 783-792 (1993), Firek et al. Plant Molec. Biol. 22: 129-142 (1993), Warner et al. Plant J. 3: 191-201 (1993), all of which are suitable for use in the present invention. Logemann et al. Describe the 5 'upstream sequence of the dicot potato wunI gene. Xu et al suggest that the wound inducible promoter (pin2) from dicotyledonous potatoes is active in monocotyledonous rice. In addition, Rohrmeier and Lehle describe the cloning of maize Wip1 cDNA which is wound-inducible and can be used to isolate cognate promoters by standard techniques. Similarly, Firek et al. Warner et al. Described wound inducible genes from monocotyledonous Asparagus officinalis expressed at local wounds and pathogen invasion sites. These promoters can be used to express the genetic wells at the plant wound site by transferring them into suitable vectors using the cloning techniques known in the art and fusion to the genes according to the invention.

i. 목수(木髓)에 바람직한 발현:i. Preferred Expressions for Carpenters:

본원에서 참조로 인용되는 특허원 제WO93/07278호에는 목수 세포에서 우선적으로 발현되는 옥수수 trpA 유전자의 분리가 기술되어 있다. 전사 시작 부위부터 약 1726bp까지에 해당되는 유전자 서열 및 프로모터가 존재한다. 표준 분자생물학 기술을 사용하여, 상기 프로모터 또는 이의 일부를 pCGN1761과 같은 벡터로 전달시킬 수 있고, 여기서 상기 프로모터는 35S 프로모터를 대체하여 외래 유전자를 목수에 바람직한 방식으로 발현시키는데 사용할 수 있다. 실제로, 목수에 바람직한 프로모터 또는 이의 일부를 함유하는 단편은 임의 벡터로 전달시켜 형질전환 식물에 유용하게 변형시킬 수 있다. Patent Application WO 93/07278, which is incorporated herein by reference, describes the isolation of maize trpA gene that is preferentially expressed in carpenter cells. There are gene sequences and promoters that correspond from the start of transcription to about 1726 bp. Using standard molecular biology techniques, the promoter or portion thereof can be delivered to a vector such as pCGN1761, where the promoter can be used to replace the 35S promoter to express foreign genes in a carpenter's preferred manner. Indeed, fragments containing a promoter or part thereof that is preferred for a carpenter can be delivered to any vector and usefully modified for transgenic plants.

j. 잎-특이적 발현:j. Leaf-specific Expression:

포스포에놀 카복실라제(PEPC)를 암호화하는 옥수수 유전자는 문헌[참조: Hudspeth & Grula, Plant Molec Biol 12: 579-589 (1989)]에 기재되어 있다. 표준 분자생물학 기술을 사용하여, 상기 유전자의 프로모터를 형질전환 식물에서 임의 유전자의 발현을 잎 특이적 방식으로 추진하는데 사용할 수 있다.Corn genes encoding phosphoenol carboxylase (PEPC) are described in Hudspeth & Grula, Plant Molec Biol 12: 579-589 (1989). Using standard molecular biology techniques, promoters of these genes can be used to drive the expression of any gene in a transgenic plant in a leaf specific manner.

k. 화분(花粉)-특이적 발현: k. Pollen-specific expression:                 

WO 93/07278에는 화분 세포에서 발현되는 옥수수의 칼슘 의존적 단백질 키나제(CDPK) 유전자의 분리가 기재되어 있다. 상기 유전자 서열과 프로모터는 전사 시작 부위부터 1400bp까지에 해당된다. 표준 분자생물학 기술을 사용하여, 상기 프로모터 또는 이의 일부를 pCGN1761과 같은 벡터로 전달시킬 수 있고, 여기서 상기 프로모터는 35S 프로모터를 대체하여 본 발명의 핵산 서열을 화분 특이적 방식으로 발현시키는데 사용할 수 있다. WO 93/07278 describes the isolation of the calcium dependent protein kinase (CDPK) gene of maize expressed in pollen cells. The gene sequence and the promoter correspond to up to 1400bp from the start of transcription. Using standard molecular biology techniques, the promoter or portion thereof can be delivered to a vector such as pCGN1761, where the promoter can be used to replace the 35S promoter to express the nucleic acid sequence of the invention in a pollen specific manner.

1. 화학적 리간드의 존재하에 수용체 매개된 트랜스활성화:1. Receptor mediated transactivation in the presence of chemical ligands:

본원에서 참조로 인용되는 미국 특허 제5,880,333호에는 이종이량체로서 함께 작용하는 에크디손 수용체(EcR) 및 울트라스피라클(Ultraspiracle; USP)과 같은 II형 호르몬 수용체가 식물 세포에서 적절한 화학적 리간드, 예를 들어, 테부페노지드의 존재하에 표적 폴리펩타이드의 발현을 조절하는 시스템이 기재되어 있다.U.S. Patent 5,880,333, which is incorporated herein by reference, discloses that type II hormone receptors such as ecdysone receptor (EcR) and Ultraspiracle (USP), which act together as heterodimers, are suitable chemical ligands in plant cells, e.g. For example, systems have been described that modulate the expression of a target polypeptide in the presence of tebufenozide.

2. 전사 터미네이터2. Warrior Terminator

발현 카세트에는 다양한 전사 터미네이터를 사용할 수 있다. 이들 전사 터미네이터는 형질전환유전자 이후의 전사 종결 및 정확한 폴리아데닐화와 관련된다. 적절한 전사 터미네이터는 식물에서 작용하는 것으로 공지되어 있는 터미네이터이며 CaMV 35S 터미네이터, tml 터미네이터, 노팔린 신타제 터미네이터 및 완두 rbcS E9 터미네이터를 포함한다. 이들 터미네이터는 단자엽 및 쌍자엽 식물 둘다에 사용할 수 있다. 또한, 유전자의 천연 전사 터미네이터를 사용할 수 있다.Various transcription terminators can be used for the expression cassette. These transcription terminators are involved in transcription termination and precise polyadenylation following the transgene. Suitable transcription terminators are terminators known to function in plants and include CaMV 35S terminators, tml terminators, nopaline synthase terminators and pea rbcS E9 terminators. These terminators can be used for both monocotyledonous and dicotyledonous plants. In addition, a natural transcription terminator of a gene can be used.

3. 발현의 증강 또는 조절을 위한 서열3. Sequences for Enhancing or Regulating Expression

다수의 서열이 전사 단위내에서 유전자 발현을 증강시키는 것으로 밝혀졌으 며 이들 서열을 본 발명의 유전자와 함께 사용하여 형질전환 식물에서 발현을 증가시킬 수 있다.A number of sequences have been found to enhance gene expression in transcription units and these sequences can be used with the genes of the invention to increase expression in transgenic plants.

다양한 인트론 서열은 특히 단자엽식물 세포에서 발현을 향상시키는 것으로 제시되었다. 예를 들어, 옥수수 Adh1 유전자의 인트론은 옥수수 세포에 도입시켰을 경우 동족 프로모터하에 야생형 유전자의 발현을 현저하게 향상시키는 것으로 밝혀졌다. 인트론 1은 클로람페니콜 아세틸트랜스퍼라제 유전자를 함유하는 융합 작제물의 발현을 특히 효적으로 증강시키는 것으로 밝혀졌다[참조문헌: Callis et al., Genes Develop 1:1183-1200 (1987)]. 동일한 실험 시스템에서, 옥수수 bronze 1 유전자로부터의 인트론 또한 발현을 증강시키는데 유사한 효과를 지닌다. 인트론 서열은 통상적으로 식물 형질전환 벡터내에, 통상적으로 비해독 리더내에 포함되어 있다. Various intron sequences have been shown to enhance expression, particularly in monocotyledonous cells. For example, introns of maize Adh1 gene have been shown to significantly enhance the expression of wild-type genes under cognate promoters when introduced into maize cells. Intron 1 has been shown to particularly enhance the expression of fusion constructs containing the chloramphenicol acetyltransferase gene (Callis et al., Genes Develop 1: 1183-1200 (1987)). In the same experimental system, introns from the corn bronze 1 gene also have a similar effect on enhancing expression. Intron sequences are typically contained within plant transformation vectors, usually within a non-toxic leader.

바이러스로부터 유래된 다수의 비해독된 리더 서열이 발현을 증강시킨다고 공지되어 있으며, 이러한 리더 서열은 쌍자엽식물 세포에서 특히 효과적이다. 구체적으로, 담배 모자이크 바이러스(TMV, "W-서열"), 옥수수 반엽 바이러스(MCMV) 및 알파파 모자이크 바이러스(AMV)로부터의 리더 서열이 발현의 증가에 효과적인 것으로 제시되었다[참조문헌: Gallie et al. Nucl.Acids Res. 15:8693-8711 (1987); Skuzeski et al. Plant Molec. Biol. 15: 65-79 (1990)].Many non-ready leader sequences derived from viruses are known to enhance expression, and such leader sequences are particularly effective in dicotyledonous cells. Specifically, leader sequences from tobacco mosaic virus (TMV, "W-sequence"), maize half lobe virus (MCMV) and alpha wave mosaic virus (AMV) have been shown to be effective in increasing expression. Gallie et al. . Nucl. Acids Res. 15: 8693-8711 (1987); Skuzeski et al. Plant Molec. Biol. 15: 65-79 (1990).

4. 세포내에서 유전자 생성물의 표적화4. Targeting Gene Products Into Cells

유전자 생성물을 표적화하는 다양한 기작이 식물에 존재하는 것으로 공지되어 있으며, 이러한 기작의 기능을 조절하는 서열도 다소 상세하게 설명되어 있다. 예를 들어, 색소체(예: 엽록체)에 대한 유전자 생성물의 표적화는, 다양한 단백질의 아미노말단 단부에서 발견되고 엽록체 유입 동안 절단되어 성숙한 단백질을 생성하는 시그널 서열에 의해 조절된다[참조문헌: Comai et al. J.Biol.Chem. 263:15104-15109(1988)]. 이들 시그널 서열은 이종 유전자 생성물에 융합되어 이종 생성물을 엽록체내로 유입시키는데 효과적일 수 있다[참조문헌: van den Broeck et al., Nature 313:358-363(1985)]. 적절한 시그널 서열을 암호하는 DNA는 RUBISCO 단백질, CAB 단백질, EPSP 신타제 효소, GS2 단백질, 및 엽록체에 위치하는 것으로 공지된 많은 기타 단백질을 암호하는 cDNA의 5' 말단으로부터 분리할 수 있다[참조: 미국 특허 제5,639,949호의 실시예에서 "Expression With Chloroplast Targeting"를 표제로 하는 단락].Various mechanisms for targeting gene products are known to exist in plants, and the sequences regulating the function of these mechanisms are also described in some detail. For example, targeting of gene products to pigments (eg chloroplasts) is regulated by signal sequences found at the amino-terminal ends of various proteins and cleaved during chloroplast influx to produce mature proteins. Comai et al. . J. Biol. Chem. 263: 15104-15109 (1988). These signal sequences may be effective for fusion to heterologous gene products to introduce heterologous products into chloroplasts (van den Broeck et al., Nature 313: 358-363 (1985)). DNA encoding the appropriate signal sequence can be isolated from the 5 'end of the cDNA encoding RUBISCO protein, CAB protein, EPSP synthase enzyme, GS2 protein, and many other proteins known to be located in the chloroplast. Paragraph entitled "Expression With Chloroplast Targeting" in the examples of patent 5,639,949.

다른 유전자 생성물은 미토콘드리아 및 퍼옥시좀과 같은 다른 소기관에 국재화되어 있다[참조문헌: Unger et al., Plant Molec. Biol. 13:411-418 (1989)]. 이러한 생성물을 암호하는 cDNA를 또한 조작하여 이종 유전자 생성물을 상기 소기관에 표적화시킬 수 있다. 이러한 서열의 예로는 핵-암호화되는 ATPase 및 미토콘드리아에 특이적인 아스파르테이트 아미노 트랜스퍼라제 이소형이 있다. 세포 단백질체의 표적화는 문헌[참조문헌: Rogers et al. Proc.Natl.Acad.Sci. USA 82: 6512-6516(1985)]에 기재되어 있다. Other gene products are localized in other organelles such as mitochondria and peroxysomes. See Unger et al., Plant Molec. Biol. 13: 411-418 (1989). CDNAs encoding such products can also be engineered to target heterologous gene products to the organelles. Examples of such sequences are nuclear-encoded ATPase and aspartate amino transferase isotypes specific for mitochondria. Targeting of cellular protein bodies is described in Rogers et al. Proc.Natl.Acad.Sci. USA 82: 6512-6516 (1985).

또한, 유전자 생성물을 다른 세포 격실로 표적화할 수 있는 서열도 설명되었다. 아미노말단 서열은 ER, 아포플라스트에 대한 표적화 및 호분 세포로부터의 세포외 분비와 관련된다[참조문헌: Koehler & Ho, Plant Cell 2:769-783 (1990)]. 또한, 아미노 말단 서열은 카복시 말단 서열과 함께 유전자 생성물의 액포로의 표적화와 관련된다[참조문헌: Shinshi et al. Plant Molec. Biol. 14:357-368 (1990)].Also described are sequences that can target gene products to other cell compartments. The amino terminal sequence is associated with targeting to ER, apoplasts and extracellular secretion from eruption cells (Kohehler & Ho, Plant Cell 2: 769-783 (1990)). In addition, the amino terminal sequence is associated with targeting of the gene product to vacuoles along with the carboxy terminal sequence. Shinshi et al. Plant Molec. Biol. 14: 357-368 (1990).

상기 기술한 적절한 표적화 서열을 형질전환유전자에 융합시켜, 형질전환유전자 생성물을 임의 소기관 또는 세포 격실로 지시할 수 있다. 엽록체 표적화를 위해, 예를 들어, RUBISCO 유전자, CAB 유전자, EPSP 신타제 유전자 또는 GS2 유전자로부터의 엽록체 시그널 서열을 프레임내에서 형질전환유전자의 아미노말단 ATG에 융합시킨다. 선택된 시그널 서열은 공지된 절단 부위를 포함해야 하며, 작제된 융합체는 절단에 필요한 절단 부위 이후의 임의 아미노산을 고려해야 한다. 일부 경우에서 이러한 요건은 절단 부위와 형질전환유전자 ATG 간에 소수의 아미노산을 첨가하거나, 또는 형질전환유전자 서열내의 일부 아미노산을 대체시켜 충촉시킬 수 있다. 엽록체 유입을 위해 작제된 융합체는 시험관내 전사된 작제물을 시험관내 해독시킨 다음, 문헌[참조문헌: Bartlett et al. In: Edelmann et al.(Eds.) Methods in Chloroplast Molecular Biology, Elsevier, pp 1081-1091(1982); Wasmann et al. Mol. Gen. Genet. 205:446-453 (1986)]에 기재된 기술을 사용하여 시험관내에서 엽록체를 흡수시킴으로써 엽록체 흡수 효능에 대하여 시험할 수 있다. 이러한 작제 기술은 당해 분야에 익히 공지되어 있으며 미토콘드리아 및 퍼옥시좀에 동일하게 적용할 수 있다.The appropriate targeting sequence described above can be fused to the transgene to direct the transgene product to any organelle or cell compartment. For chloroplast targeting, for example, chloroplast signal sequences from the RUBISCO gene, CAB gene, EPSP synthase gene or GS2 gene are fused to the amino terminal ATG of the transgene in frame. The signal sequence selected should comprise a known cleavage site and the constructed fusion should take into account any amino acids following the cleavage site necessary for cleavage. In some cases this requirement can be fulfilled by adding a few amino acids between the cleavage site and the transgene ATG, or by replacing some amino acids in the transgene sequence. Fusions constructed for chloroplast influx were then read in vitro by transcribed constructs in vitro, followed by Bartlett et al. In: Edelmann et al. (Eds.) Methods in Chloroplast Molecular Biology, Elsevier, pp 1081-1091 (1982); Wasmann et al. Mol. Gen. Genet. 205: 446-453 (1986) can be used to test for chloroplast uptake efficacy by absorbing chloroplasts in vitro. Such construction techniques are well known in the art and are equally applicable to mitochondria and peroxysomes.

상기 기술한 세포내 표적화 기작은, 표적 시그널이 유래되는 프로모터의 발현 패턴과는 상이한 발현 패턴을 가진 프로모터의 전사 조절하에 특정 세포로의 국 소화 목표를 이룰 수 있도록, 동족 프로모터와 함께 사용할 뿐만 아니라, 이종 프로모터와 함께 사용될 수도 있다.
The intracellular targeting mechanisms described above are not only used with cognate promoters to achieve localization targets to specific cells under transcriptional control of promoters with expression patterns different from those of the promoter from which the target signal is derived, It can also be used with heterologous promoters.

실시예 6: 식물 형질전환 벡터의 작제Example 6: Construction of Plant Transformation Vectors

식물 형질전환에 유용한 다수의 형질전환 벡터는 식물 형질전환 분야의 숙련가에게 공지되어 있으며, 본 발명에 적절한 유전자는 이러한 어떠한 벡터와도 함께 사용할 수 있다. 벡터의 선택은 바람직한 형질전환 기술과 형질전환용 표적 종에 따라 좌우될 수 있다. 특정 표적 종의 경우에는 상이한 항생물질 또는 살충제 선택 마커가 바람직할 수 있다. 형질전환에 통상적으로 사용되는 선택 마커로는 가나마이신 및 관련 항생제에 대한 내성을 부여하는 nptII 유전자[참조문헌: Messing & Vieira, Gene 19: 259-268(1982); Bevan et al., Nature 304:184-187(1983)], 제초제 포스피노트리신에 대한 내성을 부여하는 bar 유전자[참조문헌: White et al., Nucl. Acids Res 18: 1062 (1990), Spencer et al. Theor. Appl. Genet 79: 625-631 (1990)], 항생제 하이그로마이신에 대한 내성을 부여하는 hph 유전자[참조문헌: Blochinger & Diggelmann, Mol Cell Biol 4:2929-2931] 및 메타트렉세이트에 대한 내성을 부여하는 dhfr 유전자[참조문헌: Bourouis and Jarry, EMBO J.2(7): 1099-1104(1983)], 글리포세이트에 대한 내성을 부여하는 EPSPS 유전자[참조문헌: 미국 특허 제4,940,935호 및 제5,188,642호] 및 만노스를 대사시키는 능력을 제공하는 만노스-6-포스페이트 이소머라제 유전자[참조문헌: 미국 특허 제5,767,378호 및 제5,994,629호]가 포함된다. Many transformation vectors useful for plant transformation are known to those skilled in the field of plant transformation, and genes suitable for the present invention can be used with any of these vectors. The choice of vector may depend on the desired transformation technique and the target species for transformation. For certain target species different antibiotic or pesticide selection markers may be preferred. Selection markers commonly used for transformation include the nptII gene conferring resistance to kanamycin and related antibiotics (Messing & Vieira, Gene 19: 259-268 (1982); Bevan et al., Nature 304: 184-187 (1983)], the bar gene conferring resistance to the herbicide phosphinothricin (White et al., Nucl. Acids Res 18: 1062 (1990), Spencer et al. Theor. Appl. Genet 79: 625-631 (1990)], hph gene conferring resistance to the antibiotic hygromycin (Blochinger & Diggelmann, Mol Cell Biol 4: 2929-2931) and conferring resistance to metatrexate dhfr gene (Bourouis and Jarry, EMBO J.2 (7): 1099-1104 (1983)), EPSPS gene conferring resistance to glyphosate (US Pat. Nos. 4,940,935 and 5,188,642) And mannose-6-phosphate isomerase genes (US Pat. Nos. 5,767,378 and 5,994,629) that provide the ability to metabolize mannose.                 

1. 아그로박테리움 형질전환에 적합한 벡터1. Vectors Suitable for Agrobacterium Transformation

다수의 벡터가 아그로박테리움 튜머페이션스(Agrobacterium tumefaciens)를 사용한 형질전환에 유용하다. 이들 벡터는 통상적으로 하나 이상의 T-DNA 경계 서열을 지니며, pBIN18[참조문헌: Bevan, Nucl.Acids Res.(1984)] 및 pXYZ와 같은 벡터를 포함한다. 하기에서 아그로박테리움 형질전환에 적합한 2개의 통상적 벡터를 기술한다.Many vectors are useful for transformation with Agrobacterium tumefaciens. These vectors typically have one or more T-DNA border sequences and include vectors such as pBIN18 (Bevan, Nucl. Acids Res. (1984)) and pXYZ. In the following two conventional vectors suitable for Agrobacterium transformation are described.

a. pCIB200 및 pCIB2001:a. pCIB200 and pCIB2001:

아그로박테리움과 사용하기 위한 재조합 벡터를 작제하기 위해 이중 벡터 pCIB200과 pCIB2001을 사용하고, 다음과 같은 방식으로 작제한다. pTJS75kan는, pTJS75[참조문헌: Schmidhauser & Helinski, J Bacteriol. 164: 446-455(1985)]를 NarI 분해하여 테트라사이클린 내성 유전자를 절단한 다음, NPTII를 지니는 pUC4K[참조문헌: Vieira & Messing, Gene 19:259-268(1982); Bevan et al., Nature 304:184-187(1983); McBride et al., Plant Molecular Biology 14:266-276(1990)]로부터의 AccI 단편을 삽입하여 작제한다. XhoI 링커를 좌측 및 우측 T-DNA 경계, 식물 선택가능한 nos/nptII 키메라 유전자 및 pUC 폴리링커[참조문헌: Rothstein et al., Gene 53:153-161(1987)]를 함유하는 pCIB7의 EcoRV 단편에 연결시키고, XhoI-분해된 단편을 SalI-분해된 pTJS75kan에 클로닝하여 pCIB200을 제조한다[참조: EP 0 332 104, 실시예 19]. pCIB200은 다음의 고유한 폴리링커 제한 부위를 함유한다: EcoRI, SstI, KpnI, BglII, XbaI 및 SalI. pCIB2001은 폴리링커내로 추가의 제한 부위를 삽입하여 제조한 pCIB200의 유도체이다. pCIB2001의 폴리링커 내의 고유한 제한 부위는 EcoRI, SstI, KpnI, BglII, XbaI, SalI, MluI, BcII, AvrII, ApaI, HpaI 및 StuI이다. pCIB2001은 이러한 고유한 제한 부위 이외에도 식물 및 박테리아 가나마이신 선택 유전자, 아그로박테리움-매개된 형질전환을 위한 좌측 및 우측 T-DNA 경계 유전자, 이. 콜라이와 다른 숙주 간의 이동을 위한 RK2-유래의 trfA 작용 유전자, 및 또한 RK2로부터의 OriT 및 OriV 작용 유전자를 함유한다. pCIB2001 폴리링커는 자신의 조절 시그널을 함유하는 식물 발현 카세트를 클로닝하는데 적합하다. Dual vectors pCIB200 and pCIB2001 are used to construct recombinant vectors for use with Agrobacterium and are constructed in the following manner. pTJS75kan is described in pTJS75, Schmidhauser & Helinski, J Bacteriol. 164: 446-455 (1985)] by digesting NarI to cleave the tetracycline resistance gene, followed by pUC4K with NPTII (Vieira & Messing, Gene 19: 259-268 (1982); Bevan et al., Nature 304: 184-187 (1983); McBride et al., Plant Molecular Biology 14: 266-276 (1990), to insert the AccI fragment. XhoI linkers were added to EcoRV fragments of pCIB7 containing left and right T-DNA boundaries, plant selectable nos / nptII chimeric genes, and pUC polylinkers (Rothstein et al., Gene 53: 153-161 (1987)). Ligation and cloning XhoI-digested fragments to SalI-digested pTJS75kan to prepare pCIB200 (see EP 0 332 104, Example 19). pCIB200 contains the following unique polylinker restriction sites: EcoRI, SstI, KpnI, BglII, XbaI and SalI. pCIB2001 is a derivative of pCIB200 prepared by inserting additional restriction sites into the polylinker. Intrinsic restriction sites in the polylinker of pCIB2001 are EcoRI, SstI, KpnI, BglII, XbaI, SalI, MluI, BcII, AvrII, ApaI, HpaI and StuI. In addition to these unique restriction sites, pCIB2001 is a plant and bacterial kanamycin selection gene, left and right T-DNA border genes for Agrobacterium-mediated transformation, E. coli. RK2-derived trfA agonist genes for migration between E. coli and other hosts, and also OriT and OriV agonist genes from RK2. The pCIB2001 polylinker is suitable for cloning plant expression cassettes containing their regulatory signals.

b. pCIB10 및 이의 하이그로마이신 선택 유도체b. pCIB10 and its hygromycin selective derivatives

이중 벡터 pCIB10은 식물에서 선택을 위한 가나마이신 내성을 암호화하는 유전자 및 T-DNA 우측 및 좌측 경제 유전자를 함유하며, 숙주 범위가 넓은 플라스미드 pRK252를 포함하여 이. 콜라이 및 아그로박테리움 둘다에서 복제할 수 있다. 이의 작제는 문헌[참조문헌: Rothstein et al. Gene 53:153-161(1987)]에 기재되어 있다. pCIB10의 다양한 유도체는 문헌[참조문헌: Gritz et al., Gene 25: 179-188(1983)]에 기술된 하이그로마이신 B 포스포트랜스퍼라제의 유전자를 포함하도록 작제한다. 이들 유도체는 하이그로마이신에 대해서만(pCIB743) 또는 하이그로마이신과 가나마이신에 대해서(pCIB715, pCIB717) 형질전환 식물 세포를 선택할 수 있게 한다.
The double vector pCIB10 contains genes encoding kanamycin resistance for selection in plants and T-DNA right and left economic genes, including the broad host range plasmid pRK252. It can be replicated in both E. coli and Agrobacterium. Its construction is described in Rothstein et al. Gene 53: 153-161 (1987). Various derivatives of pCIB10 are constructed to include the genes of hygromycin B phosphotransferase described in Gritz et al., Gene 25: 179-188 (1983). These derivatives allow the selection of transgenic plant cells for hygromycin only (pCIB743) or for hygromycin and kanamycin (pCIB715, pCIB717).

2. 비-아그로박테리움 형질전환에 적합한 벡터2. Vectors Suitable for Non-Agrobacterium Transformation

아그로박테리움 튜머페이션스를 사용하지 않는 형질전환은 선택된 형질전환 벡터에서 T-DNA 서열을 반드시 필요로 않으므로, T-DNA 서열을 함유하는 상기 기술한 벡터 이외에 상기 서열이 결실된 벡터를 사용할 수도 있다. 아그로박테리움에 의존하지 않는 형질전환 기술은 입자 충격을 통한 형질전환, 원형질체 흡수(예: PEG 및 전기침투) 및 미세주입을 포함한다. 벡터의 선택은 형질전환되는 종의 바람직한 선택에 따라 크게 좌우된다. 하기에서 비-아그로박테리움 형질전환에 적합한 통상의 벡터를 설명한다.Transformation without using Agrobacterium tumutation does not necessarily require a T-DNA sequence in the selected transformation vector, so that in addition to the vector described above containing the T-DNA sequence, a vector having the sequence deleted may be used. Transformation techniques that do not depend on Agrobacterium include transformation via particle bombardment, protoplast uptake (eg PEG and electropenetration) and microinjection. The choice of vector is highly dependent on the desired choice of the species to be transformed. The following describes common vectors suitable for non-Agrobacterium transformation.

a. pCIB3064a. pCIB3064

pCIB3064는 제초제 바스타(Basta)(또는 포스피노트리신)에 의한 선택과 함께 직접적인 유전자 전달 기술에 적합한 pUC 유래의 벡터이다. 플라스미드 pCIB246은 이. 콜라이 GUS 유전자에 작동적으로 융합되어 있는 CaMV 35S 프로모터 및 CaMV 35S 전사 터미네이터를 포함하고, PCT 공개 출원 제WO 93/07278호에 기술되어 있다. 상기 벡터의 35S 프로모터는 출발 부위의 5'에 2개의 ATG 서열을 포함한다. 이들 부위는 ATG를 제거하고 제한 부위 Ssp1 및 PvuII가 생성되게 하는 방식으로 표준 PCR 기술을 사용하여 돌연변이시킨다. 새로운 제한 부위는 고유한 SalI 부위로부터 96bp 및 37bp, 실제 개시 부위로부터 101bp 및 42bp 떨어져있다. 수득되는 pCIB246의 유도체를 pCIB3025라 지정한다. 이어서, SalI 및 SacI으로 분해하여 pCIB3025로부터 GUS 유전자를 제거하고, 말단을 평활 말단화시키고 재연결시켜 플라스미드 pCIB3060을 제조한다. 플라스미드 pJIT82는 존 인네스 센터(John Innes Centre, Norwich)로부터 입수하고 스트렙토마이세스 비리도크로모게네스(Streptomyces viridochromogenes)로부터의 bar 유전자를 함유 하는 400bp SmaI 단편을 절단하여 pCIB3060의 HpaI 부위에 삽입한다[참조문헌: Thompson et al. EMBO J 6: 2519-2523(1987)]. 이로써 CaMV 35S 프로모터 및 터미네이터 조절하의 제초제 선택용 bar 유전자, 암피실린 내성용(이. 콜라이 선택용) 유전자 및 고유한 부위 SphI, PstI, HindIII 및 BamHI을 지닌 폴리링커를 포함하는 pCIB3064를 수득한다. 상기 벡터는 자신의 조절 시그널을 함유하는 식물 발현 카세트를 클로닝하는데 적합하다.pCIB3064 is a vector derived from pUC that is suitable for direct gene transfer techniques with selection by the herbicide Basa (or phosphinothricin). Plasmid pCIB246 is E. coli. CaMV 35S promoter and CaMV 35S transcriptional terminator operably fused to the E. coli GUS gene and are described in PCT Publication No. WO 93/07278. The 35S promoter of the vector comprises two ATG sequences at 5 'of the starting site. These sites are mutated using standard PCR techniques in such a way that ATG is removed and restriction sites Ssp1 and PvuII are produced. The new restriction sites are 96 bp and 37 bp from the unique SalI site and 101 bp and 42 bp from the actual start site. The derivative of pCIB246 obtained is designated pCIB3025. The plasmid pCIB3060 is then prepared by digesting with SalI and SacI to remove the GUS gene from pCIB3025, blunting the ends and relinking. Plasmid pJIT82 was obtained from the John Innes Center, Norwich and cleaved a 400 bp SmaI fragment containing the bar gene from Streptomyces viridochromogenes and inserted into the HpaI site of pCIB3060. References: Thompson et al. EMBO J 6: 2519-2523 (1987). This gives pCIB3064 comprising a herbicide selection bar gene under CaMV 35S promoter and terminator control, an ampicillin resistance (for E. coli selection) gene and a polylinker with unique sites SphI, PstI, HindIII and BamHI. The vector is suitable for cloning a plant expression cassette containing its regulatory signal.

b. pSOG19 및 pSOG35b. pSOG19 and pSOG35

pSOG35는 메토트렉세이트에 대한 내성을 부여하는 선택가능한 마커로서 이. 콜라이 유전자 디하이드로폴레이트 리덕타제(DHFR)를 사용하는 형질전환 벡터이다. PCR을 사용하여 35S 프로모터(약 800bp), 옥수수 Adh1 유전자로부터의 인트론 6( 약 550bp) 및 pSOG10로부터의 GUS 비해독된 리더 서열 18bp를 증폭시킨다. 또한, 이. 콜라이 디하이드로폴레이트 리덕타제 II형 유전자를 암호하는 250bp 단편을 PCR로 증폭시키고 이들 2가지 PCR 단편을, pUC19 벡터 골격과 노팔린 신타제 터미네이터를 포함하는 pBI221(제조원: Clontech)으로부터의 SacI-PstI 단편과 통합시킨다. 이들 단편을 집합시켜 인트론 6 서열, GUS 리더, DHFR 유전자 및 노팔린 신타제 터미네이터와 융합되어 있는 35S 프로모터를 함유하는 pSOG19를 수득한다. pSOG19 내의 GUS 리더를 옥수수 엽반병 바이러스(MCMV)로부터의 리더 서열로 대체시켜 벡터 pSOG35를 제조한다. pSOG19 및 pSOG35는 암피실린 내성에 대한 pUC 유전자를 함유하며, 외래 물질의 클로닝에 유용한 HindIII, SphI, PstI 및 EcoRI 부위를 지닌다. pSOG35 is a selectable marker that confers resistance to methotrexate. Transformation vector using E. coli gene dihydrofolate reductase (DHFR). PCR is used to amplify the 35S promoter (approximately 800 bp), Intron 6 from the maize Adh1 gene (approximately 550 bp) and GUS unread leader sequence 18 bp from pSOG10. Also, this. The 250 bp fragment encoding the coli dihydrofolate reductase type II gene was amplified by PCR and these two PCR fragments were converted to SacI-PstI from pBI221 (Clontech), which includes the pUC19 vector backbone and nopaline synthase terminator. Integrate with the fragment. These fragments are aggregated to obtain pSOG19 containing a 35S promoter fused with an Intron 6 sequence, a GUS leader, a DHFR gene and a nopaline synthase terminator. The vector pSOG35 is prepared by replacing the GUS leader in pSOG19 with the leader sequence from maize lobular virus (MCMV). pSOG19 and pSOG35 contain the pUC gene for ampicillin resistance and have HindIII, SphI, PstI and EcoRI sites useful for cloning foreign substances.                 


3. 엽록체 형질전환에 적합한 벡터

3. Vectors Suitable for Chloroplast Transformation

본 발명의 뉴클레오타이드 서열을 식물 색소체에서 발현시키기 위해, 색소체 형질전환 벡터 pPH143(WO 97/32011의 실시예 36)을 사용한다. 뉴클레오타이드 서열을 pPH143에 삽입하여 PROTOX 암호 서열을 대체하도록 한다. 이어서, 상기 벡터를 색소체 형질전환 및 스펙티노마이신 내성에 대한 형질전환체의 선택에 사용한다. 또는, 뉴클레오타이드 서열을 pPH143에 삽입하여 aadA 유전자를 대체하도록 한다. 상기 경우에 형질전환체는 PROTOX 억제제에 대한 내성으로 선택한다.
To express the nucleotide sequence of the present invention in plant plastids, the plastiform transformation vector pPH143 (Example 36 of WO 97/32011) is used. The nucleotide sequence is inserted into pPH143 to replace the PROTOX coding sequence. This vector is then used for chromatin transformation and selection of transformants for spectinomycin resistance. Alternatively, the nucleotide sequence is inserted into pPH143 to replace the aadA gene. In this case the transformants are chosen to be resistant to PROTOX inhibitors.

실시예 7: 형질전환Example 7: Transformation

일단 본 발명의 핵산 서열을 발현 시스템으로 클로닝한 후, 식물 세포내로 형질전환시킨다. 식물의 형질전환 및 재생 방법은 당해 분야에 익히 공지되어 있다. 예를 들어, Ti 플라스미드 벡터를 외래 DNA의 전달과 직접적인 DNA 흡수, 리포좀, 전기침투, 미세주입 및 미세사출에 사용하였다. 또한, 아그로박테리움 속으로부터의 세균을 사용하여 식물 세포를 형질전환시킬 수 있다. 하기에서, 쌍자엽식물 및 단자엽식물 둘다를 형질전환시키는 대표적 기술과 대표적 색소체 형질전환 기술을 설명한다.Once the nucleic acid sequence of the invention is cloned into an expression system, it is transformed into plant cells. Methods for transforming and regenerating plants are well known in the art. For example, Ti plasmid vectors were used for delivery of foreign DNA and direct DNA uptake, liposomes, electropenetration, microinjection and microinjection. Bacteria from the genus Agrobacterium can also be used to transform plant cells. In the following, representative techniques for transforming both dicotyledonous and monocotyledonous plants and representative chromatin transformation techniques are described.

1. 쌍자엽식물의 형질전환1. Transformation of Dicotyledonous Plants

쌍자엽식물용 형질전환 기술은 당해 분야에 익히 공지되어 있으며 아그로박테리움계 기술 및 아그로박테리움을 요하지 않는 기술을 포함한다. 비-아그로박테 리움 기술은 외인성 유전 물질이 색소체 또는 세포에 의해 직접적으로 흡수되는 것과 관련된다. 이는 PEG 또는 전기침투 매개된 흡수, 입자 충격-매개된 전달 또는 미세주입에 의해 달성할 수 있다. 이러한 기술의 예는 문헌[참조문헌: Paszkowski et al., EMBO J 3: 271-2722 (1984), Potrykus et al., Mol. Gen. Genet. 199: 169-177 (1985), Reich et al., Biotechnology 4: 1001-1004 (1986), 및 Klein et al., Nature 327:70-73 (1987)]에 기술되어 있다. 각 경우에 형질전환된 세포는 당해 분야에 공지된 표준 기술을 사용하여 완전한 식물로 재생시킨다.Transformation techniques for dicotyledonous plants are well known in the art and include Agrobacterium-based techniques and techniques that do not require Agrobacterium. Non-Agrobacterium technology involves the incorporation of exogenous genetic material directly by the pigment or cell. This can be accomplished by PEG or electropenetration mediated absorption, particle impact-mediated delivery or microinjection. Examples of such techniques are described in Paszkowski et al., EMBO J 3: 271-2722 (1984), Potrykus et al., Mol. Gen. Genet. 199: 169-177 (1985), Reich et al., Biotechnology 4: 1001-1004 (1986), and Klein et al., Nature 327: 70-73 (1987). In each case the transformed cells are regenerated into complete plants using standard techniques known in the art.

아그로박테리움-매개된 형질전환은 형질전환 효율성이 높고 많은 상이한 종에서 광범위하게 사용할 수 있기 때문에 쌍자엽식물의 형질전환에 바람직한 기술이다. 아그로박테리움 형질전환은 통상적으로 관심있는 외래 DNA를 지니는 이원 벡터(예: pCIB 200 또는 pCIB 2001)를 적절한 아그로박테리움 균주로 전달하는 것과 관련되며, 전달은 숙주 아그로박테리움 균주가 동시상주하는 Ti 플라스미드 상에 또는 염색체내에(예: pCIB200 및 pCIB2001에 대한 균주 CIB542) 보유하는 vir 유전자의 보완[참조문헌: Uknes et al. Plant Cell 5: 159-169 (1993)]에 따라 좌우될 수 있다. 재조합 이원 벡터의 아그로박테리움으로의 전달은 재조합 이원 벡터를 지니는 이. 콜라이, pRK2013과 같은 플라스미드를 지니며 재조합 이원 벡터를 표적 아그로박테리움 균주로 이동시킬 수 있는 보조 이. 콜라이 균주를 사용한 삼중모계 교배(triparental mating) 과정을 사용하여 달성한다. 또는, 재조합 이원 벡터는 DNA 형질전환으로 아그로박테리움으로 전달시킬 있다[참조문헌: Hofgen & Wilmitzer, Nucl. Acids Res. 16: 9877 (1988)].Agrobacterium-mediated transformation is the preferred technique for the transformation of dicotyledonous plants because of its high transformation efficiency and widespread use in many different species. Agrobacterium transformation typically involves the transfer of a binary vector with foreign DNA of interest (eg pCIB 200 or pCIB 2001) to the appropriate Agrobacterium strain, wherein the transfer is a Ti co-resident of the host Agrobacterium strain. Complement of vir genes carried on plasmids or in chromosomes (eg strain CIB542 for pCIB200 and pCIB2001). Uknes et al. Plant Cell 5: 159-169 (1993). The delivery of the recombinant binary vector to Agrobacterium is a bacterium that has a recombinant binary vector. E. coli, an adjuvant E. coli with a plasmid such as pRK2013 and capable of transferring a recombinant binary vector to a target Agrobacterium strain. This is achieved using a triple parental mating procedure using E. coli strains. Alternatively, the recombinant binary vector can be delivered to Agrobacterium by DNA transformation. See Hofgen & Wilmitzer, Nucl. Acids Res. 16: 9877 (1988).

재조합 아그로박테리움에 의한 표적 식물 종의 형질전환은 통상적으로 아그로박테리움과 식물로부터의 외식체의 동시배양과 관련되며 당해 분야에 익히 공지된 프로토콜에 따른다. 이원 플라스미드 T-DNA 경계 사이에 존재하는 항생제 또는 제초제 내성 마커를 지닌 형질전환 조직을 선택가능한 배지 상에서 재생시킨다.Transformation of target plant species by recombinant Agrobacterium is commonly associated with the coculture of Agrobacterium with explants from plants and according to protocols well known in the art. Transgenic tissues with antibiotic or herbicide resistance markers present between the binary plasmid T-DNA boundaries are regenerated on selectable media.

식물 세포를 유전자로 형질전환시키는 또 다른 접근법은 불활성이거나 생물학적으로 활성인 입자를 식물 조직 및 세포로 추진시키는 것과 관련된다. 상기 기술은 미국 특허 제4,945,050호, 제5,036,006호 및 제5,100,792호에 기술되어 있다. 일반적으로 이러한 과정은 불활성이거나 생물학적으로 활성인 입자를 세포의 외부 표면으로 침투시켜, 세포의 내부에 혼입시키기에 효과적인 조건하에 세포로 추진시키는 것과 관련된다. 불활성 입자를 사용할 경우에, 벡터는 입자를 목적하는 유전자를 함유하는 벡터로 피복시켜 세포내로 도입할 수 있다. 또는, 표적 세포를 벡터로 둘러싸서 상기 벡터가 입자의 궤적을 통해 세포내로 전달되게 할 수 있다. 생물학적 활성 입자(예: 각각 도입하고자 하는 DNA를 함유하는 건조된 효모 세포, 건조된 세균 또는 박테리오파지)를 식물 세포 조직내로 추진시킬 수도 있다.Another approach to transforming plant cells with genes involves pushing inactive or biologically active particles into plant tissues and cells. The technique is described in US Pat. Nos. 4,945,050, 5,036,006 and 5,100,792. In general, this process involves the penetration of inert or biologically active particles into the cell's outer surface and propagation into the cell under conditions effective for incorporation into the cell's interior. When inert particles are used, the vector can be introduced into cells by coating the particles with a vector containing the desired gene. Alternatively, the target cells may be surrounded by a vector such that the vector is delivered intracellularly through the trajectory of the particle. Biologically active particles, such as dried yeast cells, dried bacteria or bacteriophages, each containing DNA to be introduced, may be propagated into plant cell tissue.

2. 단자엽식물의 형질전환2. Transformation of monocots

현재는 대부분의 단자엽식물 종의 형질전환도 통상적인 것이다. 바람직한 기술로는 PEG 또는 전기침투 기술을 사용한 유전자의 원형질체내로의 직접적인 전달 및 유합조직내로의 입자 충격과 관련된다. 형질전환은 단일 DNA 종 또는 다수의 DNA 종(즉, 동시형질전환)에서 수행할 수 있으며 이들 기술은 둘다 본 발명에서 사용하기에 적합한다. 동시형질전환은 완전한 벡터 작제를 피하고, 관심있는 유전자의 위치와 선택가능한 마커가 연결되어 있지 않아서 다음 세대에서 선택가능한 마커를 제거할 수 있는 형질전환 식물을 생성시킨다는 잇점을 가질 수 있다. 그러나, 동시형질전환 사용시의 단점은 개별적 DNA 종이 100% 미만의 빈도로 게놈내로 삽입된다는 점이다[참조문헌: Schocher et al. Biotechnology 4: 1093-1096 (1986)].At present, transformation of most monocot species is also common. Preferred techniques involve direct delivery of genes into protoplasts and impacting particles into callus using PEG or electropenetration techniques. Transformation can be performed on a single DNA species or on multiple DNA species (ie cotransformation), both of which are suitable for use in the present invention. Cotransformation may have the advantage of avoiding complete vector construction and producing transgenic plants that are capable of removing selectable markers in the next generation because the selectable markers are not linked to the position of the gene of interest. However, a disadvantage with cotransformation is that individual DNA species are inserted into the genome at less than 100% frequency [Schocher et al. Biotechnology 4: 1093-1096 (1986)].

특허원 제EP 0 292 435호, 제EP 0 392 225호 및 제WO 93/07278호에는 옥수수의 우량 근교계로부터 유합조직 및 원형질체를 제조하는 기술, PEG 또는 전기침투를 사용한 원형질체의 형질전환 및 형질전환된 원형질체로부터 옥수수 식물의 재생에 관해 기술되어 있다. 고든-캄(Gordon-Kamm) 등[참조문헌: Plant Cell 2: 603-618 (1990)] 및 프롬 등[참조문헌: Biotechnology 8: 833-839 (1990)]은 입자 충격을 사용한 A188로부터의 옥수수 주의 형질전환 기술을 공개하였다. 또한, WO 93/07278 및 문헌[참조문헌: Koziel et al., Biotechnology 11: 194-200 (1993)]에는 입자 충격을 사용한 옥수수의 우량 근교계의 형질전환 기술이 기재되어 있다. 상기 기술은 수분한지 14 내지 15일 후의 옥수수 알로부터 절단된 1.5 내지 2.5mm 길이의 미성숙 옥수수 배아 및 충격용 PDS-1000He 바이오리스틱스 장치를 사용한다.Patent applications EP 0 292 435, EP 0 392 225 and WO 93/07278 describe techniques for preparing callus and protoplasts from superior suburbs of maize, transformation and transformation of protoplasts using PEG or electropenetration. Regeneration of corn plants from converted protoplasts is described. Gordon-Kamm et al. (Plant Cell 2: 603-618 (1990)) and Fromm et al. (Biotechnology 8: 833-839 (1990)) describe corn from A188 using particle bombardment. Transformation techniques of the week are disclosed. In addition, WO 93/07278 and Koziel et al., Biotechnology 11: 194-200 (1993) describe transformation techniques of superior suburbs of corn using particle bombardment. The technique uses 1.5-2.5 mm long immature corn embryos and impacted PDS-1000He bioistic devices cut from corn eggs 14-15 days after pollination.

벼의 형질전환은 원형질체를 사용한 직접적인 유전자 전달 기술 또는 입자 충격으로 수행할 수 있다. 일반계(Japonica) 품종 및 다수계(Indica) 품종에 관해 원형질체-매개된 형질전환이 기술되어 있다[참조문헌: Zhang et al. Plant Cell Rep 7: 379-384 (1988); Shimamoto et al. Nature 338: 274-277 (1989); Datta et al. Biotechnology 8: 736-740 (1990)]. 또한, 두 품종은 통상적으로 입자 충격을 사용하여 형질전환시킬 수 있다[참조문헌: Christou et al. Biotechnology 9: 957-962 (1991)]. 또한, WO 93/21335에는 전기침투를 통한 벼의 형질전환 기술이 기재되어 있다.Transformation of rice can be performed by direct gene transfer techniques using protoplasts or by particle bombardment. Protoplast-mediated transformations have been described for Japonica varieties and Indica varieties. See Zhang et al. Plant Cell Rep 7: 379-384 (1988); Shimamoto et al. Nature 338: 274-277 (1989); Datta et al. Biotechnology 8: 736-740 (1990). In addition, both varieties can typically be transformed using particle bombardment. See Christou et al. Biotechnology 9: 957-962 (1991). WO 93/21335 also describes the transformation of rice through electropenetration.

특허원 제EP 0 332 581호에는 벼과 원형질체의 발생, 형질전환 및 재생 기술이 기재되어 있다. 상기 기술로 오리새 및 밀을 형질전환시킬 수 있다. 또한, 입자 충격을 사용한 C형 장기 재생성 유합조직의 세포로의 밀 형질전환[참조문헌: Vasil et al., Biotechnology 10:667-674 (1992)] 및 미성숙 배아 및 미성숙 배아로부터 유래된 유합조직의 입자 충격을 사용한 밀 형질전환[참조문헌: Vasil et al., Biotechnology 11: 1553-1558 (1993) 및 Weeks et al., Plant Physiol. 102: 1077-1084 (1993)]이 기술된 바 있다. 그러나, 바람직한 밀 형질전환 기술은 미성숙 배아의 입자 충격에 의한 밀의 형질전환과 관련되며, 유전자 전달에 앞서 높은 슈크로스 또는 높은 말토스 단계를 포함한다. 충격에 앞서, 체세포 배아를 도입하기 위해, 임의 수의 배아(길이가 0.75 내지 1mm)를 3% 슈크로스[참조문헌: Murashiga & Skoog, Physiologia Plantarum 15:473-497 (1962)] 및 3mg/ℓ2,4-D를 함유하는 MS 배지에 도말하고 이를 암실에서 진행시킨다. 충격처리 당일에, 배아를 도입 배지로부터 제거하고 삼투조절제(osmoticum)상에 놓는다(즉, 슈크로스 또는 말토스가 목적하는 농도, 통상적으로 15%로 첨가된 도입 배지). 상기 배아를 2 내지 3시간 동안 원형질체를 분리한 다음, 충격을 가한다. 중요한 것은 아니지만 표적 플레이트당 20개의 배아가 통상적이다. 적절한 유전자 함유 플라스미드(예: pCIB3064 또는 pSG35)를 표준 공정을 사용하여 마이크로미터 크기의 금 입자 위로 침전시킨다. 배아의 각 플레이트에 약 1000psi의 파열압과 표준 80 메쉬 스크린을 사용한 DuPont BiolositicsR 헬륨 장치를 사용하여 발사한다. 충격을 가한 후, 배아를 다시 암실에 놓아서 약 24시간 동안 (삼투조절제 상에서) 회복시킨다. 24시간 후, 배아를 삼투조절제로부터 제거하여 다시 도입 배지 상에 놓고, 재생시키 전에 약 1달 동안 방치한다. 약 1달 후, 배아형성 유합조직이 발달하고 있는 배아 이식체를 적절한 선택제(pCIB3064의 경우에는 10mg/ℓ바스타 및 pSOG35의 경우에는 2mg/ℓ 메토트렉세이트)를 추가로 함유하는 재생 배지(MS+1mg/ℓ NAA, 5mg/ℓ GA)로 전달시킨다. 약 1달 후, 발육한 싹을 1/2 농도의 MS, 2% 슈크로스 및 동일한 농도의 선택제를 함유하는 "GA7"로서 공지된 대형 멸균 용기로 전달시킨다.Patent application EP 0 332 581 describes techniques for the generation, transformation and regeneration of rice and protoplasts. This technique allows the transformation of ducks and wheat. In addition, wheat transformation into cells of type C organ regenerative callus using particle bombardment (Vasil et al., Biotechnology 10: 667-674 (1992)) and of callus derived from immature embryos and immature embryos. Wheat transformation using particle bombardment [Vasil et al., Biotechnology 11: 1553-1558 (1993) and Weeks et al., Plant Physiol. 102: 1077-1084 (1993). However, a preferred wheat transformation technique involves the transformation of wheat by particle bombardment of immature embryos, and involves high sucrose or high maltose steps prior to gene transfer. Prior to the impact, to introduce somatic embryos, any number of embryos (0.75-1 mm in length) were subjected to 3% sucrose (Murashiga & Skoog, Physiologia Plantarum 15: 473-497 (1962)) and 3 mg / l 2 Smear in MS medium containing, 4-D and proceed in the dark. On the day of the impact, embryos are removed from the introduction medium and placed on an osmoticum (ie, introduction medium in which sucrose or maltose is added at the desired concentration, typically 15%). The embryos are separated for protoplasts for 2 to 3 hours and then shocked. Although not critical, 20 embryos per target plate are common. Appropriate gene containing plasmids (eg pCIB3064 or pSG35) are precipitated onto micrometer size gold particles using standard procedures. Each plate of embryos is fired using a DuPont Biolositics R helium device using a burst pressure of approximately 1000 psi and a standard 80 mesh screen. After the impact, the embryo is placed back in the dark to recover for about 24 hours (on the osmotic agent). After 24 hours, the embryos are removed from the osmotic agent and placed back on the infusion medium and left for about one month before regeneration. After about a month, embryonic implants with developing embryonic callus were regenerated medium (MS + 1 mg / s) containing additional appropriate selection agents (10 mg / l Baster for pCIB3064 and 2 mg / l methotrexate for pSOG35). 1 NAA, 5 mg / L GA). After about one month, the developing shoots are transferred to a large sterile container known as "GA7" containing 1/2 concentration of MS, 2% sucrose and the same concentration of the selection agent.

아그로박테리움을 사용한 단자엽식물의 형질전환도 기술되었다[참조문헌: WO 94/00977 및 미국 특허 제5,591,616호; 둘다 본원에서 참조로 인용된다].Transformation of monocots with Agrobacterium has also been described (WO 94/00977 and US Pat. No. 5,591,616; Both are incorporated herein by reference].

3. 색소체의 형질전환3. Transformation of Chromosome

반수체 담배(Nicotiana tabacum cv. 'Xanthi nc')의 종자를 T 아가 배지상에서 1인치 원형 배열로 플레이트당 7개씩 발아시키고, 문헌[참조: Svab,Z. and Maliga,P.(1993) PNAS 90, 913-917]에 실질적으로 기재된 바와 같이, 플라스미드 pPH143 및 pPH145로부터의 DNA로 피복한 1㎛ 텅스텐 입자(M10, 제조원: Biorad, Hercules, CA)와 함께 파종한지 12 내지 14일 후 충격을 가한다. 충격을 가한 실생을 T 배지에서 2일 동안 배양한 후, 잎을 절개하고, 500㎍/㎖ 스펙트로마이신 디하이드로클로라이드(제조원: Sigma, St. Louis, MO)를 함유하는 RMOP 배지[참조문헌: Svab, Z., Hajdukiewicz, P. and Maliga, P. (1990)]의 플레이트에 배축면을 위로 하여 밝은 광하에 놓는다. 충격을 가한지 3주 내지 8주 후에, 표백된 잎의 아래에 나타나는 내성 싹을 동일한 선택가능한 배지로 아클로닝시켜 유합조직을 형성시키고, 2차 싹을 분리하여 아클로닝시킨다. 독립적 아클론에서 형질전환된 색소체 게놈 복사체(일원형체성)의 완전한 분리를 서던 블롯팅[참조문헌: Sambrook et al., (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor]의 표준 기술을 사용하여 평가한다. BamHI/EcoRI-분해된 전체 세포 DNA[참조문헌: Maettler, I.J. (1987) Plant Mol Biol Reporter 5, 346-349]를 1% 트리스-보레이트(TBE) 아가로스 겔 상에서 분리하고 나일론 막(제조원: Amersham)으로 전달시킨 다음, rps7/12 색소체 표적화 서열의 일부를 함유하는 pC8로부터의 0.7kb BamHI/HindIII DNA 단편에 상응하는 32P-표지된 무작위 프라이밍된 DNA 서열로 프로빙한다[참조문헌: 특허원 제WO 98/11235호). 일원형체성 싹을 스펙티노마이신 함유 MS/IBA 배지[참조문헌: McBride,K.E.et al. (1994) PNAS 91, 7301-7305]에 무균적으로 정착시킨 다음, 온실로 옮긴다.Seeds of haploid tobacco (Nicotiana tabacum cv. 'Xanthi nc') are germinated 7 times per plate in a 1-inch circular arrangement on T agar medium, see Svab, Z. and Maliga, P. (1993) PNAS 90, 913-917, seeded together with 1 μm tungsten particles (M10, Biorad, Hercules, CA) coated with DNA from plasmids pPH143 and pPH145. 12 to 14 days after the shock is applied. After culturing for 2 days in shock medium, the leaves were cut and RMOP medium containing 500 μg / ml spectromycin dihydrochloride (Sigma, St. Louis, Mo., Svab). , Z., Hajdukiewicz, P. and Maliga, P. (1990). Three to eight weeks after the impact, the resistant shoots appearing under the bleached leaves are acloned in the same selectable medium to form callus, and the secondary shoots are isolated and acloned. Southern blotting for complete isolation of transformed chromatin genome copies (monotropic) in independent aclones (Sambrook et al., (1989) Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor) Evaluate using standard techniques. BamHI / EcoRI-digested whole cell DNA [Maettler, IJ (1987) Plant Mol Biol Reporter 5, 346-349] was isolated on 1% tris-borate (TBE) agarose gel and nylon membrane (Amersham) ) And then probe with a 32 P-labeled randomly primed DNA sequence corresponding to 0.7 kb BamHI / HindIII DNA fragment from pC8 containing a portion of the rps7 / 12 chromosomal targeting sequence. WO 98/11235). Monomeric shoots were treated with spectinomycin-containing MS / IBA medium [McBride, Ke et al. (1994) PNAS 91, 7301-7305, aseptically, and then transferred to the greenhouse.

실시예 8: 육종Example 8: Sarcoma

본 발명의 핵산 서열로의 형질전환을 통해 수득된 식물은 단자엽 및 쌍자엽을 포함하는 매우 다양한 식물 종 중 어느 하나일 수 있으나, 본 발명의 방법에서 사용되는 식물은 바람직하게는 상기 제시한 농업적으로 중요한 표적 작물 목록으로부터 선택된다. 본 발명의 유전자와 함께 생산 및 품질에 중요한 기타 특성의 발현은 육종을 통해 식물 주로 혼입될 수 있다. 육종 접근법 및 기술은 당해 분야에 공지되어 있다[참조문헌: Welsh J. R., Fundamentals of Plant Genetics and Breeding, John Wiley & Sons, NY (1981); Crop Breeding, Wood D. R. (Ed.) American Society of Agronomy Madisons, Wisconsin (1983); Mayo O., The Theory of Plant Breeding 2nd Edition, Clarendon Press, Oxford (1987); Singh, D.P., Breeding for Resistance to Diseases and Insect Pests, Springer-Verlag, NY (1986); Wricke and Weber, Quantitative Genetics and Selection Plant Breeding, Walter de Gruyter and Co., Berlin (1986)].The plant obtained through transformation with the nucleic acid sequence of the present invention may be any one of a wide variety of plant species, including monocotyledonous and dicotyledonous, but the plant used in the method of the present invention is preferably agriculturally It is selected from the list of important target crops. Expression of other properties important to production and quality with the genes of the present invention can be incorporated primarily into plants through breeding. Breeding approaches and techniques are known in the art. Welsh J. R., Fundamentals of Plant Genetics and Breeding, John Wiley & Sons, NY (1981); Crop Breeding, Wood D. R. (Ed.) American Society of Agronomy Madisons, Wisconsin (1983); Mayo O., The Theory of Plant Breeding 2nd Edition, Clarendon Press, Oxford (1987); Singh, D. P., Breeding for Resistance to Diseases and Insect Pests, Springer-Verlag, NY (1986); Wricke and Weber, Quantitative Genetics and Selection Plant Breeding, Walter de Gruyter and Co., Berlin (1986)].

상기 기술한 형질전환 종자 및 식물로 조작된 유전적 특성은 유성 생식 또는 영양생장에 의해 전달되므로 자손 식물에서 유지되고 전파될 수 있다. 일반적으로 이러한 유지 및 전파는 경작, 파종 또는 수확과 같은 특수한 목적에 맞게 개발된 공지된 농업 방법을 사용한다. 수경재배 또는 온실 기술과 같은 전문화된 과정을 또한 적용할 수 있다. 재배 식물이 곤충이나 감염에 의해 유발된 공격 뿐만 아니라 잡초 식물에 의한 경쟁에 취약하기 때문에, 잡초, 식물 질병, 곤충, 선충류 및 기타 악조건을 방제하여 수율을 향상시키기 위해서는 대책이 강구되어야 한다. 이는 토양 경작 또는 잡초와 감염된 식물의 제거와 같은 수단 뿐만 아니라, 제초제, 살진균제, 생식자소멸제, 살선충제, 숙성제 및 살충제와 같은 농약의 적용을 포함한다.The genetic properties engineered with the transgenic seeds and plants described above are transmitted by sexual reproduction or trophic growth and thus can be maintained and propagated in progeny plants. Generally such maintenance and propagation uses known agricultural methods developed for special purposes such as tilling, sowing or harvesting. Specialized processes such as hydroponic or greenhouse technology can also be applied. Since cultivated plants are vulnerable to competition by weed plants as well as attacks caused by insects or infections, measures must be taken to control yields by controlling weeds, plant diseases, insects, nematodes and other adverse conditions. This includes the application of pesticides such as herbicides, fungicides, gonadotropins, nematicides, aging agents and insecticides, as well as means such as soil cultivation or removal of weeds and infected plants.

추가로, 본 발명에 따르는 형질전환 식물 및 종자의 유리한 유전적 특성은 해충, 제초제 또는 스트레스에 대한 내용성과 같은 개선된 특성, 개선된 영양가, 증가된 수율 또는 도복(倒伏)이나 탈립(脫粒)으로 인한 손실을 덜 유발하는 개선된 구조를 갖는 식물을 개발하는 것을 목적으로 하는 식물 육종에서 사용할 수 있다. 다양한 육종 단계는 교배시키고자 하는 주의 선택, 모주의 직접적인 수분 또는 적합한 자손 식물의 선택 같은 잘-정의된 사람 중재를 특징으로 한다. 목적하는 성질에 따라서, 상이한 육종 수단을 취한다. 관련 기술은 당해 분야에 익히 공지되어 있으며, 하이브리드화, 근교배, 역교배 육종, 다중주 육종, 종 혼합, 이종간 하이브리드화, 이수체 기술 등을 포함하나 이에 제한되지는 않는다. 하이브리드화 기술은 또한 기계적, 화학적 또는 생물학적 수단을 사용하여 식물을 불임화시켜 웅성 또는 자성 불임 식물을 생산하는 것을 포함한다. 웅성 불임 식물의 상이한 주의 화분을 사용한 타화 수분은, 웅성 불임이지만 자성 수정능력이 있는 식물의 게놈이 균일하게 두 모계 주의 특성들을 수득할 것이라는 것을 보증한다. 따라서, 본 발명에 따르는 형질전환 종자 및 식물은 예를 들어, 제초제 또는 살충제 처리와 같은 종래의 방법의 효과를 증가시키거나 이의 변형된 유전자 특성으로 인해 상기 방법을 불필요하게 만드는 개선된 식물주의 육종에 사용될 수 있다. 또는, 최적화된 유전자 "장착(equipment)"으로 인해, 비교할만한 발달상의 악조건에 대하여 내용성이 없을 수 있는 생성물에 비해 보다 우수한 품질의 수확된 생성물을 생산할 수 있는 개선된 스트레스 내용성을 갖는 신규한 작물을 수득할 수 있다. In addition, the beneficial genetic properties of the transgenic plants and seeds according to the invention are characterized by improved properties, such as improved resistance to pests, herbicides or stresses, improved nutritional value, increased yields, or slaughter or degranulation. It can be used in plant breeding aimed at developing plants having an improved structure which causes less loss due to them. The various breeding stages are characterized by well-defined human interventions such as the selection of the strains to be crossed, the direct pollination of the parent or the selection of suitable offspring plants. Depending on the desired properties, different breeding means are taken. Related arts are well known in the art and include, but are not limited to, hybridization, cross-breeding, backcross breeding, multi-week breeding, species mixing, heterogeneous hybridization, dimer techniques, and the like. Hybridization techniques also include the use of mechanical, chemical or biological means to sterilize plants to produce male or female infertile plants. Passivated water using pollen of different strains of male sterile plants ensures that the genome of a male sterile but magnetic fertility plant will yield properties of both maternal strains uniformly. Thus, the transgenic seeds and plants according to the present invention may be used for the breeding of improved plant strains which, for example, increase the effectiveness of conventional methods such as herbicides or pesticide treatments or render the method unnecessary due to its modified genetic properties. Can be used. Or, because of the optimized gene "equipment", a novel with improved stress content that can produce a harvested product of higher quality compared to a product that may be insoluble against comparable developmental adverse conditions. Crops can be obtained.                 


실시예 9: 종자 생산Example 9: Seed Production

종자 생산에 있어, 종자의 발아 특성 및 균일성은 필수적 생산 특성인 반면에 농부가 수확하여 시판하는 종자의 발아 특성 및 균일성은 중요하지 않다. 작물을 다른 작물 및 잡초 종자로부터 분리시켜 보관하고 종자전염성 질병을 조절하고 발아가 우수한 종자를 생산하는 것이 어렵기 때문에, 순수 종자의 성장, 조건화 및 판매 분야에 종사하는 종자 생산자에 의해 매우 광범위하고 잘 정의된 종자 생산 수단이 개발되어 왔다. 따라서, 농부가 자신의 작물로부터 수확된 종자를 사용하는 것 대신에 특정 품질 기준을 만족시키는 보증된 종자를 구매하는 것이 관례이다. 종자로서 사용하고자 하는 번식 물질은 관례적으로 제초제, 살충제, 살진균제, 살균제, 살선충제, 살연체동물제 또는 이들의 혼합물을 포함하는 보호성 피복제로 처리한다. 관례적으로 사용되는 보호성 피복제는 캅탄, 카복신, 티람(TMTDR), 메탈락실(ApronR) 및 피리미포스-메틸(ActellicR)과 같은 화합물을 포함한다. 경우에 따라, 이들 화합물을 담체, 표면활성제 또는 제형 분야에서 통상적으로 사용되는 적용-촉진 보조제와 함께 제형화하여 세균, 진균 또는 동물 해충에 의해 유발되는 손상으로부터 보호한다. 보호성 피복제는 번식 물질을 액체 제형으로 침지시키거나 배합된 습윤 또는 건조 제형으로 피복시켜 적용할 수 있다. 기타 적용 방법으로 싹 또는 열매를 대상으로 한 처리와 같은 것이 가능하다.In seed production, the germination properties and uniformity of the seeds are essential production properties, while the germination properties and uniformity of the seeds harvested and marketed by the farmer are not important. Because crops are stored separately from other crops and weed seeds, it is difficult to control seed infectious diseases and produce seeds with good germination, they are very broad and well-received by seed producers working in the field of growing, conditioning and selling pure seeds. Defined seed production means have been developed. Therefore, it is customary for farmers to purchase guaranteed seeds that meet certain quality standards instead of using seeds harvested from their crops. The propagation material intended to be used as a seed is customarily treated with a protective coating comprising herbicides, insecticides, fungicides, fungicides, nematicides, fungicides or mixtures thereof. Protective coatings customarily used include compounds such as captan, carboxycin, thiram (TMTD R ), metallaxyl (Apron R ) and pyrimifos-methyl (Actellic R ). If desired, these compounds are formulated with carriers, surfactants or application-promoting adjuvants commonly used in the formulation art to protect against damage caused by bacterial, fungal or animal pests. Protective coatings may be applied by immersing the propagation material in a liquid formulation or by coating with a combined wet or dry formulation. Other methods of application are possible, such as treatment with shoots or berries.

실시예 10: 옥수수 식물 분석Example 10 Corn Plant Analysis

아그로박테리움-매개된 형질전환을 통해 플라스미드 pNOV1436, pNOV1441 및 pNOV1313로 형질전환된 옥수수 식물은 유럽조명나방 및 밤나방에 대해 100%의 치사율을 나타낸다. ELISA 데이터를 하기에 제시한다:Corn plants transformed with plasmids pNOV1436, pNOV1441 and pNOV1313 via Agrobacterium-mediated transformation show 100% mortality for European lighted moths and chestnut moths. ELISA data is presented below:

Figure 112003006523766-pct00002

Figure 112003006523766-pct00002

실시예 11: 벼 식물 분석Example 11: Rice Plant Analysis

아그로박테리움-매개된 형질전환을 통해 플라스미드 pNOV1305로 형질전환된 벼 식물은 유럽조명나방 및 밤나방에 대해 100%의 치사율을 나타낸다. ELISA 데이터를 하기에 제시한다:Rice plants transformed with plasmid pNOV1305 via Agrobacterium-mediated transformation show 100% mortality for European lighted moths and chestnut moths. ELISA data is presented below:

Figure 112003006523766-pct00003

Figure 112003006523766-pct00003

실시예 12: 양배추 식물 분석Example 12 Cabbage Plant Analysis

아그로박테리움-매개된 형질전환을 통해 플라스미드 pZU578(서열 17)로 형질 전환된 양배추 식물을 배추좀나방(Plutella xylostella)에 대해 시험한다. 형질전환 식물 및 대조 식물은 (양배추 식물과) 사육한 배추좀나방 배양물로부터 16마리의 유충을 페인트 붓으로 잎 4장에 각각 유충 4마리씩 옮겨서 감염시킨다. 감염된 식물을 시험 기간 동안 1×1×1 케이지로 옮긴다. 대조 식물은 비형질전환된 양배추 식물(민감성 대조군) 및 시판되는 Bt 살충제 Dipel로 분무한 비형질전환된 양배추 식물(내성 대조군)을 포함한다. 스코어(2주 후)는, -=손상 없음(또는 단지 작은 구멍=내성); += 식물에 큰 구멍(=민감성); ++= 다수의 큰 구멍, 식물이 심하게 손상됨(=민감성)으로 기입한다. Dipel 식물은 항상 - 스코어를 기록하며 민감성 대조군은 ++ 스코어를 기록한다. 형질전환 식물 및 대조 식물의 곤충 손상 등급 및 ELISA 데이터를 하기에 제시한다.Cabbage plants transformed with plasmid pZU578 (SEQ ID NO: 17) via Agrobacterium-mediated transformation are tested for Plutella xylostella. The transgenic plants and the control plants are infected by transferring 16 larvae from four cabbage-rooted moth cultures (with cabbage plants) to four leaves of four larvae each with a paint brush. Infected plants are transferred to a 1 × 1 × 1 cage during the test period. Control plants include untransformed cabbage plants (sensitive controls) and untransformed cabbage plants sprayed with commercially available Bt insecticide Dipel (resistant control). The score (after 2 weeks) was-= no damage (or only small pore = resistance); + = Large hole in plant (= sensitive); ++ = Many large holes, the plant is severely damaged (= sensitive). Dipel plants always record a-score and the sensitivity control records a ++ score. Insect damage grades and ELISA data of the transgenic and control plants are shown below.

Figure 112003006523766-pct00004
Figure 112003006523766-pct00004

Figure 112003006523766-pct00005

Figure 112003006523766-pct00005

상기 기술한 양태는 예시적이다. 본 발명의 내용은 본 발명의 다수의 변형을 포함하여 당해 분야의 숙련가들에게 명백하다. 이러한 모든 명백하고 예지가능한 변형은 본 발명에 의해 포함된다.
The above described embodiments are exemplary. The subject matter of the present invention is apparent to those skilled in the art, including many variations of the present invention. All such obvious and foreseeable variations are encompassed by the present invention.

<110> Syngenta Participations AG <120> Novel insecticidal toxins derived from Bacillus thuringiensis insecticidal crystal proteins <130> 5-2000-054004-2 <140> <141> <150> US 60/227,956 <151> 2000-08-25 <160> 17 <170> KopatentIn 1.7 <210> 1 <211> 3579 <212> DNA <213> Artificial Sequences <220> <223> Description of Artificial Sequence: H04 with Cry1C tail <220> <221> CDS <222> (1)..(3579) <223> H04 with Cry1C tail <300> <303> Appl. Environ. Microbiol. <304> 62 <305> 5 <306> 1537-1543 <307> 1996 <300> <310> 5,736,131 <400> 1 atg gat aac aat ccg aac atc aat gaa tgc att cct tat aat tgt tta 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 agt aac cct gaa gta gaa gta tta ggt gga gaa aga ata gaa act ggt 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 tac acc cca atc gat att tcc ttg tcg cta acg caa ttt ctt ttg agt 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 gaa ttt gtt ccc ggt gct gga ttt gtg tta gga cta gtt gat ata ata 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 tgg gga att ttt ggt ccc tct caa tgg gac gca ttt ctt gta caa att 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 gaa cag tta att aac caa aga ata gaa gaa ttc gct agg aac caa gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 att tct aga tta gaa gga cta agc aat ctt tat caa att tac gca gaa 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 tct ttt aga gag tgg gaa gca gat cct act aat cca gca tta aga gaa 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 gag atg cgt att caa ttc aat gac atg aac agt gcc ctt aca acc gct 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 att cct ctt ttt gca gtt caa aat tat caa gtt cct ctt tta tca gta 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tat gtt caa gct gca aat tta cat tta tca gtt ttg aga gat gtt tca 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 gtg ttt gga caa agg tgg gga ttt gat gcc gcg act atc aat agt cgt 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 tat aat gat tta act agg ctt att ggc aac tat aca gat cat gct gta 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 cgc tgg tac aat acg gga tta gag cgt gta tgg gga ccg gat tct aga 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 gat tgg ata aga tat aat caa ttt aga aga gaa tta aca cta act gta 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 tta gat atc gtt tct cta ttt ccg aac tat gat agt aga acg tat cca 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 att cga aca gtt tcc caa tta aca aga gaa att tat aca aac cca gta 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 tta gaa aat ttt gat ggt agt ttt cga ggc tcg gct cag ggc ata gaa 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 gga agt att agg agt cca cat ttg atg gat ata ctt aac agt ata acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 atc tat acg gat gct cat aga gga gaa tat tat tgg tca ggg cat caa 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 ata atg gct tct cct gta ggg ttt tcg ggg cca gaa ttc act ttt ccg 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 cta tat gga act atg gga aat gca gct cca caa caa cgt att gtt gct 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 caa cta ggt cag ggc gtg tat aga aca tta tcg tcc act tta tat aga 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 aga cct ttt aat ata ggg ata aat aat caa caa cta tct gtt ctt gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 ggg aca gaa ttt gct tat gga acc tcc tca aat ttg cca tcc gct gta 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac aga aaa agc gga acg gta gat tcg ctg gat gaa ata ccg cca cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 aat aac aac gtg cca cct agg caa gga ttt agt cat cga tta agc cat 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 gtt tca atg ttt cgt tca ggc ttt agt aat agt agt gta agt ata ata 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 aga gct cct atg ttc tct tgg ata cat cgt agt gca act ctt aca aat 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 aca att gat cca gag aga att aat caa ata cct tta gtg aaa gga ttt 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 aga gtt tgg ggg ggc acc tct gtc att aca gga cca gga ttt aca gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 ggg gat atc ctt cga aga aat acc ttt ggt gat ttt gta tct cta caa 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 gtc aat att aat tca cca att acc caa aga tac cgt tta aga ttt cgt 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 tac gct tcc agt agg gat gca cga gtt ata gta tta aca gga gcg gca 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 tcc aca gga gtg gga ggc caa gtt agt gta aat atg cct ctt cag aaa 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gaa ata ggg gag aac tta aca tct aga aca ttt aga tat acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 gat ttt agt aat cct ttt tca ttt aga gct aat cca gat ata att ggg 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 ata agt gaa caa cct cta ttt ggt gca ggt tct att agt agc ggt gaa 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 ctt tat ata gat aaa att gaa att att cta gca gat gca aca ttt gaa 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 gca gaa tct gat tta gaa aga gca caa aag gcg gtg aat gcc ctg ttt 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 act tct tcc aat caa atc ggg tta aaa acc gat gtg acg gat tat cat 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 att gat caa gta tcc aat tta gtg gat tgt tta tca gat gaa ttt tgt 2016 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys 660 665 670 ctg gat gaa aag cga gaa ttg tcc gag aaa gtc aaa cat gcg aag cga 2064 Leu Asp Glu Lys Arg Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg 675 680 685 ctc agt gat gag cgg aat tta ctt caa gat cca aac ttc aga ggg atc 2112 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile 690 695 700 aat aga caa cca gac cgt ggc tgg aga gga agt aca gat att acc atc 2160 Asn Arg Gln Pro Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 caa gga gga gat gac gta ttc aaa gag aat tac gtc aca cta ccg ggt 2208 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Pro Gly 725 730 735 acc gtt gat gag tgc tat cca acg tat tta tat cag aaa ata gat gag 2256 Thr Val Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Lys Ile Asp Glu 740 745 750 tcg aaa tta aaa gct tat acc cgt tat gaa tta aga ggg tat atc gaa 2304 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Glu Leu Arg Gly Tyr Ile Glu 755 760 765 gat agt caa gac tta gaa atc tat ttg atc cgt tac aat gca aaa cac 2352 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His 770 775 780 gaa ata gta aat gtg cca ggc acg ggt tcc tta tgg ccg ctt tca gcc 2400 Glu Ile Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 caa agt cca atc gga aag tgt gga gaa ccg aat cga tgc gcg cca cac 2448 Gln Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His 805 810 815 ctt gaa tgg aat cct gat cta gat tgt tcc tgc aga gac ggg gaa aaa 2496 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys 820 825 830 tgt gca cat cat tcc cat cat ttc acc ttg gat att gat gtt gga tgt 2544 Cys Ala His His Ser His His Phe Thr Leu Asp Ile Asp Val Gly Cys 835 840 845 aca gac tta aat gag gac tta ggt gta tgg gtg ata ttc aag att aag 2592 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys 850 855 860 acg caa gat ggc cat gca aga cta ggg aat cta gag ttt ctc gaa gag 2640 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 aaa cca tta tta ggg gaa gca cta gct cgt gtg aaa aga gcg gag aag 2688 Lys Pro Leu Leu Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys 885 890 895 aag tgg aga gac aaa cga gag aaa ctg cag ttg gaa aca aat att gtt 2736 Lys Trp Arg Asp Lys Arg Glu Lys Leu Gln Leu Glu Thr Asn Ile Val 900 905 910 tat aaa gag gca aaa gaa tct gta gat gct tta ttt gta aac tct caa 2784 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln 915 920 925 tat gat aga tta caa gtg gat acg aac atc gcg atg att cat gcg gca 2832 Tyr Asp Arg Leu Gln Val Asp Thr Asn Ile Ala Met Ile His Ala Ala 930 935 940 gat aaa cgc gtt cat aga atc cgg gaa gcg tat ctg cca gag ttg tct 2880 Asp Lys Arg Val His Arg Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 gtg att cca ggt gtc aat gcg gcc att ttc gaa gaa tta gag gga cgt 2928 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg 965 970 975 att ttt aca gcg tat tcc tta tat gat gcg aga aat gtc att aaa aat 2976 Ile Phe Thr Ala Tyr Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn 980 985 990 ggc gat ttc aat aat ggc tta tta tgc tgg aac gtg aaa ggt cat gta 3024 Gly Asp Phe Asn Asn Gly Leu Leu Cys Trp Asn Val Lys Gly His Val 995 1000 1005 gat gta gaa gag caa aac aac cac cgt tcg gtc ctt gtt atc cca gaa 3072 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Ile Pro Glu 1010 1015 1020 tgg gag gca gaa gtg tca caa gag gtt cgt gtc tgt cca ggt cgt ggc 3120 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 tat atc ctt cgt gtc aca gca tat aaa gag gga tat gga gag ggc tgc 3168 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys 1045 1050 1055 gta acg atc cat gag atc gaa gac aat aca gac gaa ctg aaa ttc agc 3216 Val Thr Ile His Glu Ile Glu Asp Asn Thr Asp Glu Leu Lys Phe Ser 1060 1065 1070 aac tgt gta gaa gag gaa gta tat cca aac aac aca gta acg tgt aat 3264 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn 1075 1080 1085 aat tat act ggg act caa gaa gaa tat gag ggt acg tac act tct cgt 3312 Asn Tyr Thr Gly Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg 1090 1095 1100 aat caa gga tat gac gaa gcc tat ggt aat aac cct tcc gta cca gct 3360 Asn Gln Gly Tyr Asp Glu Ala Tyr Gly Asn Asn Pro Ser Val Pro Ala 1105 1110 1115 1120 gat tac gct tca gtc tat gaa gaa aaa tcg tat aca gat gga cga aga 3408 Asp Tyr Ala Ser Val Tyr Glu Glu Lys Ser Tyr Thr Asp Gly Arg Arg 1125 1130 1135 gag aat cct tgt gaa tct aac aga ggc tat ggg gat tac aca cca cta 3456 Glu Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu 1140 1145 1150 ccg gct ggt tat gta aca aag gat tta gag tac ttc cca gag acc gat 3504 Pro Ala Gly Tyr Val Thr Lys Asp Leu Glu Tyr Phe Pro Glu Thr Asp 1155 1160 1165 aag gta tgg att gag atc gga gaa aca gaa gga aca ttc atc gtg gat 3552 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp 1170 1175 1180 agc gtg gaa tta ctc ctt atg gag gaa 3579 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 2 <211> 1193 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: H04 with Cry1C tail <400> 2 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys 660 665 670 Leu Asp Glu Lys Arg Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg 675 680 685 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile 690 695 700 Asn Arg Gln Pro Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Pro Gly 725 730 735 Thr Val Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Lys Ile Asp Glu 740 745 750 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Glu Leu Arg Gly Tyr Ile Glu 755 760 765 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His 770 775 780 Glu Ile Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 Gln Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His 805 810 815 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys 820 825 830 Cys Ala His His Ser His His Phe Thr Leu Asp Ile Asp Val Gly Cys 835 840 845 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys 850 855 860 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 Lys Pro Leu Leu Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys 885 890 895 Lys Trp Arg Asp Lys Arg Glu Lys Leu Gln Leu Glu Thr Asn Ile Val 900 905 910 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln 915 920 925 Tyr Asp Arg Leu Gln Val Asp Thr Asn Ile Ala Met Ile His Ala Ala 930 935 940 Asp Lys Arg Val His Arg Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg 965 970 975 Ile Phe Thr Ala Tyr Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn 980 985 990 Gly Asp Phe Asn Asn Gly Leu Leu Cys Trp Asn Val Lys Gly His Val 995 1000 1005 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Ile Pro Glu 1010 1015 1020 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 025 1030 1035 1040 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys 1045 1050 1055 Val Thr Ile His Glu Ile Glu Asp Asn Thr Asp Glu Leu Lys Phe Ser 1060 1065 1070 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn 1075 1080 1085 Asn Tyr Thr Gly Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg 1090 1095 1100 Asn Gln Gly Tyr Asp Glu Ala Tyr Gly Asn Asn Pro Ser Val Pro Ala 105 1110 1115 1120 Asp Tyr Ala Ser Val Tyr Glu Glu Lys Ser Tyr Thr Asp Gly Arg Arg 1125 1130 1135 Glu Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu 1140 1145 1150 Pro Ala Gly Tyr Val Thr Lys Asp Leu Glu Tyr Phe Pro Glu Thr Asp 1155 1160 1165 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp 1170 1175 1180 Ser Val Glu Leu Leu Leu Met Glu Glu 185 1190 <210> 3 <211> 1896 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene encoding the toxin portion of H04 without a tail <220> <221> CDS <222> (1)..(1896) <223> H04 toxin portion without a tail <400> 3 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 gcc gag agc gac ctg gag cgc taa 1896 Ala Glu Ser Asp Leu Glu Arg 625 630 <210> 4 <211> 631 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene encoding the toxin portion of H04 without a tail <400> 4 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 Ala Glu Ser Asp Leu Glu Arg 625 630 <210> 5 <211> 3582 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene encoding H04 with full-length Cry1Ab tail <220> <221> CDS <222> (1)..(3582) <223> H04 with full-length Cry1Ab tail <400> 5 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 gcc gag agc gac ctg gag cgc gcc cag aag gcc gtg aac gcc ctg ttc 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 acc agc agc aac cag atc ggc ctg aag acc gac gtg acc gac tac cac 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 atc gac cag gtg agc aac ctg gtg gac tgc tta agc gac gag ttc tgc 2016 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys 660 665 670 ctg gac gag aag aag gag ctg agc gag aag gtg aag cac gcc aag cgc 2064 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg 675 680 685 ctg agc gac gag cgc aac ctg ctg cag gac ccc aac ttc cgc ggc atc 2112 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile 690 695 700 aac cgc cag ctg gac cgc ggc tgg cga ggc agc acc gat atc acc atc 2160 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 cag ggc ggc gac gac gtg ttc aag gag aac tac gtg acc ctg cag ggc 2208 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly 725 730 735 acc ttc gac gag tgc tac ccc acc tac ctg tac cag ccg atc gac gag 2256 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu 740 745 750 agc aag ctg aag gcc tac acc cgc tac cag ctg cgc ggc tac atc gag 2304 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu 755 760 765 gac agc cag gac ctg gaa atc tac ctg atc cgc tac aac gcg aag cac 2352 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His 770 775 780 gag acc gtg aac gtg ccc ggc acc ggc agc ctg tgg ccc ccg agc gcc 2400 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Pro Ser Ala 785 790 795 800 ccc agc ccc atc ggc aag tgc ggg gag ccg aat cga tgc gct ccg cac 2448 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His 805 810 815 ctg gag tgg aac ccg gac cta gac tgc agc tgc agg gac ggg gag aag 2496 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys 820 825 830 tgc gcc cac cac agc cac cac ttc agc ctg gac atc gac gtg ggc tgc 2544 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys 835 840 845 acc gac ctg aac gag gac ctg ggc gtg tgg gtg atc ttc aag atc aag 2592 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys 850 855 860 acc cag gac ggc cac gcc cgc ctg ggc aat cta gag ttc ctg gag gag 2640 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 aag ccc ctg gtg ggc gag gcc ctg gcc cgc gtg aag cgt gct gag aag 2688 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys 885 890 895 aag tgg cgc gac aag cgc gag aag ctg gag tgg gag acc aac atc gtg 2736 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val 900 905 910 tac aag gag gcc aag gag agc gtg gac gcc ctg ttc gtg aac agc cag 2784 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln 915 920 925 tac gac cgc ctg cag gcc gac acc aac atc gcc atg atc cac gcc gcc 2832 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala 930 935 940 gac aag cgc gtg cac agc att cgc gag gcc tac ctg ccc gag ctg agc 2880 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 gtg atc ccc ggt gtg aac gcc gcc atc ttc gag gaa ctc gag ggc cgc 2928 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg 965 970 975 atc ttc acc gcc ttc agc ctg tac gac gcc cgc aac gtg atc aag aac 2976 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn 980 985 990 ggc gac ttc aac aac ggc ctg agc tgc tgg aac gtg aag ggc cac gtg 3024 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val 995 1000 1005 gac gtg gag gag cag aac aac cac cgc agc gtg ctg gtg gtg ccc gag 3072 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu 1010 1015 1020 tgg gag gcc gag gtg agc cag gag gtg cgc gtg tgc ccc ggc cgc ggc 3120 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 tac atc ctg cgc gtg acc gcc tac aag gag ggc tac ggc gag ggc tgc 3168 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys 1045 1050 1055 gtg acc atc cac gag atc gag aac aac acc gac gag ctc aag ttc agc 3216 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser 1060 1065 1070 aac tgc gtg gag gag gag gtt tac ccc aac aac acc gtg acc tgc aac 3264 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn 1075 1080 1085 gac tac acc gcg acc cag gag gag tac gaa ggc acc tac acc tct cgc 3312 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg 1090 1095 1100 aac agg ggt tac gac ggc gcc tac gag tcc aac agc tcc gtg cca gct 3360 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 gac tac gcc agc gcc cac gag gag aaa gcc tac acc gac ggt aga cgc 3408 Asp Tyr Ala Ser Ala His Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg 1125 1130 1135 gac aac cca tgt gag agc aac aga ggc tac ggc gac tac acc ccc ctg 3456 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu 1140 1145 1150 ccc gct gga tac gtg acc aag gag ctg gag tac ttc ccc gag acc gac 3504 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp 1155 1160 1165 aag gtg tgg atc gag att ggc gag acc gag ggc acc ttc atc gtg gac 3552 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp 1170 1175 1180 agc gtg gag ctg ctg ctg atg gag gag tag 3582 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 6 <211> 1193 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene encoding H04 with full-length Cry1Ab tail <400> 6 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys 660 665 670 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg 675 680 685 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile 690 695 700 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly 725 730 735 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu 740 745 750 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu 755 760 765 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His 770 775 780 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Pro Ser Ala 785 790 795 800 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His 805 810 815 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys 820 825 830 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys 835 840 845 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys 850 855 860 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys 885 890 895 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val 900 905 910 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln 915 920 925 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala 930 935 940 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg 965 970 975 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn 980 985 990 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val 995 1000 1005 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu 1010 1015 1020 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys 1045 1050 1055 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser 1060 1065 1070 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn 1075 1080 1085 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg 1090 1095 1100 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 Asp Tyr Ala Ser Ala His Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg 1125 1130 1135 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu 1140 1145 1150 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp 1155 1160 1165 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp 1170 1175 1180 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 7 <211> 3582 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene encoding H04 with full-length Cry1Ab tail <220> <221> CDS <222> (1)..(3582) <223> H04 with full-length Cry1Ab tail <400> 7 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 gcc gag agc gac ctg gag cgc gcc cag aag gcc gtg aac gcc ctg ttc 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 acc agc agc aac cag atc ggc ctg aag acc gac gtg acc gac tac cac 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 atc gac cag gtg agc aac ctg gtg gac tgc tta agc gac gag ttc tgc 2016 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys 660 665 670 ctg gac gag aag aag gag ctg agc gag aag gtg aag cac gcc aag cgc 2064 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg 675 680 685 ctg agc gac gag cgc aac ctg ctg cag gac ccc aac ttc cgc ggc atc 2112 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile 690 695 700 aac cgc cag ctg gac cgc ggc tgg cga ggc agc acc gat atc acc atc 2160 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 cag ggc ggc gac gac gtg ttc aag gag aac tac gtg acc ctg cag ggc 2208 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly 725 730 735 acc ttc gac gag tgc tac ccc acc tac ctg tac cag ccg atc gac gag 2256 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu 740 745 750 agc aag ctg aag gcc tac acc cgc tac cag ctg cgc ggc tac atc gag 2304 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu 755 760 765 gac agc cag gac ctg gaa atc tac ctg atc cgc tac aac gcg aag cac 2352 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His 770 775 780 gag acc gtg aac gtg ccc ggc acc ggc agc ctg tgg ccc ctg agc gcc 2400 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 ccc agc ccc atc ggc aag tgc ggg gag ccg aat cga tgc gct ccg cac 2448 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His 805 810 815 ctg gag tgg aac ccg gac cta gac tgc agc tgc agg gac ggg gag aag 2496 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys 820 825 830 tgc gcc cac cac agc cac cac ttc agc ctg gac atc gac gtg ggc tgc 2544 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys 835 840 845 acc gac ctg aac gag gac ctg ggc gtg tgg gtg atc ttc aag atc aag 2592 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys 850 855 860 acc cag gac ggc cac gcc cgc ctg ggc aat cta gag ttc ctg gag gag 2640 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 aag ccc ctg gtg ggc gag gcc ctg gcc cgc gtg aag cgt gct gag aag 2688 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys 885 890 895 aag tgg cgc gac aag cgc gag aag ctg gag tgg gag acc aac atc gtg 2736 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val 900 905 910 tac aag gag gcc aag gag agc gtg gac gcc ctg ttc gtg aac agc cag 2784 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln 915 920 925 tac gac cgc ctg cag gcc gac acc aac atc gcc atg atc cac gcc gcc 2832 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala 930 935 940 gac aag cgc gtg cac agc att cgc gag gcc tac ctg ccc gag ctg agc 2880 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 gtg atc ccc ggt gtg aac gcc gcc atc ttc gag gaa ctc gag ggc cgc 2928 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg 965 970 975 atc ttc acc gcc ttc agc ctg tac gac gcc cgc aac gtg atc aag aac 2976 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn 980 985 990 ggc gac ttc aac aac ggc ctg agc tgc tgg aac gtg aag ggc cac gtg 3024 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val 995 1000 1005 gac gtg gag gag cag aac aac cac cgc agc gtg ctg gtg gtg ccc gag 3072 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu 1010 1015 1020 tgg gag gcc gag gtg agc cag gag gtg cgc gtg tgc ccc ggc cgc ggc 3120 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 tac atc ctg cgc gtg acc gcc tac aag gag ggc tac ggc gag ggc tgc 3168 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys 1045 1050 1055 gtg acc atc cac gag atc gag aac aac acc gac gag ctc aag ttc agc 3216 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser 1060 1065 1070 aac tgc gtg gag gag gag gtt tac ccc aac aac acc gtg acc tgc aac 3264 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn 1075 1080 1085 gac tac acc gcg acc cag gag gag tac gaa ggc acc tac acc tct cgc 3312 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg 1090 1095 1100 aac agg ggt tac gac ggc gcc tac gag tcc aac agc tcc gtg cca gct 3360 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 gac tac gcc agc gcc tac gag gag aaa gcc tac acc gac ggt aga cgc 3408 Asp Tyr Ala Ser Ala Tyr Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg 1125 1130 1135 gac aac cca tgt gag agc aac aga ggc tac ggc gac tac acc ccc ctg 3456 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu 1140 1145 1150 ccc gct gga tac gtg acc aag gag ctg gag tac ttc ccc gag acc gac 3504 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp 1155 1160 1165 aag gtg tgg atc gag att ggc gag acc gag ggc acc ttc atc gtg gac 3552 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp 1170 1175 1180 agc gtg gag ctg ctg ctg atg gag gag tag 3582 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 8 <211> 1193 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene encoding H04 with full-length Cry1Ab tail <400> 8 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys 660 665 670 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg 675 680 685 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile 690 695 700 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly 725 730 735 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu 740 745 750 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu 755 760 765 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His 770 775 780 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His 805 810 815 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys 820 825 830 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys 835 840 845 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys 850 855 860 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys 885 890 895 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val 900 905 910 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln 915 920 925 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala 930 935 940 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg 965 970 975 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn 980 985 990 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val 995 1000 1005 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu 1010 1015 1020 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys 1045 1050 1055 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser 1060 1065 1070 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn 1075 1080 1085 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg 1090 1095 1100 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 Asp Tyr Ala Ser Ala Tyr Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg 1125 1130 1135 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu 1140 1145 1150 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp 1155 1160 1165 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp 1170 1175 1180 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 9 <211> 2007 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene encoding H04 plus the first 40 amino acids of the Cry1Ab tail <220> <221> CDS <222> (1)..(2007) <223> H04 with truncated Cry1Ab tail <400> 9 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 gcc gag agc gac ctg gag cgc gcc cag aag gcc gtg aac gcc ctg ttc 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 acc agc agc aac cag atc ggc ctg aag acc gac gtg acc gac tac cac 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 atc gac cag gtg agc aac ctg gtg gac tgc tta agc tag 2007 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser 660 665 <210> 10 <211> 668 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene encoding H04 plus the first 40 amino acids of the Cry1Ab tail <400> 10 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu 1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly 20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser 35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile 50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile 65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala 85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu 100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu 115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala 130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg 180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val 195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg 210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val 260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu 275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr 290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala 340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg 355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp 370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His 420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile 435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn 450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln 500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg 515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala 530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly 580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu 595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu 610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser 660 665 <210> 11 <211> 13269 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1308 <220> <221> misc_feature <222> (1)..(1896) <223> synthetic nucleotide sequence encoding the toxin portion of H04, without a tail <220> <221> misc_feature <222> (2102)..(4083) <223> Zea mays ubiquitin promoter <220> <221> misc_feature <222> (4180)..(5283) <223> PMI marker gene <220> <221> misc_feature <222> (11247)..(12647) <223> Zm Ubi promoter <400> 11 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgctaagatc tgttctgcac aaagtggagt 1920 agtcagtcat cgatcaggaa ccagacacca gacttttatt catacagtga agtgaagtga 1980 agtgcagtgc agtgagttgc tggtttttgt acaacttagt atgtatttgt atttgtaaaa 2040 tacttctatc aataaaattt ctaattccta aaaccaaaat ccaggggtac cagcttgcat 2100 gcctgcagtg cagcgtgacc cggtcgtgcc cctctctaga gataatgagc attgcatgtc 2160 taagttataa aaaattacca catatttttt ttgtcacact tgtttgaagt gcagtttatc 2220 tatctttata catatattta aactttactc tacgaataat ataatctata gtactacaat 2280 aatatcagtg ttttagagaa tcatataaat gaacagttag acatggtcta aaggacaatt 2340 gagtattttg acaacaggac tctacagttt tatcttttta gtgtgcatgt gttctccttt 2400 ttttttgcaa atagcttcac ctatataata cttcatccat tttattagta catccattta 2460 gggtttaggg ttaatggttt ttatagacta atttttttag tacatctatt ttattctatt 2520 ttagcctcta aattaagaaa actaaaactc tattttagtt tttttattta ataatttaga 2580 tataaaatag aataaaataa agtgactaaa aattaaacaa atacccttta agaaattaaa 2640 aaaactaagg aaacattttt cttgtttcga gtagataatg ccagcctgtt aaacgccgtc 2700 gacgagtcta acggacacca accagcgaac cagcagcgtc gcgtcgggcc aagcgaagca 2760 gacggcacgg catctctgtc gctgcctctg gacccctctc gagagttccg ctccaccgtt 2820 ggacttgctc cgctgtcggc atccagaaat tgcgtggcgg agcggcagac gtgagccggc 2880 acggcaggcg gcctcctcct cctctcacgg caccggcagc tacgggggat tcctttccca 2940 ccgctccttc gctttccctt cctcgcccgc cgtaataaat agacaccccc tccacaccct 3000 ctttccccaa cctcgtgttg ttcggagcgc acacacacac aaccagatct cccccaaatc 3060 cacccgtcgg cacctccgct tcaaggtacg ccgctcgtcc tccccccccc cccctctcta 3120 ccttctctag atcggcgttc cggtccatgg ttagggcccg gtagttctac ttctgttcat 3180 gtttgtgtta gatccgtgtt tgtgttagat ccgtgctgct agcgttcgta cacggatgcg 3240 acctgtacgt cagacacgtt ctgattgcta acttgccagt gtttctcttt ggggaatcct 3300 gggatggctc tagccgttcc gcagacggga tcgatttcat gatttttttt gtttcgttgc 3360 atagggtttg gtttgccctt ttcctttatt tcaatatatg ccgtgcactt gtttgtcggg 3420 tcatcttttc atgctttttt ttgtcttggt tgtgatgatg tggtctggtt gggcggtcgt 3480 tctagatcgg agtagaattc tgtttcaaac tacctggtgg atttattaat tttggatctg 3540 tatgtgtgtg ccatacatat tcatagttac gaattgaaga tgatggatgg aaatatcgat 3600 ctaggatagg tatacatgtt gatgcgggtt ttactgatgc atatacagag atgctttttg 3660 ttcgcttggt tgtgatgatg tggtgtggtt gggcggtcgt tcattcgttc tagatcggag 3720 tagaatactg tttcaaacta cctggtgtat ttattaattt tggaactgta tgtgtgtgtc 3780 atacatcttc atagttacga gtttaagatg gatggaaata tcgatctagg ataggtatac 3840 atgttgatgt gggttttact gatgcatata catgatggca tatgcagcat ctattcatat 3900 gctctaacct tgagtaccta tctattataa taaacaagta tgttttataa ttattttgat 3960 cttgatatac ttggatgatg gcatatgcag cagctatatg tggatttttt tagccctgcc 4020 ttcatacgct atttatttgc ttggtactgt ttcttttgtc gatgctcacc ctgttgtttg 4080 gtgttacttc tgcagggatc cccgatcatg caaaaactca ttaactcagt gcaaaactat 4140 gcctggggca gcaaaacggc gttgactgaa ctttatggta tggaaaatcc gtccagccag 4200 ccgatggccg agctgtggat gggcgcacat ccgaaaagca gttcacgagt gcagaatgcc 4260 gccggagata tcgtttcact gcgtgatgtg attgagagtg ataaatcgac tctgctcgga 4320 gaggccgttg ccaaacgctt tggcgaactg cctttcctgt tcaaagtatt atgcgcagca 4380 cagccactct ccattcaggt tcatccaaac aaacacaatt ctgaaatcgg ttttgccaaa 4440 gaaaatgccg caggtatccc gatggatgcc gccgagcgta actataaaga tcctaaccac 4500 aagccggagc tggtttttgc gctgacgcct ttccttgcga tgaacgcgtt tcgtgaattt 4560 tccgagattg tctccctact ccagccggtc gcaggtgcac atccggcgat tgctcacttt 4620 ttacaacagc ctgatgccga acgtttaagc gaactgttcg ccagcctgtt gaatatgcag 4680 ggtgaagaaa aatcccgcgc gctggcgatt ttaaaatcgg ccctcgatag ccagcagggt 4740 gaaccgtggc aaacgattcg tttaatttct gaattttacc cggaagacag cggtctgttc 4800 tccccgctat tgctgaatgt ggtgaaattg aaccctggcg aagcgatgtt cctgttcgct 4860 gaaacaccgc acgcttacct gcaaggcgtg gcgctggaag tgatggcaaa ctccgataac 4920 gtgctgcgtg cgggtctgac gcctaaatac attgatattc cggaactggt tgccaatgtg 4980 aaattcgaag ccaaaccggc taaccagttg ttgacccagc cggtgaaaca aggtgcagaa 5040 ctggacttcc cgattccagt ggatgatttt gccttctcgc tgcatgacct tagtgataaa 5100 gaaaccacca ttagccagca gagtgccgcc attttgttct gcgtcgaagg cgatgcaacg 5160 ttgtggaaag gttctcagca gttacagctt aaaccgggtg aatcagcgtt tattgccgcc 5220 aacgaatcac cggtgactgt caaaggccac ggccgtttag cgcgtgttta caacaagctg 5280 taagagctta ctgaaaaaat taacatctct tgctaagctg ggagctcgat ccgtcgacct 5340 gcagatcgtt caaacatttg gcaataaagt ttcttaagat tgaatcctgt tgccggtctt 5400 gcgatgatta tcatataatt tctgttgaat tacgttaagc atgtaataat taacatgtaa 5460 tgcatgacgt tatttatgag atgggttttt atgattagag tcccgcaatt atacatttaa 5520 tacgcgatag aaaacaaaat atagcgcgca aactaggata aattatcgcg cgcggtgtca 5580 tctatgttac tagatctgct agccctgcag gaaatttacc ggtgcccggg cggccagcat 5640 ggccgtatcc gcaatgtgtt attaagttgt ctaagcgtca atttgtttac accacaatat 5700 atcctgccac cagccagcca acagctcccc gaccggcagc tcggcacaaa atcaccactc 5760 gatacaggca gcccatcaga attaattctc atgtttgaca gcttatcatc gactgcacgg 5820 tgcaccaatg cttctggcgt caggcagcca tcggaagctg tggtatggct gtgcaggtcg 5880 taaatcactg cataattcgt gtcgctcaag gcgcactccc gttctggata atgttttttg 5940 cgccgacatc ataacggttc tggcaaatat tctgaaatga gctgttgaca attaatcatc 6000 cggctcgtat aatgtgtgga attgtgagcg gataacaatt tcacacagga aacagaccat 6060 gagggaagcg ttgatcgccg aagtatcgac tcaactatca gaggtagttg gcgtcatcga 6120 gcgccatctc gaaccgacgt tgctggccgt acatttgtac ggctccgcag tggatggcgg 6180 cctgaagcca cacagtgata ttgatttgct ggttacggtg accgtaaggc ttgatgaaac 6240 aacgcggcga gctttgatca acgacctttt ggaaacttcg gcttcccctg gagagagcga 6300 gattctccgc gctgtagaag tcaccattgt tgtgcacgac gacatcattc cgtggcgtta 6360 tccagctaag cgcgaactgc aatttggaga atggcagcgc aatgacattc ttgcaggtat 6420 cttcgagcca gccacgatcg acattgatct ggctatcttg ctgacaaaag caagagaaca 6480 tagcgttgcc ttggtaggtc cagcggcgga ggaactcttt gatccggttc ctgaacagga 6540 tctatttgag gcgctaaatg aaaccttaac gctatggaac tcgccgcccg actgggctgg 6600 cgatgagcga aatgtagtgc ttacgttgtc ccgcatttgg tacagcgcag taaccggcaa 6660 aatcgcgccg aaggatgtcg ctgccgactg ggcaatggag cgcctgccgg cccagtatca 6720 gcccgtcata cttgaagcta ggcaggctta tcttggacaa gaagatcgct tggcctcgcg 6780 cgcagatcag ttggaagaat ttgttcacta cgtgaaaggc gagatcacca aagtagtcgg 6840 caaataaagc tctagtggat ctccgtaccc ccgggggatc tggctcgcgg cggacgcacg 6900 acgccggggc gagaccatag gcgatctcct aaatcaatag tagctgtaac ctcgaagcgt 6960 ttcacttgta acaacgattg agaatttttg tcataaaatt gaaatacttg gttcgcattt 7020 ttgtcatccg cggtcagccg caattctgac gaactgccca tttagctgga gatgattgta 7080 catccttcac gtgaaaattt ctcaagcgct gtgaacaagg gttcagattt tagattgaaa 7140 ggtgagccgt tgaaacacgt tcttcttgtc gatgacgacg tcgctatgcg gcatcttatt 7200 attgaatacc ttacgatcca cgccttcaaa gtgaccgcgg tagccgacag cacccagttc 7260 acaagagtac tctcttccgc gacggtcgat gtcgtggttg ttgatctaaa tttaggtcgt 7320 gaagatgggc tcgagatcgt tcgtaatctg gcggcaaagt ctgatattcc aatcataatt 7380 atcagtggcg accgccttga ggagacggat aaagttgttg cactcgagct aggagcaagt 7440 gattttatcg ctaagccgtt cagtatcaga gagtttctag cacgcattcg ggttgccttg 7500 cgcgtgcgcc ccaacgttgt ccgctccaaa gaccgacggt ctttttgttt tactgactgg 7560 acacttaatc tcaggcaacg tcgcttgatg tccgaagctg gcggtgaggt gaaacttacg 7620 gcaggtgagt tcaatcttct cctcgcgttt ttagagaaac cccgcgacgt tctatcgcgc 7680 gagcaacttc tcattgccag tcgagtacgc gacgaggagg tttatgacag gagtatagat 7740 gttctcattt tgaggctgcg ccgcaaactt gaggcagatc cgtcaagccc tcaactgata 7800 aaaacagcaa gaggtgccgg ttatttcttt gacgcggacg tgcaggtttc gcacgggggg 7860 acgatggcag cctgagccaa ttcccagatc cccgaggaat cggcgtgagc ggtcgcaaac 7920 catccggccc ggtacaaatc ggcgcggcgc tgggtgatga cctggtggag aagttgaagg 7980 ccgcgcaggc cgcccagcgg caacgcatcg aggcagaagc acgccccggt gaatcgtggc 8040 aagcggccgc tgatcgaatc cgcaaagaat cccggcaacc gccggcagcc ggtgcgccgt 8100 cgattaggaa gccgcccaag ggcgacgagc aaccagattt tttcgttccg atgctctatg 8160 acgtgggcac ccgcgatagt cgcagcatca tggacgtggc cgttttccgt ctgtcgaagc 8220 gtgaccgacg agctggcgag gtgatccgct acgagcttcc agacgggcac gtagaggttt 8280 ccgcagggcc ggccggcatg gccagtgtgt gggattacga cctggtactg atggcggttt 8340 cccatctaac cgaatccatg aaccgatacc gggaagggaa gggagacaag cccggccgcg 8400 tgttccgtcc acacgttgcg gacgtactca agttctgccg gcgagccgat ggcggaaagc 8460 agaaagacga cctggtagaa acctgcattc ggttaaacac cacgcacgtt gccatgcagc 8520 gtacgaagaa ggccaagaac ggccgcctgg tgacggtatc cgagggtgaa gccttgatta 8580 gccgctacaa gatcgtaaag agcgaaaccg ggcggccgga gtacatcgag atcgagctag 8640 ctgattggat gtaccgcgag atcacagaag gcaagaaccc ggacgtgctg acggttcacc 8700 ccgattactt tttgatcgat cccggcatcg gccgttttct ctaccgcctg gcacgccgcg 8760 ccgcaggcaa ggcagaagcc agatggttgt tcaagacgat ctacgaacgc agtggcagcg 8820 ccggagagtt caagaagttc tgtttcaccg tgcgcaagct gatcgggtca aatgacctgc 8880 cggagtacga tttgaaggag gaggcggggc aggctggccc gatcctagtc atgcgctacc 8940 gcaacctgat cgagggcgaa gcatccgccg gttcctaatg tacggagcag atgctagggc 9000 aaattgccct agcaggggaa aaaggtcgaa aaggtctctt tcctgtggat agcacgtaca 9060 ttgggaaccc aaagccgtac attgggaacc ggaacccgta cattgggaac ccaaagccgt 9120 acattgggaa ccggtcacac atgtaagtga ctgatataaa agagaaaaaa ggcgattttt 9180 ccgcctaaaa ctctttaaaa cttattaaaa ctcttaaaac ccgcctggcc tgtgcataac 9240 tgtctggcca gcgcacagcc gaagagctgc aaaaagcgcc tacccttcgg tcgctgcgct 9300 ccctacgccc cgccgcttcg cgtcggccta tcgcggccgc tggccgctca aaaatggctg 9360 gcctacggcc aggcaatcta ccagggcgcg gacaagccgc gccgtcgcca ctcgaccgcc 9420 ggcgctgagg tctgcctcgt gaagaaggtg ttgctgactc ataccaggcc tgaatcgccc 9480 catcatccag ccagaaagtg agggagccac ggttgatgag agctttgttg taggtggacc 9540 agttggtgat tttgaacttt tgctttgcca cggaacggtc tgcgttgtcg ggaagatgcg 9600 tgatctgatc cttcaactca gcaaaagttc gatttattca acaaagccgc cgtcccgtca 9660 agtcagcgta atgctctgcc agtgttacaa ccaattaacc aattctgatt agaaaaactc 9720 atcgagcatc aaatgaaact gcaatttatt catatcagga ttatcaatac catatttttg 9780 aaaaagccgt ttctgtaatg aaggagaaaa ctcaccgagg cagttccata ggatggcaag 9840 atcctggtat cggtctgcga ttccgactcg tccaacatca atacaaccta ttaatttccc 9900 ctcgtcaaaa ataaggttat caagtgagaa atcaccatga gtgacgactg aatccggtga 9960 gaatggcaaa agctctgcat taatgaatcg gccaacgcgc ggggagaggc ggtttgcgta 10020 ttgggcgctc ttccgcttcc tcgctcactg actcgctgcg ctcggtcgtt cggctgcggc 10080 gagcggtatc agctcactca aaggcggtaa tacggttatc cacagaatca ggggataacg 10140 caggaaagaa catgtgagca aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt 10200 tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa 10260 gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc cctggaagct 10320 ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc 10380 cttcgggaag cgtggcgctt tctcatagct cacgctgtag gtatctcagt tcggtgtagg 10440 tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct 10500 tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg ccactggcag 10560 cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca gagttcttga 10620 agtggtggcc taactacggc tacactagaa gaacagtatt tggtatctgc gctctgctga 10680 agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa accaccgctg 10740 gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag 10800 aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac tcacgttaag 10860 ggattttggt catgagatta tcaaaaagga tcttcaccta gatccttttg atccggaatt 10920 aattcctgtg gttggcatgc acatacaaat ggacgaacgg ataaaccttt tcacgccctt 10980 ttaaatatcc gattattcta ataaacgctc ttttctctta ggtttacccg ccaatatatc 11040 ctgtcaaaca ctgatagttt aaactgaagg cgggaaacga caatctgatc atgagcggag 11100 aattaaggga gtcacgttat gacccccgcc gatgacgcgg gacaagccgt tttacgtttg 11160 gaactgacag aaccgcaacg ctgcaggaat tggccgcagc ggccatttaa atcaattggg 11220 cgcgccgaat tcgagctcgg tacaagcttg catgcctgca gtgcagcgtg acccggtcgt 11280 gcccctctct agagataatg agcattgcat gtctaagtta taaaaaatta ccacatattt 11340 tttttgtcac acttgtttga agtgcagttt atctatcttt atacatatat ttaaacttta 11400 ctctacgaat aatataatct atagtactac aataatatca gtgttttaga gaatcatata 11460 aatgaacagt tagacatggt ctaaaggaca attgagtatt ttgacaacag gactctacag 11520 ttttatcttt ttagtgtgca tgtgttctcc tttttttttg caaatagctt cacctatata 11580 atacttcatc cattttatta gtacatccat ttagggttta gggttaatgg tttttataga 11640 ctaatttttt tagtacatct attttattct attttagcct ctaaattaag aaaactaaaa 11700 ctctatttta gtttttttat ttaataattt agatataaaa tagaataaaa taaagtgact 11760 aaaaattaaa caaataccct ttaagaaatt aaaaaaacta aggaaacatt tttcttgttt 11820 cgagtagata atgccagcct gttaaacgcc gtcgacgagt ctaacggaca ccaaccagcg 11880 aaccagcagc gtcgcgtcgg gccaagcgaa gcagacggca cggcatctct gtcgctgcct 11940 ctggacccct ctcgagagtt ccgctccacc gttggacttg ctccgctgtc ggcatccaga 12000 aattgcgtgg cggagcggca gacgtgagcc ggcacggcag gcggcctcct cctcctctca 12060 cggcacggca gctacggggg attcctttcc caccgctcct tcgctttccc ttcctcgccc 12120 gccgtaataa atagacaccc cctccacacc ctctttcccc aacctcgtgt tgttcggagc 12180 gcacacacac acaaccagat ctcccccaaa tccacccgtc ggcacctccg cttcaaggta 12240 cgccgctcgt cctccccccc cccccctctc taccttctct agatcggcgt tccggtccat 12300 ggttagggcc cggtagttct acttctgttc atgtttgtgt tagatccgtg tttgtgttag 12360 atccgtgctg ctagcgttcg tacacggatg cgacctgtac gtcagacacg ttctgattgc 12420 taacttgcca gtgtttctct ttggggaatc ctgggatggc tctagccgtt ccgcagacgg 12480 gatcgatttc atgatttttt ttgtttcgtt gcatagggtt tggtttgccc ttttccttta 12540 tttcaatata tgccgtgcac ttgtttgtcg ggtcatcttt tcatgctttt ttttgtcttg 12600 gttgtgatga tgtggtctgg ttgggcggtc gttctagatc ggagtagaat tctgtttcaa 12660 actacctggt ggatttatta attttggatc tgtatgtgtg tgccatacat attcatagtt 12720 acgaattgaa gatgatggat ggaaatatcg atctaggata ggtatacatg ttgatgcggg 12780 ttttactgat gcatatacag agatgctttt tgttcgcttg gttgtgatga tgtggtgtgg 12840 ttgggcggtc gttcattcgt tctagatcgg agtagaatac tgtttcaaac tacctggtgt 12900 atttattaat tttggaactg tatgtgtgtg tcatacatct tcatagttac gagtttaaga 12960 tggatggaaa tatcgatcta ggataggtat acatgttgat gtgggtttta ctgatgcata 13020 tacatgatgg catatgcagc atctattcat atgctctaac cttgagtacc tatctattat 13080 aataaacaag tatgttttat aattattttg atcttgatat acttggatga tggcatatgc 13140 agcagctata tgtggatttt tttagccctg ccttcatacg ctatttattt gcttggtact 13200 gtttcttttg tcgatgctca ccctgttgtt tggtgttact tctgcaggtc gactctagag 13260 gatccaaca 13269 <210> 12 <211> 16179 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1436 <220> <221> misc_feature <222> (1)..(3582) <223> synthetic nucleotide sequence encoding the toxin portion of H04 plus a full-length Cry1Ab tail portion <220> <221> misc_feature <222> Complement((10390)..(11598)) <223> PhosphoMannose Isomerase (PMI) marker gene <220> <221> misc_feature <222> Complement((12718)..(13608)) <223> Maize ubiquitin (Zm Ubi) promoter <220> <221> misc_feature <222> (13613)..(16170) <223> MTL promoter <400> 12 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgcgcccaga aggccgtgaa cgccctgttc 1920 accagcagca accagatcgg cctgaagacc gacgtgaccg actaccacat cgaccaggtg 1980 agcaacctgg tggactgctt aagcgacgag ttctgcctgg acgagaagaa ggagctgagc 2040 gagaaggtga agcacgccaa gcgcctgagc gacgagcgca acctgctgca ggaccccaac 2100 ttccgcggca tcaaccgcca gctggaccgc ggctggcgag gcagcaccga tatcaccatc 2160 cagggcggcg acgacgtgtt caaggagaac tacgtgaccc tgcagggcac cttcgacgag 2220 tgctacccca cctacctgta ccagccgatc gacgagagca agctgaaggc ctacacccgc 2280 taccagctgc gcggctacat cgaggacagc caggacctgg aaatctacct gatccgctac 2340 aacgcgaagc acgagaccgt gaacgtgccc ggcaccggca gcctgtggcc cccgagcgcc 2400 cccagcccca tcggcaagtg cggggagccg aatcgatgcg ctccgcacct ggagtggaac 2460 ccggacctag actgcagctg cagggacggg gagaagtgcg cccaccacag ccaccacttc 2520 agcctggaca tcgacgtggg ctgcaccgac ctgaacgagg acctgggcgt gtgggtgatc 2580 ttcaagatca agacccagga cggccacgcc cgcctgggca atctagagtt cctggaggag 2640 aagcccctgg tgggcgaggc cctggcccgc gtgaagcgtg ctgagaagaa gtggcgcgac 2700 aagcgcgaga agctggagtg ggagaccaac atcgtgtaca aggaggccaa ggagagcgtg 2760 gacgccctgt tcgtgaacag ccagtacgac cgcctgcagg ccgacaccaa catcgccatg 2820 atccacgccg ccgacaagcg cgtgcacagc attcgcgagg cctacctgcc cgagctgagc 2880 gtgatccccg gtgtgaacgc cgccatcttc gaggaactcg agggccgcat cttcaccgcc 2940 ttcagcctgt acgacgcccg caacgtgatc aagaacggcg acttcaacaa cggcctgagc 3000 tgctggaacg tgaagggcca cgtggacgtg gaggagcaga acaaccaccg cagcgtgctg 3060 gtggtgcccg agtgggaggc cgaggtgagc caggaggtgc gcgtgtgccc cggccgcggc 3120 tacatcctgc gcgtgaccgc ctacaaggag ggctacggcg agggctgcgt gaccatccac 3180 gagatcgaga acaacaccga cgagctcaag ttcagcaact gcgtggagga ggaggtttac 3240 cccaacaaca ccgtgacctg caacgactac accgcgaccc aggaggagta cgaaggcacc 3300 tacacctctc gcaacagggg ttacgacggc gcctacgagt ccaacagctc cgtgccagct 3360 gactacgcca gcgcccacga ggagaaagcc tacaccgacg gtagacgcga caacccatgt 3420 gagagcaaca gaggctacgg cgactacacc cccctgcccg ctggatacgt gaccaaggag 3480 ctggagtact tccccgagac cgacaaggtg tggatcgaga ttggcgagac cgagggcacc 3540 ttcatcgtgg acagcgtgga gctgctgctg atggaggagt agtagatctg ttctgcacaa 3600 agtggagtag tcagtcatcg atcaggaacc agacaccaga cttttattca tacagtgaag 3660 tgaagtgaag tgcagtgcag tgagttgctg gtttttgtac cacttagtat gtatttgtat 3720 ttgtaaaata cttctatcaa taaaatttct aattcctaaa accaaaatcc agtgggtacc 3780 agcttgggct gagtggctcc ttcaacgttg cggttctgtc agttccaaac gtaaaacggc 3840 ttgtcccgcg tcatcggcgg gggtcataac gtgactccct taattctccg ctcatgatca 3900 gattgtcgtt tcccgccttc agtttaaact atcagtgttt gacaggatat attggcgggt 3960 aaacctaaga gaaaagagcg tttattagaa taacggatat ttaaaagggc gtgaaaaggt 4020 ttatccgttc gtccatttgt atgtgcatgc caaccacagg gttcccctcg ggagtgcttg 4080 gcattccgta cgataatgac ttctgttcaa ccacccaaac gtcggaaagc ctgacgacgg 4140 agcagcattc caaaaagatc ccttggctcg tctgggtcgg ctagaaggtc gagtgggctg 4200 ctgtggcttg atccctcaac gcggtcgcgg acgtagcgca gcgccgaaaa atcctcgatc 4260 gcaaatccga cgctgtcgaa aagcgtgatc tgcttgtcgc tctttcggcc gacgtcctgg 4320 ccagtcatca cgcgccaaag ttccgtcaca ggatgatctg gcgcgagttg ctggatctcg 4380 ccttcaatcc gggtctgtgg cgggaactcc acgaaaatat ccgaacgcag caagatcgtc 4440 gaccaattct tgaagacgaa agggcctcgt gatacgccta tttttatagg ttaatgtcat 4500 gataataatg gtttcttaga cgtcaggtgg cacttttcgg ggaaatgtgc gcggaacccc 4560 tatttgttta tttttctaaa tacattcaaa tatgtatccg ctcatgagac aataaccctg 4620 ataaatgctt caataatatt gaaaaaggaa gagtatgagt attcaacatt tccgtgtcgc 4680 ccttattccc ttttttgcgg cattttgcct tcctgttttt gctcacccag aaacgctggt 4740 gaaagtaaaa gatgctgaag atcagttggg tgcacgagtg ggttacatcg aactggatct 4800 caacagcggt aagatccttg agagttttcg ccccgaagaa cgttttccaa tgatgagcac 4860 ttttaaagtt ctgctatgtg gcgcggtatt atcccgtgtt gacgccgggc aagagcaact 4920 cggtcgccgc atacactatt ctcagaatga cttggttgag tactcaccag tcacagaaaa 4980 gcatcttacg gatggcatga cagtaagaga attatgcagt gctgccataa ccatgagtga 5040 taacactgcg gccaacttac ttctgacaac gatcggagga ccgaaggagc taaccgcttt 5100 tttgcacaac atgggggatc atgtaactcg ccttgatcgt tgggaaccgg agctgaatga 5160 agccatacca aacgacgagc gtgacaccac gatgcctgca gggggggggg ggggggggac 5220 atgaggttgc cccgtattca gtgtcgctga tttgtattgt ctgaagttgt ttttacgtta 5280 agttgatgca gatcaattaa tacgatacct gcgtcataat tgattatttg acgtggtttg 5340 atggcctcca cgcacgttgt gatatgtaga tgataatcat tatcacttta cgggtccttt 5400 ccggtgatcc gacaggttac ggggcggcga cctcgcgggt tttcgctatt tatgaaaatt 5460 ttccggttta aggcgtttcc gttcttcttc gtcataactt aatgttttta tttaaaatac 5520 cctctgaaaa gaaaggaaac gacaggtgct gaaagcgagg ctttttggcc tctgtcgttt 5580 cctttctctg tttttgtccg tggaatgaac aatggaagtc cccccccccc cccccccctg 5640 cagcaatggc aacaacgttg cgcaaactat taactggcga actacttact ctagcttccc 5700 ggcaacaatt aatagactgg atggaggcgg ataaagttgc aggaccactt ctgcgctcgg 5760 cccttccggc tggctggttt attgctgata aatctggagc cggtgagcgt gggtctcgcg 5820 gtatcattgc agcactgggg ccagatggta agccctcccg tatcgtagtt atctacacga 5880 cggggagtca ggcaactatg gatgaacgaa atagacagat cgctgagata ggtgcctcac 5940 tgattaagca ttggtaactg tcagaccaag tttactcata tatactttag attgatttaa 6000 aacttcattt ttaatttaaa aggatctagg tgaagatcct ttttgataat ctcatgacca 6060 aaatccctta acgtgagttt tcgttccact gagcgtcaga ccccgtagaa aagatcaaag 6120 gatcttcttg agatcctttt tttctgcgcg taatctgctg cttgcaaaca aaaaaaccac 6180 cgctaccagc ggtggtttgt ttgccggatc aagagctacc aactcttttt ccgaaggtaa 6240 ctggcttcag cagagcgcag ataccaaata ctgtccttct agtgtagccg tagttaggcc 6300 accacttcaa gaactctgta gcaccgccta catacctcgc tctgctaatc ctgttaccag 6360 tggctgctgc cagtggcgat aagtcgtgtc ttaccgggtt ggactcaaga cgatagttac 6420 cggataaggc gcagcggtcg ggctgaacgg ggggttcgtg cacacagccc agcttggagc 6480 gaacgaccta caccgaactg agatacctac agcgtgagct atgagaaagc gccacgcttc 6540 ccgaagggag aaaggcggac aggtatccgg taagcggcag ggtcggaaca ggagagcgca 6600 cgagggagct tccaggggga aacgcctggt atctttatag tcctgtcggg tttcgccacc 6660 tctgacttga gcgtcgattt ttgtgatgct cgtcaggggg gcggagccta tggaaaaacg 6720 ccagcaacgc ggccttttta cggttcctgg ccttttgctg gccttttgct cacatgttct 6780 ttcctgcgtt atcccctgat tctgtggata accgtattac cgcctttgag tgagctgata 6840 ccgctcgccg cagccgaacg accgagcgca gcgagtcagt gagcgaggaa gcggaagagc 6900 gcctgatgcg gtattttctc cttacgcatc tgtgcggtat ttcacaccgc atatggtgca 6960 ctctcagtac aatctgctct gatgccgcat agttaagcca gtatacactc cgctatcgct 7020 acgtgactgg gtcatggctg cgccccgaca cccgccaaca cccgctgacg cgccctgacg 7080 ggcttgtctg ctcccggcat ccgcttacag acaagctgtg accgtctccg ggagctgcat 7140 gtgtcagagg ttttcaccgt catcaccgaa acgcgcgagg cagcagatcc cccgatcaag 7200 tagatacact acatatatct acaatagaca tcgagccgga aggtgatgtt tactttcctg 7260 aaatccccag caattttagg ccagttttta cccaagactt cgcctctaac ataaattata 7320 gttaccaaat ctggcaaaag ggttaacaag tggcagcaac ggattcgcaa acctgtcacg 7380 ccttttgtgc caaaagccgc gccaggtttg cgatccgctg tgccaggcgt taggcgtcat 7440 atgaagattt cggtgatccc tgagcaggtg gcggaaacat tggatgctga gaaccatttc 7500 attgttcgtg aagtgttcga tgtgcaccta tccgaccaag gctttgaact atctaccaga 7560 agtgtgagcc cctaccggaa ggattacatc tcggatgatg actctgatga agactctgct 7620 tgctatggcg cattcatcga ccaagagctt gtcgggaaga ttgaactcaa ctcaacatgg 7680 aacgatctag cctctatcga acacattgtt gtgtcgcaca cgcaccgagg caaaggagtc 7740 gcgcacagtc tcatcgaatt tgcgaaaaag tgggcactaa gcagacagct ccttggcata 7800 cgattagaga cacaaacgaa caatgtacct gcctgcaatt tgtacgcaaa atgtggcttt 7860 actctcggcg gcattgacct gttcacgtat aaaactagac ctcaagtctc gaacgaaaca 7920 gcgatgtact ggtactggtt ctcgggagca caggatgacg cctaacaatt cattcaagcc 7980 gacaccgctt cgcggcgcgg cttaattcag gagttaaaca tcatgaggga agcggtgatc 8040 gccgaagtat cgactcaact atcagaggta gttggcgtca tcgagcgcca tctcgaaccg 8100 acgttgctgg ccgtacattt gtacggctcc gcagtggatg gcggcctgaa gccacacagt 8160 gatattgatt tgctggttac ggtgaccgta aggcttgatg aaacaacgcg gcgagctttg 8220 atcaacgacc ttttggaaac ttcggcttcc cctggagaga gcgagattct ccgcgctgta 8280 gaagtcacca ttgttgtgca cgacgacatc attccgtggc gttatccagc taagcgcgaa 8340 ctgcaatttg gagaatggca gcgcaatgac attcttgcag gtatcttcga gccagccacg 8400 atcgacattg atctggctat cttgctgaca aaagcaagag aacatagcgt tgccttggta 8460 ggtccagcgg cggaggaact ctttgatccg gttcctgaac aggatctatt tgaggcgcta 8520 aatgaaacct taacgctatg gaactcgccg cccgactggg ctggcgatga gcgaaatgta 8580 gtgcttacgt tgtcccgcat ttggtacagc gcagtaaccg gcaaaatcgc gccgaaggat 8640 gtcgctgccg actgggcaat ggagcgcctg ccggcccagt atcagcccgt catacttgaa 8700 gctaggcagg cttatcttgg acaagaagat cgcttggcct cgcgcgcaga tcagttggaa 8760 gaatttgttc actacgtgaa aggcgagatc accaaggtag tcggcaaata atgtctaaca 8820 attcgttcaa gccgacgccg cttcgcggcg cggcttaact caagcgttag agagctgggg 8880 aagactatgc gcgatctgtt gaaggtggtt ctaagcctcg tacttgcgat ggcatcgggg 8940 caggcacttg ctgacctgcc aattgtttta gtggatgaag ctcgtcttcc ctatgactac 9000 tccccatcca actacgacat ttctccaagc aactacgaca actccataag caattacgac 9060 aatagtccat caaattacga caactctgag agcaactacg ataatagttc atccaattac 9120 gacaatagtc gcaacggaaa tcgtaggctt atatatagcg caaatgggtc tcgcactttc 9180 gccggctact acgtcattgc caacaatggg acaacgaact tcttttccac atctggcaaa 9240 aggatgttct acaccccaaa aggggggcgc ggcgtctatg gcggcaaaga tgggagcttc 9300 tgcggggcat tggtcgtcat aaatggccaa ttttcgcttg ccctgacaga taacggcctg 9360 aagatcatgt atctaagcaa ctagcctgct ctctaataaa atgttaggcc tcaacatcta 9420 gtcgcaagct gaggggaacc actagtgtca tacgaacctc caagagacgg ttacacaaac 9480 gggtacattg ttgatgtcat gtatgacaat cgcccaagta agtatccagc tgtgttcaga 9540 acgtacgtcc gaattaattc atcggggtac ggtcgacgat cgtcaacgtt cacttctaaa 9600 gaaatagcgc cactcagctt cctcagcggc tttatccagc gatttcctat tatgtcggca 9660 tagttctcaa gatcgacagc ctgtcacggt taagcgagaa atgaataaga aggctgataa 9720 ttcggatctc tgcgagggag atgatatttg atcacaggca gcaacgctct gtcatcgtta 9780 caatcaacat gctaccctcc gcgagatcat ccgtgtttca aacccggcag cttagttgcc 9840 gttcttccga atagcatcgg taacatgagc aaagtctgcc gccttacaac ggctctcccg 9900 ctgacgccgt cccggactga tgggctgcct gtatcgagtg gtgattttgt gccgagctgc 9960 cggtcgggga gctgttggct ggctggtggc aggatatatt gtggtgtaaa caaattgacg 10020 cttagacaac ttaataacac attgcggacg tttttaatgt actgaattgt ctagacccgg 10080 ggatctcatg tttgacagct tatcatcgga tctagtaaca tagatgacac cgcgcgcgat 10140 aatttatcct agtttgcgcg ctatattttg ttttctatcg cgtattaaat gtataattgc 10200 gggactctaa tcataaaaac ccatctcata aataacgtca tgcattacat gttaattatt 10260 acatgcttaa cgtaattcaa cagaaattag atgataatca tcgcaagacc ggcaacagga 10320 ttcaatctta agaaacttta ttgccaaatg tttgaacgat ctctgcaggt cgacggatcg 10380 agctcccagc ttagcaagag atgttaattt tttcagtaag ctcttacagc ttgttgtaaa 10440 cacgcgctaa acggccgtgg cctttgacag tcaccggtga ttcgttggcg gcaataaacg 10500 ctgattcacc cggtttaagc tgtaactgct gagaaccttt ccacaacgtt gcatcgcctt 10560 cgacgcagaa caaaatggcg gcactctgct ggctaatggt ggtttcttta tcactaaggt 10620 catgcagcga gaaggcaaaa tcatccactg gaatcgggaa gtccagttct gcaccttgtt 10680 tcaccggctg ggtcaacaac tggttagccg gtttggcttc gaatttcaca ttggcaacca 10740 gttccggaat atcaatgtat ttaggcgtca gacccgcacg cagcacgtta tcggagtttg 10800 ccatcacttc cagcgccacg ccttgcaggt aagcgtgcgg tgtttcagcg aacaggaaca 10860 tcgcttcgcc agggttcaat ttcaccacat tcagcaatag cggggagaac agaccgctgt 10920 cttccgggta aaattcagaa attaaacgaa tcgtttgcca cggttcaccc tgctggctat 10980 cgagggccga ttttaaaatc gccagcgcgc gggatttttc ttcaccctgc atattcaaca 11040 ggctggcgaa cagttcgctt aaacgttcgg catcaggctg ttgtaaaaag tgagcaatcg 11100 ccggatgtgc acctgcgacc ggctggagta gggagacaat ctcggaaaat tcacgaaacg 11160 cgttcatcgc aaggaaaggc gtcagcgcaa aaaccagctc cggcttgtgg ttaggatctt 11220 tatagttacg ctcggcggca tccatcggga tacctgcggc attttctttg gcaaaaccga 11280 tttcagaatt gtgtttgttt ggatgaacct gaatggagag tggctgtgct gcgcataata 11340 ctttgaacag gaaaggcagt tcgccaaagc gtttggcaac ggcctctccg agcagagtcg 11400 atttatcact ctcaatcaca tcacgcagtg aaacgatatc tccggcggca ttctgcactc 11460 gtgaactgct tttcggatgt gcgcccatcc acagctcggc catcggctgg ctggacggat 11520 tttccatacc ataaagttca gtcaacgcgt tttgctgccc caggcatagt tttgcactga 11580 gttaatgagt ttttgcatga tcggggatcc ctgcagaagt aacaccaaac aacagggtga 11640 gcatcgacaa aagaaacagt accaagcaaa taaatagcgt atgaaggcag ggctaaaaaa 11700 atccacatat agctgctgca tatgccatca tccaagtata tcaagatcaa aataattata 11760 aaacatactt gtttattata atagataggt actcaaggtt agagcatatg aatagatgct 11820 gcatatgcca tcatgtatat gcatcagtaa aacccacatc aacatgtata cctatcctag 11880 atcgatattt ccatccatct taaactcgta actatgaaga tgtatgacac acacatacag 11940 ttccaaaatt aataaataca ccaggtagtt tgaaacggcg tctactccga tctagaacga 12000 atgaacgacc gcccaaccac accacatcat cacaaccaag cgaacaaaaa gcatctctgt 12060 atatgcatca gtaaaacccg catcaacatg tatacctatc ctagatcgat atttccatcc 12120 atcatcttca attcgtaact atgaatatgt atggcacaca catacagatc caaaattaat 12180 aaatccacca ggtagtttga aacagaattc tactccgatc tagaacgacc gcccaaccag 12240 accacatcat cacaaccaag acaaaaaaaa gcatgaaaag atgacccgac aaacaagtgc 12300 acggcatata ttgaaataaa ggaaaagggc aaaccaaacc ctatgcaacg aaacaaaaaa 12360 aatcatgaaa tcgatcccgt ctgcggaacg gctagagcca tcccaggatt ccccaaagag 12420 aaacactggc aagttagcaa tcagaacgtg tctgacgtac aggtcgcatc cgtgtacgaa 12480 cgctagcagc acggatctaa cacaaacacg gatctaacac aaacatgaac agaagtagaa 12540 ctaccgggcc ctaaccatgg accggaacgc cgatctagag aaggtagaga gggggggggg 12600 gggaggacga gcggcgtacc ttgaagcgga ggtgccgacg ggtggatttg ggggagatct 12660 ggttgtgtgt gtgtgcgctc cgaacaacac gaggttgggg aaagagggtg tggagggggt 12720 gtctatttat tacggcgggc gaggaaggga aagcgaagga gcggtgggaa aggaatcccc 12780 cgtagctgcc gtgccgtgag aggaggagga ggccgcctgc cgtgccggct cacgtctgcc 12840 gctccgccac gcaatttctg gatgccgaca gcggagcaag tccaacggtg gagcggaact 12900 ctcgagaggg gtccagaggc agcgacagag atgccgtgcc gtctgcttcg cttggcccga 12960 cgcgacgctg ctggttcgct ggttggtgtc cgttagactc gtcgacggcg tttaacaggc 13020 tggcattatc tactcgaaac aagaaaaatg tttccttagt ttttttaatt tcttaaaggg 13080 tatttgttta atttttagtc actttatttt attctatttt atatctaaat tattaaataa 13140 aaaaactaaa atagagtttt agttttctta atttagaggc taaaatagaa taaaatagat 13200 gtactaaaaa aattagtcta taaaaaccat taaccctaaa ccctaaatgg atgtactaat 13260 aaaatggatg aagtattata taggtgaagc tatttgcaaa aaaaaaggag aacacatgca 13320 cactaaaaag ataaaactgt agagtcctgt tgtcaaaata ctcaattgtc ctttagacca 13380 tgtctaactg ttcatttata tgattctcta aaacactgat attattgtag tactatagat 13440 tatattattc gtagagtaaa gtttaaatat atgtataaag atagataaac tgcacttcaa 13500 acaagtgtga caaaaaaaat atgtggtaat tttttataac ttagacatgc aatgctcatt 13560 atctctagag aggggcacga ccgggtcacg ctgcactgca ggcatgcaag cttgcacatg 13620 acaacaattg taagaggatg gagaccacaa cgatccaaca atacttctgc gacgggctgt 13680 gaagtataga gaagttaaac gcccaaaagc cattgtgttt ggaattttta gttattctat 13740 ttttcatgat gtatcttcct ctaacatgcc ttaatttgca aatttggtat aactactgat 13800 tgaaaatata tgtatgtaaa aaaatactaa gcatatttgt gaagctaaac atgatgttat 13860 ttaagaaaat atgttgttaa cagaataaga ttaatatcga aatggaaaca tctgtaaatt 13920 agaatcatct tacaagctaa gagatgttca cgctttgaga aacttcttca gatcatgacc 13980 gtagaagtag ctctccaaga ctcaacgaag gctgctgcaa ttccacaaat gcatgacatg 14040 catccttgta accgtcgtcg ccgctataaa cacggataac tcaattccct gctccatcaa 14100 tttagaaatg agcaagcaag cacccgatcg ctcaccccat atgcaccaat ctgactccca 14160 agtctctgtt tcgcattagt accgccagca ctccacctat agctaccaat tgagaccttt 14220 ccagcctaag cagatcgatt gatcgttaga gtcaaagagt tggtggtacg ggtactttaa 14280 ctaccatgga atgatggggc gtgatgtaga gcggaaagcg cctccctacg cggaacaaca 14340 ccctcgccat gccgctcgac tacagcctcc tcctcgtcgg ccgcccacaa cgagggagcc 14400 cgtggtcgca gccaccgacc agcatgtctc tgtgtcctcg tccgacctcg acatgtcatg 14460 gcaaacagtc ggacgccagc accagactga cgacatgagt ctctgaagag cccgccacct 14520 agaaagatcc gagccctgct gctggtagtg gtaaccattt tcgtcgcgct gacgcggaga 14580 gcgagaggcc agaaatttat agcgactgac gctgtggcag gcacgctatc ggaggttacg 14640 acgtggcggg tcactcgacg cggagttcac aggtcctatc cttgcatcgc tcgggccgga 14700 gtttacggga cttatcctta cgacgtgctc taaggttgcg ataacgggcg gaggaaggcg 14760 tgtggcgtgc ggagacggtt tatacacgta gtgtgcggga gtgtgtttcg tagacgcggg 14820 aaagcacgac gacttacgaa ggttagtgga ggaggaggac acactaaaat caggacgcaa 14880 gaaactcttc tattatagta gtagagaaga gattatagga gtgtgggttg attctaaaga 14940 aaatcgacgc aggacaaccg tcaaaacggg tgctttaata tagtagatat atatatatag 15000 agagagagag aaagtacaaa ggatgcattt gtgtctgcat atgatcggag tattactaac 15060 ggccgtcgta agaaggtcca tcatgcgtgg agcgagccca tttggttggt tgtcaggccg 15120 cagttaaggc ctccatatat gattgtcgtc gggcccataa cagcatctcc tccaccagtt 15180 tattgtaaga ataaattaag tagagatatt tgtcgtcggg cagaagaaac ttggacaaga 15240 agaagaagca agctaggcca atttcttgcc ggcaagagga agatagtggc ctctagttta 15300 tatatcggcg tgatgatgat gctcctagct agaaatgaga gaagaaaaac ggacgcgtgt 15360 ttggtgtgtg tcaatggcgt ccatccttcc atcagatcag aacgatgaaa aagtcaagca 15420 cggcatgcat agtatatgta tagcttgttt tagtgtggct ttgctgagac gaatgaaagc 15480 aacggcgggc atatttttca gtggctgtag ctttcaggct gaaagagacg tggcatgcaa 15540 taattcaggg aattcgtcag ccaattgagg tagctagtca acttgtacat tggtgcgagc 15600 aattttccgc actcaggagg gctagtttga gagtccaaaa actataggag attaaagagg 15660 ctaaaatcct ctccttattt aattttaaat aagtagtgta tttgtatttt aactcctcca 15720 acccttccga ttttatggct ctcaaactag cattcagtct aatgcatgca tgcttggcta 15780 gaggtcgtat ggggttgtta atagcatagc tagctacaag ttaaccgggt cttttatatt 15840 taataaggac aggcaaagta ttacttacaa ataaagaata aagctaggac gaactcgtgg 15900 attattacta aatcgaaatg gacgtaatat tccaggcaag aataattgtt cgatcaggag 15960 acaagtgggg cattggaccg gttcttgcaa gcaagagcct atggcgtggt gacacggcgc 16020 gttgcccata catcatgcct ccatcgatga tccatcctca cttgctataa aaagaggtgt 16080 ccatggtgct caagctcagc caagcaaata agacgacttg tttcattgat tcttcaagag 16140 atcgagcttc ttttgcacca caaggtcgag gatccaaca 16179 <210> 13 <211> 15643 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1441 <220> <221> misc_feature <222> (14)..(1414) <223> Maize ubiquitin (Mz Ubi) promoter <220> <221> misc_feature <222> (2037)..(5618) <223> synthetic nucleotide sequence encoding the toxin portion of H04 plus a full-length Cry1Ab tail portion <220> <221> misc_feature <222> (5821)..(6711) <223> Mz Ubi promoter <220> <221> misc_feature <222> (7831)..(9039) <223> PMI <400> 13 aagctggtac aagcttgcat gcctgcagtg cagcgtgacc cggtcgtgcc cctctctaga 60 gataatgagc attgcatgtc taagttataa aaaattacca catatttttt ttgtcacact 120 tgtttgaagt gcagtttatc tatctttata catatattta aactttactc tacgaataat 180 ataatctata gtactacaat aatatcagtg ttttagagaa tcatataaat gaacagttag 240 acatggtcta aaggacaatt gagtattttg acaacaggac tctacagttt tatcttttta 300 gtgtgcatgt gttctccttt ttttttgcaa atagcttcac ctatataata cttcatccat 360 tttattagta catccattta gggtttaggg ttaatggttt ttatagacta atttttttag 420 tacatctatt ttattctatt ttagcctcta aattaagaaa actaaaactc tattttagtt 480 tttttattta ataatttaga tataaaatag aataaaataa agtgactaaa aattaaacaa 540 atacccttta agaaattaaa aaaactaagg aaacattttt cttgtttcga gtagataatg 600 ccagcctgtt aaacgccgtc gacgagtcta acggacacca accagcgaac cagcagcgtc 660 gcgtcgggcc aagcgaagca gacggcacgg catctctgtc gctgcctctg gacccctctc 720 gagagttccg ctccaccgtt ggacttgctc cgctgtcggc atccagaaat tgcgtggcgg 780 agcggcagac gtgagccggc acggcaggcg gcctcctcct cctctcacgg cacggcagct 840 acgggggatt cctttcccac cgctccttcg ctttcccttc ctcgcccgcc gtaataaata 900 gacaccccct ccacaccctc tttccccaac ctcgtgttgt tcggagcgca cacacacaca 960 accagatctc ccccaaatcc acccgtcggc acctccgctt caaggtacgc cgctcgtcct 1020 cccccccccc ccctctctac cttctctaga tcggcgttcc ggtccatggt tagggcccgg 1080 tagttctact tctgttcatg tttgtgttag atccgtgttt gtgttagatc cgtgctgcta 1140 gcgttcgtac acggatgcga cctgtacgtc agacacgttc tgattgctaa cttgccagtg 1200 tttctctttg gggaatcctg ggatggctct agccgttccg cagacgggat cgatttcatg 1260 attttttttg tttcgttgca tagggtttgg tttgcccttt tcctttattt caatatatgc 1320 cgtgcacttg tttgtcgggt catcttttca tgcttttttt tgtcttggtt gtgatgatgt 1380 ggtctggttg ggcggtcgtt ctagatcgga gtagaattct gtttcaaact acctggtgga 1440 tttattaatt ttggatctgt atgtgtgtgc catacatatt catagttacg aattgaagat 1500 gatggatgga aatatcgatc taggataggt atacatgttg atgcgggttt tactgatgca 1560 tatacagaga tgctttttgt tcgcttggtt gtgatgatgt ggtgtggttg ggcggtcgtt 1620 cattcgttct agatcggagt agaatactgt ttcaaactac ctggtgtatt tattaatttt 1680 ggaactgtat gtgtgtgtca tacatcttca tagttacgag tttaagatgg atggaaatat 1740 cgatctagga taggtataca tgttgatgtg ggttttactg atgcatatac atgatggcat 1800 atgcagcatc tattcatatg ctctaacctt gagtacctat ctattataat aaacaagtat 1860 gttttataat tattttgatc ttgatatact tggatgatgg catatgcagc agctatatgt 1920 ggattttttt agccctgcct tcatacgcta tttatttgct tggtactgtt tcttttgtcg 1980 atgctcaccc tgttgtttgg tgttacttct gcaggtcgac tctagaggat ccaacaatgg 2040 acaacaaccc caacatcaac gagtgcatcc cctacaactg cctgagcaac cccgaggtgg 2100 aggtgctggg cggcgagcgc atcgagaccg gctacacccc catcgacatc agcctgagcc 2160 tgacccagtt cctgctgagc gagttcgtgc ccggcgccgg cttcgtgctg ggcctggtgg 2220 acatcatctg gggcatcttc ggccccagcc agtgggacgc cttcctggtg cagatcgagc 2280 agttgataaa ccaacgcata gaggaattcg cccgcaacca ggccatcagc cgcctggagg 2340 gcctgagcaa cctgtaccaa atctacgccg agagcttccg cgagtgggag gccgacccca 2400 ccaaccccgc cctgcgcgag gagatgcgca tccagttcaa cgacatgaac agcgccctga 2460 ccaccgccat ccccctgttc gccgtgcaga actaccaggt gcccctgctg agcgtgtacg 2520 tgcaggccgc caacctgcac ctgagcgtgc tgcgcgacgt cagcgtgttc ggccagcgct 2580 ggggcttcga cgccgccacc atcaacagcc gctacaacga cctgacccgc ctgatcggca 2640 actacaccga ccacgccgtg cgctggtaca acaccggcct ggagcgcgtg tggggtcccg 2700 acagccgcga ctggatcagg tacaaccagt tccgccgcga gctgaccctg accgtgctgg 2760 acatcgtgag cctgttcccc aactacgaca gccgcaccta ccccatccgc accgtgagcc 2820 agctgacccg cgagatttac accaaccccg tgctggagaa cttcgacggc agcttccgcg 2880 gcagcgccca gggcatcgag ggcagcatcc gcagccccca cctgatggac atcctgaaca 2940 gcatcaccat ctacaccgac gcccaccgcg gcgagtacta ctggagcggc caccagatca 3000 tggccagccc cgtcggcttc agcggccccg agttcacctt ccccctgtac ggcaccatgg 3060 gcaacgctgc acctcagcag cgcatcgtgg cacagctggg ccagggagtg taccgcaccc 3120 tgagcagcac cctgtaccgt cgacctttca acatcggcat caacaaccag cagctgagcg 3180 tgctggacgg caccgagttc gcctacggca ccagcagcaa cctgcccagc gccgtgtacc 3240 gcaagagcgg caccgtggac agcctggacg agatcccccc tcagaacaac aacgtgccac 3300 ctcgacaggg cttcagccac cgtctgagcc acgtgagcat gttccgcagt ggcttcagca 3360 acagcagcgt gagcatcatc cgtgcaccca tgttcagctg gattcaccgc agcgccaccc 3420 tgaccaacac catcgacccc gagcgcatca accagatccc cctggtgaag ggcttccggg 3480 tgtggggcgg caccagcgtg atcaccggcc ccggcttcac cggaggcgac atcctgcgca 3540 gaaacacctt cggcgacttc gtgagcctgc aggtgaacat caacagcccc atcacccagc 3600 gttaccgcct gcgcttccgc tacgccagca gccgcgacgc ccgtgtgatc gtgctgactg 3660 gcgccgctag caccggtgtg ggcggtcagg tgagcgtgaa catgcccctg cagaagacta 3720 tggagatcgg cgagaacctg actagtcgca ccttccgcta caccgacttc agcaacccct 3780 tcagcttccg cgccaacccc gacatcatcg gcatcagcga gcagcccctg ttcggtgccg 3840 gcagcatcag cagcggcgag ctgtacatcg acaagatcga gatcatcctg gccgacgcca 3900 ccttcgaggc cgagagcgac ctggagcgcg cccagaaggc cgtgaacgcc ctgttcacca 3960 gcagcaacca gatcggcctg aagaccgacg tgaccgacta ccacatcgac caggtgagca 4020 acctggtgga ctgcttaagc gacgagttct gcctggacga gaagaaggag ctgagcgaga 4080 aggtgaagca cgccaagcgc ctgagcgacg agcgcaacct gctgcaggac cccaacttcc 4140 gcggcatcaa ccgccagctg gaccgcggct ggcgaggcag caccgatatc accatccagg 4200 gcggcgacga cgtgttcaag gagaactacg tgaccctgca gggcaccttc gacgagtgct 4260 accccaccta cctgtaccag ccgatcgacg agagcaagct gaaggcctac acccgctacc 4320 agctgcgcgg ctacatcgag gacagccagg acctggaaat ctacctgatc cgctacaacg 4380 cgaagcacga gaccgtgaac gtgcccggca ccggcagcct gtggcccccg agcgccccca 4440 gccccatcgg caagtgcggg gagccgaatc gatgcgctcc gcacctggag tggaacccgg 4500 acctagactg cagctgcagg gacggggaga agtgcgccca ccacagccac cacttcagcc 4560 tggacatcga cgtgggctgc accgacctga acgaggacct gggcgtgtgg gtgatcttca 4620 agatcaagac ccaggacggc cacgcccgcc tgggcaatct agagttcctg gaggagaagc 4680 ccctggtggg cgaggccctg gcccgcgtga agcgtgctga gaagaagtgg cgcgacaagc 4740 gcgagaagct ggagtgggag accaacatcg tgtacaagga ggccaaggag agcgtggacg 4800 ccctgttcgt gaacagccag tacgaccgcc tgcaggccga caccaacatc gccatgatcc 4860 acgccgccga caagcgcgtg cacagcattc gcgaggccta cctgcccgag ctgagcgtga 4920 tccccggtgt gaacgccgcc atcttcgagg aactcgaggg ccgcatcttc accgccttca 4980 gcctgtacga cgcccgcaac gtgatcaaga acggcgactt caacaacggc ctgagctgct 5040 ggaacgtgaa gggccacgtg gacgtggagg agcagaacaa ccaccgcagc gtgctggtgg 5100 tgcccgagtg ggaggccgag gtgagccagg aggtgcgcgt gtgccccggc cgcggctaca 5160 tcctgcgcgt gaccgcctac aaggagggct acggcgaggg ctgcgtgacc atccacgaga 5220 tcgagaacaa caccgacgag ctcaagttca gcaactgcgt ggaggaggag gtttacccca 5280 acaacaccgt gacctgcaac gactacaccg cgacccagga ggagtacgaa ggcacctaca 5340 cctctcgcaa caggggttac gacggcgcct acgagtccaa cagctccgtg ccagctgact 5400 acgccagcgc ccacgaggag aaagcctaca ccgacggtag acgcgacaac ccatgtgaga 5460 gcaacagagg ctacggcgac tacacccccc tgcccgctgg atacgtgacc aaggagctgg 5520 agtacttccc cgagaccgac aaggtgtgga tcgagattgg cgagaccgag ggcaccttca 5580 tcgtggacag cgtggagctg ctgctgatgg aggagtagta gatctgttct gcacaaagtg 5640 gagtagtcag tcatcgatca ggaaccagac accagacttt tattcataca gtgaagtgaa 5700 gtgaagtgca gtgcagtgag ttgctggttt ttgtaccact tagtatgtat ttgtatttgt 5760 aaaatacttc tatcaataaa atttctaatt cctaaaacca aaatccagtg ggtaccagct 5820 tgcatgcctg cagtgcagcg tgacccggtc gtgcccctct ctagagataa tgagcattgc 5880 atgtctaagt tataaaaaat taccacatat tttttttgtc acacttgttt gaagtgcagt 5940 ttatctatct ttatacatat atttaaactt tactctacga ataatataat ctatagtact 6000 acaataatat cagtgtttta gagaatcata taaatgaaca gttagacatg gtctaaagga 6060 caattgagta ttttgacaac aggactctac agttttatct ttttagtgtg catgtgttct 6120 cctttttttt tgcaaatagc ttcacctata taatacttca tccattttat tagtacatcc 6180 atttagggtt tagggttaat ggtttttata gactaatttt tttagtacat ctattttatt 6240 ctattttagc ctctaaatta agaaaactaa aactctattt tagttttttt atttaataat 6300 ttagatataa aatagaataa aataaagtga ctaaaaatta aacaaatacc ctttaagaaa 6360 ttaaaaaaac taaggaaaca tttttcttgt ttcgagtaga taatgccagc ctgttaaacg 6420 ccgtcgacga gtctaacgga caccaaccag cgaaccagca gcgtcgcgtc gggccaagcg 6480 aagcagacgg cacggcatct ctgtcgctgc ctctggaccc ctctcgagag ttccgctcca 6540 ccgttggact tgctccgctg tcggcatcca gaaattgcgt ggcggagcgg cagacgtgag 6600 ccggcacggc aggcggcctc ctcctcctct cacggcacgg cagctacggg ggattccttt 6660 cccaccgctc cttcgctttc ccttcctcgc ccgccgtaat aaatagacac cccctccaca 6720 ccctctttcc ccaacctcgt gttgttcgga gcgcacacac acacaaccag atctccccca 6780 aatccacccg tcggcacctc cgcttcaagg tacgccgctc gtcctccccc cccccccctc 6840 tctaccttct ctagatcggc gttccggtcc atggttaggg cccggtagtt ctacttctgt 6900 tcatgtttgt gttagatccg tgtttgtgtt agatccgtgc tgctagcgtt cgtacacgga 6960 tgcgacctgt acgtcagaca cgttctgatt gctaacttgc cagtgtttct ctttggggaa 7020 tcctgggatg gctctagccg ttccgcagac gggatcgatt tcatgatttt ttttgtttcg 7080 ttgcataggg tttggtttgc ccttttcctt tatttcaata tatgccgtgc acttgtttgt 7140 cgggtcatct tttcatgctt ttttttgtct tggttgtgat gatgtggtct ggttgggcgg 7200 tcgttctaga tcggagtaga attctgtttc aaactacctg gtggatttat taattttgga 7260 tctgtatgtg tgtgccatac atattcatag ttacgaattg aagatgatgg atggaaatat 7320 cgatctagga taggtataca tgttgatgcg ggttttactg atgcatatac agagatgctt 7380 tttgttcgct tggttgtgat gatgtggtgt ggttgggcgg tcgttcattc gttctagatc 7440 ggagtagacg ccgtttcaaa ctacctggtg tatttattaa ttttggaact gtatgtgtgt 7500 gtcatacatc ttcatagtta cgagtttaag atggatggaa atatcgatct aggataggta 7560 tacatgttga tgtgggtttt actgatgcat atacatgatg gcatatgcag catctattca 7620 tatgctctaa ccttgagtac ctatctatta taataaacaa gtatgtttta taattatttt 7680 gatcttgata tacttggatg atggcatatg cagcagctat atgtggattt ttttagccct 7740 gccttcatac gctatttatt tgcttggtac tgtttctttt gtcgatgctc accctgttgt 7800 ttggtgttac ttctgcaggg atccccgatc atgcaaaaac tcattaactc agtgcaaaac 7860 tatgcctggg gcagcaaaac gcgttgactg aactttatgg tatggaaaat ccgtccagcc 7920 agccgatggc cgagctgtgg atgggcgcac atccgaaaag cagttcacga gtgcagaatg 7980 ccgccggaga tatcgtttca ctgcgtgatg tgattgagag tgataaatcg actctgctcg 8040 gagaggccgt tgccaaacgc tttggcgaac tgcctttcct gttcaaagta ttatgcgcag 8100 cacagccact ctccattcag gttcatccaa acaaacacaa ttctgaaatc ggttttgcca 8160 aagaaaatgc cgcaggtatc ccgatggatg ccgccgagcg taactataaa gatcctaacc 8220 acaagccgga gctggttttt gcgctgacgc ctttccttgc gatgaacgcg tttcgtgaat 8280 tttccgagat tgtctcccta ctccagccgg tcgcaggtgc acatccggcg attgctcact 8340 ttttacaaca gcctgatgcc gaacgtttaa gcgaactgtt cgccagcctg ttgaatatgc 8400 agggtgaaga aaaatcccgc gcgctggcga ttttaaaatc ggccctcgat agccagcagg 8460 gtgaaccgtg gcaaacgatt cgtttaattt ctgaatttta cccggaagac agcggtctgt 8520 tctccccgct attgctgaat gtggtgaaat tgaaccctgg cgaagcgatg ttcctgttcg 8580 ctgaaacacc gcacgcttac ctgcaaggcg tggcgctgga agtgatggca aactccgata 8640 acgtgctgcg tgcgggtctg acgcctaaat acattgatat tccggaactg gttgccaatg 8700 tgaaattcga agccaaaccg gctaaccagt tgttgaccca gccggtgaaa caaggtgcag 8760 aactggactt cccgattcca gtggatgatt ttgccttctc gctgcatgac cttagtgata 8820 aagaaaccac cattagccag cagagtgccg ccattttgtt ctgcgtcgaa ggcgatgcaa 8880 cgttgtggaa aggttctcag cagttacagc ttaaaccggg tgaatcagcg tttattgccg 8940 ccaacgaatc accggtgact gtcaaaggcc acggccgttt agcgcgtgtt tacaacaagc 9000 tgtaagagct tactgaaaaa attaacatct cttgctaagc tgggagctcg atccgtcgac 9060 ctgcagagat cgttcaaaca tttggcaata aagtttctta agattgaatc ctgttgccgg 9120 tcttgcgatg attatcatct aatttctgtt gaattacgtt aagcatgtaa taattaacat 9180 gtaatgcatg acgttattta tgagatgggt ttttatgatt agagtcccgc aattatacat 9240 ttaatacgcg atagaaaaca aaatatagcg cgcaaactag gataaattat cgcgcgcggt 9300 gtcatctatg ttactagatc cgatgataag ctgtcaaaca tgagatcccc gggtctagac 9360 aattcagtac attaaaaacg tccgcaatgt gttattaagt tgtctaagcg tcaatttgtt 9420 tacaccacaa tatatcctgc caccagccag ccaacagctc cccgaccggc agctcggcac 9480 aaaatcacca ctcgatacag gcagcccatc agtccgggac ggcgtcagcg ggagagccgt 9540 tgtaaggcgg cagactttgc tcatgttacc gatgctattc ggaagaacgg caactaagct 9600 gccgggtttg aaacacggat gatctcgcgg agggtagcat gttgattgta acgatgacag 9660 agcgttgctg cctgtgatca aatatcatct ccctcgcaga gatccgaatt atcagccttc 9720 ttattcattt ctcgcttaac cgtgacaggc tgtcgatctt gagaactatg ccgacataat 9780 aggaaatcgc tggataaagc cgctgaggaa gctgagtggc gctatttctt tagaagtgaa 9840 cgttgacgat cgtcgaccgt accccgatga attaattcgg acgtacgttc tgaacacagc 9900 tggatactta cttgggcgat tgtcatacat gacatcaaca atgtacccgt ttgtgtaacc 9960 gtctcttgga ggttcgtatg acactagtgg ttcccctcag cttgcgacta gatgttgagg 10020 cctaacattt tattagagag caggctagtt gcttagatac atgatcttca ggccgttatc 10080 tgtcagggca agcgaaaatt ggccatttat gacgaccaat gccccgcaga agctcccatc 10140 tttgccgcca tagacgccgc gccccccttt tggggtgtag aacatccttt tgccagatgt 10200 ggaaaagaag ttcgttgtcc cattgttggc aatgacgtag tagccggcga aagtgcgaga 10260 cccatttgcg ctatatataa gcctacgatt tccgttgcga ctattgtcgt aattggatga 10320 actattatcg tagttgctct cagagttgtc gtaatttgat ggactattgt cgtaattgct 10380 tatggagttg tcgtagttgc ttggagaaat gtcgtagttg gatggggagt agtcataggg 10440 aagacgagct tcatccacta aaacaattgg caggtcagca agtgcctgcc ccgatgccat 10500 cgcaagtacg aggcttagaa ccaccttcaa cagatcgcgc atagtcttcc ccagctctct 10560 aacgcttgag ttaagccgcg ccgcgaagcg gcgtcggctt gaacgaattg ttagacatta 10620 tttgccgact accttggtga tctcgccttt cacgtagtga acaaattctt ccaactgatc 10680 tgcgcgcgag gccaagcgat cttcttgtcc aagataagcc tgcctagctt caagtatgac 10740 gggctgatac tgggccggca ggcgctccat tgcccagtcg gcagcgacat ccttcggcgc 10800 gattttgccg gttactgcgc tgtaccaaat gcgggacaac gtaagcacta catttcgctc 10860 atcgccagcc cagtcgggcg gcgagttcca tagcgttaag gtttcattta gcgcctcaaa 10920 tagatcctgt tcaggaaccg gatcaaagag ttcctccgcc gctggaccta ccaaggcaac 10980 gctatgttct cttgcttttg tcagcaagat agccagatca atgtcgatcg tggctggctc 11040 gaagatacct gcaagaatgt cattgcgctg ccattctcca aattgcagtt cgcgcttagc 11100 tggataacgc cacggaatga tgtcgtcgtg cacaacaatg gtgacttcta cagcgcggag 11160 aatctcgctc tctccagggg aagccgaagt ttccaaaagg tcgttgatca aagctcgccg 11220 cgttgtttca tcaagcctta cggtcaccgt aaccagcaaa tcaatatcac tgtgtggctt 11280 caggccgcca tccactgcgg agccgtacaa atgtacggcc agcaacgtcg gttcgagatg 11340 gcgctcgatg acgccaacta cctctgatag ttgagtcgat acttcggcga tcaccgcttc 11400 cctcatgatg tttaactcct gaattaagcc gcgccgcgaa gcggtgtcgg cttgaatgaa 11460 ttgttaggcg tcatcctgtg ctcccgagaa ccagtaccag tacatcgctg tttcgttcga 11520 gacttgaggt ctagttttat acgtgaacag gtcaatgccg ccgagagtaa agccacattt 11580 tgcgtacaaa ttgcaggcag gtacattgtt cgtttgtgtc tctaatcgta tgccaaggag 11640 ctgtctgctt agtgcccact ttttcgcaaa ttcgatgaga ctgtgcgcga ctcctttgcc 11700 tcggtgcgtg tgcgacacaa caatgtgttc gatagaggct agatcgttcc atgttgagtt 11760 gagttcaatc ttcccgacaa gctcttggtc gatgaatgcg ccatagcaag cagagtcttc 11820 atcagagtca tcatccgaga tgtaatcctt ccggtagggg ctcacacttc tggtagatag 11880 ttcaaagcct tggtcggata ggtgcacatc gaacacttca cgaacaatga aatggttctc 11940 agcatccaat gtttccgcca cctgctcagg gatcaccgaa atcttcatat gacgcctaac 12000 gcctggcaca gcggatcgca aacctggcgc ggcttttggc acaaaaggcg tgacaggttt 12060 gcgaatccgt tgctgccact tgttaaccct tttgccagat ttggtaacta taatttatgt 12120 tagaggcgaa gtcttgggta aaaactggcc taaaattgct ggggatttca ggaaagtaaa 12180 catcaccttc cggctcgatg tctattgtag atatatgtag tgtatctact tgatcggggg 12240 atctgctgcc tcgcgcgttt cggtgatgac ggtgaaaacc tctgacacat gcagctcccg 12300 gagacggtca cagcttgtct gtaagcggat gccgggagca gacaagcccg tcagggcgcg 12360 tcagcgggtg ttggcgggtg tcggggcgca gccatgaccc agtcacgtag cgatagcgga 12420 gtgtatactg gcttaactat gcggcatcag agcagattgt actgagagtg caccatatgc 12480 ggtgtgaaat accgcacaga tgcgtaagga gaaaataccg catcaggcgc tcttccgctt 12540 cctcgctcac tgactcgctg cgctcggtcg ttcggctgcg gcgagcggta tcagctcact 12600 caaaggcggt aatacggtta tccacagaat caggggataa cgcaggaaag aacatgtgag 12660 caaaaggcca gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg tttttccata 12720 ggctccgccc ccctgacgag catcacaaaa atcgacgctc aagtcagagg tggcgaaacc 12780 cgacaggact ataaagatac caggcgtttc cccctggaag ctccctcgtg cgctctcctg 12840 ttccgaccct gccgcttacc ggatacctgt ccgcctttct cccttcggga agcgtggcgc 12900 tttctcatag ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc tccaagctgg 12960 gctgtgtgca cgaacccccc gttcagcccg accgctgcgc cttatccggt aactatcgtc 13020 ttgagtccaa cccggtaaga cacgacttat cgccactggc agcagccact ggtaacagga 13080 ttagcagagc gaggtatgta ggcggtgcta cagagttctt gaagtggtgg cctaactacg 13140 gctacactag aaggacagta tttggtatct gcgctctgct gaagccagtt accttcggaa 13200 aaagagttgg tagctcttga tccggcaaac aaaccaccgc tggtagcggt ggtttttttg 13260 tttgcaagca gcagattacg cgcagaaaaa aaggatctca agaagatcct ttgatctttt 13320 ctacggggtc tgacgctcag tggaacgaaa actcacgtta agggattttg gtcatgagat 13380 tatcaaaaag gatcttcacc tagatccttt taaattaaaa atgaagtttt aaatcaatct 13440 aaagtatata tgagtaaact tggtctgaca gttaccaatg cttaatcagt gaggcaccta 13500 tctcagcgat ctgtctattt cgttcatcca tagttgcctg actccccgtc gtgtagataa 13560 ctacgatacg ggagggctta ccatctggcc ccagtgctgc aatgataccg cgagacccac 13620 gctcaccggc tccagattta tcagcaataa accagccagc cggaagggcc gagcgcagaa 13680 gtggtcctgc aactttatcc gcctccatcc agtctattaa ttgttgccgg gaagctagag 13740 taagtagttc gccagttaat agtttgcgca acgttgttgc cattgctgca gggggggggg 13800 ggggggggga cttccattgt tcattccacg gacaaaaaca gagaaaggaa acgacagagg 13860 ccaaaaagcc tcgctttcag cacctgtcgt ttcctttctt ttcagagggt attttaaata 13920 aaaacattaa gttatgacga agaagaacgg aaacgcctta aaccggaaaa ttttcataaa 13980 tagcgaaaac ccgcgaggtc gccgccccgt aacctgtcgg atcaccggaa aggacccgta 14040 aagtgataat gattatcatc tacatatcac aacgtgcgtg gaggccatca aaccacgtca 14100 aataatcaat tatgacgcag gtatcgtatt aattgatctg catcaactta acgtaaaaac 14160 aacttcagac aatacaaatc agcgacactg aatacggggc aacctcatgt cccccccccc 14220 cccccccctg caggcatcgt ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc 14280 ggttcccaac gatcaaggcg agttacatga tcccccatgt tgtgcaaaaa agcggttagc 14340 tccttcggtc ctccgatcgt tgtcagaagt aagttggccg cagtgttatc actcatggtt 14400 atggcagcac tgcataattc tcttactgtc atgccatccg taagatgctt ttctgtgact 14460 ggtgagtact caaccaagtc attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc 14520 ccggcgtcaa cacgggataa taccgcgcca catagcagaa ctttaaaagt gctcatcatt 14580 ggaaaacgtt cttcggggcg aaaactctca aggatcttac cgctgttgag atccagttcg 14640 atgtaaccca ctcgtgcacc caactgatct tcagcatctt ttactttcac cagcgtttct 14700 gggtgagcaa aaacaggaag gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa 14760 tgttgaatac tcatactctt cctttttcaa tattattgaa gcatttatca gggttattgt 14820 ctcatgagcg gatacatatt tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc 14880 acatttcccc gaaaagtgcc acctgacgtc taagaaacca ttattatcat gacattaacc 14940 tataaaaata ggcgtatcac gaggcccttt cgtcttcaag aattggtcga cgatcttgct 15000 gcgttcggat attttcgtgg agttcccgcc acagacccgg attgaaggcg agatccagca 15060 actcgcgcca gatcatcctg tgacggaact ttggcgcgtg atgactggcc aggacgtcgg 15120 ccgaaagagc gacaagcaga tcacgctttt cgacagcgtc ggatttgcga tcgaggattt 15180 ttcggcgctg cgctacgtcc gcgaccgcgt tgagggatca agccacagca gcccactcga 15240 ccttctagcc gacccagacg agccaaggga tctttttgga atgctgctcc gtcgtcaggc 15300 tttccgacgt ttgggtggtt gaacagaagt cattatcgta cggaatgcca agcactcccg 15360 aggggaaccc tgtggttggc atgcacatac aaatggacga acggataaac cttttcacgc 15420 ccttttaaat atccgttatt ctaataaacg ctcttttctc ttaggtttac ccgccaatat 15480 atcctgtcaa acactgatag tttaaactga aggcgggaaa cgacaatctg atcatgagcg 15540 gagaattaag ggagtcacgt tatgaccccc gccgatgacg cgggacaagc cgttttacgt 15600 ttggaactga cagaaccgca acgttgaagg agccactcag ccc 15643 <210> 14 <211> 15503 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1305 <220> <221> misc_feature <222> (1)..(3582) <223> synthetic nucleotide sequence encoding the toxin portion of H04 plus a full-length Cry1Ab tail portion <220> <221> misc_feature <222> (3790)..(5771) <223> Zm Ubi promoter <220> <221> misc_feature <222> (5868)..(6971) <223> PMI <220> <221> misc_feature <222> (12934)..(15494) <223> MTL promoter <400> 14 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgcgcccaga aggccgtgaa cgccctgttc 1920 accagcagca accagatcgg cctgaagacc gacgtgaccg actaccacat cgaccaggtg 1980 agcaacctgg tggactgctt aagcgacgag ttctgcctgg acgagaagaa ggagctgagc 2040 gagaaggtga agcacgccaa gcgcctgagc gacgagcgca acctgctgca ggaccccaac 2100 ttccgcggca tcaaccgcca gctggaccgc ggctggcgag gcagcaccga tatcaccatc 2160 cagggcggcg acgacgtgtt caaggagaac tacgtgaccc tgcagggcac cttcgacgag 2220 tgctacccca cctacctgta ccagccgatc gacgagagca agctgaaggc ctacacccgc 2280 taccagctgc gcggctacat cgaggacagc caggacctgg aaatctacct gatccgctac 2340 aacgcgaagc acgagaccgt gaacgtgccc ggcaccggca gcctgtggcc cctgagcgcc 2400 cccagcccca tcggcaagtg cggggagccg aatcgatgcg ctccgcacct ggagtggaac 2460 ccggacctag actgcagctg cagggacggg gagaagtgcg cccaccacag ccaccacttc 2520 agcctggaca tcgacgtggg ctgcaccgac ctgaacgagg acctgggcgt gtgggtgatc 2580 ttcaagatca agacccagga cggccacgcc cgcctgggca atctagagtt cctggaggag 2640 aagcccctgg tgggcgaggc cctggcccgc gtgaagcgtg ctgagaagaa gtggcgcgac 2700 aagcgcgaga agctggagtg ggagaccaac atcgtgtaca aggaggccaa ggagagcgtg 2760 gacgccctgt tcgtgaacag ccagtacgac cgcctgcagg ccgacaccaa catcgccatg 2820 atccacgccg ccgacaagcg cgtgcacagc attcgcgagg cctacctgcc cgagctgagc 2880 gtgatccccg gtgtgaacgc cgccatcttc gaggaactcg agggccgcat cttcaccgcc 2940 ttcagcctgt acgacgcccg caacgtgatc aagaacggcg acttcaacaa cggcctgagc 3000 tgctggaacg tgaagggcca cgtggacgtg gaggagcaga acaaccaccg cagcgtgctg 3060 gtggtgcccg agtgggaggc cgaggtgagc caggaggtgc gcgtgtgccc cggccgcggc 3120 tacatcctgc gcgtgaccgc ctacaaggag ggctacggcg agggctgcgt gaccatccac 3180 gagatcgaga acaacaccga cgagctcaag ttcagcaact gcgtggagga ggaggtttac 3240 cccaacaaca ccgtgacctg caacgactac accgcgaccc aggaggagta cgaaggcacc 3300 tacacctctc gcaacagggg ttacgacggc gcctacgagt ccaacagctc cgtgccagct 3360 gactacgcca gcgcctacga ggagaaagcc tacaccgacg gtagacgcga caacccatgt 3420 gagagcaaca gaggctacgg cgactacacc cccctgcccg ctggatacgt gaccaaggag 3480 ctggagtact tccccgagac cgacaaggtg tggatcgaga ttggcgagac cgagggcacc 3540 ttcatcgtgg acagcgtgga gctgctgctg atggaggagt agtagatctg ttctgcacaa 3600 agtggagtag tcagtcatcg atcaggaacc agacaccaga cttttattca tacagtgaag 3660 tgaagtgaag tgcagtgcag tgagttgctg gtttttgtac aacttagtat gtatttgtat 3720 ttgtaaaata cttctatcaa taaaatttct aattcctaaa accaaaatcc aggggtacca 3780 gcttgcatgc ctgcagtgca gcgtgacccg gtcgtgcccc tctctagaga taatgagcat 3840 tgcatgtcta agttataaaa aattaccaca tatttttttt gtcacacttg tttgaagtgc 3900 agtttatcta tctttataca tatatttaaa ctttactcta cgaataatat aatctatagt 3960 actacaataa tatcagtgtt ttagagaatc atataaatga acagttagac atggtctaaa 4020 ggacaattga gtattttgac aacaggactc tacagtttta tctttttagt gtgcatgtgt 4080 tctccttttt ttttgcaaat agcttcacct atataatact tcatccattt tattagtaca 4140 tccatttagg gtttagggtt aatggttttt atagactaat ttttttagta catctatttt 4200 attctatttt agcctctaaa ttaagaaaac taaaactcta ttttagtttt tttatttaat 4260 aatttagata taaaatagaa taaaataaag tgactaaaaa ttaaacaaat accctttaag 4320 aaattaaaaa aactaaggaa acatttttct tgtttcgagt agataatgcc agcctgttaa 4380 acgccgtcga cgagtctaac ggacaccaac cagcgaacca gcagcgtcgc gtcgggccaa 4440 gcgaagcaga cggcacggca tctctgtcgc tgcctctgga cccctctcga gagttccgct 4500 ccaccgttgg acttgctccg ctgtcggcat ccagaaattg cgtggcggag cggcagacgt 4560 gagccggcac ggcaggcggc ctcctcctcc tctcacggca ccggcagcta cgggggattc 4620 ctttcccacc gctccttcgc tttcccttcc tcgcccgccg taataaatag acaccccctc 4680 cacaccctct ttccccaacc tcgtgttgtt cggagcgcac acacacacaa ccagatctcc 4740 cccaaatcca cccgtcggca cctccgcttc aaggtacgcc gctcgtcctc cccccccccc 4800 cctctctacc ttctctagat cggcgttccg gtccatggtt agggcccggt agttctactt 4860 ctgttcatgt ttgtgttaga tccgtgtttg tgttagatcc gtgctgctag cgttcgtaca 4920 cggatgcgac ctgtacgtca gacacgttct gattgctaac ttgccagtgt ttctctttgg 4980 ggaatcctgg gatggctcta gccgttccgc agacgggatc gatttcatga ttttttttgt 5040 ttcgttgcat agggtttggt ttgccctttt cctttatttc aatatatgcc gtgcacttgt 5100 ttgtcgggtc atcttttcat gctttttttt gtcttggttg tgatgatgtg gtctggttgg 5160 gcggtcgttc tagatcggag tagaattctg tttcaaacta cctggtggat ttattaattt 5220 tggatctgta tgtgtgtgcc atacatattc atagttacga attgaagatg atggatggaa 5280 atatcgatct aggataggta tacatgttga tgcgggtttt actgatgcat atacagagat 5340 gctttttgtt cgcttggttg tgatgatgtg gtgtggttgg gcggtcgttc attcgttcta 5400 gatcggagta gaatactgtt tcaaactacc tggtgtattt attaattttg gaactgtatg 5460 tgtgtgtcat acatcttcat agttacgagt ttaagatgga tggaaatatc gatctaggat 5520 aggtatacat gttgatgtgg gttttactga tgcatataca tgatggcata tgcagcatct 5580 attcatatgc tctaaccttg agtacctatc tattataata aacaagtatg ttttataatt 5640 attttgatct tgatatactt ggatgatggc atatgcagca gctatatgtg gattttttta 5700 gccctgcctt catacgctat ttatttgctt ggtactgttt cttttgtcga tgctcaccct 5760 gttgtttggt gttacttctg cagggatccc cgatcatgca aaaactcatt aactcagtgc 5820 aaaactatgc ctggggcagc aaaacggcgt tgactgaact ttatggtatg gaaaatccgt 5880 ccagccagcc gatggccgag ctgtggatgg gcgcacatcc gaaaagcagt tcacgagtgc 5940 agaatgccgc cggagatatc gtttcactgc gtgatgtgat tgagagtgat aaatcgactc 6000 tgctcggaga ggccgttgcc aaacgctttg gcgaactgcc tttcctgttc aaagtattat 6060 gcgcagcaca gccactctcc attcaggttc atccaaacaa acacaattct gaaatcggtt 6120 ttgccaaaga aaatgccgca ggtatcccga tggatgccgc cgagcgtaac tataaagatc 6180 ctaaccacaa gccggagctg gtttttgcgc tgacgccttt ccttgcgatg aacgcgtttc 6240 gtgaattttc cgagattgtc tccctactcc agccggtcgc aggtgcacat ccggcgattg 6300 ctcacttttt acaacagcct gatgccgaac gtttaagcga actgttcgcc agcctgttga 6360 atatgcaggg tgaagaaaaa tcccgcgcgc tggcgatttt aaaatcggcc ctcgatagcc 6420 agcagggtga accgtggcaa acgattcgtt taatttctga attttacccg gaagacagcg 6480 gtctgttctc cccgctattg ctgaatgtgg tgaaattgaa ccctggcgaa gcgatgttcc 6540 tgttcgctga aacaccgcac gcttacctgc aaggcgtggc gctggaagtg atggcaaact 6600 ccgataacgt gctgcgtgcg ggtctgacgc ctaaatacat tgatattccg gaactggttg 6660 ccaatgtgaa attcgaagcc aaaccggcta accagttgtt gacccagccg gtgaaacaag 6720 gtgcagaact ggacttcccg attccagtgg atgattttgc cttctcgctg catgacctta 6780 gtgataaaga aaccaccatt agccagcaga gtgccgccat tttgttctgc gtcgaaggcg 6840 atgcaacgtt gtggaaaggt tctcagcagt tacagcttaa accgggtgaa tcagcgttta 6900 ttgccgccaa cgaatcaccg gtgactgtca aaggccacgg ccgtttagcg cgtgtttaca 6960 acaagctgta agagcttact gaaaaaatta acatctcttg ctaagctggg agctcgatcc 7020 gtcgacctgc agatcgttca aacatttggc aataaagttt cttaagattg aatcctgttg 7080 ccggtcttgc gatgattatc atataatttc tgttgaatta cgttaagcat gtaataatta 7140 acatgtaatg catgacgtta tttatgagat gggtttttat gattagagtc ccgcaattat 7200 acatttaata cgcgatagaa aacaaaatat agcgcgcaaa ctaggataaa ttatcgcgcg 7260 cggtgtcatc tatgttacta gatctgctag ccctgcagga aatttaccgg tgcccgggcg 7320 gccagcatgg ccgtatccgc aatgtgttat taagttgtct aagcgtcaat ttgtttacac 7380 cacaatatat cctgccacca gccagccaac agctccccga ccggcagctc ggcacaaaat 7440 caccactcga tacaggcagc ccatcagaat taattctcat gtttgacagc ttatcatcga 7500 ctgcacggtg caccaatgct tctggcgtca ggcagccatc ggaagctgtg gtatggctgt 7560 gcaggtcgta aatcactgca taattcgtgt cgctcaaggc gcactcccgt tctggataat 7620 gttttttgcg ccgacatcat aacggttctg gcaaatattc tgaaatgagc tgttgacaat 7680 taatcatccg gctcgtataa tgtgtggaat tgtgagcgga taacaatttc acacaggaaa 7740 cagaccatga gggaagcgtt gatcgccgaa gtatcgactc aactatcaga ggtagttggc 7800 gtcatcgagc gccatctcga accgacgttg ctggccgtac atttgtacgg ctccgcagtg 7860 gatggcggcc tgaagccaca cagtgatatt gatttgctgg ttacggtgac cgtaaggctt 7920 gatgaaacaa cgcggcgagc tttgatcaac gaccttttgg aaacttcggc ttcccctgga 7980 gagagcgaga ttctccgcgc tgtagaagtc accattgttg tgcacgacga catcattccg 8040 tggcgttatc cagctaagcg cgaactgcaa tttggagaat ggcagcgcaa tgacattctt 8100 gcaggtatct tcgagccagc cacgatcgac attgatctgg ctatcttgct gacaaaagca 8160 agagaacata gcgttgcctt ggtaggtcca gcggcggagg aactctttga tccggttcct 8220 gaacaggatc tatttgaggc gctaaatgaa accttaacgc tatggaactc gccgcccgac 8280 tgggctggcg atgagcgaaa tgtagtgctt acgttgtccc gcatttggta cagcgcagta 8340 accggcaaaa tcgcgccgaa ggatgtcgct gccgactggg caatggagcg cctgccggcc 8400 cagtatcagc ccgtcatact tgaagctagg caggcttatc ttggacaaga agatcgcttg 8460 gcctcgcgcg cagatcagtt ggaagaattt gttcactacg tgaaaggcga gatcaccaaa 8520 gtagtcggca aataaagctc tagtggatct ccgtaccccc gggggatctg gctcgcggcg 8580 gacgcacgac gccggggcga gaccataggc gatctcctaa atcaatagta gctgtaacct 8640 cgaagcgttt cacttgtaac aacgattgag aatttttgtc ataaaattga aatacttggt 8700 tcgcattttt gtcatccgcg gtcagccgca attctgacga actgcccatt tagctggaga 8760 tgattgtaca tccttcacgt gaaaatttct caagcgctgt gaacaagggt tcagatttta 8820 gattgaaagg tgagccgttg aaacacgttc ttcttgtcga tgacgacgtc gctatgcggc 8880 atcttattat tgaatacctt acgatccacg ccttcaaagt gaccgcggta gccgacagca 8940 cccagttcac aagagtactc tcttccgcga cggtcgatgt cgtggttgtt gatctaaatt 9000 taggtcgtga agatgggctc gagatcgttc gtaatctggc ggcaaagtct gatattccaa 9060 tcataattat cagtggcgac cgccttgagg agacggataa agttgttgca ctcgagctag 9120 gagcaagtga ttttatcgct aagccgttca gtatcagaga gtttctagca cgcattcggg 9180 ttgccttgcg cgtgcgcccc aacgttgtcc gctccaaaga ccgacggtct ttttgtttta 9240 ctgactggac acttaatctc aggcaacgtc gcttgatgtc cgaagctggc ggtgaggtga 9300 aacttacggc aggtgagttc aatcttctcc tcgcgttttt agagaaaccc cgcgacgttc 9360 tatcgcgcga gcaacttctc attgccagtc gagtacgcga cgaggaggtt tatgacagga 9420 gtatagatgt tctcattttg aggctgcgcc gcaaacttga ggcagatccg tcaagccctc 9480 aactgataaa aacagcaaga ggtgccggtt atttctttga cgcggacgtg caggtttcgc 9540 acggggggac gatggcagcc tgagccaatt cccagatccc cgaggaatcg gcgtgagcgg 9600 tcgcaaacca tccggcccgg tacaaatcgg cgcggcgctg ggtgatgacc tggtggagaa 9660 gttgaaggcc gcgcaggccg cccagcggca acgcatcgag gcagaagcac gccccggtga 9720 atcgtggcaa gcggccgctg atcgaatccg caaagaatcc cggcaaccgc cggcagccgg 9780 tgcgccgtcg attaggaagc cgcccaaggg cgacgagcaa ccagattttt tcgttccgat 9840 gctctatgac gtgggcaccc gcgatagtcg cagcatcatg gacgtggccg ttttccgtct 9900 gtcgaagcgt gaccgacgag ctggcgaggt gatccgctac gagcttccag acgggcacgt 9960 agaggtttcc gcagggccgg ccggcatggc cagtgtgtgg gattacgacc tggtactgat 10020 ggcggtttcc catctaaccg aatccatgaa ccgataccgg gaagggaagg gagacaagcc 10080 cggccgcgtg ttccgtccac acgttgcgga cgtactcaag ttctgccggc gagccgatgg 10140 cggaaagcag aaagacgacc tggtagaaac ctgcattcgg ttaaacacca cgcacgttgc 10200 catgcagcgt acgaagaagg ccaagaacgg ccgcctggtg acggtatccg agggtgaagc 10260 cttgattagc cgctacaaga tcgtaaagag cgaaaccggg cggccggagt acatcgagat 10320 cgagctagct gattggatgt accgcgagat cacagaaggc aagaacccgg acgtgctgac 10380 ggttcacccc gattactttt tgatcgatcc cggcatcggc cgttttctct accgcctggc 10440 acgccgcgcc gcaggcaagg cagaagccag atggttgttc aagacgatct acgaacgcag 10500 tggcagcgcc ggagagttca agaagttctg tttcaccgtg cgcaagctga tcgggtcaaa 10560 tgacctgccg gagtacgatt tgaaggagga ggcggggcag gctggcccga tcctagtcat 10620 gcgctaccgc aacctgatcg agggcgaagc atccgccggt tcctaatgta cggagcagat 10680 gctagggcaa attgccctag caggggaaaa aggtcgaaaa ggtctctttc ctgtggatag 10740 cacgtacatt gggaacccaa agccgtacat tgggaaccgg aacccgtaca ttgggaaccc 10800 aaagccgtac attgggaacc ggtcacacat gtaagtgact gatataaaag agaaaaaagg 10860 cgatttttcc gcctaaaact ctttaaaact tattaaaact cttaaaaccc gcctggcctg 10920 tgcataactg tctggccagc gcacagccga agagctgcaa aaagcgccta cccttcggtc 10980 gctgcgctcc ctacgccccg ccgcttcgcg tcggcctatc gcggccgctg gccgctcaaa 11040 aatggctggc ctacggccag gcaatctacc agggcgcgga caagccgcgc cgtcgccact 11100 cgaccgccgg cgctgaggtc tgcctcgtga agaaggtgtt gctgactcat accaggcctg 11160 aatcgcccca tcatccagcc agaaagtgag ggagccacgg ttgatgagag ctttgttgta 11220 ggtggaccag ttggtgattt tgaacttttg ctttgccacg gaacggtctg cgttgtcggg 11280 aagatgcgtg atctgatcct tcaactcagc aaaagttcga tttattcaac aaagccgccg 11340 tcccgtcaag tcagcgtaat gctctgccag tgttacaacc aattaaccaa ttctgattag 11400 aaaaactcat cgagcatcaa atgaaactgc aatttattca tatcaggatt atcaatacca 11460 tatttttgaa aaagccgttt ctgtaatgaa ggagaaaact caccgaggca gttccatagg 11520 atggcaagat cctggtatcg gtctgcgatt ccgactcgtc caacatcaat acaacctatt 11580 aatttcccct cgtcaaaaat aaggttatca agtgagaaat caccatgagt gacgactgaa 11640 tccggtgaga atggcaaaag ctctgcatta atgaatcggc caacgcgcgg ggagaggcgg 11700 tttgcgtatt gggcgctctt ccgcttcctc gctcactgac tcgctgcgct cggtcgttcg 11760 gctgcggcga gcggtatcag ctcactcaaa ggcggtaata cggttatcca cagaatcagg 11820 ggataacgca ggaaagaaca tgtgagcaaa aggccagcaa aaggccagga accgtaaaaa 11880 ggccgcgttg ctggcgtttt tccataggct ccgcccccct gacgagcatc acaaaaatcg 11940 acgctcaagt cagaggtggc gaaacccgac aggactataa agataccagg cgtttccccc 12000 tggaagctcc ctcgtgcgct ctcctgttcc gaccctgccg cttaccggat acctgtccgc 12060 ctttctccct tcgggaagcg tggcgctttc tcatagctca cgctgtaggt atctcagttc 12120 ggtgtaggtc gttcgctcca agctgggctg tgtgcacgaa ccccccgttc agcccgaccg 12180 ctgcgcctta tccggtaact atcgtcttga gtccaacccg gtaagacacg acttatcgcc 12240 actggcagca gccactggta acaggattag cagagcgagg tatgtaggcg gtgctacaga 12300 gttcttgaag tggtggccta actacggcta cactagaaga acagtatttg gtatctgcgc 12360 tctgctgaag ccagttacct tcggaaaaag agttggtagc tcttgatccg gcaaacaaac 12420 caccgctggt agcggtggtt tttttgtttg caagcagcag attacgcgca gaaaaaaagg 12480 atctcaagaa gatcctttga tcttttctac ggggtctgac gctcagtgga acgaaaactc 12540 acgttaaggg attttggtca tgagattatc aaaaaggatc ttcacctaga tccttttgat 12600 ccggaattaa ttcctgtggt tggcatgcac atacaaatgg acgaacggat aaaccttttc 12660 acgccctttt aaatatccga ttattctaat aaacgctctt ttctcttagg tttacccgcc 12720 aatatatcct gtcaaacact gatagtttaa actgaaggcg ggaaacgaca atctgatcat 12780 gagcggagaa ttaagggagt cacgttatga cccccgccga tgacgcggga caagccgttt 12840 tacgtttgga actgacagaa ccgcaacgct gcaggaattg gccgcagcgg ccatttaaat 12900 caattgggcg cgccgaattc gagctcggta caagcttgca catgacaaca attgtaagag 12960 gatggagacc acaacgatcc aacaatactt ctgcgacggg ctgtgaagta tagagaagtt 13020 aaacgcccaa aagccattgt gtttggaatt tttagttatt ctatttttca tgatgtatct 13080 tcctctaaca tgccttaatt tgcaaatttg gtataactac tgattgaaaa tatatgtatg 13140 taaaaaaata ctaagcatat ttgtgaagct aaacatgatg ttatttaaga aaatatgttg 13200 ttaacagaat aagattaata tcgaaatgga aacatctgta aattagaatc atcttacaag 13260 ctaagagatg ttcacgcttt gagaaacttc ttcagatcat gaccgtagaa gtagctctcc 13320 aagactcaac gaaggctgct gcaattccac aaatgcatga catgcatcct tgtaaccgtc 13380 gtcgccgcta taaacacgga taactcaatt ccctgctcca tcaatttaga aatgagcaag 13440 caagcacccg atcgctcacc ccatatgcac caatctgact cccaagtctc tgtttcgcat 13500 tagtaccgcc agcactccac ctatagctac caattgagac ctttccagcc taagcagatc 13560 gattgatcgt tagagtcaaa gagttggtgg tacgggtact ttaactacca tggaatgatg 13620 gggcgtgatg tagagcggaa agcgcctccc tacgcggaac aacaccctcg ccatgccgct 13680 cgactacagc ctcctcctcg tcggccgccc acaacgaggg agcccgtggt cgcagccacc 13740 gaccagcatg tctctgtgtc ctcgtccgac ctcgacatgt catggcaaac agtcggacgc 13800 cagcaccaga ctgacgacat gagtctctga agagcccgcc acctagaaag atccgagccc 13860 tgctgctggt agtggtaacc attttcgtcg cgctgacgcg gagagcgaga ggccagaaat 13920 ttatagcgac tgacgctgtg gcaggcacgc tatcggaggt tacgacgtgg cgggtcactc 13980 gacgcggagt tcacaggtcc tatccttgca tcgctcgggc cggagtttac gggacttatc 14040 cttacgacgt gctctaaggt tgcgataacg ggcggaggaa ggcgtgtggc gtgcggagac 14100 ggtttataca cgtagtgtgc gggagtgtgt ttcgtagacg cgggaaagca cgacgactta 14160 cgaaggttag tggaggagga ggacacacta aaatcaggac gcaagaaact cttctattat 14220 agtagtagag aagagattat aggagtgtgg gttgattcta aagaaaatcg acgcaggaca 14280 accgtcaaaa cgggtgcttt aatatagtag atatatatat atagagagag agagaaagta 14340 caaaggatgc atttgtgtct gcatatgatc ggagtattac taacggccgt cgtaagaagg 14400 tccatcatgc gtggagcgag cccatttggt tggttgtcag gccgcagtta aggcctccat 14460 atatgattgt cgtcgggccc ataacagcat ctcctccacc agtttattgt aagaataaat 14520 taagtagaga tatttgtcgt cgggcagaag aaacttggac aagaagaaga agcaagctag 14580 gccaatttct tgccggcaag aggaagatag tggcctctag tttatatatc ggcgtgatga 14640 tgatgctcct agctagaaat gagagaagaa aaacggacgc gtgtttggtg tgtgtcaatg 14700 gcgtccatcc ttccatcaga tcagaacgat gaaaaagtca agcacggcat gcatagtata 14760 tgtatagctt gttttagtgt ggctttgctg agacgaatga aagcaacggc gggcatattt 14820 ttcagtggct gtagctttca ggctgaaaga gacgtggcat gcaataattc agggaattcg 14880 tcagccaatt gaggtagcta gtcaacttgt acattggtgc gagcaatttt ccgcactcag 14940 gagggctagt ttgagagtcc aaaaactata ggagattaaa gaggctaaaa tcctctcctt 15000 atttaatttt aaataagtag tgtatttgta ttttaactcc tccaaccctt ccgattttat 15060 ggctctcaaa ctagcattca gtctaatgca tgcatgcttg gctagaggtc gtatggggtt 15120 gttaatagca tagctagcta caagttaacc gggtctttta tatttaataa ggacaggcaa 15180 agtattactt acaaataaag aataaagcta ggacgaactc gtggattatt actaaatcga 15240 aatggacgta atattccagg caagaataat tgttcgatca ggagacaagt ggggcattgg 15300 accggttctt gcaagcaaga gcctatggcg tggtgacacg gcgcgttgcc catacatcat 15360 gcctccatcg atgatccatc ctcacttgct ataaaaagag gtgtccatgg tgctcaagct 15420 cagccaagca aataagacga cttgtttcat tgattcttca agagatcgag cttcttttgc 15480 accacaaggt cgaggatcca aca 15503 <210> 15 <211> 14946 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1313 <220> <221> misc_feature <222> (12)..(1993) <223> Zm Ubi promoter <220> <221> misc_feature <222> (2016)..(5597) <223> synthetic nucleotide sequence encoding the toxin portion of H04 plus a full-length Cry1Ab tail portion <220> <221> misc_feature <222> (5805)..(7786) <223> Zm Ubi promoter <220> <221> misc_feature <222> (7883)..(8986) <223> PMI <400> 15 aagcttgcat gcctgcagtg cagcgtgacc cggtcgtgcc cctctctaga gataatgagc 60 attgcatgtc taagttataa aaaattacca catatttttt ttgtcacact tgtttgaagt 120 gcagtttatc tatctttata catatattta aactttactc tacgaataat ataatctata 180 gtactacaat aatatcagtg ttttagagaa tcatataaat gaacagttag acatggtcta 240 aaggacaatt gagtattttg acaacaggac tctacagttt tatcttttta gtgtgcatgt 300 gttctccttt ttttttgcaa atagcttcac ctatataata cttcatccat tttattagta 360 catccattta gggtttaggg ttaatggttt ttatagacta atttttttag tacatctatt 420 ttattctatt ttagcctcta aattaagaaa actaaaactc tattttagtt tttttattta 480 ataatttaga tataaaatag aataaaataa agtgactaaa aattaaacaa atacccttta 540 agaaattaaa aaaactaagg aaacattttt cttgtttcga gtagataatg ccagcctgtt 600 aaacgccgtc gacgagtcta acggacacca accagcgaac cagcagcgtc gcgtcgggcc 660 aagcgaagca gacggcacgg catctctgtc gctgcctctg gacccctctc gagagttccg 720 ctccaccgtt ggacttgctc cgctgtcggc atccagaaat tgcgtggcgg agcggcagac 780 gtgagccggc acggcaggcg gcctcctcct cctctcacgg caccggcagc tacgggggat 840 tcctttccca ccgctccttc gctttccctt cctcgcccgc cgtaataaat agacaccccc 900 tccacaccct ctttccccaa cctcgtgttg ttcggagcgc acacacacac aaccagatct 960 cccccaaatc cacccgtcgg cacctccgct tcaaggtacg ccgctcgtcc tccccccccc 1020 cccctctcta ccttctctag atcggcgttc cggtccatgg ttagggcccg gtagttctac 1080 ttctgttcat gtttgtgtta gatccgtgtt tgtgttagat ccgtgctgct agcgttcgta 1140 cacggatgcg acctgtacgt cagacacgtt ctgattgcta acttgccagt gtttctcttt 1200 ggggaatcct gggatggctc tagccgttcc gcagacggga tcgatttcat gatttttttt 1260 gtttcgttgc atagggtttg gtttgccctt ttcctttatt tcaatatatg ccgtgcactt 1320 gtttgtcggg tcatcttttc atgctttttt ttgtcttggt tgtgatgatg tggtctggtt 1380 gggcggtcgt tctagatcgg agtagaattc tgtttcaaac tacctggtgg atttattaat 1440 tttggatctg tatgtgtgtg ccatacatat tcatagttac gaattgaaga tgatggatgg 1500 aaatatcgat ctaggatagg tatacatgtt gatgcgggtt ttactgatgc atatacagag 1560 atgctttttg ttcgcttggt tgtgatgatg tggtgtggtt gggcggtcgt tcattcgttc 1620 tagatcggag tagaatactg tttcaaacta cctggtgtat ttattaattt tggaactgta 1680 tgtgtgtgtc atacatcttc atagttacga gtttaagatg gatggaaata tcgatctagg 1740 ataggtatac atgttgatgt gggttttact gatgcatata catgatggca tatgcagcat 1800 ctattcatat gctctaacct tgagtaccta tctattataa taaacaagta tgttttataa 1860 ttattttgat cttgatatac ttggatgatg gcatatgcag cagctatatg tggatttttt 1920 tagccctgcc ttcatacgct atttatttgc ttggtactgt ttcttttgtc gatgctcacc 1980 ctgttgtttg gtgttacttc tgcagggatc caacaatgga caacaacccc aacatcaacg 2040 agtgcatccc ctacaactgc ctgagcaacc ccgaggtgga ggtgctgggc ggcgagcgca 2100 tcgagaccgg ctacaccccc atcgacatca gcctgagcct gacccagttc ctgctgagcg 2160 agttcgtgcc cggcgccggc ttcgtgctgg gcctggtgga catcatctgg ggcatcttcg 2220 gccccagcca gtgggacgcc ttcctggtgc agatcgagca gttgataaac caacgcatag 2280 aggaattcgc ccgcaaccag gccatcagcc gcctggaggg cctgagcaac ctgtaccaaa 2340 tctacgccga gagcttccgc gagtgggagg ccgaccccac caaccccgcc ctgcgcgagg 2400 agatgcgcat ccagttcaac gacatgaaca gcgccctgac caccgccatc cccctgttcg 2460 ccgtgcagaa ctaccaggtg cccctgctga gcgtgtacgt gcaggccgcc aacctgcacc 2520 tgagcgtgct gcgcgacgtc agcgtgttcg gccagcgctg gggcttcgac gccgccacca 2580 tcaacagccg ctacaacgac ctgacccgcc tgatcggcaa ctacaccgac cacgccgtgc 2640 gctggtacaa caccggcctg gagcgcgtgt ggggtcccga cagccgcgac tggatcaggt 2700 acaaccagtt ccgccgcgag ctgaccctga ccgtgctgga catcgtgagc ctgttcccca 2760 actacgacag ccgcacctac cccatccgca ccgtgagcca gctgacccgc gagatttaca 2820 ccaaccccgt gctggagaac ttcgacggca gcttccgcgg cagcgcccag ggcatcgagg 2880 gcagcatccg cagcccccac ctgatggaca tcctgaacag catcaccatc tacaccgacg 2940 cccaccgcgg cgagtactac tggagcggcc accagatcat ggccagcccc gtcggcttca 3000 gcggccccga gttcaccttc cccctgtacg gcaccatggg caacgctgca cctcagcagc 3060 gcatcgtggc acagctgggc cagggagtgt accgcaccct gagcagcacc ctgtaccgtc 3120 gacctttcaa catcggcatc aacaaccagc agctgagcgt gctggacggc accgagttcg 3180 cctacggcac cagcagcaac ctgcccagcg ccgtgtaccg caagagcggc accgtggaca 3240 gcctggacga gatcccccct cagaacaaca acgtgccacc tcgacagggc ttcagccacc 3300 gtctgagcca cgtgagcatg ttccgcagtg gcttcagcaa cagcagcgtg agcatcatcc 3360 gtgcacccat gttcagctgg attcaccgca gcgccaccct gaccaacacc atcgaccccg 3420 agcgcatcaa ccagatcccc ctggtgaagg gcttccgggt gtggggcggc accagcgtga 3480 tcaccggccc cggcttcacc ggaggcgaca tcctgcgcag aaacaccttc ggcgacttcg 3540 tgagcctgca ggtgaacatc aacagcccca tcacccagcg ttaccgcctg cgcttccgct 3600 acgccagcag ccgcgacgcc cgtgtgatcg tgctgactgg cgccgctagc accggtgtgg 3660 gcggtcaggt gagcgtgaac atgcccctgc agaagactat ggagatcggc gagaacctga 3720 ctagtcgcac cttccgctac accgacttca gcaacccctt cagcttccgc gccaaccccg 3780 acatcatcgg catcagcgag cagcccctgt tcggtgccgg cagcatcagc agcggcgagc 3840 tgtacatcga caagatcgag atcatcctgg ccgacgccac cttcgaggcc gagagcgacc 3900 tggagcgcgc ccagaaggcc gtgaacgccc tgttcaccag cagcaaccag atcggcctga 3960 agaccgacgt gaccgactac cacatcgacc aggtgagcaa cctggtggac tgcttaagcg 4020 acgagttctg cctggacgag aagaaggagc tgagcgagaa ggtgaagcac gccaagcgcc 4080 tgagcgacga gcgcaacctg ctgcaggacc ccaacttccg cggcatcaac cgccagctgg 4140 accgcggctg gcgaggcagc accgatatca ccatccaggg cggcgacgac gtgttcaagg 4200 agaactacgt gaccctgcag ggcaccttcg acgagtgcta ccccacctac ctgtaccagc 4260 cgatcgacga gagcaagctg aaggcctaca cccgctacca gctgcgcggc tacatcgagg 4320 acagccagga cctggaaatc tacctgatcc gctacaacgc gaagcacgag accgtgaacg 4380 tgcccggcac cggcagcctg tggcccctga gcgcccccag ccccatcggc aagtgcgggg 4440 agccgaatcg atgcgctccg cacctggagt ggaacccgga cctagactgc agctgcaggg 4500 acggggagaa gtgcgcccac cacagccacc acttcagcct ggacatcgac gtgggctgca 4560 ccgacctgaa cgaggacctg ggcgtgtggg tgatcttcaa gatcaagacc caggacggcc 4620 acgcccgcct gggcaatcta gagttcctgg aggagaagcc cctggtgggc gaggccctgg 4680 cccgcgtgaa gcgtgctgag aagaagtggc gcgacaagcg cgagaagctg gagtgggaga 4740 ccaacatcgt gtacaaggag gccaaggaga gcgtggacgc cctgttcgtg aacagccagt 4800 acgaccgcct gcaggccgac accaacatcg ccatgatcca cgccgccgac aagcgcgtgc 4860 acagcattcg cgaggcctac ctgcccgagc tgagcgtgat ccccggtgtg aacgccgcca 4920 tcttcgagga actcgagggc cgcatcttca ccgccttcag cctgtacgac gcccgcaacg 4980 tgatcaagaa cggcgacttc aacaacggcc tgagctgctg gaacgtgaag ggccacgtgg 5040 acgtggagga gcagaacaac caccgcagcg tgctggtggt gcccgagtgg gaggccgagg 5100 tgagccagga ggtgcgcgtg tgccccggcc gcggctacat cctgcgcgtg accgcctaca 5160 aggagggcta cggcgagggc tgcgtgacca tccacgagat cgagaacaac accgacgagc 5220 tcaagttcag caactgcgtg gaggaggagg tttaccccaa caacaccgtg acctgcaacg 5280 actacaccgc gacccaggag gagtacgaag gcacctacac ctctcgcaac aggggttacg 5340 acggcgccta cgagtccaac agctccgtgc cagctgacta cgccagcgcc tacgaggaga 5400 aagcctacac cgacggtaga cgcgacaacc catgtgagag caacagaggc tacggcgact 5460 acacccccct gcccgctgga tacgtgacca aggagctgga gtacttcccc gagaccgaca 5520 aggtgtggat cgagattggc gagaccgagg gcaccttcat cgtggacagc gtggagctgc 5580 tgctgatgga ggagtagtag atctgttctg cacaaagtgg agtagtcagt catcgatcag 5640 gaaccagaca ccagactttt attcatacag tgaagtgaag tgaagtgcag tgcagtgagt 5700 tgctggtttt tgtacaactt agtatgtatt tgtatttgta aaatacttct atcaataaaa 5760 tttctaattc ctaaaaccaa aatccagggg taccagcttg catgcctgca gtgcagcgtg 5820 acccggtcgt gcccctctct agagataatg agcattgcat gtctaagtta taaaaaatta 5880 ccacatattt tttttgtcac acttgtttga agtgcagttt atctatcttt atacatatat 5940 ttaaacttta ctctacgaat aatataatct atagtactac aataatatca gtgttttaga 6000 gaatcatata aatgaacagt tagacatggt ctaaaggaca attgagtatt ttgacaacag 6060 gactctacag ttttatcttt ttagtgtgca tgtgttctcc tttttttttg caaatagctt 6120 cacctatata atacttcatc cattttatta gtacatccat ttagggttta gggttaatgg 6180 tttttataga ctaatttttt tagtacatct attttattct attttagcct ctaaattaag 6240 aaaactaaaa ctctatttta gtttttttat ttaataattt agatataaaa tagaataaaa 6300 taaagtgact aaaaattaaa caaataccct ttaagaaatt aaaaaaacta aggaaacatt 6360 tttcttgttt cgagtagata atgccagcct gttaaacgcc gtcgacgagt ctaacggaca 6420 ccaaccagcg aaccagcagc gtcgcgtcgg gccaagcgaa gcagacggca cggcatctct 6480 gtcgctgcct ctggacccct ctcgagagtt ccgctccacc gttggacttg ctccgctgtc 6540 ggcatccaga aattgcgtgg cggagcggca gacgtgagcc ggcacggcag gcggcctcct 6600 cctcctctca cggcaccggc agctacgggg gattcctttc ccaccgctcc ttcgctttcc 6660 cttcctcgcc cgccgtaata aatagacacc ccctccacac cctctttccc caacctcgtg 6720 ttgttcggag cgcacacaca cacaaccaga tctcccccaa atccacccgt cggcacctcc 6780 gcttcaaggt acgccgctcg tcctcccccc ccccccctct ctaccttctc tagatcggcg 6840 ttccggtcca tggttagggc ccggtagttc tacttctgtt catgtttgtg ttagatccgt 6900 gtttgtgtta gatccgtgct gctagcgttc gtacacggat gcgacctgta cgtcagacac 6960 gttctgattg ctaacttgcc agtgtttctc tttggggaat cctgggatgg ctctagccgt 7020 tccgcagacg ggatcgattt catgattttt tttgtttcgt tgcatagggt ttggtttgcc 7080 cttttccttt atttcaatat atgccgtgca cttgtttgtc gggtcatctt ttcatgcttt 7140 tttttgtctt ggttgtgatg atgtggtctg gttgggcggt cgttctagat cggagtagaa 7200 ttctgtttca aactacctgg tggatttatt aattttggat ctgtatgtgt gtgccataca 7260 tattcatagt tacgaattga agatgatgga tggaaatatc gatctaggat aggtatacat 7320 gttgatgcgg gttttactga tgcatataca gagatgcttt ttgttcgctt ggttgtgatg 7380 atgtggtgtg gttgggcggt cgttcattcg ttctagatcg gagtagaata ctgtttcaaa 7440 ctacctggtg tatttattaa ttttggaact gtatgtgtgt gtcatacatc ttcatagtta 7500 cgagtttaag atggatggaa atatcgatct aggataggta tacatgttga tgtgggtttt 7560 actgatgcat atacatgatg gcatatgcag catctattca tatgctctaa ccttgagtac 7620 ctatctatta taataaacaa gtatgtttta taattatttt gatcttgata tacttggatg 7680 atggcatatg cagcagctat atgtggattt ttttagccct gccttcatac gctatttatt 7740 tgcttggtac tgtttctttt gtcgatgctc accctgttgt ttggtgttac ttctgcaggg 7800 atccccgatc atgcaaaaac tcattaactc agtgcaaaac tatgcctggg gcagcaaaac 7860 ggcgttgact gaactttatg gtatggaaaa tccgtccagc cagccgatgg ccgagctgtg 7920 gatgggcgca catccgaaaa gcagttcacg agtgcagaat gccgccggag atatcgtttc 7980 actgcgtgat gtgattgaga gtgataaatc gactctgctc ggagaggccg ttgccaaacg 8040 ctttggcgaa ctgcctttcc tgttcaaagt attatgcgca gcacagccac tctccattca 8100 ggttcatcca aacaaacaca attctgaaat cggttttgcc aaagaaaatg ccgcaggtat 8160 cccgatggat gccgccgagc gtaactataa agatcctaac cacaagccgg agctggtttt 8220 tgcgctgacg cctttccttg cgatgaacgc gtttcgtgaa ttttccgaga ttgtctccct 8280 actccagccg gtcgcaggtg cacatccggc gattgctcac tttttacaac agcctgatgc 8340 cgaacgttta agcgaactgt tcgccagcct gttgaatatg cagggtgaag aaaaatcccg 8400 cgcgctggcg attttaaaat cggccctcga tagccagcag ggtgaaccgt ggcaaacgat 8460 tcgtttaatt tctgaatttt acccggaaga cagcggtctg ttctccccgc tattgctgaa 8520 tgtggtgaaa ttgaaccctg gcgaagcgat gttcctgttc gctgaaacac cgcacgctta 8580 cctgcaaggc gtggcgctgg aagtgatggc aaactccgat aacgtgctgc gtgcgggtct 8640 gacgcctaaa tacattgata ttccggaact ggttgccaat gtgaaattcg aagccaaacc 8700 ggctaaccag ttgttgaccc agccggtgaa acaaggtgca gaactggact tcccgattcc 8760 agtggatgat tttgccttct cgctgcatga ccttagtgat aaagaaacca ccattagcca 8820 gcagagtgcc gccattttgt tctgcgtcga aggcgatgca acgttgtgga aaggttctca 8880 gcagttacag cttaaaccgg gtgaatcagc gtttattgcc gccaacgaat caccggtgac 8940 tgtcaaaggc cacggccgtt tagcgcgtgt ttacaacaag ctgtaagagc ttactgaaaa 9000 aattaacatc tcttgctaag ctgggagctc gatccgtcga cctgcagatc gttcaaacat 9060 ttggcaataa agtttcttaa gattgaatcc tgttgccggt cttgcgatga ttatcatata 9120 atttctgttg aattacgtta agcatgtaat aattaacatg taatgcatga cgttatttat 9180 gagatgggtt tttatgatta gagtcccgca attatacatt taatacgcga tagaaaacaa 9240 aatatagcgc gcaaactagg ataaattatc gcgcgcggtg tcatctatgt tactagatct 9300 gctagccctg caggaaattt accggtgccc gggcggccag catggccgta tccgcaatgt 9360 gttattaagt tgtctaagcg tcaatttgtt tacaccacaa tatatcctgc caccagccag 9420 ccaacagctc cccgaccggc agctcggcac aaaatcacca ctcgatacag gcagcccatc 9480 agaattaatt ctcatgtttg acagcttatc atcgactgca cggtgcacca atgcttctgg 9540 cgtcaggcag ccatcggaag ctgtggtatg gctgtgcagg tcgtaaatca ctgcataatt 9600 cgtgtcgctc aaggcgcact cccgttctgg ataatgtttt ttgcgccgac atcataacgg 9660 ttctggcaaa tattctgaaa tgagctgttg acaattaatc atccggctcg tataatgtgt 9720 ggaattgtga gcggataaca atttcacaca ggaaacagac catgagggaa gcgttgatcg 9780 ccgaagtatc gactcaacta tcagaggtag ttggcgtcat cgagcgccat ctcgaaccga 9840 cgttgctggc cgtacatttg tacggctccg cagtggatgg cggcctgaag ccacacagtg 9900 atattgattt gctggttacg gtgaccgtaa ggcttgatga aacaacgcgg cgagctttga 9960 tcaacgacct tttggaaact tcggcttccc ctggagagag cgagattctc cgcgctgtag 10020 aagtcaccat tgttgtgcac gacgacatca ttccgtggcg ttatccagct aagcgcgaac 10080 tgcaatttgg agaatggcag cgcaatgaca ttcttgcagg tatcttcgag ccagccacga 10140 tcgacattga tctggctatc ttgctgacaa aagcaagaga acatagcgtt gccttggtag 10200 gtccagcggc ggaggaactc tttgatccgg ttcctgaaca ggatctattt gaggcgctaa 10260 atgaaacctt aacgctatgg aactcgccgc ccgactgggc tggcgatgag cgaaatgtag 10320 tgcttacgtt gtcccgcatt tggtacagcg cagtaaccgg caaaatcgcg ccgaaggatg 10380 tcgctgccga ctgggcaatg gagcgcctgc cggcccagta tcagcccgtc atacttgaag 10440 ctaggcaggc ttatcttgga caagaagatc gcttggcctc gcgcgcagat cagttggaag 10500 aatttgttca ctacgtgaaa ggcgagatca ccaaagtagt cggcaaataa agctctagtg 10560 gatctccgta cccccggggg atctggctcg cggcggacgc acgacgccgg ggcgagacca 10620 taggcgatct cctaaatcaa tagtagctgt aacctcgaag cgtttcactt gtaacaacga 10680 ttgagaattt ttgtcataaa attgaaatac ttggttcgca tttttgtcat ccgcggtcag 10740 ccgcaattct gacgaactgc ccatttagct ggagatgatt gtacatcctt cacgtgaaaa 10800 tttctcaagc gctgtgaaca agggttcaga ttttagattg aaaggtgagc cgttgaaaca 10860 cgttcttctt gtcgatgacg acgtcgctat gcggcatctt attattgaat accttacgat 10920 ccacgccttc aaagtgaccg cggtagccga cagcacccag ttcacaagag tactctcttc 10980 cgcgacggtc gatgtcgtgg ttgttgatct aaatttaggt cgtgaagatg ggctcgagat 11040 cgttcgtaat ctggcggcaa agtctgatat tccaatcata attatcagtg gcgaccgcct 11100 tgaggagacg gataaagttg ttgcactcga gctaggagca agtgatttta tcgctaagcc 11160 gttcagtatc agagagtttc tagcacgcat tcgggttgcc ttgcgcgtgc gccccaacgt 11220 tgtccgctcc aaagaccgac ggtctttttg ttttactgac tggacactta atctcaggca 11280 acgtcgcttg atgtccgaag ctggcggtga ggtgaaactt acggcaggtg agttcaatct 11340 tctcctcgcg tttttagaga aaccccgcga cgttctatcg cgcgagcaac ttctcattgc 11400 cagtcgagta cgcgacgagg aggtttatga caggagtata gatgttctca ttttgaggct 11460 gcgccgcaaa cttgaggcag atccgtcaag ccctcaactg ataaaaacag caagaggtgc 11520 cggttatttc tttgacgcgg acgtgcaggt ttcgcacggg gggacgatgg cagcctgagc 11580 caattcccag atccccgagg aatcggcgtg agcggtcgca aaccatccgg cccggtacaa 11640 atcggcgcgg cgctgggtga tgacctggtg gagaagttga aggccgcgca ggccgcccag 11700 cggcaacgca tcgaggcaga agcacgcccc ggtgaatcgt ggcaagcggc cgctgatcga 11760 atccgcaaag aatcccggca accgccggca gccggtgcgc cgtcgattag gaagccgccc 11820 aagggcgacg agcaaccaga ttttttcgtt ccgatgctct atgacgtggg cacccgcgat 11880 agtcgcagca tcatggacgt ggccgttttc cgtctgtcga agcgtgaccg acgagctggc 11940 gaggtgatcc gctacgagct tccagacggg cacgtagagg tttccgcagg gccggccggc 12000 atggccagtg tgtgggatta cgacctggta ctgatggcgg tttcccatct aaccgaatcc 12060 atgaaccgat accgggaagg gaagggagac aagcccggcc gcgtgttccg tccacacgtt 12120 gcggacgtac tcaagttctg ccggcgagcc gatggcggaa agcagaaaga cgacctggta 12180 gaaacctgca ttcggttaaa caccacgcac gttgccatgc agcgtacgaa gaaggccaag 12240 aacggccgcc tggtgacggt atccgagggt gaagccttga ttagccgcta caagatcgta 12300 aagagcgaaa ccgggcggcc ggagtacatc gagatcgagc tagctgattg gatgtaccgc 12360 gagatcacag aaggcaagaa cccggacgtg ctgacggttc accccgatta ctttttgatc 12420 gatcccggca tcggccgttt tctctaccgc ctggcacgcc gcgccgcagg caaggcagaa 12480 gccagatggt tgttcaagac gatctacgaa cgcagtggca gcgccggaga gttcaagaag 12540 ttctgtttca ccgtgcgcaa gctgatcggg tcaaatgacc tgccggagta cgatttgaag 12600 gaggaggcgg ggcaggctgg cccgatccta gtcatgcgct accgcaacct gatcgagggc 12660 gaagcatccg ccggttccta atgtacggag cagatgctag ggcaaattgc cctagcaggg 12720 gaaaaaggtc gaaaaggtct ctttcctgtg gatagcacgt acattgggaa cccaaagccg 12780 tacattggga accggaaccc gtacattggg aacccaaagc cgtacattgg gaaccggtca 12840 cacatgtaag tgactgatat aaaagagaaa aaaggcgatt tttccgccta aaactcttta 12900 aaacttatta aaactcttaa aacccgcctg gcctgtgcat aactgtctgg ccagcgcaca 12960 gccgaagagc tgcaaaaagc gcctaccctt cggtcgctgc gctccctacg ccccgccgct 13020 tcgcgtcggc ctatcgcggc cgctggccgc tcaaaaatgg ctggcctacg gccaggcaat 13080 ctaccagggc gcggacaagc cgcgccgtcg ccactcgacc gccggcgctg aggtctgcct 13140 cgtgaagaag gtgttgctga ctcataccag gcctgaatcg ccccatcatc cagccagaaa 13200 gtgagggagc cacggttgat gagagctttg ttgtaggtgg accagttggt gattttgaac 13260 ttttgctttg ccacggaacg gtctgcgttg tcgggaagat gcgtgatctg atccttcaac 13320 tcagcaaaag ttcgatttat tcaacaaagc cgccgtcccg tcaagtcagc gtaatgctct 13380 gccagtgtta caaccaatta accaattctg attagaaaaa ctcatcgagc atcaaatgaa 13440 actgcaattt attcatatca ggattatcaa taccatattt ttgaaaaagc cgtttctgta 13500 atgaaggaga aaactcaccg aggcagttcc ataggatggc aagatcctgg tatcggtctg 13560 cgattccgac tcgtccaaca tcaatacaac ctattaattt cccctcgtca aaaataaggt 13620 tatcaagtga gaaatcacca tgagtgacga ctgaatccgg tgagaatggc aaaagctctg 13680 cattaatgaa tcggccaacg cgcggggaga ggcggtttgc gtattgggcg ctcttccgct 13740 tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt atcagctcac 13800 tcaaaggcgg taatacggtt atccacagaa tcaggggata acgcaggaaa gaacatgtga 13860 gcaaaaggcc agcaaaaggc caggaaccgt aaaaaggccg cgttgctggc gtttttccat 13920 aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag gtggcgaaac 13980 ccgacaggac tataaagata ccaggcgttt ccccctggaa gctccctcgt gcgctctcct 14040 gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg aagcgtggcg 14100 ctttctcata gctcacgctg taggtatctc agttcggtgt aggtcgttcg ctccaagctg 14160 ggctgtgtgc acgaaccccc cgttcagccc gaccgctgcg ccttatccgg taactatcgt 14220 cttgagtcca acccggtaag acacgactta tcgccactgg cagcagccac tggtaacagg 14280 attagcagag cgaggtatgt aggcggtgct acagagttct tgaagtggtg gcctaactac 14340 ggctacacta gaagaacagt atttggtatc tgcgctctgc tgaagccagt taccttcgga 14400 aaaagagttg gtagctcttg atccggcaaa caaaccaccg ctggtagcgg tggttttttt 14460 gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc tttgatcttt 14520 tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt ggtcatgaga 14580 ttatcaaaaa ggatcttcac ctagatcctt ttgatccgga attaattcct gtggttggca 14640 tgcacataca aatggacgaa cggataaacc ttttcacgcc cttttaaata tccgattatt 14700 ctaataaacg ctcttttctc ttaggtttac ccgccaatat atcctgtcaa acactgatag 14760 tttaaactga aggcgggaaa cgacaatctg atcatgagcg gagaattaag ggagtcacgt 14820 tatgaccccc gccgatgacg cgggacaagc cgttttacgt ttggaactga cagaaccgca 14880 acgctgcagg aattggccgc agcggccatt taaatcaatt gggcgcgccg aattcgagct 14940 cggtac 14946 <210> 16 <211> 14603 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1435 <220> <221> misc_feature <222> (1)..(2007) <223> synthetic nucleotide sequence encoding the toxin portion of H04 plus the first 40 amino acids of the Cry1Ab tail <220> <221> misc_feature <222> Complement((8814)..(10022)) <223> PMI <220> <221> misc_feature <222> (11142)..(12032) <223> Maize ubiquitin promoter <220> <221> misc_feature <222> (12037)..(14594) <223> MTL promoter <400> 16 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgcgcccaga aggccgtgaa cgccctgttc 1920 accagcagca accagatcgg cctgaagacc gacgtgaccg actaccacat cgaccaggtg 1980 agcaacctgg tggactgctt aagctagaga tctgttctgc acaaagtgga gtagtcagtc 2040 atcgatcagg aaccagacac cagactttta ttcatacagt gaagtgaagt gaagtgcagt 2100 gcagtgagtt gctggttttt gtaccactta gtatgtattt gtatttgtaa aatacttcta 2160 tcaataaaat ttctaattcc taaaaccaaa atccagtggg taccagcttg ggctgagtgg 2220 ctccttcaac gttgcggttc tgtcagttcc aaacgtaaaa cggcttgtcc cgcgtcatcg 2280 gcgggggtca taacgtgact cccttaattc tccgctcatg atcagattgt cgtttcccgc 2340 cttcagttta aactatcagt gtttgacagg atatattggc gggtaaacct aagagaaaag 2400 agcgtttatt agaataacgg atatttaaaa gggcgtgaaa aggtttatcc gttcgtccat 2460 ttgtatgtgc atgccaacca cagggttccc ctcgggagtg cttggcattc cgtacgataa 2520 tgacttctgt tcaaccaccc aaacgtcgga aagcctgacg acggagcagc attccaaaaa 2580 gatcccttgg ctcgtctggg tcggctagaa ggtcgagtgg gctgctgtgg cttgatccct 2640 caacgcggtc gcggacgtag cgcagcgccg aaaaatcctc gatcgcaaat ccgacgctgt 2700 cgaaaagcgt gatctgcttg tcgctctttc ggccgacgtc ctggccagtc atcacgcgcc 2760 aaagttccgt cacaggatga tctggcgcga gttgctggat ctcgccttca atccgggtct 2820 gtggcgggaa ctccacgaaa atatccgaac gcagcaagat cgtcgaccaa ttcttgaaga 2880 cgaaagggcc tcgtgatacg cctattttta taggttaatg tcatgataat aatggtttct 2940 tagacgtcag gtggcacttt tcggggaaat gtgcgcggaa cccctatttg tttatttttc 3000 taaatacatt caaatatgta tccgctcatg agacaataac cctgataaat gcttcaataa 3060 tattgaaaaa ggaagagtat gagtattcaa catttccgtg tcgcccttat tccctttttt 3120 gcggcatttt gccttcctgt ttttgctcac ccagaaacgc tggtgaaagt aaaagatgct 3180 gaagatcagt tgggtgcacg agtgggttac atcgaactgg atctcaacag cggtaagatc 3240 cttgagagtt ttcgccccga agaacgtttt ccaatgatga gcacttttaa agttctgcta 3300 tgtggcgcgg tattatcccg tgttgacgcc gggcaagagc aactcggtcg ccgcatacac 3360 tattctcaga atgacttggt tgagtactca ccagtcacag aaaagcatct tacggatggc 3420 atgacagtaa gagaattatg cagtgctgcc ataaccatga gtgataacac tgcggccaac 3480 ttacttctga caacgatcgg aggaccgaag gagctaaccg cttttttgca caacatgggg 3540 gatcatgtaa ctcgccttga tcgttgggaa ccggagctga atgaagccat accaaacgac 3600 gagcgtgaca ccacgatgcc tgcagggggg gggggggggg ggacatgagg ttgccccgta 3660 ttcagtgtcg ctgatttgta ttgtctgaag ttgtttttac gttaagttga tgcagatcaa 3720 ttaatacgat acctgcgtca taattgatta tttgacgtgg tttgatggcc tccacgcacg 3780 ttgtgatatg tagatgataa tcattatcac tttacgggtc ctttccggtg atccgacagg 3840 ttacggggcg gcgacctcgc gggttttcgc tatttatgaa aattttccgg tttaaggcgt 3900 ttccgttctt cttcgtcata acttaatgtt tttatttaaa ataccctctg aaaagaaagg 3960 aaacgacagg tgctgaaagc gaggcttttt ggcctctgtc gtttcctttc tctgtttttg 4020 tccgtggaat gaacaatgga agtccccccc cccccccccc cctgcagcaa tggcaacaac 4080 gttgcgcaaa ctattaactg gcgaactact tactctagct tcccggcaac aattaataga 4140 ctggatggag gcggataaag ttgcaggacc acttctgcgc tcggcccttc cggctggctg 4200 gtttattgct gataaatctg gagccggtga gcgtgggtct cgcggtatca ttgcagcact 4260 ggggccagat ggtaagccct cccgtatcgt agttatctac acgacgggga gtcaggcaac 4320 tatggatgaa cgaaatagac agatcgctga gataggtgcc tcactgatta agcattggta 4380 actgtcagac caagtttact catatatact ttagattgat ttaaaacttc atttttaatt 4440 taaaaggatc taggtgaaga tcctttttga taatctcatg accaaaatcc cttaacgtga 4500 gttttcgttc cactgagcgt cagaccccgt agaaaagatc aaaggatctt cttgagatcc 4560 tttttttctg cgcgtaatct gctgcttgca aacaaaaaaa ccaccgctac cagcggtggt 4620 ttgtttgccg gatcaagagc taccaactct ttttccgaag gtaactggct tcagcagagc 4680 gcagatacca aatactgtcc ttctagtgta gccgtagtta ggccaccact tcaagaactc 4740 tgtagcaccg cctacatacc tcgctctgct aatcctgtta ccagtggctg ctgccagtgg 4800 cgataagtcg tgtcttaccg ggttggactc aagacgatag ttaccggata aggcgcagcg 4860 gtcgggctga acggggggtt cgtgcacaca gcccagcttg gagcgaacga cctacaccga 4920 actgagatac ctacagcgtg agctatgaga aagcgccacg cttcccgaag ggagaaaggc 4980 ggacaggtat ccggtaagcg gcagggtcgg aacaggagag cgcacgaggg agcttccagg 5040 gggaaacgcc tggtatcttt atagtcctgt cgggtttcgc cacctctgac ttgagcgtcg 5100 atttttgtga tgctcgtcag gggggcggag cctatggaaa aacgccagca acgcggcctt 5160 tttacggttc ctggcctttt gctggccttt tgctcacatg ttctttcctg cgttatcccc 5220 tgattctgtg gataaccgta ttaccgcctt tgagtgagct gataccgctc gccgcagccg 5280 aacgaccgag cgcagcgagt cagtgagcga ggaagcggaa gagcgcctga tgcggtattt 5340 tctccttacg catctgtgcg gtatttcaca ccgcatatgg tgcactctca gtacaatctg 5400 ctctgatgcc gcatagttaa gccagtatac actccgctat cgctacgtga ctgggtcatg 5460 gctgcgcccc gacacccgcc aacacccgct gacgcgccct gacgggcttg tctgctcccg 5520 gcatccgctt acagacaagc tgtgaccgtc tccgggagct gcatgtgtca gaggttttca 5580 ccgtcatcac cgaaacgcgc gaggcagcag atcccccgat caagtagata cactacatat 5640 atctacaata gacatcgagc cggaaggtga tgtttacttt cctgaaatcc ccagcaattt 5700 taggccagtt tttacccaag acttcgcctc taacataaat tatagttacc aaatctggca 5760 aaagggttaa caagtggcag caacggattc gcaaacctgt cacgcctttt gtgccaaaag 5820 ccgcgccagg tttgcgatcc gctgtgccag gcgttaggcg tcatatgaag atttcggtga 5880 tccctgagca ggtggcggaa acattggatg ctgagaacca tttcattgtt cgtgaagtgt 5940 tcgatgtgca cctatccgac caaggctttg aactatctac cagaagtgtg agcccctacc 6000 ggaaggatta catctcggat gatgactctg atgaagactc tgcttgctat ggcgcattca 6060 tcgaccaaga gcttgtcggg aagattgaac tcaactcaac atggaacgat ctagcctcta 6120 tcgaacacat tgttgtgtcg cacacgcacc gaggcaaagg agtcgcgcac agtctcatcg 6180 aatttgcgaa aaagtgggca ctaagcagac agctccttgg catacgatta gagacacaaa 6240 cgaacaatgt acctgcctgc aatttgtacg caaaatgtgg ctttactctc ggcggcattg 6300 acctgttcac gtataaaact agacctcaag tctcgaacga aacagcgatg tactggtact 6360 ggttctcggg agcacaggat gacgcctaac aattcattca agccgacacc gcttcgcggc 6420 gcggcttaat tcaggagtta aacatcatga gggaagcggt gatcgccgaa gtatcgactc 6480 aactatcaga ggtagttggc gtcatcgagc gccatctcga accgacgttg ctggccgtac 6540 atttgtacgg ctccgcagtg gatggcggcc tgaagccaca cagtgatatt gatttgctgg 6600 ttacggtgac cgtaaggctt gatgaaacaa cgcggcgagc tttgatcaac gaccttttgg 6660 aaacttcggc ttcccctgga gagagcgaga ttctccgcgc tgtagaagtc accattgttg 6720 tgcacgacga catcattccg tggcgttatc cagctaagcg cgaactgcaa tttggagaat 6780 ggcagcgcaa tgacattctt gcaggtatct tcgagccagc cacgatcgac attgatctgg 6840 ctatcttgct gacaaaagca agagaacata gcgttgcctt ggtaggtcca gcggcggagg 6900 aactctttga tccggttcct gaacaggatc tatttgaggc gctaaatgaa accttaacgc 6960 tatggaactc gccgcccgac tgggctggcg atgagcgaaa tgtagtgctt acgttgtccc 7020 gcatttggta cagcgcagta accggcaaaa tcgcgccgaa ggatgtcgct gccgactggg 7080 caatggagcg cctgccggcc cagtatcagc ccgtcatact tgaagctagg caggcttatc 7140 ttggacaaga agatcgcttg gcctcgcgcg cagatcagtt ggaagaattt gttcactacg 7200 tgaaaggcga gatcaccaag gtagtcggca aataatgtct aacaattcgt tcaagccgac 7260 gccgcttcgc ggcgcggctt aactcaagcg ttagagagct ggggaagact atgcgcgatc 7320 tgttgaaggt ggttctaagc ctcgtacttg cgatggcatc ggggcaggca cttgctgacc 7380 tgccaattgt tttagtggat gaagctcgtc ttccctatga ctactcccca tccaactacg 7440 acatttctcc aagcaactac gacaactcca taagcaatta cgacaatagt ccatcaaatt 7500 acgacaactc tgagagcaac tacgataata gttcatccaa ttacgacaat agtcgcaacg 7560 gaaatcgtag gcttatatat agcgcaaatg ggtctcgcac tttcgccggc tactacgtca 7620 ttgccaacaa tgggacaacg aacttctttt ccacatctgg caaaaggatg ttctacaccc 7680 caaaaggggg gcgcggcgtc tatggcggca aagatgggag cttctgcggg gcattggtcg 7740 tcataaatgg ccaattttcg cttgccctga cagataacgg cctgaagatc atgtatctaa 7800 gcaactagcc tgctctctaa taaaatgtta ggcctcaaca tctagtcgca agctgagggg 7860 aaccactagt gtcatacgaa cctccaagag acggttacac aaacgggtac attgttgatg 7920 tcatgtatga caatcgccca agtaagtatc cagctgtgtt cagaacgtac gtccgaatta 7980 attcatcggg gtacggtcga cgatcgtcaa cgttcacttc taaagaaata gcgccactca 8040 gcttcctcag cggctttatc cagcgatttc ctattatgtc ggcatagttc tcaagatcga 8100 cagcctgtca cggttaagcg agaaatgaat aagaaggctg ataattcgga tctctgcgag 8160 ggagatgata tttgatcaca ggcagcaacg ctctgtcatc gttacaatca acatgctacc 8220 ctccgcgaga tcatccgtgt ttcaaacccg gcagcttagt tgccgttctt ccgaatagca 8280 tcggtaacat gagcaaagtc tgccgcctta caacggctct cccgctgacg ccgtcccgga 8340 ctgatgggct gcctgtatcg agtggtgatt ttgtgccgag ctgccggtcg gggagctgtt 8400 ggctggctgg tggcaggata tattgtggtg taaacaaatt gacgcttaga caacttaata 8460 acacattgcg gacgttttta atgtactgaa ttgtctagac ccggggatct catgtttgac 8520 agcttatcat cggatctagt aacatagatg acaccgcgcg cgataattta tcctagtttg 8580 cgcgctatat tttgttttct atcgcgtatt aaatgtataa ttgcgggact ctaatcataa 8640 aaacccatct cataaataac gtcatgcatt acatgttaat tattacatgc ttaacgtaat 8700 tcaacagaaa ttagatgata atcatcgcaa gaccggcaac aggattcaat cttaagaaac 8760 tttattgcca aatgtttgaa cgatctctgc aggtcgacgg atcgagctcc cagcttagca 8820 agagatgtta attttttcag taagctctta cagcttgttg taaacacgcg ctaaacggcc 8880 gtggcctttg acagtcaccg gtgattcgtt ggcggcaata aacgctgatt cacccggttt 8940 aagctgtaac tgctgagaac ctttccacaa cgttgcatcg ccttcgacgc agaacaaaat 9000 ggcggcactc tgctggctaa tggtggtttc tttatcacta aggtcatgca gcgagaaggc 9060 aaaatcatcc actggaatcg ggaagtccag ttctgcacct tgtttcaccg gctgggtcaa 9120 caactggtta gccggtttgg cttcgaattt cacattggca accagttccg gaatatcaat 9180 gtatttaggc gtcagacccg cacgcagcac gttatcggag tttgccatca cttccagcgc 9240 cacgccttgc aggtaagcgt gcggtgtttc agcgaacagg aacatcgctt cgccagggtt 9300 caatttcacc acattcagca atagcgggga gaacagaccg ctgtcttccg ggtaaaattc 9360 agaaattaaa cgaatcgttt gccacggttc accctgctgg ctatcgaggg ccgattttaa 9420 aatcgccagc gcgcgggatt tttcttcacc ctgcatattc aacaggctgg cgaacagttc 9480 gcttaaacgt tcggcatcag gctgttgtaa aaagtgagca atcgccggat gtgcacctgc 9540 gaccggctgg agtagggaga caatctcgga aaattcacga aacgcgttca tcgcaaggaa 9600 aggcgtcagc gcaaaaacca gctccggctt gtggttagga tctttatagt tacgctcggc 9660 ggcatccatc gggatacctg cggcattttc tttggcaaaa ccgatttcag aattgtgttt 9720 gtttggatga acctgaatgg agagtggctg tgctgcgcat aatactttga acaggaaagg 9780 cagttcgcca aagcgtttgg caacggcctc tccgagcaga gtcgatttat cactctcaat 9840 cacatcacgc agtgaaacga tatctccggc ggcattctgc actcgtgaac tgcttttcgg 9900 atgtgcgccc atccacagct cggccatcgg ctggctggac ggattttcca taccataaag 9960 ttcagtcaac gcgttttgct gccccaggca tagttttgca ctgagttaat gagtttttgc 10020 atgatcgggg atccctgcag aagtaacacc aaacaacagg gtgagcatcg acaaaagaaa 10080 cagtaccaag caaataaata gcgtatgaag gcagggctaa aaaaatccac atatagctgc 10140 tgcatatgcc atcatccaag tatatcaaga tcaaaataat tataaaacat acttgtttat 10200 tataatagat aggtactcaa ggttagagca tatgaataga tgctgcatat gccatcatgt 10260 atatgcatca gtaaaaccca catcaacatg tatacctatc ctagatcgat atttccatcc 10320 atcttaaact cgtaactatg aagatgtatg acacacacat acagttccaa aattaataaa 10380 tacaccaggt agtttgaaac ggcgtctact ccgatctaga acgaatgaac gaccgcccaa 10440 ccacaccaca tcatcacaac caagcgaaca aaaagcatct ctgtatatgc atcagtaaaa 10500 cccgcatcaa catgtatacc tatcctagat cgatatttcc atccatcatc ttcaattcgt 10560 aactatgaat atgtatggca cacacataca gatccaaaat taataaatcc accaggtagt 10620 ttgaaacaga attctactcc gatctagaac gaccgcccaa ccagaccaca tcatcacaac 10680 caagacaaaa aaaagcatga aaagatgacc cgacaaacaa gtgcacggca tatattgaaa 10740 taaaggaaaa gggcaaacca aaccctatgc aacgaaacaa aaaaaatcat gaaatcgatc 10800 ccgtctgcgg aacggctaga gccatcccag gattccccaa agagaaacac tggcaagtta 10860 gcaatcagaa cgtgtctgac gtacaggtcg catccgtgta cgaacgctag cagcacggat 10920 ctaacacaaa cacggatcta acacaaacat gaacagaagt agaactaccg ggccctaacc 10980 atggaccgga acgccgatct agagaaggta gagagggggg gggggggagg acgagcggcg 11040 taccttgaag cggaggtgcc gacgggtgga tttgggggag atctggttgt gtgtgtgtgc 11100 gctccgaaca acacgaggtt ggggaaagag ggtgtggagg gggtgtctat ttattacggc 11160 gggcgaggaa gggaaagcga aggagcggtg ggaaaggaat cccccgtagc tgccgtgccg 11220 tgagaggagg aggaggccgc ctgccgtgcc ggctcacgtc tgccgctccg ccacgcaatt 11280 tctggatgcc gacagcggag caagtccaac ggtggagcgg aactctcgag aggggtccag 11340 aggcagcgac agagatgccg tgccgtctgc ttcgcttggc ccgacgcgac gctgctggtt 11400 cgctggttgg tgtccgttag actcgtcgac ggcgtttaac aggctggcat tatctactcg 11460 aaacaagaaa aatgtttcct tagttttttt aatttcttaa agggtatttg tttaattttt 11520 agtcacttta ttttattcta ttttatatct aaattattaa ataaaaaaac taaaatagag 11580 ttttagtttt cttaatttag aggctaaaat agaataaaat agatgtacta aaaaaattag 11640 tctataaaaa ccattaaccc taaaccctaa atggatgtac taataaaatg gatgaagtat 11700 tatataggtg aagctatttg caaaaaaaaa ggagaacaca tgcacactaa aaagataaaa 11760 ctgtagagtc ctgttgtcaa aatactcaat tgtcctttag accatgtcta actgttcatt 11820 tatatgattc tctaaaacac tgatattatt gtagtactat agattatatt attcgtagag 11880 taaagtttaa atatatgtat aaagatagat aaactgcact tcaaacaagt gtgacaaaaa 11940 aaatatgtgg taatttttta taacttagac atgcaatgct cattatctct agagaggggc 12000 acgaccgggt cacgctgcac tgcaggcatg caagcttgca catgacaaca attgtaagag 12060 gatggagacc acaacgatcc aacaatactt ctgcgacggg ctgtgaagta tagagaagtt 12120 aaacgcccaa aagccattgt gtttggaatt tttagttatt ctatttttca tgatgtatct 12180 tcctctaaca tgccttaatt tgcaaatttg gtataactac tgattgaaaa tatatgtatg 12240 taaaaaaata ctaagcatat ttgtgaagct aaacatgatg ttatttaaga aaatatgttg 12300 ttaacagaat aagattaata tcgaaatgga aacatctgta aattagaatc atcttacaag 12360 ctaagagatg ttcacgcttt gagaaacttc ttcagatcat gaccgtagaa gtagctctcc 12420 aagactcaac gaaggctgct gcaattccac aaatgcatga catgcatcct tgtaaccgtc 12480 gtcgccgcta taaacacgga taactcaatt ccctgctcca tcaatttaga aatgagcaag 12540 caagcacccg atcgctcacc ccatatgcac caatctgact cccaagtctc tgtttcgcat 12600 tagtaccgcc agcactccac ctatagctac caattgagac ctttccagcc taagcagatc 12660 gattgatcgt tagagtcaaa gagttggtgg tacgggtact ttaactacca tggaatgatg 12720 gggcgtgatg tagagcggaa agcgcctccc tacgcggaac aacaccctcg ccatgccgct 12780 cgactacagc ctcctcctcg tcggccgccc acaacgaggg agcccgtggt cgcagccacc 12840 gaccagcatg tctctgtgtc ctcgtccgac ctcgacatgt catggcaaac agtcggacgc 12900 cagcaccaga ctgacgacat gagtctctga agagcccgcc acctagaaag atccgagccc 12960 tgctgctggt agtggtaacc attttcgtcg cgctgacgcg gagagcgaga ggccagaaat 13020 ttatagcgac tgacgctgtg gcaggcacgc tatcggaggt tacgacgtgg cgggtcactc 13080 gacgcggagt tcacaggtcc tatccttgca tcgctcgggc cggagtttac gggacttatc 13140 cttacgacgt gctctaaggt tgcgataacg ggcggaggaa ggcgtgtggc gtgcggagac 13200 ggtttataca cgtagtgtgc gggagtgtgt ttcgtagacg cgggaaagca cgacgactta 13260 cgaaggttag tggaggagga ggacacacta aaatcaggac gcaagaaact cttctattat 13320 agtagtagag aagagattat aggagtgtgg gttgattcta aagaaaatcg acgcaggaca 13380 accgtcaaaa cgggtgcttt aatatagtag atatatatat atagagagag agagaaagta 13440 caaaggatgc atttgtgtct gcatatgatc ggagtattac taacggccgt cgtaagaagg 13500 tccatcatgc gtggagcgag cccatttggt tggttgtcag gccgcagtta aggcctccat 13560 atatgattgt cgtcgggccc ataacagcat ctcctccacc agtttattgt aagaataaat 13620 taagtagaga tatttgtcgt cgggcagaag aaacttggac aagaagaaga agcaagctag 13680 gccaatttct tgccggcaag aggaagatag tggcctctag tttatatatc ggcgtgatga 13740 tgatgctcct agctagaaat gagagaagaa aaacggacgc gtgtttggtg tgtgtcaatg 13800 gcgtccatcc ttccatcaga tcagaacgat gaaaaagtca agcacggcat gcatagtata 13860 tgtatagctt gttttagtgt ggctttgctg agacgaatga aagcaacggc gggcatattt 13920 ttcagtggct gtagctttca ggctgaaaga gacgtggcat gcaataattc agggaattcg 13980 tcagccaatt gaggtagcta gtcaacttgt acattggtgc gagcaatttt ccgcactcag 14040 gagggctagt ttgagagtcc aaaaactata ggagattaaa gaggctaaaa tcctctcctt 14100 atttaatttt aaataagtag tgtatttgta ttttaactcc tccaaccctt ccgattttat 14160 ggctctcaaa ctagcattca gtctaatgca tgcatgcttg gctagaggtc gtatggggtt 14220 gttaatagca tagctagcta caagttaacc gggtctttta tatttaataa ggacaggcaa 14280 agtattactt acaaataaag aataaagcta ggacgaactc gtggattatt actaaatcga 14340 aatggacgta atattccagg caagaataat tgttcgatca ggagacaagt ggggcattgg 14400 accggttctt gcaagcaaga gcctatggcg tggtgacacg gcgcgttgcc catacatcat 14460 gcctccatcg atgatccatc ctcacttgct ataaaaagag gtgtccatgg tgctcaagct 14520 cagccaagca aataagacga cttgtttcat tgattcttca agagatcgag cttcttttgc 14580 accacaaggt cgaggatcca aca 14603 <210> 17 <211> 11127 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pZU578 <220> <221> misc_feature <222> (1485)..(3491) <223> synthetic nucleotide sequence encoding the toxin portion of H04 plus the first 40 amino acids of the Cry1Ab tail <220> <221> misc_feature <222> (5052)..(6271) <223> PMI <220> <221> misc_feature <222> (3859)..(5030) <223> SMAS promoter <220> <221> misc_feature <222> (56)..(1475) <223> Actin 2 promoter U41998 <400> 17 ggccgcagcg gccatttaaa tcaattgggc gcgccgaatt cgagctcggt accctgcatg 60 cctgcaggtc gacaaaattt agaacgaact taattatgat ctcaaataca ttgatacata 120 tctcatctag atctaggtta tcattatgta agaaagtttt gacgaatatg gcacgacaaa 180 atggctagac tcgatgtaat tggtatctca actcaacatt atacttatac caaacattag 240 ttagacaaaa tttaaacaac tattttttat gtatgcaaga gtcagcatat gtataattga 300 ttcagaatcg ttttgacgag ttcggatgta gtagtagcca ttatttaatg tacatactaa 360 tcgtgaatag tgaatatgat gaagcattgt atcttattgt ataaatatcc ataaacacat 420 catgaaagac actttctttc acggtctgaa ttaattatga cacaattcta atagaaaacg 480 aattaaatta cgttgaattg tatgaaatct aattgaacaa gccaaccacg acgacgacta 540 acgttgcctg gattgactcg gtttaagtta accactaaaa aaacggagct gtcatgtaac 600 acgcggatcg agcaggtcac agtcatgaag ccatcaaagc aaaagaacta atccaagggc 660 tgagatgatt aattagttta aaaattagtt aacacgaggg aaaaggctgt ctgacagcca 720 ggtcacgtta tctttacctg tggtcgaaat gattcgtgtc tgtcgatttt aattattttt 780 ttgaaaggcc gaaaataaag ttgtaagaga taaacccgcc tatataaatt catatatttt 840 cctctccgct ttgaattgtc tcgttgtcct cctcactttc atcagccgtt ttgaatctcc 900 ggcgacttga cagagaagaa caaggaagaa gactaagaga gaaagtaaga gataatccag 960 gagattcatt ctccgttttg aatcttcctc aatctcatct tcttccgctc tttctttcca 1020 aggtaatagg aactttctgg atctacttta tttgctggat ctcgatcttg ttttctcaat 1080 ttccttgaga tctggaattc gtttaatttg gatctgtgaa cctccactaa atcttttggt 1140 tttactagaa tcgatctaag ttgaccgatc agttagctcg attatagcta ccagaatttg 1200 gcttgacctt gatggagaga tccatgttca tgttacctgg gaaatgattt gtatatgtga 1260 attgaaatct gaactgttga agttagattg aatctgaaca ctgtcaatgt tagattgaat 1320 ctgaacactg tttaagttag atgaagtttg tgtatagatt cttcgaaact ttaggatttg 1380 tagtgtcgta cgttgaacag aaagctattt ctgattcaat cagggtttat ttgactgtat 1440 tgaactcttt ttgtgtgttt gcagctcata aaaaggatcc aacaatggac aacaacccca 1500 acatcaacga gtgcatcccc tacaactgcc tgagcaaccc cgaggtggag gtgctgggcg 1560 gcgagcgcat cgagaccggc tacaccccca tcgacatcag cctgagcctg acccagttcc 1620 tgctgagcga gttcgtgccc ggcgccggct tcgtgctggg cctggtggac atcatctggg 1680 gcatcttcgg ccccagccag tgggacgcct tcctggtgca gatcgagcag ttgataaacc 1740 aacgcataga ggaattcgcc cgcaaccagg ccatcagccg cctggagggc ctgagcaacc 1800 tgtaccaaat ctacgccgag agcttccgcg agtgggaggc cgaccccacc aaccccgccc 1860 tgcgcgagga gatgcgcatc cagttcaacg acatgaacag cgccctgacc accgccatcc 1920 ccctgttcgc cgtgcagaac taccaggtgc ccctgctgag cgtgtacgtg caggccgcca 1980 acctgcacct gagcgtgctg cgcgacgtca gcgtgttcgg ccagcgctgg ggcttcgacg 2040 ccgccaccat caacagccgc tacaacgacc tgacccgcct gatcggcaac tacaccgacc 2100 acgccgtgcg ctggtacaac accggcctgg agcgcgtgtg gggtcccgac agccgcgact 2160 ggatcaggta caaccagttc cgccgcgagc tgaccctgac cgtgctggac atcgtgagcc 2220 tgttccccaa ctacgacagc cgcacctacc ccatccgcac cgtgagccag ctgacccgcg 2280 agatttacac caaccccgtg ctggagaact tcgacggcag cttccgcggc agcgcccagg 2340 gcatcgaggg cagcatccgc agcccccacc tgatggacat cctgaacagc atcaccatct 2400 acaccgacgc ccaccgcggc gagtactact ggagcggcca ccagatcatg gccagccccg 2460 tcggcttcag cggccccgag ttcaccttcc ccctgtacgg caccatgggc aacgctgcac 2520 ctcagcagcg catcgtggca cagctgggcc agggagtgta ccgcaccctg agcagcaccc 2580 tgtaccgtcg acctttcaac atcggcatca acaaccagca gctgagcgtg ctggacggca 2640 ccgagttcgc ctacggcacc agcagcaacc tgcccagcgc cgtgtaccgc aagagcggca 2700 ccgtggacag cctggacgag atcccccctc agaacaacaa cgtgccacct cgacagggct 2760 tcagccaccg tctgagccac gtgagcatgt tccgcagtgg cttcagcaac agcagcgtga 2820 gcatcatccg tgcacccatg ttcagctgga ttcaccgcag cgccaccctg accaacacca 2880 tcgaccccga gcgcatcaac cagatccccc tggtgaaggg cttccgggtg tggggcggca 2940 ccagcgtgat caccggcccc ggcttcaccg gaggcgacat cctgcgcaga aacaccttcg 3000 gcgacttcgt gagcctgcag gtgaacatca acagccccat cacccagcgt taccgcctgc 3060 gcttccgcta cgccagcagc cgcgacgccc gtgtgatcgt gctgactggc gccgctagca 3120 ccggtgtggg cggtcaggtg agcgtgaaca tgcccctgca gaagactatg gagatcggcg 3180 agaacctgac tagtcgcacc ttccgctaca ccgacttcag caaccccttc agcttccgcg 3240 ccaaccccga catcatcggc atcagcgagc agcccctgtt cggtgccggc agcatcagca 3300 gcggcgagct gtacatcgac aagatcgaga tcatcctggc cgacgccacc ttcgaggccg 3360 agagcgacct ggagcgcgcc cagaaggccg tgaacgccct gttcaccagc agcaaccaga 3420 tcggcctgaa gaccgacgtg accgactacc acatcgacca ggtgagcaac ctggtggact 3480 gcttaagcta gagatcctct agagtcgacc atggtgatca ctgcagatcg ttcaaacatt 3540 tggcaataaa gtttcttaag attgaatcct gttgccggtc ttgcgatgat tatcatataa 3600 tttctgttga attacgttaa gcatgtaata attaacatgt aatgcatgac gttatttatg 3660 agatgggttt ttatgattag agtcccgcaa ttatacattt aatacgcgat agaaaacaaa 3720 atatagcgcg caacctagga taaattatcg cgcgcggtgt catctatgtt actagatctc 3780 tagaaagctt cgtacgttaa ttaattcgaa tccggagcgg ccgcagggct agcatcgatg 3840 gtaccgagct cgagactata caggccaaat tcgctcttag ccgtacaata ttactcaccg 3900 gtgcgatgcc ccccatcgta ggtgaaggtg gaaattaatg atccatcttg agaccacagg 3960 cccacaacag ctaccagttt cctcaagggt ccaccaaaaa cgtaagcgct tacgtacatg 4020 gtcgataaga aaaggcaatt tgtagatgtt aacatccaac gtcgctttca gggatcccga 4080 attccaagct tggaattcgg gatcctacag gccaaattcg ctcttagccg tacaatatta 4140 ctcaccggtg cgatgccccc catcgtaggt gaaggtggaa attaatgatc catcttgaga 4200 ccacaggccc acaacagcta ccagtttcct caagggtcca ccaaaaacgt aagcgcttac 4260 gtacatggtc gataagaaaa ggcaatttgt agatgttaac atccaacgtc gctttcaggg 4320 atcccgaatt ccaagcttgg aattcgggat cctacaggcc aaattcgctc ttagccgtac 4380 aatattactc accggtgcga tccccccatc gtaggtgaag gtggaaatta atgatccatc 4440 ttgagaccac aggcccacaa cagctaccag tttcctcaag ggtccaccaa aaacgtaagc 4500 gcttacgtac atggtcgata agaaaaggca atttgtagat gttaacatcc aacgtcgctt 4560 tcagggatcc cgaattccaa gcttgggctg caggtcaatc ccattgcttt tgaagcagct 4620 caacattgat ctctttctcg agggagattt ttcaaatcag tgcgcaagac gtgacgtaag 4680 tatccgagtc agtttttatt tttctactaa tttggtcgtt tatttcggcg tgtaggacat 4740 ggcaaccggg cctgaatttc gcgggtattc tgtttctatt ccaacttttt cttgatccgc 4800 agccattaac gacttttgaa tagatacgct gacacgccaa gcctcgctag tcaaaagtgt 4860 accaaacaac gctttacagc aagaacggaa tgcgcgtgac gctcgcggtg acgccatttc 4920 gccttttcag aaatggataa atagccttgc ttcctattat atcttcccaa attaccaata 4980 cattacacta gcatctgaat ttcataacca atctcgatac accaaatcga gatctgcagg 5040 gatccccgat catgcaaaaa ctcattaact cagtgcaaaa ctatgcctgg ggcagcaaaa 5100 cggcgttgac tgaactttat ggtatggaaa atccgtccag ccagccgatg gccgagctgt 5160 ggatgggcgc acatccgaaa agcagttcac gagtgcagaa tgccgccgga gatatcgttt 5220 cactgcgtga tgtgattgag agtgataaat cgactctgct cggagaggcc gttgccaaac 5280 gctttggcga actgcctttc ctgttcaaag tattatgcgc agcacagcca ctctccattc 5340 aggttcatcc aaacaaacac aattctgaaa tcggttttgc caaagaaaat gccgcaggta 5400 tcccgatgga tgccgccgag cgtaactata aagatcctaa ccacaagccg gagctggttt 5460 ttgcgctgac gcctttcctt gcgatgaacg cgtttcgtga attttccgag attgtctccc 5520 tactccagcc ggtcgcaggt gcacatccgg cgattgctca ctttttacaa cagcctgatg 5580 ccgaacgttt aagcgaactg ttcgccagcc tgttgaatat gcagggtgaa gaaaaatccc 5640 gcgcgctggc gattttaaaa tcggccctcg atagccagca gggtgaaccg tggcaaacga 5700 ttcgtttaat ttctgaattt tacccggaag acagcggtct gttctccccg ctattgctga 5760 atgtggtgaa attgaaccct ggcgaagcga tgttcctgtt cgctgaaaca ccgcacgctt 5820 acctgcaagg cgtggcgctg gaagtgatgg caaactccga taacgtgctg cgtgcgggtc 5880 tgacgcctaa atacattgat attccggaac tggttgccaa tgtgaaattc gaagccaaac 5940 cggctaacca gttgttgacc cagccggtga aacaaggtgc agaactggac ttcccgattc 6000 cagtggatga ttttgccttc tcgctgcatg accttagtga taaagaaacc accattagcc 6060 agcagagtgc cgccattttg ttctgcgtcg aaggcgatgc aacgttgtgg aaaggttctc 6120 agcagttaca gcttaaaccg ggtgaatcag cgtttattgc cgccaacgaa tcaccggtga 6180 ctgtcaaagg ccacggccgt ttagcgcgtg tttacaacaa gctgtaagag cttactgaaa 6240 aaattaacat ctcttgctaa gctgggagct cgtcgacgga tcgaattcct gcagatcgtt 6300 caaacatttg gcaataaagt ttcttaagat tgaatcctgt tgccggtctt gcgatgatta 6360 tcatataatt tctgttgaat tacgttaagc atgtaataat taacatgtaa tgcatgacgt 6420 tatttatgag atgggttttt atgattagag tcccgcaatt atacatttaa tacgcgatag 6480 aaaacaaaat atagcgcgca acctaggata aattatcgcg cgcggtgtca tctatgttac 6540 tagatctcta gaactagtgg atctgctagc cctgcaggaa atttaccggt gcccgggcgg 6600 ccagcatggc cgtatccgca atgtgttatt aagttgtcta agcgtcaatt tgtttacacc 6660 acaatatatc ctgccaccag ccagccaaca gctccccgac cggcagctcg gcacaaaatc 6720 accactcgat acaggcagcc catcagaatt aattctcatg tttgacagct tatcatcgac 6780 tgcacggtgc accaatgctt ctggcgtcag gcagccatcg gaagctgtgg tatggctgtg 6840 caggtcgtaa atcactgcat aattcgtgtc gctcaaggcg cactcccgtt ctggataatg 6900 ttttttgcgc cgacatcata acggttctgg caaatattct gaaatgagct gttgacaatt 6960 aatcatcggc tcgtataatg tgtggaattg tgagcggata acaatttcac acaggaaaca 7020 gaccatgagg gaagcggtga tcgccgaagt atcgactcaa ctatcagagg tagttggcgt 7080 catcgagcgc catctcgaac cgacgttgct ggccgtacat ttgtacggct ccgcagtgga 7140 tggcggcctg aagccacaca gtgatattga tttgctggtt acggtgaccg taaggcttga 7200 tgaaacaacg cggcgagctt tgatcaacga ccttttggaa acttcggctt cccctggaga 7260 gagcgagatt ctccgcgctg tagaagtcac cattgttgtg cacgacgaca tcattccgtg 7320 gcgttatcca gctaagcgcg aactgcaatt tggagaatgg cagcgcaatg acattcttgc 7380 aggtatcttc gagccagcca cgatcgacat tgatctggct atcttgctga caaaagcaag 7440 agaacatagc gttgccttgg taggtccagc ggcggaggaa ctctttgatc cggttcctga 7500 acaggatcta tttgaggcgc taaatgaaac cttaacgcta tggaactcgc cgcccgactg 7560 ggctggcgat gagcgaaatg tagtgcttac gttgtcccgc atttggtaca gcgcagtaac 7620 cggcaaaatc gcgccgaagg atgtcgctgc cgactgggca atggagcgcc tgccggccca 7680 gtatcagccc gtcatacttg aagctaggca ggcttatctt ggacaagaag atcgcttggc 7740 ctcgcgcgca gatcagttgg aagaatttgt tcactacgtg aaaggcgaga tcaccaaggt 7800 agtcggcaaa taaagctcta gtggatcccc gaggaatcgg cgtgacggtc gcaaaccatc 7860 cggcccggta caaatcggcg cggcgctggg tgatgacctg gtggagaagt tgaaggccgc 7920 gcaggccgcc cagcggcaac gcatcgaggc agaagcacgc cccggtgaat cgtggcaagc 7980 ggccgctgat cgaatccgca aagaatcccg gcaaccgccg gcagccggtg cgccgtcgat 8040 taggaagccg cccaagggcg acgagcaacc agattttttc gttccgatgc tctatgacgt 8100 gggcacccgc gatagtcgca gcatcatgga cgtggccgtt ttccgtctgt cgaagcgtga 8160 ccgacgagct ggcgaggtga tccgctacga gcttccagac gggcacgtag aggtttcagc 8220 agggccggcc ggcatggcca gtgtgtggga ttacgacctg gtactgatgg cggtttccca 8280 tctaaccgaa tccatgaacc gataccggga agggaaggga gacaagcccg gccgcgtgtt 8340 ccgtccacac gttgcggacg tactcaagtt ctgccggcga gccgatggcg gaaagcagaa 8400 agacgacctg gtagaaacct gcattcggtt aaacaccacg cacgttgcca tgcagcgtac 8460 gaagaaggcc aagaacggcc gcctggtgac ggtatccgag ggtgaagcct tgattagccg 8520 ctacaagatc gtaaagagcg aaaccgggcg gccggagtac atcgagatcg agctagctga 8580 ttggatgtac cgcgagatca cagaaggcaa gaacccggac gtgctgacgg ttcaccccga 8640 ttactttttg atcgatcccg gcatcggccg ttttctctac cgcctggcac gccgcgccgc 8700 aggcaaggca gaagccagat ggttgttcaa gacgatctac gaacgcagtg gcagcgccgg 8760 agagttcaag aagttctgtt tcaccgtgcg caagctgatc gggtcaaatg acctgccgga 8820 gtacgatttg aaggaggagg cggggcaggc tggcccgatc ctagtcatgc gctaccgcaa 8880 cctgatcgag ggcgaagcat ccgccggttc ctaatgtacg gagcagatgc tagggcaaat 8940 tgccctagca ggggaaaaag gtcgaaaagg tctctttcct gtggatagca cgtacattgg 9000 gaacccaaag ccgtacattg ggaaccggaa cccgtacatt gggaacccaa agccgtacat 9060 tgggaaccgg tcacacatgt aagtgactga tataaaagag aaaaaaggcg atttttccgc 9120 ctaaaactct ttaaaactta ttaaaactct taaaacccgc ctggcctgtg cataactgtc 9180 tggccagcgc acagccgaag agctgcaaaa agcgcctacc cttcggtcgc tgcgctccct 9240 acgccccgcc gcttcgcgtc ggcctatcgc ggccgctggc cgctcaaaaa tggctggcct 9300 acggccaggc aatctaccag ggcgcggaca agccgcgccg tcgccactcg accgccggcg 9360 ctgaggtctg cctcgtgaag aaggtgttgc tgactcatac caggcctgaa tcgccccatc 9420 atccagccag aaagtgaggg agccacggtt gatgagagct ttgttgtagg tggaccagtt 9480 ggtgattttg aacttttgct ttgccacgga acggtctgcg ttgtcgggaa gatgcgtgat 9540 ctgatccttc aactcagcaa aagttcgatt tattcaacaa agccgccgtc ccgtcaagtc 9600 agcgtaatgc tctgccagtg ttacaaccaa ttaaccaatt ctgattagaa aaactcatcg 9660 agcatcaaat gaaactgcaa tttattcata tcaggattat caataccata tttttgaaaa 9720 agccgtttct gtaatgaagg agaaaactca ccgaggcagt tccataggat ggcaagatcc 9780 tggtatcggt ctgcgattcc gactcgtcca acatcaatac aacctattaa tttcccctcg 9840 tcaaaaataa ggttatcaag tgagaaatca ccatgagtga cgactgaatc cggtgagaat 9900 ggcaaaagct ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg 9960 gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc 10020 ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg 10080 aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct 10140 ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca 10200 gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct 10260 cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc 10320 gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg tgtaggtcgt 10380 tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc 10440 cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc 10500 cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg 10560 gtggcctaac tacggctaca ctagaaggac agtatttggt atctgcgctc tgctgaagcc 10620 agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag 10680 cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat ctcaagaaga 10740 tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac gttaagggat 10800 tttggtcatg agattatcaa aaaggatctt cacctagatc cttttgatcc ggaattaatt 10860 cctgtggttg gcatgcacat acaaatggac gaacggataa accttttcac gcccttttaa 10920 atatccgatt attctaataa acgctctttt ctcttaggtt tacccgccaa tatatcctgt 10980 caaacactga tagtttaaac tgaaggcggg aaacgacaat ctgatcatga gcggagaatt 11040 aagggagtca cgttatgacc cccgccgatg acgcgggaca agccgtttta cgtttggaac 11100 tgacagaacc gcaacgctgc aggaatt 11127 <110> Syngenta Participations AG <120> Novel insecticidal toxins derived from Bacillus thuringiensis insecticidal       crystal proteins <130> 5-2000-054004-2 <140> <141> <150> US 60 / 227,956 <151> 2000-08-25 <160> 17 <170> KopatentIn 1.7 <210> 1 <211> 3579 <212> DNA <213> Artificial Sequences <220> <223> Description of Artificial Sequence: H04 with Cry1C       tail <220> <221> CDS (222) (1) .. (3579) <223> H04 with Cry1C tail <300> <303> Appl. Environ. Microbiol. <304> 62 <305> 5 <306> 1537-1543 <307> 1996 <300> <310> 5,736,131 <400> 1 atg gat aac aat ccg aac atc aat gaa tgc att cct tat aat tgt tta 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 agt aac cct gaa gta gaa gta tta ggt gga gaa aga ata gaa act ggt 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 tac acc cca atc gat att tcc ttg tcg cta acg caa ttt ctt ttg agt 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 gaa ttt gtt ccc ggt gct gga ttt gtg tta gga cta gtt gat ata ata 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 tgg gga att ttt ggt ccc tct caa tgg gac gca ttt ctt gta caa att 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 gaa cag tta att aac caa aga ata gaa gaa ttc gct agg aac caa gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 att tct aga tta gaa gga cta agc aat ctt tat caa att tac gca gaa 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 tct ttt aga gag tgg gaa gca gat cct act aat cca gca tta aga gaa 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 gag atg cgt att caa ttc aat gac atg aac agt gcc ctt aca acc gct 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 att cct ctt ttt gca gtt caa aat tat caa gtt cct ctt tta tca gta 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tat gtt caa gct gca aat tta cat tta tca gtt ttg aga gat gtt tca 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 gtg ttt gga caa agg tgg gga ttt gat gcc gcg act atc aat agt cgt 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 tat aat gat tta act agg ctt att ggc aac tat aca gat cat gct gta 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 cgc tgg tac aat acg gga tta gag cgt gta tgg gga ccg gat tct aga 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 gat tgg ata aga tat aat caa ttt aga aga gaa tta aca cta act gta 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 tta gat atc gtt tct cta ttt ccg aac tat gat agt aga acg tat cca 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 att cga aca gtt tcc caa tta aca aga gaa att tat aca aac cca gta 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 tta gaa aat ttt gat ggt agt ttt cga ggc tcg gct cag ggc ata gaa 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 gga agt att agg agt cca cat ttg atg gat ata ctt aac agt ata acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 atc tat acg gat gct cat aga gga gaa tat tat tgg tca ggg cat caa 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 ata atg gct tct cct gta ggg ttt tcg ggg cca gaa ttc act ttt ccg 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 cta tat gga act atg gga aat gca gct cca caa caa cgt att gtt gct 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 caa cta ggt cag ggc gtg tat aga aca tta tcg tcc act tta tat aga 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 aga cct ttt aat ata ggg ata aat aat caa caa cta tct gtt ctt gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 ggg aca gaa ttt gct tat gga acc tcc tca aat ttg cca tcc gct gta 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac aga aaa agc gga acg gta gat tcg ctg gat gaa ata ccg cca cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 aat aac aac gtg cca cct agg caa gga ttt agt cat cga tta agc cat 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 gtt tca atg ttt cgt tca ggc ttt agt aat agt agt gta agt ata ata 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 aga gct cct atg ttc tct tgg ata cat cgt agt gca act ctt aca aat 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 aca att gat cca gag aga att aat caa ata cct tta gtg aaa gga ttt 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 aga gtt tgg ggg ggc acc tct gtc att aca gga cca gga ttt aca gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 ggg gat atc ctt cga aga aat acc ttt ggt gat ttt gta tct cta caa 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 gtc aat att aat tca cca att acc caa aga tac cgt tta aga ttt cgt 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 tac gct tcc agt agg gat gca cga gtt ata gta tta aca gga gcg gca 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 tcc aca gga gtg gga ggc caa gtt agt gta aat atg cct ctt cag aaa 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gaa ata ggg gag aac tta aca tct aga aca ttt aga tat acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 gat ttt agt aat cct ttt tca ttt aga gct aat cca gat ata att ggg 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 ata agt gaa caa cct cta ttt ggt gca ggt tct att agt agc ggt gaa 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 ctt tat ata gat aaa att gaa att att cta gca gat gca aca ttt gaa 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 gca gaa tct gat tta gaa aga gca caa aag gcg gtg aat gcc ctg ttt 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 act tct tcc aat caa atc ggg tta aaa acc gat gtg acg gat tat cat 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 att gat caa gta tcc aat tta gtg gat tgt tta tca gat gaa ttt tgt 2016 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys             660 665 670 ctg gat gaa aag cga gaa ttg tcc gag aaa gtc aaa cat gcg aag cga 2064 Leu Asp Glu Lys Arg Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg         675 680 685 ctc agt gat gag cgg aat tta ctt caa gat cca aac ttc aga ggg atc 2112 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile     690 695 700 aat aga caa cca gac cgt ggc tgg aga gga agt aca gat att acc atc 2160 Asn Arg Gln Pro Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 caa gga gga gat gac gta ttc aaa gag aat tac gtc aca cta ccg ggt 2208 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Pro Gly                 725 730 735 acc gtt gat gag tgc tat cca acg tat tta tat cag aaa ata gat gag 2256 Thr Val Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Lys Ile Asp Glu             740 745 750 tcg aaa tta aaa gct tat acc cgt tat gaa tta aga ggg tat atc gaa 2304 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Glu Leu Arg Gly Tyr Ile Glu         755 760 765 gat agt caa gac tta gaa atc tat ttg atc cgt tac aat gca aaa cac 2352 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His     770 775 780 gaa ata gta aat gtg cca ggc acg ggt tcc tta tgg ccg ctt tca gcc 2400 Glu Ile Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 caa agt cca atc gga aag tgt gga gaa ccg aat cga tgc gcg cca cac 2448 Gln Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His                 805 810 815 ctt gaa tgg aat cct gat cta gat tgt tcc tgc aga gac ggg gaa aaa 2496 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys             820 825 830 tgt gca cat cat tcc cat cat ttc acc ttg gat att gat gtt gga tgt 2544 Cys Ala His His Ser His His Phe Thr Leu Asp Ile Asp Val Gly Cys         835 840 845 aca gac tta aat gag gac tta ggt gta tgg gtg ata ttc aag att aag 2592 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys     850 855 860 acg caa gat ggc cat gca aga cta ggg aat cta gag ttt ctc gaa gag 2640 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 aaa cca tta tta ggg gaa gca cta gct cgt gtg aaa aga gcg gag aag 2688 Lys Pro Leu Leu Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys                 885 890 895 aag tgg aga gac aaa cga gag aaa ctg cag ttg gaa aca aat att gtt 2736 Lys Trp Arg Asp Lys Arg Glu Lys Leu Gln Leu Glu Thr Asn Ile Val             900 905 910 tat aaa gag gca aaa gaa tct gta gat gct tta ttt gta aac tct caa 2784 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln         915 920 925 tat gat aga tta caa gtg gat acg aac atc gcg atg att cat gcg gca 2832 Tyr Asp Arg Leu Gln Val Asp Thr Asn Ile Ala Met Ile His Ala Ala     930 935 940 gat aaa cgc gtt cat aga atc cgg gaa gcg tat ctg cca gag ttg tct 2880 Asp Lys Arg Val His Arg Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 gtg att cca ggt gtc aat gcg gcc att ttc gaa gaa tta gag gga cgt 2928 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg                 965 970 975 att ttt aca gcg tat tcc tta tat gat gcg aga aat gtc att aaa aat 2976 Ile Phe Thr Ala Tyr Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn             980 985 990 ggc gat ttc aat aat ggc tta tta tgc tgg aac gtg aaa ggt cat gta 3024 Gly Asp Phe Asn Asn Gly Leu Leu Cys Trp Asn Val Lys Gly His Val         995 1000 1005 gat gta gaa gag caa aac aac cac cgt tcg gtc ctt gtt atc cca gaa 3072 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Ile Pro Glu    1010 1015 1020 tgg gag gca gaa gtg tca caa gag gtt cgt gtc tgt cca ggt cgt ggc 3120 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 tat atc ctt cgt gtc aca gca tat aaa gag gga tat gga gag ggc tgc 3168 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys                1045 1050 1055 gta acg atc cat gag atc gaa gac aat aca gac gaa ctg aaa ttc agc 3216 Val Thr Ile His Glu Ile Glu Asp Asn Thr Asp Glu Leu Lys Phe Ser            1060 1065 1070 aac tgt gta gaa gag gaa gta tat cca aac aac aca gta acg tgt aat 3264 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn        1075 1080 1085 aat tat act ggg act caa gaa gaa tat gag ggt acg tac act tct cgt 3312 Asn Tyr Thr Gly Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg    1090 1095 1100 aat caa gga tat gac gaa gcc tat ggt aat aac cct tcc gta cca gct 3360 Asn Gln Gly Tyr Asp Glu Ala Tyr Gly Asn Asn Pro Ser Val Pro Ala 1105 1110 1115 1120 gat tac gct tca gtc tat gaa gaa aaa tcg tat aca gat gga cga aga 3408 Asp Tyr Ala Ser Val Tyr Glu Glu Lys Ser Tyr Thr Asp Gly Arg Arg                1125 1130 1135 gag aat cct tgt gaa tct aac aga ggc tat ggg gat tac aca cca cta 3456 Glu Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu            1140 1145 1150 ccg gct ggt tat gta aca aag gat tta gag tac ttc cca gag acc gat 3504 Pro Ala Gly Tyr Val Thr Lys Asp Leu Glu Tyr Phe Pro Glu Thr Asp        1155 1160 1165 aag gta tgg att gag atc gga gaa aca gaa gga aca ttc atc gtg gat 3552 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp    1170 1175 1180 agc gtg gaa tta ctc ctt atg gag gaa 3579 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 2 <211> 1193 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: H04 with Cry1C       tail <400> 2 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys             660 665 670 Leu Asp Glu Lys Arg Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg         675 680 685 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile     690 695 700 Asn Arg Gln Pro Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Pro Gly                 725 730 735 Thr Val Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Lys Ile Asp Glu             740 745 750 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Glu Leu Arg Gly Tyr Ile Glu         755 760 765 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His     770 775 780 Glu Ile Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 Gln Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His                 805 810 815 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys             820 825 830 Cys Ala His His Ser His His Phe Thr Leu Asp Ile Asp Val Gly Cys         835 840 845 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys     850 855 860 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 Lys Pro Leu Leu Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys                 885 890 895 Lys Trp Arg Asp Lys Arg Glu Lys Leu Gln Leu Glu Thr Asn Ile Val             900 905 910 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln         915 920 925 Tyr Asp Arg Leu Gln Val Asp Thr Asn Ile Ala Met Ile His Ala Ala     930 935 940 Asp Lys Arg Val His Arg Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg                 965 970 975 Ile Phe Thr Ala Tyr Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn             980 985 990 Gly Asp Phe Asn Asn Gly Leu Leu Cys Trp Asn Val Lys Gly His Val         995 1000 1005 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Ile Pro Glu    1010 1015 1020 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 025 1030 1035 1040 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys                1045 1050 1055 Val Thr Ile His Glu Ile Glu Asp Asn Thr Asp Glu Leu Lys Phe Ser            1060 1065 1070 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn        1075 1080 1085 Asn Tyr Thr Gly Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg    1090 1095 1100 Asn Gln Gly Tyr Asp Glu Ala Tyr Gly Asn Asn Pro Ser Val Pro Ala 105 1110 1115 1120 Asp Tyr Ala Ser Val Tyr Glu Glu Lys Ser Tyr Thr Asp Gly Arg Arg                1125 1130 1135 Glu Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu            1140 1145 1150 Pro Ala Gly Tyr Val Thr Lys Asp Leu Glu Tyr Phe Pro Glu Thr Asp        1155 1160 1165 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp    1170 1175 1180 Ser Val Glu Leu Leu Leu Met Glu Glu 185 1190 <210> 3 <211> 1896 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene       encoding the toxin portion of H04 without a tail <220> <221> CDS (222) (1) .. (1896) <223> H04 toxin portion without a tail <400> 3 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 gcc gag agc gac ctg gag cgc taa 1896 Ala Glu Ser Asp Leu Glu Arg 625 630 <210> 4 <211> 631 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene       encoding the toxin portion of H04 without a tail <400> 4 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 Ala Glu Ser Asp Leu Glu Arg 625 630 <210> 5 <211> 3582 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene       encoding H04 with full-length Cry1Ab tail <220> <221> CDS (222) (1) .. (3582) <223> H04 with full-length Cry1Ab tail <400> 5 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 gcc gag agc gac ctg gag cgc gcc cag aag gcc gtg aac gcc ctg ttc 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 acc agc agc aac cag atc ggc ctg aag acc gac gtg acc gac tac cac 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 atc gac cag gtg agc aac ctg gtg gac tgc tta agc gac gag ttc tgc 2016 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys             660 665 670 ctg gac gag aag aag gag ctg agc gag aag gtg aag cac gcc aag cgc 2064 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg         675 680 685 ctg agc gac gag cgc aac ctg ctg cag gac ccc aac ttc cgc ggc atc 2112 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile     690 695 700 aac cgc cag ctg gac cgc ggc tgg cga ggc agc acc gat atc acc atc 2160 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 cag ggc ggc gac gac gtg ttc aag gag aac tac gtg acc ctg cag ggc 2208 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly                 725 730 735 acc ttc gac gag tgc tac ccc acc tac ctg tac cag ccg atc gac gag 2256 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu             740 745 750 agc aag ctg aag gcc tac acc cgc tac cag ctg cgc ggc tac atc gag 2304 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu         755 760 765 gac agc cag gac ctg gaa atc tac ctg atc cgc tac aac gcg aag cac 2352 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His     770 775 780 gag acc gtg aac gtg ccc ggc acc ggc agc ctg tgg ccc ccg agc gcc 2400 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Pro Ser Ala 785 790 795 800 ccc agc ccc atc ggc aag tgc ggg gag ccg aat cga tgc gct ccg cac 2448 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His                 805 810 815 ctg gag tgg aac ccg gac cta gac tgc agc tgc agg gac ggg gag aag 2496 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys             820 825 830 tgc gcc cac cac agc cac cac ttc agc ctg gac atc gac gtg ggc tgc 2544 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys         835 840 845 acc gac ctg aac gag gac ctg ggc gtg tgg gtg atc ttc aag atc aag 2592 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys     850 855 860 acc cag gac ggc cac gcc cgc ctg ggc aat cta gag ttc ctg gag gag 2640 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 aag ccc ctg gtg ggc gag gcc ctg gcc cgc gtg aag cgt gct gag aag 2688 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys                 885 890 895 aag tgg cgc gac aag cgc gag aag ctg gag tgg gag acc aac atc gtg 2736 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val             900 905 910 tac aag gag gcc aag gag agc gtg gac gcc ctg ttc gtg aac agc cag 2784 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln         915 920 925 tac gac cgc ctg cag gcc gac acc aac atc gcc atg atc cac gcc gcc 2832 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala     930 935 940 gac aag cgc gtg cac agc att cgc gag gcc tac ctg ccc gag ctg agc 2880 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 gtg atc ccc ggt gtg aac gcc gcc atc ttc gag gaa ctc gag ggc cgc 2928 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg                 965 970 975 atc ttc acc gcc ttc agc ctg tac gac gcc cgc aac gtg atc aag aac 2976 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn             980 985 990 ggc gac ttc aac aac ggc ctg agc tgc tgg aac gtg aag ggc cac gtg 3024 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val         995 1000 1005 gac gtg gag gag cag aac aac cac cgc agc gtg ctg gtg gtg ccc gag 3072 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu    1010 1015 1020 tgg gag gcc gag gtg agc cag gag gtg cgc gtg tgc ccc ggc cgc ggc 3120 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 tac atc ctg cgc gtg acc gcc tac aag gag ggc tac ggc gag ggc tgc 3168 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys                1045 1050 1055 gtg acc atc cac gag atc gag aac aac acc gac gag ctc aag ttc agc 3216 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser            1060 1065 1070 aac tgc gtg gag gag gag gtt tac ccc aac aac acc gtg acc tgc aac 3264 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn        1075 1080 1085 gac tac acc gcg acc cag gag gag tac gaa ggc acc tac acc tct cgc 3312 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg    1090 1095 1100 aac agg ggt tac gac ggc gcc tac gag tcc aac agc tcc gtg cca gct 3360 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 gac tac gcc agc gcc cac gag gag aaa gcc tac acc gac ggt aga cgc 3408 Asp Tyr Ala Ser Ala His Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg                1125 1130 1135 gac aac cca tgt gag agc aac aga ggc tac ggc gac tac acc ccc ctg 3456 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu            1140 1145 1150 ccc gct gga tac gtg acc aag gag ctg gag tac ttc ccc gag acc gac 3504 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp        1155 1160 1165 aag gtg tgg atc gag att ggc gag acc gag ggc acc ttc atc gtg gac 3552 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp    1170 1175 1180 agc gtg gag ctg ctg ctg atg gag gag tag 3582 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 6 <211> 1193 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene       encoding H04 with full-length Cry1Ab tail <400> 6 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys             660 665 670 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg         675 680 685 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile     690 695 700 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly                 725 730 735 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu             740 745 750 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu         755 760 765 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His     770 775 780 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Pro Ser Ala 785 790 795 800 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His                 805 810 815 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys             820 825 830 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys         835 840 845 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys     850 855 860 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys                 885 890 895 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val             900 905 910 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln         915 920 925 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala     930 935 940 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg                 965 970 975 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn             980 985 990 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val         995 1000 1005 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu    1010 1015 1020 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys                1045 1050 1055 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser            1060 1065 1070 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn        1075 1080 1085 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg    1090 1095 1100 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 Asp Tyr Ala Ser Ala His Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg                1125 1130 1135 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu            1140 1145 1150 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp        1155 1160 1165 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp    1170 1175 1180 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 7 <211> 3582 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene       encoding H04 with full-length Cry1Ab tail <220> <221> CDS (222) (1) .. (3582) <223> H04 with full-length Cry1Ab tail <400> 7 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 gcc gag agc gac ctg gag cgc gcc cag aag gcc gtg aac gcc ctg ttc 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 acc agc agc aac cag atc ggc ctg aag acc gac gtg acc gac tac cac 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 atc gac cag gtg agc aac ctg gtg gac tgc tta agc gac gag ttc tgc 2016 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys             660 665 670 ctg gac gag aag aag gag ctg agc gag aag gtg aag cac gcc aag cgc 2064 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg         675 680 685 ctg agc gac gag cgc aac ctg ctg cag gac ccc aac ttc cgc ggc atc 2112 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile     690 695 700 aac cgc cag ctg gac cgc ggc tgg cga ggc agc acc gat atc acc atc 2160 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 cag ggc ggc gac gac gtg ttc aag gag aac tac gtg acc ctg cag ggc 2208 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly                 725 730 735 acc ttc gac gag tgc tac ccc acc tac ctg tac cag ccg atc gac gag 2256 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu             740 745 750 agc aag ctg aag gcc tac acc cgc tac cag ctg cgc ggc tac atc gag 2304 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu         755 760 765 gac agc cag gac ctg gaa atc tac ctg atc cgc tac aac gcg aag cac 2352 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His     770 775 780 gag acc gtg aac gtg ccc ggc acc ggc agc ctg tgg ccc ctg agc gcc 2400 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 ccc agc ccc atc ggc aag tgc ggg gag ccg aat cga tgc gct ccg cac 2448 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His                 805 810 815 ctg gag tgg aac ccg gac cta gac tgc agc tgc agg gac ggg gag aag 2496 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys             820 825 830 tgc gcc cac cac agc cac cac ttc agc ctg gac atc gac gtg ggc tgc 2544 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys         835 840 845 acc gac ctg aac gag gac ctg ggc gtg tgg gtg atc ttc aag atc aag 2592 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys     850 855 860 acc cag gac ggc cac gcc cgc ctg ggc aat cta gag ttc ctg gag gag 2640 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 aag ccc ctg gtg ggc gag gcc ctg gcc cgc gtg aag cgt gct gag aag 2688 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys                 885 890 895 aag tgg cgc gac aag cgc gag aag ctg gag tgg gag acc aac atc gtg 2736 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val             900 905 910 tac aag gag gcc aag gag agc gtg gac gcc ctg ttc gtg aac agc cag 2784 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln         915 920 925 tac gac cgc ctg cag gcc gac acc aac atc gcc atg atc cac gcc gcc 2832 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala     930 935 940 gac aag cgc gtg cac agc att cgc gag gcc tac ctg ccc gag ctg agc 2880 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 gtg atc ccc ggt gtg aac gcc gcc atc ttc gag gaa ctc gag ggc cgc 2928 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg                 965 970 975 atc ttc acc gcc ttc agc ctg tac gac gcc cgc aac gtg atc aag aac 2976 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn             980 985 990 ggc gac ttc aac aac ggc ctg agc tgc tgg aac gtg aag ggc cac gtg 3024 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val         995 1000 1005 gac gtg gag gag cag aac aac cac cgc agc gtg ctg gtg gtg ccc gag 3072 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu    1010 1015 1020 tgg gag gcc gag gtg agc cag gag gtg cgc gtg tgc ccc ggc cgc ggc 3120 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 tac atc ctg cgc gtg acc gcc tac aag gag ggc tac ggc gag ggc tgc 3168 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys                1045 1050 1055 gtg acc atc cac gag atc gag aac aac acc gac gag ctc aag ttc agc 3216 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser            1060 1065 1070 aac tgc gtg gag gag gag gtt tac ccc aac aac acc gtg acc tgc aac 3264 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn        1075 1080 1085 gac tac acc gcg acc cag gag gag tac gaa ggc acc tac acc tct cgc 3312 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg    1090 1095 1100 aac agg ggt tac gac ggc gcc tac gag tcc aac agc tcc gtg cca gct 3360 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 gac tac gcc agc gcc tac gag gag aaa gcc tac acc gac ggt aga cgc 3408 Asp Tyr Ala Ser Ala Tyr Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg                1125 1130 1135 gac aac cca tgt gag agc aac aga ggc tac ggc gac tac acc ccc ctg 3456 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu            1140 1145 1150 ccc gct gga tac gtg acc aag gag ctg gag tac ttc ccc gag acc gac 3504 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp        1155 1160 1165 aag gtg tgg atc gag att ggc gag acc gag ggc acc ttc atc gtg gac 3552 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp    1170 1175 1180 agc gtg gag ctg ctg ctg atg gag gag tag 3582 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 8 <211> 1193 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene       encoding H04 with full-length Cry1Ab tail <400> 8 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser Asp Glu Phe Cys             660 665 670 Leu Asp Glu Lys Lys Glu Leu Ser Glu Lys Val Lys His Ala Lys Arg         675 680 685 Leu Ser Asp Glu Arg Asn Leu Leu Gln Asp Pro Asn Phe Arg Gly Ile     690 695 700 Asn Arg Gln Leu Asp Arg Gly Trp Arg Gly Ser Thr Asp Ile Thr Ile 705 710 715 720 Gln Gly Gly Asp Asp Val Phe Lys Glu Asn Tyr Val Thr Leu Gln Gly                 725 730 735 Thr Phe Asp Glu Cys Tyr Pro Thr Tyr Leu Tyr Gln Pro Ile Asp Glu             740 745 750 Ser Lys Leu Lys Ala Tyr Thr Arg Tyr Gln Leu Arg Gly Tyr Ile Glu         755 760 765 Asp Ser Gln Asp Leu Glu Ile Tyr Leu Ile Arg Tyr Asn Ala Lys His     770 775 780 Glu Thr Val Asn Val Pro Gly Thr Gly Ser Leu Trp Pro Leu Ser Ala 785 790 795 800 Pro Ser Pro Ile Gly Lys Cys Gly Glu Pro Asn Arg Cys Ala Pro His                 805 810 815 Leu Glu Trp Asn Pro Asp Leu Asp Cys Ser Cys Arg Asp Gly Glu Lys             820 825 830 Cys Ala His His Ser His His Phe Ser Leu Asp Ile Asp Val Gly Cys         835 840 845 Thr Asp Leu Asn Glu Asp Leu Gly Val Trp Val Ile Phe Lys Ile Lys     850 855 860 Thr Gln Asp Gly His Ala Arg Leu Gly Asn Leu Glu Phe Leu Glu Glu 865 870 875 880 Lys Pro Leu Val Gly Glu Ala Leu Ala Arg Val Lys Arg Ala Glu Lys                 885 890 895 Lys Trp Arg Asp Lys Arg Glu Lys Leu Glu Trp Glu Thr Asn Ile Val             900 905 910 Tyr Lys Glu Ala Lys Glu Ser Val Asp Ala Leu Phe Val Asn Ser Gln         915 920 925 Tyr Asp Arg Leu Gln Ala Asp Thr Asn Ile Ala Met Ile His Ala Ala     930 935 940 Asp Lys Arg Val His Ser Ile Arg Glu Ala Tyr Leu Pro Glu Leu Ser 945 950 955 960 Val Ile Pro Gly Val Asn Ala Ala Ile Phe Glu Glu Leu Glu Gly Arg                 965 970 975 Ile Phe Thr Ala Phe Ser Leu Tyr Asp Ala Arg Asn Val Ile Lys Asn             980 985 990 Gly Asp Phe Asn Asn Gly Leu Ser Cys Trp Asn Val Lys Gly His Val         995 1000 1005 Asp Val Glu Glu Gln Asn Asn His Arg Ser Val Leu Val Val Pro Glu    1010 1015 1020 Trp Glu Ala Glu Val Ser Gln Glu Val Arg Val Cys Pro Gly Arg Gly 1025 1030 1035 1040 Tyr Ile Leu Arg Val Thr Ala Tyr Lys Glu Gly Tyr Gly Glu Gly Cys                1045 1050 1055 Val Thr Ile His Glu Ile Glu Asn Asn Thr Asp Glu Leu Lys Phe Ser            1060 1065 1070 Asn Cys Val Glu Glu Glu Val Tyr Pro Asn Asn Thr Val Thr Cys Asn        1075 1080 1085 Asp Tyr Thr Ala Thr Gln Glu Glu Tyr Glu Gly Thr Tyr Thr Ser Arg    1090 1095 1100 Asn Arg Gly Tyr Asp Gly Ala Tyr Glu Ser Asn Ser Ser Val Pro Ala 1105 1110 1115 1120 Asp Tyr Ala Ser Ala Tyr Glu Glu Lys Ala Tyr Thr Asp Gly Arg Arg                1125 1130 1135 Asp Asn Pro Cys Glu Ser Asn Arg Gly Tyr Gly Asp Tyr Thr Pro Leu            1140 1145 1150 Pro Ala Gly Tyr Val Thr Lys Glu Leu Glu Tyr Phe Pro Glu Thr Asp        1155 1160 1165 Lys Val Trp Ile Glu Ile Gly Glu Thr Glu Gly Thr Phe Ile Val Asp    1170 1175 1180 Ser Val Glu Leu Leu Leu Met Glu Glu 1185 1190 <210> 9 <211> 2007 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: synthetic gene       encoding H04 plus the first 40 amino acids of the       Cry1Ab tail <220> <221> CDS (222) (1) .. (2007) <223> H04 with truncated Cry1Ab tail <400> 9 atg gac aac aac ccc aac atc aac gag tgc atc ccc tac aac tgc ctg 48 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 agc aac ccc gag gtg gag gtg ctg ggc ggc gag cgc atc gag acc ggc 96 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 tac acc ccc atc gac atc agc ctg agc ctg acc cag ttc ctg ctg agc 144 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 gag ttc gtg ccc ggc gcc ggc ttc gtg ctg ggc ctg gtg gac atc atc 192 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 tgg ggc atc ttc ggc ccc agc cag tgg gac gcc ttc ctg gtg cag atc 240 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 gag cag ttg ata aac caa cgc ata gag gaa ttc gcc cgc aac cag gcc 288 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 atc agc cgc ctg gag ggc ctg agc aac ctg tac caa atc tac gcc gag 336 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 agc ttc cgc gag tgg gag gcc gac ccc acc aac ccc gcc ctg cgc gag 384 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 gag atg cgc atc cag ttc aac gac atg aac agc gcc ctg acc acc gcc 432 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 atc ccc ctg ttc gcc gtg cag aac tac cag gtg ccc ctg ctg agc gtg 480 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 tac gtg cag gcc gcc aac ctg cac ctg agc gtg ctg cgc gac gtc agc 528 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 gtg ttc ggc cag cgc tgg ggc ttc gac gcc gcc acc atc aac agc cgc 576 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 tac aac gac ctg acc cgc ctg atc ggc aac tac acc gac cac gcc gtg 624 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 cgc tgg tac aac acc ggc ctg gag cgc gtg tgg ggt ccc gac agc cgc 672 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 gac tgg atc agg tac aac cag ttc cgc cgc gag ctg acc ctg acc gtg 720 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 ctg gac atc gtg agc ctg ttc ccc aac tac gac agc cgc acc tac ccc 768 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 atc cgc acc gtg agc cag ctg acc cgc gag att tac acc aac ccc gtg 816 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 ctg gag aac ttc gac ggc agc ttc cgc ggc agc gcc cag ggc atc gag 864 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 ggc agc atc cgc agc ccc cac ctg atg gac atc ctg aac agc atc acc 912 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 atc tac acc gac gcc cac cgc ggc gag tac tac tgg agc ggc cac cag 960 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 atc atg gcc agc ccc gtc ggc ttc agc ggc ccc gag ttc acc ttc ccc 1008 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 ctg tac ggc acc atg ggc aac gct gca cct cag cag cgc atc gtg gca 1056 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 cag ctg ggc cag gga gtg tac cgc acc ctg agc agc acc ctg tac cgt 1104 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 cga cct ttc aac atc ggc atc aac aac cag cag ctg agc gtg ctg gac 1152 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 ggc acc gag ttc gcc tac ggc acc agc agc aac ctg ccc agc gcc gtg 1200 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 tac cgc aag agc ggc acc gtg gac agc ctg gac gag atc ccc cct cag 1248 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 aac aac aac gtg cca cct cga cag ggc ttc agc cac cgt ctg agc cac 1296 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 gtg agc atg ttc cgc agt ggc ttc agc aac agc agc gtg agc atc atc 1344 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 cgt gca ccc atg ttc agc tgg att cac cgc agc gcc acc ctg acc aac 1392 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 acc atc gac ccc gag cgc atc aac cag atc ccc ctg gtg aag ggc ttc 1440 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 cgg gtg tgg ggc ggc acc agc gtg atc acc ggc ccc ggc ttc acc gga 1488 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 ggc gac atc ctg cgc aga aac acc ttc ggc gac ttc gtg agc ctg cag 1536 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 gtg aac atc aac agc ccc atc acc cag cgt tac cgc ctg cgc ttc cgc 1584 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 tac gcc agc agc cgc gac gcc cgt gtg atc gtg ctg act ggc gcc gct 1632 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 agc acc ggt gtg ggc ggt cag gtg agc gtg aac atg ccc ctg cag aag 1680 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 act atg gag atc ggc gag aac ctg act agt cgc acc ttc cgc tac acc 1728 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 gac ttc agc aac ccc ttc agc ttc cgc gcc aac ccc gac atc atc ggc 1776 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 atc agc gag cag ccc ctg ttc ggt gcc ggc agc atc agc agc ggc gag 1824 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 ctg tac atc gac aag atc gag atc atc ctg gcc gac gcc acc ttc gag 1872 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 gcc gag agc gac ctg gag cgc gcc cag aag gcc gtg aac gcc ctg ttc 1920 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 acc agc agc aac cag atc ggc ctg aag acc gac gtg acc gac tac cac 1968 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 atc gac cag gtg agc aac ctg gtg gac tgc tta agc tag 2007 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser             660 665 <210> 10 <211> 668 <212> PRT <213> Artificial Sequence <223> Description of Artificial Sequence: synthetic gene       encoding H04 plus the first 40 amino acids of the       Cry1Ab tail <400> 10 Met Asp Asn Asn Pro Asn Ile Asn Glu Cys Ile Pro Tyr Asn Cys Leu   1 5 10 15 Ser Asn Pro Glu Val Glu Val Leu Gly Gly Glu Arg Ile Glu Thr Gly              20 25 30 Tyr Thr Pro Ile Asp Ile Ser Leu Ser Leu Thr Gln Phe Leu Leu Ser          35 40 45 Glu Phe Val Pro Gly Ala Gly Phe Val Leu Gly Leu Val Asp Ile Ile      50 55 60 Trp Gly Ile Phe Gly Pro Ser Gln Trp Asp Ala Phe Leu Val Gln Ile  65 70 75 80 Glu Gln Leu Ile Asn Gln Arg Ile Glu Glu Phe Ala Arg Asn Gln Ala                  85 90 95 Ile Ser Arg Leu Glu Gly Leu Ser Asn Leu Tyr Gln Ile Tyr Ala Glu             100 105 110 Ser Phe Arg Glu Trp Glu Ala Asp Pro Thr Asn Pro Ala Leu Arg Glu         115 120 125 Glu Met Arg Ile Gln Phe Asn Asp Met Asn Ser Ala Leu Thr Thr Ala     130 135 140 Ile Pro Leu Phe Ala Val Gln Asn Tyr Gln Val Pro Leu Leu Ser Val 145 150 155 160 Tyr Val Gln Ala Ala Asn Leu His Leu Ser Val Leu Arg Asp Val Ser                 165 170 175 Val Phe Gly Gln Arg Trp Gly Phe Asp Ala Ala Thr Ile Asn Ser Arg             180 185 190 Tyr Asn Asp Leu Thr Arg Leu Ile Gly Asn Tyr Thr Asp His Ala Val         195 200 205 Arg Trp Tyr Asn Thr Gly Leu Glu Arg Val Trp Gly Pro Asp Ser Arg     210 215 220 Asp Trp Ile Arg Tyr Asn Gln Phe Arg Arg Glu Leu Thr Leu Thr Val 225 230 235 240 Leu Asp Ile Val Ser Leu Phe Pro Asn Tyr Asp Ser Arg Thr Tyr Pro                 245 250 255 Ile Arg Thr Val Ser Gln Leu Thr Arg Glu Ile Tyr Thr Asn Pro Val             260 265 270 Leu Glu Asn Phe Asp Gly Ser Phe Arg Gly Ser Ala Gln Gly Ile Glu         275 280 285 Gly Ser Ile Arg Ser Pro His Leu Met Asp Ile Leu Asn Ser Ile Thr     290 295 300 Ile Tyr Thr Asp Ala His Arg Gly Glu Tyr Tyr Trp Ser Gly His Gln 305 310 315 320 Ile Met Ala Ser Pro Val Gly Phe Ser Gly Pro Glu Phe Thr Phe Pro                 325 330 335 Leu Tyr Gly Thr Met Gly Asn Ala Ala Pro Gln Gln Arg Ile Val Ala             340 345 350 Gln Leu Gly Gln Gly Val Tyr Arg Thr Leu Ser Ser Thr Leu Tyr Arg         355 360 365 Arg Pro Phe Asn Ile Gly Ile Asn Asn Gln Gln Leu Ser Val Leu Asp     370 375 380 Gly Thr Glu Phe Ala Tyr Gly Thr Ser Ser Asn Leu Pro Ser Ala Val 385 390 395 400 Tyr Arg Lys Ser Gly Thr Val Asp Ser Leu Asp Glu Ile Pro Pro Gln                 405 410 415 Asn Asn Asn Val Pro Pro Arg Gln Gly Phe Ser His Arg Leu Ser His             420 425 430 Val Ser Met Phe Arg Ser Gly Phe Ser Asn Ser Ser Val Ser Ile Ile         435 440 445 Arg Ala Pro Met Phe Ser Trp Ile His Arg Ser Ala Thr Leu Thr Asn     450 455 460 Thr Ile Asp Pro Glu Arg Ile Asn Gln Ile Pro Leu Val Lys Gly Phe 465 470 475 480 Arg Val Trp Gly Gly Thr Ser Val Ile Thr Gly Pro Gly Phe Thr Gly                 485 490 495 Gly Asp Ile Leu Arg Arg Asn Thr Phe Gly Asp Phe Val Ser Leu Gln             500 505 510 Val Asn Ile Asn Ser Pro Ile Thr Gln Arg Tyr Arg Leu Arg Phe Arg         515 520 525 Tyr Ala Ser Ser Arg Asp Ala Arg Val Ile Val Leu Thr Gly Ala Ala     530 535 540 Ser Thr Gly Val Gly Gly Gln Val Ser Val Asn Met Pro Leu Gln Lys 545 550 555 560 Thr Met Glu Ile Gly Glu Asn Leu Thr Ser Arg Thr Phe Arg Tyr Thr                 565 570 575 Asp Phe Ser Asn Pro Phe Ser Phe Arg Ala Asn Pro Asp Ile Ile Gly             580 585 590 Ile Ser Glu Gln Pro Leu Phe Gly Ala Gly Ser Ile Ser Ser Gly Glu         595 600 605 Leu Tyr Ile Asp Lys Ile Glu Ile Ile Leu Ala Asp Ala Thr Phe Glu     610 615 620 Ala Glu Ser Asp Leu Glu Arg Ala Gln Lys Ala Val Asn Ala Leu Phe 625 630 635 640 Thr Ser Ser Asn Gln Ile Gly Leu Lys Thr Asp Val Thr Asp Tyr His                 645 650 655 Ile Asp Gln Val Ser Asn Leu Val Asp Cys Leu Ser             660 665 <210> 11 <211> 13269 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1308 <220> <221> misc_feature (222) (1) .. (1896) <223> synthetic nucleotide sequence encoding the toxin       portion of H04, without a tail <220> <221> misc_feature (2102) .. (4083) <223> Zea mays ubiquitin promoter <220> <221> misc_feature (222) (4180) .. (5283) <223> PMI marker gene <220> <221> misc_feature (222) (11247) .. (12647) <223> Zm Ubi promoter <400> 11 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgctaagatc tgttctgcac aaagtggagt 1920 agtcagtcat cgatcaggaa ccagacacca gacttttatt catacagtga agtgaagtga 1980 agtgcagtgc agtgagttgc tggtttttgt acaacttagt atgtatttgt atttgtaaaa 2040 tacttctatc aataaaattt ctaattccta aaaccaaaat ccaggggtac cagcttgcat 2100 gcctgcagtg cagcgtgacc cggtcgtgcc cctctctaga gataatgagc attgcatgtc 2160 taagttataa aaaattacca catatttttt ttgtcacact tgtttgaagt gcagtttatc 2220 tatctttata catatattta aactttactc tacgaataat ataatctata gtactacaat 2280 aatatcagtg ttttagagaa tcatataaat gaacagttag acatggtcta aaggacaatt 2340 gagtattttg acaacaggac tctacagttt tatcttttta gtgtgcatgt gttctccttt 2400 ttttttgcaa atagcttcac ctatataata cttcatccat tttattagta catccattta 2460 gggtttaggg ttaatggttt ttatagacta atttttttag tacatctatt ttattctatt 2520 ttagcctcta aattaagaaa actaaaactc tattttagtt tttttattta ataatttaga 2580 tataaaatag aataaaataa agtgactaaa aattaaacaa atacccttta agaaattaaa 2640 aaaactaagg aaacattttt cttgtttcga gtagataatg ccagcctgtt aaacgccgtc 2700 gacgagtcta acggacacca accagcgaac cagcagcgtc gcgtcgggcc aagcgaagca 2760 gacggcacgg catctctgtc gctgcctctg gacccctctc gagagttccg ctccaccgtt 2820 ggacttgctc cgctgtcggc atccagaaat tgcgtggcgg agcggcagac gtgagccggc 2880 acggcaggcg gcctcctcct cctctcacgg caccggcagc tacgggggat tcctttccca 2940 ccgctccttc gctttccctt cctcgcccgc cgtaataaat agacaccccc tccacaccct 3000 ctttccccaa cctcgtgttg ttcggagcgc acacacacac aaccagatct cccccaaatc 3060 cacccgtcgg cacctccgct tcaaggtacg ccgctcgtcc tccccccccc cccctctcta 3120 ccttctctag atcggcgttc cggtccatgg ttagggcccg gtagttctac ttctgttcat 3180 gtttgtgtta gatccgtgtt tgtgttagat ccgtgctgct agcgttcgta cacggatgcg 3240 acctgtacgt cagacacgtt ctgattgcta acttgccagt gtttctcttt ggggaatcct 3300 gggatggctc tagccgttcc gcagacggga tcgatttcat gatttttttt gtttcgttgc 3360 atagggtttg gtttgccctt ttcctttatt tcaatatatg ccgtgcactt gtttgtcggg 3420 tcatcttttc atgctttttt ttgtcttggt tgtgatgatg tggtctggtt gggcggtcgt 3480 tctagatcgg agtagaattc tgtttcaaac tacctggtgg atttattaat tttggatctg 3540 tatgtgtgtg ccatacatat tcatagttac gaattgaaga tgatggatgg aaatatcgat 3600 ctaggatagg tatacatgtt gatgcgggtt ttactgatgc atatacagag atgctttttg 3660 ttcgcttggt tgtgatgatg tggtgtggtt gggcggtcgt tcattcgttc tagatcggag 3720 tagaatactg tttcaaacta cctggtgtat ttattaattt tggaactgta tgtgtgtgtc 3780 atacatcttc atagttacga gtttaagatg gatggaaata tcgatctagg ataggtatac 3840 atgttgatgt gggttttact gatgcatata catgatggca tatgcagcat ctattcatat 3900 gctctaacct tgagtaccta tctattataa taaacaagta tgttttataa ttattttgat 3960 cttgatatac ttggatgatg gcatatgcag cagctatatg tggatttttt tagccctgcc 4020 ttcatacgct atttatttgc ttggtactgt ttcttttgtc gatgctcacc ctgttgtttg 4080 gtgttacttc tgcagggatc cccgatcatg caaaaactca ttaactcagt gcaaaactat 4140 gcctggggca gcaaaacggc gttgactgaa ctttatggta tggaaaatcc gtccagccag 4200 ccgatggccg agctgtggat gggcgcacat ccgaaaagca gttcacgagt gcagaatgcc 4260 gccggagata tcgtttcact gcgtgatgtg attgagagtg ataaatcgac tctgctcgga 4320 gaggccgttg ccaaacgctt tggcgaactg cctttcctgt tcaaagtatt atgcgcagca 4380 cagccactct ccattcaggt tcatccaaac aaacacaatt ctgaaatcgg ttttgccaaa 4440 gaaaatgccg caggtatccc gatggatgcc gccgagcgta actataaaga tcctaaccac 4500 aagccggagc tggtttttgc gctgacgcct ttccttgcga tgaacgcgtt tcgtgaattt 4560 tccgagattg tctccctact ccagccggtc gcaggtgcac atccggcgat tgctcacttt 4620 ttacaacagc ctgatgccga acgtttaagc gaactgttcg ccagcctgtt gaatatgcag 4680 ggtgaagaaa aatcccgcgc gctggcgatt ttaaaatcgg ccctcgatag ccagcagggt 4740 gaaccgtggc aaacgattcg tttaatttct gaattttacc cggaagacag cggtctgttc 4800 tccccgctat tgctgaatgt ggtgaaattg aaccctggcg aagcgatgtt cctgttcgct 4860 gaaacaccgc acgcttacct gcaaggcgtg gcgctggaag tgatggcaaa ctccgataac 4920 gtgctgcgtg cgggtctgac gcctaaatac attgatattc cggaactggt tgccaatgtg 4980 aaattcgaag ccaaaccggc taaccagttg ttgacccagc cggtgaaaca aggtgcagaa 5040 ctggacttcc cgattccagt ggatgatttt gccttctcgc tgcatgacct tagtgataaa 5100 gaaaccacca ttagccagca gagtgccgcc attttgttct gcgtcgaagg cgatgcaacg 5160 ttgtggaaag gttctcagca gttacagctt aaaccgggtg aatcagcgtt tattgccgcc 5220 aacgaatcac cggtgactgt caaaggccac ggccgtttag cgcgtgttta caacaagctg 5280 taagagctta ctgaaaaaat taacatctct tgctaagctg ggagctcgat ccgtcgacct 5340 gcagatcgtt caaacatttg gcaataaagt ttcttaagat tgaatcctgt tgccggtctt 5400 gcgatgatta tcatataatt tctgttgaat tacgttaagc atgtaataat taacatgtaa 5460 tgcatgacgt tatttatgag atgggttttt atgattagag tcccgcaatt atacatttaa 5520 tacgcgatag aaaacaaaat atagcgcgca aactaggata aattatcgcg cgcggtgtca 5580 tctatgttac tagatctgct agccctgcag gaaatttacc ggtgcccggg cggccagcat 5640 ggccgtatcc gcaatgtgtt attaagttgt ctaagcgtca atttgtttac accacaatat 5700 atcctgccac cagccagcca acagctcccc gaccggcagc tcggcacaaa atcaccactc 5760 gatacaggca gcccatcaga attaattctc atgtttgaca gcttatcatc gactgcacgg 5820 tgcaccaatg cttctggcgt caggcagcca tcggaagctg tggtatggct gtgcaggtcg 5880 taaatcactg cataattcgt gtcgctcaag gcgcactccc gttctggata atgttttttg 5940 cgccgacatc ataacggttc tggcaaatat tctgaaatga gctgttgaca attaatcatc 6000 cggctcgtat aatgtgtgga attgtgagcg gataacaatt tcacacagga aacagaccat 6060 gagggaagcg ttgatcgccg aagtatcgac tcaactatca gaggtagttg gcgtcatcga 6120 gcgccatctc gaaccgacgt tgctggccgt acatttgtac ggctccgcag tggatggcgg 6180 cctgaagcca cacagtgata ttgatttgct ggttacggtg accgtaaggc ttgatgaaac 6240 aacgcggcga gctttgatca acgacctttt ggaaacttcg gcttcccctg gagagagcga 6300 gattctccgc gctgtagaag tcaccattgt tgtgcacgac gacatcattc cgtggcgtta 6360 tccagctaag cgcgaactgc aatttggaga atggcagcgc aatgacattc ttgcaggtat 6420 cttcgagcca gccacgatcg acattgatct ggctatcttg ctgacaaaag caagagaaca 6480 tagcgttgcc ttggtaggtc cagcggcgga ggaactcttt gatccggttc ctgaacagga 6540 tctatttgag gcgctaaatg aaaccttaac gctatggaac tcgccgcccg actgggctgg 6600 cgatgagcga aatgtagtgc ttacgttgtc ccgcatttgg tacagcgcag taaccggcaa 6660 aatcgcgccg aaggatgtcg ctgccgactg ggcaatggag cgcctgccgg cccagtatca 6720 gcccgtcata cttgaagcta ggcaggctta tcttggacaa gaagatcgct tggcctcgcg 6780 cgcagatcag ttggaagaat ttgttcacta cgtgaaaggc gagatcacca aagtagtcgg 6840 caaataaagc tctagtggat ctccgtaccc ccgggggatc tggctcgcgg cggacgcacg 6900 acgccggggc gagaccatag gcgatctcct aaatcaatag tagctgtaac ctcgaagcgt 6960 ttcacttgta acaacgattg agaatttttg tcataaaatt gaaatacttg gttcgcattt 7020 ttgtcatccg cggtcagccg caattctgac gaactgccca tttagctgga gatgattgta 7080 catccttcac gtgaaaattt ctcaagcgct gtgaacaagg gttcagattt tagattgaaa 7140 ggtgagccgt tgaaacacgt tcttcttgtc gatgacgacg tcgctatgcg gcatcttatt 7200 attgaatacc ttacgatcca cgccttcaaa gtgaccgcgg tagccgacag cacccagttc 7260 acaagagtac tctcttccgc gacggtcgat gtcgtggttg ttgatctaaa tttaggtcgt 7320 gaagatgggc tcgagatcgt tcgtaatctg gcggcaaagt ctgatattcc aatcataatt 7380 atcagtggcg accgccttga ggagacggat aaagttgttg cactcgagct aggagcaagt 7440 gattttatcg ctaagccgtt cagtatcaga gagtttctag cacgcattcg ggttgccttg 7500 cgcgtgcgcc ccaacgttgt ccgctccaaa gaccgacggt ctttttgttt tactgactgg 7560 acacttaatc tcaggcaacg tcgcttgatg tccgaagctg gcggtgaggt gaaacttacg 7620 gcaggtgagt tcaatcttct cctcgcgttt ttagagaaac cccgcgacgt tctatcgcgc 7680 gagcaacttc tcattgccag tcgagtacgc gacgaggagg tttatgacag gagtatagat 7740 gttctcattt tgaggctgcg ccgcaaactt gaggcagatc cgtcaagccc tcaactgata 7800 aaaacagcaa gaggtgccgg ttatttcttt gacgcggacg tgcaggtttc gcacgggggg 7860 acgatggcag cctgagccaa ttcccagatc cccgaggaat cggcgtgagc ggtcgcaaac 7920 catccggccc ggtacaaatc ggcgcggcgc tgggtgatga cctggtggag aagttgaagg 7980 ccgcgcaggc cgcccagcgg caacgcatcg aggcagaagc acgccccggt gaatcgtggc 8040 aagcggccgc tgatcgaatc cgcaaagaat cccggcaacc gccggcagcc ggtgcgccgt 8100 cgattaggaa gccgcccaag ggcgacgagc aaccagattt tttcgttccg atgctctatg 8160 acgtgggcac ccgcgatagt cgcagcatca tggacgtggc cgttttccgt ctgtcgaagc 8220 gtgaccgacg agctggcgag gtgatccgct acgagcttcc agacgggcac gtagaggttt 8280 ccgcagggcc ggccggcatg gccagtgtgt gggattacga cctggtactg atggcggttt 8340 cccatctaac cgaatccatg aaccgatacc gggaagggaa gggagacaag cccggccgcg 8400 tgttccgtcc acacgttgcg gacgtactca agttctgccg gcgagccgat ggcggaaagc 8460 agaaagacga cctggtagaa acctgcattc ggttaaacac cacgcacgtt gccatgcagc 8520 gtacgaagaa ggccaagaac ggccgcctgg tgacggtatc cgagggtgaa gccttgatta 8580 gccgctacaa gatcgtaaag agcgaaaccg ggcggccgga gtacatcgag atcgagctag 8640 ctgattggat gtaccgcgag atcacagaag gcaagaaccc ggacgtgctg acggttcacc 8700 ccgattactt tttgatcgat cccggcatcg gccgttttct ctaccgcctg gcacgccgcg 8760 ccgcaggcaa ggcagaagcc agatggttgt tcaagacgat ctacgaacgc agtggcagcg 8820 ccggagagtt caagaagttc tgtttcaccg tgcgcaagct gatcgggtca aatgacctgc 8880 cggagtacga tttgaaggag gaggcggggc aggctggccc gatcctagtc atgcgctacc 8940 gcaacctgat cgagggcgaa gcatccgccg gttcctaatg tacggagcag atgctagggc 9000 aaattgccct agcaggggaa aaaggtcgaa aaggtctctt tcctgtggat agcacgtaca 9060 ttgggaaccc aaagccgtac attgggaacc ggaacccgta cattgggaac ccaaagccgt 9120 acattgggaa ccggtcacac atgtaagtga ctgatataaa agagaaaaaa ggcgattttt 9180 ccgcctaaaa ctctttaaaa cttattaaaa ctcttaaaac ccgcctggcc tgtgcataac 9240 tgtctggcca gcgcacagcc gaagagctgc aaaaagcgcc tacccttcgg tcgctgcgct 9300 ccctacgccc cgccgcttcg cgtcggccta tcgcggccgc tggccgctca aaaatggctg 9360 gcctacggcc aggcaatcta ccagggcgcg gacaagccgc gccgtcgcca ctcgaccgcc 9420 ggcgctgagg tctgcctcgt gaagaaggtg ttgctgactc ataccaggcc tgaatcgccc 9480 catcatccag ccagaaagtg agggagccac ggttgatgag agctttgttg taggtggacc 9540 agttggtgat tttgaacttt tgctttgcca cggaacggtc tgcgttgtcg ggaagatgcg 9600 tgatctgatc cttcaactca gcaaaagttc gatttattca acaaagccgc cgtcccgtca 9660 agtcagcgta atgctctgcc agtgttacaa ccaattaacc aattctgatt agaaaaactc 9720 atcgagcatc aaatgaaact gcaatttatt catatcagga ttatcaatac catatttttg 9780 aaaaagccgt ttctgtaatg aaggagaaaa ctcaccgagg cagttccata ggatggcaag 9840 atcctggtat cggtctgcga ttccgactcg tccaacatca atacaaccta ttaatttccc 9900 ctcgtcaaaa ataaggttat caagtgagaa atcaccatga gtgacgactg aatccggtga 9960 gaatggcaaa agctctgcat taatgaatcg gccaacgcgc ggggagaggc ggtttgcgta 10020 ttgggcgctc ttccgcttcc tcgctcactg actcgctgcg ctcggtcgtt cggctgcggc 10080 gagcggtatc agctcactca aaggcggtaa tacggttatc cacagaatca ggggataacg 10140 caggaaagaa catgtgagca aaaggccagc aaaaggccag gaaccgtaaa aaggccgcgt 10200 tgctggcgtt tttccatagg ctccgccccc ctgacgagca tcacaaaaat cgacgctcaa 10260 gtcagaggtg gcgaaacccg acaggactat aaagatacca ggcgtttccc cctggaagct 10320 ccctcgtgcg ctctcctgtt ccgaccctgc cgcttaccgg atacctgtcc gcctttctcc 10380 cttcgggaag cgtggcgctt tctcatagct cacgctgtag gtatctcagt tcggtgtagg 10440 tcgttcgctc caagctgggc tgtgtgcacg aaccccccgt tcagcccgac cgctgcgcct 10500 tatccggtaa ctatcgtctt gagtccaacc cggtaagaca cgacttatcg ccactggcag 10560 cagccactgg taacaggatt agcagagcga ggtatgtagg cggtgctaca gagttcttga 10620 agtggtggcc taactacggc tacactagaa gaacagtatt tggtatctgc gctctgctga 10680 agccagttac cttcggaaaa agagttggta gctcttgatc cggcaaacaa accaccgctg 10740 gtagcggtgg tttttttgtt tgcaagcagc agattacgcg cagaaaaaaa ggatctcaag 10800 aagatccttt gatcttttct acggggtctg acgctcagtg gaacgaaaac tcacgttaag 10860 ggattttggt catgagatta tcaaaaagga tcttcaccta gatccttttg atccggaatt 10920 aattcctgtg gttggcatgc acatacaaat ggacgaacgg ataaaccttt tcacgccctt 10980 ttaaatatcc gattattcta ataaacgctc ttttctctta ggtttacccg ccaatatatc 11040 ctgtcaaaca ctgatagttt aaactgaagg cgggaaacga caatctgatc atgagcggag 11100 aattaaggga gtcacgttat gacccccgcc gatgacgcgg gacaagccgt tttacgtttg 11160 gaactgacag aaccgcaacg ctgcaggaat tggccgcagc ggccatttaa atcaattggg 11220 cgcgccgaat tcgagctcgg tacaagcttg catgcctgca gtgcagcgtg acccggtcgt 11280 gcccctctct agagataatg agcattgcat gtctaagtta taaaaaatta ccacatattt 11340 tttttgtcac acttgtttga agtgcagttt atctatcttt atacatatat ttaaacttta 11400 ctctacgaat aatataatct atagtactac aataatatca gtgttttaga gaatcatata 11460 aatgaacagt tagacatggt ctaaaggaca attgagtatt ttgacaacag gactctacag 11520 ttttatcttt ttagtgtgca tgtgttctcc tttttttttg caaatagctt cacctatata 11580 atacttcatc cattttatta gtacatccat ttagggttta gggttaatgg tttttataga 11640 ctaatttttt tagtacatct attttattct attttagcct ctaaattaag aaaactaaaa 11700 ctctatttta gtttttttat ttaataattt agatataaaa tagaataaaa taaagtgact 11760 aaaaattaaa caaataccct ttaagaaatt aaaaaaacta aggaaacatt tttcttgttt 11820 cgagtagata atgccagcct gttaaacgcc gtcgacgagt ctaacggaca ccaaccagcg 11880 aaccagcagc gtcgcgtcgg gccaagcgaa gcagacggca cggcatctct gtcgctgcct 11940 ctggacccct ctcgagagtt ccgctccacc gttggacttg ctccgctgtc ggcatccaga 12000 aattgcgtgg cggagcggca gacgtgagcc ggcacggcag gcggcctcct cctcctctca 12060 cggcacggca gctacggggg attcctttcc caccgctcct tcgctttccc ttcctcgccc 12120 gccgtaataa atagacaccc cctccacacc ctctttcccc aacctcgtgt tgttcggagc 12180 gcacacacac acaaccagat ctcccccaaa tccacccgtc ggcacctccg cttcaaggta 12240 cgccgctcgt cctccccccc cccccctctc taccttctct agatcggcgt tccggtccat 12300 ggttagggcc cggtagttct acttctgttc atgtttgtgt tagatccgtg tttgtgttag 12360 atccgtgctg ctagcgttcg tacacggatg cgacctgtac gtcagacacg ttctgattgc 12420 taacttgcca gtgtttctct ttggggaatc ctgggatggc tctagccgtt ccgcagacgg 12480 gatcgatttc atgatttttt ttgtttcgtt gcatagggtt tggtttgccc ttttccttta 12540 tttcaatata tgccgtgcac ttgtttgtcg ggtcatcttt tcatgctttt ttttgtcttg 12600 gttgtgatga tgtggtctgg ttgggcggtc gttctagatc ggagtagaat tctgtttcaa 12660 actacctggt ggatttatta attttggatc tgtatgtgtg tgccatacat attcatagtt 12720 acgaattgaa gatgatggat ggaaatatcg atctaggata ggtatacatg ttgatgcggg 12780 ttttactgat gcatatacag agatgctttt tgttcgcttg gttgtgatga tgtggtgtgg 12840 ttgggcggtc gttcattcgt tctagatcgg agtagaatac tgtttcaaac tacctggtgt 12900 atttattaat tttggaactg tatgtgtgtg tcatacatct tcatagttac gagtttaaga 12960 tggatggaaa tatcgatcta ggataggtat acatgttgat gtgggtttta ctgatgcata 13020 tacatgatgg catatgcagc atctattcat atgctctaac cttgagtacc tatctattat 13080 aataaacaag tatgttttat aattattttg atcttgatat acttggatga tggcatatgc 13140 agcagctata tgtggatttt tttagccctg ccttcatacg ctatttattt gcttggtact 13200 gtttcttttg tcgatgctca ccctgttgtt tggtgttact tctgcaggtc gactctagag 13260 gatccaaca 13269 <210> 12 <211> 16179 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1436 <220> <221> misc_feature (222) (1) .. (3582) <223> synthetic nucleotide sequence encoding the toxin       portion of H04 plus a full-length Cry1Ab tail       portion <220> <221> misc_feature Complement ((10390) .. (11598)) <223> PhosphoMannose Isomerase (PMI) marker gene <220> <221> misc_feature Complement ((12718) .. (13608)) <223> Maize ubiquitin (Zm Ubi) promoter <220> <221> misc_feature <222> (13613) .. (16170) <223> MTL promoter <400> 12 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgcgcccaga aggccgtgaa cgccctgttc 1920 accagcagca accagatcgg cctgaagacc gacgtgaccg actaccacat cgaccaggtg 1980 agcaacctgg tggactgctt aagcgacgag ttctgcctgg acgagaagaa ggagctgagc 2040 gagaaggtga agcacgccaa gcgcctgagc gacgagcgca acctgctgca ggaccccaac 2100 ttccgcggca tcaaccgcca gctggaccgc ggctggcgag gcagcaccga tatcaccatc 2160 cagggcggcg acgacgtgtt caaggagaac tacgtgaccc tgcagggcac cttcgacgag 2220 tgctacccca cctacctgta ccagccgatc gacgagagca agctgaaggc ctacacccgc 2280 taccagctgc gcggctacat cgaggacagc caggacctgg aaatctacct gatccgctac 2340 aacgcgaagc acgagaccgt gaacgtgccc ggcaccggca gcctgtggcc cccgagcgcc 2400 cccagcccca tcggcaagtg cggggagccg aatcgatgcg ctccgcacct ggagtggaac 2460 ccggacctag actgcagctg cagggacggg gagaagtgcg cccaccacag ccaccacttc 2520 agcctggaca tcgacgtggg ctgcaccgac ctgaacgagg acctgggcgt gtgggtgatc 2580 ttcaagatca agacccagga cggccacgcc cgcctgggca atctagagtt cctggaggag 2640 aagcccctgg tgggcgaggc cctggcccgc gtgaagcgtg ctgagaagaa gtggcgcgac 2700 aagcgcgaga agctggagtg ggagaccaac atcgtgtaca aggaggccaa ggagagcgtg 2760 gacgccctgt tcgtgaacag ccagtacgac cgcctgcagg ccgacaccaa catcgccatg 2820 atccacgccg ccgacaagcg cgtgcacagc attcgcgagg cctacctgcc cgagctgagc 2880 gtgatccccg gtgtgaacgc cgccatcttc gaggaactcg agggccgcat cttcaccgcc 2940 ttcagcctgt acgacgcccg caacgtgatc aagaacggcg acttcaacaa cggcctgagc 3000 tgctggaacg tgaagggcca cgtggacgtg gaggagcaga acaaccaccg cagcgtgctg 3060 gtggtgcccg agtgggaggc cgaggtgagc caggaggtgc gcgtgtgccc cggccgcggc 3120 tacatcctgc gcgtgaccgc ctacaaggag ggctacggcg agggctgcgt gaccatccac 3180 gagatcgaga acaacaccga cgagctcaag ttcagcaact gcgtggagga ggaggtttac 3240 cccaacaaca ccgtgacctg caacgactac accgcgaccc aggaggagta cgaaggcacc 3300 tacacctctc gcaacagggg ttacgacggc gcctacgagt ccaacagctc cgtgccagct 3360 gactacgcca gcgcccacga ggagaaagcc tacaccgacg gtagacgcga caacccatgt 3420 gagagcaaca gaggctacgg cgactacacc cccctgcccg ctggatacgt gaccaaggag 3480 ctggagtact tccccgagac cgacaaggtg tggatcgaga ttggcgagac cgagggcacc 3540 ttcatcgtgg acagcgtgga gctgctgctg atggaggagt agtagatctg ttctgcacaa 3600 agtggagtag tcagtcatcg atcaggaacc agacaccaga cttttattca tacagtgaag 3660 tgaagtgaag tgcagtgcag tgagttgctg gtttttgtac cacttagtat gtatttgtat 3720 ttgtaaaata cttctatcaa taaaatttct aattcctaaa accaaaatcc agtgggtacc 3780 agcttgggct gagtggctcc ttcaacgttg cggttctgtc agttccaaac gtaaaacggc 3840 ttgtcccgcg tcatcggcgg gggtcataac gtgactccct taattctccg ctcatgatca 3900 gattgtcgtt tcccgccttc agtttaaact atcagtgttt gacaggatat attggcgggt 3960 aaacctaaga gaaaagagcg tttattagaa taacggatat ttaaaagggc gtgaaaaggt 4020 ttatccgttc gtccatttgt atgtgcatgc caaccacagg gttcccctcg ggagtgcttg 4080 gcattccgta cgataatgac ttctgttcaa ccacccaaac gtcggaaagc ctgacgacgg 4140 agcagcattc caaaaagatc ccttggctcg tctgggtcgg ctagaaggtc gagtgggctg 4200 ctgtggcttg atccctcaac gcggtcgcgg acgtagcgca gcgccgaaaa atcctcgatc 4260 gcaaatccga cgctgtcgaa aagcgtgatc tgcttgtcgc tctttcggcc gacgtcctgg 4320 ccagtcatca cgcgccaaag ttccgtcaca ggatgatctg gcgcgagttg ctggatctcg 4380 ccttcaatcc gggtctgtgg cgggaactcc acgaaaatat ccgaacgcag caagatcgtc 4440 gaccaattct tgaagacgaa agggcctcgt gatacgccta tttttatagg ttaatgtcat 4500 gataataatg gtttcttaga cgtcaggtgg cacttttcgg ggaaatgtgc gcggaacccc 4560 tatttgttta tttttctaaa tacattcaaa tatgtatccg ctcatgagac aataaccctg 4620 ataaatgctt caataatatt gaaaaaggaa gagtatgagt attcaacatt tccgtgtcgc 4680 ccttattccc ttttttgcgg cattttgcct tcctgttttt gctcacccag aaacgctggt 4740 gaaagtaaaa gatgctgaag atcagttggg tgcacgagtg ggttacatcg aactggatct 4800 caacagcggt aagatccttg agagttttcg ccccgaagaa cgttttccaa tgatgagcac 4860 ttttaaagtt ctgctatgtg gcgcggtatt atcccgtgtt gacgccgggc aagagcaact 4920 cggtcgccgc atacactatt ctcagaatga cttggttgag tactcaccag tcacagaaaa 4980 gcatcttacg gatggcatga cagtaagaga attatgcagt gctgccataa ccatgagtga 5040 taacactgcg gccaacttac ttctgacaac gatcggagga ccgaaggagc taaccgcttt 5100 tttgcacaac atgggggatc atgtaactcg ccttgatcgt tgggaaccgg agctgaatga 5160 agccatacca aacgacgagc gtgacaccac gatgcctgca gggggggggg ggggggggac 5220 atgaggttgc cccgtattca gtgtcgctga tttgtattgt ctgaagttgt ttttacgtta 5280 agttgatgca gatcaattaa tacgatacct gcgtcataat tgattatttg acgtggtttg 5340 atggcctcca cgcacgttgt gatatgtaga tgataatcat tatcacttta cgggtccttt 5400 ccggtgatcc gacaggttac ggggcggcga cctcgcgggt tttcgctatt tatgaaaatt 5460 ttccggttta aggcgtttcc gttcttcttc gtcataactt aatgttttta tttaaaatac 5520 cctctgaaaa gaaaggaaac gacaggtgct gaaagcgagg ctttttggcc tctgtcgttt 5580 cctttctctg tttttgtccg tggaatgaac aatggaagtc cccccccccc cccccccctg 5640 cagcaatggc aacaacgttg cgcaaactat taactggcga actacttact ctagcttccc 5700 ggcaacaatt aatagactgg atggaggcgg ataaagttgc aggaccactt ctgcgctcgg 5760 cccttccggc tggctggttt attgctgata aatctggagc cggtgagcgt gggtctcgcg 5820 gtatcattgc agcactgggg ccagatggta agccctcccg tatcgtagtt atctacacga 5880 cggggagtca ggcaactatg gatgaacgaa atagacagat cgctgagata ggtgcctcac 5940 tgattaagca ttggtaactg tcagaccaag tttactcata tatactttag attgatttaa 6000 aacttcattt ttaatttaaa aggatctagg tgaagatcct ttttgataat ctcatgacca 6060 aaatccctta acgtgagttt tcgttccact gagcgtcaga ccccgtagaa aagatcaaag 6120 gatcttcttg agatcctttt tttctgcgcg taatctgctg cttgcaaaca aaaaaaccac 6180 cgctaccagc ggtggtttgt ttgccggatc aagagctacc aactcttttt ccgaaggtaa 6240 ctggcttcag cagagcgcag ataccaaata ctgtccttct agtgtagccg tagttaggcc 6300 accacttcaa gaactctgta gcaccgccta catacctcgc tctgctaatc ctgttaccag 6360 tggctgctgc cagtggcgat aagtcgtgtc ttaccgggtt ggactcaaga cgatagttac 6420 cggataaggc gcagcggtcg ggctgaacgg ggggttcgtg cacacagccc agcttggagc 6480 gaacgaccta caccgaactg agatacctac agcgtgagct atgagaaagc gccacgcttc 6540 ccgaagggag aaaggcggac aggtatccgg taagcggcag ggtcggaaca ggagagcgca 6600 cgagggagct tccaggggga aacgcctggt atctttatag tcctgtcggg tttcgccacc 6660 tctgacttga gcgtcgattt ttgtgatgct cgtcaggggg gcggagccta tggaaaaacg 6720 ccagcaacgc ggccttttta cggttcctgg ccttttgctg gccttttgct cacatgttct 6780 ttcctgcgtt atcccctgat tctgtggata accgtattac cgcctttgag tgagctgata 6840 ccgctcgccg cagccgaacg accgagcgca gcgagtcagt gagcgaggaa gcggaagagc 6900 gcctgatgcg gtattttctc cttacgcatc tgtgcggtat ttcacaccgc atatggtgca 6960 ctctcagtac aatctgctct gatgccgcat agttaagcca gtatacactc cgctatcgct 7020 acgtgactgg gtcatggctg cgccccgaca cccgccaaca cccgctgacg cgccctgacg 7080 ggcttgtctg ctcccggcat ccgcttacag acaagctgtg accgtctccg ggagctgcat 7140 gtgtcagagg ttttcaccgt catcaccgaa acgcgcgagg cagcagatcc cccgatcaag 7200 tagatacact acatatatct acaatagaca tcgagccgga aggtgatgtt tactttcctg 7260 aaatccccag caattttagg ccagttttta cccaagactt cgcctctaac ataaattata 7320 gttaccaaat ctggcaaaag ggttaacaag tggcagcaac ggattcgcaa acctgtcacg 7380 ccttttgtgc caaaagccgc gccaggtttg cgatccgctg tgccaggcgt taggcgtcat 7440 atgaagattt cggtgatccc tgagcaggtg gcggaaacat tggatgctga gaaccatttc 7500 attgttcgtg aagtgttcga tgtgcaccta tccgaccaag gctttgaact atctaccaga 7560 agtgtgagcc cctaccggaa ggattacatc tcggatgatg actctgatga agactctgct 7620 tgctatggcg cattcatcga ccaagagctt gtcgggaaga ttgaactcaa ctcaacatgg 7680 aacgatctag cctctatcga acacattgtt gtgtcgcaca cgcaccgagg caaaggagtc 7740 gcgcacagtc tcatcgaatt tgcgaaaaag tgggcactaa gcagacagct ccttggcata 7800 cgattagaga cacaaacgaa caatgtacct gcctgcaatt tgtacgcaaa atgtggcttt 7860 actctcggcg gcattgacct gttcacgtat aaaactagac ctcaagtctc gaacgaaaca 7920 gcgatgtact ggtactggtt ctcgggagca caggatgacg cctaacaatt cattcaagcc 7980 gacaccgctt cgcggcgcgg cttaattcag gagttaaaca tcatgaggga agcggtgatc 8040 gccgaagtat cgactcaact atcagaggta gttggcgtca tcgagcgcca tctcgaaccg 8100 acgttgctgg ccgtacattt gtacggctcc gcagtggatg gcggcctgaa gccacacagt 8160 gatattgatt tgctggttac ggtgaccgta aggcttgatg aaacaacgcg gcgagctttg 8220 atcaacgacc ttttggaaac ttcggcttcc cctggagaga gcgagattct ccgcgctgta 8280 gaagtcacca ttgttgtgca cgacgacatc attccgtggc gttatccagc taagcgcgaa 8340 ctgcaatttg gagaatggca gcgcaatgac attcttgcag gtatcttcga gccagccacg 8400 atcgacattg atctggctat cttgctgaca aaagcaagag aacatagcgt tgccttggta 8460 ggtccagcgg cggaggaact ctttgatccg gttcctgaac aggatctatt tgaggcgcta 8520 aatgaaacct taacgctatg gaactcgccg cccgactggg ctggcgatga gcgaaatgta 8580 gtgcttacgt tgtcccgcat ttggtacagc gcagtaaccg gcaaaatcgc gccgaaggat 8640 gtcgctgccg actgggcaat ggagcgcctg ccggcccagt atcagcccgt catacttgaa 8700 gctaggcagg cttatcttgg acaagaagat cgcttggcct cgcgcgcaga tcagttggaa 8760 gaatttgttc actacgtgaa aggcgagatc accaaggtag tcggcaaata atgtctaaca 8820 attcgttcaa gccgacgccg cttcgcggcg cggcttaact caagcgttag agagctgggg 8880 aagactatgc gcgatctgtt gaaggtggtt ctaagcctcg tacttgcgat ggcatcgggg 8940 caggcacttg ctgacctgcc aattgtttta gtggatgaag ctcgtcttcc ctatgactac 9000 tccccatcca actacgacat ttctccaagc aactacgaca actccataag caattacgac 9060 aatagtccat caaattacga caactctgag agcaactacg ataatagttc atccaattac 9120 gacaatagtc gcaacggaaa tcgtaggctt atatatagcg caaatgggtc tcgcactttc 9180 gccggctact acgtcattgc caacaatggg acaacgaact tcttttccac atctggcaaa 9240 aggatgttct acaccccaaa aggggggcgc ggcgtctatg gcggcaaaga tgggagcttc 9300 tgcggggcat tggtcgtcat aaatggccaa ttttcgcttg ccctgacaga taacggcctg 9360 aagatcatgt atctaagcaa ctagcctgct ctctaataaa atgttaggcc tcaacatcta 9420 gtcgcaagct gaggggaacc actagtgtca tacgaacctc caagagacgg ttacacaaac 9480 gggtacattg ttgatgtcat gtatgacaat cgcccaagta agtatccagc tgtgttcaga 9540 acgtacgtcc gaattaattc atcggggtac ggtcgacgat cgtcaacgtt cacttctaaa 9600 gaaatagcgc cactcagctt cctcagcggc tttatccagc gatttcctat tatgtcggca 9660 tagttctcaa gatcgacagc ctgtcacggt taagcgagaa atgaataaga aggctgataa 9720 ttcggatctc tgcgagggag atgatatttg atcacaggca gcaacgctct gtcatcgtta 9780 caatcaacat gctaccctcc gcgagatcat ccgtgtttca aacccggcag cttagttgcc 9840 gttcttccga atagcatcgg taacatgagc aaagtctgcc gccttacaac ggctctcccg 9900 ctgacgccgt cccggactga tgggctgcct gtatcgagtg gtgattttgt gccgagctgc 9960 cggtcgggga gctgttggct ggctggtggc aggatatatt gtggtgtaaa caaattgacg 10020 cttagacaac ttaataacac attgcggacg tttttaatgt actgaattgt ctagacccgg 10080 ggatctcatg tttgacagct tatcatcgga tctagtaaca tagatgacac cgcgcgcgat 10140 aatttatcct agtttgcgcg ctatattttg ttttctatcg cgtattaaat gtataattgc 10200 gggactctaa tcataaaaac ccatctcata aataacgtca tgcattacat gttaattatt 10260 acatgcttaa cgtaattcaa cagaaattag atgataatca tcgcaagacc ggcaacagga 10320 ttcaatctta agaaacttta ttgccaaatg tttgaacgat ctctgcaggt cgacggatcg 10380 agctcccagc ttagcaagag atgttaattt tttcagtaag ctcttacagc ttgttgtaaa 10440 cacgcgctaa acggccgtgg cctttgacag tcaccggtga ttcgttggcg gcaataaacg 10500 ctgattcacc cggtttaagc tgtaactgct gagaaccttt ccacaacgtt gcatcgcctt 10560 cgacgcagaa caaaatggcg gcactctgct ggctaatggt ggtttcttta tcactaaggt 10620 catgcagcga gaaggcaaaa tcatccactg gaatcgggaa gtccagttct gcaccttgtt 10680 tcaccggctg ggtcaacaac tggttagccg gtttggcttc gaatttcaca ttggcaacca 10740 gttccggaat atcaatgtat ttaggcgtca gacccgcacg cagcacgtta tcggagtttg 10800 ccatcacttc cagcgccacg ccttgcaggt aagcgtgcgg tgtttcagcg aacaggaaca 10860 tcgcttcgcc agggttcaat ttcaccacat tcagcaatag cggggagaac agaccgctgt 10920 cttccgggta aaattcagaa attaaacgaa tcgtttgcca cggttcaccc tgctggctat 10980 cgagggccga ttttaaaatc gccagcgcgc gggatttttc ttcaccctgc atattcaaca 11040 ggctggcgaa cagttcgctt aaacgttcgg catcaggctg ttgtaaaaag tgagcaatcg 11100 ccggatgtgc acctgcgacc ggctggagta gggagacaat ctcggaaaat tcacgaaacg 11160 cgttcatcgc aaggaaaggc gtcagcgcaa aaaccagctc cggcttgtgg ttaggatctt 11220 tatagttacg ctcggcggca tccatcggga tacctgcggc attttctttg gcaaaaccga 11280 tttcagaatt gtgtttgttt ggatgaacct gaatggagag tggctgtgct gcgcataata 11340 ctttgaacag gaaaggcagt tcgccaaagc gtttggcaac ggcctctccg agcagagtcg 11400 atttatcact ctcaatcaca tcacgcagtg aaacgatatc tccggcggca ttctgcactc 11460 gtgaactgct tttcggatgt gcgcccatcc acagctcggc catcggctgg ctggacggat 11520 tttccatacc ataaagttca gtcaacgcgt tttgctgccc caggcatagt tttgcactga 11580 gttaatgagt ttttgcatga tcggggatcc ctgcagaagt aacaccaaac aacagggtga 11640 gcatcgacaa aagaaacagt accaagcaaa taaatagcgt atgaaggcag ggctaaaaaa 11700 atccacatat agctgctgca tatgccatca tccaagtata tcaagatcaa aataattata 11760 aaacatactt gtttattata atagataggt actcaaggtt agagcatatg aatagatgct 11820 gcatatgcca tcatgtatat gcatcagtaa aacccacatc aacatgtata cctatcctag 11880 atcgatattt ccatccatct taaactcgta actatgaaga tgtatgacac acacatacag 11940 ttccaaaatt aataaataca ccaggtagtt tgaaacggcg tctactccga tctagaacga 12000 atgaacgacc gcccaaccac accacatcat cacaaccaag cgaacaaaaa gcatctctgt 12060 atatgcatca gtaaaacccg catcaacatg tatacctatc ctagatcgat atttccatcc 12120 atcatcttca attcgtaact atgaatatgt atggcacaca catacagatc caaaattaat 12180 aaatccacca ggtagtttga aacagaattc tactccgatc tagaacgacc gcccaaccag 12240 accacatcat cacaaccaag acaaaaaaaa gcatgaaaag atgacccgac aaacaagtgc 12300 acggcatata ttgaaataaa ggaaaagggc aaaccaaacc ctatgcaacg aaacaaaaaa 12360 aatcatgaaa tcgatcccgt ctgcggaacg gctagagcca tcccaggatt ccccaaagag 12420 aaacactggc aagttagcaa tcagaacgtg tctgacgtac aggtcgcatc cgtgtacgaa 12480 cgctagcagc acggatctaa cacaaacacg gatctaacac aaacatgaac agaagtagaa 12540 ctaccgggcc ctaaccatgg accggaacgc cgatctagag aaggtagaga gggggggggg 12600 gggaggacga gcggcgtacc ttgaagcgga ggtgccgacg ggtggatttg ggggagatct 12660 ggttgtgtgt gtgtgcgctc cgaacaacac gaggttgggg aaagagggtg tggagggggt 12720 gtctatttat tacggcgggc gaggaaggga aagcgaagga gcggtgggaa aggaatcccc 12780 cgtagctgcc gtgccgtgag aggaggagga ggccgcctgc cgtgccggct cacgtctgcc 12840 gctccgccac gcaatttctg gatgccgaca gcggagcaag tccaacggtg gagcggaact 12900 ctcgagaggg gtccagaggc agcgacagag atgccgtgcc gtctgcttcg cttggcccga 12960 cgcgacgctg ctggttcgct ggttggtgtc cgttagactc gtcgacggcg tttaacaggc 13020 tggcattatc tactcgaaac aagaaaaatg tttccttagt ttttttaatt tcttaaaggg 13080 tatttgttta atttttagtc actttatttt attctatttt atatctaaat tattaaataa 13140 aaaaactaaa atagagtttt agttttctta atttagaggc taaaatagaa taaaatagat 13200 gtactaaaaa aattagtcta taaaaaccat taaccctaaa ccctaaatgg atgtactaat 13260 aaaatggatg aagtattata taggtgaagc tatttgcaaa aaaaaaggag aacacatgca 13320 cactaaaaag ataaaactgt agagtcctgt tgtcaaaata ctcaattgtc ctttagacca 13380 tgtctaactg ttcatttata tgattctcta aaacactgat attattgtag tactatagat 13440 tatattattc gtagagtaaa gtttaaatat atgtataaag atagataaac tgcacttcaa 13500 acaagtgtga caaaaaaaat atgtggtaat tttttataac ttagacatgc aatgctcatt 13560 atctctagag aggggcacga ccgggtcacg ctgcactgca ggcatgcaag cttgcacatg 13620 acaacaattg taagaggatg gagaccacaa cgatccaaca atacttctgc gacgggctgt 13680 gaagtataga gaagttaaac gcccaaaagc cattgtgttt ggaattttta gttattctat 13740 ttttcatgat gtatcttcct ctaacatgcc ttaatttgca aatttggtat aactactgat 13800 tgaaaatata tgtatgtaaa aaaatactaa gcatatttgt gaagctaaac atgatgttat 13860 ttaagaaaat atgttgttaa cagaataaga ttaatatcga aatggaaaca tctgtaaatt 13920 agaatcatct tacaagctaa gagatgttca cgctttgaga aacttcttca gatcatgacc 13980 gtagaagtag ctctccaaga ctcaacgaag gctgctgcaa ttccacaaat gcatgacatg 14040 catccttgta accgtcgtcg ccgctataaa cacggataac tcaattccct gctccatcaa 14100 tttagaaatg agcaagcaag cacccgatcg ctcaccccat atgcaccaat ctgactccca 14160 agtctctgtt tcgcattagt accgccagca ctccacctat agctaccaat tgagaccttt 14220 ccagcctaag cagatcgatt gatcgttaga gtcaaagagt tggtggtacg ggtactttaa 14280 ctaccatgga atgatggggc gtgatgtaga gcggaaagcg cctccctacg cggaacaaca 14340 ccctcgccat gccgctcgac tacagcctcc tcctcgtcgg ccgcccacaa cgagggagcc 14400 cgtggtcgca gccaccgacc agcatgtctc tgtgtcctcg tccgacctcg acatgtcatg 14460 gcaaacagtc ggacgccagc accagactga cgacatgagt ctctgaagag cccgccacct 14520 agaaagatcc gagccctgct gctggtagtg gtaaccattt tcgtcgcgct gacgcggaga 14580 gcgagaggcc agaaatttat agcgactgac gctgtggcag gcacgctatc ggaggttacg 14640 acgtggcggg tcactcgacg cggagttcac aggtcctatc cttgcatcgc tcgggccgga 14700 gtttacggga cttatcctta cgacgtgctc taaggttgcg ataacgggcg gaggaaggcg 14760 tgtggcgtgc ggagacggtt tatacacgta gtgtgcggga gtgtgtttcg tagacgcggg 14820 aaagcacgac gacttacgaa ggttagtgga ggaggaggac acactaaaat caggacgcaa 14880 gaaactcttc tattatagta gtagagaaga gattatagga gtgtgggttg attctaaaga 14940 aaatcgacgc aggacaaccg tcaaaacggg tgctttaata tagtagatat atatatatag 15000 agagagagag aaagtacaaa ggatgcattt gtgtctgcat atgatcggag tattactaac 15060 ggccgtcgta agaaggtcca tcatgcgtgg agcgagccca tttggttggt tgtcaggccg 15120 cagttaaggc ctccatatat gattgtcgtc gggcccataa cagcatctcc tccaccagtt 15180 tattgtaaga ataaattaag tagagatatt tgtcgtcggg cagaagaaac ttggacaaga 15240 agaagaagca agctaggcca atttcttgcc ggcaagagga agatagtggc ctctagttta 15300 tatatcggcg tgatgatgat gctcctagct agaaatgaga gaagaaaaac ggacgcgtgt 15360 ttggtgtgtg tcaatggcgt ccatccttcc atcagatcag aacgatgaaa aagtcaagca 15420 cggcatgcat agtatatgta tagcttgttt tagtgtggct ttgctgagac gaatgaaagc 15480 aacggcgggc atatttttca gtggctgtag ctttcaggct gaaagagacg tggcatgcaa 15540 taattcaggg aattcgtcag ccaattgagg tagctagtca acttgtacat tggtgcgagc 15600 aattttccgc actcaggagg gctagtttga gagtccaaaa actataggag attaaagagg 15660 ctaaaatcct ctccttattt aattttaaat aagtagtgta tttgtatttt aactcctcca 15720 acccttccga ttttatggct ctcaaactag cattcagtct aatgcatgca tgcttggcta 15780 gaggtcgtat ggggttgtta atagcatagc tagctacaag ttaaccgggt cttttatatt 15840 taataaggac aggcaaagta ttacttacaa ataaagaata aagctaggac gaactcgtgg 15900 attattacta aatcgaaatg gacgtaatat tccaggcaag aataattgtt cgatcaggag 15960 acaagtgggg cattggaccg gttcttgcaa gcaagagcct atggcgtggt gacacggcgc 16020 gttgcccata catcatgcct ccatcgatga tccatcctca cttgctataa aaagaggtgt 16080 ccatggtgct caagctcagc caagcaaata agacgacttg tttcattgat tcttcaagag 16140 atcgagcttc ttttgcacca caaggtcgag gatccaaca 16179 <210> 13 <211> 15643 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1441 <220> <221> misc_feature (222) (14) .. (1414) <223> Maize ubiquitin (Mz Ubi) promoter <220> <221> misc_feature (222) (2037) .. (5618) <223> synthetic nucleotide sequence encoding the toxin       portion of H04 plus a full-length Cry1Ab tail       portion <220> <221> misc_feature (222) (5821) .. (6711) <223> Mz Ubi promoter <220> <221> misc_feature (222) (7831) .. (9039) <223> PMI <400> 13 aagctggtac aagcttgcat gcctgcagtg cagcgtgacc cggtcgtgcc cctctctaga 60 gataatgagc attgcatgtc taagttataa aaaattacca catatttttt ttgtcacact 120 tgtttgaagt gcagtttatc tatctttata catatattta aactttactc tacgaataat 180 ataatctata gtactacaat aatatcagtg ttttagagaa tcatataaat gaacagttag 240 acatggtcta aaggacaatt gagtattttg acaacaggac tctacagttt tatcttttta 300 gtgtgcatgt gttctccttt ttttttgcaa atagcttcac ctatataata cttcatccat 360 tttattagta catccattta gggtttaggg ttaatggttt ttatagacta atttttttag 420 tacatctatt ttattctatt ttagcctcta aattaagaaa actaaaactc tattttagtt 480 tttttattta ataatttaga tataaaatag aataaaataa agtgactaaa aattaaacaa 540 atacccttta agaaattaaa aaaactaagg aaacattttt cttgtttcga gtagataatg 600 ccagcctgtt aaacgccgtc gacgagtcta acggacacca accagcgaac cagcagcgtc 660 gcgtcgggcc aagcgaagca gacggcacgg catctctgtc gctgcctctg gacccctctc 720 gagagttccg ctccaccgtt ggacttgctc cgctgtcggc atccagaaat tgcgtggcgg 780 agcggcagac gtgagccggc acggcaggcg gcctcctcct cctctcacgg cacggcagct 840 acgggggatt cctttcccac cgctccttcg ctttcccttc ctcgcccgcc gtaataaata 900 gacaccccct ccacaccctc tttccccaac ctcgtgttgt tcggagcgca cacacacaca 960 accagatctc ccccaaatcc acccgtcggc acctccgctt caaggtacgc cgctcgtcct 1020 cccccccccc ccctctctac cttctctaga tcggcgttcc ggtccatggt tagggcccgg 1080 tagttctact tctgttcatg tttgtgttag atccgtgttt gtgttagatc cgtgctgcta 1140 gcgttcgtac acggatgcga cctgtacgtc agacacgttc tgattgctaa cttgccagtg 1200 tttctctttg gggaatcctg ggatggctct agccgttccg cagacgggat cgatttcatg 1260 attttttttg tttcgttgca tagggtttgg tttgcccttt tcctttattt caatatatgc 1320 cgtgcacttg tttgtcgggt catcttttca tgcttttttt tgtcttggtt gtgatgatgt 1380 ggtctggttg ggcggtcgtt ctagatcgga gtagaattct gtttcaaact acctggtgga 1440 tttattaatt ttggatctgt atgtgtgtgc catacatatt catagttacg aattgaagat 1500 gatggatgga aatatcgatc taggataggt atacatgttg atgcgggttt tactgatgca 1560 tatacagaga tgctttttgt tcgcttggtt gtgatgatgt ggtgtggttg ggcggtcgtt 1620 cattcgttct agatcggagt agaatactgt ttcaaactac ctggtgtatt tattaatttt 1680 ggaactgtat gtgtgtgtca tacatcttca tagttacgag tttaagatgg atggaaatat 1740 cgatctagga taggtataca tgttgatgtg ggttttactg atgcatatac atgatggcat 1800 atgcagcatc tattcatatg ctctaacctt gagtacctat ctattataat aaacaagtat 1860 gttttataat tattttgatc ttgatatact tggatgatgg catatgcagc agctatatgt 1920 ggattttttt agccctgcct tcatacgcta tttatttgct tggtactgtt tcttttgtcg 1980 atgctcaccc tgttgtttgg tgttacttct gcaggtcgac tctagaggat ccaacaatgg 2040 acaacaaccc caacatcaac gagtgcatcc cctacaactg cctgagcaac cccgaggtgg 2100 aggtgctggg cggcgagcgc atcgagaccg gctacacccc catcgacatc agcctgagcc 2160 tgacccagtt cctgctgagc gagttcgtgc ccggcgccgg cttcgtgctg ggcctggtgg 2220 acatcatctg gggcatcttc ggccccagcc agtgggacgc cttcctggtg cagatcgagc 2280 agttgataaa ccaacgcata gaggaattcg cccgcaacca ggccatcagc cgcctggagg 2340 gcctgagcaa cctgtaccaa atctacgccg agagcttccg cgagtgggag gccgacccca 2400 ccaaccccgc cctgcgcgag gagatgcgca tccagttcaa cgacatgaac agcgccctga 2460 ccaccgccat ccccctgttc gccgtgcaga actaccaggt gcccctgctg agcgtgtacg 2520 tgcaggccgc caacctgcac ctgagcgtgc tgcgcgacgt cagcgtgttc ggccagcgct 2580 ggggcttcga cgccgccacc atcaacagcc gctacaacga cctgacccgc ctgatcggca 2640 actacaccga ccacgccgtg cgctggtaca acaccggcct ggagcgcgtg tggggtcccg 2700 acagccgcga ctggatcagg tacaaccagt tccgccgcga gctgaccctg accgtgctgg 2760 acatcgtgag cctgttcccc aactacgaca gccgcaccta ccccatccgc accgtgagcc 2820 agctgacccg cgagatttac accaaccccg tgctggagaa cttcgacggc agcttccgcg 2880 gcagcgccca gggcatcgag ggcagcatcc gcagccccca cctgatggac atcctgaaca 2940 gcatcaccat ctacaccgac gcccaccgcg gcgagtacta ctggagcggc caccagatca 3000 tggccagccc cgtcggcttc agcggccccg agttcacctt ccccctgtac ggcaccatgg 3060 gcaacgctgc acctcagcag cgcatcgtgg cacagctggg ccagggagtg taccgcaccc 3120 tgagcagcac cctgtaccgt cgacctttca acatcggcat caacaaccag cagctgagcg 3180 tgctggacgg caccgagttc gcctacggca ccagcagcaa cctgcccagc gccgtgtacc 3240 gcaagagcgg caccgtggac agcctggacg agatcccccc tcagaacaac aacgtgccac 3300 ctcgacaggg cttcagccac cgtctgagcc acgtgagcat gttccgcagt ggcttcagca 3360 acagcagcgt gagcatcatc cgtgcaccca tgttcagctg gattcaccgc agcgccaccc 3420 tgaccaacac catcgacccc gagcgcatca accagatccc cctggtgaag ggcttccggg 3480 tgtggggcgg caccagcgtg atcaccggcc ccggcttcac cggaggcgac atcctgcgca 3540 gaaacacctt cggcgacttc gtgagcctgc aggtgaacat caacagcccc atcacccagc 3600 gttaccgcct gcgcttccgc tacgccagca gccgcgacgc ccgtgtgatc gtgctgactg 3660 gcgccgctag caccggtgtg ggcggtcagg tgagcgtgaa catgcccctg cagaagacta 3720 tggagatcgg cgagaacctg actagtcgca ccttccgcta caccgacttc agcaacccct 3780 tcagcttccg cgccaacccc gacatcatcg gcatcagcga gcagcccctg ttcggtgccg 3840 gcagcatcag cagcggcgag ctgtacatcg acaagatcga gatcatcctg gccgacgcca 3900 ccttcgaggc cgagagcgac ctggagcgcg cccagaaggc cgtgaacgcc ctgttcacca 3960 gcagcaacca gatcggcctg aagaccgacg tgaccgacta ccacatcgac caggtgagca 4020 acctggtgga ctgcttaagc gacgagttct gcctggacga gaagaaggag ctgagcgaga 4080 aggtgaagca cgccaagcgc ctgagcgacg agcgcaacct gctgcaggac cccaacttcc 4140 gcggcatcaa ccgccagctg gaccgcggct ggcgaggcag caccgatatc accatccagg 4200 gcggcgacga cgtgttcaag gagaactacg tgaccctgca gggcaccttc gacgagtgct 4260 accccaccta cctgtaccag ccgatcgacg agagcaagct gaaggcctac acccgctacc 4320 agctgcgcgg ctacatcgag gacagccagg acctggaaat ctacctgatc cgctacaacg 4380 cgaagcacga gaccgtgaac gtgcccggca ccggcagcct gtggcccccg agcgccccca 4440 gccccatcgg caagtgcggg gagccgaatc gatgcgctcc gcacctggag tggaacccgg 4500 acctagactg cagctgcagg gacggggaga agtgcgccca ccacagccac cacttcagcc 4560 tggacatcga cgtgggctgc accgacctga acgaggacct gggcgtgtgg gtgatcttca 4620 agatcaagac ccaggacggc cacgcccgcc tgggcaatct agagttcctg gaggagaagc 4680 ccctggtggg cgaggccctg gcccgcgtga agcgtgctga gaagaagtgg cgcgacaagc 4740 gcgagaagct ggagtgggag accaacatcg tgtacaagga ggccaaggag agcgtggacg 4800 ccctgttcgt gaacagccag tacgaccgcc tgcaggccga caccaacatc gccatgatcc 4860 acgccgccga caagcgcgtg cacagcattc gcgaggccta cctgcccgag ctgagcgtga 4920 tccccggtgt gaacgccgcc atcttcgagg aactcgaggg ccgcatcttc accgccttca 4980 gcctgtacga cgcccgcaac gtgatcaaga acggcgactt caacaacggc ctgagctgct 5040 ggaacgtgaa gggccacgtg gacgtggagg agcagaacaa ccaccgcagc gtgctggtgg 5100 tgcccgagtg ggaggccgag gtgagccagg aggtgcgcgt gtgccccggc cgcggctaca 5160 tcctgcgcgt gaccgcctac aaggagggct acggcgaggg ctgcgtgacc atccacgaga 5220 tcgagaacaa caccgacgag ctcaagttca gcaactgcgt ggaggaggag gtttacccca 5280 acaacaccgt gacctgcaac gactacaccg cgacccagga ggagtacgaa ggcacctaca 5340 cctctcgcaa caggggttac gacggcgcct acgagtccaa cagctccgtg ccagctgact 5400 acgccagcgc ccacgaggag aaagcctaca ccgacggtag acgcgacaac ccatgtgaga 5460 gcaacagagg ctacggcgac tacacccccc tgcccgctgg atacgtgacc aaggagctgg 5520 agtacttccc cgagaccgac aaggtgtgga tcgagattgg cgagaccgag ggcaccttca 5580 tcgtggacag cgtggagctg ctgctgatgg aggagtagta gatctgttct gcacaaagtg 5640 gagtagtcag tcatcgatca ggaaccagac accagacttt tattcataca gtgaagtgaa 5700 gtgaagtgca gtgcagtgag ttgctggttt ttgtaccact tagtatgtat ttgtatttgt 5760 aaaatacttc tatcaataaa atttctaatt cctaaaacca aaatccagtg ggtaccagct 5820 tgcatgcctg cagtgcagcg tgacccggtc gtgcccctct ctagagataa tgagcattgc 5880 atgtctaagt tataaaaaat taccacatat tttttttgtc acacttgttt gaagtgcagt 5940 ttatctatct ttatacatat atttaaactt tactctacga ataatataat ctatagtact 6000 acaataatat cagtgtttta gagaatcata taaatgaaca gttagacatg gtctaaagga 6060 caattgagta ttttgacaac aggactctac agttttatct ttttagtgtg catgtgttct 6120 cctttttttt tgcaaatagc ttcacctata taatacttca tccattttat tagtacatcc 6180 atttagggtt tagggttaat ggtttttata gactaatttt tttagtacat ctattttatt 6240 ctattttagc ctctaaatta agaaaactaa aactctattt tagttttttt atttaataat 6300 ttagatataa aatagaataa aataaagtga ctaaaaatta aacaaatacc ctttaagaaa 6360 ttaaaaaaac taaggaaaca tttttcttgt ttcgagtaga taatgccagc ctgttaaacg 6420 ccgtcgacga gtctaacgga caccaaccag cgaaccagca gcgtcgcgtc gggccaagcg 6480 aagcagacgg cacggcatct ctgtcgctgc ctctggaccc ctctcgagag ttccgctcca 6540 ccgttggact tgctccgctg tcggcatcca gaaattgcgt ggcggagcgg cagacgtgag 6600 ccggcacggc aggcggcctc ctcctcctct cacggcacgg cagctacggg ggattccttt 6660 cccaccgctc cttcgctttc ccttcctcgc ccgccgtaat aaatagacac cccctccaca 6720 ccctctttcc ccaacctcgt gttgttcgga gcgcacacac acacaaccag atctccccca 6780 aatccacccg tcggcacctc cgcttcaagg tacgccgctc gtcctccccc cccccccctc 6840 tctaccttct ctagatcggc gttccggtcc atggttaggg cccggtagtt ctacttctgt 6900 tcatgtttgt gttagatccg tgtttgtgtt agatccgtgc tgctagcgtt cgtacacgga 6960 tgcgacctgt acgtcagaca cgttctgatt gctaacttgc cagtgtttct ctttggggaa 7020 tcctgggatg gctctagccg ttccgcagac gggatcgatt tcatgatttt ttttgtttcg 7080 ttgcataggg tttggtttgc ccttttcctt tatttcaata tatgccgtgc acttgtttgt 7140 cgggtcatct tttcatgctt ttttttgtct tggttgtgat gatgtggtct ggttgggcgg 7200 tcgttctaga tcggagtaga attctgtttc aaactacctg gtggatttat taattttgga 7260 tctgtatgtg tgtgccatac atattcatag ttacgaattg aagatgatgg atggaaatat 7320 cgatctagga taggtataca tgttgatgcg ggttttactg atgcatatac agagatgctt 7380 tttgttcgct tggttgtgat gatgtggtgt ggttgggcgg tcgttcattc gttctagatc 7440 ggagtagacg ccgtttcaaa ctacctggtg tatttattaa ttttggaact gtatgtgtgt 7500 gtcatacatc ttcatagtta cgagtttaag atggatggaa atatcgatct aggataggta 7560 tacatgttga tgtgggtttt actgatgcat atacatgatg gcatatgcag catctattca 7620 tatgctctaa ccttgagtac ctatctatta taataaacaa gtatgtttta taattatttt 7680 gatcttgata tacttggatg atggcatatg cagcagctat atgtggattt ttttagccct 7740 gccttcatac gctatttatt tgcttggtac tgtttctttt gtcgatgctc accctgttgt 7800 ttggtgttac ttctgcaggg atccccgatc atgcaaaaac tcattaactc agtgcaaaac 7860 tatgcctggg gcagcaaaac gcgttgactg aactttatgg tatggaaaat ccgtccagcc 7920 agccgatggc cgagctgtgg atgggcgcac atccgaaaag cagttcacga gtgcagaatg 7980 ccgccggaga tatcgtttca ctgcgtgatg tgattgagag tgataaatcg actctgctcg 8040 gagaggccgt tgccaaacgc tttggcgaac tgcctttcct gttcaaagta ttatgcgcag 8100 cacagccact ctccattcag gttcatccaa acaaacacaa ttctgaaatc ggttttgcca 8160 aagaaaatgc cgcaggtatc ccgatggatg ccgccgagcg taactataaa gatcctaacc 8220 acaagccgga gctggttttt gcgctgacgc ctttccttgc gatgaacgcg tttcgtgaat 8280 tttccgagat tgtctcccta ctccagccgg tcgcaggtgc acatccggcg attgctcact 8340 ttttacaaca gcctgatgcc gaacgtttaa gcgaactgtt cgccagcctg ttgaatatgc 8400 agggtgaaga aaaatcccgc gcgctggcga ttttaaaatc ggccctcgat agccagcagg 8460 gtgaaccgtg gcaaacgatt cgtttaattt ctgaatttta cccggaagac agcggtctgt 8520 tctccccgct attgctgaat gtggtgaaat tgaaccctgg cgaagcgatg ttcctgttcg 8580 ctgaaacacc gcacgcttac ctgcaaggcg tggcgctgga agtgatggca aactccgata 8640 acgtgctgcg tgcgggtctg acgcctaaat acattgatat tccggaactg gttgccaatg 8700 tgaaattcga agccaaaccg gctaaccagt tgttgaccca gccggtgaaa caaggtgcag 8760 aactggactt cccgattcca gtggatgatt ttgccttctc gctgcatgac cttagtgata 8820 aagaaaccac cattagccag cagagtgccg ccattttgtt ctgcgtcgaa ggcgatgcaa 8880 cgttgtggaa aggttctcag cagttacagc ttaaaccggg tgaatcagcg tttattgccg 8940 ccaacgaatc accggtgact gtcaaaggcc acggccgttt agcgcgtgtt tacaacaagc 9000 tgtaagagct tactgaaaaa attaacatct cttgctaagc tgggagctcg atccgtcgac 9060 ctgcagagat cgttcaaaca tttggcaata aagtttctta agattgaatc ctgttgccgg 9120 tcttgcgatg attatcatct aatttctgtt gaattacgtt aagcatgtaa taattaacat 9180 gtaatgcatg acgttattta tgagatgggt ttttatgatt agagtcccgc aattatacat 9240 ttaatacgcg atagaaaaca aaatatagcg cgcaaactag gataaattat cgcgcgcggt 9300 gtcatctatg ttactagatc cgatgataag ctgtcaaaca tgagatcccc gggtctagac 9360 aattcagtac attaaaaacg tccgcaatgt gttattaagt tgtctaagcg tcaatttgtt 9420 tacaccacaa tatatcctgc caccagccag ccaacagctc cccgaccggc agctcggcac 9480 aaaatcacca ctcgatacag gcagcccatc agtccgggac ggcgtcagcg ggagagccgt 9540 tgtaaggcgg cagactttgc tcatgttacc gatgctattc ggaagaacgg caactaagct 9600 gccgggtttg aaacacggat gatctcgcgg agggtagcat gttgattgta acgatgacag 9660 agcgttgctg cctgtgatca aatatcatct ccctcgcaga gatccgaatt atcagccttc 9720 ttattcattt ctcgcttaac cgtgacaggc tgtcgatctt gagaactatg ccgacataat 9780 aggaaatcgc tggataaagc cgctgaggaa gctgagtggc gctatttctt tagaagtgaa 9840 cgttgacgat cgtcgaccgt accccgatga attaattcgg acgtacgttc tgaacacagc 9900 tggatactta cttgggcgat tgtcatacat gacatcaaca atgtacccgt ttgtgtaacc 9960 gtctcttgga ggttcgtatg acactagtgg ttcccctcag cttgcgacta gatgttgagg 10020 cctaacattt tattagagag caggctagtt gcttagatac atgatcttca ggccgttatc 10080 tgtcagggca agcgaaaatt ggccatttat gacgaccaat gccccgcaga agctcccatc 10140 tttgccgcca tagacgccgc gccccccttt tggggtgtag aacatccttt tgccagatgt 10200 ggaaaagaag ttcgttgtcc cattgttggc aatgacgtag tagccggcga aagtgcgaga 10260 cccatttgcg ctatatataa gcctacgatt tccgttgcga ctattgtcgt aattggatga 10320 actattatcg tagttgctct cagagttgtc gtaatttgat ggactattgt cgtaattgct 10380 tatggagttg tcgtagttgc ttggagaaat gtcgtagttg gatggggagt agtcataggg 10440 aagacgagct tcatccacta aaacaattgg caggtcagca agtgcctgcc ccgatgccat 10500 cgcaagtacg aggcttagaa ccaccttcaa cagatcgcgc atagtcttcc ccagctctct 10560 aacgcttgag ttaagccgcg ccgcgaagcg gcgtcggctt gaacgaattg ttagacatta 10620 tttgccgact accttggtga tctcgccttt cacgtagtga acaaattctt ccaactgatc 10680 tgcgcgcgag gccaagcgat cttcttgtcc aagataagcc tgcctagctt caagtatgac 10740 gggctgatac tgggccggca ggcgctccat tgcccagtcg gcagcgacat ccttcggcgc 10800 gattttgccg gttactgcgc tgtaccaaat gcgggacaac gtaagcacta catttcgctc 10860 atcgccagcc cagtcgggcg gcgagttcca tagcgttaag gtttcattta gcgcctcaaa 10920 tagatcctgt tcaggaaccg gatcaaagag ttcctccgcc gctggaccta ccaaggcaac 10980 gctatgttct cttgcttttg tcagcaagat agccagatca atgtcgatcg tggctggctc 11040 gaagatacct gcaagaatgt cattgcgctg ccattctcca aattgcagtt cgcgcttagc 11100 tggataacgc cacggaatga tgtcgtcgtg cacaacaatg gtgacttcta cagcgcggag 11160 aatctcgctc tctccagggg aagccgaagt ttccaaaagg tcgttgatca aagctcgccg 11220 cgttgtttca tcaagcctta cggtcaccgt aaccagcaaa tcaatatcac tgtgtggctt 11280 caggccgcca tccactgcgg agccgtacaa atgtacggcc agcaacgtcg gttcgagatg 11340 gcgctcgatg acgccaacta cctctgatag ttgagtcgat acttcggcga tcaccgcttc 11400 cctcatgatg tttaactcct gaattaagcc gcgccgcgaa gcggtgtcgg cttgaatgaa 11460 ttgttaggcg tcatcctgtg ctcccgagaa ccagtaccag tacatcgctg tttcgttcga 11520 gacttgaggt ctagttttat acgtgaacag gtcaatgccg ccgagagtaa agccacattt 11580 tgcgtacaaa ttgcaggcag gtacattgtt cgtttgtgtc tctaatcgta tgccaaggag 11640 ctgtctgctt agtgcccact ttttcgcaaa ttcgatgaga ctgtgcgcga ctcctttgcc 11700 tcggtgcgtg tgcgacacaa caatgtgttc gatagaggct agatcgttcc atgttgagtt 11760 gagttcaatc ttcccgacaa gctcttggtc gatgaatgcg ccatagcaag cagagtcttc 11820 atcagagtca tcatccgaga tgtaatcctt ccggtagggg ctcacacttc tggtagatag 11880 ttcaaagcct tggtcggata ggtgcacatc gaacacttca cgaacaatga aatggttctc 11940 agcatccaat gtttccgcca cctgctcagg gatcaccgaa atcttcatat gacgcctaac 12000 gcctggcaca gcggatcgca aacctggcgc ggcttttggc acaaaaggcg tgacaggttt 12060 gcgaatccgt tgctgccact tgttaaccct tttgccagat ttggtaacta taatttatgt 12 120 tagaggcgaa gtcttgggta aaaactggcc taaaattgct ggggatttca ggaaagtaaa 12180 catcaccttc cggctcgatg tctattgtag atatatgtag tgtatctact tgatcggggg 12240 atctgctgcc tcgcgcgttt cggtgatgac ggtgaaaacc tctgacacat gcagctcccg 12300 gagacggtca cagcttgtct gtaagcggat gccgggagca gacaagcccg tcagggcgcg 12360 tcagcgggtg ttggcgggtg tcggggcgca gccatgaccc agtcacgtag cgatagcgga 12420 gtgtatactg gcttaactat gcggcatcag agcagattgt actgagagtg caccatatgc 12480 ggtgtgaaat accgcacaga tgcgtaagga gaaaataccg catcaggcgc tcttccgctt 12540 cctcgctcac tgactcgctg cgctcggtcg ttcggctgcg gcgagcggta tcagctcact 12600 caaaggcggt aatacggtta tccacagaat caggggataa cgcaggaaag aacatgtgag 12660 caaaaggcca gcaaaaggcc aggaaccgta aaaaggccgc gttgctggcg tttttccata 12720 ggctccgccc ccctgacgag catcacaaaa atcgacgctc aagtcagagg tggcgaaacc 12780 cgacaggact ataaagatac caggcgtttc cccctggaag ctccctcgtg cgctctcctg 12840 ttccgaccct gccgcttacc ggatacctgt ccgcctttct cccttcggga agcgtggcgc 12900 tttctcatag ctcacgctgt aggtatctca gttcggtgta ggtcgttcgc tccaagctgg 12960 gctgtgtgca cgaacccccc gttcagcccg accgctgcgc cttatccggt aactatcgtc 13020 ttgagtccaa cccggtaaga cacgacttat cgccactggc agcagccact ggtaacagga 13080 ttagcagagc gaggtatgta ggcggtgcta cagagttctt gaagtggtgg cctaactacg 13140 gctacactag aaggacagta tttggtatct gcgctctgct gaagccagtt accttcggaa 13200 aaagagttgg tagctcttga tccggcaaac aaaccaccgc tggtagcggt ggtttttttg 13260 tttgcaagca gcagattacg cgcagaaaaa aaggatctca agaagatcct ttgatctttt 13320 ctacggggtc tgacgctcag tggaacgaaa actcacgtta agggattttg gtcatgagat 13380 tatcaaaaag gatcttcacc tagatccttt taaattaaaa atgaagtttt aaatcaatct 13440 aaagtatata tgagtaaact tggtctgaca gttaccaatg cttaatcagt gaggcaccta 13500 tctcagcgat ctgtctattt cgttcatcca tagttgcctg actccccgtc gtgtagataa 13560 ctacgatacg ggagggctta ccatctggcc ccagtgctgc aatgataccg cgagacccac 13620 gctcaccggc tccagattta tcagcaataa accagccagc cggaagggcc gagcgcagaa 13680 gtggtcctgc aactttatcc gcctccatcc agtctattaa ttgttgccgg gaagctagag 13740 taagtagttc gccagttaat agtttgcgca acgttgttgc cattgctgca gggggggggg 13800 ggggggggga cttccattgt tcattccacg gacaaaaaca gagaaaggaa acgacagagg 13860 ccaaaaagcc tcgctttcag cacctgtcgt ttcctttctt ttcagagggt attttaaata 13920 aaaacattaa gttatgacga agaagaacgg aaacgcctta aaccggaaaa ttttcataaa 13980 tagcgaaaac ccgcgaggtc gccgccccgt aacctgtcgg atcaccggaa aggacccgta 14040 aagtgataat gattatcatc tacatatcac aacgtgcgtg gaggccatca aaccacgtca 14100 aataatcaat tatgacgcag gtatcgtatt aattgatctg catcaactta acgtaaaaac 14160 aacttcagac aatacaaatc agcgacactg aatacggggc aacctcatgt cccccccccc 14220 cccccccctg caggcatcgt ggtgtcacgc tcgtcgtttg gtatggcttc attcagctcc 14280 ggttcccaac gatcaaggcg agttacatga tcccccatgt tgtgcaaaaa agcggttagc 14340 tccttcggtc ctccgatcgt tgtcagaagt aagttggccg cagtgttatc actcatggtt 14400 atggcagcac tgcataattc tcttactgtc atgccatccg taagatgctt ttctgtgact 14460 ggtgagtact caaccaagtc attctgagaa tagtgtatgc ggcgaccgag ttgctcttgc 14520 ccggcgtcaa cacgggataa taccgcgcca catagcagaa ctttaaaagt gctcatcatt 14580 ggaaaacgtt cttcggggcg aaaactctca aggatcttac cgctgttgag atccagttcg 14640 atgtaaccca ctcgtgcacc caactgatct tcagcatctt ttactttcac cagcgtttct 14700 gggtgagcaa aaacaggaag gcaaaatgcc gcaaaaaagg gaataagggc gacacggaaa 14760 tgttgaatac tcatactctt cctttttcaa tattattgaa gcatttatca gggttattgt 14820 ctcatgagcg gatacatatt tgaatgtatt tagaaaaata aacaaatagg ggttccgcgc 14880 acatttcccc gaaaagtgcc acctgacgtc taagaaacca ttattatcat gacattaacc 14940 tataaaaata ggcgtatcac gaggcccttt cgtcttcaag aattggtcga cgatcttgct 15000 gcgttcggat attttcgtgg agttcccgcc acagacccgg attgaaggcg agatccagca 15060 actcgcgcca gatcatcctg tgacggaact ttggcgcgtg atgactggcc aggacgtcgg 15120 ccgaaagagc gacaagcaga tcacgctttt cgacagcgtc ggatttgcga tcgaggattt 15180 ttcggcgctg cgctacgtcc gcgaccgcgt tgagggatca agccacagca gcccactcga 15240 ccttctagcc gacccagacg agccaaggga tctttttgga atgctgctcc gtcgtcaggc 15300 tttccgacgt ttgggtggtt gaacagaagt cattatcgta cggaatgcca agcactcccg 15360 aggggaaccc tgtggttggc atgcacatac aaatggacga acggataaac cttttcacgc 15420 ccttttaaat atccgttatt ctaataaacg ctcttttctc ttaggtttac ccgccaatat 15480 atcctgtcaa acactgatag tttaaactga aggcgggaaa cgacaatctg atcatgagcg 15540 gagaattaag ggagtcacgt tatgaccccc gccgatgacg cgggacaagc cgttttacgt 15600 ttggaactga cagaaccgca acgttgaagg agccactcag ccc 15643 <210> 14 <211> 15503 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1305 <220> <221> misc_feature (222) (1) .. (3582) <223> synthetic nucleotide sequence encoding the toxin       portion of H04 plus a full-length Cry1Ab tail       portion <220> <221> misc_feature (222) (3790) .. (5771) <223> Zm Ubi promoter <220> <221> misc_feature (222) (5868) .. (6971) <223> PMI <220> <221> misc_feature (222) (12934) .. (15494) <223> MTL promoter <400> 14 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgcgcccaga aggccgtgaa cgccctgttc 1920 accagcagca accagatcgg cctgaagacc gacgtgaccg actaccacat cgaccaggtg 1980 agcaacctgg tggactgctt aagcgacgag ttctgcctgg acgagaagaa ggagctgagc 2040 gagaaggtga agcacgccaa gcgcctgagc gacgagcgca acctgctgca ggaccccaac 2100 ttccgcggca tcaaccgcca gctggaccgc ggctggcgag gcagcaccga tatcaccatc 2160 cagggcggcg acgacgtgtt caaggagaac tacgtgaccc tgcagggcac cttcgacgag 2220 tgctacccca cctacctgta ccagccgatc gacgagagca agctgaaggc ctacacccgc 2280 taccagctgc gcggctacat cgaggacagc caggacctgg aaatctacct gatccgctac 2340 aacgcgaagc acgagaccgt gaacgtgccc ggcaccggca gcctgtggcc cctgagcgcc 2400 cccagcccca tcggcaagtg cggggagccg aatcgatgcg ctccgcacct ggagtggaac 2460 ccggacctag actgcagctg cagggacggg gagaagtgcg cccaccacag ccaccacttc 2520 agcctggaca tcgacgtggg ctgcaccgac ctgaacgagg acctgggcgt gtgggtgatc 2580 ttcaagatca agacccagga cggccacgcc cgcctgggca atctagagtt cctggaggag 2640 aagcccctgg tgggcgaggc cctggcccgc gtgaagcgtg ctgagaagaa gtggcgcgac 2700 aagcgcgaga agctggagtg ggagaccaac atcgtgtaca aggaggccaa ggagagcgtg 2760 gacgccctgt tcgtgaacag ccagtacgac cgcctgcagg ccgacaccaa catcgccatg 2820 atccacgccg ccgacaagcg cgtgcacagc attcgcgagg cctacctgcc cgagctgagc 2880 gtgatccccg gtgtgaacgc cgccatcttc gaggaactcg agggccgcat cttcaccgcc 2940 ttcagcctgt acgacgcccg caacgtgatc aagaacggcg acttcaacaa cggcctgagc 3000 tgctggaacg tgaagggcca cgtggacgtg gaggagcaga acaaccaccg cagcgtgctg 3060 gtggtgcccg agtgggaggc cgaggtgagc caggaggtgc gcgtgtgccc cggccgcggc 3120 tacatcctgc gcgtgaccgc ctacaaggag ggctacggcg agggctgcgt gaccatccac 3180 gagatcgaga acaacaccga cgagctcaag ttcagcaact gcgtggagga ggaggtttac 3240 cccaacaaca ccgtgacctg caacgactac accgcgaccc aggaggagta cgaaggcacc 3300 tacacctctc gcaacagggg ttacgacggc gcctacgagt ccaacagctc cgtgccagct 3360 gactacgcca gcgcctacga ggagaaagcc tacaccgacg gtagacgcga caacccatgt 3420 gagagcaaca gaggctacgg cgactacacc cccctgcccg ctggatacgt gaccaaggag 3480 ctggagtact tccccgagac cgacaaggtg tggatcgaga ttggcgagac cgagggcacc 3540 ttcatcgtgg acagcgtgga gctgctgctg atggaggagt agtagatctg ttctgcacaa 3600 agtggagtag tcagtcatcg atcaggaacc agacaccaga cttttattca tacagtgaag 3660 tgaagtgaag tgcagtgcag tgagttgctg gtttttgtac aacttagtat gtatttgtat 3720 ttgtaaaata cttctatcaa taaaatttct aattcctaaa accaaaatcc aggggtacca 3780 gcttgcatgc ctgcagtgca gcgtgacccg gtcgtgcccc tctctagaga taatgagcat 3840 tgcatgtcta agttataaaa aattaccaca tatttttttt gtcacacttg tttgaagtgc 3900 agtttatcta tctttataca tatatttaaa ctttactcta cgaataatat aatctatagt 3960 actacaataa tatcagtgtt ttagagaatc atataaatga acagttagac atggtctaaa 4020 ggacaattga gtattttgac aacaggactc tacagtttta tctttttagt gtgcatgtgt 4080 tctccttttt ttttgcaaat agcttcacct atataatact tcatccattt tattagtaca 4140 tccatttagg gtttagggtt aatggttttt atagactaat ttttttagta catctatttt 4200 attctatttt agcctctaaa ttaagaaaac taaaactcta ttttagtttt tttatttaat 4260 aatttagata taaaatagaa taaaataaag tgactaaaaa ttaaacaaat accctttaag 4320 aaattaaaaa aactaaggaa acatttttct tgtttcgagt agataatgcc agcctgttaa 4380 acgccgtcga cgagtctaac ggacaccaac cagcgaacca gcagcgtcgc gtcgggccaa 4440 gcgaagcaga cggcacggca tctctgtcgc tgcctctgga cccctctcga gagttccgct 4500 ccaccgttgg acttgctccg ctgtcggcat ccagaaattg cgtggcggag cggcagacgt 4560 gagccggcac ggcaggcggc ctcctcctcc tctcacggca ccggcagcta cgggggattc 4620 ctttcccacc gctccttcgc tttcccttcc tcgcccgccg taataaatag acaccccctc 4680 cacaccctct ttccccaacc tcgtgttgtt cggagcgcac acacacacaa ccagatctcc 4740 cccaaatcca cccgtcggca cctccgcttc aaggtacgcc gctcgtcctc cccccccccc 4800 cctctctacc ttctctagat cggcgttccg gtccatggtt agggcccggt agttctactt 4860 ctgttcatgt ttgtgttaga tccgtgtttg tgttagatcc gtgctgctag cgttcgtaca 4920 cggatgcgac ctgtacgtca gacacgttct gattgctaac ttgccagtgt ttctctttgg 4980 ggaatcctgg gatggctcta gccgttccgc agacgggatc gatttcatga ttttttttgt 5040 ttcgttgcat agggtttggt ttgccctttt cctttatttc aatatatgcc gtgcacttgt 5100 ttgtcgggtc atcttttcat gctttttttt gtcttggttg tgatgatgtg gtctggttgg 5160 gcggtcgttc tagatcggag tagaattctg tttcaaacta cctggtggat ttattaattt 5220 tggatctgta tgtgtgtgcc atacatattc atagttacga attgaagatg atggatggaa 5280 atatcgatct aggataggta tacatgttga tgcgggtttt actgatgcat atacagagat 5340 gctttttgtt cgcttggttg tgatgatgtg gtgtggttgg gcggtcgttc attcgttcta 5400 gatcggagta gaatactgtt tcaaactacc tggtgtattt attaattttg gaactgtatg 5460 tgtgtgtcat acatcttcat agttacgagt ttaagatgga tggaaatatc gatctaggat 5520 aggtatacat gttgatgtgg gttttactga tgcatataca tgatggcata tgcagcatct 5580 attcatatgc tctaaccttg agtacctatc tattataata aacaagtatg ttttataatt 5640 attttgatct tgatatactt ggatgatggc atatgcagca gctatatgtg gattttttta 5700 gccctgcctt catacgctat ttatttgctt ggtactgttt cttttgtcga tgctcaccct 5760 gttgtttggt gttacttctg cagggatccc cgatcatgca aaaactcatt aactcagtgc 5820 aaaactatgc ctggggcagc aaaacggcgt tgactgaact ttatggtatg gaaaatccgt 5880 ccagccagcc gatggccgag ctgtggatgg gcgcacatcc gaaaagcagt tcacgagtgc 5940 agaatgccgc cggagatatc gtttcactgc gtgatgtgat tgagagtgat aaatcgactc 6000 tgctcggaga ggccgttgcc aaacgctttg gcgaactgcc tttcctgttc aaagtattat 6060 gcgcagcaca gccactctcc attcaggttc atccaaacaa acacaattct gaaatcggtt 6120 ttgccaaaga aaatgccgca ggtatcccga tggatgccgc cgagcgtaac tataaagatc 6180 ctaaccacaa gccggagctg gtttttgcgc tgacgccttt ccttgcgatg aacgcgtttc 6240 gtgaattttc cgagattgtc tccctactcc agccggtcgc aggtgcacat ccggcgattg 6300 ctcacttttt acaacagcct gatgccgaac gtttaagcga actgttcgcc agcctgttga 6360 atatgcaggg tgaagaaaaa tcccgcgcgc tggcgatttt aaaatcggcc ctcgatagcc 6420 agcagggtga accgtggcaa acgattcgtt taatttctga attttacccg gaagacagcg 6480 gtctgttctc cccgctattg ctgaatgtgg tgaaattgaa ccctggcgaa gcgatgttcc 6540 tgttcgctga aacaccgcac gcttacctgc aaggcgtggc gctggaagtg atggcaaact 6600 ccgataacgt gctgcgtgcg ggtctgacgc ctaaatacat tgatattccg gaactggttg 6660 ccaatgtgaa attcgaagcc aaaccggcta accagttgtt gacccagccg gtgaaacaag 6720 gtgcagaact ggacttcccg attccagtgg atgattttgc cttctcgctg catgacctta 6780 gtgataaaga aaccaccatt agccagcaga gtgccgccat tttgttctgc gtcgaaggcg 6840 atgcaacgtt gtggaaaggt tctcagcagt tacagcttaa accgggtgaa tcagcgttta 6900 ttgccgccaa cgaatcaccg gtgactgtca aaggccacgg ccgtttagcg cgtgtttaca 6960 acaagctgta agagcttact gaaaaaatta acatctcttg ctaagctggg agctcgatcc 7020 gtcgacctgc agatcgttca aacatttggc aataaagttt cttaagattg aatcctgttg 7080 ccggtcttgc gatgattatc atataatttc tgttgaatta cgttaagcat gtaataatta 7140 acatgtaatg catgacgtta tttatgagat gggtttttat gattagagtc ccgcaattat 7200 acatttaata cgcgatagaa aacaaaatat agcgcgcaaa ctaggataaa ttatcgcgcg 7260 cggtgtcatc tatgttacta gatctgctag ccctgcagga aatttaccgg tgcccgggcg 7320 gccagcatgg ccgtatccgc aatgtgttat taagttgtct aagcgtcaat ttgtttacac 7380 cacaatatat cctgccacca gccagccaac agctccccga ccggcagctc ggcacaaaat 7440 caccactcga tacaggcagc ccatcagaat taattctcat gtttgacagc ttatcatcga 7500 ctgcacggtg caccaatgct tctggcgtca ggcagccatc ggaagctgtg gtatggctgt 7560 gcaggtcgta aatcactgca taattcgtgt cgctcaaggc gcactcccgt tctggataat 7620 gttttttgcg ccgacatcat aacggttctg gcaaatattc tgaaatgagc tgttgacaat 7680 taatcatccg gctcgtataa tgtgtggaat tgtgagcgga taacaatttc acacaggaaa 7740 cagaccatga gggaagcgtt gatcgccgaa gtatcgactc aactatcaga ggtagttggc 7800 gtcatcgagc gccatctcga accgacgttg ctggccgtac atttgtacgg ctccgcagtg 7860 gatggcggcc tgaagccaca cagtgatatt gatttgctgg ttacggtgac cgtaaggctt 7920 gatgaaacaa cgcggcgagc tttgatcaac gaccttttgg aaacttcggc ttcccctgga 7980 gagagcgaga ttctccgcgc tgtagaagtc accattgttg tgcacgacga catcattccg 8040 tggcgttatc cagctaagcg cgaactgcaa tttggagaat ggcagcgcaa tgacattctt 8100 gcaggtatct tcgagccagc cacgatcgac attgatctgg ctatcttgct gacaaaagca 8160 agagaacata gcgttgcctt ggtaggtcca gcggcggagg aactctttga tccggttcct 8220 gaacaggatc tatttgaggc gctaaatgaa accttaacgc tatggaactc gccgcccgac 8280 tgggctggcg atgagcgaaa tgtagtgctt acgttgtccc gcatttggta cagcgcagta 8340 accggcaaaa tcgcgccgaa ggatgtcgct gccgactggg caatggagcg cctgccggcc 8400 cagtatcagc ccgtcatact tgaagctagg caggcttatc ttggacaaga agatcgcttg 8460 gcctcgcgcg cagatcagtt ggaagaattt gttcactacg tgaaaggcga gatcaccaaa 8520 gtagtcggca aataaagctc tagtggatct ccgtaccccc gggggatctg gctcgcggcg 8580 gacgcacgac gccggggcga gaccataggc gatctcctaa atcaatagta gctgtaacct 8640 cgaagcgttt cacttgtaac aacgattgag aatttttgtc ataaaattga aatacttggt 8700 tcgcattttt gtcatccgcg gtcagccgca attctgacga actgcccatt tagctggaga 8760 tgattgtaca tccttcacgt gaaaatttct caagcgctgt gaacaagggt tcagatttta 8820 gattgaaagg tgagccgttg aaacacgttc ttcttgtcga tgacgacgtc gctatgcggc 8880 atcttattat tgaatacctt acgatccacg ccttcaaagt gaccgcggta gccgacagca 8940 cccagttcac aagagtactc tcttccgcga cggtcgatgt cgtggttgtt gatctaaatt 9000 taggtcgtga agatgggctc gagatcgttc gtaatctggc ggcaaagtct gatattccaa 9060 tcataattat cagtggcgac cgccttgagg agacggataa agttgttgca ctcgagctag 9120 gagcaagtga ttttatcgct aagccgttca gtatcagaga gtttctagca cgcattcggg 9180 ttgccttgcg cgtgcgcccc aacgttgtcc gctccaaaga ccgacggtct ttttgtttta 9240 ctgactggac acttaatctc aggcaacgtc gcttgatgtc cgaagctggc ggtgaggtga 9300 aacttacggc aggtgagttc aatcttctcc tcgcgttttt agagaaaccc cgcgacgttc 9360 tatcgcgcga gcaacttctc attgccagtc gagtacgcga cgaggaggtt tatgacagga 9420 gtatagatgt tctcattttg aggctgcgcc gcaaacttga ggcagatccg tcaagccctc 9480 aactgataaa aacagcaaga ggtgccggtt atttctttga cgcggacgtg caggtttcgc 9540 acggggggac gatggcagcc tgagccaatt cccagatccc cgaggaatcg gcgtgagcgg 9600 tcgcaaacca tccggcccgg tacaaatcgg cgcggcgctg ggtgatgacc tggtggagaa 9660 gttgaaggcc gcgcaggccg cccagcggca acgcatcgag gcagaagcac gccccggtga 9720 atcgtggcaa gcggccgctg atcgaatccg caaagaatcc cggcaaccgc cggcagccgg 9780 tgcgccgtcg attaggaagc cgcccaaggg cgacgagcaa ccagattttt tcgttccgat 9840 gctctatgac gtgggcaccc gcgatagtcg cagcatcatg gacgtggccg ttttccgtct 9900 gtcgaagcgt gaccgacgag ctggcgaggt gatccgctac gagcttccag acgggcacgt 9960 agaggtttcc gcagggccgg ccggcatggc cagtgtgtgg gattacgacc tggtactgat 10020 ggcggtttcc catctaaccg aatccatgaa ccgataccgg gaagggaagg gagacaagcc 10080 cggccgcgtg ttccgtccac acgttgcgga cgtactcaag ttctgccggc gagccgatgg 10140 cggaaagcag aaagacgacc tggtagaaac ctgcattcgg ttaaacacca cgcacgttgc 10200 catgcagcgt acgaagaagg ccaagaacgg ccgcctggtg acggtatccg agggtgaagc 10260 cttgattagc cgctacaaga tcgtaaagag cgaaaccggg cggccggagt acatcgagat 10320 cgagctagct gattggatgt accgcgagat cacagaaggc aagaacccgg acgtgctgac 10380 ggttcacccc gattactttt tgatcgatcc cggcatcggc cgttttctct accgcctggc 10440 acgccgcgcc gcaggcaagg cagaagccag atggttgttc aagacgatct acgaacgcag 10500 tggcagcgcc ggagagttca agaagttctg tttcaccgtg cgcaagctga tcgggtcaaa 10560 tgacctgccg gagtacgatt tgaaggagga ggcggggcag gctggcccga tcctagtcat 10620 gcgctaccgc aacctgatcg agggcgaagc atccgccggt tcctaatgta cggagcagat 10680 gctagggcaa attgccctag caggggaaaa aggtcgaaaa ggtctctttc ctgtggatag 10740 cacgtacatt gggaacccaa agccgtacat tgggaaccgg aacccgtaca ttgggaaccc 10800 aaagccgtac attgggaacc ggtcacacat gtaagtgact gatataaaag agaaaaaagg 10860 cgatttttcc gcctaaaact ctttaaaact tattaaaact cttaaaaccc gcctggcctg 10920 tgcataactg tctggccagc gcacagccga agagctgcaa aaagcgccta cccttcggtc 10980 gctgcgctcc ctacgccccg ccgcttcgcg tcggcctatc gcggccgctg gccgctcaaa 11040 aatggctggc ctacggccag gcaatctacc agggcgcgga caagccgcgc cgtcgccact 11100 cgaccgccgg cgctgaggtc tgcctcgtga agaaggtgtt gctgactcat accaggcctg 11160 aatcgcccca tcatccagcc agaaagtgag ggagccacgg ttgatgagag ctttgttgta 11220 ggtggaccag ttggtgattt tgaacttttg ctttgccacg gaacggtctg cgttgtcggg 11280 aagatgcgtg atctgatcct tcaactcagc aaaagttcga tttattcaac aaagccgccg 11340 tcccgtcaag tcagcgtaat gctctgccag tgttacaacc aattaaccaa ttctgattag 11400 aaaaactcat cgagcatcaa atgaaactgc aatttattca tatcaggatt atcaatacca 11460 tatttttgaa aaagccgttt ctgtaatgaa ggagaaaact caccgaggca gttccatagg 11520 atggcaagat cctggtatcg gtctgcgatt ccgactcgtc caacatcaat acaacctatt 11580 aatttcccct cgtcaaaaat aaggttatca agtgagaaat caccatgagt gacgactgaa 11640 tccggtgaga atggcaaaag ctctgcatta atgaatcggc caacgcgcgg ggagaggcgg 11700 tttgcgtatt gggcgctctt ccgcttcctc gctcactgac tcgctgcgct cggtcgttcg 11760 gctgcggcga gcggtatcag ctcactcaaa ggcggtaata cggttatcca cagaatcagg 11820 ggataacgca ggaaagaaca tgtgagcaaa aggccagcaa aaggccagga accgtaaaaa 11880 ggccgcgttg ctggcgtttt tccataggct ccgcccccct gacgagcatc acaaaaatcg 11940 acgctcaagt cagaggtggc gaaacccgac aggactataa agataccagg cgtttccccc 12000 tggaagctcc ctcgtgcgct ctcctgttcc gaccctgccg cttaccggat acctgtccgc 12060 ctttctccct tcgggaagcg tggcgctttc tcatagctca cgctgtaggt atctcagttc 12120 ggtgtaggtc gttcgctcca agctgggctg tgtgcacgaa ccccccgttc agcccgaccg 12180 ctgcgcctta tccggtaact atcgtcttga gtccaacccg gtaagacacg acttatcgcc 12240 actggcagca gccactggta acaggattag cagagcgagg tatgtaggcg gtgctacaga 12300 gttcttgaag tggtggccta actacggcta cactagaaga acagtatttg gtatctgcgc 12360 tctgctgaag ccagttacct tcggaaaaag agttggtagc tcttgatccg gcaaacaaac 12420 caccgctggt agcggtggtt tttttgtttg caagcagcag attacgcgca gaaaaaaagg 12480 atctcaagaa gatcctttga tcttttctac ggggtctgac gctcagtgga acgaaaactc 12540 acgttaaggg attttggtca tgagattatc aaaaaggatc ttcacctaga tccttttgat 12600 ccggaattaa ttcctgtggt tggcatgcac atacaaatgg acgaacggat aaaccttttc 12660 acgccctttt aaatatccga ttattctaat aaacgctctt ttctcttagg tttacccgcc 12720 aatatatcct gtcaaacact gatagtttaa actgaaggcg ggaaacgaca atctgatcat 12780 gagcggagaa ttaagggagt cacgttatga cccccgccga tgacgcggga caagccgttt 12840 tacgtttgga actgacagaa ccgcaacgct gcaggaattg gccgcagcgg ccatttaaat 12900 caattgggcg cgccgaattc gagctcggta caagcttgca catgacaaca attgtaagag 12960 gatggagacc acaacgatcc aacaatactt ctgcgacggg ctgtgaagta tagagaagtt 13020 aaacgcccaa aagccattgt gtttggaatt tttagttatt ctatttttca tgatgtatct 13080 tcctctaaca tgccttaatt tgcaaatttg gtataactac tgattgaaaa tatatgtatg 13140 taaaaaaata ctaagcatat ttgtgaagct aaacatgatg ttatttaaga aaatatgttg 13200 ttaacagaat aagattaata tcgaaatgga aacatctgta aattagaatc atcttacaag 13260 ctaagagatg ttcacgcttt gagaaacttc ttcagatcat gaccgtagaa gtagctctcc 13320 aagactcaac gaaggctgct gcaattccac aaatgcatga catgcatcct tgtaaccgtc 13380 gtcgccgcta taaacacgga taactcaatt ccctgctcca tcaatttaga aatgagcaag 13440 caagcacccg atcgctcacc ccatatgcac caatctgact cccaagtctc tgtttcgcat 13500 tagtaccgcc agcactccac ctatagctac caattgagac ctttccagcc taagcagatc 13560 gattgatcgt tagagtcaaa gagttggtgg tacgggtact ttaactacca tggaatgatg 13620 gggcgtgatg tagagcggaa agcgcctccc tacgcggaac aacaccctcg ccatgccgct 13680 cgactacagc ctcctcctcg tcggccgccc acaacgaggg agcccgtggt cgcagccacc 13740 gaccagcatg tctctgtgtc ctcgtccgac ctcgacatgt catggcaaac agtcggacgc 13800 cagcaccaga ctgacgacat gagtctctga agagcccgcc acctagaaag atccgagccc 13860 tgctgctggt agtggtaacc attttcgtcg cgctgacgcg gagagcgaga ggccagaaat 13920 ttatagcgac tgacgctgtg gcaggcacgc tatcggaggt tacgacgtgg cgggtcactc 13980 gacgcggagt tcacaggtcc tatccttgca tcgctcgggc cggagtttac gggacttatc 14040 cttacgacgt gctctaaggt tgcgataacg ggcggaggaa ggcgtgtggc gtgcggagac 14100 ggtttataca cgtagtgtgc gggagtgtgt ttcgtagacg cgggaaagca cgacgactta 14160 cgaaggttag tggaggagga ggacacacta aaatcaggac gcaagaaact cttctattat 14220 agtagtagag aagagattat aggagtgtgg gttgattcta aagaaaatcg acgcaggaca 14280 accgtcaaaa cgggtgcttt aatatagtag atatatatat atagagagag agagaaagta 14340 caaaggatgc atttgtgtct gcatatgatc ggagtattac taacggccgt cgtaagaagg 14400 tccatcatgc gtggagcgag cccatttggt tggttgtcag gccgcagtta aggcctccat 14460 atatgattgt cgtcgggccc ataacagcat ctcctccacc agtttattgt aagaataaat 14520 taagtagaga tatttgtcgt cgggcagaag aaacttggac aagaagaaga agcaagctag 14580 gccaatttct tgccggcaag aggaagatag tggcctctag tttatatatc ggcgtgatga 14640 tgatgctcct agctagaaat gagagaagaa aaacggacgc gtgtttggtg tgtgtcaatg 14700 gcgtccatcc ttccatcaga tcagaacgat gaaaaagtca agcacggcat gcatagtata 14760 tgtatagctt gttttagtgt ggctttgctg agacgaatga aagcaacggc gggcatattt 14820 ttcagtggct gtagctttca ggctgaaaga gacgtggcat gcaataattc agggaattcg 14880 tcagccaatt gaggtagcta gtcaacttgt acattggtgc gagcaatttt ccgcactcag 14940 gagggctagt ttgagagtcc aaaaactata ggagattaaa gaggctaaaa tcctctcctt 15000 atttaatttt aaataagtag tgtatttgta ttttaactcc tccaaccctt ccgattttat 15060 ggctctcaaa ctagcattca gtctaatgca tgcatgcttg gctagaggtc gtatggggtt 15120 gttaatagca tagctagcta caagttaacc gggtctttta tatttaataa ggacaggcaa 15180 agtattactt acaaataaag aataaagcta ggacgaactc gtggattatt actaaatcga 15240 aatggacgta atattccagg caagaataat tgttcgatca ggagacaagt ggggcattgg 15300 accggttctt gcaagcaaga gcctatggcg tggtgacacg gcgcgttgcc catacatcat 15360 gcctccatcg atgatccatc ctcacttgct ataaaaagag gtgtccatgg tgctcaagct 15420 cagccaagca aataagacga cttgtttcat tgattcttca agagatcgag cttcttttgc 15480 accacaaggt cgaggatcca aca 15503 <210> 15 <211> 14946 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1313 <220> <221> misc_feature (222) (12). (1993) <223> Zm Ubi promoter <220> <221> misc_feature <222> (2016) .. (5597) <223> synthetic nucleotide sequence encoding the toxin       portion of H04 plus a full-length Cry1Ab tail       portion <220> <221> misc_feature (222) (5805) .. (7786) <223> Zm Ubi promoter <220> <221> misc_feature (222) (7883) .. (8986) <223> PMI <400> 15 aagcttgcat gcctgcagtg cagcgtgacc cggtcgtgcc cctctctaga gataatgagc 60 attgcatgtc taagttataa aaaattacca catatttttt ttgtcacact tgtttgaagt 120 gcagtttatc tatctttata catatattta aactttactc tacgaataat ataatctata 180 gtactacaat aatatcagtg ttttagagaa tcatataaat gaacagttag acatggtcta 240 aaggacaatt gagtattttg acaacaggac tctacagttt tatcttttta gtgtgcatgt 300 gttctccttt ttttttgcaa atagcttcac ctatataata cttcatccat tttattagta 360 catccattta gggtttaggg ttaatggttt ttatagacta atttttttag tacatctatt 420 ttattctatt ttagcctcta aattaagaaa actaaaactc tattttagtt tttttattta 480 ataatttaga tataaaatag aataaaataa agtgactaaa aattaaacaa atacccttta 540 agaaattaaa aaaactaagg aaacattttt cttgtttcga gtagataatg ccagcctgtt 600 aaacgccgtc gacgagtcta acggacacca accagcgaac cagcagcgtc gcgtcgggcc 660 aagcgaagca gacggcacgg catctctgtc gctgcctctg gacccctctc gagagttccg 720 ctccaccgtt ggacttgctc cgctgtcggc atccagaaat tgcgtggcgg agcggcagac 780 gtgagccggc acggcaggcg gcctcctcct cctctcacgg caccggcagc tacgggggat 840 tcctttccca ccgctccttc gctttccctt cctcgcccgc cgtaataaat agacaccccc 900 tccacaccct ctttccccaa cctcgtgttg ttcggagcgc acacacacac aaccagatct 960 cccccaaatc cacccgtcgg cacctccgct tcaaggtacg ccgctcgtcc tccccccccc 1020 cccctctcta ccttctctag atcggcgttc cggtccatgg ttagggcccg gtagttctac 1080 ttctgttcat gtttgtgtta gatccgtgtt tgtgttagat ccgtgctgct agcgttcgta 1140 cacggatgcg acctgtacgt cagacacgtt ctgattgcta acttgccagt gtttctcttt 1200 ggggaatcct gggatggctc tagccgttcc gcagacggga tcgatttcat gatttttttt 1260 gtttcgttgc atagggtttg gtttgccctt ttcctttatt tcaatatatg ccgtgcactt 1320 gtttgtcggg tcatcttttc atgctttttt ttgtcttggt tgtgatgatg tggtctggtt 1380 gggcggtcgt tctagatcgg agtagaattc tgtttcaaac tacctggtgg atttattaat 1440 tttggatctg tatgtgtgtg ccatacatat tcatagttac gaattgaaga tgatggatgg 1500 aaatatcgat ctaggatagg tatacatgtt gatgcgggtt ttactgatgc atatacagag 1560 atgctttttg ttcgcttggt tgtgatgatg tggtgtggtt gggcggtcgt tcattcgttc 1620 tagatcggag tagaatactg tttcaaacta cctggtgtat ttattaattt tggaactgta 1680 tgtgtgtgtc atacatcttc atagttacga gtttaagatg gatggaaata tcgatctagg 1740 ataggtatac atgttgatgt gggttttact gatgcatata catgatggca tatgcagcat 1800 ctattcatat gctctaacct tgagtaccta tctattataa taaacaagta tgttttataa 1860 ttattttgat cttgatatac ttggatgatg gcatatgcag cagctatatg tggatttttt 1920 tagccctgcc ttcatacgct atttatttgc ttggtactgt ttcttttgtc gatgctcacc 1980 ctgttgtttg gtgttacttc tgcagggatc caacaatgga caacaacccc aacatcaacg 2040 agtgcatccc ctacaactgc ctgagcaacc ccgaggtgga ggtgctgggc ggcgagcgca 2100 tcgagaccgg ctacaccccc atcgacatca gcctgagcct gacccagttc ctgctgagcg 2160 agttcgtgcc cggcgccggc ttcgtgctgg gcctggtgga catcatctgg ggcatcttcg 2220 gccccagcca gtgggacgcc ttcctggtgc agatcgagca gttgataaac caacgcatag 2280 aggaattcgc ccgcaaccag gccatcagcc gcctggaggg cctgagcaac ctgtaccaaa 2340 tctacgccga gagcttccgc gagtgggagg ccgaccccac caaccccgcc ctgcgcgagg 2400 agatgcgcat ccagttcaac gacatgaaca gcgccctgac caccgccatc cccctgttcg 2460 ccgtgcagaa ctaccaggtg cccctgctga gcgtgtacgt gcaggccgcc aacctgcacc 2520 tgagcgtgct gcgcgacgtc agcgtgttcg gccagcgctg gggcttcgac gccgccacca 2580 tcaacagccg ctacaacgac ctgacccgcc tgatcggcaa ctacaccgac cacgccgtgc 2640 gctggtacaa caccggcctg gagcgcgtgt ggggtcccga cagccgcgac tggatcaggt 2700 acaaccagtt ccgccgcgag ctgaccctga ccgtgctgga catcgtgagc ctgttcccca 2760 actacgacag ccgcacctac cccatccgca ccgtgagcca gctgacccgc gagatttaca 2820 ccaaccccgt gctggagaac ttcgacggca gcttccgcgg cagcgcccag ggcatcgagg 2880 gcagcatccg cagcccccac ctgatggaca tcctgaacag catcaccatc tacaccgacg 2940 cccaccgcgg cgagtactac tggagcggcc accagatcat ggccagcccc gtcggcttca 3000 gcggccccga gttcaccttc cccctgtacg gcaccatggg caacgctgca cctcagcagc 3060 gcatcgtggc acagctgggc cagggagtgt accgcaccct gagcagcacc ctgtaccgtc 3120 gacctttcaa catcggcatc aacaaccagc agctgagcgt gctggacggc accgagttcg 3180 cctacggcac cagcagcaac ctgcccagcg ccgtgtaccg caagagcggc accgtggaca 3240 gcctggacga gatcccccct cagaacaaca acgtgccacc tcgacagggc ttcagccacc 3300 gtctgagcca cgtgagcatg ttccgcagtg gcttcagcaa cagcagcgtg agcatcatcc 3360 gtgcacccat gttcagctgg attcaccgca gcgccaccct gaccaacacc atcgaccccg 3420 agcgcatcaa ccagatcccc ctggtgaagg gcttccgggt gtggggcggc accagcgtga 3480 tcaccggccc cggcttcacc ggaggcgaca tcctgcgcag aaacaccttc ggcgacttcg 3540 tgagcctgca ggtgaacatc aacagcccca tcacccagcg ttaccgcctg cgcttccgct 3600 acgccagcag ccgcgacgcc cgtgtgatcg tgctgactgg cgccgctagc accggtgtgg 3660 gcggtcaggt gagcgtgaac atgcccctgc agaagactat ggagatcggc gagaacctga 3720 ctagtcgcac cttccgctac accgacttca gcaacccctt cagcttccgc gccaaccccg 3780 acatcatcgg catcagcgag cagcccctgt tcggtgccgg cagcatcagc agcggcgagc 3840 tgtacatcga caagatcgag atcatcctgg ccgacgccac cttcgaggcc gagagcgacc 3900 tggagcgcgc ccagaaggcc gtgaacgccc tgttcaccag cagcaaccag atcggcctga 3960 agaccgacgt gaccgactac cacatcgacc aggtgagcaa cctggtggac tgcttaagcg 4020 acgagttctg cctggacgag aagaaggagc tgagcgagaa ggtgaagcac gccaagcgcc 4080 tgagcgacga gcgcaacctg ctgcaggacc ccaacttccg cggcatcaac cgccagctgg 4140 accgcggctg gcgaggcagc accgatatca ccatccaggg cggcgacgac gtgttcaagg 4200 agaactacgt gaccctgcag ggcaccttcg acgagtgcta ccccacctac ctgtaccagc 4260 cgatcgacga gagcaagctg aaggcctaca cccgctacca gctgcgcggc tacatcgagg 4320 acagccagga cctggaaatc tacctgatcc gctacaacgc gaagcacgag accgtgaacg 4380 tgcccggcac cggcagcctg tggcccctga gcgcccccag ccccatcggc aagtgcgggg 4440 agccgaatcg atgcgctccg cacctggagt ggaacccgga cctagactgc agctgcaggg 4500 acggggagaa gtgcgcccac cacagccacc acttcagcct ggacatcgac gtgggctgca 4560 ccgacctgaa cgaggacctg ggcgtgtggg tgatcttcaa gatcaagacc caggacggcc 4620 acgcccgcct gggcaatcta gagttcctgg aggagaagcc cctggtgggc gaggccctgg 4680 cccgcgtgaa gcgtgctgag aagaagtggc gcgacaagcg cgagaagctg gagtgggaga 4740 ccaacatcgt gtacaaggag gccaaggaga gcgtggacgc cctgttcgtg aacagccagt 4800 acgaccgcct gcaggccgac accaacatcg ccatgatcca cgccgccgac aagcgcgtgc 4860 acagcattcg cgaggcctac ctgcccgagc tgagcgtgat ccccggtgtg aacgccgcca 4920 tcttcgagga actcgagggc cgcatcttca ccgccttcag cctgtacgac gcccgcaacg 4980 tgatcaagaa cggcgacttc aacaacggcc tgagctgctg gaacgtgaag ggccacgtgg 5040 acgtggagga gcagaacaac caccgcagcg tgctggtggt gcccgagtgg gaggccgagg 5100 tgagccagga ggtgcgcgtg tgccccggcc gcggctacat cctgcgcgtg accgcctaca 5160 aggagggcta cggcgagggc tgcgtgacca tccacgagat cgagaacaac accgacgagc 5220 tcaagttcag caactgcgtg gaggaggagg tttaccccaa caacaccgtg acctgcaacg 5280 actacaccgc gacccaggag gagtacgaag gcacctacac ctctcgcaac aggggttacg 5340 acggcgccta cgagtccaac agctccgtgc cagctgacta cgccagcgcc tacgaggaga 5400 aagcctacac cgacggtaga cgcgacaacc catgtgagag caacagaggc tacggcgact 5460 acacccccct gcccgctgga tacgtgacca aggagctgga gtacttcccc gagaccgaca 5520 aggtgtggat cgagattggc gagaccgagg gcaccttcat cgtggacagc gtggagctgc 5580 tgctgatgga ggagtagtag atctgttctg cacaaagtgg agtagtcagt catcgatcag 5640 gaaccagaca ccagactttt attcatacag tgaagtgaag tgaagtgcag tgcagtgagt 5700 tgctggtttt tgtacaactt agtatgtatt tgtatttgta aaatacttct atcaataaaa 5760 tttctaattc ctaaaaccaa aatccagggg taccagcttg catgcctgca gtgcagcgtg 5820 acccggtcgt gcccctctct agagataatg agcattgcat gtctaagtta taaaaaatta 5880 ccacatattt tttttgtcac acttgtttga agtgcagttt atctatcttt atacatatat 5940 ttaaacttta ctctacgaat aatataatct atagtactac aataatatca gtgttttaga 6000 gaatcatata aatgaacagt tagacatggt ctaaaggaca attgagtatt ttgacaacag 6060 gactctacag ttttatcttt ttagtgtgca tgtgttctcc tttttttttg caaatagctt 6120 cacctatata atacttcatc cattttatta gtacatccat ttagggttta gggttaatgg 6180 tttttataga ctaatttttt tagtacatct attttattct attttagcct ctaaattaag 6240 aaaactaaaa ctctatttta gtttttttat ttaataattt agatataaaa tagaataaaa 6300 taaagtgact aaaaattaaa caaataccct ttaagaaatt aaaaaaacta aggaaacatt 6360 tttcttgttt cgagtagata atgccagcct gttaaacgcc gtcgacgagt ctaacggaca 6420 ccaaccagcg aaccagcagc gtcgcgtcgg gccaagcgaa gcagacggca cggcatctct 6480 gtcgctgcct ctggacccct ctcgagagtt ccgctccacc gttggacttg ctccgctgtc 6540 ggcatccaga aattgcgtgg cggagcggca gacgtgagcc ggcacggcag gcggcctcct 6600 cctcctctca cggcaccggc agctacgggg gattcctttc ccaccgctcc ttcgctttcc 6660 cttcctcgcc cgccgtaata aatagacacc ccctccacac cctctttccc caacctcgtg 6720 ttgttcggag cgcacacaca cacaaccaga tctcccccaa atccacccgt cggcacctcc 6780 gcttcaaggt acgccgctcg tcctcccccc ccccccctct ctaccttctc tagatcggcg 6840 ttccggtcca tggttagggc ccggtagttc tacttctgtt catgtttgtg ttagatccgt 6900 gtttgtgtta gatccgtgct gctagcgttc gtacacggat gcgacctgta cgtcagacac 6960 gttctgattg ctaacttgcc agtgtttctc tttggggaat cctgggatgg ctctagccgt 7020 tccgcagacg ggatcgattt catgattttt tttgtttcgt tgcatagggt ttggtttgcc 7080 cttttccttt atttcaatat atgccgtgca cttgtttgtc gggtcatctt ttcatgcttt 7140 tttttgtctt ggttgtgatg atgtggtctg gttgggcggt cgttctagat cggagtagaa 7200 ttctgtttca aactacctgg tggatttatt aattttggat ctgtatgtgt gtgccataca 7260 tattcatagt tacgaattga agatgatgga tggaaatatc gatctaggat aggtatacat 7320 gttgatgcgg gttttactga tgcatataca gagatgcttt ttgttcgctt ggttgtgatg 7380 atgtggtgtg gttgggcggt cgttcattcg ttctagatcg gagtagaata ctgtttcaaa 7440 ctacctggtg tatttattaa ttttggaact gtatgtgtgt gtcatacatc ttcatagtta 7500 cgagtttaag atggatggaa atatcgatct aggataggta tacatgttga tgtgggtttt 7560 actgatgcat atacatgatg gcatatgcag catctattca tatgctctaa ccttgagtac 7620 ctatctatta taataaacaa gtatgtttta taattatttt gatcttgata tacttggatg 7680 atggcatatg cagcagctat atgtggattt ttttagccct gccttcatac gctatttatt 7740 tgcttggtac tgtttctttt gtcgatgctc accctgttgt ttggtgttac ttctgcaggg 7800 atccccgatc atgcaaaaac tcattaactc agtgcaaaac tatgcctggg gcagcaaaac 7860 ggcgttgact gaactttatg gtatggaaaa tccgtccagc cagccgatgg ccgagctgtg 7920 gatgggcgca catccgaaaa gcagttcacg agtgcagaat gccgccggag atatcgtttc 7980 actgcgtgat gtgattgaga gtgataaatc gactctgctc ggagaggccg ttgccaaacg 8040 ctttggcgaa ctgcctttcc tgttcaaagt attatgcgca gcacagccac tctccattca 8100 ggttcatcca aacaaacaca attctgaaat cggttttgcc aaagaaaatg ccgcaggtat 8160 cccgatggat gccgccgagc gtaactataa agatcctaac cacaagccgg agctggtttt 8220 tgcgctgacg cctttccttg cgatgaacgc gtttcgtgaa ttttccgaga ttgtctccct 8280 actccagccg gtcgcaggtg cacatccggc gattgctcac tttttacaac agcctgatgc 8340 cgaacgttta agcgaactgt tcgccagcct gttgaatatg cagggtgaag aaaaatcccg 8400 cgcgctggcg attttaaaat cggccctcga tagccagcag ggtgaaccgt ggcaaacgat 8460 tcgtttaatt tctgaatttt acccggaaga cagcggtctg ttctccccgc tattgctgaa 8520 tgtggtgaaa ttgaaccctg gcgaagcgat gttcctgttc gctgaaacac cgcacgctta 8580 cctgcaaggc gtggcgctgg aagtgatggc aaactccgat aacgtgctgc gtgcgggtct 8640 gacgcctaaa tacattgata ttccggaact ggttgccaat gtgaaattcg aagccaaacc 8700 ggctaaccag ttgttgaccc agccggtgaa acaaggtgca gaactggact tcccgattcc 8760 agtggatgat tttgccttct cgctgcatga ccttagtgat aaagaaacca ccattagcca 8820 gcagagtgcc gccattttgt tctgcgtcga aggcgatgca acgttgtgga aaggttctca 8880 gcagttacag cttaaaccgg gtgaatcagc gtttattgcc gccaacgaat caccggtgac 8940 tgtcaaaggc cacggccgtt tagcgcgtgt ttacaacaag ctgtaagagc ttactgaaaa 9000 aattaacatc tcttgctaag ctgggagctc gatccgtcga cctgcagatc gttcaaacat 9060 ttggcaataa agtttcttaa gattgaatcc tgttgccggt cttgcgatga ttatcatata 9120 atttctgttg aattacgtta agcatgtaat aattaacatg taatgcatga cgttatttat 9180 gagatgggtt tttatgatta gagtcccgca attatacatt taatacgcga tagaaaacaa 9240 aatatagcgc gcaaactagg ataaattatc gcgcgcggtg tcatctatgt tactagatct 9300 gctagccctg caggaaattt accggtgccc gggcggccag catggccgta tccgcaatgt 9360 gttattaagt tgtctaagcg tcaatttgtt tacaccacaa tatatcctgc caccagccag 9420 ccaacagctc cccgaccggc agctcggcac aaaatcacca ctcgatacag gcagcccatc 9480 agaattaatt ctcatgtttg acagcttatc atcgactgca cggtgcacca atgcttctgg 9540 cgtcaggcag ccatcggaag ctgtggtatg gctgtgcagg tcgtaaatca ctgcataatt 9600 cgtgtcgctc aaggcgcact cccgttctgg ataatgtttt ttgcgccgac atcataacgg 9660 ttctggcaaa tattctgaaa tgagctgttg acaattaatc atccggctcg tataatgtgt 9720 ggaattgtga gcggataaca atttcacaca ggaaacagac catgagggaa gcgttgatcg 9780 ccgaagtatc gactcaacta tcagaggtag ttggcgtcat cgagcgccat ctcgaaccga 9840 cgttgctggc cgtacatttg tacggctccg cagtggatgg cggcctgaag ccacacagtg 9900 atattgattt gctggttacg gtgaccgtaa ggcttgatga aacaacgcgg cgagctttga 9960 tcaacgacct tttggaaact tcggcttccc ctggagagag cgagattctc cgcgctgtag 10020 aagtcaccat tgttgtgcac gacgacatca ttccgtggcg ttatccagct aagcgcgaac 10080 tgcaatttgg agaatggcag cgcaatgaca ttcttgcagg tatcttcgag ccagccacga 10140 tcgacattga tctggctatc ttgctgacaa aagcaagaga acatagcgtt gccttggtag 10200 gtccagcggc ggaggaactc tttgatccgg ttcctgaaca ggatctattt gaggcgctaa 10260 atgaaacctt aacgctatgg aactcgccgc ccgactgggc tggcgatgag cgaaatgtag 10320 tgcttacgtt gtcccgcatt tggtacagcg cagtaaccgg caaaatcgcg ccgaaggatg 10380 tcgctgccga ctgggcaatg gagcgcctgc cggcccagta tcagcccgtc atacttgaag 10440 ctaggcaggc ttatcttgga caagaagatc gcttggcctc gcgcgcagat cagttggaag 10500 aatttgttca ctacgtgaaa ggcgagatca ccaaagtagt cggcaaataa agctctagtg 10560 gatctccgta cccccggggg atctggctcg cggcggacgc acgacgccgg ggcgagacca 10620 taggcgatct cctaaatcaa tagtagctgt aacctcgaag cgtttcactt gtaacaacga 10680 ttgagaattt ttgtcataaa attgaaatac ttggttcgca tttttgtcat ccgcggtcag 10740 ccgcaattct gacgaactgc ccatttagct ggagatgatt gtacatcctt cacgtgaaaa 10800 tttctcaagc gctgtgaaca agggttcaga ttttagattg aaaggtgagc cgttgaaaca 10860 cgttcttctt gtcgatgacg acgtcgctat gcggcatctt attattgaat accttacgat 10920 ccacgccttc aaagtgaccg cggtagccga cagcacccag ttcacaagag tactctcttc 10980 cgcgacggtc gatgtcgtgg ttgttgatct aaatttaggt cgtgaagatg ggctcgagat 11040 cgttcgtaat ctggcggcaa agtctgatat tccaatcata attatcagtg gcgaccgcct 11100 tgaggagacg gataaagttg ttgcactcga gctaggagca agtgatttta tcgctaagcc 11160 gttcagtatc agagagtttc tagcacgcat tcgggttgcc ttgcgcgtgc gccccaacgt 11220 tgtccgctcc aaagaccgac ggtctttttg ttttactgac tggacactta atctcaggca 11280 acgtcgcttg atgtccgaag ctggcggtga ggtgaaactt acggcaggtg agttcaatct 11340 tctcctcgcg tttttagaga aaccccgcga cgttctatcg cgcgagcaac ttctcattgc 11400 cagtcgagta cgcgacgagg aggtttatga caggagtata gatgttctca ttttgaggct 11460 gcgccgcaaa cttgaggcag atccgtcaag ccctcaactg ataaaaacag caagaggtgc 11520 cggttatttc tttgacgcgg acgtgcaggt ttcgcacggg gggacgatgg cagcctgagc 11580 caattcccag atccccgagg aatcggcgtg agcggtcgca aaccatccgg cccggtacaa 11640 atcggcgcgg cgctgggtga tgacctggtg gagaagttga aggccgcgca ggccgcccag 11700 cggcaacgca tcgaggcaga agcacgcccc ggtgaatcgt ggcaagcggc cgctgatcga 11760 atccgcaaag aatcccggca accgccggca gccggtgcgc cgtcgattag gaagccgccc 11820 aagggcgacg agcaaccaga ttttttcgtt ccgatgctct atgacgtggg cacccgcgat 11880 agtcgcagca tcatggacgt ggccgttttc cgtctgtcga agcgtgaccg acgagctggc 11940 gaggtgatcc gctacgagct tccagacggg cacgtagagg tttccgcagg gccggccggc 12000 atggccagtg tgtgggatta cgacctggta ctgatggcgg tttcccatct aaccgaatcc 12060 atgaaccgat accgggaagg gaagggagac aagcccggcc gcgtgttccg tccacacgtt 12120 gcggacgtac tcaagttctg ccggcgagcc gatggcggaa agcagaaaga cgacctggta 12180 gaaacctgca ttcggttaaa caccacgcac gttgccatgc agcgtacgaa gaaggccaag 12240 aacggccgcc tggtgacggt atccgagggt gaagccttga ttagccgcta caagatcgta 12300 aagagcgaaa ccgggcggcc ggagtacatc gagatcgagc tagctgattg gatgtaccgc 12360 gagatcacag aaggcaagaa cccggacgtg ctgacggttc accccgatta ctttttgatc 12420 gatcccggca tcggccgttt tctctaccgc ctggcacgcc gcgccgcagg caaggcagaa 12480 gccagatggt tgttcaagac gatctacgaa cgcagtggca gcgccggaga gttcaagaag 12540 ttctgtttca ccgtgcgcaa gctgatcggg tcaaatgacc tgccggagta cgatttgaag 12600 gaggaggcgg ggcaggctgg cccgatccta gtcatgcgct accgcaacct gatcgagggc 12660 gaagcatccg ccggttccta atgtacggag cagatgctag ggcaaattgc cctagcaggg 12720 gaaaaaggtc gaaaaggtct ctttcctgtg gatagcacgt acattgggaa cccaaagccg 12780 tacattggga accggaaccc gtacattggg aacccaaagc cgtacattgg gaaccggtca 12840 cacatgtaag tgactgatat aaaagagaaa aaaggcgatt tttccgccta aaactcttta 12900 aaacttatta aaactcttaa aacccgcctg gcctgtgcat aactgtctgg ccagcgcaca 12960 gccgaagagc tgcaaaaagc gcctaccctt cggtcgctgc gctccctacg ccccgccgct 13020 tcgcgtcggc ctatcgcggc cgctggccgc tcaaaaatgg ctggcctacg gccaggcaat 13080 ctaccagggc gcggacaagc cgcgccgtcg ccactcgacc gccggcgctg aggtctgcct 13140 cgtgaagaag gtgttgctga ctcataccag gcctgaatcg ccccatcatc cagccagaaa 13200 gtgagggagc cacggttgat gagagctttg ttgtaggtgg accagttggt gattttgaac 13260 ttttgctttg ccacggaacg gtctgcgttg tcgggaagat gcgtgatctg atccttcaac 13320 tcagcaaaag ttcgatttat tcaacaaagc cgccgtcccg tcaagtcagc gtaatgctct 13380 gccagtgtta caaccaatta accaattctg attagaaaaa ctcatcgagc atcaaatgaa 13440 actgcaattt attcatatca ggattatcaa taccatattt ttgaaaaagc cgtttctgta 13500 atgaaggaga aaactcaccg aggcagttcc ataggatggc aagatcctgg tatcggtctg 13560 cgattccgac tcgtccaaca tcaatacaac ctattaattt cccctcgtca aaaataaggt 13620 tatcaagtga gaaatcacca tgagtgacga ctgaatccgg tgagaatggc aaaagctctg 13680 cattaatgaa tcggccaacg cgcggggaga ggcggtttgc gtattgggcg ctcttccgct 13740 tcctcgctca ctgactcgct gcgctcggtc gttcggctgc ggcgagcggt atcagctcac 13800 tcaaaggcgg taatacggtt atccacagaa tcaggggata acgcaggaaa gaacatgtga 13860 gcaaaaggcc agcaaaaggc caggaaccgt aaaaaggccg cgttgctggc gtttttccat 13920 aggctccgcc cccctgacga gcatcacaaa aatcgacgct caagtcagag gtggcgaaac 13980 ccgacaggac tataaagata ccaggcgttt ccccctggaa gctccctcgt gcgctctcct 14040 gttccgaccc tgccgcttac cggatacctg tccgcctttc tcccttcggg aagcgtggcg 14100 ctttctcata gctcacgctg taggtatctc agttcggtgt aggtcgttcg ctccaagctg 14160 ggctgtgtgc acgaaccccc cgttcagccc gaccgctgcg ccttatccgg taactatcgt 14220 cttgagtcca acccggtaag acacgactta tcgccactgg cagcagccac tggtaacagg 14280 attagcagag cgaggtatgt aggcggtgct acagagttct tgaagtggtg gcctaactac 14340 ggctacacta gaagaacagt atttggtatc tgcgctctgc tgaagccagt taccttcgga 14400 aaaagagttg gtagctcttg atccggcaaa caaaccaccg ctggtagcgg tggttttttt 14460 gtttgcaagc agcagattac gcgcagaaaa aaaggatctc aagaagatcc tttgatcttt 14520 tctacggggt ctgacgctca gtggaacgaa aactcacgtt aagggatttt ggtcatgaga 14580 ttatcaaaaa ggatcttcac ctagatcctt ttgatccgga attaattcct gtggttggca 14640 tgcacataca aatggacgaa cggataaacc ttttcacgcc cttttaaata tccgattatt 14700 ctaataaacg ctcttttctc ttaggtttac ccgccaatat atcctgtcaa acactgatag 14760 tttaaactga aggcgggaaa cgacaatctg atcatgagcg gagaattaag ggagtcacgt 14820 tatgaccccc gccgatgacg cgggacaagc cgttttacgt ttggaactga cagaaccgca 14880 acgctgcagg aattggccgc agcggccatt taaatcaatt gggcgcgccg aattcgagct 14940 cggtac 14946 <210> 16 <211> 14603 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pNOV1435 <220> <221> misc_feature (222) (1) .. (2007) <223> synthetic nucleotide sequence encoding the toxin       portion of H04 plus the first 40 amino acids of       the Cry1Ab tail <220> <221> misc_feature (222) Complement ((8814) .. (10022)) <223> PMI <220> <221> misc_feature <222> (11142) .. (12032) <223> Maize ubiquitin promoter <220> <221> misc_feature (222) (12037) .. (14594) <223> MTL promoter <400> 16 atggacaaca accccaacat caacgagtgc atcccctaca actgcctgag caaccccgag 60 gtggaggtgc tgggcggcga gcgcatcgag accggctaca cccccatcga catcagcctg 120 agcctgaccc agttcctgct gagcgagttc gtgcccggcg ccggcttcgt gctgggcctg 180 gtggacatca tctggggcat cttcggcccc agccagtggg acgccttcct ggtgcagatc 240 gagcagttga taaaccaacg catagaggaa ttcgcccgca accaggccat cagccgcctg 300 gagggcctga gcaacctgta ccaaatctac gccgagagct tccgcgagtg ggaggccgac 360 cccaccaacc ccgccctgcg cgaggagatg cgcatccagt tcaacgacat gaacagcgcc 420 ctgaccaccg ccatccccct gttcgccgtg cagaactacc aggtgcccct gctgagcgtg 480 tacgtgcagg ccgccaacct gcacctgagc gtgctgcgcg acgtcagcgt gttcggccag 540 cgctggggct tcgacgccgc caccatcaac agccgctaca acgacctgac ccgcctgatc 600 ggcaactaca ccgaccacgc cgtgcgctgg tacaacaccg gcctggagcg cgtgtggggt 660 cccgacagcc gcgactggat caggtacaac cagttccgcc gcgagctgac cctgaccgtg 720 ctggacatcg tgagcctgtt ccccaactac gacagccgca cctaccccat ccgcaccgtg 780 agccagctga cccgcgagat ttacaccaac cccgtgctgg agaacttcga cggcagcttc 840 cgcggcagcg cccagggcat cgagggcagc atccgcagcc cccacctgat ggacatcctg 900 aacagcatca ccatctacac cgacgcccac cgcggcgagt actactggag cggccaccag 960 atcatggcca gccccgtcgg cttcagcggc cccgagttca ccttccccct gtacggcacc 1020 atgggcaacg ctgcacctca gcagcgcatc gtggcacagc tgggccaggg agtgtaccgc 1080 accctgagca gcaccctgta ccgtcgacct ttcaacatcg gcatcaacaa ccagcagctg 1140 agcgtgctgg acggcaccga gttcgcctac ggcaccagca gcaacctgcc cagcgccgtg 1200 taccgcaaga gcggcaccgt ggacagcctg gacgagatcc cccctcagaa caacaacgtg 1260 ccacctcgac agggcttcag ccaccgtctg agccacgtga gcatgttccg cagtggcttc 1320 agcaacagca gcgtgagcat catccgtgca cccatgttca gctggattca ccgcagcgcc 1380 accctgacca acaccatcga ccccgagcgc atcaaccaga tccccctggt gaagggcttc 1440 cgggtgtggg gcggcaccag cgtgatcacc ggccccggct tcaccggagg cgacatcctg 1500 cgcagaaaca ccttcggcga cttcgtgagc ctgcaggtga acatcaacag ccccatcacc 1560 cagcgttacc gcctgcgctt ccgctacgcc agcagccgcg acgcccgtgt gatcgtgctg 1620 actggcgccg ctagcaccgg tgtgggcggt caggtgagcg tgaacatgcc cctgcagaag 1680 actatggaga tcggcgagaa cctgactagt cgcaccttcc gctacaccga cttcagcaac 1740 cccttcagct tccgcgccaa ccccgacatc atcggcatca gcgagcagcc cctgttcggt 1800 gccggcagca tcagcagcgg cgagctgtac atcgacaaga tcgagatcat cctggccgac 1860 gccaccttcg aggccgagag cgacctggag cgcgcccaga aggccgtgaa cgccctgttc 1920 accagcagca accagatcgg cctgaagacc gacgtgaccg actaccacat cgaccaggtg 1980 agcaacctgg tggactgctt aagctagaga tctgttctgc acaaagtgga gtagtcagtc 2040 atcgatcagg aaccagacac cagactttta ttcatacagt gaagtgaagt gaagtgcagt 2100 gcagtgagtt gctggttttt gtaccactta gtatgtattt gtatttgtaa aatacttcta 2160 tcaataaaat ttctaattcc taaaaccaaa atccagtggg taccagcttg ggctgagtgg 2220 ctccttcaac gttgcggttc tgtcagttcc aaacgtaaaa cggcttgtcc cgcgtcatcg 2280 gcgggggtca taacgtgact cccttaattc tccgctcatg atcagattgt cgtttcccgc 2340 cttcagttta aactatcagt gtttgacagg atatattggc gggtaaacct aagagaaaag 2400 agcgtttatt agaataacgg atatttaaaa gggcgtgaaa aggtttatcc gttcgtccat 2460 ttgtatgtgc atgccaacca cagggttccc ctcgggagtg cttggcattc cgtacgataa 2520 tgacttctgt tcaaccaccc aaacgtcgga aagcctgacg acggagcagc attccaaaaa 2580 gatcccttgg ctcgtctggg tcggctagaa ggtcgagtgg gctgctgtgg cttgatccct 2640 caacgcggtc gcggacgtag cgcagcgccg aaaaatcctc gatcgcaaat ccgacgctgt 2700 cgaaaagcgt gatctgcttg tcgctctttc ggccgacgtc ctggccagtc atcacgcgcc 2760 aaagttccgt cacaggatga tctggcgcga gttgctggat ctcgccttca atccgggtct 2820 gtggcgggaa ctccacgaaa atatccgaac gcagcaagat cgtcgaccaa ttcttgaaga 2880 cgaaagggcc tcgtgatacg cctattttta taggttaatg tcatgataat aatggtttct 2940 tagacgtcag gtggcacttt tcggggaaat gtgcgcggaa cccctatttg tttatttttc 3000 taaatacatt caaatatgta tccgctcatg agacaataac cctgataaat gcttcaataa 3060 tattgaaaaa ggaagagtat gagtattcaa catttccgtg tcgcccttat tccctttttt 3120 gcggcatttt gccttcctgt ttttgctcac ccagaaacgc tggtgaaagt aaaagatgct 3180 gaagatcagt tgggtgcacg agtgggttac atcgaactgg atctcaacag cggtaagatc 3240 cttgagagtt ttcgccccga agaacgtttt ccaatgatga gcacttttaa agttctgcta 3300 tgtggcgcgg tattatcccg tgttgacgcc gggcaagagc aactcggtcg ccgcatacac 3360 tattctcaga atgacttggt tgagtactca ccagtcacag aaaagcatct tacggatggc 3420 atgacagtaa gagaattatg cagtgctgcc ataaccatga gtgataacac tgcggccaac 3480 ttacttctga caacgatcgg aggaccgaag gagctaaccg cttttttgca caacatgggg 3540 gatcatgtaa ctcgccttga tcgttgggaa ccggagctga atgaagccat accaaacgac 3600 gagcgtgaca ccacgatgcc tgcagggggg gggggggggg ggacatgagg ttgccccgta 3660 ttcagtgtcg ctgatttgta ttgtctgaag ttgtttttac gttaagttga tgcagatcaa 3720 ttaatacgat acctgcgtca taattgatta tttgacgtgg tttgatggcc tccacgcacg 3780 ttgtgatatg tagatgataa tcattatcac tttacgggtc ctttccggtg atccgacagg 3840 ttacggggcg gcgacctcgc gggttttcgc tatttatgaa aattttccgg tttaaggcgt 3900 ttccgttctt cttcgtcata acttaatgtt tttatttaaa ataccctctg aaaagaaagg 3960 aaacgacagg tgctgaaagc gaggcttttt ggcctctgtc gtttcctttc tctgtttttg 4020 tccgtggaat gaacaatgga agtccccccc cccccccccc cctgcagcaa tggcaacaac 4080 gttgcgcaaa ctattaactg gcgaactact tactctagct tcccggcaac aattaataga 4140 ctggatggag gcggataaag ttgcaggacc acttctgcgc tcggcccttc cggctggctg 4200 gtttattgct gataaatctg gagccggtga gcgtgggtct cgcggtatca ttgcagcact 4260 ggggccagat ggtaagccct cccgtatcgt agttatctac acgacgggga gtcaggcaac 4320 tatggatgaa cgaaatagac agatcgctga gataggtgcc tcactgatta agcattggta 4380 actgtcagac caagtttact catatatact ttagattgat ttaaaacttc atttttaatt 4440 taaaaggatc taggtgaaga tcctttttga taatctcatg accaaaatcc cttaacgtga 4500 gttttcgttc cactgagcgt cagaccccgt agaaaagatc aaaggatctt cttgagatcc 4560 tttttttctg cgcgtaatct gctgcttgca aacaaaaaaa ccaccgctac cagcggtggt 4620 ttgtttgccg gatcaagagc taccaactct ttttccgaag gtaactggct tcagcagagc 4680 gcagatacca aatactgtcc ttctagtgta gccgtagtta ggccaccact tcaagaactc 4740 tgtagcaccg cctacatacc tcgctctgct aatcctgtta ccagtggctg ctgccagtgg 4800 cgataagtcg tgtcttaccg ggttggactc aagacgatag ttaccggata aggcgcagcg 4860 gtcgggctga acggggggtt cgtgcacaca gcccagcttg gagcgaacga cctacaccga 4920 actgagatac ctacagcgtg agctatgaga aagcgccacg cttcccgaag ggagaaaggc 4980 ggacaggtat ccggtaagcg gcagggtcgg aacaggagag cgcacgaggg agcttccagg 5040 gggaaacgcc tggtatcttt atagtcctgt cgggtttcgc cacctctgac ttgagcgtcg 5100 atttttgtga tgctcgtcag gggggcggag cctatggaaa aacgccagca acgcggcctt 5160 tttacggttc ctggcctttt gctggccttt tgctcacatg ttctttcctg cgttatcccc 5220 tgattctgtg gataaccgta ttaccgcctt tgagtgagct gataccgctc gccgcagccg 5280 aacgaccgag cgcagcgagt cagtgagcga ggaagcggaa gagcgcctga tgcggtattt 5340 tctccttacg catctgtgcg gtatttcaca ccgcatatgg tgcactctca gtacaatctg 5400 ctctgatgcc gcatagttaa gccagtatac actccgctat cgctacgtga ctgggtcatg 5460 gctgcgcccc gacacccgcc aacacccgct gacgcgccct gacgggcttg tctgctcccg 5520 gcatccgctt acagacaagc tgtgaccgtc tccgggagct gcatgtgtca gaggttttca 5580 ccgtcatcac cgaaacgcgc gaggcagcag atcccccgat caagtagata cactacatat 5640 atctacaata gacatcgagc cggaaggtga tgtttacttt cctgaaatcc ccagcaattt 5700 taggccagtt tttacccaag acttcgcctc taacataaat tatagttacc aaatctggca 5760 aaagggttaa caagtggcag caacggattc gcaaacctgt cacgcctttt gtgccaaaag 5820 ccgcgccagg tttgcgatcc gctgtgccag gcgttaggcg tcatatgaag atttcggtga 5880 tccctgagca ggtggcggaa acattggatg ctgagaacca tttcattgtt cgtgaagtgt 5940 tcgatgtgca cctatccgac caaggctttg aactatctac cagaagtgtg agcccctacc 6000 ggaaggatta catctcggat gatgactctg atgaagactc tgcttgctat ggcgcattca 6060 tcgaccaaga gcttgtcggg aagattgaac tcaactcaac atggaacgat ctagcctcta 6120 tcgaacacat tgttgtgtcg cacacgcacc gaggcaaagg agtcgcgcac agtctcatcg 6180 aatttgcgaa aaagtgggca ctaagcagac agctccttgg catacgatta gagacacaaa 6240 cgaacaatgt acctgcctgc aatttgtacg caaaatgtgg ctttactctc ggcggcattg 6300 acctgttcac gtataaaact agacctcaag tctcgaacga aacagcgatg tactggtact 6360 ggttctcggg agcacaggat gacgcctaac aattcattca agccgacacc gcttcgcggc 6420 gcggcttaat tcaggagtta aacatcatga gggaagcggt gatcgccgaa gtatcgactc 6480 aactatcaga ggtagttggc gtcatcgagc gccatctcga accgacgttg ctggccgtac 6540 atttgtacgg ctccgcagtg gatggcggcc tgaagccaca cagtgatatt gatttgctgg 6600 ttacggtgac cgtaaggctt gatgaaacaa cgcggcgagc tttgatcaac gaccttttgg 6660 aaacttcggc ttcccctgga gagagcgaga ttctccgcgc tgtagaagtc accattgttg 6720 tgcacgacga catcattccg tggcgttatc cagctaagcg cgaactgcaa tttggagaat 6780 ggcagcgcaa tgacattctt gcaggtatct tcgagccagc cacgatcgac attgatctgg 6840 ctatcttgct gacaaaagca agagaacata gcgttgcctt ggtaggtcca gcggcggagg 6900 aactctttga tccggttcct gaacaggatc tatttgaggc gctaaatgaa accttaacgc 6960 tatggaactc gccgcccgac tgggctggcg atgagcgaaa tgtagtgctt acgttgtccc 7020 gcatttggta cagcgcagta accggcaaaa tcgcgccgaa ggatgtcgct gccgactggg 7080 caatggagcg cctgccggcc cagtatcagc ccgtcatact tgaagctagg caggcttatc 7140 ttggacaaga agatcgcttg gcctcgcgcg cagatcagtt ggaagaattt gttcactacg 7200 tgaaaggcga gatcaccaag gtagtcggca aataatgtct aacaattcgt tcaagccgac 7260 gccgcttcgc ggcgcggctt aactcaagcg ttagagagct ggggaagact atgcgcgatc 7320 tgttgaaggt ggttctaagc ctcgtacttg cgatggcatc ggggcaggca cttgctgacc 7380 tgccaattgt tttagtggat gaagctcgtc ttccctatga ctactcccca tccaactacg 7440 acatttctcc aagcaactac gacaactcca taagcaatta cgacaatagt ccatcaaatt 7500 acgacaactc tgagagcaac tacgataata gttcatccaa ttacgacaat agtcgcaacg 7560 gaaatcgtag gcttatatat agcgcaaatg ggtctcgcac tttcgccggc tactacgtca 7620 ttgccaacaa tgggacaacg aacttctttt ccacatctgg caaaaggatg ttctacaccc 7680 caaaaggggg gcgcggcgtc tatggcggca aagatgggag cttctgcggg gcattggtcg 7740 tcataaatgg ccaattttcg cttgccctga cagataacgg cctgaagatc atgtatctaa 7800 gcaactagcc tgctctctaa taaaatgtta ggcctcaaca tctagtcgca agctgagggg 7860 aaccactagt gtcatacgaa cctccaagag acggttacac aaacgggtac attgttgatg 7920 tcatgtatga caatcgccca agtaagtatc cagctgtgtt cagaacgtac gtccgaatta 7980 attcatcggg gtacggtcga cgatcgtcaa cgttcacttc taaagaaata gcgccactca 8040 gcttcctcag cggctttatc cagcgatttc ctattatgtc ggcatagttc tcaagatcga 8100 cagcctgtca cggttaagcg agaaatgaat aagaaggctg ataattcgga tctctgcgag 8160 ggagatgata tttgatcaca ggcagcaacg ctctgtcatc gttacaatca acatgctacc 8220 ctccgcgaga tcatccgtgt ttcaaacccg gcagcttagt tgccgttctt ccgaatagca 8280 tcggtaacat gagcaaagtc tgccgcctta caacggctct cccgctgacg ccgtcccgga 8340 ctgatgggct gcctgtatcg agtggtgatt ttgtgccgag ctgccggtcg gggagctgtt 8400 ggctggctgg tggcaggata tattgtggtg taaacaaatt gacgcttaga caacttaata 8460 acacattgcg gacgttttta atgtactgaa ttgtctagac ccggggatct catgtttgac 8520 agcttatcat cggatctagt aacatagatg acaccgcgcg cgataattta tcctagtttg 8580 cgcgctatat tttgttttct atcgcgtatt aaatgtataa ttgcgggact ctaatcataa 8640 aaacccatct cataaataac gtcatgcatt acatgttaat tattacatgc ttaacgtaat 8700 tcaacagaaa ttagatgata atcatcgcaa gaccggcaac aggattcaat cttaagaaac 8760 tttattgcca aatgtttgaa cgatctctgc aggtcgacgg atcgagctcc cagcttagca 8820 agagatgtta attttttcag taagctctta cagcttgttg taaacacgcg ctaaacggcc 8880 gtggcctttg acagtcaccg gtgattcgtt ggcggcaata aacgctgatt cacccggttt 8940 aagctgtaac tgctgagaac ctttccacaa cgttgcatcg ccttcgacgc agaacaaaat 9000 ggcggcactc tgctggctaa tggtggtttc tttatcacta aggtcatgca gcgagaaggc 9060 aaaatcatcc actggaatcg ggaagtccag ttctgcacct tgtttcaccg gctgggtcaa 9120 caactggtta gccggtttgg cttcgaattt cacattggca accagttccg gaatatcaat 9180 gtatttaggc gtcagacccg cacgcagcac gttatcggag tttgccatca cttccagcgc 9240 cacgccttgc aggtaagcgt gcggtgtttc agcgaacagg aacatcgctt cgccagggtt 9300 caatttcacc acattcagca atagcgggga gaacagaccg ctgtcttccg ggtaaaattc 9360 agaaattaaa cgaatcgttt gccacggttc accctgctgg ctatcgaggg ccgattttaa 9420 aatcgccagc gcgcgggatt tttcttcacc ctgcatattc aacaggctgg cgaacagttc 9480 gcttaaacgt tcggcatcag gctgttgtaa aaagtgagca atcgccggat gtgcacctgc 9540 gaccggctgg agtagggaga caatctcgga aaattcacga aacgcgttca tcgcaaggaa 9600 aggcgtcagc gcaaaaacca gctccggctt gtggttagga tctttatagt tacgctcggc 9660 ggcatccatc gggatacctg cggcattttc tttggcaaaa ccgatttcag aattgtgttt 9720 gtttggatga acctgaatgg agagtggctg tgctgcgcat aatactttga acaggaaagg 9780 cagttcgcca aagcgtttgg caacggcctc tccgagcaga gtcgatttat cactctcaat 9840 cacatcacgc agtgaaacga tatctccggc ggcattctgc actcgtgaac tgcttttcgg 9900 atgtgcgccc atccacagct cggccatcgg ctggctggac ggattttcca taccataaag 9960 ttcagtcaac gcgttttgct gccccaggca tagttttgca ctgagttaat gagtttttgc 10020 atgatcgggg atccctgcag aagtaacacc aaacaacagg gtgagcatcg acaaaagaaa 10080 cagtaccaag caaataaata gcgtatgaag gcagggctaa aaaaatccac atatagctgc 10140 tgcatatgcc atcatccaag tatatcaaga tcaaaataat tataaaacat acttgtttat 10200 tataatagat aggtactcaa ggttagagca tatgaataga tgctgcatat gccatcatgt 10260 atatgcatca gtaaaaccca catcaacatg tatacctatc ctagatcgat atttccatcc 10320 atcttaaact cgtaactatg aagatgtatg acacacacat acagttccaa aattaataaa 10380 tacaccaggt agtttgaaac ggcgtctact ccgatctaga acgaatgaac gaccgcccaa 10440 ccacaccaca tcatcacaac caagcgaaca aaaagcatct ctgtatatgc atcagtaaaa 10500 cccgcatcaa catgtatacc tatcctagat cgatatttcc atccatcatc ttcaattcgt 10560 aactatgaat atgtatggca cacacataca gatccaaaat taataaatcc accaggtagt 10620 ttgaaacaga attctactcc gatctagaac gaccgcccaa ccagaccaca tcatcacaac 10680 caagacaaaa aaaagcatga aaagatgacc cgacaaacaa gtgcacggca tatattgaaa 10740 taaaggaaaa gggcaaacca aaccctatgc aacgaaacaa aaaaaatcat gaaatcgatc 10800 ccgtctgcgg aacggctaga gccatcccag gattccccaa agagaaacac tggcaagtta 10860 gcaatcagaa cgtgtctgac gtacaggtcg catccgtgta cgaacgctag cagcacggat 10920 ctaacacaaa cacggatcta acacaaacat gaacagaagt agaactaccg ggccctaacc 10980 atggaccgga acgccgatct agagaaggta gagagggggg gggggggagg acgagcggcg 11040 taccttgaag cggaggtgcc gacgggtgga tttgggggag atctggttgt gtgtgtgtgc 11100 gctccgaaca acacgaggtt ggggaaagag ggtgtggagg gggtgtctat ttattacggc 11160 gggcgaggaa gggaaagcga aggagcggtg ggaaaggaat cccccgtagc tgccgtgccg 11220 tgagaggagg aggaggccgc ctgccgtgcc ggctcacgtc tgccgctccg ccacgcaatt 11280 tctggatgcc gacagcggag caagtccaac ggtggagcgg aactctcgag aggggtccag 11340 aggcagcgac agagatgccg tgccgtctgc ttcgcttggc ccgacgcgac gctgctggtt 11400 cgctggttgg tgtccgttag actcgtcgac ggcgtttaac aggctggcat tatctactcg 11460 aaacaagaaa aatgtttcct tagttttttt aatttcttaa agggtatttg tttaattttt 11520 agtcacttta ttttattcta ttttatatct aaattattaa ataaaaaaac taaaatagag 11580 ttttagtttt cttaatttag aggctaaaat agaataaaat agatgtacta aaaaaattag 11640 tctataaaaa ccattaaccc taaaccctaa atggatgtac taataaaatg gatgaagtat 11700 tatataggtg aagctatttg caaaaaaaaa ggagaacaca tgcacactaa aaagataaaa 11760 ctgtagagtc ctgttgtcaa aatactcaat tgtcctttag accatgtcta actgttcatt 11820 tatatgattc tctaaaacac tgatattatt gtagtactat agattatatt attcgtagag 11880 taaagtttaa atatatgtat aaagatagat aaactgcact tcaaacaagt gtgacaaaaa 11940 aaatatgtgg taatttttta taacttagac atgcaatgct cattatctct agagaggggc 12000 acgaccgggt cacgctgcac tgcaggcatg caagcttgca catgacaaca attgtaagag 12060 gatggagacc acaacgatcc aacaatactt ctgcgacggg ctgtgaagta tagagaagtt 12120 aaacgcccaa aagccattgt gtttggaatt tttagttatt ctatttttca tgatgtatct 12180 tcctctaaca tgccttaatt tgcaaatttg gtataactac tgattgaaaa tatatgtatg 12240 taaaaaaata ctaagcatat ttgtgaagct aaacatgatg ttatttaaga aaatatgttg 12300 ttaacagaat aagattaata tcgaaatgga aacatctgta aattagaatc atcttacaag 12360 ctaagagatg ttcacgcttt gagaaacttc ttcagatcat gaccgtagaa gtagctctcc 12420 aagactcaac gaaggctgct gcaattccac aaatgcatga catgcatcct tgtaaccgtc 12480 gtcgccgcta taaacacgga taactcaatt ccctgctcca tcaatttaga aatgagcaag 12540 caagcacccg atcgctcacc ccatatgcac caatctgact cccaagtctc tgtttcgcat 12600 tagtaccgcc agcactccac ctatagctac caattgagac ctttccagcc taagcagatc 12660 gattgatcgt tagagtcaaa gagttggtgg tacgggtact ttaactacca tggaatgatg 12720 gggcgtgatg tagagcggaa agcgcctccc tacgcggaac aacaccctcg ccatgccgct 12780 cgactacagc ctcctcctcg tcggccgccc acaacgaggg agcccgtggt cgcagccacc 12840 gaccagcatg tctctgtgtc ctcgtccgac ctcgacatgt catggcaaac agtcggacgc 12900 cagcaccaga ctgacgacat gagtctctga agagcccgcc acctagaaag atccgagccc 12960 tgctgctggt agtggtaacc attttcgtcg cgctgacgcg gagagcgaga ggccagaaat 13020 ttatagcgac tgacgctgtg gcaggcacgc tatcggaggt tacgacgtgg cgggtcactc 13080 gacgcggagt tcacaggtcc tatccttgca tcgctcgggc cggagtttac gggacttatc 13140 cttacgacgt gctctaaggt tgcgataacg ggcggaggaa ggcgtgtggc gtgcggagac 13200 ggtttataca cgtagtgtgc gggagtgtgt ttcgtagacg cgggaaagca cgacgactta 13260 cgaaggttag tggaggagga ggacacacta aaatcaggac gcaagaaact cttctattat 13320 agtagtagag aagagattat aggagtgtgg gttgattcta aagaaaatcg acgcaggaca 13380 accgtcaaaa cgggtgcttt aatatagtag atatatatat atagagagag agagaaagta 13440 caaaggatgc atttgtgtct gcatatgatc ggagtattac taacggccgt cgtaagaagg 13500 tccatcatgc gtggagcgag cccatttggt tggttgtcag gccgcagtta aggcctccat 13560 atatgattgt cgtcgggccc ataacagcat ctcctccacc agtttattgt aagaataaat 13620 taagtagaga tatttgtcgt cgggcagaag aaacttggac aagaagaaga agcaagctag 13680 gccaatttct tgccggcaag aggaagatag tggcctctag tttatatatc ggcgtgatga 13740 tgatgctcct agctagaaat gagagaagaa aaacggacgc gtgtttggtg tgtgtcaatg 13800 gcgtccatcc ttccatcaga tcagaacgat gaaaaagtca agcacggcat gcatagtata 13860 tgtatagctt gttttagtgt ggctttgctg agacgaatga aagcaacggc gggcatattt 13920 ttcagtggct gtagctttca ggctgaaaga gacgtggcat gcaataattc agggaattcg 13980 tcagccaatt gaggtagcta gtcaacttgt acattggtgc gagcaatttt ccgcactcag 14040 gagggctagt ttgagagtcc aaaaactata ggagattaaa gaggctaaaa tcctctcctt 14100 atttaatttt aaataagtag tgtatttgta ttttaactcc tccaaccctt ccgattttat 14160 ggctctcaaa ctagcattca gtctaatgca tgcatgcttg gctagaggtc gtatggggtt 14220 gttaatagca tagctagcta caagttaacc gggtctttta tatttaataa ggacaggcaa 14280 agtattactt acaaataaag aataaagcta ggacgaactc gtggattatt actaaatcga 14340 aatggacgta atattccagg caagaataat tgttcgatca ggagacaagt ggggcattgg 14400 accggttctt gcaagcaaga gcctatggcg tggtgacacg gcgcgttgcc catacatcat 14460 gcctccatcg atgatccatc ctcacttgct ataaaaagag gtgtccatgg tgctcaagct 14520 cagccaagca aataagacga cttgtttcat tgattcttca agagatcgag cttcttttgc 14580 accacaaggt cgaggatcca aca 14603 <210> 17 <211> 11127 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: pZU578 <220> <221> misc_feature (222) (1485) .. (3491) <223> synthetic nucleotide sequence encoding the toxin       portion of H04 plus the first 40 amino acids of       the Cry1Ab tail <220> <221> misc_feature (222) (5052) .. (6271) <223> PMI <220> <221> misc_feature (222) (3859) .. (5030) <223> SMAS promoter <220> <221> misc_feature (222) (56) .. (1475) <223> Actin 2 promoter U41998 <400> 17 ggccgcagcg gccatttaaa tcaattgggc gcgccgaatt cgagctcggt accctgcatg 60 cctgcaggtc gacaaaattt agaacgaact taattatgat ctcaaataca ttgatacata 120 tctcatctag atctaggtta tcattatgta agaaagtttt gacgaatatg gcacgacaaa 180 atggctagac tcgatgtaat tggtatctca actcaacatt atacttatac caaacattag 240 ttagacaaaa tttaaacaac tattttttat gtatgcaaga gtcagcatat gtataattga 300 ttcagaatcg ttttgacgag ttcggatgta gtagtagcca ttatttaatg tacatactaa 360 tcgtgaatag tgaatatgat gaagcattgt atcttattgt ataaatatcc ataaacacat 420 catgaaagac actttctttc acggtctgaa ttaattatga cacaattcta atagaaaacg 480 aattaaatta cgttgaattg tatgaaatct aattgaacaa gccaaccacg acgacgacta 540 acgttgcctg gattgactcg gtttaagtta accactaaaa aaacggagct gtcatgtaac 600 acgcggatcg agcaggtcac agtcatgaag ccatcaaagc aaaagaacta atccaagggc 660 tgagatgatt aattagttta aaaattagtt aacacgaggg aaaaggctgt ctgacagcca 720 ggtcacgtta tctttacctg tggtcgaaat gattcgtgtc tgtcgatttt aattattttt 780 ttgaaaggcc gaaaataaag ttgtaagaga taaacccgcc tatataaatt catatatttt 840 cctctccgct ttgaattgtc tcgttgtcct cctcactttc atcagccgtt ttgaatctcc 900 ggcgacttga cagagaagaa caaggaagaa gactaagaga gaaagtaaga gataatccag 960 gagattcatt ctccgttttg aatcttcctc aatctcatct tcttccgctc tttctttcca 1020 aggtaatagg aactttctgg atctacttta tttgctggat ctcgatcttg ttttctcaat 1080 ttccttgaga tctggaattc gtttaatttg gatctgtgaa cctccactaa atcttttggt 1140 tttactagaa tcgatctaag ttgaccgatc agttagctcg attatagcta ccagaatttg 1200 gcttgacctt gatggagaga tccatgttca tgttacctgg gaaatgattt gtatatgtga 1260 attgaaatct gaactgttga agttagattg aatctgaaca ctgtcaatgt tagattgaat 1320 ctgaacactg tttaagttag atgaagtttg tgtatagatt cttcgaaact ttaggatttg 1380 tagtgtcgta cgttgaacag aaagctattt ctgattcaat cagggtttat ttgactgtat 1440 tgaactcttt ttgtgtgttt gcagctcata aaaaggatcc aacaatggac aacaacccca 1500 acatcaacga gtgcatcccc tacaactgcc tgagcaaccc cgaggtggag gtgctgggcg 1560 gcgagcgcat cgagaccggc tacaccccca tcgacatcag cctgagcctg acccagttcc 1620 tgctgagcga gttcgtgccc ggcgccggct tcgtgctggg cctggtggac atcatctggg 1680 gcatcttcgg ccccagccag tgggacgcct tcctggtgca gatcgagcag ttgataaacc 1740 aacgcataga ggaattcgcc cgcaaccagg ccatcagccg cctggagggc ctgagcaacc 1800 tgtaccaaat ctacgccgag agcttccgcg agtgggaggc cgaccccacc aaccccgccc 1860 tgcgcgagga gatgcgcatc cagttcaacg acatgaacag cgccctgacc accgccatcc 1920 ccctgttcgc cgtgcagaac taccaggtgc ccctgctgag cgtgtacgtg caggccgcca 1980 acctgcacct gagcgtgctg cgcgacgtca gcgtgttcgg ccagcgctgg ggcttcgacg 2040 ccgccaccat caacagccgc tacaacgacc tgacccgcct gatcggcaac tacaccgacc 2100 acgccgtgcg ctggtacaac accggcctgg agcgcgtgtg gggtcccgac agccgcgact 2160 ggatcaggta caaccagttc cgccgcgagc tgaccctgac cgtgctggac atcgtgagcc 2220 tgttccccaa ctacgacagc cgcacctacc ccatccgcac cgtgagccag ctgacccgcg 2280 agatttacac caaccccgtg ctggagaact tcgacggcag cttccgcggc agcgcccagg 2340 gcatcgaggg cagcatccgc agcccccacc tgatggacat cctgaacagc atcaccatct 2400 acaccgacgc ccaccgcggc gagtactact ggagcggcca ccagatcatg gccagccccg 2460 tcggcttcag cggccccgag ttcaccttcc ccctgtacgg caccatgggc aacgctgcac 2520 ctcagcagcg catcgtggca cagctgggcc agggagtgta ccgcaccctg agcagcaccc 2580 tgtaccgtcg acctttcaac atcggcatca acaaccagca gctgagcgtg ctggacggca 2640 ccgagttcgc ctacggcacc agcagcaacc tgcccagcgc cgtgtaccgc aagagcggca 2700 ccgtggacag cctggacgag atcccccctc agaacaacaa cgtgccacct cgacagggct 2760 tcagccaccg tctgagccac gtgagcatgt tccgcagtgg cttcagcaac agcagcgtga 2820 gcatcatccg tgcacccatg ttcagctgga ttcaccgcag cgccaccctg accaacacca 2880 tcgaccccga gcgcatcaac cagatccccc tggtgaaggg cttccgggtg tggggcggca 2940 ccagcgtgat caccggcccc ggcttcaccg gaggcgacat cctgcgcaga aacaccttcg 3000 gcgacttcgt gagcctgcag gtgaacatca acagccccat cacccagcgt taccgcctgc 3060 gcttccgcta cgccagcagc cgcgacgccc gtgtgatcgt gctgactggc gccgctagca 3120 ccggtgtggg cggtcaggtg agcgtgaaca tgcccctgca gaagactatg gagatcggcg 3180 agaacctgac tagtcgcacc ttccgctaca ccgacttcag caaccccttc agcttccgcg 3240 ccaaccccga catcatcggc atcagcgagc agcccctgtt cggtgccggc agcatcagca 3300 gcggcgagct gtacatcgac aagatcgaga tcatcctggc cgacgccacc ttcgaggccg 3360 agagcgacct ggagcgcgcc cagaaggccg tgaacgccct gttcaccagc agcaaccaga 3420 tcggcctgaa gaccgacgtg accgactacc acatcgacca ggtgagcaac ctggtggact 3480 gcttaagcta gagatcctct agagtcgacc atggtgatca ctgcagatcg ttcaaacatt 3540 tggcaataaa gtttcttaag attgaatcct gttgccggtc ttgcgatgat tatcatataa 3600 tttctgttga attacgttaa gcatgtaata attaacatgt aatgcatgac gttatttatg 3660 agatgggttt ttatgattag agtcccgcaa ttatacattt aatacgcgat agaaaacaaa 3720 atatagcgcg caacctagga taaattatcg cgcgcggtgt catctatgtt actagatctc 3780 tagaaagctt cgtacgttaa ttaattcgaa tccggagcgg ccgcagggct agcatcgatg 3840 gtaccgagct cgagactata caggccaaat tcgctcttag ccgtacaata ttactcaccg 3900 gtgcgatgcc ccccatcgta ggtgaaggtg gaaattaatg atccatcttg agaccacagg 3960 cccacaacag ctaccagttt cctcaagggt ccaccaaaaa cgtaagcgct tacgtacatg 4020 gtcgataaga aaaggcaatt tgtagatgtt aacatccaac gtcgctttca gggatcccga 4080 attccaagct tggaattcgg gatcctacag gccaaattcg ctcttagccg tacaatatta 4140 ctcaccggtg cgatgccccc catcgtaggt gaaggtggaa attaatgatc catcttgaga 4200 ccacaggccc acaacagcta ccagtttcct caagggtcca ccaaaaacgt aagcgcttac 4260 gtacatggtc gataagaaaa ggcaatttgt agatgttaac atccaacgtc gctttcaggg 4320 atcccgaatt ccaagcttgg aattcgggat cctacaggcc aaattcgctc ttagccgtac 4380 aatattactc accggtgcga tccccccatc gtaggtgaag gtggaaatta atgatccatc 4440 ttgagaccac aggcccacaa cagctaccag tttcctcaag ggtccaccaa aaacgtaagc 4500 gcttacgtac atggtcgata agaaaaggca atttgtagat gttaacatcc aacgtcgctt 4560 tcagggatcc cgaattccaa gcttgggctg caggtcaatc ccattgcttt tgaagcagct 4620 caacattgat ctctttctcg agggagattt ttcaaatcag tgcgcaagac gtgacgtaag 4680 tatccgagtc agtttttatt tttctactaa tttggtcgtt tatttcggcg tgtaggacat 4740 ggcaaccggg cctgaatttc gcgggtattc tgtttctatt ccaacttttt cttgatccgc 4800 agccattaac gacttttgaa tagatacgct gacacgccaa gcctcgctag tcaaaagtgt 4860 accaaacaac gctttacagc aagaacggaa tgcgcgtgac gctcgcggtg acgccatttc 4920 gccttttcag aaatggataa atagccttgc ttcctattat atcttcccaa attaccaata 4980 cattacacta gcatctgaat ttcataacca atctcgatac accaaatcga gatctgcagg 5040 gatccccgat catgcaaaaa ctcattaact cagtgcaaaa ctatgcctgg ggcagcaaaa 5100 cggcgttgac tgaactttat ggtatggaaa atccgtccag ccagccgatg gccgagctgt 5160 ggatgggcgc acatccgaaa agcagttcac gagtgcagaa tgccgccgga gatatcgttt 5220 cactgcgtga tgtgattgag agtgataaat cgactctgct cggagaggcc gttgccaaac 5280 gctttggcga actgcctttc ctgttcaaag tattatgcgc agcacagcca ctctccattc 5340 aggttcatcc aaacaaacac aattctgaaa tcggttttgc caaagaaaat gccgcaggta 5400 tcccgatgga tgccgccgag cgtaactata aagatcctaa ccacaagccg gagctggttt 5460 ttgcgctgac gcctttcctt gcgatgaacg cgtttcgtga attttccgag attgtctccc 5520 tactccagcc ggtcgcaggt gcacatccgg cgattgctca ctttttacaa cagcctgatg 5580 ccgaacgttt aagcgaactg ttcgccagcc tgttgaatat gcagggtgaa gaaaaatccc 5640 gcgcgctggc gattttaaaa tcggccctcg atagccagca gggtgaaccg tggcaaacga 5700 ttcgtttaat ttctgaattt tacccggaag acagcggtct gttctccccg ctattgctga 5760 atgtggtgaa attgaaccct ggcgaagcga tgttcctgtt cgctgaaaca ccgcacgctt 5820 acctgcaagg cgtggcgctg gaagtgatgg caaactccga taacgtgctg cgtgcgggtc 5880 tgacgcctaa atacattgat attccggaac tggttgccaa tgtgaaattc gaagccaaac 5940 cggctaacca gttgttgacc cagccggtga aacaaggtgc agaactggac ttcccgattc 6000 cagtggatga ttttgccttc tcgctgcatg accttagtga taaagaaacc accattagcc 6060 agcagagtgc cgccattttg ttctgcgtcg aaggcgatgc aacgttgtgg aaaggttctc 6120 agcagttaca gcttaaaccg ggtgaatcag cgtttattgc cgccaacgaa tcaccggtga 6180 ctgtcaaagg ccacggccgt ttagcgcgtg tttacaacaa gctgtaagag cttactgaaa 6240 aaattaacat ctcttgctaa gctgggagct cgtcgacgga tcgaattcct gcagatcgtt 6300 caaacatttg gcaataaagt ttcttaagat tgaatcctgt tgccggtctt gcgatgatta 6360 tcatataatt tctgttgaat tacgttaagc atgtaataat taacatgtaa tgcatgacgt 6420 tatttatgag atgggttttt atgattagag tcccgcaatt atacatttaa tacgcgatag 6480 aaaacaaaat atagcgcgca acctaggata aattatcgcg cgcggtgtca tctatgttac 6540 tagatctcta gaactagtgg atctgctagc cctgcaggaa atttaccggt gcccgggcgg 6600 ccagcatggc cgtatccgca atgtgttatt aagttgtcta agcgtcaatt tgtttacacc 6660 acaatatatc ctgccaccag ccagccaaca gctccccgac cggcagctcg gcacaaaatc 6720 accactcgat acaggcagcc catcagaatt aattctcatg tttgacagct tatcatcgac 6780 tgcacggtgc accaatgctt ctggcgtcag gcagccatcg gaagctgtgg tatggctgtg 6840 caggtcgtaa atcactgcat aattcgtgtc gctcaaggcg cactcccgtt ctggataatg 6900 ttttttgcgc cgacatcata acggttctgg caaatattct gaaatgagct gttgacaatt 6960 aatcatcggc tcgtataatg tgtggaattg tgagcggata acaatttcac acaggaaaca 7020 gaccatgagg gaagcggtga tcgccgaagt atcgactcaa ctatcagagg tagttggcgt 7080 catcgagcgc catctcgaac cgacgttgct ggccgtacat ttgtacggct ccgcagtgga 7140 tggcggcctg aagccacaca gtgatattga tttgctggtt acggtgaccg taaggcttga 7200 tgaaacaacg cggcgagctt tgatcaacga ccttttggaa acttcggctt cccctggaga 7260 gagcgagatt ctccgcgctg tagaagtcac cattgttgtg cacgacgaca tcattccgtg 7320 gcgttatcca gctaagcgcg aactgcaatt tggagaatgg cagcgcaatg acattcttgc 7380 aggtatcttc gagccagcca cgatcgacat tgatctggct atcttgctga caaaagcaag 7440 agaacatagc gttgccttgg taggtccagc ggcggaggaa ctctttgatc cggttcctga 7500 acaggatcta tttgaggcgc taaatgaaac cttaacgcta tggaactcgc cgcccgactg 7560 ggctggcgat gagcgaaatg tagtgcttac gttgtcccgc atttggtaca gcgcagtaac 7620 cggcaaaatc gcgccgaagg atgtcgctgc cgactgggca atggagcgcc tgccggccca 7680 gtatcagccc gtcatacttg aagctaggca ggcttatctt ggacaagaag atcgcttggc 7740 ctcgcgcgca gatcagttgg aagaatttgt tcactacgtg aaaggcgaga tcaccaaggt 7800 agtcggcaaa taaagctcta gtggatcccc gaggaatcgg cgtgacggtc gcaaaccatc 7860 cggcccggta caaatcggcg cggcgctggg tgatgacctg gtggagaagt tgaaggccgc 7920 gcaggccgcc cagcggcaac gcatcgaggc agaagcacgc cccggtgaat cgtggcaagc 7980 ggccgctgat cgaatccgca aagaatcccg gcaaccgccg gcagccggtg cgccgtcgat 8040 taggaagccg cccaagggcg acgagcaacc agattttttc gttccgatgc tctatgacgt 8100 gggcacccgc gatagtcgca gcatcatgga cgtggccgtt ttccgtctgt cgaagcgtga 8160 ccgacgagct ggcgaggtga tccgctacga gcttccagac gggcacgtag aggtttcagc 8220 agggccggcc ggcatggcca gtgtgtggga ttacgacctg gtactgatgg cggtttccca 8280 tctaaccgaa tccatgaacc gataccggga agggaaggga gacaagcccg gccgcgtgtt 8340 ccgtccacac gttgcggacg tactcaagtt ctgccggcga gccgatggcg gaaagcagaa 8400 agacgacctg gtagaaacct gcattcggtt aaacaccacg cacgttgcca tgcagcgtac 8460 gaagaaggcc aagaacggcc gcctggtgac ggtatccgag ggtgaagcct tgattagccg 8520 ctacaagatc gtaaagagcg aaaccgggcg gccggagtac atcgagatcg agctagctga 8580 ttggatgtac cgcgagatca cagaaggcaa gaacccggac gtgctgacgg ttcaccccga 8640 ttactttttg atcgatcccg gcatcggccg ttttctctac cgcctggcac gccgcgccgc 8700 aggcaaggca gaagccagat ggttgttcaa gacgatctac gaacgcagtg gcagcgccgg 8760 agagttcaag aagttctgtt tcaccgtgcg caagctgatc gggtcaaatg acctgccgga 8820 gtacgatttg aaggaggagg cggggcaggc tggcccgatc ctagtcatgc gctaccgcaa 8880 cctgatcgag ggcgaagcat ccgccggttc ctaatgtacg gagcagatgc tagggcaaat 8940 tgccctagca ggggaaaaag gtcgaaaagg tctctttcct gtggatagca cgtacattgg 9000 gaacccaaag ccgtacattg ggaaccggaa cccgtacatt gggaacccaa agccgtacat 9060 tgggaaccgg tcacacatgt aagtgactga tataaaagag aaaaaaggcg atttttccgc 9120 ctaaaactct ttaaaactta ttaaaactct taaaacccgc ctggcctgtg cataactgtc 9180 tggccagcgc acagccgaag agctgcaaaa agcgcctacc cttcggtcgc tgcgctccct 9240 acgccccgcc gcttcgcgtc ggcctatcgc ggccgctggc cgctcaaaaa tggctggcct 9300 acggccaggc aatctaccag ggcgcggaca agccgcgccg tcgccactcg accgccggcg 9360 ctgaggtctg cctcgtgaag aaggtgttgc tgactcatac caggcctgaa tcgccccatc 9420 atccagccag aaagtgaggg agccacggtt gatgagagct ttgttgtagg tggaccagtt 9480 ggtgattttg aacttttgct ttgccacgga acggtctgcg ttgtcgggaa gatgcgtgat 9540 ctgatccttc aactcagcaa aagttcgatt tattcaacaa agccgccgtc ccgtcaagtc 9600 agcgtaatgc tctgccagtg ttacaaccaa ttaaccaatt ctgattagaa aaactcatcg 9660 agcatcaaat gaaactgcaa tttattcata tcaggattat caataccata tttttgaaaa 9720 agccgtttct gtaatgaagg agaaaactca ccgaggcagt tccataggat ggcaagatcc 9780 tggtatcggt ctgcgattcc gactcgtcca acatcaatac aacctattaa tttcccctcg 9840 tcaaaaataa ggttatcaag tgagaaatca ccatgagtga cgactgaatc cggtgagaat 9900 ggcaaaagct ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg 9960 gcgctcttcc gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc 10020 ggtatcagct cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg 10080 aaagaacatg tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct 10140 ggcgtttttc cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca 10200 gaggtggcga aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct 10260 cgtgcgctct cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc 10320 gggaagcgtg gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg tgtaggtcgt 10380 tcgctccaag ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc 10440 cggtaactat cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc 10500 cactggtaac aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg 10560 gtggcctaac tacggctaca ctagaaggac agtatttggt atctgcgctc tgctgaagcc 10620 agttaccttc ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag 10680 cggtggtttt tttgtttgca agcagcagat tacgcgcaga aaaaaaggat ctcaagaaga 10740 tcctttgatc ttttctacgg ggtctgacgc tcagtggaac gaaaactcac gttaagggat 10800 tttggtcatg agattatcaa aaaggatctt cacctagatc cttttgatcc ggaattaatt 10860 cctgtggttg gcatgcacat acaaatggac gaacggataa accttttcac gcccttttaa 10920 atatccgatt attctaataa acgctctttt ctcttaggtt tacccgccaa tatatcctgt 10980 caaacactga tagtttaaac tgaaggcggg aaacgacaat ctgatcatga gcggagaatt 11040 aagggagtca cgttatgacc cccgccgatg acgcgggaca agccgtttta cgtttggaac 11100 tgacagaacc gcaacgctgc aggaatt 11127

Claims (59)

삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 서열번호 5, 7 및 9로 이루어진 그룹으로부터 선택되는, 하이브리드 바실러스 튜린지엔시스(Bacillus thuringiensis) 독소를 암호화하는 합성 뉴클레오타이드 서열.A synthetic nucleotide sequence encoding a hybrid Bacillus thuringiensis toxin, selected from the group consisting of SEQ ID NOs: 5, 7 and 9. 삭제delete 제10항에 있어서, 상기 하이브리드 독소가 서열번호 6, 8 및 10으로 이루어진 그룹으로부터 선택되는 아미노산 서열을 갖는 합성 뉴클레오타이드 서열.The synthetic nucleotide sequence of claim 10, wherein said hybrid toxin has an amino acid sequence selected from the group consisting of SEQ ID NOs: 6, 8, and 10. 12. 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 삭제delete 서열번호 5, 7, 9, 12, 13, 14, 15, 16 및 17로 이루어진 그룹으로부터 선택되는 뉴클레오타이드 서열을 갖는, 하이브리드 바실러스 튜린지엔시스 독소를 암호화하는 분리된 핵산 분자.An isolated nucleic acid molecule encoding a hybrid Bacillus thuringiensis toxin having a nucleotide sequence selected from the group consisting of SEQ ID NOs: 5, 7, 9, 12, 13, 14, 15, 16, and 17. 삭제delete 삭제delete 제10항 또는 제12항의 합성 뉴클레오타이드 서열 또는 제43항의 핵산 분자에 작동적으로 연결된 이종 프로모터 서열을 포함하는 키메라 유전자.A chimeric gene comprising the synthetic nucleotide sequence of claim 10 or 12 or a heterologous promoter sequence operably linked to the nucleic acid molecule of claim 43. 제46항의 키메라 유전자를 포함하는 재조합 벡터.A recombinant vector comprising the chimeric gene of claim 46. 삭제delete 제46항의 키메라 유전자 또는 제47항의 재조합 벡터를 포함하는 형질전환 식물 세포.A transgenic plant cell comprising the chimeric gene of claim 46 or the recombinant vector of claim 47. 삭제delete 제49항에 있어서, 옥수수, 면화, 벼 또는 양배추로부터 유래하는 형질전환 식물 세포.50. The transgenic plant cell of claim 49, which is derived from corn, cotton, rice or cabbage. 삭제delete 해충을 제46항의 키메라 유전자 또는 제47항의 벡터를 함유하는 형질전환 식물과 접촉시킴을 포함하여, 밤나방(fall armyworm), 분홍면화씨벌레(pink bollworm), 담배나방(tobacco budworm), 유럽조명나방(European corn borer) 및 배추좀나방(diamondback moth)으로 이루어진 그룹으로부터 선택되는 해충을 방제하는 방법.Fall armyworms, pink bollworms, tobacco budworms, European moths A method for controlling pests selected from the group consisting of European corn borer) and diamondback moth. 제53항에 있어서, 형질전환 식물이 옥수수, 면화, 벼 또는 양배추인 방법.54. The method of claim 53, wherein the transgenic plant is corn, cotton, rice or cabbage. 제10항에 따르는 합성 뉴클레오타이드 서열을 식물에 도입함을 포함하여, 해충을 방제할 수 있는 곤충-내성 식물을 생산하는 방법.A method for producing insect-resistant plants capable of controlling pests, comprising introducing a synthetic nucleotide sequence according to claim 10 into a plant. 제55항에 있어서, 해충이 인시류의 곤충인 방법.56. The method of claim 55, wherein the pest is an insect of the species. 제56항에 있어서, 해충이 밤나방, 분홍면화씨벌레, 담배나방, 유럽조명나방 또는 배추좀나방인 방법.57. The method of claim 56, wherein the pest is chestnut moth, pink cotton worm, tobacco moth, European moth or cabbage moth. 제55항에 있어서, 식물이 옥수수, 면화, 벼 또는 양배추인 방법.The method of claim 55, wherein the plant is corn, cotton, rice or cabbage. 삭제delete
KR1020037002755A 2000-08-25 2001-08-23 A hybrid Bacillus thuringiensis toxin, a nucleic acid encoding the same and a method for controlling an insect with the same KR100581163B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22795600P 2000-08-25 2000-08-25
US60/227,956 2000-08-25
PCT/EP2001/009751 WO2002015701A2 (en) 2000-08-25 2001-08-23 Bacillus thuringiensis crystal protein hybrids

Publications (2)

Publication Number Publication Date
KR20030029858A KR20030029858A (en) 2003-04-16
KR100581163B1 true KR100581163B1 (en) 2006-05-22

Family

ID=22855141

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037002755A KR100581163B1 (en) 2000-08-25 2001-08-23 A hybrid Bacillus thuringiensis toxin, a nucleic acid encoding the same and a method for controlling an insect with the same

Country Status (12)

Country Link
EP (1) EP1311162B1 (en)
JP (1) JP2004506432A (en)
KR (1) KR100581163B1 (en)
CN (1) CN100353846C (en)
AR (1) AR030576A1 (en)
AT (1) ATE296539T1 (en)
AU (2) AU2001285900B2 (en)
BR (1) BR0113500A (en)
CA (1) CA2419029A1 (en)
DE (1) DE60111236T2 (en)
ES (1) ES2243543T3 (en)
WO (1) WO2002015701A2 (en)

Families Citing this family (1054)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR048669A1 (en) 2004-03-03 2006-05-17 Syngenta Ltd BISAMIDE BICYCLE DERIVATIVES
PT1737290E (en) * 2004-03-25 2015-07-02 Syngenta Participations Ag Corn event mir604
GB0418047D0 (en) 2004-08-12 2004-09-15 Syngenta Participations Ag Fungicidal compositions
AR050891A1 (en) 2004-09-29 2006-11-29 Du Pont EVENT DAS-59122-7 OF CORN AND METHODS FOR DETECTION
GB0422401D0 (en) 2004-10-08 2004-11-10 Syngenta Participations Ag Fungicidal compositions
WO2006128570A1 (en) * 2005-06-02 2006-12-07 Syngenta Participations Ag 1143-51b insecticidal cotton
WO2006128569A2 (en) * 2005-06-02 2006-12-07 Syngenta Participations Ag 1143-14a, insecticidal transgenic cotton expressing cry1ab
AU2006254493B2 (en) 2005-06-02 2010-12-09 Syngenta Participations Ag CE43- 67B, insecticidal transgenic cotton expressing CRY1AB
WO2006128568A2 (en) * 2005-06-02 2006-12-07 Syngenta Participations Ag T342-142, insecticidal transgenic cotton expressing cry1ab
US20100024077A1 (en) * 2005-06-02 2010-01-28 Syngenta Participations Ag Ce44-69d insecticidal cotton
WO2006128572A1 (en) * 2005-06-02 2006-12-07 Syngenta Participations Ag Ce46-02a insecticidal cotton
US20080269174A1 (en) 2005-07-21 2008-10-30 Syngenta Crop Protection, Inc. Fungicidal Combinations
WO2007014844A2 (en) * 2005-07-27 2007-02-08 Basf Plant Science Gmbh Selection system for maize transformation
PT1919935E (en) 2005-08-31 2013-03-14 Monsanto Technology Llc Nucleotide sequences encoding insecticidal proteins
SI1763998T1 (en) 2005-09-16 2007-10-31 Syngenta Participations Ag Fungicidal compositions
EP1776864A1 (en) 2005-10-20 2007-04-25 Syngenta Participations AG Fungicidal compositions
AR059035A1 (en) 2006-01-16 2008-03-12 Syngenta Participations Ag INSECTICIDES DERIVED FROM ANTRANILAMIDE
WO2007140256A1 (en) 2006-05-26 2007-12-06 Monsanto Technology, Llc Corn plant and seed corresponding to transgenic event mon89034 and methods for detection and use thereof
JP2010503642A (en) 2006-09-18 2010-02-04 ビーエーエスエフ ソシエタス・ヨーロピア Ternary pesticide mixture
CN102977196B (en) * 2006-12-08 2016-03-16 先锋高级育种国际公司 Novel bacillus thuringiensis crystal polypeptides, polynucleotide and composition thereof
RU2532838C2 (en) * 2007-03-28 2014-11-10 Зингента Партисипейшнс Аг Insecticidal proteins
US9522937B2 (en) 2007-03-28 2016-12-20 Syngenta Participations Ag Insecticidal proteins
ES2636907T3 (en) 2007-04-12 2017-10-10 Basf Se Pesticide mixtures comprising a cyanosulfoximin compound
ES2564685T3 (en) * 2007-07-03 2016-03-28 Idemitsu Kosan Co., Ltd. Vaccine against swine edema disease
RU2010105010A (en) 2007-07-16 2011-08-27 Зингента Партисипейшнс Аг (Ch) NEW INSECTICIDES
GB0716414D0 (en) 2007-08-22 2007-10-03 Syngenta Participations Ag Novel insecticides
EP2614717A1 (en) 2007-09-20 2013-07-17 Basf Se Combinations comprising a fungicidal strain and at least one additional fungicide
ES2381320T3 (en) 2007-09-26 2012-05-25 Basf Se Ternary fungicidal compositions comprising boscalide and chlorothalonil
EP2315760B1 (en) 2008-07-29 2013-03-06 Basf Se Piperazine compounds with herbicidal effect
EP2183969A3 (en) 2008-10-29 2011-01-05 Basf Se Method for increasing the number of seedlings per number of sowed grains of seed
CN102171203A (en) 2008-10-02 2011-08-31 巴斯夫欧洲公司 Piperazine compounds with herbicidal effect
WO2010046423A2 (en) 2008-10-22 2010-04-29 Basf Se Use of sulfonylurea herbicides on cultivated plants
AR075466A1 (en) 2008-10-22 2011-04-06 Basf Se USE OF AUXINE TYPE HERBICIDES IN CULTIVATED PLANTS
CA2749223C (en) 2009-01-27 2017-07-04 Basf Se Method for dressing seeds
WO2010089244A1 (en) 2009-02-03 2010-08-12 Basf Se Method for dressing seeds
AR075573A1 (en) 2009-02-11 2011-04-20 Basf Se DIMETHOMORPH AS A PESTICIDE PROTECTOR WITH PHYTO-TOXIC EFFECTS
BRPI1006004A8 (en) 2009-02-11 2017-04-11 Basf Se MIXTURES, PESTICIDE COMPOSITION, METHOD FOR CONTROLING PEST AND/OR IMPROVING PLANT HEALTH, METHOD FOR PROTECTING PLANT PROPAGATION MATERIAL FROM PEST AND PLANT PROPAGATION MATERIAL
CN102307479A (en) 2009-02-11 2012-01-04 巴斯夫欧洲公司 Pesticidal mixtures
WO2010092031A2 (en) 2009-02-11 2010-08-19 Basf Se Pesticidal mixtures
WO2010092014A2 (en) 2009-02-11 2010-08-19 Basf Se Pesticidal mixtures
CA2751836A1 (en) 2009-03-04 2010-09-10 Basf Se 3-arylquinazolin-4-one compounds for combating invertebrate pests
BRPI1009420A2 (en) * 2009-03-11 2016-03-01 Athenix Corp axmi-001, axmi-002, axmi-030, and axmi-045; toxin genes and methods for their use
WO2010103065A1 (en) 2009-03-11 2010-09-16 Basf Se Fungicidal compositions and their use
BRPI1006194A2 (en) 2009-03-16 2015-09-15 Basf Se "composition, fungicide for the control of phytopathogenic harmful fungi, fungicidal agent, method for the control of phytopathogenic harmful fungi, seed and use of fluopyram and metrafenone"
PL2408298T3 (en) 2009-03-20 2016-12-30 Method for treatment of crop with an encapsulated pesticide
JP5920983B2 (en) 2009-03-26 2016-05-24 バイエル クロップサイエンス エルピーBayer Cropscience Lp Use of synthetic and biological fungicides in combination to control harmful fungi
JP2012522750A (en) 2009-04-01 2012-09-27 ビーエーエスエフ ソシエタス・ヨーロピア Isoxazoline compounds for combating invertebrate pests
WO2010115721A2 (en) 2009-04-02 2010-10-14 Basf Se Method for reducing sunburn damage in plants
WO2010142779A1 (en) 2009-06-12 2010-12-16 Basf Se Antifungal 1,2,4-triazolyl derivatives having a 5- sulfur substituent
WO2019106641A2 (en) 2017-12-03 2019-06-06 Seedx Technologies Inc. Systems and methods for sorting of seeds
WO2010146032A2 (en) 2009-06-16 2010-12-23 Basf Se Fungicidal mixtures
WO2010146006A2 (en) 2009-06-18 2010-12-23 Basf Se Fungicidal mixtures
JP2012530111A (en) 2009-06-18 2012-11-29 ビーエーエスエフ ソシエタス・ヨーロピア Antibacterial 1,2,4-triazolyl derivatives having a 5-sulfur substituent
WO2010146116A1 (en) 2009-06-18 2010-12-23 Basf Se Triazole compounds carrying a sulfur substituent
CN102459241A (en) 2009-06-18 2012-05-16 巴斯夫欧洲公司 Triazole compounds carrying a sulfur substituent
US20120088660A1 (en) 2009-06-18 2012-04-12 Basf Se Antifungal 1,2,4-triazolyl Derivatives
WO2010146115A1 (en) 2009-06-18 2010-12-23 Basf Se Triazole compounds carrying a sulfur substituent
CN102459201A (en) 2009-06-18 2012-05-16 巴斯夫欧洲公司 Antifungal 1, 2, 4-triazolyl derivatives
ES2417312T3 (en) 2009-06-19 2013-08-07 Basf Se Herbicidal Benzoxazinones
MX2011013217A (en) 2009-06-25 2012-01-20 Basf Se Use of agrochemical mixtures for increasing the health of a plant.
WO2010149758A1 (en) 2009-06-25 2010-12-29 Basf Se Antifungal 1, 2, 4-triazolyl derivatives
EP2451804B1 (en) 2009-07-06 2014-04-30 Basf Se Pyridazine compounds for controlling invertebrate pests
WO2011003776A2 (en) 2009-07-09 2011-01-13 Basf Se Substituted cyanobutyrates having a herbicidal effect
WO2011003775A2 (en) 2009-07-09 2011-01-13 Basf Se Substituted cyanobutyrates having a herbicidal effect
BR112012001001A2 (en) 2009-07-14 2016-11-16 Basf Se azole compounds of formulas i and ii, compounds of formulas i and i, compounds of formula ix, agricultural composition, use of a pharmaceutical compound, method for treating cancer or virus infections to combat zoopathogenic or humanopathogenic fungi
US9125414B2 (en) 2009-07-24 2015-09-08 Basf Se Pyridine derivatives compounds for controlling invertebrate pests
US8703649B2 (en) 2009-07-28 2014-04-22 Basf Se Pesticidal suspo-emulsion compositions
US20120129696A1 (en) 2009-07-28 2012-05-24 Basf Se Method for increasing the level of free amino acids in storage tissues of perennial plants
ES2545738T3 (en) 2009-07-30 2015-09-15 Merial, Inc. Insecticidal compounds based on 4-amino-thieno [2,3-d] -pyrimidine and procedures for its use
UY32838A (en) 2009-08-14 2011-01-31 Basf Se "HERBICIDE ACTIVE COMPOSITION THAT BENZOXAZINONAS UNDERSTANDS
TW201113377A (en) 2009-09-01 2011-04-16 Basf Agrochemical Products Bv Herbicide-tolerant plants
US11096345B2 (en) 2009-09-01 2021-08-24 Basf Se Method for treating post-emergent rice
EP2480537A1 (en) 2009-09-24 2012-08-01 Basf Se Aminoquinazoline compounds for combating invertebrate pests
CN102510720A (en) 2009-09-25 2012-06-20 巴斯夫欧洲公司 Method for reducing pistillate flower abortion in plants
KR20120105433A (en) 2009-09-29 2012-09-25 바스프 에스이 Pesticidal mixtures
MX364882B (en) 2009-09-29 2019-05-09 Basf Se Pesticidal mixtures.
WO2011039172A2 (en) 2009-09-30 2011-04-07 Basf Se Low volatile amine salts of anionic pesticides
WO2011042378A1 (en) 2009-10-09 2011-04-14 Basf Se Substituted cyanobutyrates having herbicidal effect
WO2011048120A1 (en) 2009-10-22 2011-04-28 Syngenta Participations Ag Synergistic fungicidal composition containing a n-2-(pyrazolyl) ethylphenylcarboxamide
WO2011051212A1 (en) 2009-10-28 2011-05-05 Basf Se Use of heteroaromatic compounds as herbicides
DE102010042867A1 (en) 2009-10-28 2011-06-01 Basf Se Use of heterocyclic compounds as herbicides and for controlling undesirable plants in culture of useful plants e.g. wheat, barley, rye, oats, millet and rice
DE102010042866A1 (en) 2009-10-30 2011-05-05 Basf Se New thioamide compounds, useful for controlling undesirable plant growth or weeds in cultural plants e.g. Arachis hypogaea, Allium cepa, Elaeis guineensis and Gossypium herbaceum
WO2011051393A1 (en) 2009-11-02 2011-05-05 Basf Se Herbicidal tetrahydrophthalimides
US8329619B2 (en) 2009-11-03 2012-12-11 Basf Se Substituted quinolinones having herbicidal action
JP2013510113A (en) 2009-11-06 2013-03-21 ビーエーエスエフ ソシエタス・ヨーロピア Crystalline complex of 4-hydroxybenzoic acid and selected pesticide
WO2011057989A1 (en) 2009-11-11 2011-05-19 Basf Se Heterocyclic compounds having herbicidal action
WO2011057942A1 (en) 2009-11-12 2011-05-19 Basf Se Insecticidal methods using pyridine compounds
EP2499136B1 (en) 2009-11-13 2013-12-04 Basf Se 3-(3,4-dihydro-2h-benzo[1,4]oxazin-6-yl)-1h-pyrimidin-2,4-dione compounds as herbicides
WO2011058036A1 (en) 2009-11-13 2011-05-19 Basf Se Tricyclic compounds having herbicidal action
BR112012011808B1 (en) 2009-11-17 2020-02-04 Merial Ltd fluorinated heteroarylalkylsulfide oxo derivatives to combat invertebrate pests.
WO2011064188A1 (en) 2009-11-27 2011-06-03 Basf Se Insecticidal methods using nitrogen-containing heteroaromatic compounds
WO2011067184A1 (en) 2009-12-01 2011-06-09 Basf Se 3- (4, 5 -dihydroisoxazol- 5 -yl) benzoylpyrazole compounds and mixtures thereof with safeners
JP2013512873A (en) 2009-12-02 2013-04-18 ビーエーエスエフ ソシエタス・ヨーロピア Pesticide mixture of triazamate and strobilurins
WO2011067209A2 (en) 2009-12-02 2011-06-09 Basf Se Pesticidal mixtures
GB0921343D0 (en) 2009-12-04 2010-01-20 Syngenta Participations Ag Chemical compounds
CN102712583B (en) 2009-12-04 2015-04-08 梅里亚有限公司 Pesticidal bis-organosulfur compounds
GB0921346D0 (en) 2009-12-04 2010-01-20 Syngenta Participations Ag Chemical compounds
GB0921344D0 (en) 2009-12-04 2010-01-20 Syngenta Participations Ag Chemical compounds
WO2011069912A1 (en) 2009-12-07 2011-06-16 Basf Se Triazole compounds, use thereof and agents containing said compounds
WO2011069955A1 (en) 2009-12-07 2011-06-16 Basf Se Sulfonimidamide compounds for combating animal pests
WO2011069916A1 (en) 2009-12-08 2011-06-16 Basf Se Triazole compounds, use thereof as a fungicide, and agents comprising same
CN102647903B (en) 2009-12-08 2015-09-16 巴斯夫欧洲公司 Pesticide combination
BR112012013096A2 (en) 2009-12-08 2015-09-15 Basf Se agrochemical mixture to increase plant health, pesticide composition, method for improving plant health, and use of plant
WO2011069894A1 (en) 2009-12-08 2011-06-16 Basf Se Triazole compounds, use thereof, and agents containing same
US20120316062A1 (en) 2009-12-10 2012-12-13 Basf Se Pesticidal mixtures
WO2011069930A2 (en) 2009-12-10 2011-06-16 Basf Se Pesticidal mixtures
UA112286C2 (en) * 2009-12-16 2016-08-25 ДАУ АГРОСАЙЄНСІЗ ЕлЕлСі MODIFIED INSECTICIDIC CRY1C PROTEIN AND METHOD FOR FIGHTING INSULATED INSECTS WITH ITS USE
WO2011073060A2 (en) 2009-12-18 2011-06-23 Syngenta Participations Ag Method of combating and controlling pests
US20120291159A1 (en) 2009-12-18 2012-11-15 Basf Se Azoline Compounds for Combating Invertebrate Pests
WO2011073143A1 (en) 2009-12-18 2011-06-23 Basf Se Substituted cyanobutyrates having herbicidal action
EP2525656B1 (en) 2010-01-18 2016-12-28 BASF Corporation Compound comprising a pesticide and an alkoxylate of 2-propylheptyl amine
KR20120125332A (en) 2010-02-01 2012-11-14 바스프 에스이 Substituted ketonic isoxazoline compounds and derivatives for combating animal pests
WO2011098417A1 (en) 2010-02-10 2011-08-18 Basf Se Substituted cyanobutyrates having herbicidal action
WO2011101303A2 (en) 2010-02-16 2011-08-25 Basf Se Compound comprising a pesticide and an alkoxylate of isoheptadecylamine
EP2538788A1 (en) 2010-02-25 2013-01-02 Syngenta Participations AG Pesticidal mixtures containing isoxazoline derivatives and insecticide or nematoicidal biological agent
WO2011104088A1 (en) 2010-02-25 2011-09-01 Syngenta Participations Ag Pesticidal mixtures containing isoxazoline derivatives and a fungicide
EP2363023A1 (en) 2010-03-04 2011-09-07 Basf Se Synergistic fungicidal and insecticidal mixtures
WO2011110583A2 (en) 2010-03-10 2011-09-15 Basf Se Fungicidal mixtures comprising triazole derivatives
EA028014B1 (en) 2010-03-17 2017-09-29 Басф Агрокемикэл Продактс Б.Ф. Herbicide-tolerant plants
CN102802410B (en) 2010-03-17 2015-07-22 巴斯夫欧洲公司 Compound comprising a pesticide and an alkoxylate of isononyl amine
US8853214B2 (en) 2010-03-23 2014-10-07 Basf Se Pyridazine compounds for controlling invertebrate pests
BR112012023935A2 (en) 2010-03-23 2015-09-15 Basf Se substituted pyridazine of formula i, compound for formula i, composition and method for controlling unwanted vegetation
AR081526A1 (en) 2010-03-23 2012-10-03 Basf Se PIRIDAZINAS REPLACED THAT HAVE HERBICITY ACTION
CN102812024B (en) 2010-03-23 2015-01-21 巴斯夫欧洲公司 Substituted pyridines having herbicidal action
JP2013522336A (en) 2010-03-23 2013-06-13 ビーエーエスエフ ソシエタス・ヨーロピア Pyridothiazine with herbicidal activity
BR112012023765A2 (en) 2010-03-23 2015-09-29 Basf Se substituted pyridine, composition and method for controlling unwanted vegetation
US9040537B2 (en) 2010-03-23 2015-05-26 Basf Se Pyridazine compounds for controlling invertebrate pests
US8937177B2 (en) 2010-03-23 2015-01-20 Basf Se Pyridazine compounds for controlling invertebrate pests
US8575068B2 (en) 2010-03-23 2013-11-05 Basf Se Pyrazinothiazines having herbicidal action
US20130203590A1 (en) 2010-03-24 2013-08-08 Syngenta Crop Protection Llc Pesticidal mixtures
MX2012009416A (en) 2010-03-26 2012-10-02 Basf Se Fungicidal mixtures based on azolopyrimidinylamines.
EP2371219A1 (en) 2010-04-01 2011-10-05 Basf Se Herbicidal acylhydrazides
JP2013525320A (en) 2010-04-20 2013-06-20 ビーエーエスエフ ソシエタス・ヨーロピア Bactericidal mixture containing amethoctrazine and tetrazolyl oxime derivatives
WO2011134867A1 (en) 2010-04-26 2011-11-03 Basf Se Herbicidal azolopyrimidines
WO2011134539A1 (en) 2010-04-30 2011-11-03 Basf Se Use of oxylipins as safeners and safening herbicidal compositions comprising oxylipins
WO2011138345A2 (en) 2010-05-06 2011-11-10 Basf Se Fungicidal mixtures based on gallic acid esters
WO2011144593A1 (en) 2010-05-18 2011-11-24 Basf Se Pesticidal mixtures comprising insecticides and pyraclostrobin
BR112012028760A2 (en) 2010-05-24 2018-02-06 Meiji Seika Pharma Co Ltd harmful organism control agent
MX339218B (en) 2010-05-28 2016-05-17 Basf Se Pesticidal mixtures.
US8962524B2 (en) 2010-05-28 2015-02-24 Basf Se Pesticidal mixtures
EP2575468A1 (en) 2010-05-31 2013-04-10 Syngenta Participations AG Method of crop enhancement
US20130210625A1 (en) 2010-05-31 2013-08-15 Syngenta Crop Protection Llc Spiroheterocyclic pyrrolidine derivatives based pesticides
US20130085066A1 (en) 2010-05-31 2013-04-04 Basf Se Method for Increasing the Health of a Plant
EP2576555A1 (en) 2010-05-31 2013-04-10 Syngenta Participations AG 1, 8 -diazaspiro [4.5]decane- 2, 4 -dione derivatives useful as pesticides
US20130324404A1 (en) 2010-05-31 2013-12-05 Syngenta Participations Ag 1, 8 -diazaspiro [4.5] decane- 2, 4 -dione derivatives useful as pesticides
ES2582458T3 (en) 2010-05-31 2016-09-13 Syngenta Participations Ag Pesticide Compositions
BR112012030416B1 (en) 2010-05-31 2019-05-14 Syngenta Participations Ag Pesticide compositions and method to combat and control pests
WO2011154433A2 (en) 2010-06-09 2011-12-15 Syngenta Participations Ag Pesticidal mixtures including isoxazoline derivatives
WO2011154434A2 (en) 2010-06-09 2011-12-15 Syngenta Participations Ag Pesticidal mixtures including isoxazoline derivatives
BR112012031277A2 (en) 2010-06-09 2016-09-27 Syngenta Participations Ag "pesticide mixtures comprising isoxazoline derivatives"
US20130102463A1 (en) 2010-06-24 2013-04-25 Basf Se Herbicidal Compositions
WO2011161132A1 (en) 2010-06-25 2011-12-29 Basf Se Pesticidal mixtures
WO2011161131A1 (en) 2010-06-25 2011-12-29 Basf Se Herbicidal mixtures
EP2402335A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazolopyridine compounds
EP2402340A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazolopyridine compounds
EP2402343A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazole-fused bicyclic compounds
EP2402344A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazole fused bicyclic compounds
EP2402345A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazole fused bicyclic compounds
EP2402338A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazolopyridine compounds
EP2401915A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazolopyridine compounds
EP2409570A3 (en) 2010-06-29 2013-11-13 Basf Se Fungicidal mixtures based on pyrazolopyridine compounds
EP2402336A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazolopyridine compounds
EP2402339A1 (en) 2010-06-29 2012-01-04 Basf Se Pyrazolopyridine compounds
WO2012007426A1 (en) 2010-07-13 2012-01-19 Basf Se Azoline substituted isoxazoline benzamide compounds for combating animal pests
CA2805354C (en) 2010-07-22 2019-04-16 Basf Se Herbicidal isoxazolo[5,4-b]pyridines
WO2012016989A2 (en) 2010-08-03 2012-02-09 Basf Se Fungicidal compositions
TW201210488A (en) 2010-08-09 2012-03-16 Basf Se Fungicidal mixtures
DE102011080568A1 (en) 2010-08-16 2012-02-16 Basf Se New substituted cyanobutyrate compounds useful for combating weeds in culture plants e.g. cotton, rice, maize or wheat
MX2013001742A (en) * 2010-08-19 2013-05-14 Pioneer Hi Bred Int Novel bacillus thuringiensis gene with lepidopteran activity
WO2012022729A2 (en) 2010-08-20 2012-02-23 Basf Se Method for improving the health of a plant
CA2805770A1 (en) 2010-08-24 2012-03-01 Basf Se Agrochemical mixtures for increasing the health of a plant
WO2012034959A2 (en) 2010-09-13 2012-03-22 Basf Se Pyridine compounds for controlling invertebrate pests iii
EP2616458B1 (en) 2010-09-13 2016-07-20 Basf Se Pyridine compounds for controlling invertebrate pests ii
EP2616459B1 (en) 2010-09-13 2016-05-04 Basf Se Pyridine compounds for controlling invertebrate pests i
PE20131359A1 (en) 2010-09-14 2013-12-06 Basf Se COMPOSITIONS CONTAINING A PYRIPYROPENE INSECTICIDE AND A BASE
EP2615919B1 (en) 2010-09-14 2015-01-14 Basf Se Composition containing a pyripyropene insecticide and an adjuvant
AR083112A1 (en) 2010-10-01 2013-01-30 Syngenta Participations Ag METHOD FOR CONTROLLING PHYTOPATHOGEN DISEASES AND COMPOSITIONS USEFUL FUNGICIDES FOR SUCH CONTROL
CN103237789A (en) 2010-10-01 2013-08-07 巴斯夫欧洲公司 Imine compounds
EP2621900A1 (en) 2010-10-01 2013-08-07 Basf Se Imine substituted 2, 4 - diaryl - pyrroline derivatives as pesticides
WO2012041789A1 (en) 2010-10-01 2012-04-05 Basf Se Herbicidal benzoxazinones
WO2012045737A1 (en) 2010-10-07 2012-04-12 Basf Se Use of strobilurins for increasing the gluten strength in winter cereals
EP2443923A1 (en) 2010-10-25 2012-04-25 Basf Se Composition comprising a pesticide and polycarboxylate ether
BR112013008445A2 (en) 2010-10-11 2016-06-28 Basf Se '' composition, process for the production of composition, use of polycarboxylate ether, seed, phytopathogenic fungus control, seed coating and mite infestation control methods ''
BR112013010336A2 (en) 2010-10-28 2016-07-05 Syngenta Participations Ag microbicides
EP2447262A1 (en) 2010-10-29 2012-05-02 Basf Se Pyrrole, furane and thiophene derivatives and their use as fungicides
EP2447261A1 (en) 2010-10-29 2012-05-02 Basf Se Pyrrole, furane and thiophene derivatives and their use as fungicides
EP2460404A1 (en) 2010-12-01 2012-06-06 Basf Se Compositions containing identical polyamine salts of mixed anionic pesticides
WO2012066122A1 (en) 2010-11-18 2012-05-24 Syngenta Participations Ag 2 - (pyridin- 2 -yl) -quinazoline derivatives and their use as microbicides
WO2012069366A1 (en) 2010-11-23 2012-05-31 Syngenta Participations Ag Insecticidal compounds
WO2012069601A1 (en) 2010-11-25 2012-05-31 Syngenta Participations Ag Substituted quinazolines as fungicides
WO2012076634A1 (en) 2010-12-08 2012-06-14 Basf Se Fungicidal mixtures comprising pyraclostrobin
CN103260410A (en) 2010-12-08 2013-08-21 巴斯夫欧洲公司 Pesticidal mixtures
EP2462807A1 (en) 2010-12-08 2012-06-13 Basf Se Pesticidal mixtures comprising pyraclostrobin
EP2648518A2 (en) 2010-12-10 2013-10-16 Basf Se Pyrazole compounds for controlling invertebrate pests
EP2651967A4 (en) * 2010-12-13 2014-05-14 Syngenta Participations Ag Cry1i proteins and genes for insect control
EP2465350A1 (en) 2010-12-15 2012-06-20 Basf Se Pesticidal mixtures
BR112013014782A2 (en) 2010-12-15 2016-07-19 Basf Se composition, method for controlling unwanted vegetation, use of compositions, method for protecting the phytotoxic activity of a benzoxazinone of formula I and method of protection
UY33808A (en) 2010-12-17 2012-07-31 Syngenta Participations Ag INSECTICIDE COMPOUNDS
JP2014500282A (en) 2010-12-20 2014-01-09 ビーエーエスエフ ソシエタス・ヨーロピア Pesticide active mixture containing pyrazole compounds
WO2012085081A1 (en) 2010-12-22 2012-06-28 Basf Se Sulfoximinamide compounds for combating invertebrate pests ii
CN103298346A (en) 2010-12-22 2013-09-11 巴斯夫欧洲公司 Agrochemical mixtures for increasing the health of a plant
AU2011347687A1 (en) 2010-12-23 2013-07-11 Basf Se Substituted pyridines having herbicidal activity
EP2476313A1 (en) 2011-01-14 2012-07-18 Basf Se Synergistic pesticidal compositions comprising a dithiocarbamate and an insecticide
EP2481284A3 (en) 2011-01-27 2012-10-17 Basf Se Pesticidal mixtures
EP2484210A1 (en) 2011-02-08 2012-08-08 Basf Se Pesticidal compositions
KR20140051835A (en) 2011-02-09 2014-05-02 신젠타 파티서페이션즈 아게 Insecticidal compounds
PL2672826T3 (en) 2011-02-11 2015-10-30 Basf Se Herbicidal compositions comprising topramezone, pinoxaden and cloquintocet
EA201300907A1 (en) 2011-02-16 2014-02-28 Басф Се METHOD OF FIGHTING PHYTOPATHOGEN MUSHROOMS
WO2012116939A1 (en) 2011-02-28 2012-09-07 Basf Se Composition comprising a pesticide, a surfactant and an alkoxylate of 2-propylheptylamine
US20140005235A1 (en) 2011-03-22 2014-01-02 Syngenta Participations Ag Insecticidal compounds
WO2012127009A1 (en) 2011-03-23 2012-09-27 Basf Se Compositions containing polymeric, ionic compounds comprising imidazolium groups
WO2012130823A1 (en) 2011-03-30 2012-10-04 Basf Se Suspension concentrates
BR112013025830A2 (en) 2011-04-06 2017-07-18 Basf Se substituted pyrimidinium compounds of formula (i), agricultural and / or veterinary composition, uses of a compound of formula (i), method for combating animal pests, for protecting crops from attack or pest infestation, for the protection of soil insect seeds and seedling roots and foliate soil and insect branches, seeds, for treating or protecting animals against infestation or parasite infection and process for preparing a composition for treating or protecting animals against parasite infestation or infection
AR085872A1 (en) 2011-04-08 2013-10-30 Basf Se HETEROBICICLIC DERIVATIVES N-SUBSTITUTES USEFUL TO COMBAT PARASITES IN PLANTS AND / OR ANIMALS, COMPOSITIONS THAT CONTAIN THEM AND METHODS TO COMBAT SUCH PESTS
AR086098A1 (en) 2011-04-15 2013-11-20 Syngenta Participations Ag PESTICIDED COMPOSITIONS
WO2012143395A1 (en) 2011-04-20 2012-10-26 Syngenta Participations Ag 4,5-dihydro-isoxazole derivatives as fungicides
JP2014512373A (en) 2011-04-21 2014-05-22 ビーエーエスエフ ソシエタス・ヨーロピア 3,4-Disubstituted pyrrole 2,5-diones and their use as fungicides
CA2833190C (en) 2011-05-02 2020-04-28 Basf Se A method for enhancing the performance of a pesticide with guanidines
EP2524596A1 (en) 2011-05-18 2012-11-21 Basf Se Seed treatment uses
CA2835391A1 (en) 2011-06-01 2012-12-06 Basf Se Method of preparing an aqueous tank mix comprising a base
WO2012168210A1 (en) 2011-06-06 2012-12-13 Basf Se Seed treatment formulation aid containing polymeric sticker and silicon oil
JP2014517000A (en) 2011-06-09 2014-07-17 ビーエーエスエフ ソシエタス・ヨーロピア Substituted pyridines with herbicidal activity
WO2012168241A1 (en) 2011-06-09 2012-12-13 Basf Se Substituted pyrazines having herbicidal activity
EP2532661A1 (en) 2011-06-10 2012-12-12 Syngenta Participations AG Novel insecticides
AU2012268976A1 (en) 2011-06-17 2014-01-16 Basf Se Compositions comprising fungicidal substituted dithiines and further actives
AU2012268979A1 (en) 2011-06-17 2014-01-16 Basf Se Use of tetracyanodithiines as fungicides
WO2012175474A1 (en) 2011-06-20 2012-12-27 Syngenta Participations Ag 1,2,3 triazole pesticides
AR087008A1 (en) 2011-06-22 2014-02-05 Syngenta Participations Ag DERIVATIVES OF N-OXI-PIRAZOLO-TRIAZEPINA-DIONA
EP2540718A1 (en) 2011-06-29 2013-01-02 Syngenta Participations AG. Novel insecticides
WO2013007550A1 (en) 2011-07-08 2013-01-17 Syngenta Participations Ag Fungicide mixtures
CA2840286C (en) 2011-07-13 2016-04-12 Basf Se Fungicidal substituted 2-[2-halogenalkyl-4-(phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
CN103649058A (en) 2011-07-15 2014-03-19 巴斯夫欧洲公司 Fungicidal alkyl- and aryl-substituted 2-[2-chloro-4-(dihalo-phenoxy)-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds
BR112014000821A2 (en) 2011-07-15 2016-08-23 Basf Se compounds, process, agrochemical compositions, use of compounds of formula I, method for combating harmful fungi and seed
PE20140837A1 (en) 2011-07-15 2014-07-10 Basf Se FUNGICIDE COMPOUNDS 2- [2-CHLORO-4- (4-CHLORO-PHENOXY) -PHENYL] -1- [1,2,4] TRIAZOL-1-IL-ETHANOL ALKYL SUBSTITUTE
AU2012285974A1 (en) 2011-07-15 2014-01-30 Basf Se Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests II
WO2013011010A1 (en) 2011-07-19 2013-01-24 Syngenta Participations Ag Fungizide mixtures
EP2739141A1 (en) 2011-08-02 2014-06-11 Basf Se Aqueous composition comprising a pesticide and a base selected from an alkali salt of hy-drogencarbonate
AU2012297004A1 (en) 2011-08-12 2014-03-06 Basf Se N-thio-anthranilamide compounds and their use as pesticides
BR112014003221A2 (en) 2011-08-12 2017-04-18 Basf Se compound of the general formula (i), method for preparing a gate of the formula (i), agricultural or veterinary composition, methods for combating or controlling invertebrate pests, for the protection of growing plants against invertebrate pest attack or infestation; the protection of seeds against terrestrial insects and seedling roots and branches against terrestrial and foliar insects, seed, use of a compound and method for treating a parasitized or infested animal or to prevent animals from becoming infested or infected with parasites or to protect an animal against infestation or parasite infection
WO2013024004A1 (en) 2011-08-12 2013-02-21 Basf Se N-thio-anthranilamide compounds and their use as pesticides
KR20140051403A (en) 2011-08-12 2014-04-30 바스프 에스이 Anthranilamide compounds and their use as pesticides
EP2742022A1 (en) 2011-08-12 2014-06-18 Basf Se Anthranilamide compounds and their use as pesticides
KR20140051404A (en) 2011-08-12 2014-04-30 바스프 에스이 N-thio-anthranilamide compounds and their use as pesticides
BR112014003220A2 (en) 2011-08-12 2017-03-01 Basf Se compound of formula (i), process for preparing a compound of formula i and v, use of compound of formula i, method for controlling an invertebrate pest, crystalline form, use of crystalline forms and method for controlling an invertebrate pest
US20140187423A1 (en) 2011-08-15 2014-07-03 Basf Se Fungicidal substituted 1--1H-[1,2,4]triazole compounds
CN103717578B (en) 2011-08-15 2016-12-21 巴斯夫欧洲公司 Substituted 1 { 2 [2 halo 4 (4 halogenated phenoxy) phenyl] 2 ethoxyethyl groups } 1H [1,2,4] triazole compounds of antifungal
JP2014529594A (en) 2011-08-15 2014-11-13 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Bactericidal substituted 1- {2-cyclyloxy-2- [2-halo-4- (4-halogen-phenoxy) -phenyl] -ethyl} -1H- [1,2,4] triazole compounds
EP2559688A1 (en) 2011-08-15 2013-02-20 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-butoxy-ethyl}-1h [1,2,4]triazole compounds
AU2012296885A1 (en) 2011-08-15 2014-03-06 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl-2-alkynyloxy-ethyl}-1H-[1,2,4]triazole compounds
CN103717579B (en) 2011-08-15 2016-10-12 巴斯夫欧洲公司 Substituted 1-{2-[2-halo-4-(4-halogenated phenoxy) the phenyl]-2-alkoxyl-2-ring group ethyl of antifungal }-1H-[1,2,4] triazole compounds
US9247747B2 (en) 2011-08-15 2016-02-02 Basf Se Fungicidal substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkoxy-2-alkynyl/alkenyl-ethyl}-1H-[1,2,4]triazole compounds
AR087949A1 (en) 2011-08-15 2014-04-30 Basf Se FUNGICIDE COMPOUNDS OF 1- {2- [HALO-4- (4-HALOGEN-Phenoxy) -Phenyl] -2-ALCOXI-3-METHYL-BUTIL} -1H- [1,2,4] SUBSTITUTED TRIAZOL, A METHOD FOR YOUR PREPARATION AND YOUR EMPLOYMENT IN AGROCHEMICAL COMPOSITIONS TO COMBAT PHYTO-PATHOGENIC FUNGI
JP2014524434A (en) 2011-08-18 2014-09-22 ビーエーエスエフ ソシエタス・ヨーロピア Carbamoylmethoxybenzamide and carbamoylmethylthiobenzamide and carbamoylmethylaminobenzamide for combating harmful invertebrates
BR112014003646A2 (en) 2011-08-18 2017-03-07 Basf Se compound of formula (i), method for preparing a compound of formula (i), agricultural or veterinary composition, method for combating or controlling invertebrate insect pests, arachnids or nematodes, method for protecting plants, method for seed protection , seed and method for treating a parasitized or infested animal
CN103889956A (en) 2011-08-18 2014-06-25 巴斯夫欧洲公司 Carbamoylmethoxy- and carbamoylmethylthio- and carbamoylmethylamino benzamides for combating invertebrate pests
WO2013026900A1 (en) 2011-08-23 2013-02-28 Syngenta Participations Ag Pyridine derivatives as microbiocides
PL2747564T3 (en) 2011-08-25 2015-08-31 Basf Se Herbicidal compositions comprising chloroacetamides
US20140221201A1 (en) 2011-09-02 2014-08-07 Basf Se Insecticidal active mixtures comprising arylquinazolinone compounds
CN104023535A (en) 2011-09-02 2014-09-03 巴斯夫欧洲公司 Use of pesticidal active 3-arylquinazolin-4-one derivatives in soil application methods
MX2014001866A (en) 2011-09-02 2015-04-16 Basf Se Agricultural mixtures comprising arylquinazolinone compounds.
MD4518C1 (en) 2011-09-13 2018-05-31 Basf Agrochemical Products B.V. Method of controlling parasitic weeds with herbicidal mixtures comprising acetolactate synthase inhibitors and plant growth regulators
JP2014528957A (en) 2011-10-03 2014-10-30 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト Insecticidal compounds
CA2850263A1 (en) 2011-10-07 2013-04-11 Syngenta Participations Ag Method for protecting useful plants or plant propagation material
BR112014010707A2 (en) 2011-11-04 2017-04-25 Syngenta Participations Ag pesticide compounds
US20140287916A1 (en) 2011-11-04 2014-09-25 Syngenta Participations Ag Pesticidal compounds
CA2853581A1 (en) 2011-11-04 2013-05-10 Syngenta Participations Ag Pesticidal compounds
US9040708B2 (en) 2011-11-04 2015-05-26 Syngenta Limited Pesticidal compounds
BR122019026836B1 (en) 2011-11-11 2021-02-23 Gilead Apollo, Llc compound, and, acc inhibition methods in a biological sample and a plant
BR112014011534A2 (en) 2011-11-14 2017-05-09 Basf Se compost, composition, use of a compost and method for controlling unwanted vegetation
CA2853340A1 (en) 2011-11-16 2013-05-23 Basf Se Substituted 1,2,5-oxadiazole compounds and their use as herbicides ii
AU2012338748A1 (en) 2011-11-18 2014-06-05 Basf Se Substituted 1,2,5-oxadiazole compounds and their use as herbicides III
US9024019B2 (en) 2011-11-29 2015-05-05 Syngenta Participations Ag Insecticidal triazinone derivatives
TWI572282B (en) 2011-11-30 2017-03-01 先正達合夥公司 Pesticidal mixtures including spiroheterocyclic pyrrolidine diones
UA114805C2 (en) 2011-12-05 2017-08-10 Басф Агрокемікал Продактс Б.В. Methods of controlling undesirable vegetation with imidazolinone herbicides and adjuvants in herbicide resistant crop plants
WO2013092244A1 (en) 2011-12-20 2013-06-27 Basf Se Herbicidal triazines
US20140309109A1 (en) 2011-12-21 2014-10-16 Basf Se N-Thio-anthranilamide compounds and their use as pesticides
JP6415983B2 (en) 2011-12-23 2018-10-31 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Isothiazoline compounds for controlling invertebrate pests
WO2013104561A1 (en) 2012-01-12 2013-07-18 Basf Se Herbicidal isoxazolo[5,4-b]pyridines
WO2013107794A2 (en) 2012-01-17 2013-07-25 Syngenta Participations Ag Pesticidal mixtures including spiroheterocyclic pyrrolidine diones
CN104053362B (en) 2012-01-17 2017-04-26 先正达参股股份有限公司 Pesticidal mixtures including spiroheterocyclic pyrrolidine diones
HUE045257T2 (en) 2012-01-17 2019-12-30 Syngenta Participations Ag Pesticidal mixtures including spiroheterocyclic pyrrolidine diones
WO2013107796A2 (en) 2012-01-17 2013-07-25 Syngenta Participations Ag Pesticidal mixtures including spiroheterocyclic pyrrolidine diones
WO2013113789A1 (en) 2012-02-02 2013-08-08 Basf Se N-thio-anthranilamide compounds and their use as pesticides
WO2013113788A1 (en) 2012-02-03 2013-08-08 Basf Se Fungicidal pyrimidine compounds
JP2015512873A (en) 2012-02-14 2015-04-30 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト Nematicidal cis (hetero) arylcyclopropylcarboxamide derivatives
WO2013124250A2 (en) 2012-02-20 2013-08-29 Basf Se Fungicidal substituted thiophenes
WO2013127818A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal and plant health improving action in soybeans
WO2013127859A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal, herbicidal and plant health improving action in soybeans
WO2013127780A1 (en) 2012-03-01 2013-09-06 Syngenta Participations Ag Chemical compounds
US20150150259A1 (en) 2012-03-01 2015-06-04 Basf Se Use of an agrochemical composition with herbicidal action in corn
WO2013127629A1 (en) 2012-03-01 2013-09-06 Basf Se Adjuvants based on optionally alkoxylated reaction products of glycerol carbonate and alkylamines
CA2864272A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with herbicidal action in rapeseed
WO2013127768A1 (en) 2012-03-01 2013-09-06 Syngenta Participations Ag Pyridine carboxamide pesticides
WO2013127821A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal and plant health improving action in rapeseed
WO2013127848A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal and plant health improving action in corn
WO2013127843A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal, herbicidal and plant health improving action in sunflowers
WO2013127855A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal, herbicidal and plant health improving action in cereals
WO2013127820A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal, herbicidal and plant health improving action in rapeseed
WO2013127846A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal, herbicidal and plant health improving action in corn
WO2013127845A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal, herbicidal and plant health improving action in sunflowers
WO2013127857A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with fungicidal and plant health improving action in cereals
CA2863752A1 (en) 2012-03-01 2013-09-06 Basf Se Agrochemical compositions
WO2013127861A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with herbicidal action in soybeans
CA2864263A1 (en) 2012-03-01 2013-09-06 Basf Se Use of an agrochemical composition with herbicidal action in cereals
CN104411714A (en) 2012-03-09 2015-03-11 韦斯塔隆公司 Toxic peptide production, peptide expression in plants and combinations of cysteine rich peptides
US11692016B2 (en) 2012-03-09 2023-07-04 Vestaron Corporation High gene expression yeast strain
CN104168769B (en) 2012-03-12 2016-12-14 巴斯夫欧洲公司 The method producing the aqueous suspension-concentrates preparaton of pyridine Nan Ping insecticide
MX360698B (en) 2012-03-12 2018-11-14 Basf Se Liquid concentrate formulation containing a pyripyropene insecticide i.
BR112014022497B1 (en) 2012-03-12 2021-02-23 Basf Se FORMULATION OF LIQUID CONCENTRATE, WATER PREPARATION, METHODS TO PARAPROTEGATE PLANTS OF ATTACKS OR INFESTATION BY INVERTEBRATE PAGGES, NON-THERAPEUTIC TO CONTROL INVERTEBRATED PAGES AND TO PROTECT MATERIAL DEPROPAGE FROM PLANTS AGAINST LARGE PLACES AND INVERTED PAGES.
WO2013135610A1 (en) 2012-03-13 2013-09-19 Basf Se Liquid concentrate formulation containing a pyripyropene insecticide iii
WO2013135671A1 (en) 2012-03-13 2013-09-19 Basf Se Fungicidal pyrimidine compounds
WO2013135672A1 (en) 2012-03-13 2013-09-19 Basf Se Fungicidal pyrimidine compounds
UY34688A (en) 2012-03-21 2013-09-30 Basf Se Mixing aid in liquid or particulate tank comprising a base selected from a mixture of carbonate and hydrogen carbonate
US20150051076A1 (en) 2012-03-21 2015-02-19 Basf Se Solid particulate tank mix adjuvant comprising a base selected from a carbonate and/or a phosphate
US20150031539A1 (en) 2012-03-21 2015-01-29 Basf Se Tank mix adjuvant comprising an alkyl polyglucoside and a base
AR093743A1 (en) 2012-03-21 2015-06-24 Basf Se TANK MIXING ASSISTANT CONTAINING GLYPHOSATE THAT INCLUDES A SELECTED BASE OF A CARBONATE AND / OR PHOSPHATE
EP2644595A1 (en) 2012-03-26 2013-10-02 Syngenta Participations AG. N-Cyclylamides as nematicides
WO2013144224A1 (en) 2012-03-27 2013-10-03 Syngenta Participations Ag Acetylenic microbiocides
WO2013144228A1 (en) 2012-03-29 2013-10-03 Basf Se Pesticidal methods using heterocyclic compounds and derivatives for combating animal pests
WO2013143927A1 (en) 2012-03-29 2013-10-03 Basf Se Co-crystals of dicamba and a co-crystal former b
WO2013144213A1 (en) 2012-03-30 2013-10-03 Basf Se N-substituted pyridinylidene compounds and derivatives for combating animal pests
WO2013144223A1 (en) 2012-03-30 2013-10-03 Basf Se N-substituted pyrimidinylidene compounds and derivatives for combating animal pests
US20150065343A1 (en) 2012-04-02 2015-03-05 Basf Se Acrylamide compounds for combating invertebrate pests
WO2013149903A1 (en) 2012-04-03 2013-10-10 Basf Se N- substituted hetero - bicyclic furanone derivatives for combating animal
EP2647626A1 (en) 2012-04-03 2013-10-09 Syngenta Participations AG. 1-Aza-spiro[4.5]dec-3-ene and 1,8-diaza-spiro[4.5]dec-3-ene derivatives as pesticides
WO2013150115A1 (en) 2012-04-05 2013-10-10 Basf Se N- substituted hetero - bicyclic compounds and derivatives for combating animal pests
CA2868134C (en) 2012-04-05 2020-12-08 Basf Se Herbicidal active mixtures comprising a quinclorac ammonium salt and a glutamine synthetase inhibitor such as bialaphos, glufosinate and glufosinate p.
EP2649879A1 (en) 2012-04-10 2013-10-16 Basf Se Pesticidal mixtures containing fluxapyroxad
WO2013156331A1 (en) 2012-04-16 2013-10-24 Basf Se Synergistic compositions comprising pyraclostrobin and an insecticidal compound
WO2013156431A1 (en) 2012-04-17 2013-10-24 Syngenta Participations Ag Pesticidally active pyridyl- and pyrimidyl- substituted thiazole and thiadiazole derivatives
WO2013156433A1 (en) 2012-04-17 2013-10-24 Syngenta Participations Ag Insecticidally active thiazole derivatives
IN2014MN02331A (en) 2012-04-27 2015-08-14 Basf Se
BR112014026791A2 (en) 2012-04-27 2017-06-27 Basf Se substituted n- (tetrazol-5-yl) and n- (triazol-5-yl) pyridin-3-yl-carboxamide compounds and their use as herbicides.
CN104428297A (en) 2012-04-27 2015-03-18 巴斯夫欧洲公司 Substituted N-(tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
CN104411698A (en) 2012-04-27 2015-03-11 巴斯夫欧洲公司 Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)hetarylcarboxamide compounds and their use as herbicides
WO2013164295A1 (en) 2012-05-04 2013-11-07 Basf Se Substituted pyrazole-containing compounds and their use as pesticides
EP2659777A1 (en) 2012-05-04 2013-11-06 Syngenta Participations AG. New use of a pesticide
BR112014027133A2 (en) 2012-05-09 2017-06-27 Basf Se compound, agricultural or veterinary composition, method for controlling invertebrate pests, plant propagating material and method for treating or protecting an animal.
ES2656543T3 (en) 2012-05-24 2018-02-27 Basf Se N-thio-anthranilamide compounds and their use as pesticides
JP2015523340A (en) 2012-06-01 2015-08-13 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Substituted pyridine compounds having herbicidal activity
US9480259B2 (en) 2012-06-06 2016-11-01 Basf Se Pyrazolopyrans having herbicidal and pharmaceutical properties
EP2671881A1 (en) 2012-06-07 2013-12-11 Syngenta Participations AG. Pesticidally active pyridyl- and pyrimidyl- substituted thiazole derivatives
EP2863738A2 (en) 2012-06-14 2015-04-29 Basf Se Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests
EA026929B1 (en) 2012-06-20 2017-05-31 Басф Се Pesticidal mixtures comprising a pyrazole compound and use thereof
JP2015525233A (en) 2012-06-21 2015-09-03 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Adjuvants containing 2-propylheptylamine alkoxylates, sugar-based surfactants and drift control agents and / or wetting agents
MX2014015729A (en) 2012-06-21 2015-09-04 Basf Se An aqueous composition comprising dicamba and a drift control agent.
EP2869697A1 (en) 2012-07-03 2015-05-13 Basf Se Highly concentrated aqueous formulation comprising an anionic pesticide and a base
EP2684879A1 (en) 2012-07-09 2014-01-15 Basf Se Substituted mesoionic compounds for combating animal pests
CN104411172A (en) 2012-07-09 2015-03-11 巴斯夫欧洲公司 Drift control agent comprising polypropylene glycol and a triblock polymer
EP2871960A1 (en) 2012-07-13 2015-05-20 Basf Se Substituted thiadiazoles and their use as fungicides
WO2014009293A1 (en) 2012-07-13 2014-01-16 Basf Se New substituted thiadiazoles and their use as fungicides
WO2014023531A1 (en) 2012-08-07 2014-02-13 Syngenta Participations Ag Trifluoromethylpyridine carboxamides as pesticides
EP2700634A1 (en) 2012-08-20 2014-02-26 Basf Se 5-difluoromethylpyrazole amides having herbicidal activity
EP2700635A1 (en) 2012-08-20 2014-02-26 Basf Se 5-Trifluoromethylpyrazole amides having herbicidal activity
WO2014033241A1 (en) 2012-08-31 2014-03-06 Basf Se Use of an agrochemical composition with fungicidal and plant health improving action in rice
WO2014033242A1 (en) 2012-08-31 2014-03-06 Basf Se Use of an agrochemical composition with herbicidal action in rice
BR112015006299A2 (en) 2012-09-21 2017-07-04 Basf Se '' compost, agricultural composition, method for the protection of crop plants, method for the protection of plant propagating material and propagating material ''
JP2015535838A (en) 2012-10-01 2015-12-17 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Pesticidal mixture containing anthranilamide compound
EP2903439A1 (en) 2012-10-01 2015-08-12 Basf Se Method of controlling ryanodine-modulator insecticide resistant insects
EP2903442A1 (en) 2012-10-01 2015-08-12 Basf Se Pesticidally active mixtures comprising anthranilamide compounds
CN104812242A (en) 2012-10-01 2015-07-29 巴斯夫欧洲公司 Pesticidal mixtures comprising jasmonic acid or a derivative thereof
AR093771A1 (en) 2012-10-01 2015-06-24 Basf Se METHOD TO CONTROL INSECTICIDE RESISTANT INSECTS
WO2014053407A1 (en) 2012-10-01 2014-04-10 Basf Se N-thio-anthranilamide compounds and their use as pesticides
BR112015004074A2 (en) 2012-10-01 2017-07-04 Basf Se method for controlling pests, use and seed of a cultivated plant.
WO2014053401A2 (en) 2012-10-01 2014-04-10 Basf Se Method of improving plant health
WO2014056780A1 (en) 2012-10-12 2014-04-17 Basf Se A method for combating phytopathogenic harmful microbes on cultivated plants or plant propagation material
BR112015009475A2 (en) 2012-10-31 2017-07-04 Syngenta Participations Ag insecticide compounds
WO2014079770A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079820A1 (en) 2012-11-22 2014-05-30 Basf Se Use of anthranilamide compounds for reducing insect-vectored viral infections
WO2014079774A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079728A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079804A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079841A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
PL2922395T3 (en) 2012-11-22 2019-11-29 Basf Corp Pesticidal mixtures
WO2014079772A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
CA2889775A1 (en) 2012-11-22 2014-05-30 Basf Corporation Pesticidal mixtures
CA2890635C (en) 2012-11-22 2022-12-06 Basf Corporation Synergistic pesticidal mixtures comprising bacillus subtilis mbi-600
WO2014079766A1 (en) 2012-11-22 2014-05-30 Basf Se Pesticidal mixtures
WO2014079752A1 (en) 2012-11-23 2014-05-30 Basf Se Pesticidal mixtures
WO2014079813A1 (en) 2012-11-23 2014-05-30 Basf Se Pesticidal mixtures
CN104955813A (en) 2012-11-27 2015-09-30 巴斯夫欧洲公司 Substituted [1, 2, 4] triazole compounds
WO2014082881A1 (en) 2012-11-27 2014-06-05 Basf Se Substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds and their use as fungicides
CN105008336A (en) 2012-11-27 2015-10-28 巴斯夫欧洲公司 Substituted 2-[phenoxy-phenyl]-1-[1,2,4]triazol-1-yl-ethanol compounds and their use as fungicides
WO2014082879A1 (en) 2012-11-27 2014-06-05 Basf Se Substituted [1,2,4]triazole compounds
EP2738171A1 (en) 2012-11-30 2014-06-04 Syngenta Participations AG. Pesticidally active tricyclic pyridyl derivatives
AU2013354353A1 (en) 2012-12-04 2015-07-02 Basf Se New substituted 1,4-dithiine derivatives and their use as fungicides
AU2013357564A1 (en) 2012-12-14 2015-07-02 Basf Se Malononitrile compounds for controlling animal pests
WO2014095381A1 (en) 2012-12-19 2014-06-26 Basf Se Fungicidal imidazolyl and triazolyl compounds
EP2746262A1 (en) 2012-12-19 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds for combating phytopathogenic fungi
EP2746274A1 (en) 2012-12-19 2014-06-25 Basf Se Substituted [1,2,4]triazole compounds
US20150329501A1 (en) 2012-12-19 2015-11-19 Basf Se Substituted [1,2,4]triazole compounds and their use as fungicides
EP2746255A1 (en) 2012-12-19 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP2746278A1 (en) 2012-12-19 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP3181558A1 (en) 2012-12-19 2017-06-21 Basf Se Substituted [1,2,4]triazole compounds and their use as fungicides
EP2746264A1 (en) 2012-12-19 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP2746266A1 (en) 2012-12-19 2014-06-25 Basf Se New substituted triazoles and imidazoles and their use as fungicides
WO2014095534A1 (en) 2012-12-19 2014-06-26 Basf Se New substituted triazoles and imidazoles and their use as fungicides
EP2746279A1 (en) 2012-12-19 2014-06-25 Basf Se Fungicidal imidazolyl and triazolyl compounds
EP2746276A1 (en) 2012-12-19 2014-06-25 Basf Se New substituted triazoles and imidazoles and their use as fungicides
WO2014095555A1 (en) 2012-12-19 2014-06-26 Basf Se New substituted triazoles and imidazoles and their use as fungicides
BR112015014303A2 (en) 2012-12-19 2017-07-11 Basf Se compounds of formula I, process for the preparation of compounds of formula I, agrochemical compositions, use of a compound of formula I, method for combating fungi, seed and intermediate compounds xx3
EP2746275A1 (en) 2012-12-19 2014-06-25 Basf Se New substituted triazoles and imidazoles and their use as fungicides
EP2746263A1 (en) 2012-12-19 2014-06-25 Basf Se Alpha-substituted triazoles and imidazoles
EP2745691A1 (en) 2012-12-19 2014-06-25 Basf Se Substituted imidazole compounds and their use as fungicides
EP2746256A1 (en) 2012-12-19 2014-06-25 Basf Se Fungicidal imidazolyl and triazolyl compounds
EP2746277A1 (en) 2012-12-19 2014-06-25 Basf Se Fungicidal imidazolyl and triazolyl compounds
WO2014095994A1 (en) 2012-12-20 2014-06-26 Basf Se Compositions comprising a triazole compound
EP2746260A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP2746258A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP2746257A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
BR112015014792A2 (en) 2012-12-21 2017-07-11 Basf Se use of a compound, compound of formula, method for preparing a compound of formula, agricultural and / or veterinary composition, methods for pest control, crop protection, seed protection, methods for treatment or protection of animals and for the preparation of a composition
EP2746259A1 (en) 2012-12-21 2014-06-25 Basf Se Substituted [1,2,4]triazole and imidazole compounds
US20150368236A1 (en) 2012-12-27 2015-12-24 Basf Se 2-(pyridin-3-yl)-5-hetaryl-thiazole compounds carrying an imine or imine-derived substituent for combating invertebrate pests
WO2014102065A1 (en) 2012-12-31 2014-07-03 Basf Se Herbicidal composition comprising a cornexistin
WO2014118099A1 (en) 2013-01-30 2014-08-07 Basf Se Fungicidal naphthoquinones and derivatives
WO2014132141A2 (en) 2013-01-31 2014-09-04 Basf Se Auxinic herbicide-tolerant plants
BR112015018547A2 (en) 2013-02-04 2017-07-18 Syngenta Participations Ag microbiocides
WO2014124850A1 (en) 2013-02-14 2014-08-21 Basf Se Substituted [1,2,4]triazole and imidazole compounds
WO2014128136A1 (en) 2013-02-20 2014-08-28 Basf Se Anthranilamide compounds and their use as pesticides
EP2961737B1 (en) 2013-02-27 2017-07-26 Syngenta Participations AG Novel carboxamide compounds
JP2016516011A (en) 2013-03-07 2016-06-02 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se Co-crystals of pyrimethanil and selected dithiine tetracarboximides
EP2783569A1 (en) 2013-03-28 2014-10-01 Basf Se Compositions comprising a triazole compound
JP2016515552A (en) 2013-03-28 2016-05-30 シンジェンタ パーティシペーションズ アーゲー Neonicotinoid-resistant pest control method
CN105102433B (en) 2013-04-02 2017-12-15 先正达参股股份有限公司 Pesticidal compound
JP6505080B2 (en) 2013-04-02 2019-04-24 シンジェンタ パーティシペーションズ アーゲー Insecticidal compound
WO2014167133A1 (en) 2013-04-12 2014-10-16 Syngenta Participations Ag Fungicides comprising boron
JP2016522173A (en) 2013-04-19 2016-07-28 ビーエーエスエフ ソシエタス・ヨーロピアBasf Se N-substituted acyl-imino-pyridine compounds and derivatives for controlling harmful animals
WO2014173880A1 (en) 2013-04-22 2014-10-30 Syngenta Participations Ag Novel microbiocides
AU2014262546B2 (en) 2013-05-10 2018-11-08 Gilead Apollo, Llc ACC inhibitors and uses thereof
MX2015015422A (en) 2013-05-10 2016-06-21 Nimbus Apollo Inc Acc inhibitors and uses thereof.
WO2014184014A1 (en) 2013-05-15 2014-11-20 Basf Se N-(1,2,5-oxadiazol-3-yl)carboxamide compounds and their use as herbicides
EP2997016B1 (en) 2013-05-15 2017-10-04 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
WO2014184019A1 (en) 2013-05-15 2014-11-20 Basf Se N-(1,2,5-oxadiazol-3-yl)carboxamide compounds and their use as herbicides
WO2014184058A1 (en) 2013-05-15 2014-11-20 Basf Se Substituted 1,2,5-oxadiazole compounds and their use as herbicides
CN105228448B (en) 2013-05-23 2019-03-01 先正达参股股份有限公司 The mixed product of bucket
EP3004117A1 (en) 2013-05-24 2016-04-13 Basf Se Substituted pyridine compounds having herbicidal activity
EP2813499A1 (en) 2013-06-12 2014-12-17 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP2815649A1 (en) 2013-06-18 2014-12-24 Basf Se Fungicidal mixtures II comprising strobilurin-type fungicides
EP2815647A1 (en) 2013-06-18 2014-12-24 Basf Se Novel strobilurin-type compounds for combating phytopathogenic fungi
US20160143279A1 (en) 2013-06-26 2016-05-26 Basf Se Methods for Improving the Efficacy of Anionic Herbicides under Hard Water Conditions and Suitable Compositions
RU2016103149A (en) 2013-07-02 2017-08-07 Зингента Партисипейшнс Аг PESTICIDO-ACTIVE BI-OR TRICYCLIC HETEROCYCLES WITH SURFACE-CONTAINING SUBSTITUTES
BR112016000209B1 (en) 2013-07-08 2021-10-13 Syngenta Participations Ag CARBOXAMIDE COMPOUNDS, PESTICIDE COMPOSITION, METHOD OF PROTECTION OF PLANT CROPS AND PLANT PROPAGATION MATERIAL, COATED PLANT PROPAGATION MATERIAL AND PROCESS FOR PREPARATION OF A COMPOUND
WO2015004091A1 (en) 2013-07-12 2015-01-15 Syngenta Participations Ag Nicotinamide derivatives and their use against nematodes
WO2015003991A1 (en) 2013-07-12 2015-01-15 Syngenta Participations Ag Novel microbiocides
US9497970B2 (en) 2013-07-15 2016-11-22 Basf Se Pesticide compounds
US9926284B2 (en) 2013-07-18 2018-03-27 Basf Se Substituted N-(1,2,4-triazol-3-yl)Arylcarboxamide compounds and their use as herbicides
EP2835052A1 (en) 2013-08-07 2015-02-11 Basf Se Fungicidal mixtures comprising pyrimidine fungicides
US10619138B2 (en) 2013-08-12 2020-04-14 Basf Se Herbicide-resistant hydroxyphenylpyruvate dioxygenases
WO2015021991A1 (en) 2013-08-16 2015-02-19 Cheminova A/S Combination of 2-methylbiphenyl-3-ylmethyl (z)-(1r)-cis-3-(2-chloro-3,3,3-trifluoroprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate with at least one insecticide, acaricide, nematicide and/or fungicide.
EP2839745A1 (en) 2013-08-21 2015-02-25 Basf Se Agrochemical formulations comprising a 2-ethyl-hexanol alkoxylate
CN105722833A (en) 2013-09-16 2016-06-29 巴斯夫欧洲公司 Fungicidal pyrimidine compounds
WO2015036059A1 (en) 2013-09-16 2015-03-19 Basf Se Fungicidal pyrimidine compounds
KR20160058863A (en) 2013-09-19 2016-05-25 바스프 에스이 N-acylimino heterocyclic compounds
WO2015040141A1 (en) 2013-09-23 2015-03-26 Syngenta Participations Ag Cyclobutylcarboxamides as nematicides
PL3051945T3 (en) 2013-10-03 2023-02-20 Syngenta Participations Ag Fungicidal compositions
WO2015052178A1 (en) 2013-10-10 2015-04-16 Basf Se 1,2,5-oxadiazole compounds and their use as herbicides
WO2015052173A1 (en) 2013-10-10 2015-04-16 Basf Se Tetrazole and triazole compounds and their use as herbicides
EP3055297A1 (en) 2013-10-10 2016-08-17 Basf Se Substituted n-(tetrazol-5-yl)- and n-(triazol-5-yl)arylcarboxamide compounds and their use as herbicides
BR112016008555A8 (en) 2013-10-18 2020-03-10 Basf Agrochemical Products Bv uses of the active pesticide carboxamide compound and method of protecting plant propagation material
EP2868196A1 (en) 2013-11-05 2015-05-06 Basf Se Herbicidal compositions
EP2868197A1 (en) 2013-11-05 2015-05-06 Basf Se Herbicidal compositions
EP2873668A1 (en) 2013-11-13 2015-05-20 Syngenta Participations AG. Pesticidally active bicyclic heterocycles with sulphur containing substituents
EP2881387A1 (en) 2013-12-09 2015-06-10 Basf Se Pyrazolone compounds having herbicidal activity
EP2881388A1 (en) 2013-12-09 2015-06-10 Basf Se Pyrazolone compounds having herbicidal activity
BR112016013263B1 (en) 2013-12-12 2020-08-25 Basf Se compounds, composition, use of a compound and method for combating phytopathogenic fungi
US20160318897A1 (en) 2013-12-18 2016-11-03 Basf Se Azole compounds carrying an imine-derived substituent
EP3083581A1 (en) 2013-12-18 2016-10-26 Basf Se N-substituted imino heterocyclic compounds
JP6469111B2 (en) 2013-12-20 2019-02-13 シンジェンタ パーティシペーションズ アーゲー Substituted 5,5-bicyclic heterocycles with sulfur-containing substituents having pesticidal activity
US20170000132A1 (en) 2013-12-23 2017-01-05 Syngenta Participations Ag Benzoxaborole fungicides
ES2762595T3 (en) 2013-12-23 2020-05-25 Syngenta Participations Ag Insecticidal compounds
WO2015104422A1 (en) 2014-01-13 2015-07-16 Basf Se Dihydrothiophene compounds for controlling invertebrate pests
AR100304A1 (en) 2014-02-05 2016-09-28 Basf Corp SEED COATING FORMULATION
EP2907807A1 (en) 2014-02-18 2015-08-19 Basf Se Benzamide compounds and their use as herbicides
MX2016012540A (en) 2014-03-26 2017-01-09 Basf Se Substituted [1,2,4]triazole and imidazole compounds as fungicides.
EP2924027A1 (en) 2014-03-28 2015-09-30 Basf Se Substituted [1,2,4]triazole and imidazole fungicidal compounds
US20170144985A1 (en) 2014-04-03 2017-05-25 Basf Se Diaminotriazine compound useful as herbicide
WO2015150465A2 (en) 2014-04-03 2015-10-08 Basf Se Plants having increased tolerance to herbicides
EP2930174A1 (en) 2014-04-07 2015-10-14 Basf Se Diaminotriazine derivatives as herbicides
EP3177143A2 (en) 2014-04-17 2017-06-14 Basf Se Combination of novel nitrification inhibitors and herbicides as well as combination of (thio)phosphoric acid triamides and herbicides
MX2016013924A (en) 2014-04-23 2017-03-07 Basf Se Diaminotriazine compounds as herbicides.
WO2015177063A1 (en) 2014-05-19 2015-11-26 Syngenta Participations Ag Insecticidally active amide derivatives with sulfur-substituted phenyl or pyridine groups
EP2949216A1 (en) 2014-05-30 2015-12-02 Basf Se Fungicidal substituted alkynyl [1,2,4]triazole and imidazole compounds
EP2949649A1 (en) 2014-05-30 2015-12-02 Basf Se Fungicide substituted [1,2,4]triazole and imidazole compounds
EP2952512A1 (en) 2014-06-06 2015-12-09 Basf Se Substituted [1,2,4]triazole compounds
EP2952507A1 (en) 2014-06-06 2015-12-09 Basf Se Substituted [1,2,4]triazole compounds
AR100743A1 (en) 2014-06-06 2016-10-26 Basf Se COMPOUNDS OF [1,2,4] SUBSTITUTED TRIAZOL
EP2952506A1 (en) 2014-06-06 2015-12-09 Basf Se Substituted [1,2,4]triazole and imidazole compounds
EP3151669B1 (en) 2014-06-06 2020-10-28 Basf Se Use of substituted oxadiazoles for combating phytopathogenic fungi
EP3272217A1 (en) 2014-06-25 2018-01-24 BASF Agro B.V. Pesticidal compositions
RS60016B1 (en) 2014-06-26 2020-04-30 Basf Agrochemical Products Bv Seed treatment with acetolactate synthase (als) inhibitors
EP2962567A1 (en) 2014-07-01 2016-01-06 Basf Se Ternary mixtures comprising biopesticides and at least two chemical insecticides
HUE057012T2 (en) 2014-07-14 2022-04-28 Basf Se Pesticidal compositions
EP2979549A1 (en) 2014-07-31 2016-02-03 Basf Se Method for improving the health of a plant
WO2016016131A1 (en) 2014-07-31 2016-02-04 Syngenta Participations Ag Pesticidally active cyclic enaminones
CN107074846B (en) 2014-08-12 2020-05-19 先正达参股股份有限公司 Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2016034615A1 (en) 2014-09-02 2016-03-10 BASF Agro B.V. Aqueous insecticide formulation containing hyperbranched polymer
SG10201913849RA (en) 2014-10-16 2020-03-30 Monsanto Technology Llc Novel chimeric insecticidal proteins toxic or inhibitory to lepidopteran pests
CR20170197A (en) 2014-10-16 2017-06-29 Monsanto Lechnology Llc PROTEINS OF VARIANTS OF SEQUENCES OF AMINO ACIDS OF CRY1DA1 ACTIVE FOR LEPIDOPTERS
US10487123B2 (en) 2014-10-16 2019-11-26 Monsanto Technology Llc Chimeric insecticidal proteins toxic or inhibitory to lepidopteran pests
WO2016071168A1 (en) 2014-11-07 2016-05-12 Basf Se Pesticidal mixtures
EP3214938A1 (en) 2014-11-07 2017-09-13 Basf Se Agrochemical adjuvant containing 2-oxo-1,3-dioxolan-4 carboxylates
EP3028573A1 (en) 2014-12-05 2016-06-08 Basf Se Use of a triazole fungicide on transgenic plants
EP3029025A1 (en) 2014-12-05 2016-06-08 Basf Se Method for combating soybean rust comprising treating soybean with (2e)-2-methoxyimino-2 [2 [[(e)-[(2e)-2-alkoxyimino-1-methyl-alk-3-enylidene]amino]oxymethyl]phenyl]-n-methyl-acetamides
EP3031325A1 (en) 2014-12-10 2016-06-15 Basf Se Method for combating soybean rust comprising treating soybean with (2E)-2-[2-[[1-(2,4-substi-tuted-phenyl)pyrazol-3-yl]oxymeth¬yl]-3-sub¬stituted-phenyl]-2-methoxyimino-n-methyl-acet-amides
CN107001364B (en) 2014-12-11 2020-06-16 先正达参股股份有限公司 Pesticidally active tetracyclic derivatives with sulfur-containing substituents
WO2016091675A1 (en) 2014-12-12 2016-06-16 Basf Se Method for improving the health of a plant
WO2016091674A1 (en) 2014-12-12 2016-06-16 Basf Se Use of cyclaniliprole on cultivated plants
EP3047731A1 (en) 2015-01-21 2016-07-27 Basf Se Method for combating soybean rust comprising treating soybean with (2E)-2-[3-substituted-2 [[(E)-[(2E)-2-alkoxyimino-1-methyl-2-phenyl-ethylidene]amino]oxymethyl]phenyl]-2-methoxy-imino-N-methyl-acetamides
AU2016209901B2 (en) 2015-01-21 2021-12-02 Basf Se Plants having increased tolerance to herbicides
WO2016120116A1 (en) 2015-01-29 2016-08-04 Basf Se Herbicidal phenylpyridines
MX2017009843A (en) 2015-01-30 2017-11-02 Basf Se Herbicidal phenylpyrimidines.
WO2016120182A1 (en) 2015-01-30 2016-08-04 Syngenta Participations Ag Pesticidally active amide heterocyclic derivatives with sulphur containing substituents
US10556844B2 (en) 2015-02-06 2020-02-11 Basf Se Pyrazole compounds as nitrification inhibitors
US11248234B2 (en) 2015-02-11 2022-02-15 Basf Se Herbicide-resistant hydroxyphenylpyruvate dioxygenases
EP3070080A1 (en) 2015-03-19 2016-09-21 Basf Se Herbicidal fluoromethanesulfonamides
EP3070079A1 (en) 2015-03-19 2016-09-21 Basf Se Herbicidal fluoromethanesulfonamides
CN111303116B (en) 2015-03-27 2023-10-10 先正达参股股份有限公司 Microbiocidal heterobicyclic derivatives
CA2978035A1 (en) 2015-03-31 2016-10-06 Basf Se Composition comprising a pesticide and isononanoic acid n,n-dimethyl amide
US11064696B2 (en) 2015-04-07 2021-07-20 Basf Agrochemical Products B.V. Use of an insecticidal carboxamide compound against pests on cultivated plants
WO2016169882A1 (en) 2015-04-24 2016-10-27 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur substituted five membered ring heterocyles
CN108040481B (en) 2015-04-24 2020-10-30 先正达参股股份有限公司 Pesticidally active polycyclic derivatives with sulfur-substituted five-membered ring heterocycles
WO2016174042A1 (en) 2015-04-27 2016-11-03 BASF Agro B.V. Pesticidal compositions
EP3103798A1 (en) 2015-06-09 2016-12-14 Basf Se Herbicidal fluoromethanesulfonamides
AU2016279764B2 (en) 2015-06-16 2020-09-10 Basf Agrochemical Products B.V. Method for managing flea beetles of the family Chrysomelidae in Brassica crops
US10745396B2 (en) 2015-07-01 2020-08-18 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
ES2762958T3 (en) 2015-07-01 2020-05-26 Syngenta Participations Ag Tetracyclic derivatives active as pesticides with sulfur-containing substituents
CN107809906A (en) 2015-07-02 2018-03-16 巴斯夫农业公司 Composition pesticide comprising triazole compounds
EP3111763A1 (en) 2015-07-02 2017-01-04 BASF Agro B.V. Pesticidal compositions comprising a triazole compound
WO2017009134A1 (en) 2015-07-10 2017-01-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and specific non-accase lipid synthesis inhibitors
CN107846895B (en) 2015-07-10 2024-04-19 巴斯夫农业公司 Herbicidal composition comprising a specific inhibitor of cycloheptane and protoporphyrinogen oxidase
US20180199568A1 (en) 2015-07-10 2018-07-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and pethoxamid
EP3319436B1 (en) 2015-07-10 2019-09-11 BASF Agro B.V. Herbicidal composition comprising cinmethylin and quinmerac
US10813356B2 (en) 2015-07-10 2020-10-27 BASF Agro B.V. Herbicidal composition comprising cinmethylin and dimethenamid
EP3319435B1 (en) 2015-07-10 2020-02-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and clomazone
AU2016294365B2 (en) 2015-07-10 2020-09-17 BASF Agro B.V. Herbicidal composition comprising cinmethylin and metazachlor
EA201890266A1 (en) 2015-07-10 2018-07-31 Басф Агро Б.В. HERBICID COMPOSITION CONTAINING ZINMETHYLINE AND PENDIMETALINE
WO2017009089A1 (en) 2015-07-10 2017-01-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin, metazachlor and quinolinecarboxylic acids
WO2017009140A1 (en) 2015-07-10 2017-01-19 BASF Agro B.V. Herbicidal composition comprising cinmethylin and acetochlor or pretilachlor
EP3162209A1 (en) 2015-10-27 2017-05-03 BASF Agro B.V. Herbicidal composition comprising cinmethylin and imazamox
WO2017025510A1 (en) 2015-08-12 2017-02-16 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
EP3135113A1 (en) 2015-08-31 2017-03-01 Basf Se Use of herbicidal compositions for controlling unwanted vegetation
CN108137531A (en) 2015-09-25 2018-06-08 先正达参股股份有限公司 Harmful organism active heterocycles derivative is killed with sulfur-bearing substituent group
WO2017050685A1 (en) 2015-09-25 2017-03-30 Syngenta Participations Ag Pesticidally active polycyclic derivatives with 5-membered sulfur containing heterocyclic ring systems
EP3356343B1 (en) 2015-09-28 2020-03-18 Syngenta Participations AG Pesticidally active heterocyclic derivatives with sulphur containing substituents
EP3356358B1 (en) 2015-10-02 2020-05-06 Syngenta Participations AG Microbiocidal oxadiazole derivatives
BR112018006314A2 (en) 2015-10-05 2018-10-16 Basf Se formula compound, composition, use of formula compound, method of combating phytopathogenic fungi and coated seed
WO2017067839A1 (en) 2015-10-23 2017-04-27 Syngenta Participations Ag Microbiocidal phenylamidine derivatives
WO2017067837A1 (en) 2015-10-23 2017-04-27 Syngenta Participations Ag Microbiocidal phenylamidine derivatives
JP2018537426A (en) 2015-10-28 2018-12-20 シンジェンタ パーティシペーションズ アーゲー Microbicidal oxadiazole derivatives
EP3371177A1 (en) 2015-11-02 2018-09-12 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
EP3165094A1 (en) 2015-11-03 2017-05-10 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
BR112018008288A2 (en) 2015-11-04 2018-10-30 Basf Se use of formula compounds, formula compounds, mixture, agrochemical composition and method for combating fungi
CN108349915A (en) 2015-11-04 2018-07-31 先正达参股股份有限公司 Kill the anil of microorganism
EP3165093A1 (en) 2015-11-05 2017-05-10 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017080870A1 (en) 2015-11-09 2017-05-18 Syngenta Participations Ag Fungicidal compositions
EP3167716A1 (en) 2015-11-10 2017-05-17 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
US20180343865A1 (en) 2015-11-12 2018-12-06 Basf Se Herbicidal compositions comprising isoxazolo[5,4-b]pyridines
EP3373733A1 (en) 2015-11-13 2018-09-19 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2017081310A1 (en) 2015-11-13 2017-05-18 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
CN108347937A (en) 2015-11-19 2018-07-31 巴斯夫欧洲公司 Qu Dai oxadiazoles for preventing and kill off plant pathogenic fungi
MX2018006244A (en) 2015-11-19 2018-11-09 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi.
CN108290885A (en) 2015-11-23 2018-07-17 先正达参股股份有限公司 Substituent group with sulfur-bearing and containing cyclopropyl kills harmful organism active heterocycles derivative
WO2017091600A1 (en) 2015-11-25 2017-06-01 Gilead Apollo, Llc Pyrazole acc inhibitors and uses thereof
KR20180082557A (en) 2015-11-25 2018-07-18 길리어드 아폴로, 엘엘씨 Triazole ACC inhibitors and uses thereof
WO2017091602A1 (en) 2015-11-25 2017-06-01 Gilead Apollo, Llc Ester acc inhibitors and uses thereof
US10696634B2 (en) 2015-12-01 2020-06-30 Basf Se Pyridine compounds as fungicides
US20180368403A1 (en) 2015-12-01 2018-12-27 Basf Se Pyridine compounds as fungicides
JP6930972B2 (en) 2015-12-02 2021-09-01 シンジェンタ パーティシペーションズ アーゲー Microbial oxadiazole derivative
DK3389379T3 (en) 2015-12-15 2021-04-12 Syngenta Participations Ag MICROBIOCIDE PHENYLAMIDINE DERIVATIVES
BR112018012338A2 (en) 2015-12-17 2018-12-04 Syngenta Participations Ag microbiocidal oxadiazole derivatives
CN108473444A (en) 2015-12-17 2018-08-31 巴斯夫欧洲公司 Benzamide compounds and its purposes as herbicide
CA3006911A1 (en) 2015-12-22 2017-06-29 Syngenta Participations Ag Pesticidally active pyrazole derivatives
AU2017209835C1 (en) 2016-01-22 2021-03-18 Basf Se Biodegradable polyester capsules comprising an aqueous core and a pesticide
EP3411373A1 (en) 2016-02-05 2018-12-12 Syngenta Participations AG Pesticidally active heterocyclic derivatives with sulphur containing substituents
EP3202267A1 (en) 2016-02-05 2017-08-09 Basf Se Pesticidal mixtures
EP3205209A1 (en) 2016-02-09 2017-08-16 Basf Se Mixtures and compositions comprising paenibacillus strains or metabolites thereof and other biopesticides
EP3205208A1 (en) 2016-02-09 2017-08-16 Basf Se Mixtures and compositions comprising paenibacillus strains or fusaricidins and chemical pesticides
WO2017140771A1 (en) 2016-02-18 2017-08-24 Syngenta Participations Ag Pesticidally active pyrazole derivatives
UY37137A (en) 2016-02-24 2017-09-29 Merial Inc ANTIPARASITARY COMPOUNDS OF ISOXAZOLINE, INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE THEM, METHODS AND USES OF THE SAME
CR20180434A (en) 2016-03-10 2018-11-21 Syngenta Participations Ag MICROBIOCIDE DERIVATIVES OF TYPE (UNCLE) CARBOXAMIDE OF QUINOLINE
WO2017153200A1 (en) 2016-03-10 2017-09-14 Basf Se Fungicidal mixtures iii comprising strobilurin-type fungicides
JP2019514845A (en) 2016-03-15 2019-06-06 シンジェンタ パーティシペーションズ アーゲー Microbicidal oxadiazole derivative
WO2017162868A1 (en) 2016-03-24 2017-09-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2017174449A1 (en) 2016-04-07 2017-10-12 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
ES2810827T3 (en) 2016-04-08 2021-03-09 Syngenta Participations Ag Microbiocide oxadiazole derivatives
CN109071522B (en) 2016-04-12 2022-04-12 先正达参股股份有限公司 Microbicidal oxadiazole derivatives
WO2017178408A1 (en) 2016-04-15 2017-10-19 Syngenta Participations Ag Microbiocidal silicon containing aryl derivatives
EP3245872A1 (en) 2016-05-20 2017-11-22 BASF Agro B.V. Pesticidal compositions
DK3464261T3 (en) 2016-05-24 2021-10-11 Basf Se Herbicide uracilpyridiner
WO2017202774A1 (en) 2016-05-24 2017-11-30 Basf Se Method for controlling ppo resistant weeds
US10662182B2 (en) 2016-05-30 2020-05-26 Syngenta Participations Ag Microbiocidal thiazole derivatives
WO2017207368A1 (en) 2016-06-02 2017-12-07 BASF Agro B.V. Fungicidal compositions
US11192867B2 (en) 2016-06-03 2021-12-07 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
AR108745A1 (en) 2016-06-21 2018-09-19 Syngenta Participations Ag MICROBIOCIDES OXADIAZOL DERIVATIVES
EP3269246A1 (en) 2016-07-13 2018-01-17 Basf Se Pesticidal mixtures
MX2019000665A (en) 2016-07-15 2019-10-30 Basf Se Plants having increased tolerance to herbicides.
WO2018011112A1 (en) 2016-07-15 2018-01-18 Basf Se Fungicidal mixtures comprising a carboxamide
CA3029873A1 (en) 2016-07-20 2018-01-25 Basf Se Herbicidal compositions comprising phenylpyrimidines
BR112019001229B1 (en) 2016-07-22 2022-11-16 Syngenta Participations Ag OXADIAZOLE DERIVATIVE COMPOUND, AGROCHEMICAL COMPOSITION COMPRISING THE SAME, METHOD TO CONTROL OR PREVENT INFESTATION OF USEFUL PLANTS BY PHYTOPATHOGENIC MICRO-ORGANISMS AND USE OF THE SAID COMPOUND AS FUNGICIDE
EP3487842A1 (en) 2016-07-22 2019-05-29 Syngenta Participations AG Microbiocidal oxadiazole derivatives
CN109476651A (en) 2016-07-22 2019-03-15 先正达参股股份有限公司 Kill the oxadiazole derivatives of microorganism
CN109476630A (en) 2016-07-25 2019-03-15 巴斯夫欧洲公司 The pyrimidine compound of weeding
CA3030084A1 (en) 2016-07-25 2018-02-01 Basf Se Herbicidal pyrimidine compounds
WO2018019758A1 (en) 2016-07-26 2018-02-01 Basf Se Herbicidal pyridine compounds
WO2018019721A1 (en) 2016-07-26 2018-02-01 Basf Se Herbicidal pyridine compounds
WO2018019755A1 (en) 2016-07-26 2018-02-01 Basf Se Herbicidal pyridine compounds
AU2017302983A1 (en) 2016-07-26 2019-01-03 Basf Se Herbicidal pyrimidine compounds
WO2018019767A1 (en) 2016-07-27 2018-02-01 Basf Se Herbicidal pyridine compounds
EP3490381A1 (en) 2016-07-27 2019-06-05 Basf Se Herbicidal pyrimidine compounds
CA3032014A1 (en) 2016-07-27 2018-02-01 BASF Agro B.V. Plants having increased tolerance to herbicides
EP3275877A1 (en) 2016-07-28 2018-01-31 Basf Se Herbicidal pyridine compounds
WO2018019770A1 (en) 2016-07-28 2018-02-01 Basf Se Herbicidal pyridine compounds
CA3030217A1 (en) 2016-07-28 2018-02-01 Basf Se Herbicidal pyrimidine compounds
WO2018019845A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
WO2018019842A1 (en) 2016-07-29 2018-02-01 Basf Se Method for controlling ppo resistant weeds
US20210352900A1 (en) 2016-08-05 2021-11-18 Basf Se Method for Controlling PPO Resistant Weeds
WO2018024696A1 (en) 2016-08-05 2018-02-08 Basf Se Method for controlling ppo resistant weeds
EP3278667A1 (en) 2016-08-05 2018-02-07 Basf Se Method for controlling ppo-inhibitor resistant weeds
EP3281524A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
CA3032238A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
US20190166841A1 (en) 2016-08-09 2019-06-06 Basf Se Method for Controlling PPO Resistant Weeds
CA3032223A1 (en) 2016-08-09 2018-02-15 Basf Se Method for controlling ppo resistant weeds
EP3281525A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
EP3281523A1 (en) 2016-08-09 2018-02-14 Basf Se Method for controlling ppo resistant weeds
WO2018029242A1 (en) 2016-08-11 2018-02-15 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018041729A2 (en) 2016-09-01 2018-03-08 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
US20190208783A1 (en) 2016-09-01 2019-07-11 Basf Se Fungicidal Mixtures Comprising a Formamidine
CN109788758A (en) 2016-09-13 2019-05-21 巴斯夫欧洲公司 Insecticide mixtures
WO2018055135A1 (en) 2016-09-23 2018-03-29 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018055133A1 (en) 2016-09-23 2018-03-29 Syngenta Participations Ag Microbiocidal tetrazolone derivatives
WO2018054721A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054711A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
WO2018054723A1 (en) 2016-09-26 2018-03-29 Basf Se Pyridine compounds for controlling phytopathogenic harmful fungi
EP3518676A1 (en) 2016-09-27 2019-08-07 Basf Se Pesticidal mixtures
WO2018065182A1 (en) 2016-10-04 2018-04-12 Basf Se Reduced quinoline compounds as antifuni agents
HUE053739T2 (en) 2016-10-06 2021-07-28 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018069110A1 (en) 2016-10-10 2018-04-19 Basf Se Pesticidal mixtures
WO2018069108A1 (en) 2016-10-10 2018-04-19 Basf Se Pesticidal mixtures
EP3522714B1 (en) 2016-10-10 2023-08-30 Basf Se Pesticidal mixtures
BR112019006044A2 (en) 2016-10-10 2019-06-25 Basf Se pesticide mixtures, pesticide compositions, methods for controlling phytopathogenic pests, for improving plant health and for the protection of plant propagating material and plant propagating material
WO2018073110A1 (en) 2016-10-20 2018-04-26 Basf Se Quinoline compounds as fungicides
BR112019008023A2 (en) 2016-10-21 2019-07-09 Vestaron Corp peptide, insecticide and / or nematicide protein, polynucleotide, vector, host cell, DNA construct, plant, or part thereof, and method of controlling a plague infection of a plant.
EP3532471B1 (en) 2016-10-27 2021-09-15 Syngenta Participations AG Pesticidally active heterocyclic derivatives with sulphur and hydroxylamine substituents
PL3541779T3 (en) 2016-11-15 2021-06-14 Syngenta Participations Ag Microbiocidal phenylamidine derivatives
WO2018091389A1 (en) 2016-11-17 2018-05-24 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2018095795A1 (en) 2016-11-23 2018-05-31 Syngenta Participations Ag Pesticidally active polycyclic derivatives with sulfur containing substituents
EP3329777A1 (en) 2016-11-30 2018-06-06 Basf Se Pesticidal mixtures
HUE058180T2 (en) 2016-12-01 2022-07-28 Syngenta Participations Ag Process for preparation of intermediate of pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2018108612A1 (en) 2016-12-14 2018-06-21 Basf Se Herbicidal compositions comprising isoxazolo[5,4-b]pyridines
JP7113014B2 (en) 2016-12-15 2022-08-04 シンジェンタ パーティシペーションズ アーゲー Pesticidal active heterocyclic derivatives with sulfur-containing substituents
BR112019011211A2 (en) 2016-12-16 2019-10-15 Basf Se compounds of formula I, composition, methods for combating or controlling invertebrate pests, for protecting growing plants from invertebrate pest attack or infestation, seed, use of a compound and method for treating or protecting an animal
CA3043986A1 (en) 2016-12-16 2018-06-21 Basf Se Herbicidal phenyltriazolinones
EP3339297A1 (en) 2016-12-20 2018-06-27 Basf Se Substituted oxadiazoles for combating phytopathogenic fungi
WO2018116072A1 (en) 2016-12-20 2018-06-28 Pi Industries Ltd. Heterocyclic compounds
CN110121498A (en) 2016-12-20 2019-08-13 先正达参股股份有限公司 N- cyclobutyl with eelworm-killing activity-thiazole -5- formamide
EA201991300A1 (en) 2016-12-20 2019-12-30 Басф Агро Б.В. PLANTS HIGHER TOLERANCE TO HERBICIDES
EP3338552A1 (en) 2016-12-21 2018-06-27 Basf Se Use of a tetrazolinone fungicide on transgenic plants
EP3571190A1 (en) 2017-01-23 2019-11-27 Basf Se Fungicidal pyridine compounds
EP3576528B1 (en) 2017-02-01 2021-04-07 Basf Se Emulsifiable concentrate
US20190380332A1 (en) 2017-02-02 2019-12-19 Basf Se Enhancement of soil herbicide activity with anionic alkoxylated phenols
WO2018149754A1 (en) 2017-02-16 2018-08-23 Basf Se Pyridine compounds
TWI793104B (en) 2017-02-21 2023-02-21 瑞士商先正達合夥公司 Pesticidally active heterocyclic derivatives with sulfur containing substituents
UY37623A (en) 2017-03-03 2018-09-28 Syngenta Participations Ag DERIVATIVES OF OXADIAZOL THIOPHEN FUNGICIDES
JP2020514340A (en) 2017-03-10 2020-05-21 シンジェンタ パーティシペーションズ アーゲー Microbicide oxadiazole derivative
EP3596058A1 (en) 2017-03-14 2020-01-22 Basf Se Herbicidal azines
WO2018172133A1 (en) 2017-03-20 2018-09-27 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
EP3601231B1 (en) 2017-03-28 2023-05-10 Basf Se Pesticidal compounds
WO2018178057A1 (en) 2017-03-31 2018-10-04 Syngenta Participations Ag Microbiocidal phenylamidine derivatives with improved plant safety properties
US20210101874A1 (en) 2017-04-03 2021-04-08 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
BR112019020735B1 (en) 2017-04-05 2023-12-05 Syngenta Participations Ag COMPOUNDS DERIVED FROM OXADIAZOLE MICROBIOCIDES AND THEIR USE, AGROCHEMICAL COMPOSITION AND METHOD TO CONTROL OR PREVENT INFESTATION OF USEFUL PLANTS BY PHYTOPATHOGENIC MICROORGANISMS
BR112019020739B1 (en) 2017-04-05 2023-12-19 Syngenta Participations Ag COMPOUNDS DERIVED FROM OXADIAZOLE MICROBIOCIDES AND THEIR USE, AGROCHEMICAL COMPOSITION, METHOD TO CONTROL OR PREVENT INFESTATION OF USEFUL PLANTS BY PHYTOPATHOGENIC MICROORGANISMS
US11472797B2 (en) 2017-04-05 2022-10-18 Syngenta Participations Ag Pesticidally active pyrazole derivatives
BR112019020819B1 (en) 2017-04-05 2023-12-05 Syngenta Participations Ag COMPOUND OF FORMULA (I), AGROCHEMICAL COMPOSITION, METHOD FOR CONTROLLING OR PREVENTING INFESTATION OF USEFUL PLANTS BY PHYTOPATHOGENIC MICROORGANISMS AND USE OF A COMPOUND OF FORMULA (I)
WO2018184986A1 (en) 2017-04-05 2018-10-11 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
BR112019021019B1 (en) 2017-04-05 2023-12-05 Syngenta Participations Ag Microbiocidal oxadiazole-derived compounds, agricultural composition, method for controlling or preventing infestation of useful plants by phytopathogenic microorganisms and use of an oxadiazole-derived compound
WO2018184984A1 (en) 2017-04-05 2018-10-11 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2018185191A1 (en) 2017-04-05 2018-10-11 Syngenta Participations Ag Pesticidally active pyrazole derivatives
US11040962B2 (en) 2017-04-05 2021-06-22 Syngenta Participations Ag Pesticidally active pyrazole derivatives
WO2018185211A1 (en) 2017-04-06 2018-10-11 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
CN110475772A (en) 2017-04-06 2019-11-19 巴斯夫欧洲公司 Pyridine compounds
WO2018189001A1 (en) 2017-04-13 2018-10-18 Basf Se Fungicide mixtures for use in rice
US11109591B2 (en) 2017-04-24 2021-09-07 Taminco Bvba Single phase liquids of alkanolamine salts of dicamba
US20200216441A1 (en) 2017-04-25 2020-07-09 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2018202540A1 (en) 2017-05-02 2018-11-08 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
BR112019023368A2 (en) 2017-05-08 2020-06-16 Syngenta Participations Ag IMIDAZOPYRIMIDINE DERIVATIVES CONTAINING PHENYL AND PYRIDILLA SUBSTITUTES CONTAINING SULFUR
WO2018206419A1 (en) 2017-05-12 2018-11-15 Syngenta Participations Ag Microbiocidal heterobicyclic derivatives
WO2018210658A1 (en) 2017-05-15 2018-11-22 Basf Se Heteroaryl compounds as agrochemical fungicides
WO2018210661A1 (en) 2017-05-15 2018-11-22 Basf Se Heteroaryl compounds as agrochemical fungicides
WO2018210660A1 (en) 2017-05-15 2018-11-22 Basf Se Heteroaryl compounds as agrochemical fungicides
WO2018210659A1 (en) 2017-05-15 2018-11-22 Basf Se Heteroaryl compounds as agrochemical fungicides
WO2018215304A1 (en) 2017-05-22 2018-11-29 Syngenta Participations Ag Tetracyclic pyridazine sulphur containing compounds and their use as pesticides
WO2018219935A1 (en) 2017-05-30 2018-12-06 Basf Se Benzamide compounds and their use as herbicides
JP7179777B2 (en) 2017-05-30 2022-11-29 ビーエーエスエフ ソシエタス・ヨーロピア pyridine compounds and pyrazine compounds
WO2018219936A1 (en) 2017-05-30 2018-12-06 Basf Se Benzamide compounds and their use as herbicides ii
CN110709395A (en) 2017-06-02 2020-01-17 先正达参股股份有限公司 Microbicidal oxadiazole derivatives
EP3412150A1 (en) 2017-06-06 2018-12-12 Basf Se Mixtures of meptyldinocap with sdhi fungicides
CA3064513A1 (en) 2017-06-14 2018-12-20 Basf Se Herbicidal pyrimidine compounds
JP7202371B2 (en) 2017-06-19 2023-01-11 シンジェンタ パーティシペーションズ アーゲー Pesticidal active pyrazole derivatives
AR112112A1 (en) 2017-06-20 2019-09-18 Basf Se BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES
MX2019015881A (en) 2017-06-23 2020-02-07 Basf Se Pesticidal mixtures comprising a pyrazole compound.
EP3648604A1 (en) 2017-07-05 2020-05-13 BASF Agro B.V. Fungicidal mixtures of mefentrifluconazole
WO2019008072A1 (en) 2017-07-05 2019-01-10 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2019007717A1 (en) 2017-07-06 2019-01-10 Basf Se Pesticidal mixtures
WO2019007719A1 (en) 2017-07-07 2019-01-10 Basf Se Pesticidal mixtures
US20200131177A1 (en) 2017-07-07 2020-04-30 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
EP3427587A1 (en) 2017-07-10 2019-01-16 Basf Se Pesticidal mixtures
CN110891923A (en) 2017-07-10 2020-03-17 巴斯夫欧洲公司 Mixtures comprising Urease Inhibitors (UI) and nitrification inhibitors, such as 2- (3, 4-dimethyl-1H-pyrazol-1-yl) succinic acid (DMPSA) or 3, 4-dimethylpyrazolium glycolate (DMPG)
WO2019011926A1 (en) 2017-07-11 2019-01-17 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2019011923A1 (en) 2017-07-11 2019-01-17 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
WO2019011929A1 (en) 2017-07-11 2019-01-17 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
BR112020000470A2 (en) 2017-07-11 2020-07-21 Syngenta Participations Ag microbiocidal oxadiazole derivatives
BR112020000414A2 (en) 2017-07-12 2020-07-21 Syngenta Participations Ag microbicidal oxadiazole derivatives
BR112020000371A2 (en) 2017-07-12 2020-07-14 Syngenta Participations Ag microbiocidal oxadiazole derivatives
BR112020000463A2 (en) 2017-07-13 2020-07-21 Syngenta Participations Ag microbiocidal oxadiazole derivatives
WO2019016385A1 (en) 2017-07-21 2019-01-24 Basf Se Benzamide compounds and their use as herbicides
WO2019020540A1 (en) 2017-07-26 2019-01-31 Basf Se Pesticidal mixtures
WO2019030355A1 (en) 2017-08-11 2019-02-14 Syngenta Participations Ag Pesticidally active pyrazole derivatives
AR112672A1 (en) 2017-08-11 2019-11-27 Syngenta Participations Ag THIOPHENE DERIVATIVES ACTIVE AS PESTICIDES
US11252963B2 (en) 2017-08-11 2022-02-22 Syngenta Participations Ag Pesticidally active pyrazole derivatives
AR112673A1 (en) 2017-08-11 2019-11-27 Syngenta Participations Ag PYRAZOLE DERIVATIVES ACTIVE AS PESTICIDES
EP3447048A1 (en) 2017-08-23 2019-02-27 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
EP3675638A1 (en) 2017-08-29 2020-07-08 Basf Se Pesticidal mixtures
JP7150009B2 (en) 2017-09-13 2022-10-07 シンジェンタ パーティシペーションズ アーゲー Microbicidal quinoline(thio)carboxamide derivatives
ES2906980T3 (en) 2017-09-13 2022-04-21 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
CN111164076A (en) 2017-09-13 2020-05-15 先正达参股股份有限公司 Microbicidal quinoline (thio) carboxamide derivatives
JP7202367B2 (en) 2017-09-13 2023-01-11 シンジェンタ パーティシペーションズ アーゲー Microbicidal quinoline(thio)carboxamide derivatives
EP3681868B1 (en) 2017-09-13 2021-08-04 Syngenta Participations AG Microbiocidal quinoline (thio)carboxamide derivatives
CN111094248A (en) 2017-09-13 2020-05-01 先正达参股股份有限公司 Microbicidal quinoline (thio) carboxamide derivatives
ES2894762T3 (en) 2017-09-13 2022-02-15 Syngenta Participations Ag Microbiocidal quinoline (thio)carboxamide derivatives
KR102635481B1 (en) 2017-09-18 2024-02-07 신젠타 파티서페이션즈 아게 Insecticidally active heterocyclic derivatives with sulfur-containing substituents
WO2019057660A1 (en) 2017-09-25 2019-03-28 Basf Se Indole and azaindole compounds with substituted 6-membered aryl and heteroaryl rings as agrochemical fungicides
UY37912A (en) 2017-10-05 2019-05-31 Syngenta Participations Ag PICOLINAMIDE DERIVATIVES FUNGICIDES THAT CONTAIN HETEROARILO OR HETEROARILOXI TERMINAL GROUPS
UY37913A (en) 2017-10-05 2019-05-31 Syngenta Participations Ag PICOLINAMIDE DERIVATIVES FUNGICIDES THAT CARRY A QUATERNARY TERMINAL GROUP
US11459318B2 (en) 2017-10-06 2022-10-04 Syngenta Participations Ag Pesticidally active pyrrole derivatives
EP3692038A1 (en) 2017-10-06 2020-08-12 Syngenta Participations AG Pesticidally active pyrrole derivatives
WO2019076778A1 (en) 2017-10-16 2019-04-25 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur and sulfonimidamides containing substituents
WO2019086474A1 (en) 2017-10-31 2019-05-09 Syngenta Participations Ag Pesticidally active mesoionics heterocyclic compounds
RU2020119470A (en) 2017-11-15 2021-12-15 Басф Се TANK MIXTURE
EP3710429B1 (en) 2017-11-15 2023-04-05 Syngenta Participations AG Microbiocidal picolinamide derivatives
WO2019097054A1 (en) 2017-11-20 2019-05-23 Syngenta Participations Ag Microbiocidal oxadiazole derivatives
CA3082419A1 (en) 2017-11-21 2019-05-31 Syngenta Participations Ag Fungicidal compositions
US20200305429A1 (en) 2017-11-23 2020-10-01 Basf Se Herbicidal phenylethers
CA3080276A1 (en) 2017-11-23 2019-05-31 Basf Se Herbicidal pyridylethers
CN111801012A (en) 2017-11-29 2020-10-20 巴斯夫欧洲公司 Plants with increased herbicide tolerance
JP7241751B2 (en) 2017-11-29 2023-03-17 シンジェンタ パーティシペーションズ アーゲー Microbial thiazole derivative
EP3717460A1 (en) 2017-11-29 2020-10-07 Basf Se Benzamide compounds and their use as herbicides
WO2019106638A1 (en) 2017-12-03 2019-06-06 Seedx Technologies Inc. Systems and methods for sorting of seeds
WO2019106639A1 (en) 2017-12-03 2019-06-06 Seedx Technologies Inc. Systems and methods for sorting of seeds
EP3720846A1 (en) 2017-12-04 2020-10-14 Syngenta Participations AG Microbiocidal phenylamidine derivatives
CN111511721A (en) 2017-12-13 2020-08-07 先正达参股股份有限公司 Pesticidally active mesoionic heterocyclic compounds
CN111566087A (en) 2017-12-19 2020-08-21 先正达参股股份有限公司 Microbicidal pyridine carboxamide derivatives
WO2019121373A1 (en) 2017-12-20 2019-06-27 Basf Se Herbicidal pyrimidine compounds
WO2019121352A1 (en) 2017-12-20 2019-06-27 Basf Se Herbicidal pyrimidine compounds
WO2019121408A1 (en) 2017-12-20 2019-06-27 Basf Se Herbicidal pyrimidine compounds
WO2019121374A1 (en) 2017-12-20 2019-06-27 Basf Se Herbicidal pyrimidine compounds
JP2021507911A (en) 2017-12-20 2021-02-25 ピーアイ インダストリーズ リミテッドPi Industries Ltd Fluoralkenyl compounds, their production methods and their use
CA3086083A1 (en) 2017-12-21 2019-06-27 Basf Se Pesticidal compounds
WO2019122347A1 (en) 2017-12-22 2019-06-27 Basf Se N-(1,2,5-oxadiazol-3-yl)-benzamide compounds and their use as herbicides
AR114040A1 (en) 2017-12-22 2020-07-15 Basf Se BENZAMIDE COMPOUNDS AND THEIR USE AS HERBICIDES
EP3508480A1 (en) 2018-01-08 2019-07-10 Basf Se Benzamide compounds and their use as herbicides
IL275726B2 (en) 2018-01-09 2024-06-01 Basf Se Silylethynyl hetaryl compounds as nitrification inhibitors
US20210047291A1 (en) 2018-01-15 2021-02-18 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
MX2020007682A (en) 2018-01-17 2020-09-14 Basf Se Plants having increased tolerance to herbicides.
WO2019141552A1 (en) 2018-01-18 2019-07-25 Basf Se Herbicidal triazine compounds
BR112020014474A2 (en) 2018-01-30 2020-12-01 Pi Industries Ltd. new oxadiazoles
WO2019150311A1 (en) 2018-02-02 2019-08-08 Pi Industries Ltd. 1-3 dithiol compounds and their use for the protection of crops from phytopathogenic microorganisms
WO2019162308A1 (en) 2018-02-21 2019-08-29 Basf Se Benzamide compounds and their use as herbicides
WO2019162309A1 (en) 2018-02-21 2019-08-29 Basf Se Benzamide compounds and their use as herbicides
EP3530118A1 (en) 2018-02-26 2019-08-28 Basf Se Fungicidal mixtures
EP3530116A1 (en) 2018-02-27 2019-08-28 Basf Se Fungicidal mixtures comprising xemium
WO2019166252A1 (en) 2018-02-28 2019-09-06 Basf Se Fungicidal mixtures comprising fenpropidin
WO2019166561A1 (en) 2018-02-28 2019-09-06 Basf Se Use of alkoxypyrazoles as nitrification inhibitors
MX2020009023A (en) 2018-02-28 2020-10-12 Basf Se Use of n-functionalized alkoxy pyrazole compounds as nitrification inhibitors.
US11498885B2 (en) 2018-02-28 2022-11-15 Basf Se Use of pyrazole propargyl ethers as nitrification inhibitors
EP3533333A1 (en) 2018-03-02 2019-09-04 Basf Se Fungicidal mixtures comprising pydiflumetofen
EP3533331A1 (en) 2018-03-02 2019-09-04 Basf Se Fungicidal mixtures comprising pydiflumetofen
EP3536150A1 (en) 2018-03-06 2019-09-11 Basf Se Fungicidal mixtures comprising fluxapyroxad
BR112020018403A2 (en) 2018-03-09 2020-12-22 Pi Industries Ltd. HETEROCYCLIC COMPOUNDS WITH FUNGICIDES
EP3539384A1 (en) 2018-03-15 2019-09-18 Basf Se 3-components mixtures comprising fluxapyroxad
CN112020503A (en) 2018-04-26 2020-12-01 先正达参股股份有限公司 Microbicidal oxadiazole derivatives
BR112020022659A2 (en) 2018-05-08 2021-02-02 Syngenta Crop Protection Ag methods of applying one or more certain heteroaryl-1,2,4-triazole and heteroaryl-tetrazole compounds to control damage to plants, their propagation material and plant-derived products
WO2019219689A1 (en) 2018-05-18 2019-11-21 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfoximine containing substituents
US11629129B2 (en) 2018-05-25 2023-04-18 Syngenta Participations Ag Microbiocidal picolinamide derivatives
WO2019229088A1 (en) 2018-05-30 2019-12-05 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2019229089A1 (en) 2018-05-31 2019-12-05 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
AR115495A1 (en) 2018-06-06 2021-01-27 Syngenta Crop Protection Ag HETEROCYCLIC DERIVATIVES WITH SUBSTITUENTS CONTAINING ACTIVE SULFUR AS PESTICIDES
CA3102190A1 (en) 2018-06-06 2019-12-12 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfoximine containing substituents
WO2020002472A1 (en) 2018-06-28 2020-01-02 Basf Se Use of alkynylthiophenes as nitrification inhibitors
US20210267203A1 (en) 2018-06-29 2021-09-02 Syngenta Participations Ag Pesticidally active azole-amide compounds
CN112351981A (en) 2018-06-29 2021-02-09 先正达农作物保护股份公司 Microbicidal oxadiazole derivatives
WO2020007646A1 (en) 2018-07-02 2020-01-09 Basf Se Pesticidal mixtures
WO2020007658A1 (en) 2018-07-02 2020-01-09 Syngenta Crop Protection Ag 3-(2-thienyl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as agrochemical fungicides
BR112020024823A2 (en) 2018-07-02 2021-03-02 Basf Se fungicidal mixtures, pesticidal composition, use of the mixture and method of phytopathogenic pest control
WO2020011808A1 (en) 2018-07-13 2020-01-16 Syngenta Crop Protection Ag Pesticidally-active bicyclic heteroaromatic compounds
CN112689631A (en) 2018-07-16 2021-04-20 先正达农作物保护股份公司 Microbicidal oxadiazole derivatives
CA3104256A1 (en) 2018-07-23 2020-01-30 Basf Se Use of substituted 2-thiazolines as nitrification inhibitors
HUE064943T2 (en) 2018-07-23 2024-04-28 Basf Se Use of a substituted thiazolidine compound as nitrification inhibitor
GB201812692D0 (en) 2018-08-03 2018-09-19 Syngenta Participations Ag Microbiocidal compounds
WO2020025658A1 (en) 2018-08-03 2020-02-06 Syngenta Crop Protection Ag Pesticidally-active bicyclic heteroaromatic compounds
BR112021002280A2 (en) 2018-08-07 2021-05-04 Syngenta Crop Protection Ag pesticide-active bicyclic heteroaromatic compounds
BR112021001650A2 (en) 2018-08-08 2021-05-04 Basf Se use of compounds and method of controlling phytopathogenic pests
WO2020030754A1 (en) 2018-08-10 2020-02-13 Syngenta Crop Protection Ag Pesticidally-active mesoionic bicyclic heteroaromatic compounds
WO2020035565A1 (en) 2018-08-17 2020-02-20 Syngenta Crop Protection Ag Pesticidally-active mesoionic bicyclic heteroaromatic compounds
TW202009235A (en) 2018-08-17 2020-03-01 印度商皮埃企業有限公司 1,2-dithiolone compounds and use thereof
WO2020043470A1 (en) 2018-08-27 2020-03-05 Basf Se Aqueous compositions of topramezone
US11878999B2 (en) 2018-08-29 2024-01-23 Pioneer Hi-Bred International, Inc. Insecticidal proteins and methods for their use
UY38367A (en) 2018-09-13 2020-04-30 Syngenta Participations Ag PESTICIDALLY ACTIVE AZOL-AMIDE COMPOUNDS
UY38366A (en) 2018-09-13 2020-04-30 Syngenta Participations Ag PESTICIDALLY ACTIVE AZOL-AMIDE COMPOUNDS
US20210368794A1 (en) 2018-09-19 2021-12-02 Basf Se Pesticidal mixtures comprising a mesoionic compound
WO2020058207A1 (en) 2018-09-19 2020-03-26 Syngenta Crop Protection Ag Microbiocidal quinoline carboxamide derivatives
WO2020064492A1 (en) 2018-09-28 2020-04-02 Basf Se Method of controlling pests by seed treatment application of a mesoionic compound or mixture thereof
MX2021003430A (en) 2018-10-01 2021-06-15 Pi Industries Ltd Oxadiazoles as fungicides.
AR116558A1 (en) 2018-10-01 2021-05-19 Pi Industries Ltd OXADIAZOLES
US20210395228A1 (en) 2018-10-02 2021-12-23 Syngenta Participations Ag Pesticidally active benzene- and azine-amide compounds
WO2020069876A1 (en) 2018-10-03 2020-04-09 Basf Se Microemulsion compositions of topramezone
JP2022504304A (en) 2018-10-06 2022-01-13 シンジェンタ パーティシペーションズ アーゲー Microbial quinoline dihydro- (thiazine) oxazine derivative
WO2020070132A1 (en) 2018-10-06 2020-04-09 Syngenta Participations Ag Microbiocidal quinoline dihydro-(thiazine)oxazine derivatives
WO2020078732A1 (en) 2018-10-17 2020-04-23 Syngenta Crop Protection Ag Microbiocidal oxadiazole derivatives
AR116628A1 (en) 2018-10-18 2021-05-26 Syngenta Crop Protection Ag MICROBIOCIDAL COMPOUNDS
US20210395217A1 (en) 2018-10-19 2021-12-23 Syngenta Participations Ag Pesticidally active azole-amide compounds
BR112021006045A2 (en) 2018-10-19 2021-06-29 Basf Se fungicidal mixtures, pesticide composition, use of the mixture and method for combating phytopathogenic parasites
BR112021006011A2 (en) 2018-10-19 2021-06-29 Basf Se fungicidal mixtures, pesticidal composition, use of the mixture and method for controlling phytopathogenic pests
WO2020078797A1 (en) 2018-10-19 2020-04-23 Basf Se Ternary mixtures containing fenpropimorph, succinate dehydrogenase inhibitors and one other compound
TW202035404A (en) 2018-10-24 2020-10-01 瑞士商先正達農作物保護公司 Pesticidally active heterocyclic derivatives with sulfoximine containing substituents
EP3643175A1 (en) 2018-10-24 2020-04-29 Basf Se Ternary pesticidal mixtures containing metyltetraprole and fenpropimorph
EP3643705A1 (en) 2018-10-24 2020-04-29 Basf Se Pesticidal compounds
WO2020095161A1 (en) 2018-11-05 2020-05-14 Pi Industries Ltd. Nitrone compounds and use thereof
EP3877380A1 (en) 2018-11-05 2021-09-15 Syngenta Participations Ag Pesticidally active azole-amide compounds
WO2020109039A1 (en) 2018-11-28 2020-06-04 Basf Se Pesticidal compounds
AR117200A1 (en) 2018-11-30 2021-07-21 Syngenta Participations Ag THIAZOL DERIVATIVES MICROBIOCIDES
AR117183A1 (en) 2018-11-30 2021-07-14 Syngenta Crop Protection Ag THIAZOL DERIVATIVES MICROBIOCIDES
AR117291A1 (en) 2018-12-14 2021-07-28 Syngenta Crop Protection Ag HETEROCYCLIC CYANAMIDE COMPOUNDS WITH PESTICIDE ACTIVITY
WO2020120694A1 (en) 2018-12-14 2020-06-18 Syngenta Participations Ag Pesticidally-active bicyclic heteroaromatic compounds
EA202191654A1 (en) 2018-12-18 2021-11-01 Басф Агрокемикэл Продактс Б.В. HERBICIDE COMBINATIONS
EA202191586A1 (en) 2018-12-18 2021-10-19 Басф Агрокемикэл Продактс Б.В. HERBICIDE COMPOSITION
EP3897140A1 (en) 2018-12-18 2021-10-27 BASF Agrochemical Products B.V. Herbicidal combinations
EP3897137A1 (en) 2018-12-18 2021-10-27 BASF Agrochemical Products B.V. Herbicidal combinations
EP3897141A1 (en) 2018-12-18 2021-10-27 BASF Agrochemical Products B.V. Herbicidal combinations
EP3897138A1 (en) 2018-12-18 2021-10-27 BASF Agrochemical Products B.V. Herbicidal combinations
WO2020127345A1 (en) 2018-12-21 2020-06-25 Syngenta Participations Ag Pesticidally active pyrazole derivatives
GB201821036D0 (en) 2018-12-21 2019-02-06 Syngenta Participations Ag Nematicidal compositions
JP2022515896A (en) 2018-12-31 2022-02-22 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト Pesticide-active heterocyclic derivative with sulfur-containing substituent
WO2020141135A1 (en) 2018-12-31 2020-07-09 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
EP3680223A1 (en) 2019-01-10 2020-07-15 Basf Se Mixture comprising an urease inhibitor (ui) and a nitrification inhibitor (ni) such as an ni mixture comprising 2-(3,4-dimethyl-1h-pyrazol-1-yl)succinic acid (dmpsa) and dicyandiamide (dcd)
WO2020164994A1 (en) 2019-02-13 2020-08-20 Syngenta Crop Protection Ag Pesticidally active pyrazole derivatives
WO2020164993A1 (en) 2019-02-13 2020-08-20 Syngenta Crop Protection Ag Pesticidally active pyrazole derivatives
WO2020165403A1 (en) 2019-02-15 2020-08-20 Syngenta Crop Protection Ag Phenyl substituted thiazole derivatives as microbiocidal compounds
EP3696175A1 (en) 2019-02-18 2020-08-19 Syngenta Crop Protection AG Pesticidally active azole-amide compounds
WO2020169526A1 (en) 2019-02-18 2020-08-27 Syngenta Crop Protection Ag Pesticidally-active cyanamide heterocyclic compounds
EP3698632A1 (en) 2019-02-21 2020-08-26 Basf Se Pesticidal mixtures
EP3698633A1 (en) 2019-02-25 2020-08-26 Basf Se Pesticidal mixtures
EP3698634A1 (en) 2019-02-25 2020-08-26 Basf Se Pesticidal mixtures
TW202100015A (en) 2019-02-28 2021-01-01 瑞士商先正達農作物保護公司 Pesticidally active heterocyclic derivatives with sulfur containing substituents
TW202045011A (en) 2019-02-28 2020-12-16 瑞士商先正達農作物保護公司 Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2020182577A1 (en) 2019-03-08 2020-09-17 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
BR112021017646A2 (en) 2019-03-08 2021-11-16 Syngenta Crop Protection Ag Pesticide-active azole amide compounds
JP2022525966A (en) 2019-03-20 2022-05-20 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト Pesticide active azoleamide compound
WO2020188027A1 (en) 2019-03-20 2020-09-24 Syngenta Crop Protection Ag Pesticidally active azole amide compounds
GB201903942D0 (en) 2019-03-22 2019-05-08 Syngenta Crop Protection Ag Microbiocidal compounds
WO2020193341A1 (en) 2019-03-22 2020-10-01 Syngenta Crop Protection Ag N-[1-(5-bromo-2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-2-cyclopropyl-6-(trifluoromethyl)pyridine-4-carboxamide derivatives and related compounds as insecticides
WO2020193618A1 (en) 2019-03-27 2020-10-01 Syngenta Crop Protection Ag Microbiocidal thiazole derivatives
UY38623A (en) 2019-03-29 2020-10-30 Syngenta Crop Protection Ag DIAZINE-AMIDE COMPOUNDS ACTIVE AS PESTICIDES
CN109912721B (en) * 2019-04-03 2021-03-05 中国农业大学 Method for creating insect-resistant fusion gene and application thereof
MX2021012162A (en) 2019-04-05 2021-11-03 Syngenta Crop Protection Ag Pesticidally active diazine-amide compounds.
BR112021020232A2 (en) 2019-04-08 2021-12-07 Pi Industries Ltd Innovative Oxadiazole Compounds to Control or Prevent Phytopathogenic Fungi
WO2020208510A1 (en) 2019-04-08 2020-10-15 Pi Industries Limited Novel oxadiazole compounds for controlling or preventing phytopathogenic fungi
MX2021012325A (en) 2019-04-08 2022-05-18 Pi Industries Ltd Novel oxadiazole compounds for controlling or preventing phytopathogenic fungi.
WO2020208095A1 (en) 2019-04-10 2020-10-15 Syngenta Crop Protection Ag Microbiocidal picolinamide derivatives
PE20220172A1 (en) 2019-04-11 2022-01-28 Syngenta Crop Protection Ag DIAZINE-AMIDE COMPOUNDS ACTIVE AS PESTICIDES
JP7458417B2 (en) * 2019-04-24 2024-03-29 ディーシーエム シュリラム リミテッド Codon-optimized synthetic nucleotide sequence encoding CRY2Ai protein and its use
EP3730489A1 (en) 2019-04-25 2020-10-28 Basf Se Heteroaryl compounds as agrochemical fungicides
EP3744174A1 (en) 2019-05-27 2020-12-02 Basf Se Use of metyltetraprol and mixtures of metyltetraprol for combating phytopathogenic fungi on cotton
EP3976601B1 (en) 2019-05-29 2024-02-28 Syngenta Crop Protection AG Microbiocidal derivatives
WO2020239855A1 (en) 2019-05-29 2020-12-03 Syngenta Crop Protection Ag Microbiocidal derivatives
AR119009A1 (en) 2019-05-29 2021-11-17 Syngenta Crop Protection Ag MICROBICIDE ALCOPYPYRIDINE AND ALCOXYPYRIMIDINE DERIVATIVES
AR119011A1 (en) 2019-05-29 2021-11-17 Syngenta Crop Protection Ag DERIVATIVES OF [1,3]DIOXOLO[4,5-c]PYRIDINE-4-CARBOXAMIDE, AGROCHEMICAL COMPOSITIONS THAT COMPRISE THEM AND THEIR USE AS FUNGICIDE TO CONTROL OR PREVENT THE INFESTATION OF USEFUL PLANTS
WO2020254530A1 (en) 2019-06-18 2020-12-24 Syngenta Crop Protection Ag 7-sulfonyl-n-(1,3,4-thiadiazol-2-yl)-quinoxaline-6-carboxamide derivatives and the respective -benzimidazole-5-, -imidazo[4,5-b]pyridine-5-, -3h-furo[3,2b]pyridine-5-, -quinoline-2-, and -naphthalene-2-carboxamide derivatives as pesticides
BR112021026861A2 (en) 2019-07-05 2022-02-22 Syngenta Crop Protection Ag Microbiocidal picolinamide derivatives
GB201910037D0 (en) 2019-07-12 2019-08-28 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021009311A1 (en) 2019-07-17 2021-01-21 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
EP3766879A1 (en) 2019-07-19 2021-01-20 Basf Se Pesticidal pyrazole derivatives
AU2020319744B2 (en) * 2019-07-30 2023-12-21 Dcm Shriram Limited Synthetic nucleotide sequences encoding insecticidal crystal protein and uses thereof
AR119774A1 (en) 2019-08-19 2022-01-12 Pi Industries Ltd OXADIAZOLE COMPOUNDS CONTAINING A 5-MEMBER HETEROAROMATIC RING TO CONTROL OR PREVENT PHYTOPATHOGENIC FUNGI
WO2021037614A1 (en) 2019-08-23 2021-03-04 Syngenta Crop Protection Ag Pesticidally active pyrazine-amide compounds
WO2021043642A1 (en) 2019-09-03 2021-03-11 Basf Se Polymers for spray drift control of pesticide spray
JP2022549417A (en) 2019-09-20 2022-11-25 シンジェンタ クロップ プロテクション アクチェンゲゼルシャフト Pesticidal active heterocyclic derivatives with sulfur- and sulfoximine-containing substituents
UY38885A (en) 2019-09-20 2021-04-30 Syngenta Crop Protection Ag PESTICIDALLY ACTIVE COMPOUNDS OF AZETIDINIL-, PYRROLIDINIL-, PIPERDINIL- OR PIPERAZINYL-PYRIDINYL CARBONYL
AU2020372700A1 (en) 2019-11-01 2022-05-12 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
AR120374A1 (en) 2019-11-08 2022-02-09 Pi Industries Ltd OXADIAZOLE COMPOUNDS CONTAINING FUSED HETEROCYCYL RINGS TO CONTROL OR PREVENT PHYTOPATHOGENIC FUNGI
CA3152433A1 (en) 2019-11-15 2021-05-20 Claude Taranta Methods of using a composition comprising an anionic pesticide and a buffer
CN115003666A (en) 2019-12-04 2022-09-02 先正达农作物保护股份公司 Pesticidally active fused bicyclic heteroaromatic amino compounds
US20230041050A1 (en) 2019-12-20 2023-02-09 Basf Corporation Low volatile polyamine salts of anionic pesticides
WO2021122645A1 (en) 2019-12-20 2021-06-24 Syngenta Crop Protection Ag Pesticidally active azole-amide compounds
JP2023507527A (en) 2019-12-23 2023-02-22 ビーエーエスエフ ソシエタス・ヨーロピア Enzyme-enhanced root uptake of pesticide compounds
CN115023425A (en) 2019-12-31 2022-09-06 先正达农作物保护股份公司 Pesticidally active heterocyclic derivatives with sulfur-containing substituents
TW202132300A (en) 2020-01-06 2021-09-01 瑞士商先正達農作物保護公司 Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2021144354A1 (en) 2020-01-15 2021-07-22 Syngenta Crop Protection Ag Pesticidally-active bicyclic heteroaromatic compounds
CN111100208A (en) * 2020-01-16 2020-05-05 黑龙江大鹏农业有限公司 Artificially synthesized insect-resistant protein mCry1Ia2, and preparation method and application thereof
WO2021144195A1 (en) 2020-01-16 2021-07-22 Basf Se Mixtures comprising nitrification inhibitors and carriers
BR112022013894A2 (en) 2020-01-16 2023-01-10 Basf Se MIXTURE, AGROCHEMICAL COMPOSITION, METHOD TO INCREASE THE EFFICIENCY OF FERTILIZER USE AND USE OF THE MIXTURE
US20230131903A1 (en) 2020-01-24 2023-04-27 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
EP4097098A1 (en) 2020-01-30 2022-12-07 Syngenta Crop Protection AG Pesticidally active fused bicyclic heteroaromatic amino compounds
US20230146180A1 (en) 2020-02-11 2023-05-11 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
AU2021221027A1 (en) 2020-02-11 2022-08-25 Syngenta Crop Protection Ag Method of controlling fungi
EP4110766A1 (en) 2020-02-27 2023-01-04 Syngenta Crop Protection AG Pesticidally active diazine-bisamide compounds
WO2021175822A1 (en) 2020-03-02 2021-09-10 Syngenta Crop Protection Ag Pesticidally amidine-substituted benzoic acid amide compounds
CN115297727A (en) 2020-03-13 2022-11-04 先正达农作物保护股份公司 Method for controlling or preventing plant infection by phytopathogen microorganism corynebacterium polyspora
CN115243547A (en) 2020-03-13 2022-10-25 先正达农作物保护股份公司 Method for controlling or preventing plant infection by phytopathogen microorganism corynebacterium polyspora
CN115315186A (en) 2020-03-13 2022-11-08 先正达农作物保护股份公司 Method for controlling or preventing plant infection by phytopathogen microorganism corynebacterium polyspora
CN115190761A (en) 2020-03-13 2022-10-14 先正达农作物保护股份公司 Method for controlling or preventing plant infection by phytopathogen microorganism corynebacterium polyspora
US20230126361A1 (en) 2020-03-13 2023-04-27 Syngenta Crop Protection Ag Methods of controlling or preventing infestation of plants by the phytopathogenic microorganism corynespora cassiicola, cercospora sojina and/or cercospora kikuchii
CN115279186A (en) 2020-03-13 2022-11-01 先正达农作物保护股份公司 Method for controlling or preventing plant infection by phytopathogen microorganism corynespora polymorpha
WO2021197885A1 (en) 2020-04-01 2021-10-07 Basf Se Ternary mixtures containing fenpropimorph, azoles and strobilurins
WO2021197884A1 (en) 2020-04-01 2021-10-07 Basf Se Ternary mixtures containing fenpropimorph, succinate dehydrogenase inhibitors and strobilurins
US20230148590A1 (en) 2020-04-02 2023-05-18 Basf Corporation Aqueous Formulations of Dicamba
WO2021206683A1 (en) 2020-04-06 2021-10-14 Basf Corporation High-load solution concentrates of dicamba
AR121733A1 (en) 2020-04-08 2022-07-06 Syngenta Crop Protection Ag MICROBIOCIDE DERIVATIVES OF THE DIHYDRO-(THIAZINE)OXAZINE TYPE OF QUINOLINE
BR112022020239A2 (en) 2020-04-08 2022-11-22 Syngenta Crop Protection Ag QUINOLINE DERIVATIVES DIHYDRO-(THIAZINE)OXAZINE MICROBIOCIDES
AR121734A1 (en) 2020-04-08 2022-07-06 Syngenta Crop Protection Ag DIHYDROPYRROLOPYRAZINE TYPE MICROBICIDE DERIVATIVES OF QUINOLINE
WO2021213929A1 (en) 2020-04-20 2021-10-28 Syngenta Crop Protection Ag Pesticidally active substituted 1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one derivatives with sulfur containing substituents
BR112022021631A2 (en) 2020-04-28 2022-12-06 Basf Se COMPOUNDS, COMPOSITION, METHODS TO COMBAT OR CONTROL INVERTEBRATE PEST, TO PROTECT GROWING PLANTS AND TO TREAT OR PROTECT AN ANIMAL, SEED AND USE OF A COMPOUND
GB202006386D0 (en) 2020-04-30 2020-06-17 Syngenta Crop Protection Ag Microbiocidal Compounds
GB202006399D0 (en) 2020-04-30 2020-06-17 Syngenta Crop Protection Ag Microbiocidal compounds
EP4143177A1 (en) 2020-04-30 2023-03-08 Syngenta Crop Protection AG Pesticidally active heterocyclic derivatives with sulfur containing substituents
GB202006480D0 (en) 2020-05-01 2020-06-17 Syngenta Crop Protection Ag Microbiocidal compounds
GB202006606D0 (en) 2020-05-05 2020-06-17 Syngenta Crop Protection Ag Microbiocidal compounds
WO2021224409A1 (en) 2020-05-06 2021-11-11 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
MX2022015065A (en) 2020-06-03 2023-01-11 Syngenta Crop Protection Ag Fungicidal compositions.
CR20220615A (en) 2020-06-03 2023-01-17 Syngenta Crop Protection Ag Fungicidal compositions
EP4161924A1 (en) 2020-06-03 2023-04-12 Syngenta Crop Protection AG Microbiocidal derivatives
AR122199A1 (en) 2020-06-04 2022-08-24 Syngenta Crop Protection Ag FUNGICIDE COMPOSITIONS
AR122189A1 (en) 2020-06-04 2022-08-24 Syngenta Crop Protection Ag FUNGICIDE COMPOSITIONS
CA3179042A1 (en) 2020-06-04 2021-12-09 Olivier Loiseleur Fungicidal compositions
AR122484A1 (en) 2020-06-04 2022-09-14 Syngenta Crop Protection Ag FUNGICIDE COMPOSITIONS
AR122187A1 (en) 2020-06-04 2022-08-24 Syngenta Crop Protection Ag FUNGICIDE COMPOSITIONS
AR122485A1 (en) 2020-06-04 2022-09-14 Syngenta Crop Protection Ag FUNGICIDE COMPOSITIONS
WO2021254875A1 (en) 2020-06-15 2021-12-23 Basf Se A stable, solvent-free, self-emulsifiable concentrate
MX2023000177A (en) 2020-07-06 2023-03-09 Pi Industries Ltd A pesticidally active mixture comprising thietanyloxy compound, oxides or salts thereof.
WO2022013417A1 (en) 2020-07-17 2022-01-20 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2022017975A1 (en) 2020-07-18 2022-01-27 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
TW202220557A (en) 2020-07-27 2022-06-01 印度商皮埃企業有限公司 A pesticidally active mixture comprising pyrazolopyridine anthranilamide compound, oxides or salts thereof
AR123264A1 (en) 2020-08-18 2022-11-16 Pi Industries Ltd NEW HETEROCYCLIC COMPOUNDS TO COMBAT PHYTOPATHOGENIC FUNGI
CN116018344A (en) 2020-08-31 2023-04-25 先正达农作物保护股份公司 Pesticidally active heterocyclic derivatives with sulfur containing substituents
CN116056577A (en) 2020-09-01 2023-05-02 先正达农作物保护股份公司 Pesticidally active heterocyclic derivatives with sulfur containing substituents
US20230303565A1 (en) 2020-09-02 2023-09-28 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
CN116234811A (en) 2020-09-02 2023-06-06 先正达农作物保护股份公司 Pesticidally active heterocyclic derivatives with sulfur containing substituents
UY39411A (en) 2020-09-09 2022-04-29 Syngenta Crop Protection Ag PESTICIDICALLY ACTIVE INDAZOLIL PYRAZOLE[3,4-C] PYRIDINE DERIVATIVES WITH SULFUR-CONTAINING SUBSTITUENTS
AR123501A1 (en) 2020-09-15 2022-12-07 Pi Industries Ltd NEW PICOLINAMIDE COMPOUNDS TO COMBAT PHYTOPATHOGENIC FUNGI
UY39424A (en) 2020-09-15 2022-03-31 Pi Industries Ltd NEW PICOLINAMIDE COMPOUNDS TO COMBAT PHYTOPATHOGENIC FUNGI
GB202014840D0 (en) 2020-09-21 2020-11-04 Syngenta Crop Protection Ag Microbiocidal compounds
AR123594A1 (en) 2020-09-26 2022-12-21 Pi Industries Ltd NEMATICIDAL COMPOUNDS AND THEIR USE
EP4225034A1 (en) 2020-10-08 2023-08-16 Basf Se Mixtures containing cyclobutrifluram
WO2022101265A1 (en) 2020-11-13 2022-05-19 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2022117373A1 (en) 2020-12-01 2022-06-09 Basf Se Mixtures containing metarylpicoxamid
WO2022128554A1 (en) 2020-12-15 2022-06-23 Basf Se Mixtures containing n-methoxy-n-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide
EP4018830A1 (en) 2020-12-23 2022-06-29 Basf Se Pesticidal mixtures
UY39612A (en) 2021-01-21 2022-08-31 Syngenta Crop Protection Ag HETEROCYCLIC DERIVATIVES ACTIVE AS PESTICIDES WITH SULFUR-CONTAINING SUBSTITUENTS
US20240108006A1 (en) 2021-01-23 2024-04-04 Syngenta Crop Protection Ag Pesticidally active heteroaromatic compounds
AU2022216425A1 (en) 2021-02-02 2023-08-17 Basf Se Synergistic action of dcd and alkoxypyrazoles as nitrification inhibitors
GB202102147D0 (en) 2021-02-16 2021-03-31 Syngenta Crop Protection Ag New use
WO2022175420A1 (en) 2021-02-19 2022-08-25 Syngenta Crop Protection Ag Insect and acarina pest control
WO2022175318A1 (en) 2021-02-19 2022-08-25 Syngenta Crop Protection Ag Insect and acarina pest control
WO2022180096A1 (en) 2021-02-26 2022-09-01 Syngenta Crop Protection Ag Pesticidal compositions
AR124935A1 (en) 2021-03-01 2023-05-24 Syngenta Crop Protection Ag PESTICIDE FORMULATIONS
WO2022200364A1 (en) 2021-03-25 2022-09-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
EP4313949A1 (en) 2021-03-27 2024-02-07 Syngenta Crop Protection AG Microbiocidal isonicotinic amide derivatives
EP4066643A1 (en) 2021-03-30 2022-10-05 Basf Se Pesticidal mixtures
EP4313966A1 (en) 2021-03-30 2024-02-07 Syngenta Crop Protection AG Pesticidally active cyclic amine compounds
UY39696A (en) 2021-03-31 2022-10-31 Syngenta Crop Protection Ag MICROBIOCIDA DERIVATIVES OF QUINOLIN/QUINOXALIN-BENZOTHIAZINE AS FUNGICIDAL AGENTS, IN PARTICULAR C
AR125342A1 (en) 2021-04-16 2023-07-05 Syngenta Crop Protection Ag CYCLIC AMINE COMPOUNDS ACTIVE AS PESTICIDES
BR112023021626A2 (en) 2021-04-20 2024-02-20 Syngenta Crop Protection Ag MICROBIOCIDE DERIVATIVES OF QUINOLINE/QUINOXALINE ISOQUINOLINE
UY39755A (en) 2021-05-05 2022-11-30 Pi Industries Ltd NEW CONDENSED HETEROCYCLIC COMPOUNDS TO COMBAT PHYTOPATHOGENIC FUNGI.
BR112023023856A2 (en) 2021-05-14 2024-01-30 Syngenta Crop Protection Ag CONTROL OF INSECT PESTS, MITE AND NEMATODES
BR112023023835A2 (en) 2021-05-14 2024-01-30 Syngenta Crop Protection Ag COMPOSITIONS FOR SEED TREATMENT
AR125955A1 (en) 2021-05-21 2023-08-30 Basf Se USE OF AN N-FUNCTIONALIZED ALCOXY PYRAZOLE COMPOUND AS A NITRIFICATION INHIBITOR
EP4341245A1 (en) 2021-05-21 2024-03-27 Basf Se Use of ethynylpyridine compounds as nitrification inhibitors
EP4094579A1 (en) 2021-05-28 2022-11-30 Basf Se Pesticidal mixtures comprising metyltetraprole
KR20240016327A (en) 2021-06-01 2024-02-06 신젠타 크롭 프로텍션 아게 Microbicidal tetrahydroisoquinoline derivatives
CA3221102A1 (en) 2021-06-02 2022-12-08 Michel Muehlebach Pesticidally active heterocyclic derivatives with sulfoximine containing substituents
EP4352050A1 (en) 2021-06-09 2024-04-17 Syngenta Crop Protection AG Pesticidally active diazine-amide compounds
CA3223077A1 (en) 2021-06-21 2022-12-29 Barbara Nave Metal-organic frameworks with pyrazole-based building blocks
IL308777A (en) 2021-06-24 2024-01-01 Syngenta Crop Protection Ag 2-[3-[1 [(quinazolin-4-yl)amino]ethyl]pyrazin-2-yl]thiazole-5-carbonitrile derivatives and similar compounds as pesticides
WO2022268815A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2022268813A1 (en) 2021-06-24 2022-12-29 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023280999A1 (en) 2021-07-07 2023-01-12 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
EP4376616A1 (en) 2021-07-27 2024-06-05 Syngenta Crop Protection AG Method for controlling diamide resistant pests & compounds therefor
AU2022318251A1 (en) 2021-07-29 2024-01-25 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2023012044A1 (en) 2021-08-02 2023-02-09 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
EP4380363A1 (en) 2021-08-05 2024-06-12 Syngenta Crop Protection AG Method for controlling diamide resistant pests & compounds therefor
CN117836301A (en) 2021-08-10 2024-04-05 先正达农作物保护股份公司 2, 2-difluoro-5H- [1,3] dioxolo [4,5-F ] isoindol-7-one derivatives as pesticides
AR126729A1 (en) 2021-08-10 2023-11-08 Syngenta Crop Protection Ag FUNGICIDE MIXTURE
KR20240041946A (en) 2021-08-19 2024-04-01 신젠타 크롭 프로텍션 아게 Method for controlling diamide-resistant pests and compounds therefor
CN117897378A (en) 2021-09-03 2024-04-16 巴斯夫农业种子解决方案美国有限责任公司 Plants with increased tolerance to herbicides
CN117998986A (en) 2021-09-23 2024-05-07 先正达农作物保护股份公司 Insect, acarina and nematode pest control
AU2022364034A1 (en) 2021-10-14 2024-04-04 Syngenta Crop Protection Ag Imidazo[1,2-a]pyridine derivatives
WO2023072945A1 (en) 2021-10-25 2023-05-04 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023072849A1 (en) 2021-10-27 2023-05-04 Syngenta Crop Protection Ag Pesticidally active pyridazinone compounds
AR127682A1 (en) 2021-11-19 2024-02-21 Syngenta Crop Protection Ag AUREOBASIDINE FUNGICIDE COMPOSITIONS
WO2023089049A2 (en) 2021-11-19 2023-05-25 Syngenta Crop Protection Ag Microbiocidal isonicotinic amide derivatives
WO2023094304A1 (en) 2021-11-25 2023-06-01 Syngenta Crop Protection Ag Microbiocidal heterobiaryl amide derivatives
WO2023094303A1 (en) 2021-11-25 2023-06-01 Syngenta Crop Protection Ag Microbiocidal heterobiaryl amide derivatives
AU2022402229A1 (en) 2021-12-02 2024-06-13 Syngenta Crop Protection Ag Fungicidal compositions
TW202332376A (en) 2021-12-02 2023-08-16 瑞士商先正達農作物保護公司 Method of preserving maize pollen viability under heat stress
WO2023104714A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Pesticidally active pyridazinone compounds
WO2023105065A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023105064A1 (en) 2021-12-10 2023-06-15 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023110710A1 (en) 2021-12-13 2023-06-22 Syngenta Crop Protection Ag Method for controlling diamide resistant pests & compounds therefor
EP4197333A1 (en) 2021-12-15 2023-06-21 Syngenta Crop Protection AG Method for controlling diamide resistant pests & compounds therefor
AR127922A1 (en) 2021-12-15 2024-03-13 Syngenta Crop Protection Ag BICYCLIC HETEROCYCLIC DERIVATIVES MICROBIOCIDES
EP4198023A1 (en) 2021-12-16 2023-06-21 Basf Se Pesticidally active thiosemicarbazone compounds
WO2023110871A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2023111215A1 (en) 2021-12-17 2023-06-22 Syngenta Crop Protection Ag Microbiocidal pyridine-substituted benzothiazine derivatives
AR127972A1 (en) 2021-12-17 2024-03-13 Pi Industries Ltd NOVEL FUSED SUBSTITUTED BICYCLIC CARBOXAMIDE PYRIDINE COMPOUNDS TO COMBAT PHYTOPATHOGENIC FUNGI
AR127992A1 (en) 2021-12-21 2024-03-13 Syngenta Crop Protection Ag AGROCHEMICAL COMPOSITION
WO2023118011A1 (en) 2021-12-22 2023-06-29 Syngenta Crop Protection Ag Microbiocidal aza-heterobiaryl derivatives
WO2023139166A1 (en) 2022-01-19 2023-07-27 Syngenta Crop Protection Ag Methods for controlling plant pathogens
WO2023144711A1 (en) 2022-01-27 2023-08-03 Pi Industries Ltd. 1,2,3-triazole carbonyl sulfonylamide compounds and use thereof
WO2023148206A1 (en) 2022-02-02 2023-08-10 Syngenta Crop Protection Ag Microbiocidal n-amide derivatives
WO2023148369A1 (en) 2022-02-07 2023-08-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023148368A1 (en) 2022-02-07 2023-08-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023152340A1 (en) 2022-02-10 2023-08-17 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023156402A1 (en) 2022-02-17 2023-08-24 Basf Se Pesticidally active thiosemicarbazone compounds
WO2023166067A1 (en) 2022-03-02 2023-09-07 Syngenta Crop Protection Ag Microbiocidal pyridazinone amide derivatives
WO2023187191A1 (en) 2022-04-01 2023-10-05 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2023203038A1 (en) 2022-04-19 2023-10-26 Syngenta Crop Protection Ag Insect, acarina and nematode pest control
WO2023203066A1 (en) 2022-04-21 2023-10-26 Basf Se Synergistic action as nitrification inhibitors of dcd oligomers with alkoxypyrazole and its oligomers
WO2023217989A1 (en) 2022-05-12 2023-11-16 Syngenta Crop Protection Ag Alkoxy heteroaryl- carboxamide or thioamide compounds
TW202408362A (en) 2022-06-21 2024-03-01 瑞士商先正達農作物保護公司 Microbiocidal bicyclic heterocyclic carboxamide derivatives
WO2023247360A1 (en) 2022-06-21 2023-12-28 Syngenta Crop Protection Ag Pesticidally active fused bicyclic heteroaromatic compounds
WO2024018016A1 (en) 2022-07-21 2024-01-25 Syngenta Crop Protection Ag Crystalline forms of 1,2,4-oxadiazole fungicides
WO2024022910A1 (en) 2022-07-26 2024-02-01 Syngenta Crop Protection Ag 1-[1-[2-(pyrimidin-4-yl)-1,2,4-triazol-3-yl]ethyl]-3-[2,4-dichloro-5-phenyl]urea derivatives and similar compounds as pesticides
WO2024028243A1 (en) 2022-08-02 2024-02-08 Basf Se Pyrazolo pesticidal compounds
WO2024033374A1 (en) 2022-08-11 2024-02-15 Syngenta Crop Protection Ag Novel arylcarboxamide or arylthioamide compounds
WO2024038054A1 (en) 2022-08-16 2024-02-22 Syngenta Crop Protection Ag Fungicidal compositions
WO2024056732A1 (en) 2022-09-16 2024-03-21 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2024068950A1 (en) 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2024068947A1 (en) 2022-09-30 2024-04-04 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2024089023A1 (en) 2022-10-25 2024-05-02 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2024089216A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Novel sulfur-containing heteroaryl carboxamide compounds
WO2024089191A1 (en) 2022-10-27 2024-05-02 Syngenta Crop Protection Ag Microbiocidal heterobicyclic dihydrooxadiazine derivatives
WO2024094575A1 (en) 2022-10-31 2024-05-10 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2024092330A1 (en) * 2022-11-04 2024-05-10 Empresa Brasileira De Pesquisa Agropecuária - Embrapa Truncated chimeric insecticidal proteins
WO2024100069A1 (en) 2022-11-08 2024-05-16 Syngenta Crop Protection Ag Microbiocidal pyridine derivatives
WO2024100115A1 (en) 2022-11-09 2024-05-16 Syngenta Crop Protection Ag Microbiocidal pyrazole derivatives
WO2024105104A1 (en) 2022-11-16 2024-05-23 Syngenta Crop Protection Ag Microbiocidal tetrahydroisoquinoline derivatives
WO2024110554A1 (en) 2022-11-23 2024-05-30 Syngenta Crop Protection Ag N-[(1 -[2-[6-(pyridazin-3-yl]-1,2,4-triazol-3-yl]ethyl]-quinazolin-4-amine and n-[1-[3-(6-(pyridazin-3-yl)pyrazin-2-yl]ethyl]-8-quinazolin-4-amine derivatives as pesticides
WO2024110215A1 (en) 2022-11-24 2024-05-30 Syngenta Crop Protection Ag Pesticidally active cyclic amine compounds
WO2024115509A1 (en) 2022-11-29 2024-06-06 Syngenta Crop Protection Ag Microbiocidal tetrahydroisoquinoline derivatives
WO2024115546A1 (en) 2022-11-30 2024-06-06 Syngenta Crop Protection Ag Fungicidal compositions
WO2024115512A1 (en) 2022-11-30 2024-06-06 Syngenta Crop Protection Ag Microbiocidal tetrahydroisoquinoline derivatives
WO2024121261A1 (en) 2022-12-09 2024-06-13 Syngenta Crop Protection Ag Insecticidal compound based on pyrazole derivatives
WO2024121262A1 (en) 2022-12-09 2024-06-13 Syngenta Crop Protection Ag Insecticidal compound based on pyrazole derivatives
WO2024121263A1 (en) 2022-12-09 2024-06-13 Syngenta Crop Protection Ag Insecticidal compound based on pyrazole derivatives
WO2024121264A1 (en) 2022-12-09 2024-06-13 Syngenta Crop Protection Ag Insecticidal compound based on pyrazole derivatives

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006730A1 (en) * 1993-09-02 1995-03-09 Sandoz Ltd. Hybrid toxin

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995006730A1 (en) * 1993-09-02 1995-03-09 Sandoz Ltd. Hybrid toxin

Also Published As

Publication number Publication date
WO2002015701A2 (en) 2002-02-28
ATE296539T1 (en) 2005-06-15
KR20030029858A (en) 2003-04-16
CN1449250A (en) 2003-10-15
WO2002015701A3 (en) 2003-03-06
BR0113500A (en) 2003-07-01
EP1311162A2 (en) 2003-05-21
JP2004506432A (en) 2004-03-04
AU8590001A (en) 2002-03-04
AR030576A1 (en) 2003-08-27
CA2419029A1 (en) 2002-02-28
DE60111236D1 (en) 2005-07-07
EP1311162B1 (en) 2005-06-01
CN100353846C (en) 2007-12-12
ES2243543T3 (en) 2005-12-01
AU2001285900B2 (en) 2005-02-17
DE60111236T2 (en) 2006-04-27

Similar Documents

Publication Publication Date Title
KR100581163B1 (en) A hybrid Bacillus thuringiensis toxin, a nucleic acid encoding the same and a method for controlling an insect with the same
US8759620B2 (en) Transgenic plants expressing modified CRY3A
CA2782546C (en) Combined use of cry1da and cry1fa proteins for insect resistance management
US5250515A (en) Method for improving the efficacy of insect toxins
RU2583288C2 (en) Application of cry1ab in combination with cry1be to control resistance of insects
AU2001285900A1 (en) Novel insecticidal toxins derived from Bacillus thuringiensis insecticidal crystal proteins
Sanchis et al. Construction of new insecticidal Bacillus thuringiensis recombinant strains by using the sporulation non-dependent expression system of cryIIIA and a site specific recombination vector
EA032560B1 (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
US6277823B1 (en) Insecticidal toxins and nucleic acid sequences coding therefor
UA124757C2 (en) Insecticidal polypeptides having broad spectrum activity and uses thereof
WO2001014562A1 (en) Hybrid insecticidal toxins and nucleic acid sequences coding therefor
US7919609B2 (en) Toxins
US6706860B2 (en) Toxins
KR100649909B1 (en) Novel insecticidal toxins from Xenorhabdus nematophilus, nucleic acid sequences coding therefor and a method of producing the same
EP0871737A1 (en) Method of protecting crop plants against insect pests
US20220010327A1 (en) Insecticidal proteins
AU2117800A (en) Biological control of nematodes
EP1287144B1 (en) Bacterial insecticidal proteins
US6204057B1 (en) Polynucleotides and the proteins encoded thereby, suitable for controlling lamellicorn beetles
US20030154510A1 (en) Novel delta-endotoxin gene isolated from Bacillus thuringiensis var. finitimus
Iqbal et al. Novel approach using digestive and neurotoxins to confer resistance against Helicoverpa armigera and Myzus persicae in tobacco.
RU2240003C2 (en) Isolated nucleic acid molecule, chimeric gene, recombinant vector, microorganism strain, toxin, insecticide composition, method for preparing toxin, method for preparing toxin-resistant plant and method for control of insects

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20090424

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee